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Background: Urinary incontinence (UI) following acute stroke is common, affecting between 40% and
60% of people in hospital, but is often poorly managed.
Aim: To develop, implement and evaluate the preliminary effectiveness and potential cost-effectiveness of
a systematic voiding programme (SVP), with or without supported implementation, for the management
of UI after stroke in secondary care.
Design: Structured in line with the Medical Research Council framework for the evaluation of complex
interventions, the programme comprised two phases: Phase I, evidence synthesis of combined approaches
to manage UI post stroke, case study of the introduction of the SVP in one stroke service; Phase II, cluster
randomised controlled exploratory trial incorporating a process evaluation and testing of health economic
data collection methods.
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
vii
Setting: One English stroke service (case study) and 12 stroke services in England and Wales
(randomised trial).
Participants: Case study, 43 patients; randomised trial, 413 patients admitted to hospital with stroke
and UI.
Interventions: A SVP comprising assessment, individualised conservative interventions and weekly review.
In the supported implementation trial arm, facilitation was used as an implementation strategy to support
and enable people to change their practice.
Main outcome measures: Participant incontinence (presence/absence) at 12 weeks post stroke.
Secondary outcomes were quality of life, frequency and severity of incontinence, urinary symptoms,
activities of daily living and death, at discharge, 6, 12 and 52 weeks post stroke.
Results: There was no suggestion of a beneficial effect on outcome at 12 weeks post stroke [intervention
vs. usual care: odds ratio (OR) 1.02, 95% confidence interval (CI) 0.54 to 1.93; supported implementation
vs. usual care: OR 1.06, 95% CI 0.54 to 2.09]. There was weak evidence of better outcomes on the
Incontinence Impact Questionnaire in supported implementation (OR 1.22, 95% CI 0.72 to 2.08) but
the CI is wide and includes both clinically relevant benefit and harm. Both intervention arms had a higher
estimated odds of continence for patients with urge incontinence than usual care (intervention: OR 1.58,
95% CI 0.83 to 2.99; supported implementation: OR 1.73, 95% CI 0.88 to 3.43). The process evaluation
showed that the SVP increased the visibility of continence management through greater evaluation of
patients’ trajectories and outcomes, and closer attention to workload. In-hospital resource use had to be
based on estimates provided by staff. The response rates for the postal questionnaires were 73% and
56% of eligible patients at 12 and 52 weeks respectively. Completion of individual data items varied
between 67% and 100%.
Conclusions: The trial was exploratory and did not set out to establish effectiveness; however, there are
indications the intervention may be effective in patients with urge and stress incontinence. A definitive trial
is now warranted.
Study registration: This study is registered as ISRCTN08609907.
Funding details: The National Institute for Health Research Programme Grants for Applied Research
programme. Excess treatment costs and research support costs were funded by participating NHS trusts
and health boards, Lancashire and Cumbria and East Anglia Comprehensive Local Research Networks and
the Welsh National Institute for Social Care and Health Research.
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Plain English summary
U rinary incontinence is common after stroke and can be very distressing for patients and their carers.We developed and tested a programme for assessing and treating incontinence while people are
in hospital, designed to help them become continent again. The programme included bladder training,
which encourages people to extend the time between voiding so that continence might be regained,
and prompted voiding, which aims to improve bladder control using verbal prompts and positive
reinforcement. Our study had two parts:
1. We developed the programme and tried it out in one stroke unit. We listened to what patients, families
and clinical staff told us and made changes to improve the programme.
2. We tested if it was possible to recruit and retain patients, how best to deliver the programme and
whether or not it was acceptable to patients and clinicians in a feasibility trial. In four of the units,
we used facilitation as a strategy to support and enable staff to change their practice. We compared
patients in these stroke units with those in four other units which did not introduce the programme.
We were able to recruit 413 patients and retain 85% and 88% at 6 and 12 weeks respectively. We found
that patients who took part in the programme were no more likely to be continent 6, 12 or 52 weeks
after the stroke than those who did not. However, we found that patients with urge incontinence were
potentially more likely not to have urge incontinence at 12 weeks if they had received the programme.
We believe our programme may help some stroke survivors (particularly those with urge incontinence) to
regain continence, so now we plan to test it further in a larger number of stroke services.
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Scientific summary
Background
Urinary incontinence (UI) following acute stroke is common, affecting between 40% and 60% of people
in hospital. National audit data suggest incontinence is often poorly managed. In Cochrane systematic
reviews, conservative interventions (e.g. bladder training and prompted voiding) have been shown to have
some effect; however, their effectiveness has not been demonstrated with stroke patients.
Programme aim
To develop, implement and evaluate the potential clinical effectiveness and cost-effectiveness of a
systematic voiding programme, with or without supported implementation, for the management of UI
after stroke in secondary care.
Design
A two phase programme.
Phase I (development):
l evidence synthesis of combined approaches to manage UI post stroke
l case study of the introduction of a systematic voiding programme (SVP) in one stroke service.
Phase II (feasibility):
l cluster randomised controlled exploratory trial, incorporating a process and health economic evaluation.
Two dedicated patient, public and carer groups, one comprising members with aphasia, collaborated on
the design and conduct of the programme.
Phase I: evidence synthesis
Objectives
l Determine whether or not combined behavioural interventions (CBIs) improve UI in
adults (effectiveness).
l Identify the barriers and enablers to successful implementation (acceptability).
l Describe and define the potential components/mechanisms of action of the intervention (predictors).
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Methods
Data sources were searched from inception to October 2008:
l Databases of published material, including Cochrane Central Register of Controlled Trials, MEDLINE,
EMBASE, Cumulative Index to Nursing and Allied Health Literature, PsycINFO and Allied and
Complementary Medicine Database.
l Databases of unpublished trials and theses, including metaRegister of Current Controlled Trials,
National Institutes of Health RePORTER (formerly CRISP), CentreWatch, National Institute for Health
Research, Index to Theses and Dissertation Abstracts International.
l Conference proceedings for the International Continence Society (ICS) (2006–8).
Study inclusion
Effectiveness review
Randomised and quasi-randomised controlled trials (RCTs) of CBIs in adults. CBIs were defined as
interventions that include more than one behavioural technique directly targeted at improving
the management of incontinence.
Acceptability and feasibility review
Studies collecting qualitative or quantitative data from service users or staff about their perceptions of
experiences of behavioural interventions.
Predictors of adherence or treatment outcome review
Observational studies or clinical trials that included multivariate analysis on the association between a
predictor variable and treatment adherence to a behavioural UI intervention of any kind, or treatment
outcome for a CBI.
Results
Effectiveness
Ten studies with 13 intervention–comparison pairs and 1163 participants. For the primary outcome of
number of people remaining incontinent at post treatment, results for comparisons with another treatment
were marginally non-significant [relative risk (RR) 0.87, 95% confidence interval (CI) 0.75 to 1.01]. Results
for non-treatment comparisons were significant, favouring the CBI (RR 0.81, 95% CI 0.70 to 0.94).
Acceptability and feasibility
Six studies involving 184 participants identified service users’ views. Barriers to continence promotion
included increased fear of being wet, attitude to exercises and fitting them into daily life. For elderly
people in residential care, influencing factors included a tolerance for UI symptoms and a preference for
interventions that facilitated independence from staff. Enablers to participation included having realistic
goals and expectations, and gaining a sense of mastery and control.
Six studies involving 427 participants identified staff views. Barriers to continence promotion included aims
of treatment, staff motivation, education and conflicting work priorities. Enablers to the promotion of
continence included staff education, adequate staffing and experience of success.
Predictors of adherence or treatment outcome
Seven studies with 882 participants identified independent predictors using multivariate analysis. The only
variable confirmed as a predictor of improvement in more than one study was treatment adherence.
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Phase I: case study
Objectives
l Identify the organisational context for embedding a SVP.
l Explore health professionals’ views around embedding the SVP into practice.
l Measure presence/absence of UI and frequency of UI.
Design
Mixed-methods single case study including diagnostic analysis of context using interviews with clinical
leaders analysed with soft systems methodology; a process evaluation using interviews with staff delivering
the intervention and analysed with normalisation process theory (NPT); and outcome evaluation using
data collected from patients receiving the SVP and analysed using descriptive statistics.
Setting
An 18-bedded acute stroke unit in a large trust serving a population of 370,000.
Participants
Health professionals and clinical leaders with a role in either delivering the SVP or linking with it in any capacity
were recruited. Patients were aged ≥ 18 years with a diagnosis of stroke and UI as defined by the ICS.
Intervention
A SVP comprising assessment (including a comprehensive continence assessment), individualised conservative
interventions tailored to the physical and cognitive capabilities of each patient and weekly review.
Results
Organisational context
Eighteen health professionals took part in four group interviews. Findings suggest an environment not
conducive to therapeutic continence management and a focus on containment.
Embedding the systematic voiding programme into practice
Twenty-one unit staff took part in six group interviews. After initial confusion there was an embedding of
processes facilitated by new routines and procedures.
Outcome evaluation
Forty-three patients were recruited, 28 commencing the SVP. Of these, six out of 28 (21%) were continent
at 6 weeks post-stroke or discharge.
Conclusion
It was possible to embed the SVP into practice despite an organisational context not conducive to
therapeutic continence care.
Phase II: exploratory cluster randomised controlled trial with
integrated process and health economic evaluation
Objectives
l Assess feasibility in terms of rates of participant recruitment and retention.
l Assess fidelity to the intervention.
l Conduct a qualitative assessment of feasibility from the perspective of multiple stakeholders.
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l Conduct a preliminary evaluation of supported implementation (using facilitation as an implementation
strategy to support and enable people to change their practice) compared with implementation alone.
l Investigate patient-related factors affecting patient outcome.
l Investigate stroke service-level factors potentially affecting stroke service outcomes to estimate the
amount of unexplained variability in outcomes between trusts and between patients.
l Confirm the choice of primary and secondary outcome measures for a full-scale cluster randomised trial
to evaluate effectiveness.
l Develop and test data collection tools for an economic evaluation within a full-scale cluster
randomised trial.
Design
A three-arm, parallel, open, exploratory, pragmatic, cluster RCT of a SVP, with or without supported
implementation, for the management of UI after stroke in secondary care.
Setting
Twelve NHS stroke services in England and Wales.
Participants
Four hundred and thirteen patients with UI were recruited between 1 January 2011 and 31 July 2012;
124 usual care, 164 intervention and 125 supported implementation.
Baseline data were collected for all patients. The overall response rate at 6 weeks was 85% (306/362),
excluding patients recruited at 6 weeks and those who had died. At 12 weeks, the overall response rate
was 88% (330/374), excluding one patient recruited at 12 weeks and those who had died. At 52 weeks,
data were collected for 176 out of 315 (56%) participants excluding those who had died.
Intervention
Systematic voiding programme.
Main outcome measures
Primary outcome was presence/absence of incontinence measured by the International Consultation on
Incontinence Modular Questionnaire (ICIQ). Secondary outcomes were quality of life (QoL), frequency and
severity of incontinence, urinary symptoms and activities of daily living.
Results
There was no suggestion of a beneficial effect of the intervention on outcome at 6 weeks post stroke.
Findings were similar at 12 weeks post stroke [intervention vs. usual care: odds ratio (OR) 1.02,
95% CI 0.54 to 1.93; supported implementation vs. usual care: OR 1.06, 95% CI 0.54 to 2.09].
There was no evidence of better outcomes on the ICIQ or Incontinence Severity Index at 6 weeks post stroke.
At 12 weeks, there was weak evidence of better outcomes on the ICIQ in supported implementation
(OR 1.22, 95% CI 0.72 to 2.08), but the CI is wide and includes both clinically relevant benefit and harm. Both
intervention arms had higher estimated odds of continence for patients with urge incontinence than usual care
(intervention: OR 1.58, 95% CI 0.83 to 2.99; supported implementation: OR 1.73, 95% CI 0.88 to 3.43). There
was a similar increase in the estimated odds of continence for patients with stress incontinence in supported
implementation (OR 1.82, 95% CI 0.82 to 4.01), but this was not as marked in intervention (OR 1.04, 95% CI
0.45 to 1.82). Findings are suggestive of a potential reduction in the odds of specific types of incontinence.
Per-protocol analysis suggested that those who received the intervention according to protocol had better
outcomes than usual care, although this did not appear to hold for supported implementation (OR relative to
usual care intervention: 1.52, 95% CI 0.67 to 3.41; supported implementation 1.02, 95% CI 0.38 to 2.76).
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Process evaluation
Methods
An integrated multiple component evaluation, underpinned by a logic model, was conducted in order to
describe implementation and assist in explaining why the intervention and its components were or were
not successful.
Delivery of the intervention to individuals: assessed through an analysis of adherence to the protocol in
terms of management of catheterisation and intervention documentation.
Response of individuals: assessed through semistructured interviews with patients at discharge.
Response of clusters, recruitment and reach in individuals, delivery to and response of individuals and
maintenance of processes over time: assessed using NPT. Qualitative, semistructured interviews with health
professionals involved in the intervention to explore experiences of implementation.
Context in which the trial was conducted: assessed using soft systems methodology.
Results
Delivering the intervention
Some aspects of catheterisation appeared closer to protocol recommendations in supported implementation
in terms of catheter removal [median 13 days, interquartile range (IQR) 5–35 days vs. median 20 days,
IQR 8.75–35.25] and patients still catheterised at discharge (19, 15.2% vs. 35, 21.3%).
Documentation of the regime interval and the schedule of proposed voiding times in the clinical logs was
done on less than half of occasions (38.9% in intervention; 31.9% in supported implementation).
Response of individuals
Twelve interviews with participants from six sites, eight from intervention and four from
supported implementation.
Findings categorised according to the logic model are:
l Thinking: educational element of the intervention helped participants understand that post-stroke UI
was a common and treatable problem.
l Planning: knowledge of ward systems was important, for example in timing toileting requests to allow
for delays at ‘busy’ times.
l Doing: perseverance and adaptation of the programme were identified as important.
l Evaluating: setting and achieving realistic outcomes was important.
Response of clusters
Thirty-two interviews, conducted with 38 staff from intervention sites. Findings describing embedding are:
l Thinking: taking part in Identifying Continence OptioNs after Stroke and introducing the SVP led to
changed perceptions of continence as a legitimate focus for rehabilitative practice.
l Planning: the logical structure provided by the SVP enabled a route to improved planning of care.
l Doing: the SVP helped staff make the shift to practice ‘routinised’ around 2-hourly toileting.
Individualising voiding intervals were difficult to achieve.
l Evaluating: the SVP increased the visibility of continence management through greater evaluation of
patients’ trajectories and outcomes and closer attention to workload.
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Context
Fifty interviews, conducted with 59 staff from all 12 sites. Findings describing pre-intervention context are:
l Thinking: nursing was ascribed with expertise in continence, but in reality no evidence was being used
and practice revolved around containment.
l Planning: the default position regarding services was a lack of clinical leadership and a mismatch
between skills, knowledge and practice.
l Doing: there were strong contextual barriers to individualised continence management, including
insurmountable routine systems.
l Evaluating: services within the trial demonstrated little, if any, attention to systematic evaluation of
clinical practice or patient outcomes around UI.
Health economic evaluation
Objective
The development and evaluation of data collection methods to inform an economic evaluation within a
full-scale cluster randomised trial. This included description of the costs associated with the SVP and
a preliminary exploration of potential cost-effectiveness.
Methods
Data were recorded on the cost of the training, the programme and post-hospital resources. Resource use
and trial data were combined to assess evidence of potential cost-effectiveness.
Results
The cost of the SVP had to be calculated using staff estimates. These were provided by 8 out of 12 (66.7%)
of the sites, which translated into an average per patient cost for the SVP of £1482 (intervention) and
£1830 (supported implementation). The total cost of training was £12,185 per trial arm with an additional
cost of £9642 for supporting implementation. The postal questionnaire response rate for eligible patients
was approximately 73% and 56% at 12 and 52 weeks, respectively; response rates were similar across
groups. When questionnaires were returned, the response rates across items varied but there was little
difference between groups regarding the number of items completed. The programme draws on resources
in the short term but we did not measure the opportunity cost (fewer patients being incontinent and its
associated reduction in input). The mean 52-week costs in the trial arms were £9563 (usual care), £12,423
(intervention) and £10,913 (supported implementation). All trial arms showed a reduction in quality-adjusted
life-years from baseline: –0.45 (usual care), –0.36 (intervention) and –0.41 (supported implementation).
It is unclear if this loss of quality-adjusted life-years is due to the SVP not working, the European Quality of
Life-5 Dimensions (on which the quality-adjusted life-year was based) failing to pick up a meaningful
difference, or a combination of factors.
Conclusions
The exploratory trial has demonstrated it is feasible to conduct a full cluster RCT.
Recommendations for research
The future trial will adopt this design with the following modifications.
Trial arms
l Include two trial arms only, intervention and usual care.
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Recruitment
l Obtain consent as soon as possible after admission, regardless of whether or not participants are
medically stable.
Data collection
l Use 12 weeks post consent as the main outcome point.
l Include reduction in incontinence episodes as a secondary outcome.
l Consider approaches to increasing response rate at long-term follow-up.
l Introduce more rigorous procedures for monitoring catheterisation (including ‘trial without catheter’).
Health economic component:
l Record in-hospital episodes of incontinence and the resources required to respond to such episodes.
l Identify resources required to perform the programme through direct observation.
l Consider obtaining post-hospital resource use data by asking patients to maintain diaries or going
directly to providers of services.
l Identify resource use items more directly related to the effects of incontinence.
l Include a range of QoL measures.
Study registration
This study is registered as ISRCTN08609907.
Funding
The National Institute for Health Research Programme Grants for Applied Research programme. Excess
treatment costs and research support costs were funded by participating NHS trusts and health boards,
Lancashire and Cumbria and East Anglia Comprehensive Local Research Networks and the Welsh National
Institute for Social Care and Health Research.
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Chapter 1 Introduction
Background
Urinary incontinence (UI) following stroke is common, with prevalence estimates suggesting around half
of stroke survivors are affected in the acute phase. Findings are similar across countries (e.g. UK 48%,1
Denmark 47%,2 Germany 53%3). As many as 43.5% and 38% stroke survivors remain incontinent at
3 months and 1 year respectively.4 In longer-term stroke survivors (on average 9 years post stroke),
prevalence has been reported as 17%.5
Problems with continence have been shown to be amenable to early intervention, particularly in the
3 months following stroke.6 Stroke outcome may be better in those stroke survivors who remain
continent or regain continence.7 Although there are problems with attributing better stroke outcome
to improvements in continence, it is possible early intervention aimed at promoting recovery from
incontinence may improve morale and self-esteem and therefore speed overall stroke recovery.7,8 It is
also possible that the recovery of continence reduces barriers to participation in rehabilitation activity.
Despite the availability of clinical guidelines for the management of UI in women9 and after stroke,10
national audit data11 suggest incontinence is often poorly managed. In the latest Sentinel audit,11 63% of
patients had a plan for continence management, an increase of only 5% since 2004. Improvements in
continence have not kept pace with those in other aspects of stroke care, for example establishing a safe
swallow, where the proportion assessed has increased from 63% to 83% over the same period. Although
continence is already recognised as a component of organised stroke care, it is known that nurses find
managing continence in the context of stroke challenging,12 with over-reliance on urinary catheterisation
as a management strategy especially in the acute phase of illness.13 There are medical therapies which
can be appropriately used to assist continence but these need to be based on appropriate first-line
assessment and behavioural management in line with national guidelines.10
The more severe the stroke, the greater the likelihood of UI;14,15 other factors linked to UI include older age
or cognitive impairment.16 Problems experienced include urinary retention or complete incontinence. The
most likely pattern of incontinence is urinary frequency, urgency (a sudden compelling desire to pass urine
which is difficult to defer) and urge incontinence (involuntary leakage immediately following, or concurrent
with, an urgent sensation of needing to void).6 Urge incontinence is the most common type after stroke,17
but the cerebral lesion may also lead to practical difficulties with bladder control caused by, for example,
motor impairment, depression and aphasia18 (termed functional incontinence).
The symptoms of UI are reported to be more severe and have more of an effect on the lives of stroke
survivors, when compared with other groups of people.19 Incontinence is not just a physical problem, but
impacts on what people can do, for example participate in rehabilitation activities, and how they feel.
Depression is twice as common in stroke survivors who are incontinent20 and there may be a link
between depression associated with urinary symptoms and suicide.21 Continuing incontinence is
associated with poor outcome in both stroke survivor and carer.2 Furthermore, the negative social
consequences of dealing with incontinence for both survivor and carer cannot be ignored, as both may
become isolated and marginalised.22 If post-stroke incontinence is targeted early, not only is there the
potential to reduce the poor outcome of stroke associated with incontinence, but also the negative social
consequences associated with it post-hospital discharge.
Evidence to guide the management of UI after stroke is poor; our systematic review23 found no rigorously
conducted studies evaluating interventions in secondary care. No published trials of behavioural
interventions for UI after stroke were found other than a single trial of pelvic floor muscle training (PFMT).24
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Available conservative interventions for UI include bladder training (BT),25 timed voiding (TV),26 prompted
voiding (PV),27 habit retraining (HT)28 and PFMT.29 BT is generally used for urge incontinence and aims
to increase the time interval between voids so continence is regained. It involves patient education,
scheduled voiding and positive reinforcement, but can also include self-monitoring and urge suppression
techniques. PV and TV have mainly been used with people who have cognitive deficits. They are based on
a system of scheduled voids, with PV including reminders and reinforcement for self-initiation of toileting.
To date, trials of PV have mainly taken place in US nursing homes; however, there was no a priori reason
why this approach should not be introduced into the care of stroke patients in secondary care in the UK.
The effectiveness of conservative interventions has been systematically reviewed in adults. The review of
TV26 included only two trials of poor methodological quality and concluded there was no empirical
evidence for or against the intervention. Similarly, the review of HT28 found insufficient evidence of an
effect on continence outcomes to recommend this approach. In the review of BT,25 trials tended to
favour BT and there was no evidence of adverse effects. The review of PV27 found evidence of increased
self-initiated voiding and decreased incontinent episodes in the short term.
Pelvic floor muscle training may also be effective in assisting the individual to manage urge, stress or mixed
incontinence29 and has been shown to be effective as a combined intervention with BT.30,31
As urge strategies have been shown to be effective in stress incontinence32 and stress strategies in urge
incontinence,33 a number of trials have tested combined behavioural interventions (CBIs) for both stress
and urge incontinence, on the premise that combining techniques may be more effective than single
techniques. Existing reviews have considered mixed types of interventions (e.g. physical+ behavioural) for
UI.34–36 There are also two reviews that have included pooled results for CBIs,37,38 but these reviews are
specific to women and include studies relating to the prevention of incontinence, i.e. including continent
people. There is no current review of CBIs for UI.
Despite a growing evidence base, existing evidence for continence management has not been widely
implemented in clinical practice, even by stroke specialist teams working on recognised stroke units.12
This lack of implementation in stroke clinical practice is in keeping with a recent and growing recognition
that the implementation of research in practice is influenced not only by individual clinicians, but also
by the organisational context in which they operate.39–44 Organisational context has been defined as
‘the environment or setting in which the proposed change is to be implemented’.45 At its simplest level,
context may refer to the physical environment where health care takes place. However, Rycroft-Malone
et al.45 concluded from their concept analysis that contexts conducive to research implementation included
a range of less tangible process elements: ‘clearly defined boundaries; clarity about decision-making
processes; clarity about patterns of power and authority; resources; information and feedback systems;
active management of competing “force fields”. . . and systems in place that enable dynamic processes of
change and continuous development’.45
Theories underpinning organisational influence include those of learning organisations (with characteristics
encompassing hierarchical structure, information systems, human resource practices, organisational
culture and leadership46) and knowledge management (how organisational mechanisms affect knowledge
uptake and use47–49). Successful implementation of an intervention to improve the management
of post-stroke UI is likely to be mediated not only by individual members of staff and availability of
evidence-based guidance, but also by the complexity of the intervention as well as the interplay of patient,
social and organisational factors.49,50 Careful attention needs to be paid to the specific barriers to change
in any given setting, identified through ‘diagnostic analysis’ at levels that may include the individual,
groups or teams, organisations and the wider health-care system.51 Strategies then need to be ‘tailored’
to overcome barriers identified.52
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The intervention in our programme focused on conservative strategies shown to have some effect with
participants in studies included in Cochrane systematic reviews,25,27,29,53,54 but which had not had their
effectiveness demonstrated with stroke patients. These strategies included a combined package of BT and
(where possible) PFMT and PV.
We also evaluated whether or not supported implementation, through targeted organisational development
aimed at ‘normalising’ the intervention,55–58 showed more preliminary evidence of effectiveness than
introduction of the intervention alone, as well as evaluating both in comparison to usual care.
Programme aims
The programme aimed to develop, implement and evaluate the preliminary clinical effectiveness and
cost-effectiveness of a systematic voiding programme (SVP), with or without supported implementation,
for the management of UI after stroke in secondary care. The programme was structured in line with the
Medical Research Council (MRC) framework for the evaluation of complex interventions59,60 and comprised
two phases:
Phase I (MRC development phase):
l evidence synthesis of quantitative and qualitative literature on combined approaches to manage UI
post stroke
l case study of the introduction of the SVP in one stroke service.
Phase II (MRC feasibility and piloting phase):
l cluster randomised controlled exploratory trial, incorporating a process and health economic evaluation.
Structure of the monograph
Chapter 2 summarises the aims, methods and findings of the evidence synthesis. Development of
the interventions (SVP and supported implementation) is described in Chapter 3. The case study of the
introduction of the SVP in one stroke service is reported in Chapter 4. Phase II comprised the exploratory
cluster randomised controlled trial (RCT) and is reported in Chapters 5 and 7 (methods and findings,
respectively); evaluation of process in Chapters 6 and 8 (methods and findings, respectively) and health
economic evaluation in Chapter 9. Finally, we report the methods and evaluation of patient, public and
carer (PPC) involvement (see Chapter 10). Chapter 11 discusses implications of the programme for the
Phase III trial.
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Chapter 2 Combined behavioural interventions
for urinary incontinence: systematic review of
effectiveness, acceptability, feasibility and predictors
of treatment outcome
Introduction
Overview
Our systematic review of interventions to promote urinary continence after stroke showed a lack of
evidence to inform practice.23 Current guidelines recommend behavioural strategies targeted to the type
of incontinence as a first-line therapy in UI for both men and women, and also suggest that combining
behavioural interventions may be useful.9 This chapter presents the evidence for combined interventions
from three linked reviews: a descriptive review of intervention content, an effectiveness review including
meta-analysis of randomised and quasi-RCTs specific to voiding function and a narrative review of barriers
and enablers to successful behavioural interventions.
Description of the intervention
Behavioural interventions aim to improve bladder control by altering the behaviour of the recipient.
This may include changing attitudes, knowledge or skills in order to encourage or enable the
implementation of alternative strategies to manage voiding activity (e.g. using distraction, muscle
clamping). Behavioural components specifically targeting voiding activity can include PFMT, bladder
inhibition training, PV, urge suppression techniques (urge strategies), urethral occlusion techniques
(stress strategies), urethral emptying techniques, or lifestyle management such as altering dietary or fluid
intake. Additional behavioural components may be directed at enhancing adherence to therapy by
increasing sensory or cognitive awareness [e.g. biofeedback (BIO), or by motivational techniques such as
coaching]. A meta-study of systematic reviews of behavioural interventions has called for clarity in the
theory underpinning the use of behavioural interventions for UI.53,54
Systematic reviews of the effectiveness of single behavioural interventions already exist for BT;25 TV;26 PV;27
HT28 and PFMT.29 As urge strategies have been shown to be effective in stress urinary incontinence (SUI)32
and stress strategies in urge urinary incontinence (UUI),33 a number of trials have tested CBIs for both
SUI and UUI, on the premise that combining techniques may be more effective than single techniques.
Existing reviews have considered mixed types of interventions (e.g. physical+ behavioural) for UI.34–36
There are also two reviews that have included pooled results for CBIs,37,38 but these reviews are specific to
women and include studies relating to the prevention of incontinence, i.e. including continent people.
There is therefore no current review of CBIs for UI.
Our review found no published trials of behavioural interventions for UI after stroke other than a single
trial of PFMT,24 so a systematic review limited to stroke is not an option. In addition, the conditions and
contexts for successful implementation of behavioural interventions for UI have not been reviewed.
This review therefore aimed to evaluate the effectiveness of CBIs in the general population together with
the evidence for factors influencing adherence and outcome, to inform the design of an intervention
specific to post-stroke UI.
An effective intervention could be more easily replicated if it were explicitly described. The focus of
this review is a complex intervention, combining multiple behavioural intervention components
targeting UI with additional cognitive and/or behavioural components to improve uptake or adherence.
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Maximising the potential for the success of the intervention will depend on clear specification of, and
fidelity to, distinctive techniques. A secondary purpose of this review is therefore to construct a standard
intervention, by clear description and categorisation of intervention content from existing research.
To maximise the potential for success, staff implementing the intervention will need to tailor it to the
characteristics of their client group and setting. The third purpose of the review is to identify moderators
of successful outcome of behavioural interventions for UI.
Objectives
To identify best practice in the delivery of an optimal behavioural intervention for UI, the objectives of the
review were to:
1. Determine whether or not combined/complex behavioural interventions improve urinary continence in
adults, compared with usual care or another/single intervention.
A secondary objective was to determine the effect of CBIs on:
– subjective or objective improvement in severity or symptoms
– quality of life (QoL)
– treatment satisfaction
– adverse effects; and
– socioeconomic outcomes (e.g. cost).
2. Describe and define the potential components/mechanisms of action of the intervention.
3. Identify the barriers to and enablers of the successful implementation of a behavioural intervention for
UI in adults.
Scope of the review
First, a descriptive review delineates intervention content using a standardised model. The effectiveness
review includes a meta-analysis of randomised and quasi-RCTs of CBIs that are specific to urinary voiding
function. The narrative review considers three separate types of information relating to barriers and
enablers of successful behavioural interventions for UI:
(a) studies reporting client or staff views of barriers and enablers
(b) data relating to rates of uptake and adherence; and
(c) studies identifying independent predictors of adherence or outcome.
Structure of the review
The following section outlines the review methods. The results of the review are presented in four sections:
l Description of the included studies and the content of the behavioural interventions
l Findings: studies of effectiveness
l Findings: narrative review of acceptability and feasibility, comprising three subsections:
¢ Client views
¢ Staff views
¢ Studies of feasibility.
l Findings: predictors of adherence and treatment outcome.
The report’s conclusions will draw together the findings from the different sources of information and
evaluate the implications for the design of an intervention for post-stroke UI.
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Review methods
Search strategy for the identification of studies
A composite search was used to underpin all of the review components, drawing on the search
developed by the Cochrane Incontinence Review Group for terms related to UI. Specific terms related
to behavioural interventions or terms for relevant research aims/designs (e.g. behaviour therapy,
predictor, behavioural research, etc.) were collated from the Cochrane Effective Professional and
Organisational Care Review Group search strategy, and from previous Cochrane reviews on behaviour
change. The searches above were combined, and then limited for exclusions related to age (child),
condition (pregnancy, prostatectomy) and language (non-English). The search was designed for MEDLINE
(see Appendix 1) and then adapted for other databases.
The following sources were searched:
l Databases of published material, including Cochrane Central Register of Controlled Trials (latest issue),
MEDLINE (1966 to October 2008), EMBASE (1980 to October 2008), Cumulative Index to Nursing
and Allied Health Literature (1982 to October 2008), PsycINFO (1966 to October 2008), Allied and
Complementary Medicine Database (1985 to October 2008).
l Databases of unpublished trials and theses, including metaRegister of Controlled Trials, CRISP,
CentreWatch, National Institutes for Health Research (including back searches on National Research
Register/Research Findings Register), Index to Theses and Dissertation Abstracts International.
l Conference proceedings of the International Continence Society (ICS) (2006–8).
l Forward and lateral citation searching, via ISI Web of Knowledge for all included studies, and on
references for included studies from existing systematic reviews of behavioural interventions for UI
(traced via Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of
Effectiveness, and International Health Technology Assessment).
Searches on smaller databases used the free-text terms ‘incontinence’ or ‘urinary incontinence’ depending
on suitability.
After removal of duplicate records and records obviously not relevant to the review by one reviewer (BF),
two reviewers (BF, LT) independently screened the remaining records on title and abstract (see Appendix 2
for screening criteria). Full-text papers were obtained for screened records identified by either reviewer.
Two reviewers (BF, LT) also independently filtered all full-text papers for inclusion, using the filtration
pro-forma (see Appendix 3).
Data extraction templates for different types of study were designed with suitable outcome formats and
criteria for critical appraisal (see Appendix 4), together with coding frames and guidance (see Appendix 5).
After training and inter-rater reliability checks for coding and quality assessment, critical appraisal and data
extraction were undertaken independently by two reviewers (BF, LT).
Inter-rater reliability for such complex data extraction was difficult to maintain at a consistently high level.
In particular, despite a detailed coding frame, difficulties were experienced with reliabilities in the
classification of the behavioural strategies used in interventions and the predictor variables tested in
multivariate analyses, mainly because of inadequate detail in the original studies. Therefore all differences
in data extraction and classification between the two reviewers were discussed and agreed throughout
the process of data extraction, with one of two additional reviewers (ML/CS) checking outcome data
extraction and predictor classification.
We contacted triallists to obtain data collected but not reported, or where data were reported in a form
that could not be used. Only further details of study design were obtained, with no additional outcome
data gained via this route.
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Narrative review search additions
The search undertaken for the full review was also used to identify studies for the narrative review.
The identification of studies relating to predictors was not found to be reliable during filtering because
it did not include studies testing predictors of adherence for single behavioural interventions, or trials
including subgroup analysis. Therefore, all trials included in existing systematic reviews of single
behavioural interventions identified by the original search were checked. The review of predictor variables
by Goode61 was also used to trace further studies, with forward and lateral citation searching for all
included studies.
Criteria for considering studies for inclusion
Criteria for included study types (i.e. trials, observational/qualitative studies) were different for each
component of the review, but other aspects could also be slightly different. For example, the effectiveness
review was limited to a tight definition of CBIs to ensure homogeneity of included studies, whereas
the narrative review of barriers and enablers included any study collating people’s views of any behavioural
intervention for UI. The definitions used for the effectiveness review will be given first, followed by any
differences in inclusion criteria for other review components.
Review of effectiveness
Participants
Adults aged ≥ 18 years, diagnosed either by symptom classification or urodynamic study as having any
type of UI, excluding people with short-term incontinence for physiological reasons (e.g. within 1 year of
urological surgery or childbirth). UI was defined in its widest sense to include people with signs, symptoms
or urodynamic evaluation of overactive bladder or urine leakage, as defined by the study authors. People
with or without cognitive impairment were included, on condition that the person had an active role in the
behavioural intervention (e.g. behaviour modification).
Interventions
Inclusions Interventions with more than one behavioural technique directly targeted at improving the
management of different types of incontinence were included (e.g. PFMT+ BT, PFMT+ urge strategies,
BT+ stress strategies).
Pelvic floor muscle training was included as a behavioural intervention, because it could be argued that
it targets behaviour change to develop muscle training as an established habit. Although the mechanism
of action of PFMT on UI is possibly physical, this is unlikely to be effective without sustained practice over a
period of time. Encouraging and sustaining behavioural practice is therefore a focus of the intervention in
many PFMT trials, as much as ensuring correct physical technique.
Prompted voiding was included because the behavioural component is primarily targeted to influencing
the behaviour of the person with UI.
Trials using BIO could be included if BIO was used as an intermittent assessment or aid to teaching the
correct use of pelvic muscles.
Exclusions Trials using BIO as a continuous component of the intervention were excluded, as this could
be categorised as a physiological treatment rather than a behavioural intervention. Trials using physical
mechanisms to augment or enhance muscle training, such as the use of vaginal cones or electrical
stimulation, were excluded for the same reason.
Habit retraining or TV were excluded as behavioural techniques because the behavioural component
targets the behaviour of staff or carers as much as the person with UI.
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Interventions where an additional behavioural mechanism was targeted towards improving adherence to a
single behavioural intervention for UI (e.g. reminders for PFMT) were excluded, as their primary outcome
for comparison was adherence, with secondary impact on incontinence. Interventions composed of mixed
behavioural interventions (e.g. BT+ exercise, PFMT+ lifestyle adaptations) were also excluded, because
they include components not designed to target different types of incontinence.
Comparisons The specific comparisons to be made in the effectiveness review included:
l multicomponent behavioural intervention compared with no treatment, attention control or usual care
l multicomponent behavioural intervention compared with another intervention.
If enough comparisons were available, the second group would be split into:
l CBI compared with single behavioural intervention
l CBI compared with another treatment (e.g. drug therapy).
Types of study Randomised or quasi-RCTs where one arm includes a CBI, compared with no treatment
control, or another treatment/single behavioural intervention.
Outcomes The primary outcome for the meta-analysis of the impact of CBIs on UI was the number
of people who reported continuing UI. This was defined by subjective measures (e.g. the number of
incontinent episodes as measured in a urinary diary, mean per week) or objective measures (e.g. pad test
of quantified leakage).
Secondary outcomes included:
l patient/carer perceptions of improvement
l objective measures of severity (e.g. grams of urine lost per 24 hours on pad test)
l patient/carer perceptions of severity of incontinence
l urinary symptoms
l QoL or symptom distress
l satisfaction with treatment
l adverse effects; and
l costs for the client or service.
Short-term (up to 12 months post treatment) follow-up measures were collated for primary and secondary
outcomes. If data from multiple follow-up time points were available from a single study, the time point
nearest to 6 months post treatment was used because this was judged to be a reasonable length of time
to assess whether or not behavioural change has been embedded.
Review of acceptability and feasibility
Acceptability
Study designs included were qualitative or quantitative, where data were collected from service users or
from staff about their perceptions or experiences of behavioural interventions, including information on
factors influencing:
l choice or uptake of behavioural interventions for UI
l adherence to/maintenance of a behavioural programme
l withdrawal/dropout from a behavioural programme.
Studies exploring client experience of self-management strategies for UI in general were excluded if
behavioural interventions (i.e. BT, PFMT, PV) were not referred to specifically.
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
9
Feasibility and implementation data
We had planned to review information about implementation of behavioural interventions from studies
reporting the process of development or implementation of a behavioural intervention for UI. These
studies were screened and filtered, but owing to the high number of studies found (n= 33), detailed
information on implementation was not extracted and processed. However, data on rates of uptake,
treatment adherence and withdrawal were extracted from any study implementing a behavioural
intervention for UI.
Review of predictors of treatment adherence or outcome
Studies of predictors of adherence or treatment outcome of CBIs, or studies of predictors of adherence to
single behavioural interventions were included. Predictors of adherence for single interventions were
included because they were thought to be generalisable to behavioural adherence to combined
interventions. Predictors of treatment outcome of single interventions were not included because they
were not judged to be reliably predictive of treatment outcome for combined interventions, due to the
potential for differences in physiological mechanisms of action.
Study designs included were:
l prospective longitudinal cohort studies or clinical trials
l RCTs that include subgroup analysis of factor(s) influencing adherence/outcome
l retrospective cohort or cross-sectional studies.
To be included, studies had to include a description of the method of data analysis, and provide data on
the relationship between the predictor and outcome based on individual study participants (other than the
baseline value of that variable). For full data extraction of results for predictor variables, studies had to
identify independent predictors using multivariate analysis. Studies using univariate analysis were only
partially data extracted, for the identification and listing of potential predictor variables.
The dependent variables included were any of the following:
l intention to adhere/short- or long-term adherence
l treatment failure/non-response
l cure
l improvement
l psychological status/QoL.
Any time points for outcome measurement were considered.
Methods of the review
Review of effectiveness
Data relevant to the pre-stated outcome measures, characteristics of the study, interventions and
participants were extracted. The elements of the voiding intervention were categorised based on a
previous meta-study.53,54 The categorisation of the client behaviour change intervention was based on
a taxonomy of behaviour change techniques.62
Assessment of methodological quality was undertaken using the Cochrane Collaboration Risk of Bias Tables to
include assessment of adequate sequence generation; allocation concealment; blinding of outcome assessors;
incomplete data addressed; freedom from selective reporting; and freedom from other bias (see Appendix 4).
Where appropriate, data were quantitatively combined using meta-analysis to determine the typical
effect of the intervention. Intention-to-treat analysis was used, where participants are analysed
in the group to which they are randomised. Trial data were processed as described in the Cochrane
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Collaboration Handbook63 using the Cochrane Collaboration statistical package RevMan 4.2.8
(The Cochrane Collaboration, The Nordic Cochrane Centre, Copenhagen, Denmark).
For individual clinical indicators, a fixed-effects model was used to calculate pooled estimates of treatment
effects with 95% confidence intervals (CIs) using:
l relative risk (RR) for binary data
l weighted mean difference (WMD) for continuous data using similar measurement
l standardised mean difference (SMD) for continuous data from different measurement sources
l standardised effect (SE) when generic inverse variance (GIV) was used to pool binary and
continuous outcomes.
For trials with missing data, primary analysis was based on observed data, without imputation. Assessment
of heterogeneity of intervention effects was made using the I2 statistic. If substantial heterogeneity of
treatment effects was evident (I2≥ 50%), a random-effects model was used.
A priori subgroup analyses were planned as follows.
Client group factors:
l type of incontinence – SUI only, UUI only, mixed urinary incontinence (MUI)
l sex – female only, male only, mixed
l age – mean age < 65 years, ≥ 65 years
l cognitive status – people with cognitive incapacity excluded/not excluded.
Intervention factors:
l intervention content – BT primary, PFMT primary, PV primary
l intervention level – basic (i.e. the delivery of multiple strategies aimed at increasing the effectiveness of
urinary function activities); enhanced (i.e. the addition of strategies aimed at tailoring an intervention to
the specific needs of the individual or enhancing adherence or commitment to practice/activities,
e.g. goal-setting, reminder systems, coaching)
l intervention duration – i.e. length of time in weeks in contact with intervention delivery (≥ 8 weeks,
> 8 weeks)
l intervention intensity – i.e. number of contacts with the person providing the intervention for content
delivery or monitoring/feedback (at least weekly, less than weekly).
A priori sensitivity analyses were planned for type of comparison group (no treatment vs. another
treatment), study quality to include allocation concealment (adequate, unclear/not adequate) and loss to
follow-up (≤ 20%, > 20%).
Subgroup and sensitivity analyses were performed using a chi-squared test for heterogeneity (via the
decomposition of the Q-statistic).
Review of acceptability and feasibility
Acceptability
Data were extracted as follows:
l client group recruitment and inclusion/exclusion criteria (age, ethnicity, sex, UI type, cognitive status,
functional ability)
l research design classification (qualitative study, survey, process evaluation, action research)
l intervention classification (combined, PFMT, BT, PV, generic)
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l data collection and analysis methods (framework/model)
l findings [researcher theme(s), categories and codes].
Findings were identified from secondary data, i.e. the study authors’ aggregate themes, categories or
codes relating to potential barriers and enablers to behavioural interventions, and not at the level of
the original data (e.g. quotes from respondents). Findings were categorised based on Davidson et al.64 and
National Institute for Health and Care Excellence (NICE) guidance on interventions to support behaviour
change65 as follows:
l intervention – combined, PFMT, BT, PV, generic behavioural
l influencing factor source – client, intervention or context
l influencing factor direction – enabler or barrier
l outcome – choice/uptake, participation/adherence, longer-term sustainability, withdrawal/dropout.
Descriptive data extraction was undertaken by one reviewer and checked by a second reviewer. Data
extraction and categorisation of findings, and quality appraisal were undertaken by two reviewers
independently. Quality assessment was based on quality criteria for qualitative studies or observational
designs,66 including criteria related to participant selection and representativeness, data collection
and analysis, methods of representation and testing the robustness of findings (see Appendix 4).
Feasibility
Rates of non-participation (i.e. people who were eligible to participate and who did not opt to do so),
treatment adherence and withdrawal or dropout (short and long term) were extracted, together with the
reasons if given. Data were tabulated, averaged and reported in the context of intervention type, client
group and setting.
Review of predictors of treatment adherence or outcome
Data were extracted for (independent) predictor variables relating to characteristics of the client group
as follows:
l sociodemographic variables, i.e. age, ethnicity, sex, education/income
l physiological variables, i.e. gynaecologic/obstetric status and history, weight/body mass index (BMI),
urodynamic variables, prior treatment, type, duration of UI, severity of UI/symptoms
l health/functional variables, i.e. general health status/comorbidities, self-care ability, functional ability,
cognitive status, mental health
l psychological variables, i.e. health/treatment perceptions; perceived QoL, self-efficacy/esteem,
attributions of control, prior adherence, knowledge/skill, motivation/attitude, goal orientation
l social variables, i.e. social influences and demands.
A coding frame for the definition and classification of predictor variables was used (see Appendix 4).
Using a standardised protocol, data extraction for studies using multivariate analysis included:
l research design classification (prospective cohort/clinical trial, RCT, retrospective cohort/
cross-sectional study)
l client group classification (age range, sex, UI type, cognitive status)
l intervention classification (combined, PFMT, BT, PV)
l selection and measurement of independent variables (hypothesis/model for selection, definition,
who/how measured, timing, validity and reliability of measurement)
l measurement of outcome variables (who/how measured, timing, validity and reliability of
measurement, definition of outcome categorisation)
l statistical analysis method
l variables entered into univariate analysis
l variables entered into multivariate analysis
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l statistically significant results from univariate analysis not subsequently confirmed as an
independent predictor
l statistically significant results for independent predictor variables for:
¢ intention to adhere/adherence behaviour
¢ treatment failure
¢ cure
¢ improvement
¢ psychological status
¢ QoL.
Descriptive data extraction was undertaken by one reviewer and checked by a second reviewer. Data
extraction of predictor and outcome variables and quality appraisal was undertaken by two reviewers
independently. Quality assessment was based on quality criteria for observational studies67 and for
regression studies,68 and included criteria related to participant selection and representativeness, predictor
and outcome variable selection, definition and measurement, adequacy of sample size, follow-up and
analysis (see Appendix 4).
Stakeholder involvement in the review process
Review Management Group
The Review Management Group was composed of the named authors on the review. They met quarterly
during the review process and their input included:
l discussion of studies referred by reviewers where inclusion was unclear, with subsequent refinement
of the criteria for inclusion and exclusion
l feasibility testing of the classification structures for the review and review of the data
extraction proforma
l checking back to the original study data from the results to comment on robustness of interpretation
l reading and commenting on all review outputs.
Service User Group
The PPC involvement group were involved at three stages for consultation on the review:
l to advise on the parameters and scope of the review, and the included interventions, comparisons
and outcomes
l to consider the draft results of the review and comment on their perceptions and priorities for the
components of the intervention and mediating factors
l once the review was completed, to assist in the translation of the findings into practical products
for implementation.
Trial Management and Steering Groups
The review findings were presented to the Identifying Continence OptioNs after Stroke (ICONS) Trial
Management and Steering Groups, who then made suggestions for:
l the content of the behavioural intervention for UI to be used with people after stroke
l optimal conditions of implementation on which to base the tailoring of the intervention to client
groups and settings
l hypotheses about potential mediators and moderators for consideration in the design of the pilot trial.
Their suggestions were then used to adapt the intervention and data collection protocols for use in the
case study.
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Description of included studies
Results of the search
The main database search identified 8289 records. Duplicate records (n= 1807) and records which were
clearly irrelevant on title (n= 4224) were removed, leaving 2258 records for screening. Another 31 records
were added from additional searches of trial registers, databases of unpublished studies and conference
proceedings, plus 68 records from secondary references. Of the 2357 records screened for inclusion,
538 full-text papers were retrieved. Four records could not be traced.
The 538 papers were filtered independently by two reviewers who discussed any disagreement and were
coded as relevant to one or more of the review components. Exclusions were as follows:
l not English language (n= 1)
l not research (n= 80)
l not behavioural (n= 46)
l not UI (n= 25)
l excluded client group (e.g. pregnancy, post prostatectomy) (n= 1)
l not CBI (n= 65)
l single UI intervention plus adherence intervention (n= 9)
l compares methods of delivery of behavioural intervention (n= 54)
l confounded intervention (n= 25)
l not appropriate research design (n= 75); and
l review (n= 47); these were combed for secondary references.
Excluded records totalled 428.
Of the remaining 110 papers, 33 related to the implementation of behavioural interventions, either from
reports of intervention development, process evaluations or feasibility studies. Owing to the volume of
material, these studies were not reviewed in detail, other than to extract data from the feasibility studies
on rates of uptake, adherence and withdrawal.
Table 1 details the remaining papers, identifying published, unpublished and ongoing studies exclusive to each
component of the review. The number of studies that the published papers refer to are given in brackets.
In total, 77 papers detailing 56 studies were included at filtration. The table also identifies the number
of studies excluded after filtering. The rationale for exclusion is given in a table of excluded studies
at Appendix 7. No exclusions are shown for the review of predictors, as filtering was reapplied specifically
for predictor studies after the main filtering was completed.
Thirty-three published studies contributed data to different review components (Table 2). Details of the
individual studies are given in a table of included studies at Appendix 6.
TABLE 1 Numbers of papers per review component
Status of paper
Meta-analysis Narrative review
Predictors TotalEffectiveness Acceptability Feasibility
Published 20 (10) 12 (11) 2 (2) 11 (10) 45 (33)
Unpublished 0 3 (1) 0 4 (3) 7 (4)
Ongoing 3 (3) 0 0 0 3 (3)
Excluded 14 (8) 6 (6) 2 (2) 0 22 (16)
Total papers 37 (21) 21 (18) 4 (4) 15 (13) 77 (56)
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TABLE 2 Included published studies
Study Effectiveness Acceptability Feasibility Predictors
Alewijnse et al. 2001,69 200370 ✓
Aslan et al. 200871 ✓ ✓
Baigis-Smith et al. 198972 ✓
Bear et al. 199773 ✓ ✓
Burgio et al. 199833 ✓ ✓
Burgio et al. 200374 ✓
Dingwall and McLafferty 200675 ✓
Dougherty et al. 200276 ✓ ✓
Mather and Bakas 200277 ✓
Gerard 199778 ✓
Hay-Smith et al. 200779 ✓
Johnson et al. 200180 ✓
Kafri et al. 2007,81 200882 ✓ ✓
Kincade et al. 199983 ✓
Kincade et al. 200184 ✓
Lee et al. 200585 ✓
Lekan-Rutledge et al. 199886 ✓
Macaulay et al. 198787 ✓ ✓
McDowell et al. 199288 ✓
McDowell et al. 199989 ✓ ✓ ✓
McFall et al. 200090,91 ✓
MacInnes 200892 ✓
Milne and Moore 200693 ✓
O’Dell et al. 200894 ✓
Oldenberg and Millard 198695 ✓
Perrin et al. 200596 ✓
Remsburg et al. 199997 ✓
Resnick et al. 200698 ✓
Rose et al. 199099 ✓
Subak et al. 2002100 ✓ ✓ ✓
Svengalis et al. 1995101 ✓
Tadic et al. 2007102 ✓
Wyman et al. 199831 ✓ ✓ ✓
Total per review component 10 11 11 13
Note
Some studies contributed data to more than one review component. Bold ticks show primary focus of article,
as per published studies line in Table 1.
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Description of studies of effectiveness
Included studies
Of the 21 studies identified for the effectiveness review, eight were excluded (reasons are given in the
table of excluded studies in Appendix 7). Three studies are ongoing.82,103,104 There were no unpublished
studies. The remaining 10 studies are detailed in Table 3.
Study design
The 10 studies included 1163 participants in 13 intervention–comparison pairs. Table 3 details the trial
arms compared against CBIs. Of the seven control comparisons, three were attention controls,33,71,89
two were waitlist controls90,91,100 and two were no treatment controls.73,76 The remaining six treatment
comparisons included three medications [propantheline bromide (Pro-Banthine®, Roxane Laboratories Inc.)
or oxybutinin (Ditropan, several manufacturers) (× 2)],33,81,82,87 two single behavioural interventions (BT or
PFMT)31 and one psychotherapy comparison.87
Seven of the trials were undertaken in the USA31,33,73,76,89–91,100 one in the UK,87 one in Turkey71 and
one in Israel.81,82 Three were quasi-RCTs.71,73,81 All of the quasi-RCTs and the oldest trial87 had fewer than
100 participants. The remaining trials all had more than 100 participants. One of the quasi-RCTs73 was
an external pilot for a larger RCT.89 One study did not provide outcome data suitable for pooling.87
Client group and setting All of the trials except one89 were limited to female participants, and the
sample for McDowell et al.89 was also 90% female. Only three trials included people aged > 55 years,
and two of these had samples with a mean age of ≥ 55 years.31,81
Three trials were undertaken with participants with UUI.33,81,87 The remaining trials were undertaken with
people with all types of incontinence. One trial provides outcome data for intervention subgroups based
on urodynamic diagnosis.31
TABLE 3 Studies included in the effectiveness review
Study Study design Comparison(s) Client group/setting
Aslan et al. 200871 (Turkey) Quasi-RCT (n= 64) Attention control F, aged ≥ 65 years, rest home
Bear et al. 199773 (USA) Quasi-RCT (n= 24) No treatment control F, aged ≥ 55 years, home
Burgio et al. 199833 (USA) RCT (n= 197) 1. Medication
2. Attention control
F, aged ≥ 55 years, UUI, community
Dougherty et al. 200276 (USA) RCT (n= 178) No treatment control F, aged ≥ 55 years, rural area, home
Kafri et al. 2007,81 200882 (Israel) Quasi-RCT (n= 44) Medication F, UUI, community
Macaulay et al. 198787 (UK) RCT (n= 50) 1. Psychotherapy
2. Medication
F, UUI
McDowell et al. 199989 (USA) RCT (n= 105) Attention control M/F, aged ≥ 60 years, home bound
McFall et al. 200090,91 (USA) RCT (n= 145) Waitlist control F, aged ≥ 65 years, community
Subak et al. 2002100 (USA) RCT (n= 152) Waitlist control F, aged ≥ 55 years, community
Wyman et al. 199831 (USA) RCT (n= 204) 1. BT
2. PFMT
F, community
F, female; M, male.
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The definition of incontinence differs slightly: four trials specifying that UI episodes had to occur at least
twice a week,33,73,76,89 one trial specifying at least once a week31 and one trial specifying more than
two episodes a month.71 Of the remaining four trials, two confirmed UUI by urodynamic testing,81,87
McFall et al.90 used self-report of UI for 3 months or more as an inclusion criteria and Subak et al.100 did
not define UI but referred to standard diagnostic criteria sourced from US guidelines.
Two related studies73,89 were undertaken with people who were housebound and a further study was
undertaken using home visits to women from rural areas of the USA.76 One study was undertaken with
people in rest homes.71 Five studies involved community samples with interventions delivered in clinic
visits.31,33,81,90,100 The setting for one study was unclear.87
Three trials did not exclude people with cognitive impairment. Two of these required that a person with
cognitive impairment had a caregiver present who was willing to undertake PV.73,76 One other trial did not
exclude people with cognitive impairment,89 but outcome data are only reported for people without
cognitive impairment.
Description of urinary incontinence interventions
Table 4 summarises details of the interventions used in the 10 trials, including the components of the
intervention, method of delivery, and the duration and intensity of contact with professionals. Some of
these details were provided by contact with study authors.
All of the trials included PFMT, albeit to various degrees. All of the trials except one33 included BT, with
one trial73 including BT or PV, depending on the cognitive status of the individual. Six trials included
the teaching of either urge strategies (e.g. distraction) or stress strategies (e.g. muscle clamping), with
three trials teaching both31,33,89 and three trials teaching one or the other.71,81,90 However, description and
labelling of the techniques used tended to be inconsistent. Three trials included other strategies, such as
advice about alterations to diet and/or fluid intake.73,76,90
Interventions in two trials were delivered to groups.90,100 The delivery format was unclear in two trials81,87
and the remainder were delivered to individuals. Eight out of 10 interventions were delivered by nurses,
with another intervention predominantly delivered by nurses but including other professions.90 One
intervention was delivered by physical therapists.81
Most of the interventions ran over 6–12 weeks, with interventions in two related trials running over a
minimum of 6 weeks and a maximum of 24 weeks.73,76
Three trials had weekly contacts with a health-care professional for the duration of the intervention,71,89,100
with four trials having at least bi-weekly contact.31,33,87,90 The number of contacts was stated as being in the
range of 2 to 40 contacts in an intervention lasting a minimum of 6 weeks and a maximum of 24 weeks
in one pilot trial.73 This is unstated, but likely to be similar in the related trial.76 Most of the trials stated
a requirement for practice of the techniques between contacts.
Intensity of intervention was defined as the ratio of the number of contacts with a person delivering the
intervention to the length of the intervention period. An intensity of 1 is weekly contact. Intensity could
not be derived for the two trials that did not specify the exact number of contacts.73,76 Three trials had at
least weekly contact71,89,100 and four trials had at least bi-weekly contact.31,33,87,90 Only one trial had less
than bi-weekly contact.81
Features of urinary incontinence intervention components
Table 5 details the features of the BT and PFMT interventions in the included trials. A dash in the table
means that the feature was not stated in the paper. The level of description of the interventions was
variable and lack of description cannot be interpreted as absence of the feature in practice.
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TABLE 4 Urinary incontinence intervention description
Study
UI intervention components Method of delivery Duration/intensity
PV BT PFMT
Urge
strategies
Stress
strategies Other I or G H or C N or O
Number of
weeks
Number of
contacts
Intensity of contact
(weekly= 1)
Aslan et al. 200871 ✓ ✓ ✓ I H N 8 8 1
Bear et al. 199773 ✓ ✓ ✓ ✓ I H N 6–24 2–40 –
Burgio et al. 199833 ✓ ✓ ✓ I C N 8 4 0.5
Dougherty et al. 200276 ✓ ✓ ✓ I H N 6–24 NS –
Kafri et al. 200781 ✓ ✓ ✓ ?G C O 12 5 0.4
Macaulay et al. 198787 ✓ ✓ NS C N 12 7 0.6
McDowell et al. 199989 ✓ ✓ ✓ ✓ I H N 8 8 1
McFall et al. 200090 ✓ ✓ ✓ ✓ G C N/O 9 5 0.6
Subak et al. 2002100 ✓ ✓ G C N 6 6 1
Wyman et al. 199831 ✓ ✓ ✓ ✓ I C N 12 9 0.8
?G, likely to be group delivery; C, clinic; G, group; H, home; I, individual; N, nurse; NS, not stated; O, other.
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Bladder training
Core features of BT were identified from the Cochrane systematic review of BT,25 to include patient
education, scheduled voiding, positive reinforcement, self-monitoring and urge suppression.
i. Patient education about basic urinary physiology and function was stated as included in six out of nine
trials.31,71,76,89,90,100 Eight out of nine trials described a system of scheduled voiding, where voiding
intervals were specified.31,71,73,76,81,87,89,100
ii. Six trials31,71,73,76,89,100 described the use of a system of gradually increasing void intervals tailored to the
baseline and progress of the individual, as described by Wyman and Fantl.105 Two trials described
gradual increases in voiding interval81,87 without describing tailoring to the individual. The remaining
trial just described the intervention as bladder retraining without further detail.90
iii. Four out of nine trials specifically described positive reinforcement for progress.31,71,76,89 One other trial73
is likely to have included positive reinforcement because they were using the same protocol, but it is
not specifically mentioned in the trial report.
iv. All of the trials except one87 described using bladder diaries for self-monitoring of voiding patterns.
Two trials73,76 used 3-day diaries and the remainder used daily diaries.
v. Four out of nine trials specifically detail instruction in urge suppression techniques such as distraction.31,76,89,90
Pelvic floor muscle training
Core features of PFMT were identified from the review by Bo,106 including details of the exercises (e.g. type of
exercise, frequency, intensity and duration). In terms of PFMT, this relates to whether contractions are maximal
or submaximal, the duration of exercise and relaxation periods, the speed and duration of muscle contraction,
and the amount of exercise in the form of repetitions and duration. Additional data were extracted about
whether or not exercise was generalised to different body positions and activities/situations, whether or not
practice was progressive in terms of intensity or amount, and the method of teaching. Table 6 gives details of
PFMT teaching regimes included in the trials.
TABLE 6 Details of PFMT regime
Study Exercise detail Positions Activities
Increased
pressures
PFMT teaching
method
Number of
teaching sessions
Aslan et al. 200871 NS ✓ – – Digital 1
Bear et al. 199773 NS – – – BIO NS
Burgio et al. 199833 15, three times a day,
aim for a 10-second
contraction
✓ ✓ ✓ BIO 2–4
Dougherty et al.
200276
45 per day, three times
per week
– – – BIO 1
Kafri et al. 200781 12, two times a day,
aim for a 10-second
submaximal contraction
✓ – ✓ Digital 1
Macaulay et al.
198787
NS – – – NS NS
McDowell et al.
199989
10–15, three times
a day, aim for a
10-second contraction
✓ ✓ – BIO ≤ 4
McFall et al. 200090 NS – – – NS NS
Subak et al.
2002100
100 per day, 2–3 second
tighten/relax five times,
as quickly as possible
– – – Verbal –
Wyman et al.
199831
50 per day, 10 fast,
40 sustained
– – – BIO ≤ 4
✓, feature present; –, feature not present; digital, digital vaginal palpation; NS, not stated.
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Four trials did not give details of the exercises.71,73,87,90 Three of the remaining trials aimed for 30–50
repetitions daily.31,33,89 Two trials had lower intensities of practice76,81 and one trial had a higher intensity
of practice.100 Most of the trials specified aiming for 10-second maximum sustained contractions,
except Subak et al.100 which used sets of rapid 2–3-second contractions. Wyman et al.31 used a mix of
fast and sustained contractions.
i. Three trials did not describe confirming correct initial pelvic floor muscle contraction technique, either
by digital palpation or BIO.87,90,100 One other trial did use digital palpation, but 30% of older women
living in a nursing home refused.71
ii. Three trials did not describe individual instruction for PFMT.87,90,100 Of these, two used
group teaching.90,100
iii. Two out of nine trials report the level of adherence of the individual to the prescribed
exercise regime.31,89
iv. Five trials describe repeating sessions (or the opportunity to repeat session dependent on progress)
of BIO during the intervention.31,33,73,76,89
v. Of the 10 trials using PFMT, five had a longer intervention period (i.e. ≥ 12 weeks) where sustained
impact on muscle performance is more likely to be achieved.31,73,76,81,87
Features of behavioural intervention components
Table 7 details and categorises the behavioural component of the interventions, as per the taxonomy of
behavioural interventions described by Abrahams and Michie.62 The categorisation was based only on the
published accounts given of the interventions. The level of description of intervention components was
variable. Given the restrictions on length of publication, absence of description of a feature may not
constitute its absence in practice.
TABLE 7 Behavioural intervention description
Study
Behavioural intervention components
Information
provision Self-monitoring
Adherence
reminders
Tailoring/
goal-setting
External
monitoring
External
motivation Counseling
Aslan et al.
200871
✓ ✓ – – ✓ ✓ –
Bear et al.
199773
✓ ✓ – ✓ ✓ – –
Burgio et al.
199833
✓ ✓ – – ✓ ✓ –
Dougherty
et al. 200276
✓ ✓ – ✓ ✓ – –
Kafri et al.
200781
✓ ✓ – – – – –
Macaulay
et al. 198787
– – – – – – –
McDowell
et al. 199989
✓ ✓ – ✓ ✓ – –
McFall et al.
200090
✓ ✓ – ✓ ✓ ✓ ✓
Subak et al.
2002100
✓ ✓ – – ✓ – –
Wyman
et al. 199831
✓ ✓ – – ✓ ✓ ✓
✓, feature present; –, feature not present.
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Information provision
Information provision could include providing general information on health, health behaviour, or the
consequences of behaviour; or providing explicit instruction on how to perform a behaviour. All except one
of the trials87 described some level of information provision, although the content varied markedly.
Nine of the 10 trials described skills instruction on behavioural techniques. Two trials describe only skills
instruction.33,81 Additional educational content described by other trials included:
l Structure and function of the urinary tract, normal voiding mechanisms and the causes and symptoms
of incontinence.71,100
l Two trials31,76 that describe patient education as per the protocol for BT by Fantl et al.32 This includes
discussion of normal bladder control; explanation of the pathophysiology underlying different types of
incontinence; and stressing the importance of continence as a learned behaviour and brain control over
lower urinary tract function. Three other trials used this protocol71,73,89 but do not refer to the content
of their information provision. Two of these trials identify giving lifestyle advice on dietary or fluid
intake behaviour, or environmental adaptations.71,73,89 McFall et al.90 also taught definitions and types
of UI, identified resources which provided educational material on UI and included the aim ‘to learn
that the condition is treatable’. No trial reported including information about the consequences of
behavioural techniques (e.g. pros and cons), although McFall et al.90 did include discussion of coping
strategies that help control incontinence or its negative consequences.
Self-monitoring and adherence reminders
Self-monitoring involves keeping a record of specified behaviours. Nine trials included a behavioural
technique for self-monitoring of urinary function by the inclusion of a bladder diary – only the early trial
by Macaulay et al.87 did not include a regular bladder diary during treatment. Two trials also included
self-monitoring of treatment adherence behaviour.31,89
Adherence reminders include the use of passive or interactive devices or systems to self-prompt practice
(e.g. sheets to fill in, computerised counters, display items such as fridge magnets). No trial specifically
mentioned a reminder system, or a method of recording that served a dual purpose of data collection
and behavioural prompting, although it is likely that the simple presence of the bladder diary did
have a reminder function. One trial did use audio cassettes for PFMT practice, which could have a
reminder function.31
Tailoring/goal-setting
A number of techniques are relevant to tailoring and goal-setting, including intention formation, barrier
identification, relapse prevention, setting graded tasks, detailed goal-setting, review of behavioural goals
and agreeing a behavioural contract.
By their nature, both BT and PFMT involve setting goals and graded tasks based on operant conditioning
principles, but these are also based on physiological reasons related to bladder capacity or muscle fibre
action. The setting of goals and the incremental nature of the targets are not necessarily behavioural
techniques to assist learning and do not tend to meet the definitions given in Abraham and Michie62
as described below.
Intention formation
Intention formation involves encouraging the person to set a general goal or resolution to decide to
change. It does not involve planning exactly what will be done, when and how, which would be
classified as goal-setting. Two trials included reference to people being asked about their own goals
for continence.73,76
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Barrier identification
Barrier identification involves thinking about potential barriers and planning ways to overcome them.
One trial included reference to strategies to remove environmental barriers (e.g. installing night lights,
assistive mobility devices such as grab bars, etc.).89
Relapse prevention
Relapse prevention involves identifying situations that increase the likelihood or failing to perform a
new health behaviour and planning to manage the situation. One trial referred to reviewing the voiding
diary for ‘problem-solving’.90
Setting graded tasks
Setting graded tasks involves planning a sequence of actions or task components that increase in difficulty
over time until the target behaviour is reached. No trials explicitly met this criterion for what appeared
to be behavioural reasons, but separating physiological from behavioural rationales was almost impossible
to do. Details of intervention components (other than straightforward BT or PFMT schedules where void
intervals/exercise intensity increases over time) that could be seen as graded in difficulty for behavioural
reasons are described here.
Seven trials sequenced the introduction of components of the intervention,31,33,73,76,81,89,90 but only three
of these appear to base sequencing on increasing task difficulty. One trial referred to teaching BT after
urge strategies had been taught, so that participants could use the skills learned to suppress urge
sensations during BT.89 Two trials included practising PFMT against increasing bladder pressure, once
PFMT had been learned.33,81 Four trials referred to generalising skills, by practising exercises in different
positions, and during different activities.33,71,81,89 This could be interpreted as practising learned skills in
situations of increasing challenge.
Goal-setting and behavioural contracts
This requires detailed planning of what the person will do, where, when and how. Both BT and PFMT
include detailed instruction, so all trials could be said to include an element of this. However, using
behavioural principles for the learning and application of the techniques by detailed planning of goals
for the individual subject is not a strong feature of any of the trials. Two trials included formal review of
individual goals at each stage of the programme,73,76 but because this goal-setting did not include detailed
planning, it was categorised as intention formation, and reported earlier.
Monitoring, motivation and reinforcement
Adherence interventions included in this section include feedback on performance, provision of general
encouragement or contingent reward, teaching to use prompts and cues, prompting practice and use
of follow-up prompts.
Feedback on performance Six trials described regular external review and feedback on performance
by a health professional, via the bladder diary. Three trials included weekly review,71,89,100 and two trials
reported bi-weekly review.33,89 In one other trial,90 the review was weekly, but it is not clear if the
bladder diary review was done on an individual basis, as the teaching was done in fairly large groups.
Two trials stated a review of progress was done at the end of each phase of the intervention73,76 and
one trial did not refer to feedback.87
Provision of general encouragement/rewards Four trials describe providing general encouragement to
adhere to the programme.31,33,71,90 The other six trials do not explicitly describe providing encouragement
or reinforcement, but, of these, four were following the BT protocol by Fantl et al.,32 which includes the
requirement for positive reinforcement.73,76,89,100 No trials included the provision of contingent rewards.
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Use of prompts and cues Two trials referred to embedding behavioural practices into daily routines,89,90
but none of the trials included prompts to practice other than regular contact with professionals. Two trials
used written recording of adherence to the programme.31,89
Counseling and coaching strategies These include prompting self-talk, identification as a role model,
planning social support, using social comparison, motivational interviewing and techniques for stress and
time management. Wyman et al.31 used affirmations and self-statements. McFall et al.90 referred to the
opportunities for modelling of behaviour and the social support provided by delivering the intervention in
a group setting.
Allocation of interventions
Not all participants received the same interventions in all trials. In two trials73,76 participants received
intervention components dependent on need. Participants were allocated to a self-monitoring phase if
they had problematic fluid or caffeine intake, excessive daytime void intervals, nocturia or constipation.
Participants were then allocated to BT, or to PV if functionally or mentally dependent on a caregiver.
Finally, participants progressed to PFMT if insufficient progress had been made in earlier stages. How many
participants progressed through each phase of the intervention is not reported for Bear et al.,73 but
Dougherty et al.76 report that out of 94 people in the intervention group, the number progressing through
each phase was as follows: self-monitoring (n= 41), BT (n= 89), PFMT (n= 45).
In the trial by McDowell et al.,89 urge strategies were taught to participants who reported involuntary urine
loss following a strong urge to void (85/105), stress strategies were taught to those who reported leaking
urine with sudden increases in abdominal pressure (44/105), and only participants who reported frequent
voiding got BT. However, in a related paper Engberg et al.107 reported that many participants had high
urinary frequency.
Outcomes
The 10 trials used a range of outcome measures, measurement statistics and time intervals for follow-up.
Outcomes measured are detailed in Table 8 and summarised below.
Primary outcome
The primary outcome was the number of people continent after treatment (i.e. cured). Three trials included
a measure of cure,31,33,90 all defined as the number of people reporting 100% improvement in the number
of incontinent episodes as measured in a urinary diary (mean per week). One additional trial87 reported
the percentage of patients with UI in graphical form, but did not provide numerical results other than
p-values for difference between groups.
No trials reported cure using objective measures (e.g. number of people reporting 0% leakage using a pad
test of quantified leakage).
Secondary outcomes
Improvement The most common method used to express the degree of improvement in UI was reporting
the number of incontinent episodes per day or week. This measure of improvement was included in all
trials except Macaulay et al.87 Three trials also included the participants’ perception of improvement; two
using a scale of much better, better, no change, or worse;31,33 and one trial reporting whether the
intervention had helped a great deal, moderately, slightly, or not at all.100
Severity Of the four trials that used a pad test, two did not report data.31,73 One trial reported grams of
urine lost in 24 hours.76 The same trial also reported a subjective assessment of the severity of urine
loss, rated from 1 to 7 from ‘the best bladder control you can imagine’ (1), to ‘the worst bladder control
you can imagine’ (7). Another trial71 reported binary data on the number of people with improved
(vs. no change or worse) results on a pad test.
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Urinary symptoms Six trials reported urinary symptoms. Five trials reported frequency: four trials
reporting frequency of voiding per day or week;76,81,90,100 and one trial reporting number of people reporting
urinary frequency as better, unchanged or worse.71 The same trial reported number of people
reporting urinary urgency as better, unchanged or worse; and the number of people reporting nocturia as
better, unchanged or worse. Four other trials measured frequency of nocturnal micturition.33,81,90,100
Quality of life Five trials included a measure of QoL, but data could not be extracted from one trial because
the data were not provided separately for intervention and control groups.90 Of the remaining four trials, two
used the Incontinence Impact Questionnaire (IIQ), which measures symptom distress,31,76 one trial used the
Incontinence Quality of Life (Questionnaire) (I-QOL),81 and one trial used the Urogenital Distress Inventory (UDI).31
Satisfaction with treatment Two trials reported on satisfaction with treatment,31,33 using a four-point
scale from not at all satisfied, to very satisfied. One other trial100 asked for participant’s reports on how the
behavioural therapy had helped them in dealing with their urine leakage problem (rated not at all, slightly,
moderately, or a great deal).
Adverse effects One trial reported total number of adverse events (e.g. discomfort, fatigue, side effects
of drugs).81
Outcome measurement timing
Post-treatment measurement timing was variable (Table 9), with post-treatment measurement at 6 weeks
in one trial,100 8–10 weeks in four trials,33,71,89,90 3 months in three trials31,81,87 and 6 months in two trials.73,76
Follow-up timing also varied, with the most common being 6 months, which was included in seven
trials.31,71,81,87,89,90,100 Long-term follow-up of ≥ 12 months was included in four trials.76,81,89,90
Quality of included effectiveness studies
The quality of the included studies was assessed against the Cochrane criteria of adequate sequence
generation and allocation concealment; completeness of data reporting and blinding for each main class
of outcome measure; selective outcome reporting; and any other sources of bias.
Of the 10 studies, three trials had adequate description of the random sequence generation procedure;33,89,100
five trials stated that sequence allocation was random but did not describe the procedure;31,73,76,87,90 and
two trials used non-random sequence generation processes, i.e. alternate allocation.71,81
Allocation was judged to be adequately concealed in one trial,100 unclear in seven trials31,33,73,76,87,89,90 and
not adequately concealed in two trials.71,81
In the three trials that used objective measures of urine loss, blinding of analysts to the results was judged
to be unclear in two trials71,73 and adequate in one trial.76 Blinding of analysts to the results of the bladder
diary was judged adequate in two trials,33,100 unclear in five trials71,73,76,87,89 and not adequate in three
trials.31,81,90 In the seven trials that used subjective outcome measurements, blinding of outcome assessors
to the results was deemed unclear in two trials76,87 and not adequate in five trials.31,33,81,90,100
Objective outcome data were judged to be complete in two trials71,73 and not complete in one trial.76 Data
from bladder diaries were judged to be complete in four trials,33,73,89,90 unclear in two trials31,71 and not
complete in three trials.76,81,100 Data from subjective measurements were judged to be unclear in three
trials31,33,87 and not complete in four trials.76,81,90,100
Outcome reporting was judged to be free of the suggestion of selective outcome reporting in five
trials,31,33,76,81,87 unclear in one trial89 and selective in four trials.71,73,90,100
Two trials had over 20% loss to follow-up.73,90
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Generalisability of the included effectiveness studies
All except one of the studies were limited to females, with the remaining study being 10% male.89
The majority of studies were also limited to older women.
All types of incontinence were included, but there are more data relating to participants with UUI (46%)
than with MUI (40%) or SUI (14%). Most of the studies were undertaken with participants who had
established and moderate to severe incontinence. Only one study related to people with mild or very
mild symptoms.90 This was the only study to recruit mainly from community populations rather than from
clinical settings, although a few other trials did include community advertising as an additional route
of recruitment.
In general, people with cognitive impairments were excluded, although two trials did not exclude people
with cognitive impairment if a carer was available and willing to be involved.73,76 One specifically targeted
older people who were homebound89 and one was undertaken in a nursing home,71 suggesting that
behavioural UI interventions could at least be feasible with frailer client groups.
Most of the studies have been undertaken in a North American or Middle Eastern setting, with only
one early study in a European setting. However, given that these are mostly clinic or home delivered
interventions, there is no reason to believe that they are not transferable.
Description of studies of acceptability and feasibility
Description of studies of client experience
Table 10 lists the studies identified by the search. Eight studies were identified: two studies were
unpublished and therefore no data extraction was undertaken.108,109
TABLE 10 Description of studies of client experience
Study Client Method Focus Uptake Adherence Dropout
Johnson et al.
200180
USA (n= 79)
Frail older adults, UI Postal survey UI treatment ✓ – –
Milne and Moore
200693
Canada (n= 38)
Individuals, UI Qualitative, interviews
and focus groups
Self-care
strategies
✓ ✓ –
O’Dell et al.
200894
USA (n= 25)
Older women, UI Qualitative, interviews Pelvic floor
care
✓ ✓ –
Hay-Smith et al.
200779
New Zealand
(n= 20)
Women, SUI Qualitative, interviews PFMT – ✓ –
MacInnes 200892
UK (n= 12)
Women, SUI Qualitative, telephone
interviews
PFMT – – ✓
Kincade et al.
199983
USA (n= 10)
Women, UI Qualitative, interviews Combined
intervention
– – ✓
✓, feature present; –, feature not present.
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Of the remaining six studies, three were completed in the USA,80,83,94 one in Canada,93 one in New
Zealand79 and one in the UK.92
Study type
There are five qualitative studies,79,83,92–94 and one survey.80 All studies collected data from clients, but
Johnson et al.80 collected data from proxy respondents and also collected data from family members and
nursing staff. Four studies used face-to-face interviews79,83,93,94 and one of these studies also used focus
groups.93 One study used telephone interviews92 and one study used postal questionnaires.80
Participants
The samples for two studies were designed to include both men and women,80,93 the rest included women
only. Two studies targeted older adults: community dwelling80 and in residential care.94 Two studies were
specific to women participating in a programme of PFMT for SUI;79,92,110 the remaining studies included
people with mixed types of UI.
Kincade et al.83 included both men and women in the overall study, but only interviewed women who
had not completed their programme. One study did not exclude participants who were continent at the
time of interview (9/38 participants reported no or rare wetness), but who had experience of self-care
strategies;93 and one study included proxy respondents who did not themselves have UI.80
Interventions
Two studies were not specific to a particular type of behavioural intervention, but included material
relevant to uptake of or adherence to behavioural self-care strategies.93,94 One study elicited preferences
for treatment, including behavioural options.80 Two studies concerned client experiences with PFMT79,92 and
one study concerned client experience of a combined intervention using PFMT and BT.83
Outcomes
Client perceptions or experiences could relate to factors influencing choice or programme uptake;
participation, maintenance and adherence during the programme; sustainability in the longer term; or
failure/withdrawal from the programme. One study (n= 79) explored the treatment preferences of frail
older nursing home residents80 and two studies (n= 22) explored reasons for dropout/withdrawal from
treatment.83,92 The remaining three studies (n= 83) were more wide ranging, covering factors influencing
uptake and/or adherence.
Quality of included studies
In the main, sampling methods were clear although one study did not include an explanation of the final
sample or reasons for non-response92 and one survey did not provide characteristics of the respondents
because proxy respondents were used.80 In general, analysis of data was poorly described, with four
studies providing very little description of the analysis process including how findings were selected and
managed.80,83,92,94 However, findings in these studies are predominantly descriptive. One study referred to
a process for testing the validity of interpretation with respondents,94 with two other studies using an
external researcher to check coding.79,93 Two studies explicitly considered the potential for bias in the
methods used.79,94
In summary, two studies met most of the appraisal criteria, where any weaknesses were unlikely to impact
on the credibility of findings.79,93 Two studies had weaknesses mainly in the description of analysis such
that weaknesses had the potential to impact on the credibility of the findings.83,94 The qualitative
component in two studies was poorly described.80,92 However, it should be noted that both of these
studies were mainly descriptive in nature.
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Generalisability of included studies
Age, sex The included studies are mostly generalisable only to women. Two studies included men: a study
of treatment preferences in residential care80 where no details are given of the sample; and a study of
factors impacting on self-care93 that included five men out of 38 respondents.
Cognitive ability, socioeconomic status All of the studies required participants to be cognitively able to
participate. In the main, respondents were a staff or self-selected volunteer sample – with the possibility
that they would not be representative of the wider population.
Type of incontinence Two studies are generalisable to relatively younger women with SUI.79,92 Two
studies are generalisable to older women83,93 with mixed types of incontinence. The study by O’Dell et al.94
included residents with pelvic floor dysfunction including disorders of urination, defaecation or vaginal
prolapse. Twenty-three people out of 25 had UI, but 13 out of 25 also had other problems. Findings
are defined by the different conditions and in the main it is clear when findings are referring to UI.
Johnson et al.80 included proxy respondents without UI.
Setting Two studies are relevant to older adults in residential care,80,94 although both of these studies
required participants to be cognitively able. Residential facilities were in the USA, so findings may not be
generalisable to other care systems.
Description of studies of staff experience
Six studies elicited the opinions of staff about aspects of delivering behavioural interventions
for UI (Table 11).
One of the studies80 is also included in the client experience section. Five studies were completed in
long-term care (LTC) facilities in the USA77,80,86,97,98 and one in acute care in the UK.75 Two of the studies
were within the last 3 years,75,98 four studies were conducted between 12 and 16 years ago.77,80,86,97
Two studies used questionnaires to collect data;86,97 four studies used group interviews or focus groups,
with two of these studies also using a small number of individual interviews.75,80 All of the studies collected
data from nurses, four studies collected data from mixed grades of nursing staff, with two studies specific
to nursing assistants (NAs).77,86 Two studies86,97 were undertaken to elicit the views of staff about a PV
intervention that they had participated in; the remaining four studies were about views on aspects of
general continence care that could include behavioural intervention.75,77,80,98
TABLE 11 Description of studies of staff experience
Study Staff group Data collection method Focus
Lekan-Rutledge et al. 199886 NA, LTC (n= 141) Questionnaire PV
Remsburg et al. 199997 Nursing, LTC (n= 88) Questionnaire PV
Johnson et al. 200180 Nursing, LTC (n= 66) Group interviews Continence care
Mather and Bakas 200277 NA, LTC (n= 31) Focus groups Continence care
Dingwall and McLafferty 200675 Nursing, acute (n= 63) Focus groups, interviews Continence care
Resnick et al. 200698 Nursing, LTC (n= 38) Focus groups Continence care
LTC, long-term care; NA, nursing assistant.
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Quality of included studies
Four studies collected qualitative data.75,77,80,98 Sample selection was adequately described in all studies,
but two studies provided insufficient detail of the final sample.80,98 All studies adequately detailed
data collection methods, but analysis processes were only adequately detailed by one study.98 Results
were clearly presented in all studies, but methods of testing credibility of the findings were not described
in two studies.75,98
Two studies collected quantitative data.86,97 Both studies adequately described sample selection, but details
of the final sample were insufficient in Remsburg et al.’s study.97 Methods of data collection and analysis
were insufficiently described in both studies.
Generalisability of included studies
In the main, findings are most relevant to nursing staff working in LTC settings in the USA.77,80,86,97,98 There
is only one study relevant to acute care in the UK.75 However, most studies are reporting barriers to the
provision of adequate continence care (including forms of behavioural intervention) to older people.
Description of studies measuring predictors of treatment adherence
or outcome
Table 12 lists the 16 studies identified by the search. There were 13 studies where the primary focus was
analysis of predictors and three RCTs from the effectiveness review that also included regression testing
for moderators of outcome. Three studies were unpublished and did not progress to data extraction.
Two linked studies,69,70 considered as one because they relate to the same sample, measured intention to
adhere and long-term adherence at different time points.
TABLE 12 Studies identified for analysis of predictors of adherence or outcome
Study Type of intervention Type of analysis Dependent variable Unpublisheda
Alewijnse et al. 2001,69 200370 Combined M A –
Baigis-Smith et al. 198972 Combined U O –
Burgio et al. 200374 Combined M O –
Chen 2001 Single (PFMT) M A ✓
Gerard 199778 Combined U O –
Kartha 1989 Combined M A ✓
Kincade et al. 200184 Combined U A –
McDowell et al. 199288 Combined U O –
McDowell et al. 199989 Combined M O –
Oldenburg and Millard 198695 Combined M O –
Rose et al. 199099 Combined U O –
Shishani 2003 Single (PFMT) M A ✓
Subak et al. 2002100 Combined M O –
Svengalis et al. 1995101 Single (PFMT) U A –
Tadic et al. 2007102 Combined M O –
Wyman et al. 199831 Combined M O –
✓, feature present; –, feature not present; A, adherence; M, multivariate; O, outcome; U, univariate.
a Unpublished studies excluded from data extraction.
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Of the 13 studies that progressed to data extraction, seven studies used multivariate analysis,31,69,70,74,89,95,100,102
one measured predictors of adherence69,70 and six measured predictors of outcome.31,74,89,95,100,102 Six studies
used univariate analysis only:72,78,84,88,99,101 two measuring predictors of adherence,84,101 and four measuring
predictors of outcome.72,78,88,99
Only descriptive data on the variables tested were extracted from univariate analyses, as univariate
analysis does not provide robust information on independent predictors. However, it is useful to know
which predictors have been selected and tested as potentially predictive, to understand what the
confirmed independent predictors have been selected from and compared against. Therefore, variables
included in all univariate analyses are described separately in the results.
Table 13 summarises the main details of the studies using multivariate analysis to predict different
dependent variables, including adherence, improvement in UI, cure and QoL. The predictors of each
independent variable will be considered in turn.
Predictors of treatment adherence
Two linked studies undertaken in the Netherlands measured predictors of different aspects of adherence in
the same sample (n= 129) at different time points.69,70
Study type
Alewijnse et al.69 is a cross-sectional study undertaken on a sample of women from primary care who
self-reported problems with continence. Alewijnse et al.70 reports data from women who subsequently
agreed to participate in a RCT.
Participants
Participants were women recruited from 23 practice registers in the Netherlands between 1995 and 1998,
selected by a recorded risk factor for UI, and who then self-reported UI. Women unable to fill out
questionnaires, or those suffering from neurological conditions, were excluded.
TABLE 13 Summary details of studies using multivariate analysis
Study Study design Dependent variable Client group/setting
Alewijnse et al. 2001,69 200370
(Netherlands)
CS, RCT (n= 129) Adherence F
Burgio et al. 200374 (USA) RCT (n= 197) Cure (n= 49)
Improvement (n= 128)
F, aged ≥ 55 years, UUI
McDowell et al. 199989 (USA) RCT (n= 105) Improvement (n= 105)
Responder vs. non-responder (NS)
M/F, aged ≥ 60 years,
home-bound
Oldenburg and Millard 198695
(Austraila)
CT (n= 53) Improvement F, UUI
Subak et al. 2002100 (USA) RCT (n= 152) Improvement F, aged ≥ 55 years
Tadic et al. 2007102 (USA) RCT (n= 42) QoL F, aged ≥ 60 years, UUI
Wyman et al. 199831 (USA) RCT (n= 204) Cure (n= 62)
Improvement
QoL
F
CS, cross-sectional study; CT, clinical trial; F, female; M, male; NS, not stated.
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Interventions
The behavioural intervention consisted of PFMT on an individual basis with a physiotherapist, together with
a self-help guide modelled on health education theory.
Outcomes
The outcome measured in the first study69 was ‘intention to adhere’, measured by two questions: ‘Do you
intend to adhere to the exercise advice?’ and ‘Do you intend to exercise every day?’, using a seven-point
scale and summed to form one score.
The outcome measured in the second study70 was long-term adherence behaviour, measured by
self-report in a 7-day diary of number of days per week women had followed the physiotherapist’s
behavioural advice, categorised as optimal, moderate or poor adherence, and validated by three
items in a self-report questionnaire.
Time points of outcome measurement
Measurement of intention to adhere in the first study was prior to the trial, and measurement of long-term
adherence in the second study was 1 year post treatment.
Predictor variables
Variables included in multivariate analysis for prediction of intention to adhere or long-term adherence
behaviour were:
l physiological: severity of UI, type of UI
l general health: subjective general health
l psychological: health perceptions; history of sexual abuse after 18 years of age; health knowledge; sex
education at school; self-efficacy (abilities and difficulties); attitudes (pros and cons); pre-trial intention
to adhere; self-report of adherence behaviour during treatment
l social: social norms (normative beliefs of important persons about PFMT); social modelling (how many
other women known with PFMT experience); social support (how many other women discussed UI and
therapy); social demands (hours per week paid labour).
Quality of included studies
The first study69 was cross-sectional with data on predictors and outcome from self-report, collected at the
same time point, including UI type and severity. Ordering of questions is unclear. The selection of predictor
and outcome variables is model based, with clear definition of variables but the authors acknowledge
some problematic measurement issues. Sample size was sufficient for the reduced number of variables
included in multivariate analyses, but not for the number of variables included in the initial univariate
model. Analysis was judged inadequate because of choice of statistical tests for data type, and a
potentially inappropriate approach to adjustment for confounders.
The second study70 had the same problems of measurement of predictor variables, but outcome variable
definition and measurement was stronger. Sample size was again sufficient for multivariate analysis but
not for the number of variables included in the univariate model. There was 80% follow-up from the
original trial cohort, but more than 20% loss to analysis from outliers and missing data, with only 75 out
of 103 included in the multivariate analysis.
Generalisability of included studies
Both studies were women (only) with self-reported UI and who agreed to participate in a behavioural
intervention trial.
Predictors of treatment outcome
Six studies were included: one from more than 20 years ago,95 four over 10 years old,31,74,89,100 and
one from the past 10 years.102 Five studies were from the USA31,74,89,100,102 and one from Australia.95
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
33
There were 814 participants in the six studies for whom data were available. Two studies89,100 do not
report separate results according to type of incontinence (n= 257); the remaining studies reported results
separately for participants with SUI (n= 205) and urinary urgency/UUI or detrusor instability (n= 352).
Study type
One study was a clinical trial of a behavioural treatment programme95 and the remaining five were
analyses within RCTs of behavioural training.31,74,89,100,102
Participants
Only one study included both men and women.89 These participants were older (mean age 76 years)
housebound people. The other five trials were all limited to female participants, with two studies reporting
samples with a mean age > 70 years,100,102 two studies having samples with a mean age 60–70 years,31,74
and Oldenburg and Millard95 having a much younger sample with a mean age of 43 years.
Type of UI was urodynamically confirmed in four studies.31,74,95,102 The remaining two studies diagnosed
UI type by history.89,100 Two studies present separate results for women with SUI and UUI,31,74 two studies
present results for women with UUI only95,102 and two studies present results for MUI types.89,100
The definition of UI differed slightly between studies. Three studies specified a minimum of two episodes
of UI per week74,89,102 and two studies specified one episode of UI per week31,100 (as minimum for inclusion).
One study did not define minimum standards, instead referring to participants suffering from ‘excessive
frequency and urgency of micturition’.95 All studies required participants to be mentally/cognitively intact or
able to participate.
Interventions
All trials used PFMT with some degree of BIO. An exception was Subak et al.’s trial,100 where the low
intensity intervention provided verbal and written instruction on exercises. All trials except Burgio et al.74
and Tadic et al.102 included BT, and three trials74,89,102 also include stress and/or urge strategy training.
Outcomes
Cure Two studies reported cure of UI (defined as 100% reduction in UI episodes and measured using
self-report bladder diaries).31,74
Improvement All six studies measured degree of improvement using self-report bladder diaries: two studies
defined improvement as ≥ 75% reduction in incontinent episodes;31,74 two studies89,100 measured percentage
reduction in UI episodes; and McDowell et al.89 also classified people as responders (> 0% improvement)
and non-responders (0% improvement). Oldenburg and Millard95 reported patient rating of degree of
improvement in UI (defining success as cure or significant improvement) and patient rating of severity
of urological symptoms [defining scores 1 standard deviation (SD) above the group mean as failure and
scores less than this as success]. Severity was measured using a Bladder Symptom Score (no further details).
Other Two studies measured QoL using the IIQ, UDI31 and the Urge Impact Scale.102
Time points of outcome measurement All studies included a post-treatment measure of outcome.
One study95 only included therapist perception of outcome post treatment, but used all patient-derived
measurement at 18 months post treatment. Wyman et al.31 also included measurement at 3 months
post-treatment.
Predictor variables Variables entered into multivariate analyses as predictors of treatment outcomes for
CBIs are detailed in Table 14.
Sociodemographic variables Sex89 and years of education.74,89
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TABLE 14 Predictor variables included in multivariate analyses for treatment outcome
Variable category Indicator
Oldenburg and
Millard 198695
Wyman et al.
199831
McDowell et al.
199989
Burgio et al.
200374
Subak et al.
2002100
Tadic et al.
2007102
Sociodemographic Sex ✓
Education – – ✓ ✓ – –
Physiological Severity of UI ✓ ✓ ✓ ✓ –
Symptom severity ✓ – – – – –
Type of UI ✓ – ✓
Duration of UI ✓ – – – – –
Bladder capacity – – – ✓ – –
Previous treatment ✓ – – ✓ – –
Health/functional Medical history: arthritis – – – ✓ – –
Uses assistive device – – ✓ – – –
Self-care: functional status – – ✓ – – –
Caregiver requirement – – ✓ – – –
Psychological Adherence ✓ – ✓ – – –
Psychological problems ✓ – ✓ – – ✓
Perceptions of seriousness ✓ – – – – –
Perceptions of control ✓ – – – – –
Social Lives alone/with others – – ✓ – – –
✓, feature present; –, feature not present.
Shaded areas= study sample limited by sex or UI type so not available as a predictor variable.
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Physiological variables All studies except two89,102 included the major predictor variable of severity of UI.
McDowell et al.89 was the only study not limited to one type of UI or analysed in subgroups according
to type of UI. Previous treatment was included in two studies,74,95 and duration of UI95 and bladder
capacity74 in one study.
General health/functional ability variables One study included an aspect of medical history (arthritis)74
and one study included measures of functional ability or independence.89
Psychological variables Two studies that included measures of adherence and measures of psychological
problems as predictor variables89,95 investigated the impact of history of depression and current depressive
status on QoL and UI improvement.
Social variables Only the study by McDowell et al.89 with older housebound people included a social
predictor of lives alone/with others.
Quality of included studies Participant selection and characteristics were clear in all studies except
Oldenburg and Millard.95 The rationale for selection of predictors was unstated in all studies, although all
except McDowell et al.89 and Tadic et al.102 included the major variables of type/severity of UI. Definition
and measurement of predictor variables was clear in four studies.31,89,100,102 In the other two studies,
descriptive details and evidence of validity and reliability were lacking for some measurements, or some
variable parameters were not clearly specified.74,95 Outcome measurement was clear in four studies31,74,100,102
and unclear in two studies.89,95 No study described blinding of predictor and outcome measurement,
although one study indicated that analysts were blinded.100
Predictor variables were present in a significant proportion of the population in all studies, except
Tadic et al.102 Sample size was inadequate for the number of variables entered into multivariate analysis
in two studies.89,95 The number lost to follow-up and/or reasons for dropouts are not reported in three
trials.74,95,100 All studies used appropriate statistical tests except Oldenberg and Millard.95 Three trials
accounted for important confounders,31,74,100 but only two trials provided data on the precision of estimates
in the analysis.74,89
In summary, only two trials had a low number of design flaws that were unlikely to impact on internal
validity.31,100 One trial from the 1980s95 was considerably flawed, such that results were unlikely to be valid.
The remaining studies had significant weaknesses in either variable definition, sample size or confounding,
such that internal validity was also likely to be compromised to some extent.
Generalisability of included studies The representativeness of the sample was limited to older
housebound people in McDowell et al.,89 to women in the other five trials, and to women with urge
incontinence in Oldenburg and Millard95 and Tadic et al.102
Findings: studies of effectiveness
Results are presented for primary outcomes and then secondary outcomes. For each outcome,
post-treatment results will be presented, then results for follow-up to 12 months. Results of the
subgroup and sensitivity analyses will be presented at the end of the section.
For each outcome, results are split into subtotals for:
(a) comparisons against no treatment, usual care, placebo or attention control
(b) comparisons against another treatment.
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Subtotals are not pooled to give an overall treatment effect, as these were thought likely to differ between
no treatment and another treatment comparisons.
To avoid repetition, ‘no treatment’, placebo or usual care comparison groups are described using the
generic term ‘no treatment control’. The term also includes waitlist or attention control groups.
The comparisons in each trial are described in Description of included studies.
Two trials31,33 have three arms and therefore include two different intervention–comparison pairs. To avoid
including the same trial twice in a pooled effect, they have been dealt with as follows.
The trial by Burgio et al.33 includes two comparison groups: an attention control comparison; and another
treatment comparison (drug). These two comparison groups will be pooled separately in the comparison
subgroups above, so will not be counted twice.
In the trial by Wyman et al.,31 there are two comparison groups against another treatment (i.e. CBI vs. BT
or PFMT). To avoid overinflation of the pooled effect, the comparison least favourable to the combined
intervention on the primary outcome has been selected for inclusion, i.e. the comparison against BT
(referred to in the forest plots as aWyman 199831). This choice will be carried through all analyses.
However, if the comparison with PFMT (referred to in the forest plots as bWyman 199831) would be less
favourable to the combined intervention for any particular outcome, this will be given preference to
preserve the most conservative estimate of treatment effect. Although the difference in treatment effect
for the two comparison groups was usually very small, a sensitivity analysis including the other comparator
was always undertaken, and is presented where influential.
Results are presented for unfavourable events in the main. A reduction in unfavourable events is a positive
treatment impact. This is graphically displayed to the left of a forest plot (see Figure 1). However, three
outcomes are presented as a gain in favourable events (i.e. degree of improvement, subjective perceptions
of improvement and satisfaction with treatment). For these outcomes, a positive treatment impact is
displayed to the right of the forest plot (see Figures 4, 5 and 15). The exception is QoL which is displayed
as a reduction (i.e. to the left of the forest plot, because most QoL scales are scaled so that lower scores
are better). QoL scores which do not follow this rule, for example I-QOL have been multiplied by –1 so that
they can be pooled. Favourable results for QoL are therefore displayed to the left of a forest plot (e.g. less
impact of incontinence on QoL, less symptom distress).
Results are presented as:
l RR for binary (dichotomous) outcomes (e.g. continent/not continent)
l WMD for continuous data (e.g. grams of urine lost, number of incontinent episodes)
l SMD for continuous data where outcomes have been measured using different scales (e.g. QoL)
l SE when GIV has been used to pool binary and continuous outcomes.
All results are presented with 95% CIs.
Interpretations of value have been made as follows.
Effect sizes are statistically significant if p≤ 0.05, and are described as marginally statistically and
non-significant from p= 0.05 to 0.07. This small range was chosen for clarity, but it should be noted that
many of the p-values for treatment effects are below p= 0.10 and p-values in this range are therefore
reported for information.
Standardised mean differences and SEs are categorised as small (≤ 0.34), moderate (0.35–0.65) and large
(> 0.65), based on Cohen’s108 rules of thumb guidance from the social sciences of a SMD of 0.20 as a
small effect, 0.50 as a moderate effect and 0.80 as a large effect.
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Primary outcome
Cure
Number of people remaining incontinent (post treatment)
Three trials31,33,90 gave results for the proportion of participants remaining incontinent at post treatment,
by self-report in 1- or 2-week bladder diaries (i.e. not achieving 100% reduction in incontinent episodes).
The pooled results are presented in Figure 1.
For two trials33,90 with no treatment comparisons (n= 275, data available for 85%), the pooled effect was
statistically significant, favouring the CBI (RR 0.81, 95% CI 0.70 to 0.94).
For two trials31,33 with alternative treatment comparisons (n= 267, data available for 96%), the results
were marginally statistically non-significant (RR 0.87, 95% CI 0.75 to 1.01; p= 0.06).
Number of people remaining incontinent (follow-up to 12 months)
Wyman et al.31 (n= 204, data available for 91%) reported the proportion of participants not achieving
continence at 3 months post treatment (6 months post baseline). Results were not statistically significant
(RR 0.87, 95% CI 0.72 to 1.05).
Secondary outcomes
Improvement
Number of incontinent episodes per week (post treatment)
Eight trials31,33,73,76,82,89,90,100 including nine intervention comparison pairs reported the number of episodes
of incontinence per week at post treatment (between 6 and 12 weeks), measured by self-report in
1- or 2-week bladder diaries (except two trials73,76 where 3-day diaries were used). Bear et al.73 did not
provide data suitable for pooling. The results of the remaining eight studies are summarised in Figure 2.
Five trials33,76,89,90,100 included a no treatment comparison (n= 750, data available for 79%). Pooled
results show a statistically significant mean reduction in episodes of incontinence per week in CBI trials
(WMD –3.57, 95% CI –5.52 to –1.62).
Three trials (n= 309, data available for 95%) included comparison against another intervention.31,33,81
Pooled results were marginally statistically non-significant (WMD –2.18, 95% CI –4.53 to 0.17; p= 0.07).
Number of incontinent episodes per week (follow-up to 12 months)
Three trials31,76,81 reported follow up data (Figure 3). One trial with a no treatment comparison76 reported
statistically significant results favouring the CBI at 6 months post treatment (12 months post baseline)
(WMD –5.60, 95% CI –9.92 to –1.28).
Two trials31,81 with comparisons against other treatments (n= 179, data available for 88%) report results
for 3 months post treatment (6 months post baseline). The pooled effect was not statistically significant
(WMD –1.40, 95% CI –4.59 to 1.79).
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Review:
Comparison:
Outcome:
Combined behavioural training for UI
01 CURE
01 Number of people still incontinent post treatment
Study or subcategory
Treatment
n/N
Control
n/N
RR (fixed)
95% CI
Weight
(%)
RR (fixed)
95% CI
Combined behavioural treatment vs. placebo or no treatment
Combined behavioural treatment compared against another treatment
bBurgio 199833
McFall 200090
aBurgio 199833
aWyman 199831
Subtotal (95% CI)
Total events: 86 (treatment), 106 (control)
Test for heterogeneity: χ2 = 0.31, df = 1 (p = 0.58), l 2 = 0%
Test for overall effect: z = 1.87 (p = 0.006)
Subtotal (95% CI)
Total events: 76 (treatment), 101 (control) 
Test for heterogeneity: χ2 = 0.02, df = 1 (p = 0.89), l 2 = 0%
Test for overall effect: z = 2.76 (p = 0.006) 
44/63
32/49
112
44/63
42/61
124
50/65
56/68
133
54/62
47/59
121
56.07
43.93
100.00
0.80 (0.66 to 0.97)
0.82 (0.64 to 1.04)
0.81 (0.70 to 0.94)
48.17
57.83
100.00
0.91 (0.74 to 1.12)
0.84 (0.68 to 1.02)
0.87 (0.75 to 1.01)
0.5 0.7 1.0 1.5 2.0
Favours treatment Favours control
FIGURE 1 Number of people remaining incontinent: post treatment. aBurgio 199833= another treatment comparison (drug); bBurgio 199833= attention control comparison;
aWyman 199831= combined intervention vs. BT. df, degrees of freedom.
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Review:
Comparison:
Outcome:
Combined behavioural training for UI
02 IMPROVEMENT
01 Number of episodes of incontinence per week post treatment
Study or subcategory n n
304 100.00292
Treatment
mean (SD)
Control
mean (SD)
WMD (random)
95% CI
WMD (random)
95% CI
Weight
(%)
CBI vs. no treatment, placebo or usual care
bBurgio 199833
Dougherty 200276
McDowell 199989
McFall 200090
Subak 2002100
Subtotal (95% CI)
Test for heterogeneity: χ2 = 8.85, df = 4 (p = 0.07), l2 = 54.8%
Test for overall effect: z = 3.58 (p = 0.0003) 
63
78
48
49
66
2.80 (4.70)
7.00 (13.30)
1.80 (2.90)
3.55 (7.18)
5.20 (6.80)
62
69
45
59
57
8.20 (11.60)
12.60 (13.30)
3.50 (3.00)
5.90 (8.46)
11.00 (17.40)
18.36
11.53
40.78
19.65
9.69
–5.40 (–8.51 to –2.29)
–5.60 (–9.91 to –1.29)
–1.70 (–2.90 to –0.50)
–2.35 (–5.30 to –0.60)
–5.80 (–10.61 to –0.99)
–3.57 (–5.52 to –1.62)
144 100.00149
CBI vs. another treatment
aBurgio 199833
Kafri 200781
aWyman 199831
Subtotal (95% CI)
Test for heterogeneity: χ2 = 2.46, df = 2 (p = 0.29), l2 = 18.8%
Test for overall effect: z = 1.82 (p = 0.07) 
63
20
61
2.80 (4.70)
3.30 (7.70)
6.80 (10.70)
65
16
68
5.70 (9.80)
2.60 (5.40)
10.60 (16.30)
50.80
26.44
22.76
–2.90 (–5.55 to –0.25)
0.70 (–3.59 to 4.99)
–3.80 (–8.51 to 0.91)
–2.18 (–4.53 to 0.17)
–10 –5
Favours treatment Favours control
0 5 10
FIGURE 2 Number of incontinent episodes: post treatment. aBurgio 199833= another treatment comparison (drug); bBurgio 199833= attention control comparison;
aWyman 199831= combined intervention vs. BT. df, degrees of freedom.
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Review:
Comparison:
Outcome:
Combined behavioural training for UI
02 IMPROVEMENT
02 Number of episodes of incontinence per week at follow-up
Study or subcategory n n
59 100.00 –5.60 (–9.92 to –1.28)52
Treatment
mean (SD)
Control
mean (SD)
WMD (fixed)
95% CI
WMD (fixed)
95% CI
Weight
(%)
CBI vs. no treatment, placebo or usual care
Dougherty 200276
Subtotal (95% CI)
Test for heterogeneity: not applicable
Test for overall effect: z = 2.54 (p = 0.01) 
59 6.30 (11.20) 52 11.90 (11.90) 100.00 –5.60 (–9.92 to –1.28)
80 100.00 –1.40 (–4.59 to 1.79)78
45.79
54.21
–0.80 (–5.51 to 3.91)
–1.90 (–6.23 to 2.43)
CBI vs. another treatment
20
60
3.70 (8.90)
8.10 (12.40)
16
62
4.50 (5.40)
10.00 (12.00)
Kafri 200781
aWyman 199831
–10 –5
Favours treatment Favours control
0 5 10
Subtotal (95% CI)
Test for heterogeneity: χ2 = 0.11, df = 1 (p = 0.74), l2 = 0%
Test for overall effect: z = 0.86 (p = 0.39) 
FIGURE 3 Number of incontinent episodes: follow-up to 12 months. aWyman 199831= combined intervention vs. BT. df, degrees of freedom.
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1
Proportion of people achieving 75% or more reduction in incontinent
episodes (post treatment)
Three trials31,33,90 with four relevant intervention comparison pairs gave results for the proportion of
participants achieving 75% or more reduction in incontinent episodes at post treatment, by self-report in
1- or 2-week bladder diaries (see Figure 4).
For two trials33,90 including no treatment comparisons (n= 275, data available for 85%), the pooled effect
was statistically significant favouring the CBI (RR 2.16, 95% CI 1.58 to 2.95).
Two trials31,33 included another treatment comparison. The pooled effect (n= 265, data available for 97%)
was statistically significant favouring the CBI for the comparison including the Wyman et al.31 BT comparison
group (RR 1.40, 95% CI 1.12 to 1.75; as illustrated in Figure 4); but statistically non-significant with the
inclusion of the Wyman et al.31 PFMT comparison group (RR 1.60, 95% CI 0.94 to 2.73; p= 0.08).
Proportion of people achieving 75% or more reduction in incontinent
episodes (follow-up to 12 months)
One of the trials31 also reported results for 75% or more reduction in incontinent episodes at 6 months
post baseline (3 months post treatment). The effect size (n= 204, data available for 92%) was statistically
significant favouring the CBI for the comparison with BT (RR 1.79, 95% CI 1.16 to 2.78); but not
statistically significant for the comparison with PFMT (RR 1.32, 95% CI 0.92 to 1.91).
Subject perceptions of improvement
Post treatment
Two trials31,33 with three relevant comparison groups gave results for the proportion of participants who
classified their incontinence as ‘much better’ at post treatment, by self-report on four- or five-point scales.
Results are summarised in Figure 5.
One trial33 reported comparison against a placebo control group (n= 130, data available for 85%), with a
statistically significant effect size favouring the CBI (RR 2.75, 95% CI 1.72 to 4.42).
Two trials31,33 included comparisons against another treatment (n= 265, data available for 91%).
The pooled effect was also statistically significant favouring the CBI (RR 1.42, 95% CI 1.12 to 1.81).
Follow-up to 12 months
One trial31 comparing a CBI with either BT or PFMT (n= 204, results available for 90%) gave results
for patient perception of UI as ‘much better’ at 6 months post baseline (3 months post treatment).
The effect size was just statistically significant for the BT comparison group favouring the CBI (RR 1.53,
95% CI 1.00 to 2.32; p= 0.05); but not statistically significant for the PFMT comparison group (RR 1.43,
95% CI 0.96 to 2.12; p= 0.08).
Severity of incontinence
Grams of urine lost in 24 hours (post treatment)
Four studies used a pad test to evaluate severity of urine loss31,71,73,76,109 (Wyman et al.31 reported in
Elser et al.109). However, Elser et al.109 did not report data separately for each treatment group, and
Bear et al.73 reported mean grams of urine loss per day, but no SDs. Results for the remaining trials using
no treatment comparison groups71,76 are illustrated in Figure 6.
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Review:
Comparison:
Outcome:
Combined behavioural training for UI
02 IMPROVEMENT
03 75% or more reduction in incontinent episodes 
Study or subcategory
Treatment
n/N
Control
n/N
RR (fixed)
95% CI
Weight
(%)
RR (fixed)
95% CI
CBI vs. no treatment, placebo or usual care 
CBI vs. another treatment (including aWyman 1998 BT)
bBurgio 199833 
McFall 200090
aBurgio 199833
aWyman 199831
Subtotal (95% CI)
Total events: 79 (treatment), 60 (control)
Test for heterogeneity: χ2 = 0.86, df = 1 (p = 0.35), I2 = 0%
Test for overall effect: z = 2.95 (p = 0.003)
Subtotal (95% CI)
Total events: 71 (treatment), 35 (control) 
Test for heterogeneity: χ2 = 0.13, df = 1 (p = 0.72), I2 = 0%
Test for overall effect: z = 4.84 (p = 0.00001) 
46/63
25/49
112
46/63
33/61
124
37/65
23/68
133
20/62
15/59
121
59.70
40.30
100.00
2.26 (1.53 to 3.35)
2.01 (1.20 to 3.36)
2.16 (1.58 to 2.95)
62.61
37.39
100.00
1.28 (0.99 to 1.66)
1.60 (1.07 to 2.40)
1.40 (1.12 to 1.75)
0.5 1.0 5.0 10.0
Favours control Favours treatment
0.1 0.2 2.0
FIGURE 4 Seventy-five per cent or more reduction in incontinent episodes: post treatment. aBurgio 199833= another treatment comparison (drug); bBurgio 199833= attention
control comparison; aWyman 199831= combined intervention vs. BT. df, degrees of freedom.
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Review:
Comparison:
Outcome:
Combined behavioural training for UI
03 PATIENT PERCEPTIONS
01 Subjective judgement: urinary incontinence as much better post treatment
Study or subcategory
Treatment
n/N
Control
n/N
RR (fixed)
95% CI
Weight
(%)
RR (fixed)
95% CI
CBI vs. no treatment, placebo or usual care 
bBurgio 199833 43/58 14/52
CBI vs. another treatment
aBurgio 199833
aWyman 199831
Subtotal (95% CI)
Total events: 75 (treatment), 53 (control)
Test for heterogeneity: χ2 = 0.04, df = 1 (p = 0.84), I 2 = 0%
Test for overall effect: z = 2.87 (p = 0.004)
Subtotal (95% CI)
Total events: 43 (treatment), 14 (control) 
Test for heterogeneity: not applicable
Test for overall effect: z = 4.20 (p < 0.0001) 
58
43/58
32/61
119
28/55
25/66
121
52
100.00
100.00
2.75 (1.72 to 4.42)
2.75 (1.72 to 4.42)
54.48
45.52
100.00
1.46 (1.08 to 1.97)
1.38 (0.94 to 2.05)
1.42 (1.12 to 1.81)
0.5 1.0 5.0 10.0
Favours control Favours treatment
0.1 0.2 2.0
FIGURE 5 Subject perceptions of improvement: post treatment. aBurgio 199833= another treatment comparison (drug); bBurgio 199833= attention control comparison;
aWyman 199831= combined intervention vs. BT. df, degrees of freedom.
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Results were pooled using GIV and a random-effects model given the substantial heterogeneity of
treatment effect (I2= 77.9%) (see Figure 6). The result was not statistically significant (SE –0.70,
95% CI –2.41 to 1.01).
Dougherty et al.76 also provided a subjective measure of severity of urine loss, rated 1–7, with 7 defined as
‘the best bladder control you can imagine’ and 1 defined as ‘the worst bladder control you can imagine’.
Treatment effects were significantly different between experimental and control conditions favouring the
CBI (SMD –1.21, 95% CI –0.86 to –1.56).
Grams of urine lost in 24 hours (follow-up to 12 months)
The same two trials included follow-up data: Dougherty et al.76 at 12 months post baseline (6 months post
treatment) and Aslan et al.71 at 6 months post baseline (4 months post treatment).
The pooled effect (Figure 7) using GIV and a fixed-effects model was statistically significant favouring
the CBI (SE –0.43, 95% CI –0.80 to –0.06). However, by using a random-effects model to facilitate
comparison at post treatment and follow-up, the pooled effect was not statistically significant (SE –0.60,
95% CI –1.47 to 0.26).
Symptoms
Urinary frequency (post treatment)
Five studies provided data on the number of voids during the day (Figure 8). Four studies (n= 579, data
available for 75%) compared a CBI with no treatment.71,76,90,100 GIV was used to combine dichotomous
outcomes from Aslan et al.71 with the continuous outcome data from the other three trials. Using a
random-effects model given the substantial heterogeneity of treatment effects (I2= 74.9%), the pooled
result was statistically significant favouring the CBI (SE –0.55, 95% CI –0.97 to –0.13).
The result for one quasi-randomised trial81 comparing a CBI against GIV was used to combine dichotomous
outcomes from Aslan et al.71 with the continuous outcome another treatment (n= 44, data available for
82%) was not statistically significant (SE –0.04, 95% CI –0.70 to 0.62; WMD –0.10, 95% CI –1.83 to 1.63).
Urinary frequency (follow-up to 12 months)
Three studies reported follow-up results for frequency of micturition during the day. Two studies (n= 282,
data available for 57%) compared combined behavioural training against a no-treatment control (Figure 9).
Aslan et al.71 reported data for 6 months post baseline (4 months post treatment). Dougherty et al.76
reported data for 12 months post-baseline (6 months post treatment). Using a random-effects model given
the substantial heterogeneity of treatment effects (I2= 74.3%), the pooled effect was not statistically
significant (SE –0.63, 95% CI –1.48 to 0.22).
In a quasi-experimental study comparing a CBI against medication, Kafri et al.81 reported a statistically
significant treatment effect favouring the CBI for 6 months post-baseline (3 months post treatment)
(SE –0.71, 95% CI –1.39 to –0.03; WMD –1.70, 95% CI –3.26 to –0.14).
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Review:
Comparison:
Outcome:
Combined behavioural training for UI
05 SYMPTOMS
01 Frequency: number of voids during the day at post treatment 
Study or subcategory SE
SE (random)
95% CI
Weight
(%)
SE (random)
95% CI 
100.00
Combined behavioural treatment vs. no treatment, placebo or usual care
Aslan 200871
Dougherty 200276
McFall 200090
Subak 2002100
Subtotal (95% CI)
Test for heterogeneity: χ2 = 11.97, df = 3 (p = 0.007), l2 = 74.9%
Test for overall effect: z = 2.54 (p = 0.01) 
–1.4160 (0.4100)
–0.0600 (0.1660)
–0.6400 (0.1990)
–0.4900 (0.1840)
14.98
29.50
27.24
28.27
–1.42 (–2.22 to –0.61)
–0.06 (–0.39 to 0.27)
–0.64 (–1.03 to –0.25)
–0.49 (–0.85 to –0.13)
–0.55 (–0.97 to –0.13)
100.00 –0.04 (–0.70 to 0.62)
Combined behavioural treatment vs. another treatment
Kafri 200781
Subtotal (95% CI)
Test for heterogeneity: not applicable
Test for overall effect: z = 0.12 (p = 0.91) 
–0.0400 (0.3370) 100.00 –0.04 (–0.70 to 0.62)
–4 –2
Favours treatment Favours control
0 2 4
FIGURE 8 Frequency (number of voids during the day): post treatment. df, degrees of freedom.
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Review:
Comparison:
Outcome:
Combined behavioural training for UI
05 SYMPTOMS
02 Frequency: number of voids during the day at follow-up
Study or subcategory SE
SE (random)
95% CI
Weight
(%)
SE (random)
95% CI 
Combined behavioural treatment vs. no treatment, placebo or usual care
Aslan 200871
Dougherty 200276
Subtotal (95% CI)
Test for heterogeneity: χ2 = 3.89, df = 3 (p = 0.05), I 2 = 74.3%
Test for overall effect: z = 1.44 (p = 0.15) 
–1.1430 (0.4050)
–0.2600 (0.1910)
35.17
64.83
100.00
–1.14 (–1.94 to –0.35)
–0.26 (–0.63 to –0.11)
–0.63 (–1.48 to –0.22)
Combined behavioural treatment vs. another treatment
Kafri 200781
Subtotal (95% CI)
Test for heterogeneity: not applicable
Test for overall effect: z = 2.05 (p = 0.04) 
–0.7100 (0.3470) 100.00
100.00
–0.71 (–1.39 to –0.03)
–0.71 (–1.39 to –0.03)
–4 –2
Favours treatment Favours control
0 2 4
FIGURE 9 Frequency (number of voids during the day): at follow-up to 12 months. df, degrees of freedom.
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9
Nocturia (post treatment)
Six trials reported results for the number of voids during the night. The results for five trials33,71,76,90,100 using
a no treatment comparison are illustrated in Figure 10.
Generic inverse variance was used to combine dichotomous and continuous outcomes, and substantial
heterogeneity of treatment effect (I2= 89.5%) necessitated the use of a random-effects model. Pooled
results (n= 709, data available for 72%) were not statistically significant (SE –0.33, 95% CI –0.95 to 0.29).
Two trials33,81 compared a CBI against another treatment (drug therapy). Results (n= 176, data available
for 73%) were statistically significant favouring the CBI (SE –0.46, 95% CI –0.81 to –0.11; WMD –0.36,
95% CI –0.67 to –0.04).
Nocturia (follow-up to 12 months)
Three trials reported data for nocturia at follow-up.71,76,81
Two trials reported no treatment comparisons: Aslan et al.71 reported results for 6 months post baseline
(4 months post treatment); Dougherty et al.76 reported results for 12 months post baseline (6 months
post treatment). Results are illustrated in Figure 11.
Pooled results (n= 282, data available for 59%) were not statistically significant (SE –0.97,
95% CI –3.30 to 1.37).
One quasi-randomised trial81 compared combined behavioural training with another treatment. Results
(n= 44, data available for 82%) at 6 months post baseline (4 months post treatment) were statistically
significant favouring the CBI (SE –0.89, 95% CI –1.59 to –0.19; WMD –1.00, 95% CI –1.75 to –0.25).
Urgency (post treatment)
Only one quasi-randomised trial71 reported results for urinary urgency (n= 64, data available for 78%).
The number of people reporting that symptoms of urgency were unchanged or worse was statistically
significant post-treatment favouring the CBI, compared with a no treatment control group (RR 0.57,
95% CI 0.37 to 0.89).
Urgency (follow-up to 12 months)
Aslan et al.71 also reported results for urinary urgency at 6 months post baseline (4 months post treatment).
The number of people (n= 64, data available for 78%) reporting that symptoms of urgency were
unchanged or worse was statistically non-significant (RR 0.67, 95% CI 0.41 to 1.07; p= 0.09).
Quality of life
Post treatment
Two different aspects of QoL were measured in the trials: scales measuring the impact of incontinence;
and scales measuring symptom distress. Owing to the difference in the underlying concepts, these
measures were not pooled and results are presented separately.
Impact of incontinence (post treatment)
Five trials included a measure of disease-specific QoL but two of these trials did not report data in a form
suitable for pooling. Aslan et al.71 used the King’s Health Questionnaire, but post-treatment data were
not reported. McFall et al.90 used the Short Form questionnaire-36 items (SF-36), but do not report data
separately for treatment and control group, other than mean scores on one subscale.
Three trials reported data suitable for pooling. Dougherty et al.76 and Wyman et al.31 used the IIQ
(lower score= improvement). Kafri et al.81 used the I-QOL (higher score= improvement). To harmonise the
direction of scores, results for Kafri et al.81 were entered as negative. Substantial between trial heterogeneity
(I2= 75.8%) necessitated the use of a random-effects model for pooling. Results are presented in Figure 12.
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Review:
Comparison:
Outcome:
Combined behavioural training for UI
05 SYMPTOMS
03 Nocturia: number of voids during the night at post treatment
Study or subcategory SE
SE (random)
95% CI
Weight
(%)
SE (random)
95% CI 
Combined behavioural treatment vs. no treatment, placebo or usual care
Aslan 200871
bBurgio 199833
Dougherty 200276
McFall 200090
Subak 2002100
Subtotal (95% CI)
Test for heterogeneity: χ2 = 37.97, df = 4 (p = 0.0001), l2 = 89.5%
Test for overall effect: z = 1.04 (p = 0.30) 
–1.7700 (0.8200)
–0.9200 (0.2300)
–0.5000 (0.1680)
–0.0400 (0.1940)
–0.6300 (0.1860)
7.92
22.04
23.72
23.05
23.26
100.00
–1.77 (–3.38 to –0.16)
–0.92 (–1.37 to –0.47)
–0.50 (–0.83 to –0.17)
0.04 (–0.34 to 0.42)
0.63 (0.27 to 0.99)
–0.33 (–0.95 to 0.29)
Combined behavioural treatment vs. another treatment
aBurgio 199833
Kafri 200781
–0.4200 (0.2090)
–0.5800 (0.3440)
54.97
45.03
100.00
–0.42 (–0.83 to –0.01)
–0.58 (–1.25 to 0.09)
–0.46 (–0.81 to –0.11)Subtotal (95% CI)
Test for heterogeneity: χ2 = 0.16, df = 1 (p = 0.69), l2 = 0%
Test for overall effect: z = 2.59 (p = 0.010) 
–4 –2
Favours treatment Favours control
0 2 4
FIGURE 10 Nocturia (number of voids during the night): post treatment results for no treatment comparisons. aBurgio 199833= another treatment comparison (drug);
bBurgio 199833= attention control comparison. df, degrees of freedom.
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1
Review:
Comparison:
Outcome:
Combined behavioural training for UI
05 SYMPTOMS
05 Nocturia: number of voids during the night at follow-up
Study or subcategory SE
SE (random)
95% CI
Weight
(%)
SE (random)
95% CI 
Combined behavioural treatment vs. no treatment, placebo or usual care
Aslan 200871
Dougherty 200276
Subtotal (95% CI)
Test for heterogeneity: χ2 = 8.15, df = 3 (p = 0.004), l2 = 87.7%
Test for overall effect: z = 0.81 (p = 0.42) 
–2.2960 (0.8170)
–0.1000 (0.1910)
35.52
64.48
100.00
–2.30 (–3.90 to –0.69)
0.10 (–0.27 to 0.47)
–0.97 (–3.30 to 1.37)
Combined behavioural treatment vs. another treatment
Kafri 200782
Subtotal (95% CI)
Test for heterogeneity: not applicable
Test for overall effect: z = 2.51 (p = 0.01) 
–0.8900 (0.3550) 100.00
100.00
–0.89 (–1.59 to –0.19)
–0.89 (–1.59 to –0.19)
–4 –2
Favours treatment Favours control
0 2 4
FIGURE 11 Nocturia (number of voids during the night): follow-up to 12 months for no treatment comparisons. df, degrees of freedom.
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2
Review:
Comparison:
Outcome:
Combined behavioural training for UI
06 QUALITY OF LIFE
01 Quality of life: impact of incontinence post treatment
Study or subcategory n n
78 69
Treatment
mean (SD)
Control
mean (SD)
SMD (random)
95% CI
SMD (random)
95% CI
Weight
(%)
CBI vs. no treatment, placebo or usual care
Dougherty 200276
Subtotal (95% CI)
Test for heterogeneity: not applicable
Test for overall effect: z = 2.81 (p = 0.005) 
78 38.90 (11.00) 69 44.70 (13.50) 100.00
100.00
–0.47 (–0.80 to –0.14)
–0.47 (–0.80 to –0.14)
81 82
30.83
69.17
100.00
–1.19 (–1.91 to –0.47)
–0.36 (–0.71 to –0.01)
–0.71 (–1.52 to 0.09)
CBI vs. another treatment
20
61
–95.40 (13.50)
46.60 (65.30)
–73.20 (22.90)
72.10 (75.20)
16
66
Kafri 200781
aWyman 199831
–4 –2
Favours treatment Favours control
0 2 4
Subtotal (95% CI)
Test for heterogeneity: χ2 = 4.14, df = 1 (p = 0.04), l2 = 75.8%
Test for overall effect: z = 1.74 (p = 0.08) 
FIGURE 12 Quality of life (impact of incontinence): post treatment. aWyman 199831= combined intervention vs. BT. df, degrees of freedom.
D
O
I:
1
0
.3
3
1
0
/p
g
fa
r0
3
0
1
0
P
R
O
G
R
A
M
M
E
G
R
A
N
TS
FO
R
A
P
P
LIE
D
R
E
S
E
A
R
C
H
2
0
1
5
V
O
L.
3
N
O
.
1
©
Q
u
e
e
n
’s
P
rin
te
r
a
n
d
C
o
n
tro
lle
r
o
f
H
M
S
O
2
0
1
5
.
T
h
is
w
o
rk
w
a
s
p
ro
d
u
ce
d
b
y
T
h
o
m
a
s
e
t
a
l.
u
n
d
e
r
th
e
te
rm
s
o
f
a
co
m
m
issio
n
in
g
co
n
tra
ct
issu
e
d
b
y
th
e
S
e
cre
ta
ry
o
f
S
ta
te
fo
r
H
e
a
lth
.
T
h
is
issu
e
m
a
y
b
e
fre
e
ly
re
p
ro
d
u
ce
d
fo
r
th
e
p
u
rp
o
se
s
o
f
p
riva
te
re
se
a
rch
a
n
d
stu
d
y
a
n
d
e
xtra
cts
(o
r
in
d
e
e
d
,
th
e
fu
ll
re
p
o
rt)
m
a
y
b
e
in
clu
d
e
d
in
p
ro
fe
ssio
n
a
l
jo
u
rn
a
ls
p
ro
vid
e
d
th
a
t
su
ita
b
le
a
ck
n
o
w
le
d
g
e
m
e
n
t
is
m
a
d
e
a
n
d
th
e
re
p
ro
d
u
ctio
n
is
n
o
t
a
sso
cia
te
d
w
ith
a
n
y
fo
rm
o
f
a
d
ve
rtisin
g
.
A
p
p
lica
tio
n
s
fo
r
co
m
m
e
rcia
l
re
p
ro
d
u
ctio
n
sh
o
u
ld
b
e
a
d
d
re
sse
d
to
:
N
IH
R
Jo
u
rn
a
ls
Lib
ra
ry,
N
a
tio
n
a
l
In
stitu
te
fo
r
H
e
a
lth
R
e
se
a
rch
,
E
va
lu
a
tio
n
,
T
ria
ls
a
n
d
S
tu
d
ie
s
C
o
o
rd
in
a
tin
g
C
e
n
tre
,
A
lp
h
a
H
o
u
se
,
U
n
ive
rsity
o
f
S
o
u
th
a
m
p
to
n
S
cie
n
ce
P
a
rk
,
S
o
u
th
a
m
p
to
n
S
O
1
6
7
N
S
,
U
K
.
5
3
Impact of incontinence (follow-up to 12 months)
The same three trials measured impact of incontinence at follow-up: Dougherty et al.76 at 12 months
post baseline (6 months post treatment); and the other two trials31,81 at 6 months post baseline
(3 months post treatment) (Figure 13).
Dougherty et al.76 compared a CBI with no treatment control. The effect (n= 218, data available for 51%)
was marginally statistically non-significant (SMD –0.36, 95% CI –0.74 to 0.01; p= 0.06).
A random-effects model was used due to the heterogeneity of treatment effect (I2= 85.7%) to pool the
two trials using comparison against another treatment.31,81 The pooled effect size (n= 179, data available
for 86%) was not statistically significant (SMD –0.57, 95% CI –1.62 to 0.49).
Symptom distress (post treatment)
Two studies used measures of symptom distress or impact. Burgio et al.33 used the Symptom-Checklist-90-
Revised; Wyman et al.31 used the UDI. Results are summarised in Figure 14.
One trial33 compared combined behavioural training with a placebo control group (n= 130, data available
for 61%). Results showed no statistically significant difference (SMD –0.05, 95% CI –0.44 to 0.34).
A random-effects model was used to pool the results of the two trials using comparisons against another
treatment because of substantial heterogeneity in treatment effects (I2= 92.5%). Results (n= 265, data
available for 89%) showed no statistically significant between-groups difference in treatment effects
(SMD –0.46, 95% CI –1.41 to 0.50).
Symptom distress (follow-up to 12 months)
One trial31 assessed symptom distress at 6 months post baseline (3 months post treatment). The treatment
effect (n= 135, data available for 89%) was marginally statistically non-significant for the BT comparison
group (SMD –0.36, 95% CI –0.72 to 0.01; p= 0.06); but not statistically significant for the comparison
with PFMT (SMD –0.24, 95% CI –0.59 to 0.12).
Satisfaction with treatment
For the outcome of satisfaction, only comparisons with another treatment were included, as satisfaction for
a non-treatment condition is not a meaningful outcome.
Two studies using comparisons against another treatment reported rates of satisfaction. Burgio et al.33
used a three-point scale (completely, somewhat, or not at all satisfied) with a comparison group who
received the drug oxybutinin. Wyman et al.31 used a four-point scale (very, slightly, neither, dissatisfied,
or very dissatisfied) in comparison groups receiving single behavioural interventions, i.e. BT or PFMT.
Results are presented for people who scored ‘completely satisfied’ in Burgio et al.33 and for people who
scored ‘very satisfied’ in Wyman et al.31 (Figure 15).
Satisfaction with a CBI was statistically significantly higher than for other treatments (RR 1.41, 95% CI
1.18 to 1.68).
Adverse effects
Two studies33,81 comparing a CBI against drug therapy were the only studies to measure adverse events
(n= 241, data available for 66%). Burgio et al.33 used an adverse events checklist for the side effects of
oxybutinin, and also asked women whether or not they were comfortable enough with treatment to
continue indefinitely.
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Review:
Comparison:
Outcome:
Combined behavioural training for UI
06 QUALITY OF LIFE
02 Quality of life: impact of incontinence at follow-up to 12 months
Study or subcategory n n
52
Treatment
mean (SD)
Control
mean (SD)
SMD (random)
95% CI
SMD (random)
95% CI
Weight
(%)
CBI vs. no treatment, placebo or usual care
Dougherty 200276
Subtotal (95% CI)
Test for heterogeneity: not applicable
Test for overall effect: z = 1.89 (p = 0.06) 
59
59
38.20 (11.60) 52 43.10 (15.30) 100.00
100.00
–0.36 (–0.74 to –0.1)
–0.36 (–0.74 to –0.1)
38.51
61.49
100.00
–1.15 (–1.87 to –0.44)
–0.07 (–0.43 to 0.29)
–0.57 (–1.62 to 0.49)
CBI vs. another treatment
20
58
78
–94.20 (15.50)
59.80 (83.90)
–70.60 (24.60)
65.70 (80.20)
16
60
76
Kafri 200781
aWyman 199831
–4 –2
Favours treatment Favours control
0 2 4
Subtotal (95% CI)
Test for heterogeneity: χ2 = 6.99, df = 1 (p = 0.008), I2 = 85.7%
Test for overall effect: z = 1.05 (p = 0.29) 
FIGURE 13 Quality of life: impact of incontinence: follow up to 12 months. aWyman 199831= combined intervention vs. BT. df, degrees of freedom.
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Review:
Comparison:
Outcome:
Combined behavioural training for UI
06 QUALITY OF LIFE
03 Quality of life: symptom distress post treatment
Study or subcategory n n
57 46
Treatment
mean (SD)
Control
mean (SD)
SMD (random)
95% CI
SMD (random)
95% CI
Weight
(%)
CBI vs. no treatment, placebo or usual care
bBurgio 199833
Subtotal (95% CI)
Test for heterogeneity: not applicable
Test for overall effect: z = 0.25 (p = 0.080) 
57 50.80 (12.80) 46 51.40 (10.90) 100.00
100.00
–0.05 (–0.44 to 0.34)
–0.05 (–0.44 to 0.34)
118 119
49.84
50.16
100.00
0.03 (–0.34 to 0.41)
–0.94 (–1.31 to –0.58)
–0.46 (–1.41 to 0.50)
CBI vs. another treatment
57
61
50.80 (12.80)
46.40 (48.60)
50.40 (10.00)
95.50 (54.40)
52
67
aBurgio 199833
aWyman 199831
–4 –2
Favours treatment Favours control
0 2 4
Subtotal (95% CI)
Test for heterogeneity: χ2 = 13.34, df = 1 (p = 0.0003), I2 = 92.5%
Test for overall effect: z = 0.93 (p = 0.35) 
FIGURE 14 Quality of life (symptom distress): post treatment. aBurgio 199833= another treatment comparison (drug); bBurgio 199833= attention control comparison;
aWyman 199831= combined intervention vs. BT. df, degrees of freedom.
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Review:
Comparison:
Outcome:
Combined behavioural training for UI
07 SATISFACTION WITH TREATMENT
01 Number of people satisfied with treatment
Study or subcategory
Treatment
n/N
Control
n/N
RR (fixed)
95% CI
Weight
(%)
RR (fixed)
95% CI
CBI vs. another treatment
aBurgio 199833
aWyman 199831
Subtotal (95% CI)
Total events: 95 (treatment), 53 (control)
Test for heterogeneity: χ2 = 1.20, df = 1 (p  = 0.27), l2 = 16.9%
Test for overall effect: z  = 3.73 (p  = 0.0002)
45/58
50/61
119
27/55
42/66
121
40.72
59.28
100.00
1.58 (1.17 to 2.14)
1.29 (1.04 to 1.60)
1.41 (1.18 to 1.68)
0.5 1.0 5.0
Favours control Favours treatment
0.2 2.0
FIGURE 15 Satisfaction with treatment: post treatment. aBurgio 199833= another treatment comparison (drug); aWyman 199831= combined intervention vs. BT.
df, degrees of freedom.
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Although 96% of the group receiving the behavioural intervention were happy to continue, 55% of the
drug therapy group and 43% of the placebo group were happy to continue.
One quasi-experimental study81 comparing a CBI against drug treatment with oxybutinin measured the
total number of adverse events per patient for the study period (n= 44, data available for 82%). The effect
size was just statistically significant favouring the CBI (WMD –1.20, 95% CI –2.40 to 0.00; p= 0.05).
Summary: review of effectiveness
Pooled effect sizes for all outcomes are provided in Table 15. Pooled results for comparison with
another treatment will be summarised first. If results are not significant for any outcome, results from
the no treatment comparison will be considered.
Post treatment
Table 15 shows a summary of pooled effect sizes per outcome.
TABLE 15 Summary of pooled effect sizes per outcome: post treatment
Outcome
Pooled effect size (95% CI)
Number of
comparisons
No treatment
comparison
Number of
comparisons
Another treatment
comparison
Not cured: number of
people remaining
incontinent
2 RR 0.81 (0.70 to 0.94)b 2 RR 0.87 (0.75 to 1.01)a
Improvement: number
of incontinence
episodes
5 WMD –3.57 (–5.52 to –1.62)b 3 WMD –2.18 (–4.53 to 0.17)a
Improvement: ≥ 75%
reduction in UI
episodes
2 RR 2.16 (1.58 to 2.95)b 2 RR 1.60 (0.94 to 2.73)
Subject perceptions of
improvement (much
better)
1 RR 2.75 (1.72 to 4.42)b 2 RR 1.42 (1.12 to 1.81)b
Severity of incontinence
(grams urine lost per
24 hours)
2 SE –0.70 (–2.41 to 1.01) 0 –
Symptoms: frequency 4 SE –0.55 (–0.97 to –0.13)b 1 SE –0.04 (–0.70 to 0.62)
Symptoms: nocturia 5 SE –0.33 (–0.95 to 0.29) 2 SE –0.46 (–0.81 to –0.11)b
Symptoms: urgency 1 RR 0.57 (0.37 to 0.89)b 0 –
QoL: impact of
incontinence
1 SMD –0.47 (–0.80 to –0.14)b 2 SMD –0.71 (–1.52 to 0.09)
QoL: symptom distress 1 SMD –0.05 (–0.44 to 0.34) 2 SMD –0.46 (–1.41 to 0.50)
Satisfaction with
treatment
0 – 2 RR 1.41 (1.18 to 1.68)b
Adverse events – – 1 WMD –1.20 (–2.40 to 0.00)b
SE, standardised effect (via GIV).
a Marginally statistically non-significant (p= 0.05 to 0.07).
b Statistically significant.
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Comparison with another treatment
Primary outcome Pooled results for the number of people remaining incontinent were marginally
statistically non-significant (RR 0.87, 95% CI 0.75 to 1.01; p= 0.06).
Secondary outcomes Results were statistically significant favouring the CBI for:
l subject perceptions of improvement
l nocturia
l satisfaction with treatment
l number of adverse events.
Results were marginally statistically (non)-significant for:
l number of incontinence episodes.
Results were not statistically significant for:
l 75% or more reduction in incontinent episodes
l urinary frequency
l QoL – impact of incontinence, symptom distress.
Comparison against no treatment
Primary outcome The pooled effect for the chance of a person remaining incontinent was statistically
significant favouring the CBI (RR 0.81, 95% CI 0.70 to 0.94).
Secondary outcomes The secondary outcomes that were not statistically significant (marginal or
otherwise) in comparison with another treatment that were statistically significant favouring the CBI
when compared with placebo, no treatment or usual care, are:
l number of incontinence episodes
l 75% or more reduction in incontinent episodes
l urinary frequency
l QoL – impact of incontinence.
One other outcome that was not tested against another treatment was statistically significant favouring
the CBI when compared against placebo, no treatment or usual care:
l urinary urgency.
Two outcomes were not statistically significant in any comparison:
l severity of incontinence (grams of urine lost per 24 hours)
l QoL – symptom distress.
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Follow-up to 12 months
Table 16 shows a summary of pooled effect sizes per outcome.
Comparison against another treatment
Primary outcome The pooled effect size for number of people remaining incontinent at follow-up was
not statistically significant (RR 0.87, 95% CI 0.72 to 1.05).
Secondary outcomes Two outcomes showed a statistically significant difference favouring the CBI
at follow-up:
l urinary frequency
l nocturia.
Outcomes that showed no statistically significant difference at follow-up included:
l number of incontinence episodes
l 75% or more reduction in incontinent episodes
l subject perceptions of improvement
l QoL – impact of incontinence, symptom distress.
TABLE 16 Summary of pooled effect sizes per outcome: follow up to 12 months
Outcome
Pooled effect size (95% CI)
Number of
comparisons
No treatment
comparison
Number of
comparisons
Another treatment
comparison
Not cured: number of
people remaining
incontinent
0 – 1 RR 0.87 (0.72 to 1.05)
Improvement: number
of incontinence
episodes
1 WMD –5.60 (–9.92 to –1.28)b 2 WMD –1.40 (–4.59 to 1.79)
Improvement: ≥ 75%
reduction in UI
episodes
0 – 1 RR 1.32 (0.92 to 1.91)
Subject perceptions of
improvement (much
better)
0 – 1 RR 1.43 (0.96 to 2.12)
Severity of incontinence
(grams urine lost per
24 hours)
2 SE –0.60 (–1.47 to 0.26) 0 –
Symptoms: frequency 2 SE –0.63 (–1.48 to 0.22) 1 SE –0.71 (–1.39 to –0.03)b
Symptoms: nocturia 2 SE –0.97 (–3.30 to 1.37) 1 SE –0.89 (–1.59 to –0.19)b
Symptoms: urgency 1 RR 0.67 (0.41 to 1.07) 0 –
QoL: impact of
incontinence
1 SMD –0.36 (–0.74 to 0.01)a 2 SMD –0.57 (–1.62 to 0.49)
QoL: symptom distress 0 – 1 SMD –0.24 (–0.59 to 0.12)
SE, standardised effect (via GIV).
a Marginally statistically non-significant (p= 0.05 to 0.07).
b Statistically significant.
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Comparison against no treatment
Primary outcome No trial provided data on the number of people remaining incontinent at follow-up, in
comparison against no treatment.
Secondary outcomes Of the outcomes that were marginal or not statistically significant in comparison
against another treatment, outcomes that were statistically significant favouring the CBI in
comparison against no treatment included:
l number of incontinence episodes.
One outcome showed a marginal (non)-statistically significant difference:
l QoL – impact of incontinence.
Outcomes that showed no statistically significant difference in either comparison condition included:
l severity of incontinence (grams of urine lost in 24 hours)
l urinary urgency.
Quality of results
The results presented above need to be considered in the light of the quality of evidence to support them.
Tables 15 and 16 illustrate that not many trials contributed data to each outcome. Trials were also judged
to be of good, moderate, or poor quality as follows:
l good quality (++): studies where the results are unlikely to be affected by any weaknesses in study
design or conduct
l moderate quality (+): studies where weakness in study design or conduct has the potential to impact
on the validity or reliability of the results
l poor quality (–): studies were the results are likely to be affected by weaknesses of study design
or conduct.
For each outcome, results that are supported by trials of moderate or good quality will be summarised,
together with any other quality issues (number of respondents, per cent of respondents data are available
for, heterogeneity of pooled treatment effect) that could influence interpretation of the quality of the
evidence. For each outcome, results for comparison with another treatment will be presented first,
followed by results for no treatment comparisons.
Number of people remaining incontinent
The result of borderline statistical non-significance when compared against another treatment was
supported by two trials of moderate quality.31,33 In the no treatment comparison, the treatment effect
was statistically significant favouring the CBI, supported by one trial of moderate quality33 and one
of poor quality.90
Number of incontinence episodes
The borderline non-significant result when compared against another treatment was supported by two
trials of moderate quality.31,33 In the no treatment comparison, this outcome was statistically significant
favouring the CBI, supported by four trials of moderate quality.33,76,89,100
Seventy-five per cent or more reduction in incontinent episodes
The comparison against another treatment was not statistically significant and was supported by two trials
of moderate quality.31,33 The no treatment comparison was statistically significant favouring the CBI and
supported by one trial of moderate quality.33
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Subject perceptions of improvement
The statistically significant result for this outcome favouring the CBI in comparison with another treatment
was supported by two trials of moderate quality,31,33 and by one trial of moderate quality in the no
treatment comparison.33
Severity of incontinence
This outcome was not tested in a comparison against another treatment. In a no treatment comparison,
the result was not statistically significant, supported by one trial of moderate quality76 and one of poor
quality.71 There was significant heterogeneity of treatment effect in these two trials.
Symptoms
Findings for urinary symptoms were variable.
Effect size for urinary frequency was not statistically significant in comparison against another treatment,
but this result was from a small study of poor quality.81 Frequency was statistically significant favouring the
CBI in comparison against no treatment, supported by two trials of moderate quality76,100 and two of poor
quality.71,90 However, there was substantial heterogeneity of treatment effects.
There was a statistically significant difference in between-groups effect size for nocturia favouring the CBI
for another treatment comparison, supported by one study of moderate quality33 and one study of poor
quality.81 Results for no treatment comparisons were not statistically significant, supported by five trials,
three of moderate quality33,76,100 and two of poor quality.71,90 However, there was substantial heterogeneity
of treatment effects in these five studies.
Urgency was only tested against a no treatment comparison. The statistically significant result favouring
the CBI is supported by one small quasi-experimental trial of poor quality.71
Quality of life
The non-significant effect for impact of incontinence on QoL in comparison with another treatment was
supported by one study of moderate quality31 and one of poor quality.81 The statistically significant effect
for impact of incontinence in the no treatment comparison group favouring the CBI was supported by one
study of moderate quality.76
The non-significant effect for symptom distress in comparison against another treatment was supported
by two studies of moderate quality,31,33 and was also not statistically significant in the no treatment
comparison, supported by one study of moderate quality,33 although data were only available for 51%
of participants.
Satisfaction with treatment
The statistically significant effect for treatment satisfaction in comparison against another treatment
favouring the CBI was supported by two studies of moderate quality,31,33 although data were only available
for 63% of participants.
Adverse events
The result of marginal statistical significance for the risk of adverse events in comparison with another
treatment was only supported by one small trial of poor quality81 and was not measured in any trial with
no treatment comparison.
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Generalisability of results
Comparisons with another treatment
All of the outcome results relate only to females. Most outcomes are from groups that include people with
different types of incontinence, except results for frequency, nocturia and adverse events, which relate
solely to people with urge incontinence. None of the results are specific to a particular age group.
Comparison with no treatment
Most of the outcomes relate only to females. Number of incontinent episodes was the only outcome to
include males in the sample, from one out of five trials that contributed results. Results for most outcomes
related to people with different types of incontinence (except those for subject perceptions of improvement)
and symptom distress (which relate only to women with urge incontinence). All of the results relate to
women aged ≥ 55 years, but the results for urinary urgency relate only to women aged ≥ 65 years.
Subgroup analyses
Planned subgroup analyses included investigating the effects of client group factors of type of incontinence, age,
sex and cognitive status, and intervention factors of content, level, duration and intensity. Subgroup analyses
for sex and cognitive status could not be conducted due to a lack of relevant trials in a subgroup.
All subgroup analyses were conducted on the outcome of improvement measured as ‘number of
incontinent episodes per week’, as this was the only outcome with sufficient trials to make subgroup
analysis viable. Data on number of incontinent episodes was not presented in a form suitable for pooling
for two out of the nine trials that collected outcome data from bladder diaries.71,73
If there was more than one comparison group in a trial, the group least favourable to the combined
intervention on the outcome ‘number of incontinent episodes per week (post treatment)’ was chosen for
inclusion in the subgroup analyses. Therefore, the drug comparison group was included from the trial by
Burgio et al.33 and the PFMT comparison group was chosen from the trial by Wyman et al.31 The exception
to this is the subgroup analysis for type of incontinence, where a probable error was detected in the results
for the PFMT group in Wyman et al.31 with a SD of 0.00 for the stress incontinence subgroup. Results for
the BT group were therefore used for the subgroup analysis for type of incontinence.
Type of incontinence
Two trials included only people with UUI as the predominant pattern.33,81 Four trials presented results for
combinations of UI type (i.e. MUI, SUI or UUI) without subgroup data.76,89,90,100 One trial presented
subgroup data for people with SUI or MUI.31 Results are presented in Figure 16.
Age
Two trials had younger samples (i.e. with a mean age of less than 65 years)31,81 and five trials had relatively
older samples (i.e. aged ≥ 65 years).33,76,89,90,100 Results are presented in Figure 17.
No statistically significant difference in treatment effects was found between the three types of UI (p= 0.34).
No statistically significant difference in treatment effects was found for younger versus older age
groups (p= 0.50).
Type of intervention
Four intervention–comparison pairs31,76,90,100 were judged to have an initial or primary emphasis on BT
and four intervention–comparison pairs were judged to have an initial or primary emphasis on PFMT.31,33,81,89
Results are presented in Figure 18. No statistically significant difference in treatment effects was found for
type of intervention, but there was a trend towards BT (p= 0.08).
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Review:
Comparison:
Outcome:
Combined behavioural training for UI (Version 01)
10 SUBGROUP ANALYSES: number of incontinence episodes per week
01 Type of incontinence (stress, urge, mixed)
Study or subcategory n n
Treatment
mean (SD)
Control
mean (SD)
WMD (fixed)
95% CI
WMD (fixed)
95% CI
Weight
(%)
Urge incontinence
aBurgio 199833
Kafri 200781
Subtotal (95% CI)
Test for heterogeneity: χ2 = 1.96, df = 1 (p = 0.16), I2 = 49.0%
Test for overall effect: z = 1.66 (p = 0.10) 
2.80 (4.70)
3.30 (7.70)
83
63
20
257
42
42
48
382 378
249
78
48
49
66
16
81
65
16
69
45
59
57
19
5.70 (9.80)
2.60 (5.40)
12.60 (13.30)
3.50 (3.00)
5.90 (8.46)
11.00 (17.40)
6.20 (9.10)
12.50 (8.30)
12.01
4.59
16.60
–2.90 (–5.55 to –0.25)
0.70 (–3.59 to 4.99)
–1.91 (–4.16 to –0.35)
Mixed incontinence
Dougherty 200276
McDowell 199989
McFall 200090
Subak 2002100
bWyman 199831 
7.00 (13.30)
1.80 (2.90)
3.55 (7.18)
5.20 (6.80)
5.80 (9.50)
Subtotal (95% CI)
Test for heterogeneity: χ2 = 5.54, df = 4 (p = 0.24), I2 = 27.8%
Test for overall effect: z = 4.09 (p = 0.0001)
5.54
58.52
9.69
3.65
2.20
78.61
–5.60 (–9.91 to –1.29)
–1.70 (–2.90 to –0.50)
–2.35 (–5.30 to 0.60)
–5.80 (–10.61 to –0.99)
–0.40 (–6.60 to 5.80)
–2.16 (–3.20 to –1.12)
Stress incontinence 
bWyman 199831 7.20 (11.50)
48
4.79
4.79
100.00
–5.30 (–9.50 to –1.10)
–5.30 (–9.50 to –1.10)
–2.27 (–3.19 to –1.35)
Subtotal (95% CI)
Test for heterogeneity: not applicable
Test for overall effect: z = 2.48 (p = 0.01)
Total (95% CI)
Test for heterogeneity: χ2 = 9.65, df = 7 (p = 0.21), I2 = 27.5%
Test for overall effect: z = 4.84 (p = 0.00001)
–10 –5 5 10
Favours treatment Favours control
0
FIGURE 16 Subgroup analysis: type of incontinence. aBurgio 199833= another treatment comparison (drug); bWyman 199831= combined intervention vs. PFMT.
df, degrees of freedom.
C
O
M
B
IN
E
D
B
E
H
A
V
IO
U
R
A
L
IN
TE
R
V
E
N
TIO
N
S
FO
R
U
R
IN
A
R
Y
IN
C
O
N
TIN
E
N
C
E
N
IH
R
Jo
u
rn
a
ls
Lib
ra
ry
w
w
w
.jo
u
rn
a
lslib
ra
ry.n
ih
r.a
c.u
k
6
4
Review:
Comparison:
Outcome:
Combined behavioural training for UI
12 SUBGROUP ANALYSES 2
04 Age
Study or subcategory n n
Treatment
mean (SD)
Control
mean (SD)
WMD (fixed)
95% CI
WMD (fixed)
95% CI
Weight
(%)
Under 65 years
Kafri 200781
bWyman 199831 
Subtotal (95% CI)
Test for heterogeneity: χ2 = 1.44, df = 1 (p = 0.23), l2 = 30.7%
Test for overall effect: z = 0.88 (p = 0.38) 
3.30 (7.70)
6.80 (10.70)
81
20
61
304 295
63
78
48
49
66
80
16
64
65
69
45
59
57
2.60 (5.40)
9.60 (10.80)
43.59
56.41
100.00
0.70 (–3.59 to 4.99)
–2.80 (–6.57 to 0.97)
–1.27 (–4.11 to 1.56)
65 years and over
aBurgio 199833
Dougherty 200276
McDowell 199989
McFall 200090
Subak 2002100
2.80 (4.70)
7.00 (13.30)
1.80 (2.90)
3.55 (7.18)
5.20 (6.80)
Subtotal (95% CI)
Test for heterogeneity: χ2 = 5.54, df = 4 (p = 0.24), l2 = 27.8%
Test for overall effect: z = 4.09 (p = 0.0001)
13.58
5.14
66.18
10.96
4.13
100.00
–2.90 (–5.55 to –0.25)
–5.60 (–9.91 to –1.29)
–1.70 (–2.90 to –0.50)
–2.35 (–5.30 to 0.60)
–5.80 (–10.61 to –0.99)
–2.30 (–3.28 to –1.33)
5.70 (9.80)
12.60 (13.30)
3.50 (3.00)
5.90 (8.46)
11.00 (17.40)
–10 –5 5 10
Favours treatment Favours control
0
FIGURE 17 Subgroup analysis: age. aBurgio 199833= another treatment comparison (drug); bWyman 199831= combined intervention vs. PFMT. df, degrees of freedom.
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5
Review:
Comparison:
Outcome:
Combined behavioural training for UI
10 SUBGROUP ANALYSES: number of incontinence episodes per week
05 Intevention content (BT primary, PFMT primary) 
Study or subcategory n n
Treatment
mean (SD)
Control
mean (SD)
WMD (fixed)
95% CI
WMD (fixed)
95% CI
Weight
(%)
BT primary
Dougherty 200276
McFall 200090
Subak 2002100
bWyman 199831
7.00 (13.30)
3.55 (7.18)
5.20 (6.80)
6.80 (10.70)
78
49
66
61
69
59
57
64
12.60 (13.30)
5.90 (8.46)
11.00 (17.40)
9.60 (10.80)
4.49
9.58
3.61
5.87
–5.60 (–9.91 to –1.29)
–2.35 (–5.30 to 0.60)
–5.80 (–10.61 to –0.99)
–2.80 (–6.57 to 0.97)
–3.61 (–5.49 to –1.73)Subtotal (95% CI)
Test for heterogeneity: χ2 = 2.50, df = 3 (p = 0.48), l2 = 0%
Test for overall effect: z = 3.76 (p = 0.0002) 
254
147
401 394
249 23.56
145
100.00 –2.16 (–3.07 to –1.24)
63
20
48
16
65
16
45
19
5.70 (9.80)
2.60 (5.40)
3.50 (3.00)
6.20 (9.10)
PFMT primary 
aBurgio 199833
Kafri 200781
McDowell 199989
aWyman 199831
2.80 (4.70)
3.30 (7.70)
1.80 (2.90)
5.80 (9.50)
11.88
4.54
57.86
2.17
76.44
–2.90 (–5.55 to –0.25)
0.70 (–3.59 to 4.99)
–1.70 (–2.90 to –0.50)
–0.40 (–6.60 to 5.80)
–1.71 (–2.75 to –0.66)Subtotal (95% CI)
Test for heterogeneity: χ2 = 2.16, df = 3 (p = 0.54), l2 = 0%
Test for overall effect: z = 3.20 (p = 0.01)
Total (95% CI)
Test for heterogeneity: χ2 = 7.66, df = 7 (p = 0.36), l2 = 8.6%
Test for overall effect: z = 4.63 (p = 0.00001)
–10 –5 5 10
Favours treatment Favours control
0
FIGURE 18 Subgroup analysis: type of intervention. aBurgio 199833= another treatment comparison (drug); aWyman 199831= combined intervention vs. BT;
bWyman 199831= combined intervention vs. PFMT. df, degrees of freedom.
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Level of intervention
Trials were classified dependent on whether they were judged to be basic (i.e. delivery of behavioural
strategies aimed at increasing the effectiveness of urinary function activities) or enhanced (i.e. additional
behavioural strategies aimed at tailoring an intervention to the specific needs of the individual or
enhancing adherence or commitment to practice/activities, e.g. goal-setting, reminder systems, coaching).
Two trials were judged to be focused on basic delivery of strategies aimed at voiding function.81,100
The remaining five trials were judged to have at least some enhancement to basic delivery of a voiding
function intervention,31,33,76,89,90 although the relative emphasis on additional behavioural strategies varied.
Results are illustrated in Figure 19.
No statistically significant difference in treatment effects was found for level of intervention (p= 0.92).
Duration of intervention
Trials were categorised into those with 8 weeks or less intervention delivery, or more than 8 weeks.
Three trials had an intervention delivery period of 8 weeks or less.33,89,100 Four trials had intervention
delivery periods of more than 8 weeks.31,76,81,90 Results are presented in Figure 20.
No statistically significant difference in treatment effects was found for duration of intervention (p= 0.71).
Intensity of intervention
Intensity of intervention was defined as the ratio of the number of contacts with a person delivering
the intervention to the length of the intervention period, with subgroups defined as contact at least
weekly or less than weekly. Five trials had less than weekly contact,31,33,76,81,90 and two had at least weekly
contact.89,100 Results are illustrated in Figure 21.
No statistically significant difference in treatment effects was found for duration of intervention (p= 0.48).
Sensitivity analyses
Planned sensitivity analyses included type of comparison group (no treatment vs. another treatment), study
quality, allocation concealment (adequate, unclear/not adequate) and loss to follow-up (≤ 20%, > 20%).
Planned sensitivity analyses for study quality could not be undertaken, as only one trial was judged to have
adequate allocation concealment100 and only one contributing trial had more than 20% loss to follow-up.90
Type of comparison group
Five trials had no treatment intervention–comparison pairs.33,76,89,90,100 Three trials had intervention versus
another treatment comparison groups.31,33,81 Results are illustrated in Figure 22.
No statistically significant difference in treatment effects was found for type of comparison
group (p= 0.48).
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Review:
Comparison:
Outcome:
Combined behavioural training for UI (Version 01)
10 SUBGROUP ANALYSES: number of incontinence episodes per week
06 Level of intervention (basic, enhanced)
Study or subcategory n n
Treatment
mean (SD)
Control
mean (SD)
WMD (fixed)
95% CI
WMD (fixed)
95% CI
Weight
(%)
Basic
Kafri 200781
Subak 2002100
Subtotal (95% CI)
Test for heterogeneity: χ2 = 3.91, df = 1 (p = 0.05), I 2 = 74.4%
Test for overall effect: z = 1.34 (p = 0.18) 
3.30 (7.70)
5.20 (6.80)
86
20
66
299 302
63
78
48
49
61
73
16
57
65
69
45
59
64
2.60 (5.40)
11.00 (17.40)
4.64
3.69
8.33
0.70 (–3.59 to 4.99)
–5.80 (–10.61 to –0.99)
–2.18 (–5.38 to 1.02)
Enhanced
aBurgio 199833
Dougherty 200276
McDowell 199989
McFall 200090
bWyman31
2.80 (4.70)
7.00 (13.30)
1.80 (2.90)
3.55 (7.18)
6.80 (10.70)
Subtotal (95% CI)
Test for heterogeneity: χ2 = 3.43, df = 4 (p = 0.49), I 2 = 0%
Test for overall effect: z = 4.46 (p = 0.0001)
12.14
4.59
59.15
9.80
6.00
91.67
–2.90 (–5.55 to –0.25)
–5.60 (–9.91 to –1.29)
–1.70 (–2.90 to –0.50)
–2.35 (–5.30 to 0.60)
–2.80 (–6.57 to 0.97)
–2.20 (–3.16 to –1.23)
385 375 100.00 –2.19 (–3.12 to –1.27)Total (95% CI)
Test for heterogeneity: χ2 = 7.35, df = 6 (p = 0.29), I 2 = 18.3%
Test for overall effect: z =  4.66 (p < 0.00001)
5.70 (9.80)
12.60 (13.30)
3.50 (3.00)
5.90 (8.46)
9.60 (10.80)
–10 –5 5 10
Favours treatment Favours control
0
FIGURE 19 Subgroup analysis: level of intervention. aBurgio 199833= another treatment comparison (drug); bWyman 199831= combined intervention vs. PFMT.
df, degrees of freedom.
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8
Review:
Comparison:
Outcome:
Combined behavioural training for UI
12 SUBGROUP ANALYSES 2
07 Intervention duration
Study or subcategory n n
Treatment
mean (SD)
Control
mean (SD)
WMD (fixed)
95% CI
WMD (fixed)
95% CI
Weight
(%)
8 weeks or less
aBurgio 199833
McDowell 199989
Subak 2002100
2.80 (4.70)
1.80 (2.90)
5.20 (6.80)
63
48
66
65
45
57
5.70 (9.80)
3.50 (3.00)
11.00 (17.40)
Subtotal (95% CI)
Test for heterogeneity: χ2 = 3.05, df = 2 (p = 0.022), l 2 = 34.5%
Test for overall effect: z = 3.85 (p = 0.0001) 
177
78
20
49
61
167
69
16
59
64
16.19
78.89
4.92
100.00
–2.90 (–5.55 to –0.25)
–1.70 (–2.90 to –0.50)
–5.80 (–10.61 to –0.99)
–2.10 (–3.16 to –1.03)
More than 8 weeks 
Dougherty 200276
Kafri 200781
McFall 200090
bWyman 199831
7.00 (13.30)
3.30 (7.70)
3.55 (7.18)
6.80 (10.70)
18.35
18.53
39.15
23.97
100.00
–5.60 (–9.91 to –1.29)
0.70 (–3.59 to 4.99)
–2.35 (–5.30 to 0.60)
–2.80 (–6.57 to 0.97)
–2.49 (–4.34 to –0.64)
12.60 (13.30)
2.60 (5.40)
5.90 (8.46)
9.60 (10.80)
208 208Subtotal (95% CI)
Test for heterogeneity: χ2 = 4.16, df = 3 (p = 0.24 ), l 2 = 27.9%
Test for overall effect: z = 2.64 (p < 0.008)
–10 –5 5 10
Favours treatment Favours control
0
FIGURE 20 Subgroup analysis: duration of intervention. aBurgio 199833= another treatment comparison (drug); bWyman 199831= combined intervention vs. PFMT.
df, degrees of freedom.
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9
Review:
Comparison:
Outcome:
Combined behavioural training for UI (version 01)
10 SUBGROUP ANALYSES: number of incontinence episodes per week
09 Intervention intensity (at least weekly contact, less than weekly)
Study or subcategory n n
Treatment
mean (SD)
Control
mean (SD)
WMD (fixed)
95% CI
WMD (fixed)
95% CI
Weight
(%)
Weekly contact or more
McDowell 199989
Subak 2002100
Subtotal (95% CI)
Test for heterogeneity: χ2 = 2.63, df = 1 (p = 0.10), l 2 = 62.0%
Test for overall effect: z = 3.27 (p = 0.001) 
1.81 (2.90)
5.20 (6.80)
114
48
66
102
45
57
3.50 (3.00)
11.00 (17.40)
59.15
3.69
62.84
–1.70 (–2.90 to –0.50)
–5.80 (–10.61 to –0.99)
–1.94 (–3.11 to –0.78)
271 273
63
78
20
49
61
65
69
16
59
64
Less than weekly contact
aBurgio 199833
Dougherty 200276
Kafri 200781
McFall 200090
bWyman 199831 
2.80 (4.70)
7.00 (13.30)
3.30 (7.70)
3.55 (7.18)
6.80 (10.70)
Subtotal (95% CI)
Test for heterogeneity: χ2 = 4.22, df = 4 (p = 0.38), l 2 = 5.3%
Test for overall effect: z = 3.40 (p = 0.0007)
12.14
4.59
4.64
9.80
6.00
37.16
–2.90 (–5.55 to –0.25)
–5.60 (–9.91 to –1.29)
0.70 (–3.59 to 4.99)
–2.35 (–5.30 to 0.60)
–2.80 (–6.57 to 0.97)
–2.62 (–4.14 to –1.11)
5.70 (9.80)
12.60 (13.30)
2.60 (5.40)
5.90 (8.46)
9.60 (10.80)
385 375 100.00 –2.19 (–3.12 to –1.27)Total (95% CI)
Test for heterogeneity: χ2 = 7.35, df = 6 (p = 0.29), l 2 = 18.3%
Test for overall effect: z = 4.66 (p = 0.00001)
–10 –5 5 10
Favours treatment Favours control
0
FIGURE 21 Subgroup analysis: intensity of intervention. aBurgio 199833= another treatment comparison (drug); bWyman 199831= combined intervention vs. PFMT.
df, degrees of freedom.
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0
Review:
Comparison:
Outcome:
Combined behavioural training for UI (Version 01)
11 SENTIVITY ANALYSES: number of incontinence episodes per week
01 Type of comparison (no treatment, another treatment)
Study or subcategory n n
Treatment
mean (SD)
Control
mean (SD)
WMD (fixed)
95% CI
WMD (fixed)
95% CI
Weight
(%)
Another treatment
aBurgio 199833
Kafri 200781
bWyman 199831
Subtotal (95% CI)
Test for heterogeneity: χ2 = 2.12, df = 2 (p = 0.35), I 2 = 5.6%
Test for overall effect: z = 3.27 (p = 0.001) 
2.80 (4.70)
3.30 (7.70)
6.80 (10.70)
144
63
20
61
145
65
16
64
5.70 (9.80)
2.60 (5.40)
9.60 (10.80)
11.16
4.26
5.51
20.93
–2.90 (–5.55 to –0.25)
0.70 (–3.59 to 4.99)
–2.80 (–6.57 to 0.97)
–2.14 (–4.08 to –0.21)
304 292
63
78
48
49
66
62
69
45
59
57
No treatment
bBurgio 199833
Dougherty 200276
McDowell 199989
McFall 200090
Subak 2002100
2.80 (4.70)
7.00 (13.30)
1.80 (2.90)
3.55 (7.18)
5.20 (6.80)
Subtotal (95% CI)
Test for heterogeneity: χ2 = 8.85, df = 4 (p = 0.07), I 2 = 54.8%
Test for overall effect: z = 4.99 (p = 0.00001)
8.09
4.22
54.36
9.00
3.39
79.07
–5.40 (–8.51 to –2.29)
–5.60 (–9.91 to –1.29)
–1.70 (–2.90 to –0.50)
–2.35 (–5.30 to 0.60)
–5.80 (–10.61 to –0.99)
–2.54 (–3.53 to –1.54)
8.20 (11.60)
12.60 (13.30)
3.50 (3.00)
5.90 (8.46)
11.00 (17.40)
448 437 100.00 –2.45 (–3.34 to –1.57)Total (95% CI)
Test for heterogeneity: χ2 = 11.09, df = 7 (p = 0.13), I 2 = 36.9%
Test for overall effect: z = 5.34 (p = 0.00001)
–10 –5 5 10
Favours treatment Favours control
0
FIGURE 22 Sensitivity analysis: type of comparison group (no treatment, another treatment). aBurgio 199833= another treatment comparison (drug); bBurgio 199833= attention
control comparison; bWyman 199831= combined intervention vs. PFMT. df, degrees of freedom.
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Findings: narrative review of acceptability and feasibility
Client views
Research aims
Table 17 details the stated aims of the six included studies: two studies mainly referred to factors
influencing choice/uptake of UI treatments in older people in residential care;80,94 two studies provided
information about factors influencing participation and adherence to behavioural therapies;79,93 and
two studies focused on reasons for dropout from a UI treatment programme.83,84,92
Findings
Choice/uptake
Table 18 details the results of the two studies considering factors impacting on choice or uptake of
behavioural treatments for UI.80,94 Both of these studies considered the treatment preferences of older
adults in LTC facilities in the USA. Results suggest that clients may have a higher tolerance for symptoms
and a lower tolerance for disturbance, with a preference for interventions promoting independence and
comfort, and resistance to any invasive intervention. Behavioural interventions such as PV can be viewed
as embarrassing and resulting in dependence on others, with residents in care facilities disliking the
subsequent reliance on nursing staff.
Both of these studies did not limit data collection to respondents with UI. In one study, other problems
with elimination were not differentiated94 and in the other study, respondents without UI were used
as proxies.80
TABLE 17 Client views: stated aims of the included studies
Study Choice/uptake Participation/adherence Failure/withdrawal
Johnson et al.
200180
To describe and compare
preferences for different UI
treatments in LTC from
groups likely to act as proxy
decision-makers
O’Dell et al. 200894 Self-perceived needs and
preferences for pelvic floor
dysfunction care
Milne and Moore
200693
Factors influencing self-care
choices and factors that impede
or facilitate maintenance of
behavioural therapies
Hay-Smith et al.
200779
To seek women’s experiences of
PFMT, their understandings of the
exercises and the way they
exercised
MacInnes 200892 To understand why some
women with SUI do not
complete therapy
Kincade et al.
199983
To explore why patients
withdrew from a behavioural
programme
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Participation/adherence
Table 19 details the results of two studies considering factors impacting on participation in and adherence
to behavioural interventions. Hay-Smith et al.79 was specific to PFMT, whereas Milne and Moore93 referred
to client factors impacting on adherence to both BT and PFMT.
For BT, a barrier to adherence was increased fear of accidents, whereas for both BT and PFMT,
respondents identified difficulty with developing a routine and fitting the intervention into daily life,
but a feeling of mastery and control if successful. Enablers included realistic goals and adaptation
of daily routines.
There were negative perceptions of PFMT, including the difficulty of learning the exercises and knowing
whether or not they were done correctly. Respondents valued feedback and follow-up. Contextual
features that impacted on adherence included the requirement for privacy. Both of the studies were
conducted with women, with one study specific to women with SUI.79
Withdrawal/dropout
Two studies considered women’s reasons for withdrawal from behavioural UI programmes. PFMT was a
major component of both programmes. The findings are detailed in Table 20.
Women cited other health problems, competing pressures, the inconvenience of attending clinics and
negative perceptions of PFMT as barriers. Due to the difficulty of knowing whether or not practice was
successful, feedback was viewed as helpful by some respondents in both studies. Both of these studies
were completed on non-attenders of established continence clinics, so the results may not be generalisable
beyond these specific examples.
TABLE 18 Findings of client views studies: factors impacting on choice/uptake
Barrier Enabler
Client factor
l High tolerance for pelvic floor dysfunction symptoms94 l Interventions need to be suitable for the individual’s
needs81
l UI management could disturb sleep94
Intervention factor
l PV is viewed as difficult, results in dependence,
and embarrassing80
l Resistance to the idea of a pelvic examination,94
respondents did not want anything internal80
l Older adults aim was for containment of incontinence,
with preference for independence and no further
testing or intervention94
l Older adults’ main criteria were that the intervention
should be easy and not foster dependence, and be
natural, comfortable and non-invasive; other criteria
were that the intervention should not be embarrassing,
and be dry, odour free, simple and not bulky80
Context factor
l Respondents perceived staff to be unable or unwilling
to implement UI interventions80
l Being unable to use bathroom because of safety
restrictions94
l Close proximity and availability of a clean bathroom (PV)94
l Delays between asking for and receiving help94
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TABLE 19 Findings of client views studies: factors impacting on participation/adherence
Barrier Enabler
Client factor
BT l Increased fear of being wet (BT)93
l Difficulty of fitting BT into daily life93
l Sense of mastery for some if successful93
PFMT l PFMT exercises: trying to develop routines,
finding the time and remembering to do them79
l Maintaining an exercise routine (PFMT)93
l Competing interests (PFMT)93 l Realistic goals and expectations (PFMT)93
l Mastery of PFMT exercises and regaining control
were valued79
l Adapting a number of daily routines and
accommodating treatment to own life (PFMT)79
l UI could have only minor psychosocial impact
(PFMT)93
Intervention factor
l Insufficient information and obscure nature of PFMT
exercises;93 hard to obtain accurate information
about PFMT79
l Feedback (PFMT);93 confirmation by palpation seen as
helpful by at least one woman79 (PFMT)
l Difficulty of knowing whether or not exercises were done
correctly (PFMT);93 hard to understand how to do the
PFMT exercises, plus difficult to continue without
noticeable benefit79
l Regular follow-up/professional involvement;
awareness and affirmation of progress (PFMT)93
l PFMT exercises viewed as boring, a chore, tedious, etc.79 l Preferences for exercise type (PFMT)79
Context factor
l Some women felt they needed privacy which limited the
times/places they could do PFMT exercise79
l Some women felt they could do PFMT exercises
anywhere79
l Cost of private physiotherapy for PFMT93
TABLE 20 Findings of client views studies: factors impacting on withdrawal/dropout
Barrier Enabler
Client factor
l Negative experiences, attitudes or feelings towards
PFMT83,92
l Other health problems83,92
l Forgotten appointments92
l Unwilling to practice exercises: too many other demands,
not enough energy83
Intervention factor
l Treatment not perceived to be appropriate/effective for
UI status83
l Exercises boring83
l Unable to tell if effective without BIO83 l BIO perceived to be helpful83
l Preference for delivery mode, e.g. group vs. individual83
Context factor
l Other social demands, e.g. caring role, housing issues92
l Problems with billing83
l Problems with travel to the clinic for older people83
l Treatment inconvenience: clinic conflicts with work
demands for younger people,83 no evening clinic92
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Summary: client experiences
Table 21 brings together the evidence for barriers and enablers to behavioural UI therapies overall,
grouped as client, intervention or contextual factors.
Client factors Uptake and maintenance of behavioural therapies could be affected by clients’ values and
lifestyle preferences, prior experiences with behavioural therapies and their perceptions of the potential
consequences – both positive and negative. Adherence was helped by having realistic goals and
expectations and experiencing the positive consequences of success.
Intervention factors Barriers included difficulty knowing whether or not PFMT exercises were being done
correctly and fitting interventions into daily life. Professional follow-up and feedback helped adherence,
as did tailoring interventions to the individual’s needs and routines.
Contextual factors The convenience or cost of treatment options could affect adherence, as could the
availability of a suitable environment for practice. People in residential care valued independence and
preferred to avoid increased reliance on nursing staff. They could therefore show a preference for
containment strategies for UI, rather than behavioural therapies.
TABLE 21 Summary of client views: factors impacting on behavioural UI therapy
Barrier Enabler
Client
l Guilt about not acting earlier, pay-off not immediate,
choices not well informed79
l A sense of mastery and control if successful79,93
l Stigma about having a continence problem and
attending clinic92
l Perceptions of UI severity83
l High tolerance for pelvic floor dysfunction symptoms in
older residents in nursing homes, with a preference
for non-invasive interventions which promote independence
from nursing staff and comfort80,94
l Increased fear of being wet with BT93
l Negative experiences, attitudes and feelings
towards PFMT79,83,92
l Competing interests, other health problems, other
social demands83,92,93
l Realistic goals and expectations93
Intervention
l Lack of accessible information about PFMT and difficulty
of knowing whether or not PFMT is done correctly/no
noticeable benefit79,83,93
l Feedback on correct performance of exercises79,83,93
l Professional follow-up79,93
l Difficulty of developing routines and fitting them into daily
life for BT and PFMT79,93
l Interventions tailored to the individuals needs
and preferences80
l Adapting daily routines to include PFMT79
l Availability of privacy for PFMT79
l Availability of accessible and clean bathroom in
residential care94
l Delivery mode83
Context
l Residents perceptions that staff in residential care are
unwilling or unable to implement UI interventions80,94
l Convenience/cost of treatment provision83,92
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Quality of findings
As well as the number of studies supporting a particular finding, the quality of the original study needs to
be considered. Table 22 takes the main category of findings from Table 21 and attaches levels of evidence.
The number of studies are identified, with a quality classification as follows:
l studies where the credibility of the findings are unlikely to be affected by any weaknesses in study
design or conduct (++)
l studies where weaknesses in study design or conduct have the potential to impact on the credibility of
the findings (+)
l studies were the credibility of the findings is likely to be affected by weaknesses of study design or
conduct (–).
Researcher conclusions and implications for practice
As well as extracting the original data, we extracted any suggestions by the researchers on their
conclusions about suggested ways of improving practice. Although not primary data originating from
clients, these conclusions are useful to researchers who are designing future interventions. The data was
sourced from the conclusions and implications for practice sections of research reports. The suggestions
were simply classified as either relating to the structure of health care (e.g. resources, staff training), or the
process of health care (i.e. what should be done). Suggestions were identified as relevant to the stage of
informed choice and assessment of suitability for an intervention, or encouraging adherence and
preventing dropout.
TABLE 22 Levels of evidence for main findings
Barrier Enabler
Client
l Perceptions of the UI problem (1++, 1+)
l Stigma about having a continence problem and attending
clinic (1 –)
l High tolerance for UI symptoms and preference for
interventions which promote independence (1+, 1 –)
l Increased fear of being wet with BT (1++); negative
experiences, attitudes and feelings towards PFMT
(1++, 1+, 1 –)
l A sense of mastery and control if successful (2++)
l Competing interests/demands (1++, 1+, 1 –) l Realistic goals and expectations (1++)
Intervention
l Difficulty of doing PFMT exercises correctly (2++, 1+) l Feedback on correct performance of exercises
(2++, 1+) professional follow-up (2++)
l Difficulty of developing routines and fitting them into
daily life (2++)
l Adapting daily routines to include PFMT (1++)
l Delivery mode (1+) l Interventions tailored to the individuals needs and
preferences (1 –)
Context
l Residents perceptions that staff in residential care are
unwilling or unable to implement UI interventions (1+, 1 –)
l Convenience/cost of treatment provision (1+, 1 –) l Availability of privacy for PFMT (1++)
l Availability of accessible and clean bathroom in
residential care (1+)
All of the findings are supported by at least one study of moderate quality, except those in italics, i.e. the stigma of
attending continence services and interventions tailored to individual preferences.
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Informed choice and assessment
Table 23 presents researcher suggestions impacting at the stage of initial client choice and uptake of
treatment options.
Suggestions about improvements to health-care structures related to the timing, siting and labelling of
interventions, and ensuring a basic level of staff knowledge to enable informed choice to happen.
Suggestions about process improvements included eliciting and honouring client preferences and values
(particularly with older people), eliciting clients’ goals and their expectations of treatment, and including an
assessment of self-efficacy and barriers to uptake of UI treatments in the initial stages of treatment.
Encouraging adherence and preventing withdrawal from treatment
Table 24 presents researcher suggestions relevant to maintaining client participation in treatment.
TABLE 23 Researcher suggestions for future intervention design: treatment choice
Structure Process
Informed choice/assessment
l Division of initial assessment into two sessions to
reduce fatigue83
l Signs for continence clinics should be discreet, with
directions given in the letter to avoid people having
to ask for directions92
l Removal of barriers could include the option of house
calls or evening clinic92
l Ensure a fundamental level of knowledge among
nurses and other professionals93
l QoL of frail older people in residential care may not be
improved by interventions for incontinence, and care
should be guided by the individuals’ preferences and
values, such as comfort, security and choice94
l Elicit the individual’s treatment preferences. When
possible, the person themselves should be asked, as
people likely to serve as proxies may have very different
preferences for UI treatment80
l A more holistic nursing assessment of patients is required,
to include women’s goals92
l Discussion of patient expectations for treatment and
perceived barriers at initial visit83
l Assess self-efficacy for PFMT79
l Patients who have previously failed therapy should discuss
their options and choose a path they want to follow92
TABLE 24 Researcher suggestions for future intervention design: treatment adherence
Structure Process
Encouraging adherence and preventing dropout
l Patients should be provided with written information92
l Consistent and standardised information is needed at
the primary care level. Clients need to know the
length of time it takes to see improvement, the
importance of persistence, the average frequency of
the exercise and methods to assess correct
performance at home93
l Group teaching may be a useful strategy93
l Client-focused teaching that is grounded in the
individual’s daily realities and goals93
l Development of a personalised prescription sheet with a
personalised practice schedule for the patient to carry out
between visits83
l PFMT may be easier to maintain within a defined daily
routine rather than sporadic practice93
l Allowing room to manoeuvre and adapt strategies to
maintain individualised lifestyle, setting realistic goals and
encouraging follow-up visits may enhance adherence93
l Patients should have their progress monitored regularly
and goals evaluated at each appointment92
l Use brief motivational interviewing79
l Use feedback of objective data to enhance motivation
to change79
l People who dropout should receive a letter offering to
discuss further treatment options92
l Use appointment reminders and offer rebooking for
people who fail to attend92
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Suggestions about improvements to health-care structures that could impact on client participation and
withdrawal included the provision of adequate written information to enable adherence and consideration
for delivering treatment in a group setting.
Suggestions to improve the processes of health care included client-focused teaching and realistic goals;
personalised practice schedules adapted to the clients daily routine; regular professional follow-up with
feedback of objective data and goal evaluation; consideration of the use of strategies such as reminders or
motivational interviewing; with early follow-up and alternative options for people who fail to attend.
Staff views
Research aims
Table 25 details the stated aims of the six included studies. One study mainly referred to factors
influencing choice/uptake of UI treatments for older people in residential care.80 Three studies detailed
the factors influencing the provision of continence care: one in acute care settings75 and two in LTC
settings.77,98 Two studies (from the last decade) focused on staff perceptions of delivering a PV intervention
in LTC settings.86,97
Although the studies had slightly different aims, they all included factors that potentially impacted on the
methods selected and used for the promotion of continence by staff, including factors relating to clients,
interventions and context. Factors are presented as relating to generic continence promotion, except for
those factors specific to an intervention, which are labelled as such in the tables.
Findings
Client factors
The included studies identified characteristics of the client that would affect the continence promotion
strategies that staff used, or their chances of success, as detailed in Table 26.
From a staff perspective, the success of continence promotion strategies was affected by clients’ views
on UI and their past experiences; their functional, cognitive and communication abilities; their motivation;
and whether or not their continence improved. Ensuring functional ability to participate and the
appropriate assessment of clients’ suitability for participation were seen as enablers to appropriate
continence promotion.
TABLE 25 Staff views: stated aims of the included studies
Study Therapy uptake Continence care PV programmes
Johnson et al. 200180 Criteria for choice
of therapy
Dingwall and McLafferty 200675 Nurses’ views of promotion of
continence in acute care
Mather and Bakas 200277 NAs’ perceptions of ability to
provide continence care in LTC
Resnick et al. 200698 Barriers and enablers to UI
management in LTC
Lekan-Rutledge et al. 199886 NAs’ perceptions of problems
of implementing PV
Remsburg et al. 199997 Staff perceptions of a
PV programme
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Intervention-related factors
Table 27 identifies the factors that staff identified as potentially influencing the use of
specific interventions.
Contextual factors
Contextual factors were most frequently identified by staff as impacting on their ability to promote
continence, as detailed in Table 28.
In summary, factors which could act as a barrier to continence promotion by staff included:
l views on UI in older people
l different views on aims of UI therapy than clients or family
l referral and admission routes
l nursing assessment procedures
l staff motivation and education
l lack of staff and conflicting work priorities
l the requirements of manual handling
l perceptions of treatment effectiveness
l scheduling conflicts.
TABLE 26 Findings of staff views studies: client factors
Barrier Enabler
l Clients may accept UI,75,98 clients may hide UI, under-report,75 clients’
acceptance of treatment varies dependent on duration of UI, past
coping strategies75
l Factors affecting whether or not continence promotion strategies
were used included:
¢ pain, functional ability75,98
¢ cognitive ability, client ability to communicate and
retain information75
¢ co-operation and motivation75,77
¢ depression75
¢ psychosocial problems: laziness, denial of the problem, not
wanting to ask to urinate, fear of falling, resident embarrassed
to ask for help98
l For some residents the intervention (PV) does not make a difference/
no change in wetness noted97
l Focus on improving pain and function98
l Nursing assessment of incontinence status
and selection of appropriate residents for
PV (i.e. those who are ‘able and willing’)
(key issue)86
l Get to know residents’ toileting schedule98
All of the findings are supported by at least one study of moderate quality, except those in italics.
TABLE 27 Findings of staff views studies: intervention factors
Barrier Enabler
l Improved efficiency of pads may be a reason for not promoting
continence: staff view patients as comfortable, dry, UI is not visible,
odour is reduced75
l Pads may be used alongside continence promotion, but that can
make it harder to toilet75
l Get clothes that are easy to pull on/off98
l Staff views on interventions (e.g. PFMT) not viewed as a nursing
role,75 PV viewed as too time-consuming97
l Procedures may not be followed appropriately75,97
All of the findings are supported by at least one study of moderate quality, except those in italics.
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Factors that could act as enablers to continence promotion included:
l education
l teamwork
l adequate staffing
l methods of work allocation
l sufficient and appropriate equipment and supplies
l experience of success.
The two studies specific to the NA role in the promotion of continence or the implementation of PV also
identified methods to improve management of the NA contribution to care, including:
l regular assignments77
l inclusion in the plan of care, and in reports on mobility and functional status77
l increased accountability for adhering to a toileting plan98
l more autonomy and freedom to prioritise, work as a team77
l recognition and reward of contribution to continence promotion and management77,98
l identification of role models.98
TABLE 28 Findings of staff views studies: contextual factors
Barrier Enabler
l Acute care nurses can view UI as a factor of old age, with a
focus on containment rather than continence promotion75,98
l Nurses used criteria related to avoidance of infection and
increase in self-esteem more than clients or family; and used
criteria relating to comfort, non-invasiveness and effectiveness
less than residents or family80
l Clients with UI on admission or those transferred from
another area with UI are less likely to be assessed with a view
to promotion of continence75
l Nursing dissatisfaction with assessment procedures,
particularly around tools used and with multidisciplinary
involvement in assessment. Assessment viewed as nursing
role rather than multidisciplinary, with lack of referral
to specialists75
l Inconsistency of approach, variations in staff supportiveness
for programmes, staff disinterest75,86,98
l Lack of staff education around types of UI, approaches to
continence promotion, and psychological and social impact
of UI75,98
l Educate about the importance and benefit
of treatment77,86,98
l Lack of communication, co-operation and teamwork77,98 l Improve teamwork,77,98 staff communication and
support (including monitoring) for PV86
l Lack of staff, low staffing levels, and lack of qualified staff
for workloads75,77,86
l Adequate staff-to-resident ratios77,98
l Conflicting demands/priorities of staff75,86,98 l Consider alternative means of PV implementation,
e.g. team, limit the number of residents on PV86
l Negative attitude about the effectiveness of treatments98 l Staff felt rewarded when approaches
were successful75
l Scheduling conflict – patient at therapy or appointments98
All of the findings are supported by at least one study of moderate quality, except those in italics.
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Quality of findings
The quality of the studies related to staff views was poor overall, with only one study of good quality
(1++)98 and two studies of moderate quality (1+).75,77 However, all of the findings were supported by at
least one study of moderate quality, except those that are given in italics relating to the differences
between staff, clients and family preferences, and some specific enablers for PV implementation such as
assessment, allocation and staff monitoring.
Generalisability of findings
The generalisability of most of the findings related to barriers is confirmed in both acute and LTC settings,
in the USA and the UK. However, the generalisability of findings related to enablers is mostly confined to
NAs working in LTC settings in the USA.
Researcher conclusions and implications for practice
Researcher suggestions to improve the general delivery of continence interventions extracted from the
discussion or conclusions included:
l changing the philosophy from one of accepting incontinence, and the use of self-efficacy-based
motivational interventions to help staff and residents believe continence can be improved98
l identifying residents most likely to benefit from routine toileting77,97
l staff education97 including ways in which behavioural interventions may help improve urinary control98
l staff skills in promoting mobility and continence, the experience of caregiving and strategies for
mutual support86
l presenting realistic expectations of outcome to staff
l supervising/monitoring nursing staff performance86,97 and providing appropriate incentives to ensure
adherence to behavioural-based continence care programmes by staff, patient and family98
l sufficient staff77,86 and a team approach to continence care77,98
l appropriate infrastructure/organisational environment86,98
l new technologies to facilitate documenting continence care and new technologies such as
bladder scanners98
l examination of routines that promote or hinder productivity.86
The two studies specific to the NA role also suggested:
l consistency of NA assignments to allow the development of relationships77
l a substantial role for NAs in developing continence care plans for residents for whom they
are responsible77,97
l including NAs in the daily nursing report77
l nursing recognition and commendation of the contributions of NAs to successful continence care.77
Studies of feasibility
Eleven studies provided details of uptake, adherence or withdrawal for a CBI (as detailed in Table 29).
All of the studies were quasi-randomised or RCTs except Perrin et al.,96 which was a feasibility study.
Only one of the samples included men.89 One feasibility study was designed to test a CBI with women
aged ≥ 75 years, recruited from urology clinics.96 An additional six studies recruited people aged
≥ 55 years.33,71,73,76,89,100 Of the studies recruiting older people, one71 was undertaken in a nursing
home; one89 with homebound people, and two related studies were undertaken with women from
rural areas.73,76
Six of the studies provided information about rates of refusal to participate,33,71,82,87,89,96 of which four
reported rates of 16–18%.33,71,82,89 One study reporting a refusal of 4% was recruiting participants from
within an existing study.87 The feasibility study96 reporting a refusal rate of 38% was recruiting older
people than those in other studies.
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Information on rates of non-adherence to recommended behavioural treatment components was given
in four studies,31,85,89,96 with rates ranging from 18% to 28%. Only one study31 reported longer-term
adherence, with 60% non-adherence to BT and 47% non-adherence to PFMT at 3 months after
treatment completion.
Ten of the 11 studies reported loss to follow-up, but not all studies differentiated between withdrawals/
dropouts and other reasons for loss to follow-up (e.g. illness). Dropout is from the treatment group
receiving the behavioural intervention at first follow-up if data were available, or from treatment and
control if both groups received the same intervention. Mean loss to follow-up was 18.7% (SD 13.6) but
rates varied widely. Four studies with samples of younger women31,33,82,87 reported loss to follow-up of less
than 15% (mean 7.75% SD 3.5). All of the studies with loss to follow-up rates of 15% and over had
samples of older people (mean 26%, SD 12.9).
In summary, based on information in previous trials of combined behavioural therapy predominantly
undertaken with older women with established levels of UI, it is expected that rates would
be approximately:
l 20% for refusal to participate
l 20–30% for non-adherence to exercise/therapy recommendations
l 30% for loss to follow-up from therapy.
TABLE 29 Combined behavioural UI treatments: uptake, adherence, withdrawal
Study Client group
% declined
to participate
% non-adherence
during treatment
% non-adherence
at follow up
Withdrawal from
programme
Aslan et al. 200871 F, aged ≥ 65 years,
nursing home
16 24
Bear et al. 1997
(quasi)73
F, aged ≥ 55 years,
rural
50
Burgio et al.
199833
F, aged ≥ 55 years,
UUI
17 6
Dougherty et al.
200276
F, aged ≥ 65 years,
rural
18
Kafri et al. 2008
(quasi)82
F, UUI 17 13
Lee et al. 200585 F 28
Macaulay et al.
198787
F, UUI 4 6
McDowell et al.
199989
M/F, aged ≥ 60 years,
housebound
18 24 15
Perrin et al. 2005
(CT)96
F, aged ≥ 75 years 38 18 30
Subak et al.
2002100
F, aged ≥ 55 years 19
Wyman et al.
199831
F 20 60a 6
CT, clinical trial; F, female; M, male; quasi, quasi-RCT.
a At 3 months, pelvic floor muscle exercise non-adherence= 47%, BT non-adherence= 60%.
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Findings: predictors of adherence and treatment outcome
Studies that include multivariate analysis
Eight papers31,69,70,74,89,95,100,102 report separate multivariate analyses. Two papers69,70 report data taken from
the same sample at different time points and are therefore treated as one study. Results are presented first
for predictors of adherence and then for measures of treatment outcome including improvement in UI,
UI cure, QoL and psychological outcomes.
Predictors of adherence
Two papers relating to one study reported multivariate analyses of predictors of adherence. Alewijnse et al.69
tested predictors of intention to adhere to a behavioural programme, prior to the intervention starting.
At 1-year post treatment, Alewijnse et al.70 measured predictors of long-term adherence (i.e. up to 1 year
post treatment) to a behavioural exercise regime in the same cohort of women, in a RCT.
Three factors were found to be independent predictors of intention to adhere: severity of UI (more urine
loss per wet episode); self-efficacy difficulties (perceived ability to perform exercises as required); and
self-efficacy abilities (perceived ability to perform required exercises in various situations).
At 1 year post treatment, severity of UI was again a predictor of long-term adherence behaviour. Two
other variables were independent predictors of long-term adherence: not having sex education at school;
and adherence behaviour during treatment.
Predictors of improvement in urinary incontinence
Four studies tested predictors of improvement in UI.74,89,95,100 Improvement was defined and measured in
various ways and at different time points. Studies also presented results for different subgroups, and one
study included two regression models.95
Predictors of improvement in urinary incontinence at post treatment
One trial100 did not identify any variables as significant. Table 30 summarises the results at post treatment
for the remaining three trials identifying predictors of improvement in UI.74,89,95 Results are summarised as
negatively or positively associated with improvement.
TABLE 30 Predictors of improvement in UI at post treatment
Negative predictor Positive predictor
Socioeconomic
Male89
Education89
Physiological
Severity of UI74
Previous treatment74
Health/functional
Use of an assistive device89
Improved functional status89
Partial caregiver requirement89
Psychological
Fewer psychological problems89
Adherence89,95
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Six variables were identified as independent predictors that were negatively associated with improvements
in UI. The trial by McDowell et al.89 of a behavioural intervention in older housebound men and women
found that male sex and more years of education were negatively associated with improvement
(defined as percentage change in UI episodes). Male sex and use of an assistive device were also an
independent predictor of poorer outcome. Improved functional status was also negatively associated
with improvement.
Burgio et al.74 identified two variables as negatively associated with more than 75% improvement in UI
episodes in women with SUI: severity of UI (defined as greater frequency of UI episodes per week) and
previous treatment for UI (consisting of any treatment or evaluation, surgery or medication). Burgio et al.74
also found severity of UI (defined as use of garment protection) to be negatively associated with more than
75% improvement in UI in women with UUI.
Three variables were independent predictors that were positively associated with improvements in UI.
In McDowell et al.,89 having fewer psychological problems (defined as lower scores on the Geriatric
Depression Scale), was positively associated with improvement in UI. Partial caregiver requirement (vs. none
or full) and adherence were also positively associated with reduction in UI episodes. Adherence (measured
by clinic attendance, recording and self-report) was also positively associated with therapist evaluation of
cure or significant improvement in UI in Oldenburg and Millard.95
Predictors of improvement in urinary incontinence at follow-up
Two studies explored the relationship between predictors and treatment outcome at follow-up time points.
Wyman et al.31 tested severity and type of UI as predictors of treatment outcome of a CBI at 3 months
post treatment and found no association. In a study measuring outcome at 18 months post treatment,95
treatment adherence was positively associated with patient perception of degree of improvement in UI.
Previous surgical treatment, chronic urological symptoms and perceptions of seriousness as measured by
the Health Worry Index were all negatively associated with scores for urge symptoms and UUI on the
Bladder Symptom Score.
Predictors of urinary incontinence cure
Two studies measured cure (defined as 100% reduction in UI episodes). Wyman et al.31 found no
significant association between rates of cure and severity and type of UI in their RCT of CBIs, at
post treatment, or at 3 months post treatment. In women with UUI, Burgio et al.74 found a positive
association between rates of cure and previous surgery; severity of UI as measured by baseline diary
(but not as measured by self-report); use of garment protection; and a lower number of years
of education.
Other outcomes
Wyman et al.31 found a positive association between type of UI and QoL measures. At post treatment,
women with SUI reported less life impact (IIQ) and women with urge incontinence reported less symptom
distress (UDI). No significant associations were found at 3 months post treatment.
Tadic et al.102 identified history of depression to be a predictor of QoL (as measured by the Urge Impact
Scale) in older women with UUI.
Testing of predictor variables
The results above identify independent predictors of adherence or treatment outcome, but these have to
be viewed against the number of times the variable relationship has been included and tested in univariate
and multivariate analyses, and the proportion of studies where the variable was confirmed to be an
independent predictor.
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Univariate analyses
Thirteen studies report a univariate analysis.69,70,72,74,78,84,88,89,95,99–102 The number of times variables have
been included in a univariate analysis is identified in Table 31. Variables included in the three studies
measuring predictors of adherence are presented separately to the ten studies measuring predictors of
treatment outcome.
Sociodemographic variables
Of the 13 studies, only five were not sex specific.72,84,88,89,99 Three of these five tested sex as a variable.72,89,99
Age was tested in 10 out of 13 studies,69,70,72,74,78,84,88,89,99,101 but ethnicity has only been included in three
out of 13 studies.74,84,89
Physical variables
The influence of the major variables of type and severity of UI have been included in most studies. Severity
of UI has been included in 10 out of 13 studies.69,70,72,74,84,88,89,95,100,101 Five studies targeted people with a
specific type of UI,78,95,99,101,102 and of the remaining eight studies, seven included type of UI as a predictor
variable.69,70,74,84,88,89,100 Bagis-Smith et al.72 did not include UI as a predictor variable.
Six studies considered the influence of prior treatment.74,88,89,95,99,101 A small proportion of studies have
included other urodynamic or physiological variables such as bladder capacity, or weight.
TABLE 31 Number of times variables were included in univariate analyses
Variable category Variable Adherence (three studies) Outcome (10 studies)
Sociodemographic Sex – 3
Age 3 6
Ethnicity 1 2
Education/income 3 4
Physical Physiological variables 1 1
Weight/BMI 1 1
Urodynamic variables 1 3
Previous treatment 1 5
Duration of UI 3 6
Type of UI 2 5
Severity of UI 3 7
Health/functional General health/comorbidities 2 3
Functional status – 2
Cognitive status – 3
Mental Health perceptions 1 1
Psychological symptoms – 3
Condition/treatment perceptions 1 2
Self-efficacy/esteem 1 1
Attributions of control 1 2
Adherence 3 2
Knowledge/skill 1 –
Attitude/motivation 1 –
Social Social influences 3 1
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Health/functional variables
Only three studies included measures of general health or function as potential predictors of treatment
outcome. Of the six studies that did not state exclusion of people with significant levels of cognitive
impairment, two studies89,99 included mental capacity [e.g. as measured by Mini Mental State Examination
(MMSE) scores] as a predictor variable. One other study74 also included mental status scores in a sample
that excluded people with a lower score.
Mental variables
One study of predictors of adherence69,70 measured a wide array of psychological variables at different time
points. Two other studies included a measure of adherence as a predictor of treatment completion.84,101
Few studies have included psychological variables as a predictor of outcome.
Social variables
Social variables such as number of dependants or availability of a carer have been included in all three
studies of adherence,69,70,84,101 and one study of outcome.89
Multivariate analyses
Independent predictors of intention to adhere and treatment adherence were measured in one study.69,70
Severity of UI and self-efficacy were found to be predictors of intention to adhere, but only severity
of UI was also a predictor of adherence at 1 year post treatment, together with lack of sex education at
school and treatment adherence behaviour.
Table 32 summarises the number of times predictors have been tested against treatment outcome in a
multivariate analysis. Results are summarised for each category of predictor variable in terms of how many
studies have included the variable in multivariate analysis, and the results across studies. Associations
between variables are described as positive or negative.
Socioeconomic variables
Socioeconomic variables were included in two studies of treatment outcome.74,89 One study found male sex
to be predictive of less improvement in UI in older housebound adults.89 Level of education was included
as a variable in two studies. More education was found to be predictive of less improvement in older
housebound adults;89 and lower educational level was found to be predictive of likelihood of cure in
older women with urge UI.74 Age, ethnicity and socioeconomic status have not been tested as
independent predictors.
Physiological variables
Physiological variables have been tested in four studies. The urodynamic variable bladder capacity was
tested in one study but not found to be significant.74 Previous treatment has been tested in two studies,
with varying results. Previous treatment with medication was found to be predictive of less improvement
in women with SUI.74 Previous treatment with surgery was found to be predictive of less improvement in
younger women with UUI,95 but predictive of greater likelihood of cure in older women with UUI.74
Weight/BMI has not been tested.
Type of UI was included in two studies and was not found to be a significant predictor of improvement or
cure,100 but was related to symptom distress and symptom impact on QoL in one study.31 Severity of UI
was included in four studies.31,74,95,100 In three out of four studies correlating severity with degree of
improvement in UI,31,95,100 severity was not found to be an independent predictor, but was found to be an
independent predictor of worse outcome by Burgio et al.74 in women with stress or UUI. In three studies
correlating severity with likelihood of cure, two studies including women with stress and urge incontinence
did not find severity to be an independent predictor of likelihood of cure,31,95 while one study confirmed
lower severity of UI at baseline as a positive predictor of cure in women with UUI.74 Chronic urological
symptoms were predictive of less improvement in younger women with UUI in one study.95
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TABLE 32 Tests for independent predictors in studies using multivariate analysis
Predictor
variable
Wyman
et al.
199831
Burgio
et al.
200374
McDowell
et al.
199989
Subak
et al.
2002100
Oldenburg
and Millard
198695
Tadic
et al.
2007102 Dependent variable
Socioeconomic
Sex N Male < IMP
Education P Less
education
>C
N More
education
< IMP
Physical
Urodynamic
variables
✗
Previous
treatment
N Prior
medication
< IMP (SUI)
N Prior
surgery
< IMP
P >C (UUI)
Type of UI P ✗ ✗ Type of UI < impact on
QoL
Severity of UI ✗ N ✗ ✗ Greater
severity
< IMP
P Lower
severity
>C
Duration of UI N Chronic
symptoms
< IMP
Health and function
General health
status
✗
Functional
status
N Assistive
device
< IMP, <C
N Greater
function
< IMP
Mental
Psychological
problems
P P Less
symptoms
>C
P More
depression
> impact on
QoL
Perceptions of
problem
N More worry < IMP
Perceptions of
control
✗
Adherence P P More
adherence
> IMP, >C
Social
Social
influences
P Social
situation
> IMP, >C
<, less; >, more; ✗, tested but not confirmed as a predictor; C, cure; IMP, improvement in UI; N, negative association with
improved outcome; P, positive association with improved outcome.
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Health and functional status variables
Aspects of general health status were measured in one study and not found to be a predictor of UI
improvement.74 Measures of functional status were included in one study.89 Use of an assistive device for
mobility was predictive of less improvement, but greater functional status was reported to be correlated
with less likelihood of improvement or cure. Cognitive status has not been tested.
Psychological variables
Psychological problems have been tested in three studies. Less affective symptoms in older housebound
people correlated with more likelihood of cure89 and a history of depression was associated with greater
improvement in QoL.102 A greater degree of worry was correlated with less improvement in younger
women with UUI.95 Perceptions of control were measured in one study but not found to be predictive of
improvement.95 Self-reported degree of adherence was measured in two studies, and found to be
predictive of improvement and cure in older housebound people89 and predictive of cure in younger
women with urge UI.95
Social variables
Social variables were included in one study. The partial presence of a caregiver was found to be predictive
of improvement with older housebound people.89 Not living alone was also predictive of the likelihood of
cure in the same study.
Quality of evidence
The previous section identified that many of the variables have only been included in one or two studies,
with the most tested variable (severity of UI) included in three studies. Evidence for each predictor variable
is therefore relatively weak, but the quality of the study also has to be taken into account in interpreting
the strength of evidence. The description of the quality of included studies identified two studies as of
reasonably good quality (++),31,100 three studies of moderate quality (+),74,89,102 and one study of poor
quality (–).95 The final table (Table 33) summarises the strength of evidence for each predictor of adherence
or treatment outcome of behavioural interventions for UI.
Socioeconomic variables
Male sex is a significant predictor of less improvement in UI in one study of moderate quality.89 Level of
education was measured in two studies of moderate quality.74,89
Physical variables
Prior treatment with medication is a significant predictor of less improvement in one study of moderate
quality.74 The same study also found prior surgery to be predictive of more chance of cure, but one study
of poor quality found prior surgery to be predictive of less improvement.95
Duration of UI was measured in one study of low quality and found to be predictive of degree of
improvement, but not cure.95 Type of UI has not been confirmed as a significant predictor of outcome in
two studies of good quality,74,100 but was predictive of less symptom distress and impact of UI on QoL in
one study of good quality.31
Severity of UI was also not found to be a significant predictor of improvement or cure in the same two
good quality studies31,100 together with one study of poor quality.95 Severity of UI was found to be a
significant predictor of greater adherence in one study of moderate quality, but less improvement or cure
in another study of moderate quality.74
General health and function variables
General health status was not found to be a significant predictor of adherence in one study of moderate
quality,69 or of improvement in one study of moderate quality.74 One study of moderate quality89 provided
mixed results around functional status, with use of an assistive device for mobility associated with less
chance of cure, but greater overall functional status associated with less improvement.
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Psychological variables
Greater worry is predictive of less improvement in one study of poor quality.95 Fewer psychological
problems are associated with greater likelihood of cure in one study of moderate quality,74 but a history
of depression was associated with greater improvement in QoL in one study of moderate quality.102
Adherence has been found to be a significant predictor of improvement in two studies of moderate
quality69,89 and one study of poor quality.95 Perceptions of control are not a significant predictor of
outcome in one study of poor quality.95
Social variables
One study of moderate quality89 found social situation (defined as living arrangements of partial presence
of a caregiver) to be predictive of improvement and cure.
Generalisability of evidence
There was variation in the client groups included in the studies, so variables may only be confirmed
predictors in specific client groups. Results for predictors of adherence are generalisable to women with
self-reported UI.69,70 Severity of UI was a predictor of worse outcome in women with SUI or UUI.74,95
Previous treatment was a predictor of worse outcome in women with UUI.74,95 Sex, functional and social
TABLE 33 Strength of evidence for predictor variables at post treatment
Association between predictor and outcome
Not a significant predictorNegative Positive
Socioeconomic
(IMP) Male (1+)
(IMP) More education (1+) (A, C) Less education (2+)
Physiological
(IMP) Bladder capacity (1+)
(IMP) Prior medication (1+)
(IMP) Prior surgery (1 –) (C) Prior surgery (1+)
(IMP) Duration of UI (1 –) (C) Duration of UI (1 –)
(QoL) Type of UI (1+) (IMP) Type of UI (2++)
(IMP, C) Severity of UI (1+) (A) Severity of UI (1+) (C) Severity of UI (1++, 1 –)
(IMP) Severity of UI (1++)
Health + function
(A, IMP) Health status (2+)
(C) Assistive device (1+)
(IMP) Greater function (1+)
Psychological
(IMP) Greater worry (1 –) (C) Psychological problems (1+) (QoL) Perceptions of control (1 –)
(QoL) Depression (1+)
(IMP) Adherence (2+, 1 –)
Social
(IMP, C) Social situation (1+)
A, adherence to treatment; C, cure; IMP, improvement in UI.
Number in brackets refers to number of studies, with quality of study indicated by ++ (good), + (moderate) and – (poor).
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status variables were predictors of outcome in older housebound people.89 Fewer psychological problems
were also predictors of improvements in UI in older housebound people and improvements in perceived
QoL in women.102 Type of UI was also found to be related to QoL in women.31
Modelling predictor variable relationships
Although individual studies can provide information about individual predictor variables, none of the
studies tested predictive models, so there is little information available about how predictor variables
might interact.
Figure 23 summarises the independent predictor variable relationships from at least one study of moderate
quality (dotted line). Black lines indicate negative impact, i.e. worse outcomes, while blue lines indicated
positive impact. Dark green dotted lines indicate where evidence for the direction of correlation is mixed.
The only correlation to be confirmed in more than one study (illustrated by a solid line) is the link between
adherence and improved outcome.
Discussion
Review of effectiveness: summary of results
Ten studies (n= 1163)31,33,71,73,76,81,87,89,91,100 with 13 intervention–comparison pairs were included in the
review. Two studies did not provide data suitable for pooling.73,87
Primary outcome
Results for comparisons with another treatment in the number of people remaining incontinent at
post treatment were marginally not statistically significant (RR 0.87, 95% CI 0.75 to 1.01) in two trials of
moderate quality.31,33 Follow-up results had a similar estimate of effect size but were not statistically
significant for comparison with another treatment (RR 0.87, 95% CI 0.72 to 1.05). Results for no
treatment comparisons were statistically significant favouring the CBI (RR 0.81, 95% CI 0.70 to 0.94) from
two trials33,90 (one of moderate quality33), with no measurements available at follow-up.
Self-efficacy Adherence
Severity of UI
Functional status
History of depression
Improvement
Cure
Quality of 
life
Prior surgery
Less education
Social situation
Older
homebound
Behavioural
UI
Intervention 
Male gender
More education
Prior medication
Type of UI
Fewer psychological problems
FIGURE 23 Draft model of predictor variable relationships.
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Secondary outcomes
Results for number of incontinent episodes at post treatment were marginally statistically non-significant
(WMD –2.18, 95% CI –4.53 to 0.17) in comparisons with another treatment in three trials,31,33,81 two of
which were of moderate quality.31,33 Follow-up results were also not statistically significant in two trials,31,81
one of these was of moderate quality31 (WMD –1.40, 95% CI –4.59 to 1.79). Results were statistically
significant favouring the CBI (WMD –3.57, 95% CI –5.52 to –1.62) in five trials with no treatment
comparisons, four of which were of moderate quality. Follow-up results were also statistically significant
favouring the CBI (WMD –5.60, 95% CI –9.92 to –1.28) in one trial of moderate quality.
Results for comparison with another treatment were statistically significant favouring the CBI for improvement
in UI at post treatment in terms of subject perceptions of improvement (RR 1.42, 95% CI 1.12 to 1.81) in two
trials of moderate quality.31,33 At follow-up to 12 months the effect was of similar magnitude but was not
statistically significant (RR 1.43, 95% CI 0.96 to 2.12). In comparison with another treatment, the effect size
for 75% or more reduction in incontinent episodes was not statistically significant at post treatment (RR 1.60,
95% CI 0.94 to 2.73) or follow-up (RR 1.32, 95% CI 0.92 to 1.91). The no treatment comparison was
statistically significant post treatment favouring the CBI (RR 2.16, 95% CI 1.58 to 2.95), but was not
measured at follow-up.
Results for severity of UI for comparison with another treatment were not measured at post treatment or
follow-up. No treatment comparison in two trials71,76 (one of moderate quality76) was not statistically
significant at post treatment (SE –0.70, 95% CI –2.41 to 1.01) or follow-up (SE –0.60, 95% CI –1.47
to 0.26).
From a single trial,81 the effect for symptoms in terms of urinary frequency was not statistically significantly
different from that of another treatment in one trial (SE –0.04, 95% CI –0.70 to 0.62), but was statistically
significantly different from the no treatment comparison favouring the CBI (SE –0.55, 95% CI –0.97 to –0.13)
in four trials,71,76,91,100 two of which were of moderate quality.76,100 Results for nocturia were statistically
significant favouring the CBI (SE –0.46, 95% CI –0.81 to –0.11) in comparison against another treatment in
two trials,33,81 one of which was of moderate quality.33 Results for nocturia were also statistically significant at
follow-up favouring the CBI (SE –0.71, 95% CI –1.39 to –0.03) in comparison with another treatment, in one
study of poor quality.81 Urinary urgency was not measured at post treatment in any trial using comparison
against another treatment, but results were statistically significant for a no treatment comparison favouring
the CBI (RR 0.57, 95% CI 0.37 to 0.89) in one trial of poor quality. Effect differences for urgency at follow-up
were not statistically significant (RR 0.67, 95% CI 0.41 to 1.07).
Results for QoL were not statistically significant for either impact of incontinence or symptom distress in
comparison against another treatment at post treatment or at follow-up. For a no treatment comparison,
reduction in impact of incontinence on QoL was statistically significant at post treatment favouring the CBI
(SMD –0.47, 95% CI –0.80 to –0.14) in one trial of moderate quality,76 and was marginally statistically
non-significant at follow-up (SMD –0.36, 95% CI –0.74 to 0.01) in the same trial.
The chance of satisfaction with treatment was statistically significantly different favouring the CBI (RR 1.41,
95% CI 1.18 to 1.68) when compared against other treatments in two trials of moderate quality.31,33
Results for number of adverse events were also just statistically significant favouring the CBI (WMD –1.20,
95% CI –2.40 to 0.00), with more adverse events in the drug comparison group in one trial of
poor quality.81
In summary, there is evidence that, in comparison against no treatment, CBIs show gains in the number of
people cured, objective and subjective measures of the degree of improvement in UI, reduction in some
symptoms and impact of incontinence on QoL, but not severity of incontinence or symptom distress.
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In comparison with other treatments, CBIs seem to be more advantageous for subjective perceptions of
improvement and satisfaction with treatment. CBIs are possibly more advantageous than other treatments
in terms of reducing the number of incontinent episodes and nocturia, but there is insufficient evidence for
gains in rates of cure, frequency of micturition, or improvements in QoL.
There is evidence that in comparison with usual care, treatment effects on the number of incontinent
episodes, the severity of incontinence and the impact of incontinence on QoL, can persist into the longer
term. In comparison with other treatments, the magnitude of effect at follow-up is similar to the
post-treatment effect, but only achieves statistical significance favouring the CBI for urinary symptoms
of nocturia and urgency.
Review of effectiveness: quality of the evidence
In general, results were supported by at least one trial of moderate quality.73 However, out of the 10 trials,
one did not provide data suitable for pooling and two quasi-experimental trials reported some large
treatment effects that were not consistent with other trial results.71,81 Although eight31,33,73,76,87,89,90,100 out of
10 trials reported random allocation, only three provided an adequate description of the procedure;33,89,100
and allocation concealment was judged adequate in only one trial.100 However, judgements about the
quality of trials are based on the trial reports and not on contact with trials authors, so may refer more to
the quality of trial reporting. This effectiveness review is the basis for a Cochrane review, and trial authors
will be contacted as part of that process.
Although most of the results are supported by at least one trial of moderate quality, there are some
inconsistencies in the results, which need exploring. These are in part due to the small number of trials
contributing to each outcome, meaning that the direction and magnitude of effect does not necessarily
show consistency across no treatment and another treatment comparisons, or across post treatment and
follow-up results for the same outcomes. This may be in part due to the fact that different trials contribute
to the comparisons, with variation in trial quality, client groups and timing of outcome measurement.
The statistical significance of an effect is often variable across different outcome measurement time points,
whereas the effect size is relatively similar.
Rates of cure, number of people achieving 75% of more reduction in incontinent episodes and number
of incontinent episodes were all sourced from the same data in bladder diaries. In comparing CBIs
against another treatment, the difference in the number of incontinent episodes and the number of
people cured were marginally statistically non-significant, whereas the number of people gaining
75% or more reduction was not statistically significant. However, the general pattern is for statistically
significant difference favouring the CBI in the number of incontinent episodes when compared against no
treatment, but marginal or statistically non-significant differences of smaller size when compared against
other treatments.
Subject perceptions appear to be more positive than relatively more objective data such as bladder
diaries. One explanation might suggest increased contact with a health professional affecting subjective
perceptions. However, this explanation would not be consistent with the evidence. The review of PFMT
identifies average time of intervention as 8–12 weeks,29 whereas the average time of CBI delivery is also
8–12 weeks.79 There could be increased intensity of contact within the programme duration, but the PFMT
review identified weekly clinic contacts as the average, whereas CBI interventions had slightly more than
weekly contact, on average. Alternatively, the differences seen could be an artefact of comparing severely
right-skewed distributions for which the SDs are very large relative with the means (effectively making the
mean for number of incontinent episodes insensitive to change).
Results for urinary symptoms are at times inconsistent and also subject to considerable heterogeneity,
which is in some part attributable to the results from two quasi-experimental trials.71,81 For urinary
frequency, effects are heterogenous for no treatment comparisons at post treatment, mainly due to the
large treatment effects from one quasi-experimental trial.71 The inconsistency in statistically significant
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results favouring the CBI for nocturia in comparisons with another treatment, but not in no treatment
comparisons, could be because the significant difference is sourced only from a small quasi-experimental
trial.81 However, there is also a high degree of heterogeneity in the treatment effects of the no treatment
trials, attributable to large treatment effects from Aslan et al.71 as before, but also results favouring the
control group from two trials.90,100 In both trials, this was attributable to a rise in nocturnal micturitions in
the treatment group. Neither author offers a possible explanation. Last, only one quasi-experimental trial
contributes to the statistically significant treatment effects favouring the CBI seen for urinary urgency.71
Owing to the inconsistency and heterogeneity of treatment effects without plausible clinical explanation,
results for urinary symptoms therefore appear unreliable.
Results for QoL are more consistent, in that there is no statistically significant difference seen in either
impact of incontinence or symptom distress on QoL for two trials using comparisons against another
treatment,31,81 but results for impact of incontinence are statistically significant favouring the CBI in one
trial using comparison with no treatment,76 and marginally statistically non-significant with smaller effect
size at follow-up for the same trial. However, there was significant heterogeneity of treatment effect
observed for both impact of incontinence and symptom distress, in some part attributable to large
treatment effects observed in one quasi-experimental trial.81 Owing to the small number of trials
contributing data and the heterogeneity of treatment effects, results for QoL also appear unreliable.
Results for satisfaction with treatment are based on two trials of moderate quality,31,33 but results for
adverse effects are based on only one quasi-experimental trial,81 so should be interpreted with caution.
Review of effectiveness: overall completeness and applicability of evidence
The results would suggest that, in terms of effectiveness immediately after treatment, the choice between
CBIs and other treatments (mainly drugs or single interventions) is based on greater subject perceptions of
improvement, greater satisfaction with treatment, and the potential for more people to achieve greater
levels of improvement (75% or more) in UI. Results for symptom reduction or improvements in QoL are
inconsistent. We found no trials that included a comparative assessment of the cost of delivering CBIs
compared with other interventions, but the contact time and patterns do not appear significantly different
to PFMT trials.
The results for effectiveness over the longer term are less clear, with no clear benefit over other
treatments, other than in symptom reduction, where the evidence is potentially unreliable. The effect size
estimates at follow-up are generally consistent with post-treatment effect sizes, with only a small estimated
reduction over time. However, the small number of trials and the smaller sample size at follow-up makes
interpretation very difficult.
Few trials used objective measures of UI, such as a pad test for grams of urine lost per day. Most trials
included the number of incontinent episodes, so could report degree of improvement and number of
people cured, but only three trials reported on the primary outcome of cure. Requests for further outcome
data were made to some authors, with no success.
Overall, the results are more relevant to people with UUI or MUI, as only 14% of participants were
classified as having genuine SUI only. In the main, results are applicable to people with established,
moderate to severe UI, with only one trial including people with mild UI.90 The results are also mainly
applicable to women, with only a few men included in one trial.89 Participants had a mean age > 55 years
in 9 out of 10 trials, > 60 years in eight trials and > 70 years in three trials. Most participants were
cognitively able.
The review documents the degree of diversity in the content, main focus, duration and intensity,
enhancement, and allocation of interventions, and in what they are compared against. However, there is
sufficiently similar content in terms of main components and methods of delivery that CBIs can be easily
differentiated from single interventions and their results feasibly combined. However, there are not
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sufficient trials using the same outcome measure in any one comparison of main features to clarify what
might be the dominant mechanisms of effect. None of the subgroups of intervention characteristics
showed any significant difference and, in truth, it was difficult to allocate interventions to such broad
brush categories as basic or enhanced delivery. The benefit of such an in-depth description of intervention
content may lie more in delineating potential mechanisms of action to be tested in future trials.
In terms of acceptability and safety of the intervention, there was no evidence of adverse effect,
although few trials explicitly monitored them.33,81 Although trials have mostly been conducted in US
settings,31,33,73,76,89,90,100 there is no reason to think that they might not be acceptable to either staff or
clients in the UK, or feasible in a UK health-care context. However, only one trial used a truly community
derived sample,76 and most participants were self-selecting after being in contact with health-care services.
Three trials included people who were older and home-bound or in nursing homes,71,73,89 so interventions
seem feasible with this client group, although loss to follow-up was higher, and there were aspects of the
interventions that were not fully accepted, such as the internal examination for PFMT.
Review of effectiveness: potential limitations of the review process
For the purpose of gaining an overall picture, the review structure has leaned towards combining the results
of trials, but the degree of heterogeneity in treatment effects for some outcomes suggests that the pooled
results may be unreliable. Subgroup analyses were only possible on one outcome, and were in the main
not statistically significant, so did not provide much information about potential sources for the observed
heterogeneity. However, the explanation is likely to be in the combination of differences in client group,
intervention type, comparison group, setting and study quality in the included trials. The detailed description
of the included interventions may help to detect potential mechanisms of action for exploration in
future trials.
The alternative to pooling is to consider each trial in isolation, and to undertake narrative review for each
outcome. In effect, the review has also done this, in terms of a detailed description and comparison of the
interventions, and narrative consideration of likely sources of heterogeneity for each outcome. Another
alternative would be to structure the review comparisons differently; in particular, to use types of incontinence
as subgroups rather than type of comparison group. However, even though the sensitivity analysis for type of
comparison group was not statistically significant and there is therefore no evidence for not pooling results,
the review group prefers to maintain the distinction. Only three trials offer the potential to analyse results by
type of incontinence,31,33,81 and the effect of this has been checked in a subgroup analysis.
The choice of primary outcome measure was a matter for considerable discussion, as the review
group felt that cure was not necessarily the most appropriate outcome to be expected of a behavioural
intervention, although it might be the most desirable. Behavioural interventions were thought more likely
to incur improvement in continence and urinary symptoms. There was also discussion about whether or
not subject perceptions of improvement should be preferenced over relatively less subjective measures such
as bladder diaries. If subject perceptions had been chosen as the primary outcome, CBI would be viewed
as successful, whereas less benefit is observed in more objective measures such as number of incontinent
episodes, or number of people regaining continence. The measure of cure was eventually chosen as the
primary outcome because it is the end target of treatment for urinary continence, and as such is a gold
standard against which all treatments can be compared. There remains the potentially valid criticism that
we may have chosen the wrong outcome measure as primary, and that an alternative comparison
structure should have been used.
The choice of post-treatment timing and up to 12 months follow-up are not perhaps the most desirable
choice, as long-term continence would be the most valuable end point. However, few trials measure
longer-term outcomes, and those that do measure at variable time points. Post-treatment scores were
thought likely to be the most comparable. In this review, a number of trials measured medium-term
(i.e. up to 12 months) outcomes,76,89,90 but only three trials provided outcome data past 12 months
follow-up.76,81,90
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Narrative review of acceptability and feasibility: summary of findings
Client views
Six studies of the experiences of clients were found: five qualitative studies (n= 105)79,83,92–94 and one
postal survey (n= 79).80
Factors identified by at least one study of moderate quality that could act as a barrier to continence
promotion for clients included:
l perceptions of UI as a problem and level of tolerance for symptoms
l preference for interventions that promote independence and avoiding reliance on staff in
residential care
l increased fear of being wet with BT, negative attitudes to and experiences of PFMT and difficulty of
doing exercises properly
l competing interests/demands, and difficulty developing routines and fitting them into daily life
l convenience and cost of treatment
l delivery mode (e.g. group vs. individual).
Factors identified by at least one study of moderate quality that could act as an enabler to continence
promotion for clients included:
l having realistic goals and expectations, and gaining a sense of mastery and control if successful
l adapting daily routines to include PFMT with feedback on correct performance of exercises and
professional follow-up
l availability of an accessible and clean bathroom in residential care.
Additional suggestions by researchers to facilitate treatment choice and adherence included:
l considering the timing, siting and labelling of interventions, and the training of staff
l eliciting and honouring client preferences and their goals and expectations for treatment
l including an assessment of self-efficacy and barriers to uptake of treatment in the initial stages
l the provision of adequate written information
l consideration of the use of strategies such as reminders or motivational intervention, with early
follow-up and alternative options for people who fail to attend
l consideration of group teaching as a strategy.
Staff views
Six studies of the views of nursing staff were also included about continence care including behavioural
strategies in general (n= 273);75,77,80,98 or about involvement in PV interventions (n= 154).86,97
Factors identified by at least one study of moderate quality that could act as a barrier to continence
promotion for clients included:
l views of staff about the aims of treatment
l likelihood of continence assessment affected by routes of admission or referral
l lack of suitable assessments and involvement of the multidisciplinary team (MDT)
l staff motivation and education
l conflicting work priorities, lack of staff, requirements of manual handling, scheduling conflicts
l perceptions of treatment effectiveness.
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Factors identified by at least one study of moderate quality that could act as enabler to continence
promotion for clients included:
l education
l teamwork, adequate staffing, methods of work allocation
l sufficient and appropriate equipment and supplies
l experience of success.
Specific suggestions relating to enablers for the involvement of NAs in the promotion of
continence included:
l regular allocation of clients
l inclusion in planning and reporting of care
l increased accountability for adherence, more autonomy and freedom to prioritise
l recognition and reward for contribution
l identification of role models.
Additional suggestions by researchers to facilitate continence promotion by staff included:
l changing philosophy of care away from accepting continence
l the use of self-efficacy-based motivational interventions for both staff and clients
l targeting clients most likely to benefit
l providing realistic expectations of outcome to staff
l supervision and monitoring or staff performance
l incentives to adherence to behavioural programmes
l technology to support continence care (e.g. bladder scanners).
Narrative review of acceptability and feasibility: quality of the evidence
The quality of studies was mixed, with the potential for bias originating in the main from poor description
of methods of data analysis, or methods of testing the robustness of the findings. However, most of the
qualitative studies were descriptive rather than in-depth studies, so the identification and listing of
potential barriers and facilitators to the delivery or uptake of behavioural interventions is unlikely to be
problematic, in terms of interpretation or synthesis. Only a small number of data was extracted from
the descriptive component of the two surveys,80,97 such as the frequency of agreement with barriers to
the use of behavioural methods for continence promotion, or additional barriers identified in free-text
responses. However, most of the findings were supported by at least one study of moderate quality.
Narrative review of acceptability and feasibility: overall completeness and
applicability of the evidence
Although there were 12 studies included in the narrative analysis focusing on broadly the same topic,
there was relatively little overlap between their specific focus, with three studies of treatment choice;80,93,94
three of treatment adherence;79,93,94 two of treatment withdrawal,83,92 two of PV implementation;86,97
two of continence promotion in LTC;80,94 and one in acute care.75 Only one study79 collected detailed
information about clients’ experiences of a particular behavioural therapy (i.e. PFMT), so there is in fact
very little in-depth exploration of client responses to behavioural therapies.
The available evidence for clients relates to cognitively able women in the main, but apart from that
similarity, the samples differed. Two of the studies were restricted to women with SUI,79,92 and the samples
in these two studies were younger. Two of the studies related to older women in residential care,80 and
one study was a community sample.93 The mix of samples and the different focus of the studies means
that the barriers and enablers identified should be viewed as context specific, rather than generalisable to
any client group or setting.
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There is no information relating to client experiences of behavioural therapies other than PFMT, and none
of the studies were longitudinal, so not much is known about how views might change and develop over
time. There is very little information about particular subgroups, for example those with severe or mild
incontinence, or about men’s experience of behavioural therapies.
The available evidence for staff all relates to nursing staff, predominantly those working in long-term
residential care, although one study was undertaken in acute care.75 The samples of four of the studies
included a mix of grades from NA through to charge nurse and director of nursing. The identified barriers
and enablers related in the main to the direct delivery of care and although two studies did take a rather
wider view that included some system features, there is not a strong whole systems approach overall.
The focus on behavioural therapies in the general studies of continence care was rather small, with the
impression being that nurses did not know much about them. There were no studies in a community
setting, and none relevant to the delivery of a specific behavioural therapy other than PV.
Narrative review of acceptability and feasibility: limitations of the
review process
The synthesis of qualitative data is not a straightforward mechanical process, and some issues were
encountered that need to be taken into consideration when reading the synthesis.
The extraction of the findings
In the main, we identified as ‘findings’ the study authors’ themes, categories and codes (i.e. secondary data).
We did not collate respondents’ quotes, specific examples, or detailed data. The level at which we were most
likely to identify and extract ‘factors’ was at the level of the category in the original study – although this
differed depending on whether the original study was purely descriptive, or more interpretive. There were
occasional differences in the level of data extraction by reviewers, where one reviewer might extract a barrier
or facilitator that was described as an example from a single client. Identified factors could therefore be
based on one or many respondents’ views, and we have not differentiated or made any interpretation of
relative importance or size of impact. We have only grouped similar or related factors and identified where
multiple studies have described the same factor.
The classification of the findings
We used different classifications of the data to facilitate its presentation and synthesis, but these were
imposed by us rather than being inherent in the original data.
i. Factors were classified as either relating to client, therapy or context. Contextual issues were easy to
differentiate, but it was sometimes difficult to identify whether characteristics were inherent to
interventions, or whether they were solely attributable to client perceptions (e.g. the statement that
PFMT exercises were difficult). Reports of client experiences or feelings tended to be categorised as
client attributes, whereas more concrete features tended to be linked to the intervention.
ii. Factors were also classified as barriers and enablers. However, many more barriers were identified with
fewer enablers, and sometimes factors could be interpreted as either. Our decision was to classify
according to the expression in the text as far as was possible and duplicate factors in both if necessary.
If it was unclear whether a factor acted as a barrier, enabler or both, our decision was to go with
whatever was our agreed interpretation by both reviewers, rather than using a consistent rule.
iii. Factors were classified as relating to different stages in the process of treatment: uptake, participation
and withdrawal. This was sometimes explicit in the study design or reporting (e.g. a study of factors
influencing withdrawal from behavioural treatment), but other studies included factors relating to
multiple stages – sometimes explicitly, and sometimes not. Again, we used our judgement to assign
factors to stages. However, we did not try to duplicate factors in multiple stages, but rather to assign a
factor to the most appropriate stage.
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iv. Factors were classified according to which behavioural therapy they were reported to affect (i.e. BT,
PFMT, PV). However, some studies were more related to generic management of incontinence with
behavioural therapy as one of the considered options. It was not possible in these studies to narrow
down to a specific therapy, but where it was possible factors are reported as related to a
specific therapy.
These issues of classification and interpretation of the original data need to be taken into account when
reading the synthesis, as does the inevitable loss of detail when summarising studies.
Review of predictors of adherence or outcome: summary of results
Independent predictors confirmed in at least one study of moderate quality include, for:
l intention to adhere – self-efficacy
l longer-term adherence behaviour – greater severity of UI, lack of sex education at school and
treatment adherence behaviour
l improvement in UI – social situation, educational level, gender in older housebound people, and
adherence behaviour and prior treatment with medication in women
l cure – fewer psychological problems, prior surgery for SUI, less education
l QoL – history of depression, type of UI.
Results for functional status and severity of UI are conflicting.
The only predictor confirmed in more than one study was adherence as a predictor of improvement.
Review of predictors of adherence or outcome: quality of the evidence
Only two studies were of good quality,31,100 and these two studies only measured the two major variables of
type and severity of UI, and did not confirm either variable as an independent predictor of improvement,
although type of UI was correlated to QoL in one study.31 The remaining studies were of moderate quality
overall, although all had some weakness in the definition or measurement of predictor or outcome variables,
and none had adequate blinding of assessors.
As most of the predictors have only been confirmed in one study, the results need to be treated with
caution. In particular, results for prior treatment or severity of UI are mixed, and are probably related to the
type of UI. The only result that can be viewed with any level of confidence is the relationship between
adherence and treatment outcome.
Review of predictors of adherence or outcome: completeness and
applicability of the evidence
Although many variables have been included in univariate analyses, the majority of variables tested in
multivariate analysis have been physiological, with few studies including social or psychological variables.
Only three studies have included mental or cognitive status,89,95,102 and only one study has considered
functional status.89
The studies also cover different populations, with one study specific to older housebound people, and the
remainder specific to either older versus younger women, or women with different types of UI. Women
made up the majority of the study samples, with only a few males included in one study.89
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Conclusions
Results of the review were presented to and discussed by the ICONS Management and Steering Groups,
and also to the Patient, Carer and Public Involvement Groups. From those sources, the implications for the
ICONS trial were drawn up.
Implications for practice
l Include the teaching of stress strategies as a component of the PFMT protocol.
l Consider how to check the performance of PFMT exercises.
l Use behavioural headings in the protocol for the intervention, so that nurses have clear content to
direct them on behavioural components, i.e.
¢ patient education: provision of instruction, modelling behaviour
¢ review: intention formation, barrier identification, tailoring to individual’s goals, provision of
feedback on review
¢ maintenance: reminders, encouragement, motivation, dealing with anxieties/fears.
l Reflect the same structure in the patient booklet by adding a section about ‘What other people have
said’, and a section about ‘keeping up the practice’, together with strategies for this, for example have
small goals in mind, try to do the exercises at certain times of the day so you remember them, do not
get disheartened if there is not immediate improvement, etc.
Implications for research
l Include questions on confidence in instruction/doing PFMT exercise, and whether or not feedback was
available in interviews with both staff and patients.
l Review the measurement of adherence in the trial to ensure that adherence to different components of
the intervention is monitored.
l Include measurement of staff adherence, i.e. per cent completion of scheduled activity, fidelity of
adherence to protocol.
l Consider alternatives to bladder diaries for people with communication problems.
l Include questions related to subjective experience in interviews with patients:
¢ fears, negative attitudes to interventions
¢ expectations
¢ tailoring intervention to individual and circumstance
¢ mastery/control
¢ assessment of correct performance, receipt of feedback.
l Include questions related to subjective experiences in interviews with staff:
¢ named barriers/enablers
¢ staff training in the assessment of incontinence
¢ availability of continence assessments
¢ workload, team allocation, etc.
l Include information from the review in staff education.
l Definition and measurement of outcome varies considerably in the trials included in the review, and the
ICONS trial should take into consideration the Cochrane recommendations for outcome measurement.
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l Predictor variables with sufficient consistent evidence to be taken into consideration in trial design
include type of incontinence and adherence. Evidence related to the severity of incontinence is
inconsistent, but should also be measured.
l Predictor variables hypothesised to be influential but with insufficient testing include:
¢ cognitive status
¢ functional status
¢ psychological status
¢ perceptual and sensory difficulties
¢ difficulties with learning
¢ self-efficacy
¢ attitude
¢ perceptions of control
¢ educational background.
l Data collection on these variables should be considered.
l There is insufficient evidence in the review on the use of BT or PFMT in men. One excluded trial of
mixed behavioural strategies does include men, but does not provide data on incontinence.110 In the
absence of any data from the review, we may need to refer back to the literature on the use of
conservative methods for UI after prostatectomy for intervention type, timing and intensity to be used
with men.
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Chapter 3 Developing the interventions
Overview
In this chapter, we report the development and rationale behind interventions used in the research
programme and how they were informed by the evidence synthesis. The effectiveness component of the
evidence synthesis suggested CBIs impact on rates of cure, objective and subjective measures of degree of
improvement, reduction in some symptoms and impact of incontinence on QoL. In comparison with other
treatments, CBIs are more advantageous for subjective perceptions of improvement and satisfaction with
treatment, and are possibly more advantageous than other treatments in terms of reducing the number of
incontinent episodes and nocturia. We therefore selected a combined approach comprising BT and PFMT
as a key component of the intervention.
Systematic voiding programme
Assessment of continence status
The assessment phase comprised two components, a 3-day bladder diary and a comprehensive continence
assessment. Ward staff completed a 3-day bladder diary (see Appendix 8) for all patients admitted to the
participating unit with a confirmed stroke. The aim of the diary was twofold: to identify patients who were
incontinent and to use the pattern of incontinence to inform the initial voiding interval on the BT or
PV programme.
All patients who were not continent by the end of the 3-day diary underwent a full assessment of their
incontinence based on a set of evidence-based assessment criteria and conducted by nursing staff
(see Appendix 9). Assessment criteria were taken from a systematic review of methods of diagnosis and
assessment of UI,111 these included an initial assessment (including history taking and physical examination);
urine dipstick examination and (if indicated) a mid-stream urine specimen tested by microscopic examination,
culture and sensitivities; an estimation of post-void residual urine volume, when indicated by the history/3-day
diary (using the bladder scanner provided by the project); and an identification of the type of incontinence
[UUI, SUI, MUI (both UUI and SUI), ‘functional’ UI or unclear]. Following this assessment, nursing and medical
staff determined the route most appropriate to each patient using the algorithm provided (see Appendix 10).
Conservative interventions
The intervention comprised algorithm-driven individualised SVPs tailored to the physical and cognitive
capabilities of each patient. The algorithm specified two routes: a combined package including BT and
PFMT for those patients who are cognitively able, and PV for those with cognitive impairment. Protocols
for ward staff are shown in Appendices 11–13. BT included three main components: (1) focused education
for patients and carers [including information on the anatomy and physiology of the lower urinary tract,
the rationale behind the programme and strategies to suppress the urge to void (e.g. distraction and
relaxation)31,112]; (2) individualised voiding regimens designed to restore normal voiding patterns by
progressively lengthening the time interval between voids, based on assessment of participants’ normal
voiding patterns and self-monitoring; and (3) patient-held voiding diary, a cognitive intervention designed
to promote self-awareness of voiding habits.100,113
Pelvic floor muscle training was designed to strengthen types I and II muscle fibres in the pelvic floor.
It was intended that patients would perform five fast (3 seconds) and 10–20 sustained (10 seconds)
contractions with 10-second relaxation periods between contractions twice a day in line with the protocol
by Wyman et al.31
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For those patients with cognitive impairments, the programme consisted of elements traditionally classified
as PV. Unlike BT and PFMT, PV is not designed to affect bladder function but to avoid or minimise
episodes of incontinence.114 Participants were approached according to individualised schedules (e.g. every
2 hours during waking hours), asked if they are dry or wet, and prompted to use the toilet.115 Verbal praise
was offered for correct reporting of dryness/wetness and successful toileting. Participants with cognitive
impairments were given the opportunity to participate in the education and patient-held diary components
of the intervention.
Participants not able to walk to the toilet were assisted by nursing staff. Weekly review of progress, with
adjustment or change of route as appropriate, was recommended. Participants were provided with written
information about their SVP to enable them to continue with it after discharge from hospital.
Table 34 shows how the intervention was informed by the findings of the evidence synthesis on the
barriers and enablers to successful implementation of conservative interventions for UI (see Chapter 2), in
line with the MRC framework for developing and evaluating complex interventions.59,60
The SVP was incorporated into routine practice by all staff in day-to-day contact with patients. All nursing
staff [including health-care assistants (HCAs), night staff and student nurses] were provided with an
education programme of both theory and practice (developed by the research team and the research
programme’s two dedicated PPC groups) enabling them to implement the programme. Training was
largely web-based to facilitate easy access and flexibility, but face-to-face sessions were offered to cover
the practical aspects of intervention delivery and recording. The online training programme has been
endorsed by the UK Stroke Forum Education and Training (UKFST, URL: http://ukfst.org/, reference number
QM0056) and can be accessed at URL: http://breeze01.uclan.ac.uk/p9llwxl5z18/, with the username
‘iconsuser@uclan.ac.uk’ and the password ‘stroke’.
Additional 2.8 whole-time equivalent HCAs (i.e. one extra HCA per daytime shift, including weekends)
were employed on the unit for the duration of the intervention period. Participating units in both the case
study and trial phase were also provided with a bladder scanner and training in its use from the supplier
(Verathon®, Medical UK Ltd).
TABLE 34 Elements of the intervention informed by evidence synthesis
Recommendation for practice Action taken
(1) Include teaching of stress strategies in PFMT protocol Exercises to strengthen pelvic floor muscles included in
protocol
(2) Check performance of PFMT exercises Guidance provided for men and women in protocol
(3) Use behavioural headings in intervention protocols Headings such as ‘patient education’, ‘review’ and
‘maintenance’ included in protocols
(4) Add section to the patient education booklet entitled
‘what other people have said’ and ‘keeping up the
practice’, together with strategies for doing this
Sections added to the patient education booklet
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Systematic voiding programme plus supported implementation
This trial arm received the intervention as outlined above, plus supported implementation using facilitation.
Designing the implementation strategy
The implementation literature highlights the non-linear flow of knowledge, including evidence from
research, into and within health-care organisations.41 This emphasises the need to embed the investigation
of implementation issues within evaluation programmes,59,60 including consideration of how use of the SVP
could be maximised within this randomised trial and subsequently.
As a science, knowledge translation lacks conceptual and theoretical clarity,116 where implementation,
improvement, innovation, change management and organisational learning can be blurred. Although all
these fields include some elements of change processes, variations exist in the nature and sources of
knowledge driving change. Although components of the SVP have been shown to be effective in some
(mainly primary care) settings,25,27 its adoption within acute stroke services is new. Specific implementation
challenges may be anticipated through variation in both beliefs about the transferability or clinical ‘fit’
between the SVP and the acute stroke care context,117 the credibility of underpinning evidence,45 and the
quality of processes used to support implementation.118
Considerable effort has been spent in exploring the utility of psychological theories of behaviour change in
explaining individual clinician’s use of evidence119,120 and across organisational settings.121 However, there is
growing recognition that the implementation of evidence in practice is also influenced by the organisational
context in which clinicians operate.40–43,122 Organisational context has been defined as ‘the environment or
setting in which the proposed change is to be implemented’.123 At its simplest level, context may refer to the
physical environment where health care takes place. However, Rycroft-Malone et al. concluded from their
concept analysis that contexts conducive to research implementation included a range of less tangible
process elements: ‘clearly defined boundaries; clarity about decision-making processes; clarity about patterns
of power and authority; resources; information and feedback systems; . . . and systems in place that enable
dynamic processes of change and continuous development’.45,124
Theories underpinning organisational influences on implementation include that of learning organisations
(with characteristics encompassing hierarchical structure, information systems, human resource practices,
organisational culture and leadership46) and knowledge management (how organisational mechanisms
affect knowledge uptake and use).47,48,125 Although barriers and enablers may be identified through
evaluation of these aspects of the implementation context, other factors associated with the target practice
and its organisation will also need assessment and management.
In this study, the implementation of systematic voiding regimes may be influenced by staff knowledge and
skills, resource availability, competing clinical demands and the systems that may influence practice in this
area. Although both contextual perspectives may be a legitimate focus of attention within implementation
initiatives, tensions exist between designing multicomponent implementation strategies that have maximum
impact126 and ensuring explanatory power through theoretical integrity in strategy selection.
Successful implementation of an intervention to improve the management of post-stroke UI is likely to be
mediated by individual members of staff and availability of evidence-based guidance, the complexity of the
intervention as well as the interplay of patient, social and organisational factors.49,50 The literature suggests
that careful attention needs to be paid to the specific barriers to change in any given setting, identified
through ‘diagnostic analysis’ at levels that may include the individual, groups or teams, organisations and
the wider health-care system.51 Tailoring in implementation can refer both to the adaptation of evidence
to local clinical settings,116 and the selection of strategies to change professional practice that take account
of recognised obstacles to, or enablers of, implementation.52 A common theoretical approach used in
implementation research draws on Lewin’s127 classic work on force field analysis, where competing fields
require active management for successful change. Although consideration of context provides some
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indication as to where influencing factors may be identified, how they influence implementation will
only become evident (and potentially managed) as the new practice is ‘normalised’, or embedded within
other clinical work.
Approaching implementation from a ‘normalisation’ theoretical lens55–58 is expected to provide real-time
information on barriers and enablers of change as clinicians engage in the work of implementing the SVP.
We anticipated this information would be a useful resource for supporting implementation at a local level.
In addition, this focus on implementation work would address the limitations of considering contextual
influences associated with either the acute stroke service configuration or the implementation context
described earlier.
We therefore evaluated whether or not supported implementation, through targeted organisational
development aimed at ‘normalising’ the intervention, was more effective than introduction of the
intervention alone.
Services randomised to the supported implementation arm of the trial received the SVP together with
supported implementation comprising diagnostic analysis of context at the level of the organisation;
identification of barriers (defined as ‘factors that impede the implementation of change in professional
practice’52); and facilitators to the intervention, as well as targeted organisational development activities.
Facilitation
To support the process of implementing the SVP, we used a form of facilitation, a model that has been
used successfully in secondary care settings128,129 and is currently the focus of an international trial of
‘technical’ and ‘enabling’ facilitation in a nursing home context.130 The process of facilitation involves
supporting and enabling people to change their practice.128,129 Although approaches to facilitation vary,
they are based on the principle that ownership is with the group.131,132 The facilitator guides the group
towards accomplishing a goal, helping members identify the obstacles that may impede progress and
enabling them to identify strategies to overcome them.132
Facilitation has not received much attention in systematic reviews of implementation strategies to change
professional practice,133 although it is likely there is overlap between this strategy and the use of local
opinion leaders and educational outreach (or academic detailing), respectively, identified as interventions of
variable and consistent effectiveness.133 It has come to prominence principally as a component of the
Promoting Action on Research Implementation in Health Services130 framework.43,130,134
Although there was a focus on goal attainment (defined as the normalisation of the SVP), our approach to
facilitation primarily focused on ‘enabling’ rather than ‘doing for’ others,128,129 with an emphasis on
developing and empowering both individuals and teams.
We used both internal and external facilitation. External facilitation aimed to help internal facilitators at the
research sites to understand how to bring about change in health professional practice in order to embed
the SVP within usual practice. External facilitators (EFs) also supported local facilitators in the form of
encouragement, mentoring and providing feedback. These activities are in line with Stetler et al.’s132
findings from their retrospective evaluation of facilitation from the viewpoint of implementation change
agents. Enablers of external facilitation were providing motivation and leadership; team understanding and
support of the role; maintaining contact with internal change agents and appointing facilitators with the
requisite skills; and experience and/or personal attributes.
We employed the expertise and experience of at least one specialist practitioner (staff members expert in
the field of stroke and incontinence) per stroke service allocated to the ‘supported implementation’ arm to
serve as internal facilitators. Internal facilitators were required to possess characteristics outlined in Box 1.
Their aim was to help teams work together, provide the necessary information and training, maintain
motivation and give feedback and practical help when needed.
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Underpinning the facilitation process was the facilitation manual (see Appendix 14). The manual was
loosely based on an action planning framework which allows barriers and enablers to be made explicit,
and addressed through facilitation activities. Barriers and enablers were identified a priori, drawing on
findings from the case study and the soft systems analysis of the continence system; there was also scope
for these to emerge through ongoing internal facilitation activities. The manual also included a ‘toolkit’ of
facilitation interventions and strategies based on the recent taxonomy developed by Dogherty et al.135
Internal facilitators were asked to record which strategies they used and to reflect on these in terms of
their usefulness in enabling and supporting change.
External facilitators worked with each site to develop an action plan (see Appendix 15) to structure
facilitation work and encourage the development of objectives, action plans and an analysis of barriers and
facilitators to implementing these. EFs provided support throughout the intervention period through a
mixture of face-to-face meetings, teleconferences and e-mail correspondence.
BOX 1 Selection criteria for internal facilitators
l Has some knowledge of good practice in continence care and has an interest in the topic (has a positive
attitude towards evidence and how evidence can help develop this aspect of care and can demonstrate
some essential knowledge of continence promotion and key aspects of best practice in continence
management, e.g. assessment, use of continence aids).
l Knows coworkers (has been in the organisation long enough to know the staff and how they work).
l Knows the environment (has some insight into the culture of the setting).
l Knows the organisation (knows their way around the organisation, e.g. who’s who, policies in place,
decision-making structures).
l Occupies a clinical leadership position (one where they have authority or are able to negotiate authority to
make decisions about practice; how practice is organised; resources impacting on practice).
l Possesses effective communication skills (could include attributes of being open minded, being creative, has
experience of managing meetings/groups, able to talk in front of groups).
l Is self-aware and resilient (has insight into their support needs, but is also not afraid of challenge/conflict;
willing to engage in own professional development).
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Chapter 4 Case study
Overview
Our research programme aimed to develop, implement and explore the potential clinical effectiveness
and cost-effectiveness of a SVP (including BT and PFMT for patients who are cognitively able and PV for
patients with cognitive impairments), with or without supported implementation, for the management of
UI after stroke in secondary care. The programme design was based on the UK MRC framework for the
evaluation of complex interventions.59,60 This chapter presents the development phase, a case study of the
introduction of the SVP in one stroke service in north-west England.
Objectives
Objectives were to inform the Phase II trial by:
l identifying systems affecting the likelihood of the SVP becoming embedded in mainstream stroke
clinical care
l exploring health professionals’ views about the acceptability of the SVP
l measuring presence/absence of UI and frequency of UI episodes at baseline and 6 weeks post stroke
l investigating factors affecting discharge UI
l assessing adherence to intervention paperwork (3-day diaries and daily clinical logs).
Methods
Design
A mixed-methods single case study approach136 was chosen for its suitability in investigating highly
contextualised and complex phenomena.137 Methods included analysis of context using interviews with
clinical leaders analysed using soft systems methodology; a process evaluation using focus or group
interviews with staff delivering the intervention and analysed using normalisation process theory (NPT); and
outcome evaluation using data collected from patients receiving the SVP and analysed using
descriptive statistics.
Setting
An 18-bedded acute stroke unit in a large trust serving a population of 370,000 and with teaching and
foundation trust status.
Subjects and sampling
Patient inclusion criteria:
1. aged ≥ 18 years with a diagnosis of stroke based on the World Health Organization (WHO) criteria138
(no upper age limit)
2. UI as defined by the ICS139 as ‘involuntary loss of urine’
3. conscious (defined as a Glasgow Coma Score140 of ≥ 12)
4. medically stable as judged by the clinical team
5. incontinence classified as SUI, UUI, MUI or ‘functional’ UI.141
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Health professional and clinical leader inclusion criteria:
1. health professionals either delivering the intervention or linking with the intervention in any capacity.
Consent
Local research ethical approval was granted by Bolton Research Ethics Committee on 24 April 2009
(09/H1009/15). Research and development and site-specific approval was given on 26 November 2009;
approval was also obtained from the University of Central Lancashire Faculty of Health and Social Care
Ethics Committee (FHEC) on 2 July 2009 (CA 138).
Participant consent process
All patients admitted to the unit during the intervention period were screened for eligibility; patients were
recruited as early as possible following admission. Informed consent to collect baseline and outcome data
was sought from all patients meeting the inclusion criteria. Nursing staff asked these patients whether or
not their name could be given to the research team. If the patient agreed, a member of the research team
visited the patient to explain the project, answer any questions the patient (and their families/carers) had
and provided a participant information sheet (see Appendix 16). Patients were given at least 24 hours to
consider participation and were visited by a member of the research team after this period; patients
choosing to participate signed the consent form at this stage.
For patients unable to consent for themselves, a person able to advise on the presumed wishes of the
patient was approached to act in the role of consultee. This is in line with the recommendations of
the Mental Capacity Act 2005 (www.legislation.gov.uk/ukpga/2005/9/contents).142
Health professional and clinical leader consent process
Health professionals and clinical leaders were identified by the research team in collaboration with senior
nurses, medical staff and other health professionals working in the stroke service. Health professionals and
clinical leaders were approached by a member of the research team. An initial appointment was made
with each potential participant, where the study was explained and a participant information sheet
provided (see Appendix 17). Health professionals and clinical leaders indicated they may like to take part
by returning a card to the research team. A further appointment was made with those indicating they
might like to take part, where signed consent was obtained.
The intervention
The intervention (see Chapter 3) comprised a SVP including assessment (including a 3-day diary and
comprehensive continence assessment), algorithm-driven individualised conservative interventions tailored
to the physical and cognitive capabilities of each patient and weekly review.
All eligible patients admitted to the participating stroke service were treated using the SVP, regardless
of whether or not they consented to collection of outcome data: successful implementation of the
intervention was deemed more likely if all eligible patients were included. Risks to patient safety were
minimal, although there was a potential risk of demoralisation if the programme was unsuccessful.
The ward manager, two ward sisters, 12 staff nurses and 13 HCAs completed the online training
programme. Additional training was provided by a clinical nurse specialist in the workplace and comprised
one half-day session (repeated several times to ensure the majority of ward staff had the opportunity to
participate). The content of face-to-face training is shown in Table 35; training materials are available
on request.
Methods of evaluation
Four methods of evaluation were used.
CASE STUDY
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Identifying organisational context for embedding the systematic
voiding programme
A soft systems approach143 was used to identify systems affecting the likelihood of the SVP becoming
embedded in mainstream stroke care. The stroke pathway can be conceptualised in terms of the patient’s
journey through constituent services which vary in purpose, structure, location and workforce. The patient’s
experience of UI is similarly longitudinal, and has the capacity to span the entire pathway. This poses a
challenge to achieving continuity in all aspects of incontinence care and associated patient management,
which is similarly multifaceted drawing on different interventions delivered by different professional
groups in different contexts. These contexts include, among others, different settings (acute stroke unit,
rehabilitation unit, community, care home) and different practice paradigms (emergency/acute, rehabilitation,
continuing, palliative).
The ICONS study clinical intervention can be conceptualised as one component of a whole incontinence
care system and our aim was to ensure that the intervention could be embedded within this. The first step
was to understand the incontinence care system. This information was used to inform subsequent stages
of the research which focus on implementation of the new intervention, and the degree to which it is
embedded in systems and clinical practice. To ensure this phase of the research programme was
manageable within planned resources, the analysis focused in detail on the stroke unit and primary
discharge destinations, and considered other components of the pathway in general.
In systems theory, services are considered as complex human activity systems143 which can be understood
in terms of the relationships between their structure, process and outcomes. The aim of systems analysis
was to describe relationships and use them to generate a definition of how the service or, as in this
TABLE 35 Case study: content of face-to-face ward staff training
Topic Content
Introduction to the ICONS study Study aim and methods of the case study phase
Definitions of ‘continence’ and ‘incontinence’
Anatomy and physiology of the lower urinary tract Normal urinary functioning
l Micturition cycle
Deviations from normal functioning
l Generic
l Stroke specific
Types of UI UUI
SUI
MUI and SUI
Overflow incontinence
UI following stroke Detrusor hyper-reflexia (overactive bladder)
Detrusor hyporeflexia (underactive bladder)
Outflow obstruction
Assessment of UI
Introduction to conservative interventions BT
PV
PFMT
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context, groups of services worked. This is known as the root definition of the service and describes the
relationship between six factors:
l customers (patients and their family carers)
l actors (providers of UI care)
l transformations (key changes occurring as a result of the service)
l world view (the value system and policy context in which the service operates or the justification for
the service)
l owners or stakeholders of the system (agencies involved in commissioning the service)
l environment (local conditions that enable or limit UI care).
Although not a hypothesis to be tested in this research programme, understanding the whole system
within which the intervention was delivered may have enhanced the degree to which implementation was
successful. In addition, when led by theory, this ‘diagnostic analysis’ information may help in the design of
transferable implementation strategies by highlighting barriers and facilitators to implementation,
workforce education and training issues, and process factors such as requirements for
clinical documentation.
A purposive sample of staff engaged in managing and delivering the incontinence systems were approached
for inclusion in this study component. Subjects were selected to ensure breadth of coverage in terms of the
range of health professionals who provide UI interventions in both primary and secondary care.
The aim of the systems analysis was to evaluate CATWOE (customers, actors, transformations, worldview,
ownership and environment) elements and use them to generate a definition of how continence provision
worked as a clinical system, highlighting the barriers and facilitators that were anticipated to impede or
enhance implementation of the SVP. Qualitative data relating to the evaluation of organisational context
were analysed using a directed content analytic approach.144 This involved drawing deductively on
categories derived from pre-existing theory to guide the analysis of interview data within the soft systems
framework.145 The purpose of analysis was to develop new and more specific insights into implementation
context by extending the theoretical position within the particular clinical focus of the case study.
Practically, interviews were coded using the major concepts of the framework. Each data set was analysed
by two people independently. At regular stages of the analysis, agreement was explored, disagreements
discussed and coding frame guidance revised accordingly as more nuanced understandings of the concepts
in the study context emerged. During the final stages of analysis, a site summary was created by merging
findings across interviews, linking related text chunks together for key concepts and condensing to
remove overlap.
Stroke unit staff views of embedding the systematic voiding programme
Six audio-taped focus or group interviews were conducted with health professionals involved in delivering
the programme at 1 to 2 monthly intervals throughout the case study. Interviews explored views of the
behavioural approaches and their acceptability and feasibility, and the perceived impact of different
components of care (e.g. focused education, individualised voiding regimens).
Normalisation process theory55–58 provided the theoretical framework for implementing and evaluating
the SVP. The model is designed to facilitate understanding of the practical issues involved in embedding
complex interventions into routine practice (e.g. ease of use and integration), and has been used in a
range of settings.55,146 It provides a theoretical framework for both implementation and its evaluation and
our intervention provided a good fit with May et al.’s definition of complex interventions as comprising
‘multiple behavioural, technological, and organisational components’.57 In addition, the model’s view of
change as resulting from collective, rather than individual, action57 is in line with our aim of bringing about
change through group activity. The NPT also has a similar emphasis on organisational context. It comprises
16 dimensions in four categories, illustrated in simplified form147 in Table 36.
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Initially, focus or group interviews were coded using the NPT framework by two people independently;
at the completion of coding each interview, agreement was explored, disagreements discussed and coding
frame guidance revised accordingly (see Appendix 18). Multiple comments relating to the same point
were condensed for each NPT dimension to remove overlap and redundancy. Comments were labelled
by respondent to facilitate identifying any variation in findings by staff grade (i.e. HCA for health-care
assistant, or Q for qualified staff).
Second, a site summary was created by merging the findings across the six interviews, linking related text
chunks together for each NPT dimension and condensing down to remove overlap and redundancy, taking
care to avoid loss of meaning or viewpoint. Findings were categorised and reported as either barriers or
facilitators to implementation of the SVP. Implications for the trial phase were built from these by the
research team and discussed at Steering Group meetings. These were used to refine the SVP intervention,
facilitation manual and implementation plan.
Patient outcome and factors affecting discharge continence status
Baseline data
Baseline information about consented participants included:
l age
l gender
l ethnicity
l date of admission
l date of stroke onset
l date baseline questionnaire completed
l location when recruited into the study
l consciousness level (defined as either ‘alert’ or ‘drowsy’ on the ‘Clinical Status on Admission’ item of
the European Stroke Database)
l type of stroke
l stroke subtype [Oxford Community Stroke Project (OCSP) classification]148
l comorbidities
l Barthel Index at baseline and day 7 post stroke149
l Pre-stroke modified Rankin Scale (mRS) handicap score150
l Incontinence Severity Index (ISI)151
l Leicester Urinary Symptom Questionnaire (LUSQ) – pre and post stroke152
l functional incontinence
l cognitive ability (Abbreviated Mental Test Score)153
TABLE 36 Dimensions of the NPT
Sense-making Cogntive participation Collective action Reflexive monitoring
Could people see how
the new practice differs?
Who were the key people
driving the new practice
forward?
Could people do what the
new practice required?
Could people determine the
effects of the new practice?
Did people agree with the
new practice?
Did people agree they should
be involved?
Did people feel confident in
each other’s work and
expertise?
Do people agree about the
worth of the new practice?
Did people understand
what they were supposed
to do?
Did people organise
themselves to undertake the
work required?
Did people have the right
skills and training?
Do the people involved think
the new practice is worth
doing?
Do people think the new
practice has value for
them?
Did people work together to
build the procedures
required?
Was the new practice
adequately supported and
resourced?
Did people make changes to
the new practice?
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l fluid intake
l bowel function
l relevant clinical investigations (e.g. mid-stream urine, bladder scan)
l medications.
Outcome data
The ICONS research nurse recorded the following information for patients on discharge from the unit or
discharge from the SVP, whichever was sooner:
l date questionnaire completed
l date of discharge (if applicable)
l discharge status (alive or dead)
l discharge destination
l Barthel Index149
l LUSQ152
l ISI.151
Questionnaires were scanned using ABBYY form reader optical character recognition software (version 6.4,
ABBYY Software Ltd, London), transferred into the Statistical Product and Service Solutions (SPSS; IBM
SPSS Statistics, Armonk, NY, USA) and analysed using descriptive statistics. For the purpose of analysis, UI
was defined as a response other than ‘never’ on the ISI question ‘How often do you experience urinary
leakage?’. UUI was defined as the response ‘yes’ to the LUSQ question ‘When you get the urge to pass
urine, does any leak before you get to the toilet?’. SUI as the response ‘yes’ to the LUSQ question ‘Do you
ever leak when you do any of the following?’. MUI as both SUI and UUI; and functional UI as mobility or
balance restrictions stopping patients reaching the toilet on time.
Urinary incontinence at discharge or 6 weeks (whichever was sooner) for patients who started the
programme was explored using descriptive statistics; factors affecting discharge/6-week incontinence
outcomes were investigated using regression modelling. Using presence/absence of incontinence and
number of incontinent episodes in the last 5 days, we performed various analyses to help identify
characteristics predictive of outcome. Given the limited sample available, we used findings from the
evidence synthesis and discussions with experts, including members of the Steering Group, to identify
a set of characteristics previously found to be predictive of outcome among those incontinent following a
stroke. These were age, gender, functional ability, prior treatment for UI and prior surgery for UI. The main
analysis for identification of characteristics predictive of outcome was based on number of UI episodes in
the 5 days prior to discharge. This was based on the following assumptions: for those discharged prior
to 6 weeks post stroke, continence levels will be maintained from discharge (as most discharged
substantially earlier than this will be fully continent); cases dying between entry into the study and
6 weeks should be excluded. Sensitivity analysis was applied to determine whether or not these
assumptions affected the conclusions.
Modelling used approaches appropriate for count data. Given the expected clustering at zero (among those
who had regained full continence prior to discharge) and consequent over dispersion, it was anticipated that
a negative binomial model might provide a better fit than a Poisson (or normal) model; this was explored
during the data analysis which was based around a flexible forward stepwise selection procedure, but always
including the number of incontinence episodes in the first 5 days following recruitment. Analysis was
repeated for presence/absence of incontinence using logistic regression modelling based initially on terms
included in the model for number of incontinent episodes in the last 5 days prior to discharge. Subsequently,
terms were selected using stepwise backward elimination (using a 10% significance level for exclusion and a
5% level for reclusion) and any differences in effect sizes investigated and interpreted in the context of the
case study.
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Adherence to the intervention
Implementation fidelity has been defined as ‘the degree to which an intervention was implemented as was
intended’.154 Measuring the extent to which key components of the SVP, the 3-day diary, BT and PV,
were delivered as per protocol was particularly relevant given the exploratory nature of this phase of the
research programme. Adherence to intervention paperwork was used to measure fidelity; data was
extracted from daily clinical logs specific to each route on the programme and from the 3-day diary.
Daily clinical logs
A clinical log was a single sheet of paper on which nursing staff recorded the patient’s activity on the
programme for 1 day. One clinical log should therefore have been completed for each patient for each day
that they received the ICONS programme. Given that there are two different types of regime, PV and BT,
there were two different types of clinical logs, corresponding to each regime. It was the role of clinical
staff to determine which regime a patient should receive (see Chapter 3).
In order to assess adherence to the daily BT or PV regime, all clinical logs were collected for consented
patients. The method used to input and analyse data from the clinical logs was based on the identification
of key quality indicators of adherence. Indicators were assessed in stages, and are shown in Appendix 19.
Summary measures of the key quality indicators for each clinical log were entered using a proforma to
facilitate data input (see Appendix 20). A filtering system was developed, whereby data input for an
individual clinical log could be terminated at one of two stages (stage 1 or 2; see Appendix 19). This
meant that for each clinical log details of how it performed at each stage were entered, with later stages
omitted if earlier stages did not meet the quality indicator.
Data input was initially undertaken by one researcher. Any issues encountered or assumptions made were
recorded. Following initial data input, this researcher met with a senior researcher to address any issues
that had arisen and verify whether or not assumptions made were reasonable. Any duplicate clinical logs
(arising from photocopying errors) were identified and removed from the data set. Finally, the senior
researcher checked 10% of the clinical logs for inputting errors. As this revealed an error rate of less than
5%, it was agreed that the team could be confident about the accuracy of the data input and no further
data verification was deemed necessary.
The final analysis of the data was undertaken jointly by two researchers. A simple descriptive analysis was
undertaken, exploring how well clinical logs performed against the different quality indicators.
Three-day diary
Research nurses were asked to submit a copy of 3-day diaries for all participants for whom one was
recorded (i.e. participants who were incontinent at baseline or whose catheter was removed before
discharge; participants catheterised throughout their stay were not eligible to complete the diary). Each
diary was assessed using a filtering system, with data input for an individual terminated at stage 1 to stage
4 if it failed to achieve the stage’s key quality indicator. These were:
l Is there a paper copy of the 3-day diary present?
l Is the diary complete?
l Is there an entry on each of the 3 days of the diary?
l Are there three or more entries on EACH day with a time recorded in the ‘time went to the
toilet’ column?
l Are there three or more entries on EACH day where a ‘time went to the toilet’ entry has a value in the
‘leaked’ column?
The assessment of ‘yes’ or ‘no’ for each applicable stage was entered into the SPSS.
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Findings
Centre
The original centre chosen as the case study site was not able to supply the excess treatment costs
required; this only became apparent after all the initial engagement and training work had been done.
It was therefore necessary to find another site and obtain research and development approval, resulting in
a delay of around 9 months to the start of this phase. The centre chosen was an 18-bedded acute stroke
unit in a large trust serving a population of 370,000 and with teaching and foundation trust status.
Organisational context for embedding the systematic voiding programme
Four group interviews were conducted between February and July 2010. Eighteen staff took part in
interviews; Table 37 shows the level of staff present in each interview.
Customers
Incontinence was viewed as a significant problem in terms of prevalence, and these problems were
compounded by the complexity of stroke-related disease consequences and the high prevalence of
comorbidities such as dementia. Other challenges related to a lack of patient awareness, where nurses
perceived that
a lot of people don’t know [they’re incontinent].
(interview number) 1; (transcript line) 118
TABLE 37 Interview participants: soft systems analysis
Interview Interviewer Staff present
Number of
respondents Interview length (minutes)
1 CB/LT Staff nurse 2 57
HCA 2
Total 4
2 CB/HD Speech and language therapist 1 Audio-recording failure – notes
written post interview
Physiotherapy student 2
Occupational therapist 3
Dietitian 1
Total 7
3 CB/LT HCA 2 35
Stroke specialist nurse 1
Ward sister 1
General manager for medicine 1
Total 5
4 CB/HD District nursing area team co-ordinator 1 51
Continence advisor 1
Total 2
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In the following example, the complexities associated with delivering safe moving and handling processes
challenged the delivery of effective incontinence care:
with the hoisting of the patients as well even though if they can tell you that yes I need the toilet . . .
by the time you have got the machine, you’ve got the sling in, you’ve hoisted them up onto the bed,
got the garments down and hoisted them back up again over the bed pan it could be too late
because they can’t hold. So then you can get embarrassment and things like that.
1;41
The focus on containment of incontinence related to views about the inpatient and community contexts of
continence care, and variations in clinical priorities. Although there was a recognition that different
patients may attach different levels of importance to continence issues, continence was considered more
of a priority for community services:
what is a major thing to one patient is small to another and vice versa and I think it’s whatever’s most
really concerning that patient at that time . . . maybe immediately post stroke that isn’t the least of
their worries really and maybe that is something that as they get home continence is more of
a problem.
3;49
Actors
Responsibility for assessment of continence issues appeared to lay primarily with a ‘link nurse’: a registered
nurse with lead responsibility for practice and an appointed source of practice-related knowledge.
At the time of the interview this individual worked night shifts and there were no reported links with
community-based specialist continence service. As such, the effectiveness of this approach to knowledge
transfer was questionable:
there isn’t a clear strategy for gaining expertise up to date information about best approaches to
incontinence are mostly through the link nurse.
2;3
Multiple sources of information for assessment and care planning were available in addition to any
assessments completed by the link nurse, although the utility of these was questionable. They included
information from family members (although this was reported to be unreliable); other clinical
documentation such as fluid balance charts (which reported patients as wet or dry at various times);
and from other services accessed during a patient’s journey through the hospital:
it’s in one of the questions inside the kardex on the front sheet – how is your continence, how were
you before. That’s mostly down to MAU [Medical Assessment Unit] anyway.
1;134
Different contributions to the assessment of UI appeared to be provided by different allied professional
groups relating to their domain of professional practice (rather than some framework underpinning needs
assessment). Although this was reported to have some beneficial impacts for care planning and delivery, it
was not always clear how these contributions were integrated:
A lot of people, different therapies do some assessment work in relation to incontinence that’s fed
into the notes and discussed within the clinical team on a regular basis but that information is also
then conveyed into and discussed within multidisciplinary team meetings.
2;3
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In any case, discussions of continence care within a MDT context were not goal oriented, and usually
occurred within the context of ‘preventing discharge’ or where it ‘limits people’s ability to engage in the
rehabilitation process’ (2;3).
Staff were perceived to have a ‘generalist’ role in relation to incontinence, drawing on:
their experience, knowledge and expertise that they have developed through their professional career.
2;3
However, nurses reported their learning in this area to be limited by the service model, with:
limited opportunity to see how patients progress beyond the ward because of the nature of the
stroke pathway.
2;3
Transformations
Within the acute stroke context, the overarching aims of (in)continence care related primarily
to containment:
make sure they are all clean, dry, comfortable whatever they need whether if there is a continent
patient that needs help taking to the toilet you still have to make the time to take them so they don’t
have an accident, become stressed and embarrassed.
1;18
Continence issues were rarely discussed in terms of rehabilitation or recovery goals. For example, nursing
handover sheets primarily focused on what needed to be done in relation to incontinence:
. . . at handovers they’ll say [someone has] been grossly incontinent. They wouldn’t say right we’ve got
to do this we’ve got to that. It sort of highlights who you’ve got to think about as being potentially
wet or dry.
1;164
In this respect, the espoused role for nursing in continence care would appear to relate primarily to work
associated in dealing with incontinence.
Transformations were addressed mainly in routinised, patterned practice around ‘2-hourly back rounds’.
These were thought helpful as they:
l mimicked routines at home (e.g. going to the toilet after lunch)
l integrated with patterns of mobility-oriented interventions (e.g. hoisting patterns)
l integrated with other work routines (e.g. personal hygiene and meal times):
We do back rounds or what we call back rounds which are 2-hourly and especially for incontinent
ones or if they need like for the skin and integrity you know they have 2–4 hour back rounds. Try
to get it where like you would at home, when you get up the first thing you do is you want the
bathroom, it’s same before lunch, after lunch you know in between mid-afternoon if they are
going back on bed rest.
1;28
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Worldview
The predominant view shared in group interviews was that community services should be the focus of
continence care, with acute care delivering incontinence care around containment, balanced with other
clinical priorities:
the degree to which it features is influenced by individual problems that a patient may have, but it
may fall down the list when there are other issues, particularly ones like patient’s safety, cognition
or wandering.
2;3
The views that appeared to justify this delineation in service responsibility related to the ‘home’ as the
setting in which people would have to adjust to the consequences of incontinence:
that’s why perhaps the hospital haven’t placed such a big importance on that assessment in that
things do change when they get home.
3.42
The focus on containment may relate to other views about incontinence care as being ‘time consuming’:
. . . we can come in in the morning and somebody is wet, bed bath and tidy them up get them dry
and go away to somebody else and you have to keep going back to people which it’s not their fault;
1;7
it’s the time and if you’re tied up accidents will happen you can’t be everywhere at once so you know.
1;23
The demand of this ‘incontinence work’ was felt to have negative consequences for other patients:
so many patients incontinent, so many that aren’t . . . the patients that aren’t incontinent don’t get the
time that we could spend with them in patient care. They don’t get that one to one.
1;11
Consequently, staff appeared to make trade-offs between the level of continence care that can be
provided and other pressures:
We are still doing medicines which can take an hour and a half . . . obviously you know you’ve got to
focus on your medicines, you can’t be doing your toileting.
1;53
Ownership
Continence care was variously described as a key nursing function, but with shared responsibility for
assessment and monitoring:
the trigger questions need to be asked by whoever that patient and carer come in contact with.
3;70
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This was viewed as important when problems associated with UI may be hidden. However, this key
function did not translate easily into professional practice in the following ways:
l A lack of nursing input into MDT meetings made it difficult to highlight continence issues:
Interviewer: So what in your experience about incontinence does go on in MDT?
1;155: . . . not a lot really. Not a clue never sat in one. I’ve only done one so. We are not allowed
in them.
l Confusion regarding decision-making in some aspects of continence care [e.g. trial without
catheter (TWOC)]:
Interviewer: Would a TWOC . . . be sort of a nursing decision?
1;151: Not normally just a nursing decision. Occasionally a doctor’s. It’s usually higher level.
l Decisions regarding the selection of incontinence aids:
How would you decide which one that you would go for? That’s for management really. There is
only one type at the moment.
1;216
Environment
Specialist continence services and expertise were located within the community, reflecting where the
majority of the sample felt that continence care beyond containment occurred. Two key characteristics of
the environment underpinning continence care within the acute stroke period were highlighted: (dis)
continuity and teamworking.
Numerous potential areas for discontinuity were identified at both clinical practice (e.g. assessment during
inpatient stay) and organisational (e.g. between inpatient, hospital and community services) levels.
Strategic links between specialist continence services in the community and the inpatient stroke service
that existed were opportunistic and historical, dependent on existing relationships between individuals:
[Name] sometimes does, is based at . . . and yes I think the proximity to the hospital allows for that in
an advisory capacity. [It’s] much easier and its historical.
3;36
Teamworking around continence care was felt to be difficult due the scope of the problem, the complexity
of the relevant services, and a focus on traditional ways of ‘enabling’ teamwork:
when you’re looking at really effective continence care post stroke there is such a lot of different
specialities, professionals involved and there are a lot of people, we are talking about quite a large
number of patients. So to have a specialist multidisciplinary meeting where you looked at every patient
would be completely, we just couldn’t do it I don’t think.
3;86
The root definition generated from the soft systems analysis is shown in Table 38.
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Stroke unit staff views of embedding the systematic voiding programme
Interviews were conducted at 1 or 2 monthly intervals throughout the intervention period. Twenty-one
staff took part in interviews. Of these, two were ward sister/ward manager level (band 6 and band 7,
respectively); seven were staff nurses (band 5) and 12 were HCAs (band 2 or 3). Table 39 shows the level
of staff present in each interview.
Coherence: the sense-making work that people do when faced with a
new practice
Differentiation
Differentiation is about whether or not staff perceive a difference between what they were doing before
and the new practice. Components of the intervention such as positive praise, bladder diaries and PV were
not seen as new:
the prompted voiding thing, we did that anyway . . . it was just never recorded.
Q1
TABLE 38 Root definition of urinary continence care within the case study site
CATWOE
heading Definition Root definition
Customer System beneficiaries Incontinence is a prevalent problem, compounded by stroke-related
disease consequences and comorbidities
Patients have different priorities around incontinence
Actors People that carry out activities
within the system
Lead nursing responsibility for assessment
Multiple professional inputs around assessment (driven by domains of
professional practice)
Integration of information and inputs unclear
Knowledge transfer underpinning practice perceived as ineffective
Transformations Changes brought about by the
system
Containment within the acute stroke period
Interventions to manage containment
Focused on routinised, patterned practice
Worldview What views justify the system? Clinical issue viewed as ‘incontinence work’, the priority of which is
relative to other aspects of clinical work
Community services were viewed as the place for continence care
Ownership Who drives the system? Diffuse: generalist responsibility of all staff
Claims around the nursing role not always represented in
decision-making processes
Confused responsibility for some clinical decisions (e.g. TWOC)
Environment Constraints on the system Expertise and specialist practice existed in community settings
Significant potential for discontinuity
Teamworking challenging
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However, staff recognised how the components of the intervention were used more frequently,
I suppose it wasn’t as often . . .
Q3
and that the programme also made them more aware of time:
you realise how quickly time goes.
HCA3
Practice was seen as different in terms of time spent focusing on the issue of continence,
at least you’re . . . sitting down and discussing things with them
Q2
and the outcome was also seen as different:
the patients – many of them become continent . . . it is different from the normal experience.
Q2
TABLE 39 Interview participants: focus or groups interviews with ward staff
Interview Interviewer Staff present Number of respondents Interview length (minutes)
1 (month 2) LT Ward sister (band 6) 1 54
Staff nurse 2
HCA 2
Total 5
2 (month 4) LT Staff nurse 1 35
HCA 2
Total 3
3 (month 6) LT Staff nurse 1 57
HCA 2
Total 3
4 (month 8) HD Staff nurse 1 27
HCA 2
Total 3
5 (month 9) HD Staff nurse 1 41
HCA 2
Total 3
6 (month 10) HD Ward manager (band 7) 1 41
Staff nurse 1
HCA 2
Total 4
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Communal specification
Communal specification is about whether or not people have a shared understanding of the new practice.
There was no evidence that staff did not have a shared understanding of the intervention on the basis of
the training received; there was also no evidence of disagreement about the overall aim of the
intervention. In fact, the intervention could act as a focus for patients to work with staff towards a
common goal:
Plus it gives the patient the incentive as well doesn’t it, cos you’re saying right, 2-hourly . . . to keep
you dry.
Q4
There was some comment relating to initial changes in the intervention:
it was supposed to be physio doing bladder training.
Q3
Also, the patients’ families could misunderstand the purpose or intended outcome of the intervention,
thinking it might prolong treatment:
I’ve had two patients come to me and say, oh, they’re not doing that well why? It’ll prolong the
treatment. I want them to come home.
HCA6
There was some indication that the intervention was interpreted quite widely, as in the case of a
gentleman who couldn’t hold his bottle but was continent otherwise:
I would think why was he on it because he is not incontinent? He may have a few accidents but he
knows he is having an accident . . . but like [staff name] said, it’s all about how best for him to use
his bottle.
HCA2
Individual specification
Individual specification is about whether or not individuals understand what the new practice requires of
them. There were numerous examples of initial misunderstanding over who was responsible for delivering
the intervention by all grades of staff. There were also a number of examples of staff not being involved
from the beginning so missing explanations of the intervention, or missing the training. However, there
were also perceptions that staff were choosing not to be aware of what the new practice required:
. . . some people haven’t got a clue what they are supposed to be doing . . . cos they’re not bothered.
HCA5
The algorithm was perceived as clear and helpful and the view was that staff should not have difficulty
understanding what to do:
to be honest, the laminated sheets that are up behind the nurse station tell you everything you
need to do.
Q3
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However, even though the instructions were seen to be clear, not everybody appears to have been
informed, although this was perceived by other staff as an issue of motivation rather than knowledge:
you have the laminated sheets as big as that you can’t miss it, and even last week a staff nurse said to
me ‘I didn’t know anything about it’. . . so unless it’s actually saying you are responsible for that
particular piece of work they said I didn’t know.
Q3
Although there was a perception that there had been adequate initial preparation, staff commented on
the need to keep up with changes in how the protocol was administered over time:
That (weekly review) was the result of the last meeting, because things were being missed, and I
didn’t know I had to do that.
Q3
It is possible that people might not have been informed of changes in how the protocol was being done
on the ward because they were off duty. So, despite the fact that there was a simple and easily
understood algorithm, there may also be a need for a procedure or responsibility for keeping new or
temporary staff involved and for keeping all staff updated.
The paperwork and documentation appeared to be an area for lack of understanding, such as the change
to a 7-day diary and the scoring system for amount of UI. However, the paperwork might also have been
acting as a prompt sheet for tasks that qualified staff were not fully aware of responsibility for:
you know you’re going through the blue sheet . . . has this been done, has that been done . . . is this
meaning that should have been done?
Q4
The impact of the training on people’s understanding of what they were supposed to do appeared to be
low; many commented that the training should be more practically orientated, rather than theoretical.
However, specific examples of areas of confusion in understanding included confusion about the types of
incontinence and how these relate to the different interventions. There appeared to be some difficulty in
choosing a time schedule for voiding,
you look at it and think, maybe 3 (hours), maybe 2,
Q6
and a lack of clarity about the method of increasing the time between voids, with most staff talking in
terms of increasing time in 1-hour slots whatever the patient’s voiding pattern:
Well if they’re incontinent every 5 minutes then you do it every 2 hours, but if they’re not, then you
could leave it every 3 hours.
Q4
Internalisation
Internalisation concerns whether or not people see the potential value of a new practice. The ICONS
intervention appears to be valued under specific conditions:
I would say that it’s worth doing cos it does benefit . . . I’d give it a go. If you’ve got the staff it works.
HCA4
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However, some aspects of the new practice were not uniformly valued: and may not have been used:
I didn’t self-praise them at the end, I think it belittled them.
HCA5
Continence care was not recognised as a priority over other aspects of care on a routine day-to-day basis:
You can’t just leave one dependent person, just to put somebody on the toilet.
HCA1
Continence was also viewed as less important than other needs:
you know their condition is not going to deteriorate, I know it sounds horrible, but nobody’s going to
die if. . ., but if somebody can’t cannulate them or give them a drug, yes they will.
Q3
The acute care setting also impacted on the priority given to continence:
the busier, the more acute the ward gets, the more the toileting programmes get put to one side,
which is understandable.
Q3
Staff could see the benefit of the intervention for some patients and the importance of continence to
patients was recognised:
. . . it’s devastating even for an old person . . . it’s not the fact that they can’t move so much or the
speech has gone a little deteriorated . . . its someone’s continence that brings them to tears.
Q3
Success with the intervention could increase the priority of continence:
I think as a result of the ICONS, everybody on the ward realised how important it was because we can
see improvements, so you can see it works.
Q2
However, staff did not view the intervention as of value for everyone, particularly those who did not make
any progress, but they could not necessarily predict who would benefit. Some patients also did not want
to be involved:
Some of the patients just don’t want to do it anyway, do they?
HCA4
while another patient was reported as asking to continue the intervention after discharge from the ward.
In general, staff could easily see the value of the intervention for patients, but not so easily for themselves.
The success of the intervention could increase feelings of guilt for staff if the intervention was not able to
be delivered properly:
You feel bad because [patient’s name] knows and she is trying to ask you . . . and it’s a shame when
you can’t get to her . . .
HCA4
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Cognitive participation: the relational work that people do to build and
sustain a new practice
Initiation
Initiation is about whether or not key individuals drive the new practice forward. The ICONS HCAs
reported taking responsibility for keeping the paperwork available and informing other staff:
I would make sure I went round each ICONS patient, make sure they had a sheet, and then inform
whoever is in that team if they go to the loo, . . . if I don’t get back, will you do it? Just go through it
with them. We have a lot of bank staff as well.
HCA2
Qualified staff were also involved in inducting new staff, and ensuring that everyone was aware of ICONS
on the morning hand over:
you just have to point it out in the mornings . . . and identify anybody that is on the ICONS study and
just try and push that forward.
Q1
A link nurse for continence was also involved in increasing awareness of the ICONS programme. The ward
manager had been reported as stating that they wanted to continue the programme once ICONS had
finished. There was also some evidence that qualified staff were to some extent balancing negative
comment with positive comment, particularly around positive outcomes for patients and the work saved
for staff in terms of not having to change beds.
Enrolment
Enrolment is about whether or not people agree that the new practice should be part of their work.
There was consistent reference to initial difficulty in knowing who was responsible for ICONS work and
numerous examples of confusion, although these appear to have been resolved over time.
The major issue of enrolment of patients centred around who should be eligible for the programme, with
numerous comments by staff about whether or not patients with cognitive difficulties should be involved:
I think it’s the individual patient as well, their cognitive issues, and that’s made a big difference hasn’t
it on how the patient responds. Its the cognitively impaired patients that we don’t seem to have a
great amount of success.
HCA1
Staff thought there were patients who would never be successful on the programme:
no matter how long you do this with certain people I don’t think it’s going to work, I don’t think you
can get the continence back so I think that needs to be looked at really.
Q1
Staff were also not completely convinced that patients should be put on the programme in the very
early stages:
. . . in the early days, when they are just not with it at all, then there’s no way they can learn,
it’s too early.
HCA4
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I agree, they’re putting them on you’re thinking why? They haven’t got a clue. But maybe then later
on 2 or 3 weeks, when they come round a bit more . . .
HCA4
We’re not giving them time to come to terms with having a stroke.
HCA4
Staff debated whether the programme would work better on a rehabilitation rather than acute ward, and
expressed uncertainty about whether nursing homes would carry on with the programme.
In terms of enrolment to different routes of the programme, not many people seemed to be on BT. Staff
said this was because they lost them from the ward before they reached the stage of being able to
undertake this route. One member of staff thought BT would not be useful,
because of the type of patient we had on ICONS, they didn’t understand 100% what we were saying.
HCA2
Staff thought that patients probably agreed to enrolment in the programme, but were not interested in
the paperwork:
they don’t have the concentration span to sit there and read. The families – they read it, but I’m not
sure about the patients.
HCA1
Some patients or their relatives were not willing to be involved, but one family tried to enrol their relative
on the programme even though she wasn’t incontinent. One family refused incontinence assessment as
they found it intrusive. A further patient was taken off the programme because her daughter did not want
her mother labelled as incontinent, and felt that 2-hourly toileting was ‘mythering’ her. Staff referred to
the difficulty of talking to families about the continence status of their relative:
I was asking a man about his mother, whether they were [incontinent] before, it was a bit
embarrassing . . .
Q5
Legitimation
Legitimation refers to whether or not people buy into the new practice, and whether or not they are
willing and able to organise themselves. There was evidence that, on the whole, staff were organising
themselves to undertake the work required although there was repeated reference to the reluctance of
some staff to get involved, and some ongoing areas of difficulty such as the hard work of organising two
members of staff to toilet patients together in the mornings:
it can be hard work, especially if everyone is doing washes and things.
HCA1
There were also areas where responsibility was still being negotiated or worked out between qualified staff
and HCAs; these were altering voiding intervals and completing continence assessments.
Staff commented on the inability or unwillingness of some patients to undertake the work required by the new
practice. They referred to patients not putting the effort in, not co-operating, manipulating the programme
or not wanting to walk to the toilet, and suggested that patients might not want the programme to interfere
with visiting time. Staff thought that patients were not able to fill in their own bladder diaries and their families
were not happy filling in diaries either.
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There were specific aspects of the intervention that both staff and patients reported difficulty with. Staff
referred to the patients’ difficulty with dealing with urinary urgency:
getting them to hold on for 2 hours that’s challenging sometimes, and then they might think they’re
taking a backward step if they are incontinence at some time, its like ‘Oh, I can’t do it’.
Q4
This was also challenging for staff to deal with in terms of knowing how to distract the patient. It was also
suggested that patients were sometimes incapable of participating because of communication difficulties:
some of the patients can’t give you an answer if you go up to them and said do you want to go to
the toilet, some stroke patients’ can’t answer you properly can they?
HCA2
Activation
Activation refers to whether or not people work together to develop the new practice. There was evidence
that after initial difficulties, people were working together to develop and embed the new practice:
. . . it was very disruptive at first. Everybody else presumed everybody else was doing it. They’d go to
the toilet and you wrote it down and then there would be no chart there, and then you’d go find it
and you are backtracking on through fluid balance. It was confusing. I think we got the swing of it in
the end.
HCA2
Staff talked about getting into a routine (especially with the paperwork) and working out responsibilities
between themselves. They also described a system of allocating daily responsibility and informing staff
of people allocated to the programme. Night staff were involved in preparing paperwork; this was driven
by the link nurse for continence, who worked permanent night shifts. Staff also talked about adapting the
discharge information to include ICONS-related material. They also talked about how they were dealing
with problems such as what to do if you miss a toileting time:
well it helps us to put down ‘short staffed’, or ‘had an emergency’; [than to] not put anything because
then we’re none the wiser as to what’s going on.
Q3
Some of the collective procedures needed to sustain the new practice were still under development.
Qualified staff referred to the difficulty in filling out the assessment because of lack of information either
due to patients’ communication difficulties or lack of family input, and stop–start points where the
assessment was stopped while waiting for information and then took longer than the suggested 3 days.
There was also some discussion around the difficulty of negotiating extended toileting times in
collaboration with patients who were reluctant to agree to longer intervals:
it’s harder to get them to go any longer than 2 hours.
HCA1
Once you get going you seem to be going every hour and a half, we’re not making it longer, we are
making it shorter.
Q1
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There was some level of discord between qualified staff and HCAs about when people should be taken
off the programme if it wasn’t working. HCAs perceived that they were doing the work, and that qualified
staff were making the decision to continue even though the programme was perceived as fruitless:
it’s us that are doing it and you’re thinking, its make no difference, even though we’re doing it, but
they’re keeping them on it, why? . . . It’s the ones in blue making the decision, but it’s the ones in
green doing the work.
HCA5
The main difficulty with activation was related to certain aspects of the paperwork. Staff questioned
whether or not the screening register needed to be filled in and whether or not totals on daily logs needed
to be calculated. There was confusion about the scoring system for amount of UI and some staff talked
about wanting something on the paperwork to indicate whether or not someone had used the toilet.
There was also some confusion over filling in the time on the diary and also on the daily log.
Collective action: the operational work that people do to enact a new practice
Interactional workability
Interactional workability concerns whether staff or patients are able to do the tasks required of the new
practice. There was a perception that the ICONS programme was
being done as much as we can do.
Q1
but that ‘fitting it in around everything else’ was the main challenge. There was also a recognition that
despite their efforts it didn’t always work out, and that, like anything new, there was work involved in
developing a routine, and
getting it into your workload.
Q6
The dominant theme in interactional workability was that ICONS was ‘extra work’ (Q3), including extra
paperwork. Challenges to staff being able to execute the programme successfully included the nature of
the acute care setting with staff allocated to other priorities such as thrombolysis; the number and level of
dependency of the patients on the ward at any one time coupled with the availability of the staff resource;
staff perception of priorities of need:
we could be feeding seven or eight patients . . . nutrition is more important in my mind.
HCA1
Managing the time-constrained nature of the intervention was challenging, including consistency of effort
within time limits:
. . . it can be hard work and difficult to do it all the time . . . ;
Q1
or at busy times of day. The extra paperwork was questioned, particularly in relation to admission:
we have so much to do when people come in admitted . . . and we‘ve got all that paperwork . . . ;
Q1
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and also at other busy times such as the morning. There was a reference to overlap in paperwork between
the fluid balance charts and some ICONS forms, but it was noted that this could also work to advantage
if one was missed.
The physical nature of the intervention was a consideration. Staff referred to the ‘hard work’ of trying to
integrate the intervention with other physical tasks like washing, and the need to schedule toileting with
other required positional changes, but stated that it got better with practice. They referred to the
requirement for two people to move someone and the sheer physical difficulty of moving people with
hoists, especially if speed was required:
When women are in chairs really it’s a problem . . . you’ve missed it by the time you get them on the bed.
HCA1
The short time frame for toileting was sometimes difficult to meet and sometimes staff were not always
able to get there in time. This had consequences for patients, but staff also felt guilty. One qualified nurse
referred to being honest in recording what was not done, and why.
Specific difficulties staff saw for patients included not being able to hold on for 2 hours. Staff referred to
the difficulty of extending the time, with distraction seen as ineffective:
regardless of how you distract them, they’re sat clock watching. There’s nothing else for them
to do . . .
Q6
Staff referred to the need to work toileting times around visiting times, as patients did not want to go to
the toilet while visitors were present, and the difficulty of knowing whether a patient had actually used the
toilet. Patients were thought to be unable to fill out bladder diaries.
In terms of the intervention as a whole, there was some difficulty in assessing within 3 days if the staff had
to wait to talk to relatives, and some difficulty of maintaining continuity between individual patients
and staff:
. . . there’s lots of stop–start points . . . like speaking to relatives, leaving the literature out, and when
you look at nurses’ rotas . . . being dotted here there and everywhere, it’s very difficult to be part of
the process the whole way through.
Q6
Staff also did not think there was much opportunity for people to progress to BT within the short time
frame in the acute setting.
Relational integration
Relational integration refers to whether or not staff or patients are confident in each other’s work and
expertise in relation to the new practice. There was initial confusion in roles:
everybody presumed everybody else was doing it,
HCA2
and a continuing lack of understanding in some staff:
. . . even now 6 months into it not all the staff on the ward are aware of what they should be doing;
Q3
although this was also interpreted as making excuses for not doing the work.
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There were a number of actions staff were taking so that people knew about and were doing what they
were supposed to do, including meetings to discuss and resolve issues; checks that the work was being
done when it was supposed to be done; clarifying roles and responsibilities between teams; writing on the
front of the Kardex that ICONS was everyone’s responsibility; and systems for communicating between
staff, for example at discharge. There was also some acknowledgement that things were not always
followed through, and that with a new practice people forget and need reminding.
There was underlying grumbling reference by HCAs that qualified staff did not perceive toileting to be
their job and that they were avoiding it:
sometimes you get it . . . ’no, I’m the trained staff, I’ve done my bit, you’re ICONS nurse.’ And yet they
could have toileted that person while you’ve been on break.
HCA3
An opposing view was that for:
some HCAs on the ward . . . they don’t know what pilot study means and because it’s a research study
that’s trained staff.
Q3
Staff on the acute ward were confident that staff in the community had the skills and knowledge to
undertake the programme (and a report from one patient confirmed this was happening), but they also
referred to the possibility that nursing homes might not continue the programme, or that the continuation
of ICONS in the community might not work:
because there is no obvious crossover between the hospital side of the study and the community side.
Q6
Skill set workability
Skill set workability refers to whether or not the work of the new practice is appropriately allocated to
people with the rights skills or training. There was again reference to initial confusion over the allocation of
work to ICONS nurses and also the allocation of work to specific grades of staff:
. . . we assumed at the beginning it would be the ICONS nurses that would set up the sheet and
everything, the assessment, but then it turned out to be trained, but most of the trained didn‘t know
this did they?
HCA2
Lack of clarity was cleared up, and:
somebody would take responsibility on each shift as being an identified ICONS nurse . . .
HCA2
This HCA referred to taking responsibility for communicating with other staff who may not know the
system, like bank staff. However, it was not clear if this responsibility was seen as endemic practice, or just
the initiative of this individual. Other systems to ensure allocation of work included laminated sheets to
ensure that staff were aware of the ICONS process and the ward manager putting a notice on the front of
the Kardex.
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Some aspects of the allocation of work were perhaps not as well embedded; these were articulated as
requests within interviews that things should happen in a certain way in the future, including:
if you’re dealing with the person fill the paperwork in . . . ;
HCA3
when you roll this out as full blown research, right from day one . . . make sure you emphasise that it’s
every nurse on the ward that takes part in it.
Q3
Like we had the trained staff that do the initial assessments yeah? And then you direct us what
pathways, so from then its everybody . . . so it doesn’t matter what rank, forget ranks . . .
HCA3
The division of labour between qualified staff and HCAs was a relatively consistent theme, including who
took responsibility for changes to an individual patient’s programme and responsibility for assessment.
Night staff had been drawn into involvement by doing nightly reviews which were reported as being
completed most of the time. Other work to integrate ICONS into existing systems for review included
specifying that charts were reviewed every night and programmes were reviewed every weekend at night.
The involvement of senior and junior staff in the administration of ICONS as a research programme was
hampered by other responsibilities:
I’m coming here, then all of a sudden I’ve got the stroke bleep, I’ve got called to another meeting,
and the same applies to other staff . . . [name HCA] can’t today, we’ve got a thrombolysis.
Q6
The response to the training provided was mixed; in general qualified staff thought it was adequate,
whereas unqualified staff found it too difficult. The consensus was that it should include more practical
detail on the ICONS programme.
Contextual integration
Contextual integration refers to whether or not the new practice is adequately supported by the host
organisation. The main message was about staffing:
it’s fine if you’ve got the staff to do it,
Q1
and that the ward did not always receive the extra staff funded by the study. There was a recognition that
consistency of staffing was also needed, although demand depended on how many patients were on the
programme at once and the requirement for multiple staff to be available for positional changing.
Identifying Continence OptioNs after Stroke-funded staffing was not always protected, with lack of control
over staff movement between wards, especially by inexperienced staff nurses at weekends. There was a
perception that the protection of staffing had got worse over time, and also a recognition of the need for
fairness in staffing and whether or not keeping extra staff would always be fought for:
it depends on how somebody else is struggling.
Q6
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The programme was seen to be supported by the involvement of the ward manager. There was some
perception that the ICONS programme was perhaps more suitable in a rehabilitation than an acute setting,
because staff were pulled away for other priorities in an acute setting, whereas there was more routine in
a rehabilitation environment.
Training time was not seen to be supported by the organisation and there was some suggestion that it
was not perceived to be acceptable for HCAs to spend time on it:
there’s no way they are going to let you sit behind a desk for 3 hours.
HCA5
Reflexive monitoring: the appraisal work that people do to assess and
understand how a new practice affects them and others
Systematisation
Systematisation refers to the ability of people to determine the effectiveness of an intervention. Staff could
recognise success,
. . . we’ve had some good successes,
HCA3
and the contribution made by the programme towards overall recovery:
. . . you just see what you’re doing is working . . . they come in they’re unconscious . . . then 3 or
4 weeks later they walk off the ward . . . we’ve done something right.
Q3
Staff could also broadly differentiate levels of progress:
. . . they have all done well out of it, more or less,
HCA2
and quicker improvement in people on BT (Q3). Staff could also identify factors that influenced
programme success such as staffing levels.
Although staff had an overall sense that the programme worked for some patients, some of the time, they
struggled to remember individuals and could not always see the connection between the decisions they
made and patient progress:
Interviewer: the assessments . . . did they help you decide what regime the patients went on?
Q5: Erm, erm, well they must have up to a point, yeah, I don’t know. I can’t think of any individual . . .
They also did not think patients necessarily appreciated the significance of the activity being undertaken
for their benefit:
. . . you don’t seem to get a reaction from patients do you? Like they don’t really understand what is
going on.
HCA2
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The evaluation paperwork was an aspect of the programme that drew comment. There was a lack of
understanding about the purpose of some data collection, including the screening register, and that some
information required on the forms was confusing, including:
the blue sheet, the things that it’s asking you, is this meaning that it should have been done? . . . a PV
examination, a PR . . . ?
Q4
and the scoring system for amount of UI. Staff did not see the value of all of the data collection forms:
I think they were a bit repetitive . . . the daily ones.
HCA5
Staff pointed out that forms do not capture all required information:
. . . you asked whether they want to go to the toilet, doesn’t necessarily mean she went . . . you don’t
know if she has gone to the toilet between 9 a.m. and 6 p.m. . . .
HCA2
Although this information was on the fluid balance chart and did not record useful summary information:
And it would help the next shift coming on . . . whether they can use a bed pan . . . or toilet.
HCA2
One respondent commented that not all possible evaluation information was collected:
it’s a shame we didn’t do a pressure sore survey concurrently . . .
Q6
The bladder diaries were identified as useful, even though they were completed by staff; however, staff
did not get to see summary information from diaries:
I think you would have to ask the ICONS nurse because they take them away, don’t they.
HCA2
Communal appraisal
Communal appraisal concerns whether or not people can use formal monitoring to collectively evaluate if
a practice is worthwhile. In the case study, because staff were not necessarily involved in the analysis, this
was interpreted as whether people could identify or receive feedback from formal measurement
of outcomes.
When asked if they would like more feedback information, staff said that they would, and their comments
seemed to indicate that they could not judge whether or not their efforts to implement the programme
were successful:
We don’t know how we’re doing . . . just let us know if we are doing it right. You could say for
example, the 3-hourly toileting regime prompting, that is being done, that’s lovely, and the
paperwork’s being done.
Q3
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Staff also did not seem to know generally about incontinence prevalence and their comparative performance
against a baseline. In response to examples of success, one respondent asked the interviewer:
OK, that sounds really positive. I was just wondering, is this different to your normal experience . . .?
Q2
One of the reasons why process feedback might be needed is that staff do not necessarily receive outcome
feedback, especially over the longer term: patients move on before completing the programme, or before
moving onto the BT regime:
We’re possibly losing a big percentage of the group before some progressed to that point.
Q6
One consequence of patients moving on is that staff do not see the benefits of their efforts:
patients are moved on . . . so we don’t reap the benefits do we? . . . So we don’t see the total
outcome. We do all the hard work.
Q1
Individual appraisal
Individual appraisal is about whether or not individuals think a practice is worth doing. Staff could
appreciate the benefits of the programme for patients, including improved self-esteem, QoL and
independence; and less complications, anxiety, agitation and embarrassment. Staff thought the
programme gave patients a goal, and that patients could see improvement, which was a boost to morale.
They did not think it necessarily impacted on destination at discharge, and that a negative consequence
was that patients could be ‘stressed out’ by the programme (Q4).
Staff did not think that the programme worked for everyone, but they could not necessarily predict who it
would work for from the beginning. Progress was summed up as ‘hit and miss’ (HCA5), with the
programme having worked overall ‘up to a point’ (Q5). Their main comment on programme effectiveness
was that it related mainly to cognitive awareness:
it just depended on the individual really. If they were with it, it was no problem . . . There’s no answer
for everybody.
Q5
Qualified staff were concerned about trying to improve who the programme was targeted at and the
HCAs commented about when the programme was not working:
Carrying it on with some of them . . . it’s making no difference whatsoever and they’re still doing it
and you’re thinking, what a waste . . .
HCA5
In contrast, staff did not immediately see benefits for themselves:
I can’t see any benefit for staff, sorry but I can’t.
Q1
Staff did comment about possible benefits for them in terms of ‘saving effort later’ (HCA6), such as
less washing, changing beds and less treatment of pressure sores. The main benefit was in seeing
improvement in patients and the satisfaction of seeing the documentation completed well. There was also
a benefit of having a goal, and learning. Possible negative aspects for staff included stress due to the
pressure of additional work balanced against the benefit of seeing patients progress.
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Reconfiguration
Reconfiguration is about how people modify their work in response to their evaluation of the new
practice. There was some suggestion that individual members of staff were slightly modifying aspects of
the programme they found difficult, such as not making patients resist feelings of urinary urgency for long,
and also modifying their own approach to managing continence:
. . . whereas before you didn’t really clock-watch, now . . . you realise how quickly time goes.
HCA3
There was also some indication that aspects of the programme were being modified perhaps because they
were misunderstood, such as starting people on a 3 hourly schedule, and if that did not work, moving
them to 2 hourly (Q4).
There were also reports of formal meetings where aspects of process (i.e. how the work was to be done)
were modified, including involving night staff and starting daily reviews of forms and weekly reviews
of progress. Staff requested specific modification to some aspects of the paperwork, such as the screening
register and daily logs.
Summary of facilitators and barriers to introducing the systematic
voiding programme
Facilitators and barriers to introducing the programme are shown in Table 40.
Patient outcomes and predictors of discharge continence status
Patient characteristics
Forty-three patients were recruited between January and September 2010. The total number of patients
screened was 263. Of those screened, 163 (62%) were continent, 31 (11.8%) were medically unstable
and three (1.1%) had a Glasgow Coma Score less than 12. The remaining 23 patients were not recruited
for various reasons including refusal to consent (n= 1), transferred (n= 4), or discharged (n= 1). Table 41
shows characteristics of all patients recruited and all patients who were put on the programme.
Patient trajectory
Twenty-eight patients commenced the SVP and 15 patients did not (Figure 24); some were ineligible due
to becoming continent on the 3-day diary, discharge before completing the 3-day diary and, in one case,
death on the day of recruitment. A further three patients might have been eligible for the programme
after catheter or penile sheath removal; it is unclear why these patients did not commence
the programme.
The majority of patients (19, 68%) commenced a PV routine, four (14%) commenced BT, three (11%)
had both regimes (in two cases moving from PV to BT) and for two (7%) the route was unknown.
Most patients remained on the programme between 0 and 13 days (8, 30.8%) and 14 and 27 days
(13, 50%) [median 16.5 days, interquartile range (IQR) 5.75–26.25 days, range 0–64 days].
Implementing PFMT required the support of the physiotherapy team in terms of assessing whether or not
participants were able to exercise their pelvic floor muscles. The physiotherapy team were reluctant to
participate in this and it was therefore not possible to implement this part of the SVP.
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TABLE 40 Facilitators and barriers to introducing the SVP
NPT
constructs Facilitator Barrier
Coherence
Differentiation Can see the newness of the programme as a
whole, and the emphasis on continence
Do not view the programme components as new
Communal
specification
General agreement on the aim of the programme
in terms of impact on continence
Possibility of wide interpretation of intervention
purpose/outcome in staff and in patients/relatives
Individual
specification
Good algorithm clearly explains programme. Most
staff understand what to do
Some difficulty in keeping up with changes and in
specific aspects of programme delivery – mainly
paperwork – but also determining voiding interval
Internalisation Value of the programme for some patients is
clearly recognised, but benefit is only achievable
with additional staffing
Value of prioritising continence may not be agreed
for all patients. Benefit is balanced against other
priorities in acute care, and the effort needed
Cognitive participation
Initiation Qualified staff, nominated HCAs and ward
manager influential in embedding and supporting
programme
Some qualified staff appear less involved
Enrolment Some patients and their relatives agreed to
enrolment in the programme, if not every detail.
Staff agreed to enrolment on condition of extra
staffing
Eligibility of patients with cognitive or
communication difficulty, those showing no
progress, or those very early in recovery was
disputed
Legitimation Staff were organising themselves to carry out the
programme, including issues of responsibility for
or input into decision making about programme
changes for individual patients
Some patients were perceived as unwilling or
unable to participate, and both staff and patients
had difficulty dealing with urinary urgency
Activation After initial difficulties, staff were working
together to develop new routines and procedures.
Some collective procedures are still under
development
There is some discord between HCAs and
qualified staff about involvement in toileting, and
discontinuing the programme for individuals
Collective action
Interactional
workability
The programme is being done as well as they
are able
The programme is extra physical work, which is
difficult to manage within time constraints in an
acute setting, where other tasks take precedence
Relational
integration
People are clear about their responsibilities, and
in the main things are being done when they
should be
There was some suspicion that the programme
would not be continued in other settings
Skill set
workability
There are systems in place to allocate work There are some tensions between HCAs and
qualified staff
Contextual
integration
The programme was seen to be supported by
management at ward level
Extra staffing and training time requirements were
not seen to be consistently supported
Reflexive monitoring
Systematisation Staff could recognise success, broad levels and
speed of progress, and influencing factors
Staff did not understand or see the value of all of
the data collection
Communal
appraisal
On the whole, staff can see the value of the
intervention in individual patient’s progress to
continence
Staff do not receive sufficient feedback on process
or longer-term outcome
Individual
appraisal
Staff can appreciate the benefits for certain
patients
Staff do not easily appreciate the benefits for
themselves
Reconfiguration The formal organisation of programme
modification is ongoing in meetings, etc.
Individual staff report trying to informally modify
aspects of the programme they find difficult to
manage, but there is no formal system for this
feedback loop
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TABLE 41 Characteristics of all patients and patients on the programme
Characteristica All patients (n= 43) Patients on programme (n= 28)
Age (years): mean (SD) 75.1 (13.5) 76.8 (13.1)
Sex: male 16 (37.2%) 10 (35.7%)
Ethnicity
Caucasian 41 (95.3%) 26 (93%)
Indian 1 (2.3%) 1 (3.5%)
Black African 1 (2.3%) 1 (3.5%)
Stroke subtype
TACSb 15 (34.9%) 9 (32.1%)
PACS 18 (41.9%) 12 (42.9%)
LACS 9 (20.9%) 6 (21.4%)
POCS 1 (2.3%) 1 (3.6%)
Barthel Index at baseline: median (IQR)
(n= 41, 26)
3 (1–6.5) 4 (1–7)
Barthel Index at day 7: median (IQR)
(n= 41, 27)
4 (1–7) 5 (1–7)
Pre-stroke mRS (n= 41, 27)
No symptoms 1 (2.4%) 1 (3.7%)
Minor symptoms 1 (2.4%) 0 (0%)
Minor handicap 15 (36.6%) 12 (44.4%)
Moderate handicap 11 (26.8%) 5 (18.5%)
Moderate severe handicap 8 (19.5%) 7 (25.9%)
Severe handicap 5 (12.2%) 2 (7.4%)
LUSQ 1 (2.4%) 1 (3.7%)
Pre-stroke SUI (n= 35, 24)
No 19 (54.3%) 14 (58.3%)
Yes 8 (22.9%) 5 (20.8%)
Not known 9 (25.7%) 5 (20.8%)
Pre-stroke UUI (n= 40, 26)
No 19 (47.5%) 14 (53.8%)
Yes 11 (27.5%) 7 (26.9%)
Not known 10 (25%) 5 (19.3%)
Pre-stroke MUI (n= 41, 27)
No 19 (46.3%) 14 (51.9%)
Yes 8 (19.5%) 5 (18.5%)
Not Known 14 (34.1%) 8 (29.6%)
LACS, lacunar stroke; PACS, partial anterior circulation syndrome; POCS, posterior circulation syndrome; TACS, total anterior
circulation syndrome.
a Numbers in parentheses indicate number of patients for whom data were available when some data were missing.
b Any patients recorded as unconscious were classified as TACS.
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Characteristics of recruited patients are shown in Table 41. Mean age of patients recruited was 75 years;
the range was 42–98 years. Two-thirds were female and the majority of patients were Caucasian
(41/43, 95.3%). Most patients (33/43, 76.8%) had middle cerebral artery strokes [total anterior circulation
syndrome (TACS) or partial anterior circulation syndrome (PACS)] and minor to severe handicap pre stroke,
with only two patients (4.8%) having no or minor symptoms. Eleven were incontinent prior to stroke,
with eight (22.9%) having SUI, 11 (27.5%) UUI and eight (19.5%) MUI (UUI and SUI).
Table 42 shows baseline continence status of all patients on the programme. Most patients had functional
incontinence (23/25, 92%), with 5 out of 27 (19%) having both UUI and SUI. Nearly half of patients for
whom data were available and who were put on the programme (12/25, 48%) had very severe
incontinence as measured by the ISI.
Patient outcome
Table 43 shows patient outcomes for patients who undertook the SVP.
Of the 28 patients on the programme, six (21%) reported being continent at 6 weeks post stroke.
Similar numbers of patients reporting the reason for their incontinence reported UUI, SUI, MUI and other
incontinence problems. More than half of those with continence problems (12/22, 55%) reported severe
or very severe problems on the ISI. The median reduction in the number of incontinence episodes
(over a 5-day period) was three episodes overall, rising to seven in patients with the highest number
of incontinent episodes at baseline. Only four (17%) patients were recorded as being discharged to a
private address, none of whom returned to living alone.
Factors affecting discharge continence status of patients on the programme
Forward selection led to gender (p< 0.0001), baseline Barthel Index category (p= 0.001) and age
(p= 0.078) being included in the best-fitting Poisson model; OCSP category was non-significant (p= 0.14).
Recruited
On programme
Not on
programme 
 (n =15)
Continent on
3-day diary 
(n = 3) 
Discharged on
3-day diary 
(n = 1)
Catheterised
throughout 
(n = 7) 
Catheterised at
baseline 
(n = 2)
Using uridom
at baseline  
(n = 1)
Died 
(n = 1) 
(N = 43)
(n = 28)
FIGURE 24 Route taken by recruited patients.
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
137
TABLE 42 Baseline continence status of patients on SVP
Characteristica Patients on programme (n= 28)
Median (IQR) UI episodes in the 5 days following recruitment (n= 26) 8.5 (4–13)
Baseline continence status (n= 27)
Continent 2 (7%)
Incontinent 25 (93%)
Baseline SUI (n= 26)
No 5 (19%)
Yes 6 (23%)
Not known 15 (58%)
Baseline UUI (n= 27)
No 5 (19%)
Yes 13 (48%)
Not known 9 (33%)
Baseline MUI (n= 27)
No 5 (19%)
Yes 5 (19%)
Not known 17 (62%)
Baseline functional incontinence (n= 25)
No 1 (4%)
Yes 23 (92%)
Not known 1 (4%)
Baseline ISI category (n= 25)
None (0) 2 (8%)
Slight (1–2) 3 (12%)
Moderate (3–6) 5 (20%)
Severe (8–9) 3 (12%)
Very severe (12) 12 (48%)
Time on programme in days (n= 26)
0–13 8 (31%)
14–27 13 (50%)
28–41 3 (12%)
≥ 42 2 (8%)
a Numbers in parentheses indicate number of patients for whom data were available when some data were missing.
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TABLE 43 Patient outcomes
Outcomea Patients on programme (n= 28)
Median (IQR) number of UI episodes in the 5 days prior to discharge (n= 19) 5 (2–8)
Change in number of UI episodes (5 days prior to discharge minus 5 days
following recruitment) (n= 18)
3 (–0.3 to 8.3)
Change in number of UI episodes (5 days prior to discharge minus 5 days
following recruitment) for patients with 1–7 UI episodes in first 5 days (n= 5)
0 (–1 to –2)
Change in number of UI episodes (5 days prior to discharge minus 5 days
following recruitment) for patients with 8–17 UI episodes in first 5 days (n= 12)
7 (0.75–10.5)
Stroke unit discharge status
Alive 27 (96%)
Dead 1 (4%)
Stroke unit discharge destination (n= 23)
Private address (not alone) 4 (17%)
Residential home 3 (13%)
Nursing home 3 (13%)
Rehabilitation unit 5 (22%)
Other hospital 2 (9%)
Other ward (same hospital) 6 (26%)
Median (IQR) Barthel Index (n= 27) 8 (5–11)
Continence status (n= 28)
Continent 6 (21%)
Incontinent 20 (71%)
Catheterised 1 (1%)
Missingb 1 (%)
ISI category (n= 17)
None (0) 4 (15%)
Slight (1–2) 5 (19%)
Moderate (3–6) 5 (19%)
Severe (8–9) 3 (11%)
Very severe (12) 9 (35%)
SUI (n= 12)
No 6 (50%)
Yes 6 (50%)
UUI (n= 14)
No 7 (50%)
Yes 7 (50%)
MUI (n= 12)
No 9 (75%)
Yes 3 (25%)
a Numbers in parentheses indicate number of patients for whom data were available when some data were missing.
Results are frequency (percentage) unless stated otherwise.
b Patient died in hospital at 7 weeks post stroke.
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These terms were then considered in the logistic regression model for presence/absence of incontinence.
Age (p= 0.96) and baseline Barthel index category (p= 0.27) were eliminated from the model at the first
two steps, leaving only sex as a predictor of incontinence. Moreover, when considered as a potential
additional predictor, OCSP category was again non-significant (p= 0.720) and age did not re-enter the
model on removal of baseline Barthel Index category (p= 0.99) (Table 44).
Adherence to the intervention
Three-day diary
Table 45 shows quality of completion of the 3-day diary. Completed diaries were present for 30 patients.
Two patients who commenced a regime did not have a diary, while four patients had a diary but did
not start a regime: in three cases they were continent by the end of the diary period and for one patient
TABLE 44 Baseline characteristics affecting 6-week outcome for the patients on SVP: univariate and multiple
logistic regression modelling
Characteristica Continent Incontinent
Multiple logistic regression
OR (95% CI) p-value
Sex 0.091
Maleb 4 (40.0%) 6 (60.0%) –
Female 2 (11.1%) 16 (88.9%) 5.33 (0.77 to 37.09)
Baseline Barthel Index (n= 26) 0.27
0–6b 3 (15.8%) 16 (84.2%) –
7–13 3 (42.9%) 4 (57.1%) 3.13 (0.41 to 24.02)
Mean (SD) agec 77.0 (13.6) 76.7 (13.3) 0.99 (0.46 to 2.16) 0.99
OCSP classification (n= 27) 0.72
TACSb 2 (22.2%) 7 (77.8%) –
PACS 3 (25.0%) 9 (75.0%) 3.19 (0.14 to 74.85)
LACS 1 (16.7%) 5 (83.3%) 1.22 (0.08 to 19.37)
LACS, lacunar stroke; OR, odds ratio.
a Numbers in parentheses indicate number of patients for whom data were available when some data were missing.
b Indicates comparator group for ORs.
c OR uses 10 year units.
TABLE 45 Quality of completion of the 3-day diary
Stage Key quality indicator
Number (%) meeting
quality indicator
Number (%) not meeting
quality indicator
1. Diary present Is there a paper copy of the 3-day diary
present?
30 0
2. Diary completed Is the diary completed? 30 (100) 0
3. Entry on each
of 3 days
Is there an entry on each of the 3 days of
the diary?
27 (90) 3 (10)
4. ‘Time went to
the toilet’
completed
Are there three or more entries on EACH
day with a time recorded in the ‘time went
to the toilet’ column?
7 (23.3) 23 (76.7)
5. Values in
‘leaked’ column
completed
Are there three or more entries on EACH
day where a ‘time went to the toilet’ entry
has a value in the ‘leaked’ column?
6 (20) 24 (80)
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the reason is not clear. The majority of diaries completed (27, 90%) had an entry on each of the 3 days.
Few patients (7, 23.3%) had three or more entries on each day with a time recorded in the ‘time went to
the toilet’ column. Of these, six (20%) patients had three or more entries on each day where a ‘time went
to the toilet’ entry had a value in the ‘leaked’ column.
Daily clinical logs
Clinical logs were received and analysed for 331 days from 22 patients; 261 (78.9%) were for PV and
70 (21.1%) were for BT. Table 46 shows quality of completion of the daily logs. Although the majority
(80.1%) had a regime interval documented, only 39.3% had a regime interval and correct schedule
of proposed times. For these clinical logs, it was documented that patients were taken to the toilet within
30 minutes of the scheduled time on 59.0% of occasions; on average, it was documented that patients on
PV were asked if they were dry or wet on 74.7% of occasions, and encouragement was documented as
given on 75.2% of occasions.
TABLE 46 Quality of completion of daily clinical logs
Stage Quality indicator Result
1 % (of clinical logs processed) with regime interval present and correctly documented 80.1
2 % (of clinical logs processed) with both regime interval and schedule of proposed times present and
correctly documented
39.3
For clinical logs that achieved both stage 1 and stage 2 (n = 130)
3(b) On average, how often was a ‘time toileted’ documented that was within 30 minutes of the proposed
time? (%)
59.0
4(a) On average, how often was it documented that the patient had been asked if they were wet?a (%) 74.7
4(b) On average, how often was encouragement documented as given? (%) 75.2
a This applies to PV clinical logs only.
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Implications for the trial phase
The proportion of all patients admitted with incontinence (100/263, 38%) was at the lower end of
expected prevalence4,16 and of these, fewer than expected were recruited (43/100, 43%). Recruited
patients tended to be at the more severe end of the spectrum in terms of stroke and incontinence severity;
a possible reason could be that patients with mild incontinence and less severe strokes were among those
transferred or discharged before they could be recruited. This has implications for the trial in terms of
extending estimates of the recruitment period. Trial participants were also likely to be at the severe end in
terms of both stroke and incontinence severity posing practical challenges in implementing the SVP with
patients needing considerable assistance with toileting.
Findings from the soft systems analysis suggest the intervention was introduced into an environment not
conducive to therapeutic continence management. The overarching aim of continence care was keeping
patients ‘clean, dry and comfortable’, with continence rarely discussed in terms of rehabilitation or recovery
goals. A similar focus on containment rather than rehabilitative activities has been reported elsewhere.12,75
Continence care was usually couched in terms of being ‘time consuming’ and staff appeared to make
trade-offs between the level of continence care that could be provided, and other pressures.
Soft systems analysis revealed a context where incontinence was viewed as a significant problem, but this
was not reflected in the organisation and delivery of continence care. There was a mismatch between
stated importance and clinical practice, with continence peripheral to, rather than embedded in,
rehabilitation. The site was therefore starting from a low base characterised by a lack of clinical and
organisational structures facilitating continence management. It was clear implementation effort required
in the trial phase were considerable if sites were comparable to the case study site.
Normalisation process theory findings showed that although there was misunderstanding and confusion
during initial implementation of the SVP in terms of roles and tasks, over time there was embedding of
processes facilitated by new routines and procedures. The value of the programme was recognised for
some patients and visible examples of success motivated staff to continue, although benefits for cognitively
impaired patients were less obvious. Staff broadly agreed about the purpose of the intervention and found
the programme understandable, although aspects of the paperwork and determining the voiding interval,
posed some difficulty. Adherence data also reflects problems staff encountered with paperwork: 3-day
diaries were completed, and the majority had entries on all 3 days, but detailed completion of voiding
times and wet episodes was rare. Similarly, although the majority of daily clinical logs had a voiding
interval documented and there was evidence of variation in toileting interval, only a third had proposed
times present and correctly documented. A more in-depth training in SVP paperwork and processes,
with adequate time and support to practice, was recommended for the trial phase.
In terms of building and sustaining the new practice, qualified staff (in particular the link nurse), HCAs and
the ward manager were key, with some qualified staff less involved. Methods of engaging qualified staff
will need consideration prior to the trial phase; this is required if active continence management is to be
viewed as a specific therapeutic intervention155 and given increased status comparable with other
rehabilitation activities.
The acute setting meant continence care had to be balanced against other priorities and for some staff was
of less importance at this stage of the patients’ trajectory. Furthermore, outcomes of continence work were
not visible, as patients were often transferred before an improvement could be seen. Early intervention is
recommended in the latest policy10 and we therefore included acute units in the trial phase, but also the
rehabilitation units linked to these to enhance exposure to the SVP across both phases of the patients’ stay
in hospital.
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Only 28/43 (65%) of recruited patients began the SVP. Catheterisation (or penile sheath use) was cited as
the reason for 10 of these; however, it is not clear (a) why patients catheterised throughout did not have
catheters removed and (b) why patients catheterised at baseline were not subsequently put on the SVP.
Attention to catheter removal needed to be made explicit in the trial protocol in line with policy;10 systems
for documenting reasons why patients do not begin the SVP also needed revising.
The case study did not set out to assess the effectiveness of the programme, and the acute unit context
meant few patients received the SVP for longer than 4 weeks; at least 6 weeks is recommended.25,31
One-quarter of patients became continent and there was a median reduction of three incontinent episodes
over a 5-day period, with a median reduction of seven episodes in patients with more incontinent
episodes at baseline; this was viewed as clinically significant by our ICONS PPC involvement groups.
Adherence to the intervention paperwork left room for improvement with only six (20%) of the 3-day
diaries fully completed and only 39.3% of daily logs with both regime interval and schedule of proposed
times documented. Problems with paperwork were also highlighted in ward staff NPT interviews and
indicated revisions and clarifications were needed prior to the trial phase.
Although implementing the programme was viewed by the research team as encompassing all the MDT,
and efforts were made to spread awareness and encourage participation in ICONS training, in practice it
fell almost exclusively to nursing staff. In particular, physiotherapy staff did not feel able to assess if
patients were able to exercise their pelvic floor muscles, a necessary requisite before beginning PFMT,
therefore it was not possible to introduce the combined intervention. Lack of therapist involvement in
identifying, assessing and managing UI after stroke is also highlighted by Dumoulin et al.;156 this is
concerning given the key role recommended by both evidence157–159 and policy,141 and highlighted the
need for enhanced strategies to promote ‘buy in’ in the trial phase.
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Chapter 5 Exploratory cluster randomised
controlled trial: methods
Overview
This chapter describes methods used in Phase II of the research programme (MRC feasibility and piloting
phase), a cluster randomised controlled exploratory trial.
Aim
The trial aimed to assess the feasibility of a full-scale cluster randomised trial through testing the
interventions for preliminary evidence of clinical effect and providing information to enable estimates of
the number of sites and patients who would need to be recruited for a full-scale cluster randomised trial to
evaluate effectiveness.
Objectives
The trial objectives were to:
l assess feasibility in terms of rates of participant recruitment and retention (cluster level)
l assess fidelity to the intervention (cluster level)
l conduct a qualitative assessment of feasibility from the perspective of multiple stakeholders
(cluster level)
l conduct a preliminary evaluation of supported implementation and intervention alone, relative to usual
care (cluster level)
l investigate patient-related factors affecting patient outcome (cluster and individual patient level)
l investigate stroke service-level factors potentially affecting stroke service outcomes to estimate the
amount of unexplained variability in outcomes between trusts and between patients (cluster and
individual patient level)
l confirm the choice of primary and secondary outcome measures for a full-scale cluster randomised trial
to evaluate effectiveness (cluster level)
l develop and test data collection tools for an economic evaluation within a full-scale cluster randomised
trial (cluster level).
Design
A three-arm, parallel, open, exploratory, pragmatic, cluster RCT of a SVP (including BT and PFMT for
patients who are cognitively able and PV for patients with cognitive impairments), with or without
supported implementation, for the management of UI after stroke in secondary care. The intention was for
the whole stroke unit team to implement the SVP so, to minimise contamination, allocation was based on
clusters, and the unit of randomisation and analysis was the stroke service.
Study setting
Twelve NHS stroke services in England and Wales. For the purpose of the trial, a stroke service comprised
both acute and rehabilitation stroke units. Stroke units were defined according to the definition provided
by the Royal College of Physicians, London, for the National Sentinel Stroke Audit.160
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Inclusion and exclusion criteria
Stroke services
Inclusion criteria
1. Stroke services with specialist acute and rehabilitation stroke services (either separate or
combined units).
2. Access to appropriate excess treatment costs.
Exclusion criteria
1. Stroke service without specialist acute and rehabilitation stroke units (either separate or combined).
Patients
Inclusion criteria
1. Aged ≥ 18 years with a diagnosis of stroke based on the WHO criteria138 (no upper age limit).
2. UI as defined by the ICS139 as ‘involuntary loss of urine’.
3. Conscious (defined as either ‘alert’ or ‘drowsy’ on the ‘Clinical Status on Admission’ item of the
European Stroke Database).
4. Medically stable as judged by the clinical team.
AND
5. Incontinence classified as SUI, UUI, MUI or ‘functional’ UI.
OR
6. Catheterised in the acute phase of the stroke.
Participants who had incontinence before the index stroke were included. Given the expected age range
of the population, there was likely to be a high prevalence of pre-stroke incontinence among potential
participants. Furthermore, there is evidence to suggest patients with longstanding incontinence may
benefit from a programme of behavioural interventions.25,27
Participants who were catheterised were recruited; if the catheter was removed, they were assessed as per
protocol and began the SVP if they were still incontinent. Participants who were continent after catheter
removal and those discharged with a catheter still in situ were not put onto the SVP.
Exclusion criteria
1. Pre-existing long-term catheter.
2. Routine self-catheterisation prior to stroke.
3. Patients who refused consent.
4. Patients unable to consent for whom a consultee did not agree that the patient would wish to
be included.
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Health professionals and clinical leaders
Inclusion criteria
1. Health professionals either delivering the intervention or linking with the intervention in any capacity.
Centre recruitment process
The trial was adopted onto the Stroke Research Network (SRN) portfolio and was identified as open to
new sites using SRN procedures. The original intention was to include sites in north-west England only and
the research team made contact with all stroke services in this region and invited expressions of interest.
Six stroke services in Lancashire and Cumbria were able to find the excess treatment costs; service support
costs were provided by the Comprehensive Local Research Network (CLRN). Eight stroke services in
Cheshire and Merseyside expressed an interest in participating, but were unable to supply excess treatment
cost funding. It was not feasible to include a further 10 services in Greater Manchester as they used a ‘hub
and spoke’ model with multiple rehabilitation units linked to one acute unit. Consequently, an approach
was made to the Welsh National Institute for Social Care and Health Research (NISCHR); excess treatment
costs are held centrally by the Welsh Office rather than with each health board and initial discussions
suggested there was likely to be a favourable response to supporting the trial. Potential sites in Wales were
invited to attend a meeting to discuss suitability for inclusion; six sites met the inclusion criteria and agreed
to participate.
Following randomisation, one Welsh site declined participation due to changes taking place within their
stroke service, leaving little scope for supporting a new study. A replacement site with similar throughput
and Sentinel Stroke Audit score was recruited (the rehabilitation unit accepting patients from the acute
unit used in the case study phase). Newcastle Clinical Trials Unit advised substituting the Welsh site with
the recruited site in the randomisation stratum and rerandomising this stratum. Subsequently, a further
Welsh site was found to have a much lower number of admissions per annum than anticipated
(around 120 compared with an original estimate of 300). A chance meeting with the assistant lead nurse
of a potential site in West Anglia led to the inclusion of a replacement site. Newcastle Clinical Trials Unit
advised substituting the old with the new site rather than rerandomising at this stage, as training had
begun in several sites randomised to receive the intervention by this time.
Participant recruitment process
All patients admitted to participating stroke units were screened within 72 hours of admission using a
screening form in line with the inclusion criteria (see Appendix 21).
Patients not catheterised
In intervention units, potential participants who met the inclusion criteria began a 3-day bladder diary
(see Appendix 8). The consent process then began for all patients where the diary showed evidence of
involuntary leakage of urine and who were medically stable. In usual care, potential participants identified
as incontinent by ward nursing staff were screened for eligibility. In all trial arms, potential participants
who were not yet medically stable were reassessed by the research nurses and the ward team at regular
intervals until they were deemed to meet this criterion.
Patients catheterised
These patients began the consent process as soon as they were medically stable.
Nursing staff asked each eligible patient whether or not his/her name could be given to the research team.
If the patient agreed, a member of the research team visited the patient, explained the project, answered
any questions and provided a participant information leaflet (see Appendix 22). Patients were given at least
24 hours to consider participation and were visited by a member of the research team after this period;
patients choosing to participate signed the consent form at this stage (see Appendix 23).
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For patients unable to consent for themselves, a person able to advise on the presumed wishes of the
patient was approached to act in the role of consultee. This is in line with the recommendations of
the Mental Capacity Act (2005)142 and in line with the expressed wish of the study PPC involvement groups
that everyone who was eligible should have the opportunity to participate.
Recruitment rates in each cluster were monitored on a regular basis to identify both quantitative
(i.e. numbers of participants recruited) and qualitative (i.e. patient characteristics) imbalance across clusters.161
If identified, imbalance was thought to be indicative of likely selection bias (e.g. cluster with low proportion
of stroke patients identified as eligible but high proportion of those eligible with severe incontinence), we
reviewed the recruitment process and addressed any issues identified.
Interventions
Systematic voiding programme
Participants received the SVP (see Chapter 3) comprising assessment (including a 3-day diary and
comprehensive continence assessment); algorithm-driven individualised conservative interventions tailored
to the physical and cognitive capabilities of each patient; and weekly review. In the light of case study
findings, the following changes were made:
l greater focus on preparing ward staff adequately before the intervention began
l increased focus on obtaining therapist ‘buy in’, through meetings with the programme co-ordinator
and encouragement to attend training sessions
l more emphasis on practical aspects of implementing the SVP in face-to-face training, including detailed
explanation of paperwork
l simplification of daily clinical logs.
Systematic voiding programme plus supported implementation
This trial arm received the intervention as outlined above, plus supported implementation using facilitation
(see Chapter 3).
Usual care (control group)
Participants in this group received usual care provided by the stroke service. This could comprise checking
for urinary tract infection; checking for overflow incontinence (using the bladder scanner provided);
containment using a variety of devices (e.g. absorbent products) with regular changes and some form of
toileting schedule.
Outcomes
The primary effectiveness outcome was participant incontinence (presence/absence). Presence or absence,
rather than severity of incontinence, was chosen on the advice of the PPC groups based on their view
that achievement of full continence was key for people with stroke. Measures were taken at 6, 12 and
52 weeks post stroke. The primary analysis was initially of the 6-week data as conservative interventions
for continence typically last 6 weeks,25,31 and an effect was most likely to be seen at this time point.
However, it quickly became apparent that 6 weeks after commencement of the intervention was more
in line with 12 weeks post stroke owing to participants not being recruited as soon after stroke as
anticipated. The Trial Steering Group therefore approved a change to primary analysis of 12-week data.
Secondary effectiveness outcomes were QoL, frequency and severity of incontinence, urinary symptoms,
activities of daily living (ADLs) and death; at discharge, 6, 12 and 52 weeks post stroke.
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Ascertainment of outcomes
Presence/absence of incontinence was measured by the International Consultation on Incontinence Modular
Questionnaire – Urinary Incontinence (ICIQ-UI) Short Form.162 Absence of incontinence was defined as the
response ‘never’ to question 3, ‘How often do you leak urine?’; presence of incontinence was defined as any
other response to question 3 (ranging from ‘about once a week or less often’ to ‘all the time’). The ICIQ-UI
Short Form has received a grading of Anew – highly recommended from the International Consultation on
Incontinence Symptoms and Quality of Life Committee indicating published reports of acceptable reliability,
validity and responsiveness in at least one study.163 To our knowledge, the ICIQ-UI Short Form has not been
used in the post-stroke population. We have conducted preliminary validation of the tool with six stroke
survivors from our PPC involvement group using the approach recommended by the ICIQ developers
(Dr Nikki Cotterill, University of Bristol, 2009, personal communication); all thought the tool was appropriate
for use post stroke and few problems were identified.
Quality of life was measured using the I-QOL164,165 and the European Quality of Life-5 Dimensions (EQ-5D).166
As the I-QOL has only been validated for people with incontinence, data were not analysed for patients who
were continent or catheterised. Frequency and severity of incontinence was ascertained using the ISI.151
Urinary symptoms were measured using the LUSQ152 and ADL using the Barthel Index.149
In addition, the following baseline information about the patient were recorded following consent:
date of birth (age to be calculated*); sex; ethnicity; date of admission; date of stroke onset; date baseline
questionnaire completed; location when recruited into the study; consciousness level (defined as either
‘alert’ or ‘drowsy’ on the ‘Clinical Status on Admission’ item of the European Stroke Database); side of
body affected by stroke; type of stroke; stroke subtype (OCSP classification148); day 7 Barthel Index;149
pre-stroke mRS*;150 pre-stroke living circumstances*; LUSQ;152 type of UI (UUI, SUI, MUI, ‘functional’ UI or
unclear); cognitive ability (six-item Cognitive Impairment Test167); fluid intake; bowel function; relevant
clinical investigations (e.g. mid-stream urine, bladder scan); medications; living circumstances; verbal
subsection of the Glasgow Coma Scale*;140 ability to lift both arms off the bed*; ability to walk
independently*; ICIQ-UI Short Form;162 ISI;151 EQ-5D.166
The six factors highlighted with a ‘*’ above form the Edinburgh stroke case-mix adjuster168 and were
collected to enhance patient-level prognostic adjustment of the statistical modelling of outcomes.
Data collection
Baseline data were collected on entry to the trial by the research nurse. Outcome data were collected
at 6, 12 and 52 weeks via postal questionnaires (or researcher administered questionnaires if participants
were still in hospital at 6 or 12 weeks; see Appendix 24). All participants with aphasia were offered a
face-to-face interview with the research nurse to collect outcome data; this was conducted using
appropriate communication aids (e.g. pictorial cards with a ‘thumbs up’ picture indicating ‘yes’ and a
‘thumbs down’ card indicating ‘no’). Specialist help was available from speech and language therapists
and Speakeasy, a specialist aphasia charity based in Ramsbottom, Bury (www.buryspeakeasy.org.uk/),
if this was needed.
Postal and telephone reminders were used if questionnaires were not returned within 2 weeks. Where
completion of postal questionnaires was not possible, participants (or carers if a proxy was needed) were
invited to complete assessments over the telephone. If neither postal or telephone completion was
possible, a face-to-face assessment in the participant’s home was offered.
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Sample size
The sample size was chosen pragmatically, rather than on the basis of a formal sample size calculation.
Our aim was to balance practicalities and the need for reasonable precision in the estimation of effects to
inform the sample size calculation for a full-scale trial to test effectiveness.
The use of four stroke services per arm (12 in total) was deemed to suffice for an indication of likely
effectiveness and helped us address any feasibility issues relating to the delivery of the interventions. It also
provided some degree of confirmation regarding the size of the intra-class correlation coefficient and
enabled us to perform a review of the number of sites (and the number of patients needed per site) for
each arm of the trial for a full-scale trial. It also provided some information on stroke service-level factors
which may help explain the variability in outcome between stroke services in each arm, thus potentially
helping to reduce the intraclass correlation coefficient and hence achieve efficiency in terms of the number
of stroke services required for a full-scale trial.
We estimated that 12 stroke services would admit around 4500 patients per year, of whom we expected
around 20% would meet the trial inclusion criteria and consent to participate. To achieve better balance in
the number of participants recruited per trust/health board, we planned to recruit for 12 months in services
recorded as admitting 300 or less patients per year and for 9 months in trusts recorded as admitting more
than 300 patients per year; our initial target for recruitment was 780 patients across the 12 services.
Centre randomisation
Sequence generation
In order to ensure comparability of trial arms with respect to type of unit, quality of care and throughput,
stroke services were placed into four strata. These were based, in order of priority, on (i) whether they had
separate or combined acute and rehabilitation units at the time (in one site separate units had combined
by the start of recruitment); (ii) their average performance on the ‘nine key indicators of stroke care’ in the
National Sentinel Stroke Audit Phase II11 (clinical audit); and (iii) the number of stroke patients admitted
per year. Services were randomly allocated to intervention (n= 4), supported implementation (n= 4) and
usual care (n= 4) arms by the Newcastle Clinical Trials Unit. After allocating hospitals to the strata, the
randomisation schedule was generated using block randomisation (block length of three) to allocate
one site to each arm within every stratum. The software package Stata (version nine; StataCorp LP,
College Station, TX, USA) was used.
Allocation concealment
Allocation was based on clusters. Within each stratum, stroke services were not informed of their intervention
allocation until ALL stroke services within that stratum were recruited to take part in the trial. However,
when two sites required substitution the rest of the stratum were already aware of their allocation.
Blinding
Once stroke services within a stratum were recruited, services were then made aware of their allocation, as
were staff identifying and recruiting trial participants from within that service. Outcome assessment for
participants still inpatients at 6 and 12 weeks post stroke was done by research nurses; therefore blinded
outcome assessment was not possible. Although we originally intended research nurses to collect outcome
data in sites other than their own (and in which they were unaware of allocation), the geographical spread
of sites meant this was not feasible.
The trial statistician was not blinded during the analysis, although the statistical analysis plan was finalised
prior to any outcome data being available to the trial statistician. Some post-hoc subgroup analyses and
sensitivity analyses were, however, determined subsequently.
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Data analysis
Recruitment
Each month, proportions of stroke patients meeting the inclusion criteria for the trial and proportions of
these patients actually recruited were compared descriptively between clusters and intervention groups.
Baseline data
Baseline characteristics were summarised using means (with SDs), or median (IQR) if the data were
continuous or counts, respectively, or frequency (percentage) if the data were dichotomous or categorical.
All outcome data were summarised in a similar manner.
Outcome data
The primary analysis was performed using intention to treat. All stroke services randomised were retained
in the trial. Outcome data were collected from all consented patients whenever possible, whatever their
level of subsequent engagement with the allocated intervention programme. For the 6-week outcome
time point, outcome data received no later than 10 weeks post stroke were included in the primary
analysis; for 12- and 52-week outcomes, all data received were included.
To account for the cluster randomisation, we used mixed-effects modelling for continuous, ordinal and
dichotomous outcomes to compare the two groups on primary and secondary outcome data. Baseline
measures of the outcomes variables (where appropriate), stroke subtype and the other prognostic
patient-level information (from the Edinburgh case-mix adjuster168) were included as individual-level
covariates in the models for outcome data.
Missing outcome data were imputed according to the particular outcome. For the primary analysis,
dichotomous and ordinal outcomes for those who withdrew, died or were otherwise lost to follow-up
were imputed using a worst-case scenario (e.g. for the primary outcome variable, all those for whom
incontinence status was not recorded at the respective time points post stroke were assumed to be
incontinent). For continuous outcomes (I-QOL), the primary analysis used a non-parametric multiple
imputation approach.169 Missing baseline data were not imputed.
The effect of stroke service-level factors was also explored in the modelling with the intention of
investigating potential stratification factors for a future effectiveness trial, and to potentially reduce
the size of the intrastroke service correlation coefficient by reducing the unexplained component of the
variability between stroke services.
Subgroup analyses
Pre-planned exploratory subgroup analyses were for the following variables:
l pre-stroke incontinence (with/without)
l sex (male/female)
l type of incontinence (UUI; SUI; MUI; ‘functional’ UI; unclear)
l sex combined with type of incontinence
l OCSP subtypes [unconscious; TACS; PACS; posterior circulation syndrome (POCS); lacunar stroke
(LACS); unclassifiable]
l baseline bowel function (7-day Barthel item: incontinent or occasional accident; fully continent)
l baseline ISI (dry; slight; moderate; severe)
l pre-stroke mRS (0–2 little or no handicap; 3–5 moderate or severe handicap)
l type of stroke (ischaemia; haemorrhage)
l side of stroke (left; right; both; neither)
l type of intervention (catheterised throughout; intervention with BT at some stage; intervention
but never BT).
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Additional post-hoc exploratory subgroup analyses were performed for age (as a continuous variable),
baseline cognitive impairment status (not cognitively impaired; cognitively impaired or unknown cognitive
status), SUI (presence; absence) and UUI (presence; absence).
Subgroup analyses were performed by adding to the model an interaction between the (three-group)
intervention factor and each of the factors listed above individually. Interactions significant at α= 0.1 were
deemed indicative of a potential subgroup effect. It was also planned to explore jointly any interactions
individually significant at α= 0.1.
Sensitivity analysis
Various sensitivity analyses were performed on the primary outcome measure. These analyses included:
l the use of alternative analytical approaches, given the small number of clusters
l complete case analysis
l alternative imputation methods using a non-parametric multiple imputation169 approach for
dichotomous and ordinal outcomes data
l per-protocol analysis, using varying definitions of ‘receipt of sufficient of the intervention’
l varying the eligibility criteria for timely response at each outcome time point
l excluding patients with pre-stroke incontinence
l excluding patients catheterised throughout their hospitalisation.
Ethical aspects
The trial was approved by Bradford Research Ethics Committee (Reference number 10/H1302/60), which
has a lead responsibility for studies with mental capacity issues, on 10 August 2010; site research and
development departments; and by the University of Central Lancashire FHEC on 11 August 2010 (CA168).
Informed consent to participate in the trial was sought from participants themselves or from a consultee,
as outlined above. All patients were informed that participation was voluntary and that they were able to
withdraw at any time. UI is a sensitive issue and the approach taken with participants needed to reflect
this. Our study had two dedicated PPC involvement groups; both provided advice on recruitment strategies
as well as assisting in the development of patient documentation.
Trial management and monitoring
The Trial Management Group (comprising all programme applicants) met every 3 months to discuss
the day-to-day management and running of the programme. The Trial Steering Committee met every
6 months with a remit including review of objectives and progress against plans and objectives
and monitoring the quality of the research to help ensure it contributes to knowledge at a national and
international level.
The Independent Data Monitoring Committee (IDMC) were responsible for safeguarding the interests
of trial participants, assessing the effect of the interventions during the trial, and for monitoring the overall
conduct of the clinical trial. The IDMC were advisory to the trial sponsor and the Trial Steering Group and
met biannually.
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Chapter 6 Process evaluation: methods
Overview
This chapter presents methods of the process evaluation. We introduce the logic model underpinning the
evaluation and describe the evaluation structure in line with Grant et al.’s170 framework for process
evaluations of cluster RCTs.
Process evaluation of implementation
An integrated multiple component evaluation was conducted in order to describe implementation and
assist in explaining why the intervention and its components were, or were not, successful. Process
evaluations examine what the intervention comprises and how it is delivered to target participants;154 they
are designed to evaluate fidelity and provide explanatory evidence around trial outcomes. Fidelity is defined
as ‘the degree to which programs . . . are implemented as intended by the program developers’.171 At its
simplest level, fidelity is measured in terms of adherence to the intervention (i.e. content, coverage,
frequency and duration154). However, potential moderators of adherence, such as intervention complexity,
strategies used to facilitate implementation, quality of delivery and participant responsiveness,172 also need
consideration. Moderators may also work together to contribute to outcome.
Reflecting best practice in complex intervention research, we developed a logic model to underpin the
process evaluation using Hasson’s154 adaptation of Carroll et al.’s172 framework. The model represents
practitioners’ implementation activities (Figure 25), expected impacts (Table 47) and contextual mediators
of change (Box 2). To increase explanatory power of the model, we synthesised principles from theoretical
frameworks underpinning the study (e.g. principles underlying the implementation strategy, facilitation and
NPT) into mechanisms of action to explain conditions necessary for activities to impact on outcomes.
Mechanisms were:
l thinking: conceptual work associated with the SVP (e.g. increasing awareness)
l planning: organising systems or processes to align and drive new practice
l doing: enacting the SVP
l evaluating: reflecting on performance and progress.
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TABLE 47 Logic model b: expected impacts
Stage
Impact
Patient Staff Organisation
Thinking Aware of continence status
Sensory awareness
Awareness of continence
Knowledge of continence
Knowledge of individual need
Decision-making
Collective understanding and
knowledge of:
l continence
l SVP
Planning Know a plan is in place
Know their regime
Know who is incontinent
Know who is on SVP
Know what to do for patient
Can establish a voiding pattern
Better management of
workload/patient need
Doing Increased continence talk
Skill in managing urgency
Lengthening time intervals
between voids
Increase in:
l skill
l competence
l avoiding harm
l continence talk
l appropriate investigations
More consistency of good
practice
More efficiency
Evaluating Aware of progress
Positive emotions
Satisfaction
Knowledge of performance
Knowledge of impact
More aware of need
Knowledge of performance
and impact
Outcomes Increased bladder capacity
Reduced harm, e.g. urinary
tract infection
Less incontinent episodes
Less incontinent amount
More likely to go home
Increased therapeutic role Less waste
Less use of inappropriate
products, e.g. catheters, pads
Research citizenship/kudos
BOX 2 Logic model c: contextual mediators of change
Contextual mediators of change
l Stroke severity.
l Patient gender.
l Ward layout.
l Presence of ward routines.
l Team working.
l Therapist engagement.
l Degree of change required to do the SVP.
l Leadership.
l Use of resources.
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Although our original intention was to use Hasson’s model154 to underpin the process evaluation,
Grant et al.170 have recently published a framework specific to cluster RCTs. Most domains are found in
both; however, Grant et al.170 also include maintenance (sustainability of processes over time), unintended
consequences and theory used to develop the intervention. Table 48 shows domains and methods used
to address each domain in our trial.
Cluster characteristics
Key characteristics of each site were recorded. These comprised type of hospital; catchment population
of trust or health board; number of stroke admissions per annum; type of unit; total number of beds;
number of dedicated stroke beds; 2008 Sentinel Audit score (average of nine key indicators of stroke care);
and the average number of qualified, unqualified and total nursing staff on duty on morning and
afternoon shifts (including ICONS funded HCAs).
TABLE 48 Domains and methods for evaluating process
Domain Research question
Research methods used:
intervention arm
Additional research methods used:
supported implementation arm
Recruitment of
clusters
How were clusters sampled
and recruited?
Documentation of
recruitment process
Documentation of cluster
characteristics
Delivery to clusters Which intervention was
delivered for each cluster?
Analysis of intervention
documentation
Analysis of meeting notes and
internal facilitator records
Interviews with internal and EFs
Response of
clusters
How was the intervention
adopted by clusters?
Interviews with ward staff Interviews with internal and EFs
Recruitment and
reach in
individuals
Who received the
intervention in each setting
and are they representative?
Baseline data on patient
characteristics
Interviews with ward staff
Delivery to
individuals
Which intervention is
delivered in each cluster?
Interviews with ward staff Interviews with internal and EFs
How well did staff adhere to
the intervention?
Analysis of intervention
documentation
Monitoring adherence to
protocol
Analysis of meeting notes and
internal facilitator records
Interviews with internal and EFs
Response of
individuals
How did the target
population respond?
Interviews with patients
and families
Interviews with ward staff
Maintenance How were processes
sustained over time?
Interviews with ward staff Interviews with internal and EFs
Theory What theory was used to
develop the intervention?
Soft systems
NPT
Implementation theory: facilitation
Context What was the wider context
in which the trial was
conducted?
Soft systems methodology
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Delivery of the intervention to individuals
Staff adherence was assessed through an examination of:
l completion of intervention documentation (3-day diaries and daily clinical logs for participants
on BT and PV)
l adherence to the protocol in terms of allocation of participants to the appropriate regime and the
management of catheterisation.
Completion of intervention documentation
Three-day diary
Research nurses were asked to submit a copy of the 3-day diary for all participants for whom one was
recorded, i.e. participants who were incontinent at baseline or whose catheter was removed before
discharge. Participants catheterised throughout their stay were not eligible to complete the diary. Each
diary was assessed using a filtering system, with data input for an individual diary terminated at any stage
if it failed to achieve that stage’s key quality indicator. The assessment of ‘yes’ or ‘no’ for each applicable
stage was entered into the SPSS. For a summary of the stages and key quality indicators, see Chapter 4.
Daily clinical logs for bladder training and prompted voiding
We collected daily clinical logs for all participants in the intervention groups during three (for sites with a
9-month intervention period) or four (for sites with a 12-month intervention period) randomly selected weeks
during each 3-month period in which the stroke service was recruiting participants into the trial. The methods
used to process, input and analyse the clinical logs collected from the main trial sites were identical to the
methods used for the clinical logs collected in the case study phase (see Chapter 4), with two additions.
Addition 1
In the main trial, for some clinical logs the quality of the photocopy was insufficient and as a result some
parts of these clinical logs were impossible to read. A code was created, entitled ‘unable to process’.
This code was applied to a clinical log if any data pertaining to the first three quality indicators (regime interval,
proposed times and ‘times toileted’) was unreadable due to poor photocopy quality. Once the code was
applied, the clinical log was not processed further.
Addition 2
For ‘times toileted’ that were either more than 30 minutes earlier or later than the proposed time or that were
missing, one researcher scrutinised any comments documented in order to identify whether or not a ‘clinically
justifiable’ explanation was provided. The main criteria for comments to be deemed ‘clinically justifiable’ were
agreed with a key group of researchers from the ICONS trial. Examples of ‘clinically justifiable’ and ‘clinically
non-justifiable’ comments are shown in Table 49. Comments recorded as ‘clinically justifiable’ were reviewed
by a senior researcher in order to check validity. An additional analysis was then performed for stage 3b
(quality indicator: ‘times toileted – within schedule’), in which an exemption was made for occasions on which
clinically justifiable explanations were given for early, late or missing ‘times toileted’.
Adherence to the protocol: allocation of participants to the appropriate
regime and the management of catheterisation
The protocol required all participants who were incontinent during the 3-day diary period to be assessed
for their suitability for BT or PV, with the appropriate regime commencing the day after completion of the
3 day diary. The recommended route for participants with cognitive impairment or no control over their
bladder was PV; for all other participants it was BT. Ward staff were encouraged to move participants
onto BT once they regained some bladder control or their cognitive function improved. For participants
catheterised in the acute stage, ward staff were asked to conduct a TWOC as early as possible unless there
was a valid clinical reason not to do so.
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Our assessment of site adherence to the protocol included the following:
(a) Length of time from the last day of the 3-day diary to commencement of regime.
(b) Proportion of eligible patients allocated to regime.
(c) Proportion of eligible patients allocated to the correct regime, based on the following criteria:
– PV: patients with cognitive impairment, defined as a score of 8 or more on the 6-Item Cognitive
Impairment Test; OR patients who had no control over their bladder, defined as answering ‘all the
time’ to the ICIQ question ‘how often do you leak urine?’
– BT: patients with no cognitive impairment, defined as a score of 0–7 on the 6-Item Cognitive
Impairment Test, and some control over their bladder, defined as answering ‘several times a day’,
‘about once a day’, ‘two or three times a week’ or ‘about once a week or less often’ to the ICIQ
question ‘how often do you leak urine’?
(d) Length of time spent on the regime.
(e) Number of participants catheterised in the acute stage.
(f) Number of participants catheterised at discharge.
(g) Time from entry to removal of catheter.
Response of individuals
Semistructured interviews were conducted with patients at discharge and sought patients’ experiences of
their treatment for incontinence and their views of the effectiveness of treatment (see Appendix 25 for
interview schedule).
We used maximum variance sampling173 to generate a range of participants in terms of gender, age,
ethnicity, type of incontinence and stroke severity. Participants were also chosen to reflect those with a
range of outcomes at discharge (defined in terms of the frequency of incontinent episodes).
Interviews were conducted by a researcher or research nurse. They were audiotaped and fully transcribed;
all transcripts were checked against the recording to ensure accuracy. If the participant declined to be
recorded, written notes were made by the researcher.
Initial coding was undertaken using thematic analysis. Codes were then clustered and findings integrated
within the evolving logic model.
TABLE 49 Criteria for comments to be deemed ‘clinically justifiable’ in relation to an early/late/missing
‘time toileted’
Type of comments deemed to be ‘clinically justifiable’
in relation to an early, late or missing ‘time toileted’
Type of comments not deemed to be ‘clinically
justifiable’
Patient sleeping
Patient catheterised
Patient not on the ward. (Only if location is either out of
hospital, or in hospital NOT with an AHP, or is non-specified,
AND if time off ward is either non-specified OR is of
sufficient length to preclude toileting at scheduled time)
Patient refused/declined/did not want toilet. (The underlying
assumption is that the patient was asked)
Staffing issues, e.g. staff too busy
Patient at physiotherapy or occupational therapy
Patient lost buzzer
Toileting time fell during meal time
Patient did not need to go. (The underlying assumption is
that, although the patient did not need to go to the toilet,
they should still have been asked to go – giving them the
opportunity to decline if they so wished)
AHP, Allied Health Professional.
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Response of clusters, recruitment and reach in individuals, delivery to and
response of individuals and maintenance of processes over time
As in the case study phase, NPT55–58 provided the theoretical framework for implementing and evaluating
the SVP. The aim was to facilitate understanding of the practical issues involved in embedding the
intervention into routine practice.
Qualitative, semistructured interviews were performed with health professionals involved in the
intervention to explore experiences of implementing the intervention, and drivers and barriers to successful
implementation (n= 15–20 per intervention group, but with the numbers determined by data saturation).
The interview schedule is shown in Appendix 26.
Each site was rated by the trial manager according to key parameters with a theoretical link to participant
outcome, with the aim of checking the validity of the NPT analysis. These parameters included the
extent of engagement with the programme, the level of research nurse involvement and the extent to
which the ward manager provided leadership and direction in programme implementation. The full list of
parameters and scoring system is shown in Appendix 27.
Interview summaries were initially constructed (interviews could include up to three respondents).
First, the transcript was coded into the NPT framework (see Chapter 4). The respondents’ comments were
then condensed for each NPT dimension to remove overlap and redundancy (such as when multiple
respondents repeated broadly the same point, or the same respondent said something more than once);
summarised to retain the essence of the points being made; and given an identifying label for the site
(letter) and interview (number), for example AA2.
Site summaries were then created across all respondent interviews (an example is shown in Appendix 28).
This involved merging all interview summaries for one site, linking related text chunks together for each
NPT dimension and condensing down to remove overlap and redundancy, taking care to avoid loss of
meaning or viewpoint. A short sentence summary was made for each unique salient point keeping as
closely as possible to the expression of the respondents, with the number of respondents making a similar
point in brackets [e.g. It is running smoothly (3) but it adds to the pressure/frustration if we can’t do it (3).
It is (1)/isn’t (1) being done properly. Sometimes we just can’t do it because of staffing or workload (2)].
This allowed demonstration of convergent or divergent views within a site, or outlier viewpoints.
Across site summaries were made for each NPT dimension, by merging the site summaries so that the
range of views expressed across all sites, and the main agreements and differences between sites, could be
identified. The number of sites contributing to a particular finding is indicated in brackets at the end of the
sentence, for example ‘Sites reported some difficulties with assessment (4), weekly reviews (2), and daily
logs (1)’, or is reported in the text, for example ’Four sites had a toileting regime in place’.
Data analysis quality checks
All coding was undertaken by two coders independently (BF, JMc). Inter-rater reliability of coding was
checked using side-by-side comparison, discussion of difference, agreement on final code(s) and accuracy
of summarising, and adaptation of the coding framework if necessary. Identification and extraction of key
points for coding across both coders was consistently reliable. Initially, there were regular differences in
allocation to some codes between the two coders; a main code was discussed and agreed as differences
arose. After main codes were agreed, internal consistency of coding was high.
The across site summary was populated by one researcher (BF) with direct quotes from respondents, to
illustrate meanings. A second researcher (JMc) then checked back to the original transcripts, to ensure that
the sense of meaning in the quotes used had been maintained, and to verify the number of sites
supporting a statement. This was done to check reliability of interpretation.
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The second researcher also checked the spread of quotes used to ensure that there was a balance of
perspective from across the sites and from different respondent grades (e.g. qualified and unqualified
staff). Within-site divergence between respondents of different grade could be lost to some extent in the
site summary174 (e.g. if a particular grade of staff were more expressive, numerous or dominant in group
interviews). To ensure that any differences of opinion between staff of different grades was maintained,
a subgroup analysis was undertaken to check whether or not divergent views could be attributed to
respondent grade for any NPT dimension. This is pointed out in the findings if present.
External consistency of interpretation of the data was reviewed by a management team member with
experience of using the NPT framework in other research studies (FC).
Data synthesis
Barriers and facilitators to implementation
The main aim of using the NPT framework was to identify factors in the implementation of the
intervention which might have influenced its success. Findings were categorised as barriers/difficulties or
facilitators/suggestions for improving the implementation of the SVP within each NPT dimension.
Implications for a future trial were built from these by the research team, and discussed at Steering
Group meetings.
Potential mechanisms of action
To investigate links between features of the intervention and outcome, we extracted respondents’ views
about how the intervention might work to impact on outcome. These potential mechanisms of action
were mapped against the logic model of the intervention, described earlier in the chapter.
Context in which the trial was conducted
A soft systems analysis was used to define the clinical system within which ICONS SVP interventions were
to be implemented (or not), and to uncover complex, messy systems, within which multiple perspectives
may be found. Consequently, an exploratory research design and inclusive approach to sampling was
required. Soft systems methodology143 was used to describe relationships between structure, process and
outcome within the stroke service and to generate a definition of how the service worked (see Chapter 4).
Objectives were to:
l provide a description of the incontinence system
l explore the ‘fit’ between the SVP and existing services in primary and secondary care environments
l highlight the barriers and facilitators that might impede or enhance programme implementation within
a continuous system of continence care.
A purposive sample of participants engaged in managing and delivering the clinical system were
approached for inclusion in this study component. The sample was selected to ensure breadth of coverage
in terms of the system and the range of professional roles that provide UI interventions.
Qualitative interviews were held with clinical leaders in the intervention and supported implementation trial
arms before the intervention phase began. Health professionals in usual care were also interviewed to
facilitate comparison in terms of continence management across trial arms. In order to minimise any
change in practice, interviews in this trial arm were conducted at the end of the data collection period.
The interview schedule is shown in Appendix 29.
Evaluation of supported implementation
This concerned the supported implementation trial arm only. Evaluation comprised two strands.
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First strand: key informant semistructured interviews175 with internal
facilitators, their deputies and external facilitators
Interviews explored experiences of implementing facilitation using the four domains of NPT as a
framework: coherence (negotiating the intervention); cognitive participation (developing the intervention
processes); collective action (implementing the new processes); and reflexive monitoring (evaluating the
intervention processes).
All interviews were audio taped, transcribed and subjected to thematic analysis using NPT as a framework.
The qualitative data analysis programme NVivo (QSR International, Warrington, UK) was used to code and
categorise text; validity of interpretation was assessed through discussion by the project team.
Second strand: internal facilitator records
Descriptive analysis of weekly logs focused on which strategies were implemented; evidence from meeting
notes was again analysed using NPT assisted by NVivo as above.
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Chapter 7 Exploratory cluster randomised
controlled trial: findings
Overview
In this chapter we present quantitative findings from the RCT. Findings from the process and health
economic evaluations are presented in Chapters 8 and 9.
Recruitment
Twelve sites commenced recruitment between January 2011 and January 2012 (Figure 26). No site
dropped out, each recruiting participants either for at least their planned duration of 9 or 12 months or
until recruitment ceased at all sites on 31 July 2012 (see Figures 30 and 31). Site recruitment periods
ranged from 9 to 14 months (Figure 27; site identifiers have been removed to protect anonymity).
Four hundred and thirteen patients were recruited into the trial; 124 usual care, 164 intervention and
125 supported implementation. A total of 6060 patients were screened for eligibility; of these 2675 (44%)
had not had a confirmed stroke. The number of non-stroke patients screened was highest in the
intervention (1515/3078, 49%) and supported implementation (981/1999, 49%) arms and lowest
in usual care (179/983, 18%). There was large variation across sites, with non-stroke patients screened
ranging from 2 (1%) to 448 (79%).
The proportion of patients eligible for recruitment was similar across trial arms (usual care 155/804, 19%;
intervention 259/1563, 17%; and supported implementation 176/1018, 17%). Of these, 80% (124/155)
were recruited in usual care, 63% (164/259) in intervention and 71% (125/176) in supported
implementation; the proportion of eligible patients recruited ranged from 10 (50%) to 46 (98%)
across sites.
Data completeness
Baseline data were collected for all patients. The overall response rate at 6 weeks was 85% (306/362),
excluding 34 patients recruited at more than 6 weeks post stroke and 17 who had died (usual care
96/114, 84%; intervention 122/139, 88%; supported implementation 88/109, 81%). At 12 weeks, the
overall response rate was 88% (330/374), excluding one patient recruited at 12 weeks and 38 who had
died (usual care 98/112, 88%; intervention 132/148, 89%; supported implementation 100/114, 88%).
At 52 weeks, the overall response rate was 56%, excluding 98 who had died (usual care 53/95, 56%;
intervention 70/124, 57%; supported implementation 53/96, 55%).
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Analysed: 98
Lost to follow-up
Analysed: 53
Lost to follow-up
Analysed: 70
Lost to follow-up
Analysed: 53
Lost to follow-up
Analysed: 132
Lost to follow-up
Excluded
Assessed for eligibility
Randomised: 12 stroke services
32 stroke services
• Refused to participate:
• Inadequate throughput: 
• Not able to find excess 
   Treatment costs:
• Hub and spoke service model:
   
Allocated to usual care
Analysed: 96
Recruited at 6 weeks or beyond: 6
Lost to follow-up
Allocated to intervention Allocated to supported
implementation
• 4 stroke services
• 124 participants
• 4 stroke services
• 164 participants
• 4 stroke services
• 125 participants
• 0 stroke services/22 participants
   (4 dead and 18 completed after
   cut-off date/missing)
• 0 stroke services/32 participants
   (16 dead, 11 missing and  
   5 withdrawn/lost to study)
• 0 stroke services/24 participants
   (10 dead, 12 missing and  
   2 withdrawn/lost to study)
• 0 stroke services/26 participants
   (12 dead, 13 missing and
   1 withdrawn)
• 0 stroke services/71 participants
   (29 dead, 34 missing and  
   8 withdrawn/lost to study)
• 0 stroke services/94 participants
   (40 dead, 42 missing and 
   12 withdrawn/lost to study)
• 0 stroke services/72 participants
   (29 dead, 32 missing and  
   11 withdrawn/lost to study)
Analysed: 122
Recruited at 6 weeks or beyond: 18
Lost to follow-up
Analysed: 88
Recruited at 6 weeks or beyond: 10
Lost to follow-up
Analysed: 100
Recruited at 12 weeks or beyond: 1
Lost to follow-up
• 0 stroke services/24 participants
   (7 dead, 16 completed after
   cut-off date/missing and 1 withdrawn)
• 0 stroke services/27 participants
   (6 dead, 20 completed after
   cut-off date/missing and 1 withdrawn)
6
12
52
1 stroke service
1 stroke service
8 stroke services
10 stroke services
FIGURE 26 Flow of clusters and participants through the trial.
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Baseline characteristics
Participant characteristics at baseline are shown in Table 50. Median age was 79 (IQR 70.5–85.0) years
and was similar between arms. Overall, nearly half were male (189, 46%); with slightly more males in
intervention (86, 52%) compared with the usual care (51, 41%) and supported implementation (52, 42%)
arms. Median 7-day Barthel Index was 4 (IQR 2–7) and similar across arms. The number of patients with no
symptoms on the pre-stroke mRS was 139 (34%) overall; the proportion was slightly higher in usual care
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FIGURE 27 Participant recruitment chart.
TABLE 50 Patient characteristics at baseline [frequency (%) unless stated otherwise]
Measure All sites (n= 413) Usual care (n= 124) Intervention (n= 164)
Supported
implementation
(n= 125)
Age (years), median (IQR) 79 (70.5–85.0) 80 (72–86) 77 (68–83) 81 (74–85)
Male, n % 189 46% 51 41% 86 52% 52 42%
Ethnicity, n %
White British 397 97% 123 99% 155 96% 119 95%
Other 14 3% 1 1% 7 4% 6 5%
Type of stroke, n %
Ischaemic 350 85% 101 81% 143 88% 106 85%
Haemorrhagic infarct 49 12% 17 14% 14 9% 18 15%
Primary intracerebral
haemorrhage
12 3% 6 5% 6 4% 0 0%
OCSP classification, n %
TACS 185 46% 37 30% 80 51% 68 54%
PACS 118 29% 54 44% 31 20% 33 26%
LACS 88 22% 28 23% 44 28% 16 13%
POCS 14 3% 3 2% 3 2% 8 6%
continued
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TABLE 50 Patient characteristics at baseline [frequency (%) unless stated otherwise] (continued )
Measure All sites (n= 413) Usual care (n= 124) Intervention (n= 164)
Supported
implementation
(n= 125)
Side of body affected by stroke
Left side 207 50% 58 47% 86 53% 63 50%
Right side 176 43% 55 44% 69 43% 52 42%
Both sides 6 1% 2 2% 2 1% 2 2%
Neither side 21 5% 9 7% 4 2% 8 6%
7-day Barthel Index, median
(IQR)
4 (2–7) 5 (2–9) 3 (2.0–6.3) 5 (3.0–7.5)
Pre-stroke mRS, n %
No symptoms 139 34% 52 42% 54 33% 33 27%
No significant disability 166 41% 39 31% 72 44% 55 45%
Slight disability 30 7% 4 3% 19 12% 7 6%
Moderate disability 54 13% 21 17% 10 6% 23 19%
Moderately severe disability 18 4% 7 6% 6 4% 5 4%
Severe disability 2 0% 1 1% 1 1% 0 0%
Pre-stroke living type, n %
House 324 79% 94 76% 134 84% 96 77%
Flat 47 12% 21 17% 11 7% 15 12%
Sheltered housing 20 5% 4 3% 8 5% 8 6%
Residential home 15 4% 5 4% 4 3% 6 5%
Nursing home 1 0% 0 0% 1 1% 0 0%
Other 1 0% 0 0% 1 1% 0 0%
Pre-stroke living circumstances, n %
Alone 162 40% 51 41% 64 40% 47 38%
With partner 194 47% 57 46% 77 48% 60 48%
With other family 37 9% 11 9% 14 9% 12 10%
With other 16 4% 5 4% 5 3% 6 5%
Speech, n %
None 47 11% 10 8% 22 14% 15 12%
Incomprehensible 63 15% 19 15% 22 14% 22 18%
Inappropriate 72 18% 25 20% 32 20% 15 12%
Cognitive ability, n %
Confused 83 20% 26 21% 22 14% 35 28%
Orientated 146 36% 44 35% 64 40% 38 30%
Edinburgh case-mix
probability of survival
free of dependency at
6 months, median (IQR)
0.02 (0.01–0.08) 0.02 (0.01–0.05) 0.02 (0.01–0.11) 0.02 (0.01–0.08)
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(52, 42%) compared with the intervention (54, 33%) and supported implementation (33, 27%) arms.
The median probability of survival free of dependency at 6 months (measured by the Edinburgh Case
mix-adjuster168) overall was 0.02 (IQR 0.01–0.08) and was similar across arms.
Stroke subtype classified according to the OCSP classification148 is shown in Figure 28. The majority of
patients had middle cerebral artery strokes (TACS or PACS 303, 74%), although the proportion of patients
with PACS was higher in usual care (54, 44%) compared with the intervention (31, 19%) and the
supported implementation (33, 26%) arms.
The majority of patients lived in their own home pre stroke (371/408, 91%), with nearly half of patients
living alone (162/409, 40%). At baseline, only two-fifths of patients were able to converse and were
orientated (146/411, 36%), only 33/413 (8%) were able to lift their arms and only 31/413 (8%) were able
to walk independently.
Tables 51 and 52 show continence and EQ-5D status at baseline.
Forty-seven per cent (195/413) of patients were catheterised at recruitment and for these patients,
questions about continence status were collected on catheter removal. Median time to catheter removal
was 19 days, although the IQR was wide (IQR 8.5–34.0 days). Seventeen per cent (72/413) remained
catheterised throughout. Over four-fifths of patients (300/341, 88%) were incontinent at baseline, with
41/341 (12%) continent, usually after catheter removal but in a few cases due to delay in completing the
baseline assessment. The majority of patients were incontinent several times a day (189/299, 63%).
Median score on the ISI was 8 in all trial arms (IQR 4–8 overall), with 230/325 (71%) falling within the
‘severe’ category. Over four-fifths of patients had UUI (265, 82%) and functional incontinence (289, 88%).
The majority of patients were dependent in terms of mobility, self-care and usual activities at baseline as
measured by the EQ-5D, with only 19 out of 307 (6%), 25 out of 306 (8%) and 9 out of 304 (3%) having
no problems with mobility, self-care and usual activities respectively. Two-fifths of patients (126/303, 42%)
had pain or discomfort and nearly half (139/303, 46%) were anxious or depressed.
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FIGURE 28 Baseline stroke subtype by trial arm.
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TABLE 51 Continence status at baseline
Outcome
Trial arm
Usual care Intervention
Supported
implementation All sites
Catheterised (% of returned) 21 17% 33 20% 18 14% 72 17%
Potential respondents for incontinence measures
(% of due)
103 83% 131 80% 107 86% 341 83%
Primary outcomes
Presence/absence of incontinence (ICIQ-UI Short-Form Q3)
Continenta 10 10% 20 15% 12 11% 42 12%
Incontinentb 93 90% 111 85% 95 89% 299 88%
ICIQ-UI Short Form
Never 10 11% 20 18% 12 13% 42 14%
About once a week or less often 6 7% 3 3% 1 1% 10 3%
Two or three times per week 11 12% 12 11% 9 10% 32 11%
About once a day 9 10% 20 18% 17 19% 46 16%
Several times a day 63 70% 70 64% 56 62% 189 64%
All the time 2 2% 0 0% 2 2% 4 1%
Secondary outcomes
ISI score
Median (IQR) 8 6–8 8 6–8 8 4–8 8 4–8
None (0) 10 10% 20 16% 12 12% 42 13%
Slight (1–2) 2 2% 1 1% 0 0% 3 1%
Moderate (3–4) 12 12% 9 7% 29 30% 50 15%
Severe (6–8) 77 76% 96 76% 57 58% 230 71%
LUSQ
Frequency of toilet visits during daytime
At least every 30 minutes 0 0% 2 2% 0 0% 2 1%
Every hour 9 10% 6 5% 5 6% 20 7%
Every 90 minutes 23 26% 10 9% 3 3% 36 12%
Every 2 hours 42 47% 59 54% 35 39% 136 46%
Less often than every 2 hours 20 22% 33 30% 47 52% 100 34%
Type of incontinence
UUI present 86 85% 97 78% 82 85% 265 82%
SUI present 65 80% 30 50% 43 74% 138 69%
Functional incontinence present 91 90% 110 85% 88 89% 289 88%
Classification of continence status
Continent 10 8% 20 12% 11 9% 41 10%
UUI 7 6% 9 6% 3 3% 19 5%
SUI 1 1% 0 0% 0 0% 1 0%
MUI 64 51% 30 18% 43 34% 137 33%
Functional incontinence only 0 0% 1 1% 1 1% 2 1%
Unclear incontinence type 21 17% 71 43% 49 39% 141 34%
Catheterised 21 17% 33 20% 18 14% 72 17%
a Defined as never on ICIQ-UI Short Form response Q3.
b Defined as any non-missing response other than ‘never’ on ICIQ-UI Short Form.
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Adverse events
Events most likely to be related to the ICONS intervention were falls, urinary tract infections and bladder
catheterisations. A total of 91 adverse events were recorded, 30 in usual care, 33 in intervention and 28 in
the supported implementation arm.
Sixty-six patients had a recorded fall, urinary tract infection, bladder catheterisation or a combination of
these. Twenty of these patients were in usual care (20/124, 16%); 25 out of 164 (15%) in intervention and
21 out of 125 (17%) in the supported implementation arm. Table 53 shows the number and proportion
of adverse events by trial arm. As some patients had more than one fall or urinary tract infection, Tables 54
and 55 show the number of patients with one or more of these adverse events in each trial arm.
TABLE 52 European Quality of Life-5 Dimensions status at baseline
EQ-5D item Usual care Intervention Supported implementation All sites
Mobility, n %
No problems 8 8% 6 5% 5 6% 19 6%
Some problems 53 52% 35 29% 48 56% 136 44%
Confined to bed 40 40% 79 66% 33 38% 152 50%
Self-care, n %
No problems 5 5% 9 8% 11 13% 25 8%
Some problems 50 50% 45 38% 36 42% 131 43%
Unable to wash or dress self 46 46% 65 55% 39 45% 150 49%
Usual activities, n %
No problems 2 2% 4 3% 3 4% 9 3%
Some problems 46 46% 35 30% 36 42% 117 38%
Unable to perform 53 52% 79 67% 46 54% 178 59%
Pain or discomfort, n %
None 68 67% 55 47% 54 46% 177 58%
Moderate 33 33% 54 46% 28 24% 115 38%
Extreme 0 0% 8 7% 3 3% 11 4%
Anxiety or depression, n %
None 61 61% 63 53% 40 47% 164 54%
Moderate 36 36% 45 38% 44 52% 125 41%
Extreme 3 3% 10 8% 1 1% 14 5%
TABLE 53 Number and proportion of adverse events by trial arm
Trial arm (n participants)
Adverse event
Fall Urinary tract infection Bladder catheterisation Total
Usual care (124) 16 (53.3%) 13 (43.3%) 1 (3.3%) 30 (100%)
Intervention (164) 11 (33.3%) 18 (54.5%) 4 (12.1%) 33 (100%)
Supported implementation (125) 4 (14.3%) 23 (82.1%) 1 (3.6%) 28 (100%)
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Overall, the number of adverse events was similar across trial arms. There were more falls reported in usual
care, and more urinary tract infections in both intervention arms compared with usual care. The intervention
arm had more catheterisations, although numbers reported were small.
Length of stay, discharge destination and discharge
continence status
Length of stay
Overall median (IQR) length of stay in the stroke unit was 47 (30–68) days; 43.0 (28.3–59.0) days in usual
care; 52.5 (35.0–70.8) days in intervention; and 47 (27–78) days in supported implementation.
Discharge destination
Table 56 shows discharge destination from the participating hospital. Overall, nearly half of patients were
discharged home (185, 45.4%); the proportion was lower in supported implementation (47, 38.2%)
due to the more frequent practice of discharging patients to community hospitals.
TABLE 54 Number of patients with falls by trial arm and number of falls
Trial arm (n participants)
Number of falls
Total1 2 3 5
Usual care (124) 4 2 1 1 8
Intervention (164) 5 3 0 0 8
Supported implementation (125) 2 1 0 0 3
TABLE 55 Number of patients with urinary tract infections by trial arm and number of infections
Trial arm (n participants)
Number of UTIs
Total1 2 3
Usual care (124) 13 0 0 13
Intervention (164) 14 2 0 16
Supported implementation (125) 16 2 1 19
UTI, urinary tract infection.
TABLE 56 Discharge destination from participating hospital
Patient destination on discharge from
participating hospital
Trial arm
Overall
(n= 407)
Usual care
(n= 120)
Intervention
(n= 164)
Supported
implementation
(n= 123)
Home alone 20 (16.7%) 14 (8.5%) 17 (13.8%) 51 (12.5%)
Home not alone 36 (30%) 68 (41.5%) 30 (24.4%) 134 (32.9%)
Nursing or residential home 30 (25.0%) 63 (38.4%) 25 (20.3%) 118 (29.0%)
Other hospital 26 (21.7%) 7 (4.3%) 39 (31.7%) 72 (17.7%)
Dead 8 (6.7%) 12 (7.3%) 12 (9.8%) 32 (7.9%)
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Before discharge from hospital, 21 patients (5.1%) were discharged from the stroke unit to another ward
in the same hospital (usual care 10, 8.1%; intervention 8, 4.9%; supported implementation 3, 2.4%).
Twenty-eight patients (6.8%) died on the stroke unit (usual care 6, 4.8%; intervention 11, 6.7%;
supported implementation 11, 8.9%), a further four patients died after discharge to another ward in the
same hospital.
For patients admitted from their own home, one quarter overall (105, 27.2%) were discharged to a
residential or nursing home (Table 57). More intervention patients were discharged to a residential or
nursing home (usual care 27, 23.5%; intervention 56, 36.1%; supported implementation 22, 18.8%),
whereas patients in usual care and supported implementation were more likely to be discharged to
community hospitals for further rehabilitation.
Continence status at discharge
At discharge, 38 (31%) of usual care, 72 (44%) of intervention and 51 (41%) of supported implementation
participants were continent. Relative to usual care, the intervention arm had an odds ratio (OR) of 1.47
(95% CI 0.81 to 2.67) of being discharged continent, with supported implementation having an OR of
1.54 (95% CI 0.83 to 2.85); the overall difference between trial arms was non-significant (p= 0.32).
Overall, combined intervention arm participants had 1.50 (95% CI 0.88 to 2.57, p= 0.13) times the odds
of continence at discharge than usual care participants.
Patient outcomes at 6 weeks post stroke
Table 58 shows patient outcomes at 6 weeks post stroke. An OR > 1 favours the intervention (intervention or
supported implementation arms). Only 66 (29%) patients reported being continent, with another 76 (25%)
reporting being catheterised. There was no real suggestion of a beneficial effect of either intervention relative
to usual care on outcome, with adjusted OR estimates for the dichotomised form of ICIQ question 3 of 0.94
(95% CI 0.46 to 1.94) for intervention and 0.62 (95% CI 0.28 to 1.37) for supported implementation arms,
and, for the original ordinal form of the question, 0.83 (95% CI 0.49 to 1.38) and 0.89 (95% CI 0.52 to 1.51)
respectively. These were reflected in the ORs for secondary outcomes, with most suggesting no positive
effect of either intervention relative to usual care. Overall, almost 50% of the non-catheterised respondents
reported severe incontinence on the ISI, with similar percentages with severe incontinence in each trial arm
(47% usual care; 45% intervention; 40% supported implementation). However, almost 50% of patients had
received less than 2 weeks of their allocated intervention by 6 weeks post stroke and over 25% had spent
less than 7 days on the programme by this time point.
TABLE 57 Discharge destination for patients admitted from home
Patient destination from
participating hospital for
patients who were
admitted from home
Trial arm
Overall
(n= 387)
Usual care
(n= 115)
Intervention
(n= 155)
Supported
implementation
(n= 117)
Home alone 20 (17.4%) 13 (8.4%) 17 (14.5%) 50 (12.9%)
Home not alone 36 (31.3%) 67 (43.2%) 30 (25.6%) 133 (34.4%)
Nursing or residential home 27 (23.5%) 56 (36.1%) 22 (18.8%) 105 (27.1%)
Other hospital 26 (22.6%) 7 (4.5%) 37 (31.6%) 70 (18.1%)
Dead 6 (5.2%) 12 (7.7%) 11 (9.4%) 29 (7.5%)
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TABLE 58 Patient outcomes at 6 weeks post stroke
Measure
Trial arm
All sites ICCbUsual care Intervention
Intervention
vs. usual care,
OR (95% CI)
Supported
implementation
Supported
implementation
vs. usual care,
OR (95% CI)a
Questionnaires returned 96 122 88 306
Catheterised (% of returned) 21 22% 37 30% 18 20% 76 25%
Potential respondents for incontinence
measures (% age of returned)
75 78% 85 70% 70 80% 230 75%
Primary outcomes
Presence/absence of incontinence
(ICIQ-UI Short-Form Q3)
0.94 (0.46 to 1.94) 0.62 (0.28 to 1.37) 0
Continentc 21 28% 29 34% 16 23% 66 29%
Incontinentd 54 72% 56 66% 54 77% 164 71%
ICIQ-UI Short Form (usual care 75;
intervention 83; supported
implementation 70; all 228)e
0.83 (0.49 to 1.38) 0.89 (0.52 to 1.51) 0
Never 21 30% 29 41% 16 24% 66 31%
About once a week or less often 8 11% 7 10% 11 16% 26 12%
Two or three times per week 12 17% 10 14% 8 12% 30 14%
About once a day 9 13% 11 15% 12 18% 32 15%
Several times a day 25 35% 25 35% 22 32% 72 34%
All the time 0 0% 1 1% 1 1% 2 1%
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Measure
Trial arm
All sites ICCbUsual care Intervention
Intervention
vs. usual care,
OR (95% CI)
Supported
implementation
Supported
implementation
vs. usual care,
OR (95% CI)a
Secondary outcomes
ISI score (usual care 75; intervention 84;
supported implementation 68; all 227)e
0.87 (0.48 to 1.57) 0.84 (0.46 to 1.56) 0
Median (IQR) 4 (0–8) 4 (0–8) 4 (1–8) 4 (0–8)
None (0) 21 28% 29 35% 16 24% 66 29%
Slight (1–2) 6 8% 6 7% 7 10% 19 8%
Moderate (3–4) 13 17% 11 13% 18 26% 42 19%
Severe (6–8) 35 47% 38 45% 27 40% 100 44%
Leicester Urinary Symptoms
Frequency of toilet visits during daytime
(usual care 71; intervention 71;
supported implementation 68; all 210)e
0.43 (0.22 to 0.84) 0.60 (0.30 to 1.22) 0.017
At least every 30 minutes 0 0% 0 0% 0 0% 0 0%
Every hour 0 0% 0 0% 0 0% 0 0%
Every 90 minutes 2 3% 2 3% 1 1% 5 2%
Every 2 hours 2 3% 2 3% 10 15% 14 7%
Less often than every 2 hours 67 94% 67 94% 57 84% 191 91%
Types of incontinence
UUI present (usual care 75;
intervention 84; supported
implementation 68; all 227)e
52 70% 50 59% 1.35 (0.67 to 2.71) 48 71% 0.89 (0.41 to 1.91) 150 66% 0
SUI present (usual care 71;
intervention 78; supported
implementation 57; all 206)e
36 51% 32 41% 1.01 (0.42 to 2.43) 33 58% 0.82 (0.34 to 1.61) 101 49% 0
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TABLE 58 Patient outcomes at 6 weeks post stroke (continued )
Measure
Trial arm
All sites ICCbUsual care Intervention
Intervention
vs. usual care,
OR (95% CI)
Supported
implementation
Supported
implementation
vs. usual care,
OR (95% CI)a
EQ-5D
Mobility (usual care 96; intervention 114;
supported implementation 88; all 298)e
1.27 (0.69 to 2.34) 1.37 (0.74 to 2.53)
No problems 13 14% 10 9% 6 7% 29 10%
Some problems 51 53% 44 39% 48 55% 143 48%
Confined to bed 32 33% 60 53% 34 39% 126 42%
Self-care (usual care 96; intervention
114; supported implementation 88;
all 298)e
0.61 (0.34 to 1.09) 0.75 (0.40 to 1.39) 0
No problems 13 14% 13 11% 13 15% 39 13%
Some problems 49 51% 47 41% 36 41% 132 44%
Unable to wash or dress 34 35% 54 47% 39 44% 127 43%
Usual activity (usual care 96; intervention
114; supported implementation 88;
all 298)e
0.42 (0.22 to 0.81) 0.79 (0.41 to 1.51) 0
No problems 6 6% 5 4% 5 6% 16 5%
Some problems 44 46% 30 26% 34 39% 108 36%
Unable to perform 46 48% 79 69% 49 56% 174 58%
Pain or discomfort (usual care 95;
intervention 111; supported
implementation 84; all 290)e
0.66 (0.38 to 1.16) 0.63 (0.34 to 1.14) 0
None 62 65% 58 52% 52 62% 172 59%
Moderate 32 34% 48 43% 29 35% 109 38%
Extreme 1 1% 5 5% 3 4% 9 3%
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Measure
Trial arm
All sites ICCbUsual care Intervention
Intervention
vs. usual care,
OR (95% CI)
Supported
implementation
Supported
implementation
vs. usual care,
OR (95% CI)a
Anxiety or depression (usual care 95;
intervention 107; supported
implementation 83; all 285)e
0.56 (0.33 to 0.95) 0.86 (0.49 to 1.51) 0
None 51 54% 47 44% 47 57% 145 51%
Moderate 42 44% 54 50% 33 40% 129 45%
Extreme 2 2% 6 6% 3 4% 11 4%
I-QOL, mean (SD)f (usual care 53;
intervention 43; supported
implementation 38; all 134)e
75 (56.7–90.9) 78.4 (37.5–89.8) –10.1 (–29.5 to 9.3) 74.4 (48.3–92.1) –10.1 (–28.6 to 8.3) 76 (51.7–91.2) 0.184
Barthel Index, median (IQR) (usual care
96; intervention 117; supported
implementation 88; all 301)e
8.5 (3–14) 7 (3–11) 0.68 (0.43 to 1.07) 7.5 (4–12) 0.70 (0.43 to 1.13) 8 (3–12) 0
Dead (usual care 118; intervention 145;
supported implementation 114; all 377)e
4 3% 7 5% 1.01 (0.43 to 2.39) 6 5% 0.72 (0.31 to 1.71) 17 5% 0.0087
ICC, intracluster correlation coefficient.
a ORs based on imputed data; values > 1 favour intervention or supported implementation over usual care.
b Any ICC estimate < 10–6 is presented as 0.
c Defined as never on ICIQ-UI Short Form response Q3.
d Defined as any non-missing response other than ‘never’ on ICIQ-UI Short Form.
e Data available for usual care, intervention, supported implementation, all sites.
f Excluding participants recorded as continent or catheterised.
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Results were relatively insensitive to assumptions regarding missing data; for example, complete case
analysis showed continence OR estimates of 1.02 (95% CI 0.50 to 2.12) for intervention and 0.91
(95% CI 0.42 to 1.96) for supported implementation relative to usual care, and hot deck multiple
imputation gave continence OR estimates of 1.09 (95% CI 0.52 to 2.31) for intervention and 0.90
(95% CI 0.43 to 1.87) for supported implementation. Per-protocol analysis suggested that those who
received the intervention according to protocol had better outcomes than usual care, particularly as
requirements for protocol adherence were strengthened; for those who had received at least 14 days
of intervention, the estimated continence OR relative to usual care was 2.60 (95% CI 0.99 to 6.82),
although that for supported implementation increased only to 0.98 (95% CI 0.29 to 3.28). Moreover,
an analysis of the effect of duration of treatment on outcomes showed that, in the intervention arm,
there was a potential effect of duration of intervention, with a continence OR estimate of 1.26 (95% CI
0.94 to 1.69) for each additional week on treatment; however, the comparative effect of supported
implementation was only 1.06 (95% CI 0.72 to 1.55).
Findings were insensitive to the exclusion of patients who were either catheterised throughout their time in
the stroke unit, never incontinent following removal of a catheter, or both; however, excluding patients
with pre-stroke incontinence led to a reduction in the continence OR estimates relative to usual care for
both intervention (OR 0.76, 95% CI 0.33 to 1.76) and supported implementation (OR 0.37, 95% CI 0.14
to 0.96) arms.
Six (50%) of the centres were in the bottom quartile on the average performance on the ‘nine key
indicators of stroke care’ in the National Sentinel Stroke Audit Phase II11 (clinical audit), with only one
centre in the top quartile. Findings for supported implementation were relatively sensitive to adjustment,
seemingly due to the respective performance of the supported implementation sites (three from the
bottom quartile and one from the top quartile of the National Sentinel Stroke Audit performance score).
There was no strong evidence that either the annual admission rate or type of unit (combined/separate
acute and rehabilitation units) impacted on continence rates at 6 weeks post stroke, although the OR of
1.84 (95% CI 0.69 to 4.86) suggested a potentially greater chance of continence at 6 weeks among
the larger units, whereas for type of stroke unit, the estimated OR of 0.70 (95% CI 0.36 to 1.36)
suggested a lower chance of continence in the combined units.
There was little or no evidence of clustering effects, with almost all intracluster correlation coefficient (ICC)
estimates being very close to 0. Owing to the small number of clusters, CIs for the ICC were wide and
highly sensitive to the estimation approach.
Subgroup analyses
Table 59 shows subgroup analyses for 6-week ICIQ absence of incontinence and frequency of
incontinence outcomes. There is some evidence to suggest patients with pre-stroke incontinence were
more likely to be continent at 6 weeks in supported implementation (p= 0.069); however, this finding was
not replicated in the analysis of the ordinal form of the outcome. There was a stroke subtype interaction
effect with intervention arm on the dichotomised (but not the ordinal) form of the outcome; in usual care
(p= 0.017), outcome appeared generally better for TACS than LACS, with a reversal of this patter in
the intervention and supported implementation arms. Baseline ISI category interacted significantly with the
intervention arm in the analysis of the ordinal form of outcome; this suggests that baseline severity may
have had less impact on incontinence frequency at 6 weeks post stroke in the intervention and supported
implementation arms than in usual care. In terms of component of the SVP received, BT may have led to
better outcome than PV or usual care, particularly in the intervention arm (p= 0.070 dichotomised;
p= 0.094 ordinal categorisation). None of the other subgroup effects of the intervention were significant
(p> 0.1), although some investigations were not possible due to sparse categories (see Table 59).
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TABLE 59 Subgroup analyses for 6-week ICIQ outcomes
Subgrouping variable
Absence of
incontinence
(p-value)
Frequency of
incontinence
(p-value) Reason for non-convergence
Pre-stroke incontinence: yes; no 0.069a 0.34
Sex: male; female 0.53 0.90
Pre-stroke mRS: independent (0–2);
dependent (3–5)
b b Of the 66 patients continent at 6 weeks
post stroke, only one (supported
implementation) patient was not
independent pre stroke
Type of stroke: ischaemia; primary
intracerebral haemorrhage
b b No participant with primary intracerebral
haemorrhage in supported implementation
Side of body affected by stroke: left;
right (non-specific side excluded)
0.87 0.88
OCSP:c TACS; PACS; LACS 0.017a 0.31
Baseline bowel function: incontinent or
occasional accident; continent
b b All supported implementation patients who
were continent at 6 weeks post stroke were
fully continent for bowel function at
baseline
Type of incontinence: UUI; SUI; MUI;
functional only; unclear
b b Only one participant (usual care) had SUI
alone and two patients had functional
incontinence alone (none in usual care)
Type of incontinence by sex interaction b b As above
Baseline ISI: none; mild or moderate;
severe
0.19 0.050a
Leicester Urinary Symptoms UUI: yes; no 0.19 0.21
Leicester Urinary Symptoms SUI: yes; no 0.74 0.30
Treatment plan type: catheterised
throughout; BT at some stage; not BT
at any stage; no intervention
0.070a 0.094a
Aged 0.14 0.38
Baseline cognitive impairment: yes; no 0.29 0.42
Site annual stroke patient numbers:
high: ≥ 300; low: < 300
0.54 0.62
a Significant at the 10% level (p< 0.1).
b Non-convergence due to sparse categories.
c POCS excluded due to sparse category leading to non-convergence.
d Continuous variable.
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Patient outcomes at 12 weeks post stroke
Table 60 shows patient outcomes at 12 weeks post-stroke. There was no evidence of better outcomes on
the ICIQ or ISI in either intervention arm, with all OR estimates close to 1; OR estimates for the dichotomised
form of ICIQ question three were 1.02 (95% CI 0.54 to 1.93) for intervention and 1.06 (95% CI 0.54 to
2.09) for supported implementation arms compared with usual care, and, for the original ordinal form
of the question, 0.97 (95% CI 0.58 to 1.61) and 1.22 (95% CI 0.72 to 2.08) respectively. However, both
intervention arms had a higher estimated odds of continence than usual care with respect to urgency
(intervention OR 1.58, 95% CI 0.83 to 2.99; supported implementation OR 1.73, 95% CI 0.88 to 3.43);
there was a greater estimated odds of continence with respect to stress in supported implementation
(OR 1.82, 95% CI 0.82 to 4.01) but not intervention (OR 1.04, 95% CI 0.45 to 1.82) compared with
usual care. Although none of these increases was statistically significant, such increases are suggestive of a
potential reduction in the odds of specific types of incontinence; evidence is more consistent across the
arms for UUI. None of the other incontinence outcomes showed a strong suggestion of a substantial
improvement in outcomes in the intervention and/or supported implementation arms relative to usual care.
However, there was a consistent pattern of worse estimated effects of the intervention on the EQ-5D
outcomes, but only the CIs for the effect of intervention (relative to usual care) on mobility and on self-care
suggested ORs < 1 (poorer QoL).
Results were relatively insensitive to assumptions regarding missing data; for example, complete case
analysis showed continence ORs of 1.02 (95% CI 0.52 to 1.98) for intervention and 1.02 (95% CI 0.50
to 2.07) for supported implementation relative to usual care, and hot deck multiple imputation gave
continence OR estimates of 0.91 (95% CI 0.48 to 1.75) for intervention and 0.95 (95% CI 0.47 to 1.92)
for supported implementation. Per-protocol analysis suggested that those who had received the
intervention according to protocol had better outcomes than usual care, although this did not appear to
hold for supported implementation; for those who had received at least 14 days of intervention, the
estimated continence OR relative to usual care was 1.54 (95% CI 0.69 to 3.47), and that for supported
implementation was 1.07 (95% CI 0.40 to 2.90). However, an analysis of the effect of duration of
treatment on outcomes showed little or no evidence of an effect, with OR of 1.04 (95% CI 0.90 to 1.21)
and 0.96 (95% CI 0.83 to 1.12) in the intervention and supported implementation arms respectively.
Excluding patients who were catheterised throughout their time in the stroke unit or never incontinent
following removal of a catheter, or both, had relatively little impact in supported implementation, although
the continence OR estimate increased slightly when each exclusion criteria was applied separately, and
further to 1.30 (95% CI 0.65 to 2.61) in intervention when both exclusion criteria were applied. On
excluding patients with pre-stroke incontinence, a reduction in the continence OR estimates for both
intervention (OR 0.84, 95% CI 0.34 to 2.05) and, particularly, supported implementation (OR 0.71,
95% CI 0.28 to 1.79) relative to usual care was observed.
As for the 6-week outcome, findings for supported implementation were relatively sensitive to adjustment
for the centre factors used in the stratification. There was no strong evidence that either the annual
admission rate or type of unit (combined/separate acute and rehabilitation units) impacted on continence
rates at 12 weeks post stroke, although the OR of 0.62 (95% CI 0.15 to 2.64) suggested a potentially
lesser chance of continence at 12 weeks among the larger units, whereas for type of stroke unit,
the estimated OR of 1.40 (0.51 to 3.79) suggested a potentially greater chance of continence in the
combined units.
There was, again, little or no evidence of clustering effects, with almost all ICC estimates being very close
to 0. Owing to the small number of clusters, CIs for the ICC were wide and highly sensitive to the
estimation approach.
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TABLE 60 Patient outcomes at 12 weeks post stroke
Outcome
Trial arm
All sites ICCbUsual care Intervention
Intervention
vs. usual care,
OR (95% CI)
Supported
implementation
Supported
implementation
vs. usual care,
OR (95% CI)a
Questionnaires returned 98 132 100 330
Catheterised (% of returned) 18 18% 27 20% 13 13% 58 17%
Potential respondents for incontinence
measures (% age of returned)
80 82% 105 80% 86 86% 271 82%
Primary outcomes
Presence/absence of incontinence
(ICIQ-UI Short-Form Q3)
Continentc 24 30% 43 41% 1.02 (0.54 to 1.93) 27 31% 1.06 (0.54 to 2.09) 94 35% 0
Incontinentd 56 70% 62 59% 59 68% 177 65%
ICIQ-UI Short Form (usual care 80; intervention
104; supported implementation 86; all 270)e
0.97 (0.58 to 1.61) 1.22 (0.72 to 2.08) 0
Never 24 30% 43 41% 27 31% 94 35%
About once a week or less often 12 15% 9 9% 10 12% 31 12%
Two or three times per week 12 15% 13 12% 11 13% 36 13%
About once a day 12 15% 6 6% 10 12% 28 10%
Several times a day 18 23% 25 24% 27 31% 70 26%
All the time 2 3% 8 8% 1 1% 11 4%
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TABLE 60 Patient outcomes at 12 weeks post stroke (continued )
Outcome
Trial arm
All sites ICCbUsual care Intervention
Intervention
vs. usual care,
OR (95% CI)
Supported
implementation
Supported
implementation
vs. usual care,
OR (95% CI)a
Secondary outcomes
ISI score (usual care 80; intervention 102;
supported implementation 86; all 268)e
0.86 (0.50 to 1.50) 0.92 (0.52 to 1.64) 0
Median (IQR) 3 (0–6) 2.5 (0–8) 4 (0–8) 3 (0–8)
None (0) 24 30% 43 42% 28 33% 95 35%
Slight (1–2) 10 13% 8 8% 6 7% 24 9%
Moderate (3–4) 19 24% 12 12% 17 20% 48 18%
Severe (6–8) 27 34% 39 38% 35 41% 101 38%
Leicester Urinary Symptoms
Frequency of toilet visits during daytime
(usual care 73; intervention 88; supported
implementation 71; all 232)e
0.85 (0.47 to 1.54) 1.09 (0.60 to 1.96) 0.0075
At least every 30 minutes 0 0% 0 0% 0 0% 0 0%
Every hour 0 0% 0 0% 1 1% 1 0%
Every 90 minutes 5 7% 2 2% 4 6% 11 5%
Every 2 hours 10 14% 11 13% 6 8% 27 12%
Less often than every 2 hours 58 79% 75 85% 60 85% 193 83%
Type of incontinence
UUI present (usual care 79; intervention 103;
supported implementation 85; all 267)e
53 67.1% 52 50.5% 1.58 (0.83 to 2.99) 49 57.6% 1.73 (0.88 to 3.43) 154 57.7% 0
SUI present (usual care 72; intervention 83;
supported implementation 72; all 227)e
38 52.8% 29 34.9 1.04 (0.45 to 1.82) 31 43.1 1.82 (0.82 to 4.01) 98 43.2% 0
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Outcome
Trial arm
All sites ICCbUsual care Intervention
Intervention
vs. usual care,
OR (95% CI)
Supported
implementation
Supported
implementation
vs. usual care,
OR (95% CI)a
EQ-5D
Mobility (usual care 96; intervention 129;
supported implementation 92; all 317)e
0.92 (0.52 to 1.62) 0.79 (0.44 to 1.41) 0
No problems 19 20% 16 12% 10 11% 45 14%
Some problems 53 55% 62 48% 57 62% 172 54%
Confined to bed 24 25% 51 40% 25 27% 100 32%
Self-care (usual care 97; intervention 126;
supported implementation 92; all 315)e
0.45 (0.26 to 0.79) 0.65 (0.36 to 1.16) 0
No problems 25 26% 21 17% 18 20% 64 20%
Some problems 42 43% 47 37% 40 43% 129 41%
Unable to wash or dress 30 31% 58 46% 34 37% 122 39%
Usual activities (usual care 97; intervention 126;
supported implementation 91; all 314)e
0.49 (0.27 to 0.90) 0.63 (0.34 to 1.17) 0
No problems 10 10% 9 7% 8 9% 27 9%
Some problems 43 44% 39 31% 32 35% 114 36%
Unable to perform 44 45% 78 62% 51 56% 173 55%
Pain or discomfort (usual care 95; intervention
123; supported implementation 93; all 311)e
0.73 (0.43 to 1.23) 0.88 (0.50 to 1.54) 0
None 55 58% 51 41% 50 54% 156 50%
Moderate 37 39% 58 47% 34 37% 129 41%
Extreme 3 3% 14 11% 9 10% 26 8%
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TABLE 60 Patient outcomes at 12 weeks post stroke (continued )
Outcome
Trial arm
All sites ICCbUsual care Intervention
Intervention
vs. usual care,
OR (95% CI)
Supported
implementation
Supported
implementation
vs. usual care,
OR (95% CI)a
Anxiety or depression (usual care 95;
intervention 122; supported implementation 92;
all 309)e
0.67 (0.39 to 1.13) 0.95 (0.54 to 1.67) 0
None 53 56% 47 39% 47 51% 147 48%
Moderate 37 39% 66 54% 37 40% 140 45%
Extreme 5 5% 9 7% 8 9% 22 7%
I-QOL,f mean (SD) (usual care 51; intervention
47; supported implementation 35; all 133)e
72.6 (58.3–83.0) 76.1 (42.5–94.3) –5.5 (–24.1 to 13.1) 67.1 (51.1–85.2) –1.9 (–21.2 to 17.4) 72.6 (52.9–87.5) 0.216
Barthel Index, median (IQR) (usual care 94;
intervention 128; supported implementation 95;
all 317)e
11 (4–16) 8 (4–13) 0.71 (0.46 to 1.11) 11 (6–15) 0.97 (0.61 to 1.54) 10 (4–15) 0
Dead (usual care 123; intervention 159;
supported implementation 122; all 404)e
12 10% 16 10% 1.04 (0.56 to 1.92) 10 8% 1.15 (0.60 to 2.19) 38 9% 0
a ORs based on imputed data; values > 1 favour intervention or supported implementation over usual care.
b Any ICC estimate < 10–6 is presented as 0.
c Defined as never on ICIQ-UI Short Form response Q3.
d Defined as any non-missing response other than ‘never’ on ICIQ-UI Short Form.
e Data available for usual care, intervention, supported implementation, all sites.
f Excluding participants recorded as continent or catheterised.
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Subgroup analyses
Table 61 shows subgroup analyses for 12-week ICIQ absence of incontinence and frequency of incontinence
outcomes. Stroke subtypes other than TACS may be more likely to be continent in intervention and supported
implementation (p= 0.054) arms. Patients with pre-stroke UI and older participants may be relatively more
likely to be continent in supported implementation than the other trial arms (p= 0.048 and p= 0.024
respectively). In terms of other characteristics, participants with stroke affecting the right side of the body may
be more likely to have greater incontinence frequency at 12 weeks (p= 0.080) and patients with baseline
faecal incontinence may be relatively more likely to have UI at 12 weeks in supported implementation than
the other trial arms.
TABLE 61 Subgroup analyses for 12-week ICIQ outcomes
Subgrouping variable
Absence of
incontinence
(p-value)
Frequency of
incontinence
(p-value) Reason for non-convergence
Pre-stroke incontinence: yes; no 0.048a 0.12
Sex: male; female 0.76 0.25
Pre-stroke mRS: independent (0–2);
dependent (3–5)
b b Only six patients dependent pre stroke were
continent at 12 weeks, none of whom were
in usual care
Type of stroke: ischaemia; primary
intracerebral haemorrhage
b b There were no participants with primary
intracerebral haemorrhage in supported
implementation
Side of body affected by stroke: left;
right (non-specific side excluded)
0.19 0.080a
Stroke subtype:c TACS; PACS; LACS 0.054a 0.27
Baseline bowel function: incontinent or
occasional accident; continent
0.003a 0.46
Type of incontinence: UUI; SUI; MUI;
functional only; unclear
b b Only one participant (usual care) had SUI
alone and two patients had functional
incontinence alone (none in usual care)
Type of incontinence by sex interaction b b As above
Baseline ISI: none; mild or moderate;
severe
0.42 0.24
Leicester Urinary Symptoms UUI: yes;
no
0.17 0.34
Leicester Urinary Symptoms SUI: yes;
no
0.49 0.55
Treatment plan type: catheterised
throughout; BT at some stage; not BT
at any stage; no intervention
0.15 0.34
Aged 0.024a 0.24
Baseline cognitive impairment: yes; no 0.78 0.65
Site annual stroke patient numbers:
high ≥ 300; low < 300
0.54 0.96
a Significant at the 10% level (p< 0.1).
b Non-convergence due to sparse categories.
c POCS excluded due to sparse category leading to non-convergence.
d Continuous variable.
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Patient outcomes at 52 weeks post stroke
Table 62 shows participant outcomes at 52 weeks post stroke. Mortality and attrition rates were both high
at 52 weeks, with outcomes were available for only 176 out of 413 (43%) of participants. The primary
analysis suggests that the intervention and supported implementation participants may have worse
outcomes than those who received usual care, with estimated continence ORs of 0.56 (95% CI 0.27 to
1.16) for intervention and 0.60 (95% CI 0.27 to 1.30) for supported implementation. However, despite
high but similar rates of missing data across the three trial arms (usual care 71/124, 57%, intervention
94/164, 57%, supported implementation 72/125, 58%, including those who died or withdrew) findings
were not particularly sensitive to the assumptions made in the handling of missing data: continence ORs
for complete case analysis were 0.63 (95% CI 0.27 to 1.45) for intervention and 0.60 (95% CI 0.25 to
1.47) for supported implementation, and hot deck multiple imputation gave ORs of 0.53 (95% CI 0.18
to 1.62) for intervention and 0.63 (95% CI 0.19 to 2.03) for supported implementation, the wider CIs
reflecting the high percentages of missing data. For the secondary outcomes, estimated ORs tended to be
below 1 for the intervention arm (relative to usual care) with the supported implementation arm having OR
estimates closer to and sometimes above 1, although 95% CIs were almost always consistent with ‘no
differential effect’. Findings consistent with improved outcomes for UUI and SUI in intervention arms
observed at earlier outcome time points were not replicated at 52 weeks post stroke.
Results from per-protocol analyses were similar to those from the primary approach, although OR estimates
in the intervention arm tended to be a little closer to 1 and those in the supported implementation arm
tended to be a little further from 1. However, an analysis of the effect of duration of treatment on
outcomes showed little or no evidence of an effect; the ORs of 0.59 (95% CI 0.25 to 1.43) and 0.63
(95% CI 0.27 to 1.48) in the intervention and supported implementation arms, respectively, were
very similar to those obtained in the primary analysis.
Excluding patients who were catheterised throughout their time in the stroke unit or never incontinent
following removal of a catheter, or both, had relatively little impact on the intervention effect estimates in
either trial arm. Findings showed a similar pattern to those of the per-protocol analysis. On excluding those
with pre-stroke incontinence, a reduction in the continence OR estimates for both intervention (OR 0.44,
95% CI 0.19 to 1.00) and supported implementation (OR 0.54, 95% 0.23 to 1.28) relative to usual care
was again observed.
As for the 6- and 12-week outcomes, findings, particularly for supported implementation arms, were
relatively sensitive to adjustment for the centre factors used in the stratification. With only 12 centres,
there was little evidence provided as to the effects of the stratification factors on outcome; the estimated
effects of admission to a large unit (OR 1.58, 95% CI 0.08 to 30.94) and of admission to a combined unit
(OR 2.08, 95% CI 0.40 to 10.69) were both positive.
As for the 6- and 12-week outcomes, there was little or no evidence of clustering effects, with ICC
estimates mostly being very close to 0 and estimated with poor precision, with sensitivity to the estimation
approach used.
EXPLORATORY CLUSTER RANDOMISED CONTROLLED TRIAL: FINDINGS
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TABLE 62 Patient outcomes at 52 weeks post stroke
Outcome
Trial arm
All sites ICCbUsual care Intervention
Intervention
vs. usual care,
OR (95% CI)
Supported
implementation
Supported
implementation
vs. usual care,
OR (95% CI)a
Questionnaires returned 53 70 53 176
Catheterised (% of returned) 3 6% 7 10% 2 4% 12 7%
Potential respondents for incontinence
measures (% age of returned)
50 94% 62 89% 50 94% 162 92%
Primary outcomes
Presence/absence of incontinence
(ICIQ-UI Short Form Q3)
0.56 (0.27 to 1.16) 0.60 (0.27 to 1.30) 0
Continentc 21 42% 23 37% 15 30% 59 36%
Incontinentd 29 58% 39 63% 35 70% 103 64%
ICIQ-UI Short Form (usual care 50; intervention
62; supported implementation 49; all 161)e
0.65 (0.36 to 1.15) 0.87 (0.47 to 1.59) 0
Never 21 42% 23 37% 15 31% 59 37%
About once a week or less often 9 18% 6 10% 15 31% 30 19%
Two or three times per week 4 8% 9 15% 4 8% 17 11%
About once a day 4 8% 6 10% 1 2% 11 7%
Several times a day 8 16% 11 18% 9 18% 28 17%
All the time 4 8% 7 11% 5 10% 16 10%
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TABLE 62 Patient outcomes at 52 weeks post stroke (continued )
Outcome
Trial arm
All sites ICCbUsual care Intervention
Intervention
vs. usual care,
OR (95% CI)
Supported
implementation
Supported
implementation
vs. usual care,
OR (95% CI)a
Secondary outcomes
ISI score (usual care 50; intervention 62;
supported implementation 49; all 161)e
0.67 (0.36 to 1.25) 0.84 (0.44 to 1.60) 0
Median (IQR) 2 (0–6) 3 (0–6.5) 2 (0–8) 2 (0–6)
None (0) 21 42% 23 37% 15 31% 59 37%
Slight (1–2) 8 16% 5 8% 14 29% 27 17%
Moderate (3–4) 7 14% 12 19% 5 10% 24 15%
Severe (6–8) 14 28% 22 35% 15 31% 51 32%
Leicester Urinary Symptoms
Frequency of toilet visits during daytime
(usual care 39; intervention 52; supported
implementation 40; all 131)e
0.81 (0.48 to 1.38) 1.06 (0.60 to 1.84) 0
At least every 30 minutes 0 0 0 0% 0 0% 0 0%
Every hour 0 0 0 0% 0 0% 0 0%
Every 90 minutes 2 5% 3 6% 3 8% 8 6%
Every 2 hours 5 13% 7 13% 3 8% 15 11%
Less often than every 2 hours 32 82% 42 81% 34 85% 108 82%
UUI present (usual care 49; intervention 61;
supported implementation 47; all 157)e
23 47% 33 54% 0.60 (0.30 to 1.23) 27 57% 0.64 (0.30 to 1.40) 83 53% 0
SUI present (usual care 49; intervention 58;
supported implementation 46; all 153)e
7 14% 20 34% 0.19 (0.05 to 1.08) 5 11% 1.08 (0.28 to 4.19) 32 21% 0.108
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Outcome
Trial arm
All sites ICCbUsual care Intervention
Intervention
vs. usual care,
OR (95% CI)
Supported
implementation
Supported
implementation
vs. usual care,
OR (95% CI)a
I-QOL (usual care 26; intervention 33; supported
implementation 28; all 87)e
5.5 (–30.0 to 40.9) –12.2 (–49.2 to 24.9) 0.278
Median (IQR) 69.8 (56.3–88.4) 81.6 (46.5–92.0) 80.7 (48.3–88.3) 77.3 (52.3–88.8)
Barthel Index (usual care 50; intervention 63;
supported implementation 49; all 162)e
0.69 (0.42 to 1.14) 0.83 (0.49 to 1.39) 0
Median (IQR) 14 (7–18) 8 (4–16) 11 (6.5–16) 11 (5–16.25)
EQ-5D
Mobility (usual care 51; intervention 66;
supported implementation 51; all 168)e
0.67 (0.36 to 1.25) 1.22 (0.67 to 2.25) 0
No problems 8 16% 9 14% 8 16% 25 15%
Some problems 34 67% 37 56% 37 73% 108 64%
Confined to bed 9 18% 20 30% 6 12% 35 21%
Self-care (usual care 53; intervention 68;
supported implementation 51; all 172)e
0.40 (0.20 to 0.77) 0.88 (0.46 to 1.68) 0
No problems 18 34% 14 21% 15 29% 47 27%
Some problems 23 43% 20 29% 23 45% 66 38%
Unable to wash or dress 12 23% 34 50% 13 25% 59 34%
Usual activities (usual care 51; intervention 68;
supported implementation 52; all 171)e
0.54 (0.27 to 1.08) 0.92 (0.46 to 1.82) 0
No problems 10 20% 7 10% 5 10% 22 13%
Some problems 23 45% 22 32% 21 40% 66 39%
Unable to perform 18 35% 39 57% 26 50% 83 49%
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TABLE 62 Patient outcomes at 52 weeks post stroke (continued )
Outcome
Trial arm
All sites ICCbUsual care Intervention
Intervention
vs. usual care,
OR (95% CI)
Supported
implementation
Supported
implementation
vs. usual care,
OR (95% CI)a
Pain or discomfort (usual care 51; intervention
69; supported implementation 52; all 172)e
0.87 (0.50 to 1.53) 1.10 (0.61 to 1.98) 0
None 22 43% 25 36% 22 42% 69 40%
Moderate 25 49% 40 58% 24 46% 89 52%
Extreme 4 8% 4 6% 6 12% 14 8%
Anxious or depressed (usual care 50;
intervention 69; supported implementation 50;
all 169)e
0.84 (0.47 to 1.47) 1.28 (0.71 to 2.33) 0
None 31 62% 32 46% 22 44% 85 50%
Moderate 16 32% 30 43% 26 52% 72 43%
Extreme 3 6% 7 10% 2 4% 12 7%
Dead (usual care 116; intervention 152;
supported implementation 114; all 382)e
29 25% 40 26% 1.20 (0.72 to 2.00) 29 25% 0.99 (0.58 to 1.69) 98 26% 0
a ORs based on imputed data; values > 1 favour intervention or supported implementation over usual care.
b Any ICC estimate < 10–6 is presented as 0.
c Defined as never on ICIQ-UI Short Form response Q3.
d Defined as any non-missing response other than ‘never’ on ICIQ-UI Short Form.
e Data available for usual care, intervention, supported implementation, all sites.
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Subgroup analyses
Table 63 shows subgroup analyses for 52-week ICIQ absence of incontinence and frequency of
incontinence outcomes. Participants with stroke affecting the right side of the body may be more likely
to have greater frequency of incontinence at 52 weeks (p= 0.0012) or, similarly, to be less likely to be
continent (p= 0.034). The effect of baseline ISI category on continence at 52 weeks post stroke appeared
less strong in the intervention arm than the other two trial arms (p= 0.086), a finding replicated in the
analysis of incontinence frequency (p= 0.022). The effect of baseline UUI on the risk of incontinence at
52 weeks may be less strong in the intervention arm than the other two arms (p= 0.066), although the
corresponding effect on incontinence frequency was not quite significant (p= 0.13). None of the other
subgroup effects were statistically significant (p> 0.1), although some investigations were not possible due
to sparse categories (see Table 63).
TABLE 63 Subgroup analyses for 52-week ICIQ outcomes
Subgrouping variable
Absence of
incontinence
(p-value)
Frequency of
incontinence
(p-value) Reason for non-convergence
Pre-stroke incontinence: yes; no 0.59 0.96
Sex: male; female 0.83 0.72
Pre-stroke mRS: independent (0–2);
dependent (3–5)
a 0.27 There were only two participants who
were dependent pre stroke and
who had a good outcome
Type of stroke: ischaemia; primary
intracerebral haemorrhage
a a There were no participants with
primary intracerebral haemorrhage in
supported implementation
Side of body affected by stroke: left; right
(non-specific side excluded)
0.034b 0.0012b
Stroke subtype:c TACS; PACS; LACS 0.55 0.59
Baseline bowel function: incontinent or
occasional accident; continent
0.38 0.83
Type of incontinence: UUI; SUI; MUI;
functional only; unclear
a a Only one participant (usual care)
had SUI alone and two patients had
functional incontinence alone (none in
usual care)
Type of incontinence by sex interaction a a As above
Baseline ISI: none; mild or moderate; severe 0.086b 0.022b
Leicester Urinary Symptoms UUI: yes; no 0.066b 0.13
Leicester Urinary Symptoms SUI: yes; no 0.64 a Sparse categories across multiple
variables cause problems with
convergence
Treatment plan type: catheterised
throughout; BT at some stage; not BT at
any stage; no intervention
0.29 0.31
Aged 0.88 0.50
Baseline cognitive impairment: yes; no 0.92 0.67
Site annual stroke patient numbers: high
≥ 300; low < 300
0.20 0.92
a Non-convergence due to sparse categories.
b Significant at the 10% level (p< 0.1).
c POCS excluded due to sparse category leading to non-convergence.
d Continuous variable.
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Additional analysis: maintenance of continence status
after discharge
In order to explore whether those patients continent at discharge maintained this status after leaving
the hospital, we examined whether or not patients discharged before their 6- or 12-week outcome
assessment remained continent at these time points. At 6 weeks, data were available for 138 out
of 140 patients; of these, 53 (38.4%) were continent, 64 (46.4%) were incontinent and 21 (15.2%) were
catheterised. 6-week continence status was available for 46 out of 53 patients continent at discharge;
eight of these completed their 6-week questionnaire on the day of or before discharge and were therefore
excluded from this analysis (Table 64).
Overall, over half the patients continent at discharge were incontinent at 6 weeks (22/38, 57.9%), with a
higher proportion incontinent in supported implementation (7/9, 77.8%).
For patients continent at discharge but incontinent at 6 weeks, median (IQR) length of time from discharge
from the stroke unit to the completion of the 6-week questionnaire overall was 23.5 (14.0–34.5) days.
The median (IQR) length of time by trial arm was 18 (6–33) days for usual care, 29.5 (21.0–37.5) days for
intervention and 17 (14–34) days for supported implementation. For patients who were continent at
discharge and at 6 weeks, the median length of time from discharge from the stroke unit to the completion
of the 6-week questionnaire overall was 23 (7–34) days. The median length of time by trial arm was 28.00
(18.25–36.75) days for the usual care arm, 22.5 (4.0–33.5) days for the intervention arm and 15 days
(only one patient) for the supported implementation arm. Length of time since discharge does not therefore
seem to affect whether patients retain continence at 6 weeks.
At 12 weeks, data were available for 169 out of 171 patients; of these, 67 (39.6%) were continent, 57
(33.7%) were incontinent and 45 (26.6%) were catheterised. 12-week continence status was available for
54 out of 67 patients discharged before 12 weeks and continent at discharge and is shown in Table 65.
No patients continent at discharge were catheterised at 12 weeks.
TABLE 64 Continence status at 6 weeks for patients continent at discharge
Continence status at
6 weeks
Trial arm
Overall
(n= 38)
Usual care
(n= 13)
Intervention
(n= 16)
Supported implementation
(n= 9)
Continent 6 (46.2%) 8 (50%) 1 (11.1%) 15 (39.5%)
Incontinent 7 (53.8%) 8 (50%) 7 (77.8%) 22 (57.9%)
Catheterised 0 0 1 (11.1%) 1 (2.6%)
TABLE 65 Continence status at 12 weeks for patients continent at discharge
Continence status at
12 weeks
Trial arm
Overall
(n= 54)
Usual care
(n= 14)
Intervention
(n= 24)
Supported implementation
(n= 16)
Continent 6 (42.9%) 17 (70.8%) 9 (56.2%) 32 (59.3%)
Incontinent 8 (57.1%) 7 (29.2%) 7 (43.8%) 22 (40.7%)
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Overall, two-fifths of patients continent at discharge were incontinent at 12 weeks (22/54, 40.7%); a
smaller proportion of patients were incontinent in the intervention arm (7, 29.2%) compared with usual
care (8, 57.1%) and supported implementation (7, 43.8%).
For patients who were continent at discharge and at 12 weeks, median (IQR) length of time from discharge
from the stroke unit to the completion of the 12-week questionnaire overall was 31.00 (23.75–41.00) days.
The median length of time was 30.00 (17.75–54.50) days for usual care, 39.0 (26.0–45.5) days for
intervention and 28 (20–34) days for the supported implementation arm.
For patients continent at discharge but incontinent at 12 weeks, median (IQR) length of time from
discharge from the stroke unit to the completion of the 12-week questionnaire overall was 27.50
(18.75–54.00) days. The median length of time by trial arm was 23.5 (17.5–28.0) days for usual care,
51 (24–66) days for intervention and 27 (18–29) days for supported implementation. Intervention patients
who became incontinent had been discharged for a much longer period of time; this might explain the
greater proportion incontinent in this trial arm at 12 weeks.
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Chapter 8 Exploratory cluster randomised
controlled trial: findings from the process evaluation
Overview
In this chapter, we report findings from the process evaluation structured according to
Grant’s framework.170
Cluster characteristics
Characteristics of clusters not recruited appeared broadly similar to recruited clusters in terms of stroke
admissions per annum and average of nine indicators in the 2008 Sentinel Audit. There were two hospitals
in both usual care and intervention admitting ≥ 300 stroke patients per annum, but only one in supported
implementation. Usual care was the only arm without a university hospital; these sites also tended to
have higher Sentinel Audit scores.
Table 66 shows characteristics of participating stroke services; site codes have been removed to
protect anonymity.
Delivery of the intervention to individuals
Staff adherence to the intervention
Staff adherence was assessed through an examination of:
1. intervention documentation (3-day diaries and daily clinical logs for participants on BT and PV)
2. adherence to the protocol in terms of allocation of participants to the appropriate regime and the
management of catheterisation.
Table 67 shows adherence to the intervention by trial arm. Information on catheterisation practice was also
available for usual care sites and is included in this table.
Completion of intervention documentation
Three-day diary
Diaries were received for two-thirds of patients who commenced the SVP in the intervention group
(70/102, 68.6%) and four-fifths of patients in the supported implementation group (66/82, 80.5%).
All diaries in the intervention group were completed; five diaries in the supported implementation group
were returned blank. Half of the diaries in the intervention group (52/102, 51%) and two-thirds in the
supported implementation group (54/82, 65.9%) had an entry on each of the 3 days. Few diaries in
the intervention group had three entries for ‘time went to the toilet’ on each day (13/102, 12.7%) or
three entries in the corresponding ‘leaked’ columns completed (10/102, 9.8%). Figures were slightly higher
in the supported implementation group, 17 out of 82 (20.7%) and 16 out of 82 (19.5%) respectively.
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TABLE 66 Characteristics of participating stroke services
Type of
hospital
Catchment
population
of trust/
health board
Number of
stroke
admissions
per annum Type of unit Unit layout
Total
number
of beds
Number of
stroke beds
2008 Sentinel
Audit score
(average of
nine indicators)
Average number of staff during recruitment period
(including ICONS funded HCAs)
Participation in
other initiatives
during recruitment
phase
Morning shift Afternoon shift
Total
staff
Qualified
staff HCAs
Total
staff
Qualified
staff HCAs
Usual care
District
general
R: 320,000
C: 350,000
212 Acute and
rehabilitation
Long ward with
central desk,
four-bedded bays
and single rooms
16 16 58
District
general
(NS) 340,000 163 Rehabilitation Four-bedded bays,
Nightingale style
14 14 73 5 2 3 5 2 3 Safety Express –
November 2012
onwards; Intentional
Rounding –
September 2012
onwards
District
general
(NS) 676,000 302 Acute and
rehabilitation
L-shaped ward,
four- and
one-bedded
rooms
30 30 60 8 4 4 6 3 3
District
general
(NS) 676,000 304 Acute and
rehabilitation
Hub and spoke,
two by
eight-bedded
bays and five
single rooms
21 21 (6 acute,
15 rehabilitation)
62 8 4 4 6 3 3 Intentional Rounding –
October 2011
onwards
Intervention
Teaching;
foundation
trust
R: 440,000 459 Acute and
rehabilitation
Long ward, central
desk, four-bedded
bays and single
rooms
31 31 (15 acute,
16 rehabilitation)
61 6–9 2–4 3–7 5–7 2–3 2–4 None
District
general
R: 370,000 194 Rehabilitation Hub and spoke,
six-bedded bays
and single rooms
23 Also admitted
medical patients
33 7 3 4 5 3 2 Intentional Rounding –
September 2011
onwards
University (NS) 340,000 127 Rehabilitation Long ward, six
four-bedded bays
and single rooms
29 29 76
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Type of
hospital
Catchment
population
of trust/
health board
Number of
stroke
admissions
per annum Type of unit Unit layout
Total
number
of beds
Number of
stroke beds
2008 Sentinel
Audit score
(average of
nine indicators)
Average number of staff during recruitment period
(including ICONS funded HCAs)
Participation in
other initiatives
during recruitment
phase
Morning shift Afternoon shift
Total
staff
Qualified
staff HCAs
Total
staff
Qualified
staff HCAs
District
general
R: ≥500,000 577 Acute and
rehabilitation
(split site)
Acute: hub and
spoke, four-
bedded bays and
single rooms
Rehab: L-shaped,
four-, two- and
one-bedded
rooms
22/24 22 in acute
unit; 24 in
rehabilitation
unit
61 8
a
3 5 5 2 3 Safety Express and
Intentional Rounding –
dates not known
Supported implementation
District
general
R: 320,000
C: 350,000
258 Acute and
rehabilitation
Hub and spoke,
eight-, four-,
two- and
one-bedded
rooms
24 24 58 7 3 4 5 2 3 None
University;
foundation
trust
C: 450,000 552 Rehabilitation L-shaped ward, all
four-bedded bays
(new build)
26 18 80 8 4 4 7 3 4
District
general
R: 289,400 201 Acute and
rehabilitation
(split site)
Acute: hub and
spoke
Rehab: L-shaped
ward with two
central desks
28/27 12 in acute
unit; 27 in
rehabilitation
unit
56 8 3 5 6 3 3 None
University R: 445,000 159 Acute and
rehabilitation
Nightingale ward
with additional
four- and
two-bedded
rooms
23 23 (6 acute,
17 rehabilitation)
55 8 4 4 6 3 3 None
C, catchment population; NS, not stated; R, resident population.
a Information available from rehabilitation unit only.
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TABLE 67 Adherence to the SVP by intervention group [values in cells refer to n (%) unless otherwise stated]
Adherence to the SVP Usual care (n= 124) Intervention (n= 164)
Supported implementation
(n= 125)
Catheterisation
Patients catheterised in acute stage 56 (45.2) 80 (48.8) 59 (47.2)
Time to removal of catheter (days) Mean 25.22; median 20;
SD 17.12; range 4–66;
IQR 10.25–32.00
Mean 26.83; median 20;
SD 26.12; range 1–130;
IQR 8.75–35.25
Mean 21.92; median 13;
SD 21.11; range 3–78;
IQR 5–35
Patients catheterised in acute stage
and at discharge
16 (12.9) 35 (21.3) 19 (15.2)
3-day diary
Present N/A 70 (68.6) 66 (80.5)
Completed N/A 70 (68.6) 61 (74.4)
Entry on each of 3 days N/A 52 (51.0) 54 (65.9)
‘Time went to toilet’ completed N/A 13 (12.7) 17 (20.7)
‘Leaked’ column completed N/A 10 (9.8) 16 (19.5)
Allocation to regime
Patients eligible for regime N/A 114 (69.5) 93 (74.4)
Patients put on regime N/A 102 (89.5) 82 (88.2)
Allocation to regime N/A PV: 86 (86.0)
BT: 14 (14.0)
PV: 72 (90.0)
BT: 8 (10.0)
Allocation to the correct regime N/A Yes: 42 (42.0)
No: 58 (58.0)
Yes: 44 (55.0)
No: 36 (45.0)
Patients changing regime 10 patients (9 PV to BT,
1 BT to PV)
1 patient (PV to BT)
Time to start regime from end date
of 3-day diary (days)
N/A Mean 2.57; median 2;
SD 4.31; range –8 to 23;
IQR 1–4
Mean 2.74; median 1;
SD 5.23; range –4 to 30;
IQR 1.00–2.25
Number of days on regime N/A Mean 27.99; median 24;
SD 19.08; range 1–93;
IQR 14–37
Mean 37.14; median 21.5;
SD 41.05; range 1–186;
IQR 9.50–26.25
Weekly review
At least one weekly review
completed (for those on
programme for at least 7 days)
N/A 74 (83.1) 47 (78.3)
Staff adherence to intervention paperwork
Clinical logs adherence
Total no. of clinical logs
received
405 331
Total no. of clinical logs
processed (NB. This excludes
clinical logs that were coded as
‘unable to process’ due
to insufficient quality of
photocopy)
396 320
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Daily clinical logs for bladder training and prompted voiding
Similar numbers of clinical logs were processed for both the intervention and the supported implementation
groups (396 vs. 320 respectively). On 38.9% of processed clinical logs in the intervention group, both a
correct regime interval and a correct schedule of proposed times (two prerequisites to be able to undertake
the daily programme) were recorded. A lower proportion of processed clinical logs in supported
implementation (31.9%) were found to have achieved this.
Processed clinical logs for which both key quality indicators (stages 1 and 2) had been successfully achieved
were then examined further. For these clinical logs it was documented that patients were taken to the
toilet within 30 minutes of the scheduled time on 54.8% of occasions in intervention and on 56.0% of
occasions in supported implementation.
Two key aspects of ‘best practice’, asking the patient if they are dry or wet and giving the patient
encouragement, were done relatively well. For the processed clinical logs that had achieved stages 1 and
2, it was, on average, documented that patients were asked if they were dry or wet on 57.9% of
occasions in intervention and on 65.9% of occasions in supported implementation. On average
encouragement was documented as given on 58.4% of occasions in intervention and on 57.5% of
occasions in supported implementation.
TABLE 67 Adherence to the SVP by intervention group [values in cells refer to n (%) unless
otherwise stated] (continued )
Adherence to the SVP Usual care (n= 124) Intervention (n= 164)
Supported implementation
(n= 125)
No. of patients 40 31
Percentage of clinical logs processed
according to type of regime
PV: 90.4; BT: 9.6 PV: 100.0; BT: 0.0
Stage 1: % (of clinical logs
processed) with regime interval
present and correctly documented
83.3 89.4
Stage 2: % (of clinical logs
processed) with both regime interval
and schedule of proposed times
present and correctly documented
38.9 31.9
No. of processed clinical logs that
achieved both stages 1 and 2
154 102
For the processed clinical logs that
achieved both stages 1 and 2
Stage 3: On average, how often
was a ‘time toileted’ documented
that was within 30 minutes of
the proposed time? (NB. Occasions
on which a clinically justifiable
explanation was given for an early/
late/missing time toileted were
exempted from this analysis)
54.8% (SD 29.3) 56.0% (SD 34.1)
Stage 4a: On average, how often
was it documented that the patient
had been asked if they were wet?a
57.9% (31.2) 65.9% (32.0)
Stage 4b: On average, how often
was encouragement documented
as given?
58.4% (34.6) 57.5% (33.2)
N/A, not applicable.
a This applies to PV clinical logs only.
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Adherence to the protocol: management of catheterisation and
allocation of participants to the appropriate regime
Participants catheterised
Nearly half of patients in intervention arms were catheterised in the acute stage (139/289, 48.1%);
fifty-four patients (54/289, 18.7%) remained catheterised at discharge, a higher proportion of these
were in intervention (35, 21.3%) compared with supported implementation (19, 15.2%). There is
also evidence that catheters were not removed promptly, with a median (IQR) time from entry to
removal for combined intervention arms of 16.0 (7.5–35.0) days; removal appeared to be quicker in
supported implementation (median 13 days, IQR 5–35 days) compared with intervention (median 20 days,
IQR 8.75–35.25 days).
Commencing bladder training or prompted voiding
Almost three-quarters of patients in both groups were eligible to begin a regime (114, 69.5% intervention;
93, 74.4% supported implementation). Patients catheterised throughout and those continent after
catheter removal were not eligible. In both intervention arms, the majority of patients eligible to receive
BT or PV actually received it (intervention 102/114, 89.5%; supported implementation 82/93, 88.2%).
Furthermore, there is evidence that conservative interventions started promptly after completion of the
3-day diary in line with the protocol (intervention median 2 days, IQR 1–4 days; supported implementation
median 1 day, IQR 1.00–2.25 days). Using the criteria outlined previously (see Chapter 6), only around
half of patients received the correct regime (86/180, 47.8%); fewer intervention patients (42/100, 42%)
received the correct regime compared with supported implementation (44/80, 55%).
Median number of days on the programme was 24 days in intervention and 21.50 days in supported
implementation. The IQR was wide in both groups: 14–37 days and 9.50–26.25 days respectively.
Response of individuals
Patient interviews
Patient characteristics
Twelve interviews were undertaken with participants from across six ICONS study sites, eight from the
intervention arm and four from the supported implementation trial arm. Patient characteristics are shown
in Table 68.
Seven participants were male, five were female. The median age was 76.5 years (range 60–88 years)
and all participants were of white British ethnicity. Half the participants had pre-stroke UI. Post-stroke UI
types included functional UI (n= 3), MUI (n= 3), UUI (n= 2), UUI and functional UI (n= 2). One participant
was continent after catheter removal and for one continence status was unknown. Continence status at
discharge from the stroke unit was continent (n= 8), incontinent (n= 3) and unknown (n= 1).
Participants could, if they wished, be interviewed with a carer. Eight patients were interviewed alone;
two with their wife, and two with their daughter.
Most participants (n= 9) had no communication problem or cognitive impairment. Two had aphasia; one
was noted to have apparent cognitive problems during the interview. Two interviews were not digitally
recorded: one owing to a noisy environment and one at the request of the participant, who had aphasia.
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TABLE 68 Characteristics of patients interviewed: findings
Site Gender Age Ethnicity
Pre-stroke
incontinence Type of incontinence
ISI score
baseline
ICIQ-UI score
baseline
Continence status
at discharge
Interview
with:
Communication or
cognitive impairment
Usual care
None
SVP
AA F 73 White Yes UUI 8 14 Continent Patient None
AA F 80 White No Functional 8 14 Continent Patient Possible cognitive
impairment
AA M 74 White Unknown N/A – continent after
catheter removal
0 1 Continent Patient None
AA M 79 White No UUI; functional 8 16 Continent Patient and
wife
Aphasia
BB F 88 White Yes MUI 8 19 Incontinent Patient and
daughter
Aphasia
BB M 68 White No Functional 8 9 Missing Patient and
wife
None
BB F 73 White Yes Functional 6 6 Incontinent Patient None
EE M 60 White Yes UUI; functional 8 16 Continent Patient None
SVP plus supported implementation
HH M 85 White Not known Not known Missing Missing Continent Patient None
KK M 84 White No MUI; functional 8 16 Continent Patient None
LL M 69 White Yes UUI 3 9 Incontinent Patient and
daughter
None
LL F 80 White Yes MUI 4 7 Continent Patient None
F, female; M, male; N/A, not applicable.
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Findings
Preliminary phase: making a decision
There were three key themes discussed by patients and carers relating to making a decision about UI in
the ‘preliminary’ phase of the model:
Physical impact of incontinence Participants talked about their UI in terms of lack of control, or lack
of awareness.
Urinary incontinence was felt to have physically unpleasant effects, notably wet bedding or wet clothing.
Skin discomfort was also mentioned:
Lying in it is just absolutely dreadful, I got so sore.
AA061
it affects me tremendously, my skin feels as if it’s burning, which meant when I went for a shower I
had to be very careful, in fact on one or two occasions I thought I wonder if I’ve got scalded with
the shower
AA061
Psychological impact of incontinence There were many negative emotions relating to the experience of
UI, such as the worry, upset or embarrassment of having UI:
the more you do it the more frustrated you get . . .and the more depressed you get.
BB004
it can get you down . . . it feels like it’s . . . took part of your life, you know what I mean
EE036
Its impact on a partner was also a concern for some:
I’d be very, very worried . . . ruining a good bed, and . . . wetting a nice partner
AA061
Beliefs about incontinence and stroke Some participants held the belief that incontinence was an
inevitable consequence of stroke:
I just felt it was just part for the course really . . . I suppose so many people do have incontinence
problems when they’ve had a stroke
BB031
However, there was also an opposing view, held by some participants who had experienced pre-stroke UI
or urinary frequency, that their symptoms had improved since the stroke:
I think it’s just a natural effect of the stroke I think, I have heard it said that people who have had a
stroke often urinate less frequently afterwards
HH042
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The assessment phase
Many patients did not remember much about the initial assessment, perhaps because it had taken place
early after the stroke when they were still acutely unwell. As with the clinical assessment of UI, the
assessment process was seen as enabling the patient to acknowledge the problem and the need
for intervention:
your programme gets the person to admit they’ve got incontinence, and once they admit they’ve got
it and that they need help, that’s the big thing
LL002
The benefit of staff engaging in discussion of UI as part of the therapeutic relationship was also identified:
I think it’s probably helped a lot, with somebody else taking an interest
AA061
Patients and carers also engaged actively in the process of assessment in the preliminary phase
in the first week we wrote it in the booklet and we kept a note of things
LL002
There was also some evidence of misunderstanding in the assessment phase regarding the diagnosis of UI,
with some people erroneously believing that functional UI was not a form of UI and that it did not warrant
going on the ICONS programme:
Once they realised that it weren’t a ‘bladder out of control’, then they chose not to put me on
the ICONS.
BB004
Core phase: timing decision
Trial and error There was, perhaps inevitably, an element of trial and error in selecting the appropriate
TV interval:
the 2 and a half hour was, I couldn’t make it, but the 2 hour I could do it
AA049
Nursing time and effort It was also recognised that participation in ICONS meant that nursing staff had
to devote considerable time and effort to the TV programme:
So the fact that the nurses consciously set a time aside and go and ask and do it regularly
BB002
Conflict with other activities However, it was challenging to co-ordinate TV with other activities in the
patient’s day, such as therapy sessions or off-ward visits for investigations or interventions:
I was surprised the nurses would think about it often enough, cos you’re out and about all over
the place
LL002
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
201
Core phase: adapting timing or programme
Keeping motivated Participants identified that the SVP was not a quick fix. They realised that although
setbacks might arise, it was important to keep motivated during the programme:
if you have an accident, fair enough it can’t be helped, but you don’t give up on yourself
AA049
Managing timing Particularly for those who needed practical assistance with toileting, timing was crucial.
If they requested help too early, they would find that they were unable to urinate after all; if too late, they
might have an episode of UI. As well as the ability to recognise the urge to urinate, they needed to
develop detailed knowledge of how quickly the nursing staff were likely to respond, which might vary at
different times of day depending on the ward routine.
I’d normally press the buzzer just in time – not too early because nothing might happen – so I time it
as best I can
AA061
Self-monitoring As with the initial assessment, some participants took an active role in self-monitoring
throughout the programme. However, the ‘official’ ICONS paper work was found to be somewhat
cumbersome. Ownership of their progress monitoring was demonstrated by those who adapted the
process for their own needs:
I found the notepad was easier ‘cos it’s a smaller piece of paper and you can just flick through the days
LL002
Bladder training and prompted voiding
Using distraction Distraction techniques were found to be of limited use. Exercises such as ‘counting
backwards from 100 in sevens’, suggested in the programme, were not well received. It was felt that such
measures were challenging even as a stand-alone exercise, and were very hard to achieve in the context of BT:
it was so hard to do, it was one of the memory tests they gave him as well counting in sevens . . .
I couldn’t, couldn’t do it
LL002
Getting back in the habit The PV programme was found to be useful in re-establishing a regular pattern
of micturition:
It meant you got very good attention, frequent reminders, that you got back into the habit of going
AA062
Participants also found that the PV programme enabled them to gradually take control of their own toileting:
they asked you if you wanted the bedpan, and now you’re more ringing for it yourself
BB002
Prompted voiding was found to be especially useful for people with post-stroke aphasia, who might have
otherwise had difficulty in formulating and expressing a request for toileting. The regular regime made it
comparatively easy for them to respond to a staff query about their toileting needs:
it might have taken longer to know what she wanted to say; it is sometimes difficult to make
us understand.
BB002
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Context in which the trial was conducted
Fifty semistructured interviews were conducted with staff across the 12 study sites. Of the 12 sites, four
sites were allocated to each of the three pilot trial arms: intervention; supported implementation; and
usual care. Forty-three interviews were conducted individually and seven interviews were undertaken as a
small group interview comprising two or three staff members. In total, the 50 interviews involved
59 respondents across four main staff groups as illustrated in Table 69.
Nursing respondents included nursing staff ranging in grade from HCAs through to ward manager level.
This group also comprised SRN nurses, specialist nurses and stroke nurse co-ordinators. Three nurses
performed a dual role incorporating the role of ICONS research nurse. Nursing managerial respondents
included nursing staff at grade of matron and above including deputy chief nurse and directorate
manager. Medical staff respondents comprised solely of consultant level staff. Allied Health Professional
(AHP) respondents included lead physiotherapists, lead occupational therapists, physiotherapists,
occupational therapists and one speech and language therapist.
Data collection
Potential participants were invited to participate by letter. Arranged by study administrators, interviews
were conducted within clinical sites participating in the study at a time to minimise disruption. Participants
were able to participate in individual or group interviews according to personal preference and logistics.
The interview spine was developed around the six dimensions of a root definition of a soft system,
and refined through a pilot study. Interviews were digitally recorded with the participants’ consent and
fully transcribed. All transcripts were checked against the original recording to ensure accuracy.
All interviews were conducted between March 2011 and November 2012 by senior researchers
from University of Central Lancashire (LT, JG and DF). Three joint interviews were conducted by LT and
CB. Interview lengths varied by staff group, study location and individual interview versus group interview.
Table 70 illustrates the total and mean (SD) interview length of the 43 individual interviews by staff group.
TABLE 69 Soft systems analysis: staff group and number of respondents
Staff group Number of respondents
Nursing 36 (61%)
Nursing managerial (matrons and above) 4 (6.8%)
AHPs 14 (23.7%)
Medical 5 (8.5%)
Total 59 (100%)
AHP, Allied Health Professional.
TABLE 70 Soft systems analysis: individual interview length by staff group
Staff group (n) Individual interviews, total time (minutes) Mean interview time (minutes) SD
Nursing (27) 732.0 27.1 7.3
Nursing managerial (3) 97.0 32.3 1.5
AHPs (9) 305.0 33.9 7.5
Medical (4) 96.0 24.0 24.8
Total (43)
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Seven group interviews were conducted across four study sites (FF; HH; MM; JJ). The mean group interview
length was 40.7 minutes (SD 8.2 minutes). Respondents were from varied staff groups as illustrated
in Table 71.
Interview lengths across the 12 study sites ranged from 15 minutes to a maximum of 57 minutes with a
mean interview length of 30.3 minutes (SD 9.3 minutes). Table 72 illustrates number of interviews, mean
interview length, SD and total minutes of interviews by site and by trial arm.
TABLE 71 Soft systems analysis: group interview characteristics
Study site (number of
group interviews)
Total site interviews
(minutes) Number of respondents Staff groups
FF (2) 82 Six (three in each group) Nursing and medical AHPs
HH (2) 75 Four (two in each group) Nursing managerial and
ICONS research nurse
AHPs
MM (1) 57 Two Nursing
JJ (2) 71 Four (two in each group) Nursing
Dual role nurses
Total time of group
interviews (minutes)
285
TABLE 72 Soft systems analysis: number of interviews, mean length and total minutes of interviews by site and
trial arm
Trial arm Study site Number of interviews
Mean interview
length (minutes) SD
Total
minutes/site
Intervention AA 6 26.2 6.6 157
EE 4 29.8 3.3 119
CC 1 23.0 – 23
BB 2 37.5 6.4 75
Total minutes (arm): 374
Intervention and facilitation KK 8 34.6 10.3 277
LL 3 28.7 14.2 86
FF 6 32.5 9.8 195
HH 3 35.3 3.8 106
Total minutes (arm): 664
Usual care MM 2 47.0 14.1 94
GG 5 28.6 3.4 143
JJ 3 34.7 2.9 104
DD 7 19.4 2.1 136
Total minutes (arm): 477
Total sample: number of interviews, mean
interview length, SD and total number of minutes
of interviews
50 30.3 9.3 1515
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Data management and analysis
Interview transcripts were managed using Atlas-Ti software (version 6, Scientific Software Development
GmbH, Berlin, Germany). Completed by two analysts, who jointly developed and refined a coding
framework, the initial phase of the analysis required immersion in each transcript through multiple
readings, noting initial reflections in the form of memos. The coding framework (Table 73) was developed
from the six soft systems dimensions outlined earlier, and was refined through joint coding of interview
transcripts across three study sites.
The coding framework was then applied to the transcripts, focusing on elements of text that covered a
specific issue or perspective. Special attention was paid to the following:
l data that report first-hand experience of the clinical system, rather than general statements of
opinion, and
l data obtained from participants working within those components of the acute stroke pathway directly
involved in the ICONS study.
TABLE 73 Coding framework for soft systems dimensions
Major code Description
CUSTOMER Data relating to descriptors of service recipients (both patients/family carers; and at individual and
group level). These data will include stroke-related problems; needs; aspirations; experiences;
demographics, as they relate to matters of urinary continence
ACTOR Data relating to professional and support staff who have responsibility/performed activities or health
interventions that are directly or indirectly relevant to urinary continence
TRANSFORMATION Data which describe changes that, by reporting or logical inference, are made as a result of the
interventions and responsibilities completed by ‘actors’
Assessment and diagnosis; patient education; routinised care
WORLDVIEW Data about any aspect of the continence care system that have potential explanatory value; clinical
priorities
Statements about patient and family carer factors (e.g. empowerment) when these reflect critiques
of the system (e.g. is currently disempowering)
OWNERSHIP Data relating to leadership of the system
Finance issues; financial flows relevant to the urinary continence system
Systems and processes that control resources and equipment
Feedback from service users and staff that drives service redesign/practice development
ENVIRONMENT Data relating to clinical and other environments in which the continence care system operates.
The environment may be multidimensional, as follows:
Equipped/unequipped to deliver urinary continence care
Geography (e.g. physical layout, social and emotional meaning)
Team culture/working
Continuity across settings
Absence or presence of clinical information
Absence or presence of knowledge and skills/learning culture
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The analysis then reflected the principles of framework approach,176 including the production of charts for
each dimension across each study site to allow within and cross-site comparison. These charts were then used
to identify patterns of meaning within and across interviews in the form of themes. Themes have been used
to construct a narrative synthesis which describes the post-stroke UI system, and the range of perspectives
within each domain across the sites as a whole. This thematic analysis was used to identify elements of the
clinical system that could logically be used to characterise ICONS sites. Following theoretical triangulation with
other sources of data, these elements were considered within four overarching mechanisms that explained
SVP fidelity and impacts within the trial.
Findings
Findings are presented as themes which characterise participants’ responses within each of the
six dimensions of the post-stroke UI clinical system. Exemplary quotations are included to highlight the
meaning and scope of each theme. For auditing purposes, quotations are accompanied by a code
indicating the participating site, participant and location of the quotation in the interview transcript.
Customer themes
The ‘prevalence’ of incontinence
Although there was variation in the reported proportions of patients with UI, there was consistent
reporting of the significant size of the clinical population who were thought to be incontinent of urine
after stroke:
the majority of our patients do have continence issues . . . We do use a lot of continence products
really when they are here.
DD07; 4
Generally, the presence of UI was linked in the minds of participants to stroke severity and the complexity
of associated patients’ needs:
Other patients who have had strokes and are quite good, they’re up and about walking and things,
they are generally continent it’s just the patients who’ve had large strokes
DD05; 32
our patients . . . who maybe are doubly incontinent they are likely to be severely globally impaired in a
cognitive state and/or the language state so you are talking about a complex patient who you know
needs a high level of nursing care
EE02; 204
Importantly, staff recognised that UI may have been pre-existing, linked to a complex picture of underlying
poor health:
some of the patients are known . . . to the continence service already and they come in with the pad
that’s been supplied by them so they’ve already had their assessment undertaken.
AA03; 36
The hidden nature of incontinence
Despite consistent reports of the high prevalence of post-stroke UI, many staff participants mentioned
instances where incontinence was actively hidden by some patients:
patients if they are mobile tend to hide it.
GG02; 33
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This may reflect the patterns of coping that some individuals had developed to address a pre-stroke
continence problem:
some of the gentlemen with urge incontinence and things like that prostate problems, and again
some of the ladies that’ll just go and buy pads from Boots and keep quiet about it.
FF09; 38
Particularly in relation to older groups of patients, there was agreement that the topic of continence could
be taboo for some:
I don’t know whether many patients would be happy for it to be discussed
EE01; 76
think some of our patients especially the older generation, they don’t actually like their family to know
that they’ve got a continence problem.
AA05; 44
There was some evidence that staff felt they were adept at uncovering incontinence:
a lot of patients are quite good at covering up problems that they have . . . but the staff are usually
pretty good picking things up.
JJ02; 67
However, there were instances where it was evident that problems with continence had been missed. For
example, a medical consultant reported that:
sometimes it’s the patient who raises it as a problem, like a patient did today and nobody else had
mentioned it.
FF08; 8
Discussions about prevalence highlighted a complex interplay between UI, comorbidity, and the
consequences of stroke which made it difficult for staff to understand the nature of UI from the patient
perspective. Many participants referred to ‘cognitive impairments’ as being a significant problem for
patients who ‘perhaps don’t grasp the implications of [UI] very well’ (AA02, 242). Participants discussed
active strategies used by patients, such as denial and problems with mental capacity, that compounded the
assessment of urinary continence. It also appeared hard for participants to be able to distinguish between
denial and mental capacity, as articulated in the following excerpt:
they generally go and ask the patients [about incontinence] which is fine if the patient has got
capacity and things, but if they’re in denial and that, even with capacity if they’re in denial, they tend
not to see it as it is.
LL01; 29
For some participants there was a view that increasing patient age was associated with a lower personal
importance attached to continence:
other people, depends on the ages, they’re not always interested, the more elderly ones aren’t
sometimes, just want to be left alone.
JJ04; 528
Some participants reported that patients could be ‘quite happy to be quite passive can’t they? You know
would happily stay in bed’. However, this participant, a physiotherapist, also reflected on the same
individual who would be able to ‘toilet herself independently if we had a raised toilet seat and a frame
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was around it’ (HH04, 93), highlighting that unmet needs could complicate engagement in other aspects of
care around incontinence. There was also recognition of the disruptive nature of stroke on pre-existing
coping mechanisms ‘by virtue of the fact they’ve now had a catastrophic event’ (EE02, 18).
Family carers as ‘customers’ and ‘actors’
Although most of the interview discussions focused on patients, there was a recognition of the importance
of engaging family carers as recipients of aspects of care within the clinical system. Family carers were seen
as an important source of information on a patient’s pre-stroke life, including any continence issues or
incontinence coping mechanisms:
we have a family meeting and continence is nearly always discussed.
GG05; 41
However, the main substance of this talk focused on repositioned family carers as both recipients of care
and ‘actors’ supporting the delivery of the clinical system in practice:
they get involved sometimes towards discharge planning if they’re going to go home with catheters.
They come in and get involved in catheter management, how to empty the bags, when to change the
bags, how to apply the . . . night bags.
GG01; 91
Actors themes
Integrated working around (in)continence
Reflecting the complexity of post-stroke UI, the data demonstrate a wide range of professional groups
involved in the system:
stroke’s so wide ranging you . . . can find people . . . cognitively impaired as a result of the stroke, you
can have people with speech and language difficulties . . . and you can certainly have . . . people with
comorbidity, so they might have dementia or confusion, they might have other underlying pathologies
that mean that their wishes aren’t easily accessible.
LL03; 22
Nurses were generally seen as the ‘glue’ of the clinical system, largely owing to the continuous
professional involvement in inpatient settings:
well its normally the . . . nursing staff, but the physiotherapy and the occupational therapy staff get
involved as well. Predominantly it’s the nursing staff ‘cos they’re here twenty-four hours.
MM01; 174
Much of the data relating to the nature of working relationships between nursing and support workers
focused on the delegation of work around the management of UI:
there is somebody who needs toileting every so many hours then it usually tends to be the delegated
job for a clinical support worker.
DD06; 36
There were instances where other professional groups were reported to contribute to this work:
it would be the health care assistants and the nurses . . . possibly physios . . . or OTs [occupational
therapists] if they had them in they would take them to the toilet as well,
AA05; 89
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but these instances were exceptional. Although the predominant model of practice was team-working, the
challenges of co-ordinating work through the clinical system were evident:
communication . . . somebody thinks the other person’s done it and the other person hasn’t done it
and you’re just . . . you know it’s been assumed. I don’t think it’s been done intentionally.
DD01; 173
However, the data also demonstrated evidence of co-ordinated and integrated working in other aspects of
work within the clinical system. Physiotherapists described how addressing toileting needs and goals were
integrated into functional rehabilitation:
we’re involved . . . in washing and dressing, so toileting is obviously part of that
HH04; 6
and for sharing continence-related information across the care team:
we’re all responsible for completing the assessment each time we toilet a patient or do a change.
The whole team’s responsible for that, from the health cares to the therapists
GG01; 101
part of our rehab is involved in looking at toilet transfers and once we‘ve, I suppose bed to chair
transfers we start off with and then we would look at doing toilet transfers and then looking at
educating with the nursing staff on how best to transfer onto the toilet or commode.
HH04; 5
Although aspects of team-working and information sharing across professional groups were evident in the
data, there were instances in which integrated working was discussed in more nuanced terms, often in
relation to professional interests. There were some views expressed that incontinence issues were really
only addressed by some professional groups when it impinged on other aspects of their contribution:
therapists only really if it affects their ability to deliver their care
AA06; 41
if we’re aware as a medic that there’s a problem then we will do medical assessment as well.
LL02; 29
There was evidence that different professional groups were reflecting on a greater need for engagement
in line with changes to the service model:
we’re discharging a lot earlier . . . we need to be thinking about how we can how we outreach into
them if our patients have been moved very fast. We probably need to be getting more involved.
GG05; 275
However, these concerns were contrasted with a lack of evidence and policy driving further contributions
to the clinical system:
we looked at the RCP [Royal College of Physicians’] guidelines to see what we as OTs [occupational
therapists] should be doing in the hospital with our stroke patients and it’s not you know [UI is] not a
big thing for OTs . . . In fact I’m not even sure it’s mentioned.
FF03; 29
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Generally, discussions about integrated working around post-stroke UI mirrored broader structures and
processes for team-working in the study sites. Key features of these discussions focused on the
‘multidisciplinary team meeting’, and how this was organised. For example, when multidisciplinary
meetings had little nursing involvement, UI may have received less attention:
It isn’t really addressed because it’s more of a therapy handover than a nursing handover . . . because
we haven’t really got a nurse on the team as such.
EE04; 12
This reflected a view that:
within the multidisciplinary team . . . there are certain areas which are deemed as the responsibility of
certain disciplines, and there the twain meets, so . . . nursing is continence and medication, and so
we’re a bit silo-oriented within the MDT.
LL01; 44
On the other hand, there was evidence that UI was ‘a continuing thing that crops up in goal planning
meetings’ (LL03, 16). In these situations there appeared to be a more integrated approach to
multidisciplinary meetings:
its probably something that comes up in our multidisciplinary meeting . . . we’ve got nursing and
therapists there, so when we feel that the patient’s reached a point at which we should expect them
to at least be able to manage continence from a . . . medical condition point of view.
MM02; 53
Transformation themes
The importance of assessment
A considerable amount of ‘talk’ within interviews focused on the importance of the assessment of
incontinence, and generally participants reported satisfaction with the ability to develop an understanding
of each patient’s problems and needs:
they’re first assessed . . . is quite good, because you can look at that and you can get a clear picture
whether or not they do have any incontinence problems . . . so that’s managed quite well.
EE01; 205
Early assessment appeared to be important, although this often reflected institutional norms:
there’s an actual incontinence assessment sheet, so all patients that hit the unit or . . . hit any of the
wards within [name of hospital] that would have a continence assessment within 24 hours of being on
the ward.
AA05; 6
Within the stroke service, there was evidence that assessments were used to develop a management plan:
we put them on a 3-day chart to monitor continence, how many times we’re changing . . .
incontinence products or how many times they’re needing to be toileted, keep that for 3 days and
then we set up a management plan.
GG01; 26
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Although this quotation also demonstrates a willingness to adapt approaches to patient management, this
was far from the norm. A number of examples were identified in the data that demonstrated a lack of
connection between assessment, problem identification and the development of a continence plan for an
individual patient:
I don’t think we . . . actually diagnose what causes the continence, whether it’s stress, urge, functional
or whatever, we do tend to be a little bit . . . I suppose anecdotal in some respects as we get to know
the patients and then you find out what . . . you know what usually starts it off and why they are
incontinent, that tends to be the way it’s . . . kind of managed.
LL01; 17
just gives us an overall . . . picture really of when they’re incontinent, but then we don’t do anything
off the back of it you know as effectively, we don’t do voiding or anything like that
LL01; 11
sometimes they’re padded up and there isn’t really a full assessment done as to what the problem is
FF08; 14
As most patients’ pathways included access to emergency or early assessment facilities outside of the
stroke service, there was potential for interventions that complicated the assessment of urinary continence:
when we receive them sometimes they’ve been catheterised . . . in A&E [accident and emergency] or
AMU [acute medical unit].
JJ04; 62
Variations in practice were observed around the use of assessment tools, with little reported knowledge of
sensitivity or specificity:
there are several continence assessment tools . . . and basically you can choose which one you use,
and . . . in the past we have used the continence assessment tool that they used in the day hospital
continence clinic, so we . . . have tried to use that.
LL01; 90
In this sense, the selection and use of tools was associated more with custom and practice.
There was a recognition that, despite systematic approaches to assessment, some patients had the
potential to ‘fall through the net’, including those with communication difficulties:
if they can’t communicate it the chances are that they may actually be too severely impaired to use a
reference point to communicate [incontinence].
EE02; 171
Consequently, there was a recognition that flexible approaches to ongoing assessment were required.
This enabled staff to be able to identify changing needs across the patient pathway:
we promote continence and we’re actively monitoring the patient regularly, and when there’s a
change in the patient we . . . change the intervention to match the patient I suppose.
DD01; 164
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The importance of routine
Approaches to work within the clinical system could be characterised as organisational routines
associated principally with both ‘checking’ whether patients were wet or dry, or helping patients to use
toilet facilities:
we do the checks, we have four-hourly checks and maybe 2-hourly checks.
DD01; 107
We’re all pretty good at doing that, we toilet them every 2 hours if we have to and, that’s all I can say
about it really.
DD03; 96
There was some evidence that these routines were structured to coincide with other activities associated
with patient care, or activities such as mealtimes, that could have broader meaning for patients:
we go round and do rounds like at certain times, unless like they ring the bell and ask for the toilet.
We normally do rounds like in the morning when we’re sitting them up, and then we check them like
when we’re washing them, and check them before dinner, then we check them after dinner.
DD03; 17
Balancing routine and individuals’ needs
The data demonstrated beliefs that more proactive approaches:
stroke patients can benefit from being asked to go to the toilet rather than just leaving them when
they’re . . . and then they do become incontinent, so more regular toileting maybe
DD01; 59
and tailored approaches:
we all know that timed toileting is the best way to proceed
HH02; 5
were potentially more effective. Examples of approaches to tailoring included varying practice across day
and night shifts; increasing the gap between toileting activities; and beginning to build patterns that would
reflect routines in other care settings or at home:
the intentional rounding we have for patients which we go to them every 2 hours during the day to
check their continence, . . . and then at night the . . . night staff will check them as well and if need be
they will toilet them at the same times so . . . but then, once we have a pattern usually things improve
JJ01; 20
you get him up in a morning . . . take him over to the loo before breakfast, so . . . then you kind of try
and stretch it to just before lunch or something like that you know, so that so they know when
they’re hopefully going to go, and . . . its good then, because if he goes home with care and the other
times perhaps and the people will be coming in at, and they could manage to do it with him as well
JJ04; 156
we . . . start a chart on the end of the bed and we ask all the staff to toilet them whether we decide
it’s half hourly, hourly or 2 hourly. And then over time we build that up in time length in between so
that hopefully they’re starting to go more like a normal person
GG01; 68
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There was a view that timed approaches to toileting could be particularly effective for ‘people with
cognitive problems’ (FF10, 57). However, where participants had received some information about the
SVP interventions being evaluated within the ICONS research programme, there was some uncertainty
regarding the balance between routinised and tailored approaches, with the potential for individual
regimes to regress towards an organisational pattern:
There might be a lot of patients on 2-hourly toileting, but it’s not because we’ve decided everybody
should be on 2-hourly toileting, it’s because when we’ve done their diaries that’s what they require.
AA05; 177
Worldview themes
The clinical paradigm underpinning the management of post-stroke urinary continence was mixed, with
participants essentially ascribing different levels of priority to incontinence relative to other aspects of care
within the acute stroke pathway; attaching different levels of status to practice in continence care; holding
different views on the natural progression of UI; and, consequently, holding different views about the
legitimacy of UI as a focus for rehabilitation effort.
Balancing clinical priorities
There was some recognition of the importance of urinary continence for patients:
continence is top of the list of priorities of things, they find it hugely embarrassing to be incontinent.
LL03; 97
However, there were varying views about the priority of continence care within the context of the full
range of patient problems and needs within the acute stroke period where ‘you’re doing things to save
lives you know, the patients are medically unstable’ (EE01, 139). Consequently, other aspects of care were
considered to be more important at different stages of a patient’s journey, particularly when staffing
resources were considered to be low:
there’s a lot of input needed from the nursing staff in the majority of patients, so I think if it came down
to whether they have the . . . their IV [intravenous] drug infusion that was due, or you know taking them
a . . . bedpan, I think that would come first. . . it’s just in the nature of . . . nurses. If you . . . could get
more staff then it would be very much at the forefront of their minds, but I think they have to prioritise
EE01; 142
it isn’t always an ideal world as you can imagine on a 36 bedded ward, it is really busy and we try our
best. But sometimes with the staffing that we have, it’s difficult to get to everybody at the right times
DD07; 14
Importantly, some participants reflected that the priority attached to continence issues was also shaped by
non-clinical issues such as the:
emphasis to complete . . . this new paperwork. Sometimes that takes precedence over things that
perhaps would be more useful . . . there’s pressure to . . . make sure that’s completed.
JJ01; 44
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There was also some discussion about the influence of staffing resources on the priorities attached to
different aspects of continence care, specifically where delivering the work of managing incontinence was
prioritised to prevent harm to patients:
if . . . you’re under staffed and . . . you’re prioritising . . . continence care based on the people that are
going to suffer the most as a result of being incontinent . . . the likes of your very bed bound patients
who need to be turned to avoid pressure sores and pressure damage if they’re in a pad and you need
to keep going back to check them.
LL03; 40
Other factors which dampened the priority attached to continence issues in the acute stroke period related
to the validity of the clinical picture, and concerns about:
whether, what the patients presenting will be as a true picture of their stroke-related continence.
EE02; 12
There was some evidence that staff considered that a lower priority attached to continence in the acute
stroke period reflected the perspectives of patients and family members:
I think most patients and their families wouldn’t automatically consider continence in the first few
hours of stroke.
EE03; 32
This contrasted with the view that:
if the patients see [incontinence] as a problem it’s more prioritised probably than if perhaps the
patients hadn’t mentioned it.
JJ01; 62
The generalist nature of stroke incontinence practice
Reflecting the varying degrees of priority attached to UI issues, there was mixed opinion about the status
of practice within the clinical system. There was a view that UI care within stroke services would be no
different to any other clinical area:
I think from a general point of view they would be treated like any other patient
EE04; 82
and that the status of this care was low:
[continence care is] just the basic things
FF09; 20
Reinforcing this view, this participant, a qualified nurse, went on to say later that:
the clinical support workers are the ones that normally do the basic, I don’t mean to be disrespectful
but the basic nursing care.
FF09; 104
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As such, it was felt that, within nursing, continence care has:
probably never been perhaps perceived as . . . an attractive aspect of care
MM01; 256
Views about the generalist nature of continence care were associated with views about the importance of
experiential forms of knowledge, rather than evidence from research:
if it’s somebody fairly senior that’s had . . . lots of . . . experience with looking after incontinent patients
then, and can use past . . . remedies if you like for it.
LL01; 20
you can often use your intuition, . . . you’ve got the idea that if a patient’s agitated, if they’re
fidgeting, if . . . they’re trying to get up and walk around . . . one of the first things on the list of
questions that you’ll ask that patient is, do you want to use the toilet
LL03; 49
In some sites there was a clear strategic shift away from specialisation around continence issues
where nurses:
lose ownership of it as an issue . . . first thing they do is oh we’ve got a continence problem and we’ll
ring the continence nurse rather than what are we [participant’s emphasis] going to do about it.
HH01; 27
The inevitability and intractability of incontinence after stroke
The lack of specialisation in this clinical system appeared to be mirrored by views that post-stroke UI was
either an inevitable problem, an intractable problem, or both:
a lot of our patients will be getting incontinence care rather than continence care, because their
condition is such that that’s all that’s appropriate at that time.
MM01; 328
Some participants provided more nuanced perspectives on this issue:
I don’t think they see it as inevitable, but I think they see it as almost intractable . . . it’s a different
mind-set really to think this is a . . . problem and we can ameliorate the effects of this problem, as
opposed to thinking we can cure this problem.
AA06; 86
This doctor went on to say that post-stroke UI is ‘not really rehabilitable as such’ (AA06, 92), which reflects
other views about the general futility of practice in this area:
I think there’s just an acceptance on the ward that people are incontinent you know and it’s a
statement rather than a kind of well this is an issue that we might need to deal with.
FF03; 11
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Feelings of the futility of intervention appeared to be justified with views that any improvement in, or
resolution of problems with continence were unrelated to professional input:
and if you lucky all of a sudden you’ll become continent, or if you’re unlucky you’ll spend the rest of
your life incontinent, and your option is get a catheter put in, and that sounds very harsh, but that is a
true picture.
AA05; 123
they improve as [JJ04] was just saying as patients improve . . . it resolves itself
JJ02; 40
The legitimacy of incontinence as a focus for rehabilitation
As a whole, the data provide evidence of mixed views about the status of UI, either as a legitimate focus
for rehabilitation endeavour, as a mediator of the success of functional rehabilitation, or timely transfer
of care. There were clear examples of the importance of rehabilitation to resolve or reduce the impacts of
UI in the data:
every person’s allocated a key contact and that might be a therapist, and I can just think of one
patient now where a therapist agreed a goal with the patient that was around promoting continence
MM01; 168
The importance of a practice framework to underpin this rehabilitation approach was also evident, where
staff did:
try and set goals and things like that. But . . . there isn’t much of a plan to try to toilet them more
frequently or ask them more frequently if they need the toilet. There isn’t an actual form like a formal
plan so to speak that we use.
DD07; 28
This lack of a practice framework within which to organise continence promotion was evident in
other interviews:
I don’t think that continence was promoted . . . they are incontinent and that’s it. We . . . change them
when they’re wet, there was no way of promoting . . . no set procedure in place for incontinent
patients. I don’t think it was dealt with . . . in a systematic way at all
EE01; 43
In interviews where the dominant perspective was on the mediation of rehabilitation, the discussion
focused on the management of incontinence to prevent harm:
looking at . . . their skin to make sure that not going to be any pressure damage for incontinence
DD01; 35
and the impact of UI on the success of rehabilitation where:
[UI] would . . . cut into the therapy session
HH04; 5
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Where this was the case, there was evidence that this could be addressed constructively:
during the multidisciplinary team meetings [which] will flag that up as an issue, which we have to try
and sort out about it some way . . . in order to try and allow the therapy to progress etc. So it might
be simple things like pads.
AA06; 38
Other discussions focused on the mediating effect of UI on the ability to arrange a timely transfer of care
from the stroke service:
although we do try to manage continence, it’s not effectively managed at admission. It generally tends
to be on discharge. It’s the reason why we tend to not discharge people home
LL03; 5
I think some people think it as a, they do really think of it as a discharge necessity rather than an
in-patient requirement.
FF10; 84
There were some instances in the data which showed that, although staff approached UI from a
rehabilitation perspective, there were significant environmental deficiencies, such as the distance to
useable toilet facilities, that made this problematic:
I do have an issue . . . making people walk to the toilet when they are actually desperate for the toilet
and instead of wheeling them and walking them back. That’s an issue with me you know. There’s no
dignity there is there if you’re going to wet yourself on the way to the toilet.
DD02; 130
Ownership themes
Distributed leadership
Interviews demonstrated multiple, distributed sources of leadership within the clinical system around issues
relevant to continence. Nursing was ascribed a persistent source of clinical leadership, although this was
predominantly discussed in relation to the management of incontinence:
continence is seen as a nursing issue historically isn’t it.
EE04; 10
Within the nursing profession, participants debated the practical challenges of delegating work to
support staff:
auxiliaries tend to take the lead. Sometimes the staff nurses may have other jobs to do, but we try and
keep a check . . . But isn’t very regularly that it ever happens to be honest.
DD07; 34
However, there was also evidence of strategic leadership across both registered and support staff around
the development of practices around urinary continence:
You need to have somebody who’s passionate about the continence like I say, I mean I’ve always
tried to . . .
AA03; 149
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I think there’s several HCAs who are I think who are very proactive and who have been here quite a
long time and they have a system at work
HH04; 74
we’ve got lots of nurses who do subscribe to the Nursing Times, who do subscribe to all sorts of
applications, and they’re quite happy to bring that level of information to their colleagues and to share
that learning
LL03; 146
The focus on leadership around incontinence work was further highlighted in the processes of onward
referral for specialist advice and support where:
. . . it’s likely to be the consultant that would refer. It might be the nursing staff that flag up an issue
but realistically I think that’s more likely to be the consultant or the medical staff.
EE03; 64
This quotation is characteristic of a more general lack of clarity about, and potentially mismatch between,
clinical leadership and authority for decision-making around UI.
Clinical impact of stock control
Exploring stock flows around the clinical system highlighted some reported disparities between patients’
needs, demand and responsibility for planning care, largely to control costs:
the trust as a whole . . . want us to save fifty thousand pounds in continence products.
MM03; 12
This meant that some staff participants felt that appliances and products to manage UI had limited
availability, or were not of sufficient quality:
we have very limited pads and things what we can use, I think we have two different sorts, we have
these horrible net knickers . . . We used to get really nice continence products but were not allowed
anymore so yeah it does limit it yeah definitely
DD05; 42
there’s only one sheath that we can have in stock . . . I think, we’re quite restricted from that point
of view
JJ01; 125
a lot of the time we don’t have the products that we need on the ward either . . . and then we use
conveens on the gentlemen and half the time it’s never topped up . . . and the sizes aren’t there that
we need
GG03; 232
There were some instances where family members were complementing ward resources to address
concerns about quality:
we’ve had some relatives buy pads in you know because they’ve felt that the ones that we had
weren’t appropriate. . . which you know costs a lot of money to that patient’s relative.
DD07; 22
EXPLORATORY CLUSTER RANDOMISED CONTROLLED TRIAL: FINDINGS FROM THE PROCESS EVALUATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
218
Organisational strategy
Although the cost of products to support the management of incontinence was an important driver of
practice around post-stroke UI, there was clear evidence of organisational drivers which influenced the
importance attached to, and content of, this practice system. These related primarily to ‘intentional
rounding’ programmes, where nursing and support staff were tasked with checking patients on a
regular basis:
we fill in . . . if they’ve been wet, dry . . . had their bowels open. So we go round every 2 hours and
check the patients . . . unless like they go to the toilet themselves, or if they ring the bell and let us
know, you know but if they’re incontinent we check them every two hours really
DD03; 23
Consistent reference was made to performance management strategies that included, or were relevant to,
UI. These included participation in national audits of stroke care:
we . . . do the RCP [Royal College of Physicians’] Sentinel Audit every year which obviously covers
continence, well . . . basically is the patient continent or not and do we succeed in managing
the continence.
LL01; 117
Other examples of audits were driven by local stakeholders to meet commissioners quality requirements:
we recently did the nursing quality assessment tool . . . and we failed drastically on continence . . . both
urinary and . . . faecal incontinence because the assessments that we were doing weren’t adequate
enough for the PCT [primary care trust].
FF09; 17
However, there was also evidence of home-grown performance management programmes:
Continence is one of the clinical indicators that we audit monthly, and it’s also one of the Essence of
Care areas that’s audited but I think that’s just once a year now, unless there’s problems and then it’s
audited more frequently, but certainly the . . . clinical indicators are monthly. It’s an audit of five
patients at random, picked at random . . . do they have appropriate management tools in place, have
they been assessed, do they have the care plans . . . have they got review dates, that kind of thing
GG01; 164
These were the approaches to performance management that were most closely linked by participants to
practice development where:
they do offer us advice across the trust . . . from the point of view of promoting continence.
HH01; 42
Environmental themes
Unsurprisingly, the environmental attributes of the clinical system were multiple, providing both
opportunities and challenges to staff and patients alike. These influences related to the layout of clinical
settings within which the system operated; the history of change; differing approaches to risk management
across the system; the availability of knowledge, skills and expertise; information quality; and the continuity
of provision and patient experience throughout the system relative to their recovery pathway.
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Clinical geography
The evaluation of clinical facilities by participants focused principally on issues of access and privacy:
we never have enough . . . toilets . . . we’ve got . . . fourteen men up in this . . . area with one toilet at
one end of that . . . area and two toilets in the corridor beyond that for the men to use, so if you’re
not very mobile . . . you’ve got quite a long run
LL01; 147
we haven’t got a lot of space . . . to chat with patients privately
JJ04; 348
The data demonstrated that staff were creative in their use of clinical settings to meet an individual
patient’s needs:
I think they do put people if they are just starting to walk a little bit independent, they’ll position them
in the bed by the nearest toilet on the ward . . . the environment isn’t perfect.
FF04; 163
Rather than simply an issue of the number of toilet facilities available in clinical areas, patterns of access
associated with individuals’ needs appeared to be important in shaping demand and use:
we do use the disabled toilet at both ends for male and female quite a lot because it’s got quite a lot
of hand rails for patients . . . sometimes you get a queue at them toilets . . . so if they had a couple
then that would be helpful
DD05; 124
The toilets are too low, there’s not enough room. We’ve got 4 toilets down near the ladies’ and they
tend to use just one particular toilet because it has the bars around it
DD02; 120
Generally, the degree of fit between the physical layout of clinical areas and the work associated with
continence care appeared to depend on whether clinical areas were purpose-built, or whether stroke
services had developed within existing care facilities:
ward wasn’t built as a rehab facility, so we’ve had to do some minor adjustments as best we can to
some of the toilets to make sure that they’re disability friendly, but they’re not, still not ideal . . . they
wouldn’t . . . allow somebody in a wheelchair to toilet themselves independently
MM01; 362
There was evidence that in some sites, staff had been able to influence the design of clinical settings
around their experiences of care provision, specifically with reference to access issues:
when they did the plans they had a toilet and then a bathroom and a toilet but we’ve asked them to
do it as . . . an en suite type of thing, so that they’ve got a wash basin there as well, so the patient can
go in there and do their ablutions in . . . privacy and you know without having to . . . have people
barging in behind curtains
JJ01; 161
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History of change
Another attribute of the clinical environment on which participants drew to evaluate the potential to alter
aspects of the clinical system, including use of the SVP, was the history of change, and how change had
been experienced:
with all of the ward moves and everything else it has been a very, very, very hard last 2 years . . .
18 months to 2 years.
HH02; 115
Some of the features of successful change included generating broad commitment to change:
it was a big push to get everybody on board it worked well.
HH02; 137
Strong leadership that set change within the context of a clear rationale, including performance relative to
peer organisations and services, was highlighted as being particularly important:
I do think that continence care is possibly one of the weak areas and certainly that is what the Sentinel
stroke audit’s telling us. So we really need to unpick that
EE03; 104
the ward manager tends to discuss with us what’s been happening and what’s come from the audits
and how well we’re doing in comparison to other trusts
DD06; 80
We’re trying to see what the other hospitals do around the [region] and see how they manage an
actual plan if there’s a formal plan that they use cos we just don’t have one at all . . . the Cardiac and
Stroke Network have been helping us in that way
DD07; 68
Embedding change within national initiatives was generally discussed in positive terms:
being part of 90–10 Improvement Programme was a big lever as well in terms of improvements.
FF10; 152
However, not all change initiatives reported in interviews had been positive, particularly where some of the
more positive features of the organisational context for change cited earlier were not evident:
trying to get change is very difficult. I’ve just recently done some constraint induced movement
therapy which is the best evidence that a stroke rehab there is but we need to plan it and do it
properly before we can implement it and you know. I e-mailed all the senior managers and haven’t
had a reply for 3 weeks.
FF03; 57
Balancing risk between hospital and home
The data demonstrated clear differences in how risk was managed within the clinical system across
different settings within the stroke pathway. At home there was more opportunity for specificity to an
individual patient’s needs:
the home environment can be set up for that particular patient. So if they need a rail or a bar or a
toilet raiser, that may be appropriate for them, but they won’t always be available in hospital.
LL02; 143
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Consequently, there was a recognition that long-term approaches to promoting continence were hard to
achieve in the hospital setting:
often we get right up to the stage of discharge and patients are still pressing the bell to go.
It’s kind of learned behaviour I guess, institutionalisation. But it doesn’t help us when we’re saying,
‘well if you’ . . . you know, ‘why aren’t you going on your own because that’s what you’re going
to have to do at home’
FF03; 121
Every patient has a manual handling risk assessment and as a matter of course, and again, this may be
custom and practice, patients are asked to ring the bell before they go to the toilet because they are
having to walk across a ward with lots of obstacles in the way.
FF03; 121
Importantly, there was evidence of tailoring rehabilitation input to address anticipated continence needs
associated with transfer of care:
we would support the nursing staff in handling . . . so that Mr X can go to his weak side every time he
goes to the toilet because that’s what he’s gonna need to do when he gets home.
HH04; 11
Contrastingly, approaches to managing incontinence developed within the hospital setting sometimes had
to be drastically altered to accommodate transfer of care:
sometimes we manage them here with pads, but going home they can’t be managed back home with
them because they haven’t got the carers or family to go in and do the changes that we would do. So
we then have to make a decision to catheterise
GG01; 53
so we might be able to get patients continent with prompted voiding in hospital, but then who’s
going to prompt them at home if they haven’t got 24-hour care?
MM01; 72
Availability of knowledge, skills and expertise
A considerable amount of discussion within interviews focused on the availability of knowledge, clinical
skills and expertise in the right place, and at the right time to meet patients’ needs. Many participants
focused on their ability to access education and training provided principally by specialist services:
continence service here developed workshop days that you’d go to and attend . . . and we can also
gain you know the . . . policies and things like that they use,
MM03; 177
or by commercial suppliers of incontinence products:
[education and training] tends to be product related
GG03; 148
Although there were opportunities for nursing and support staff:
we try and send all, both . . . and I have the support workers and our qualified can go on, but that’s it
really with training
LL01; 62
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there was little evidence of access to education and training for other professional groups. In the absence
of formalised approaches, there was strong evidence of reliance on experiential sources of knowledge:
well I’ve been here for that . . . it’s the nurses who can do it . . . I haven’t been on any
incontinence course.
DD04; 95
In addition to attendance at education and training events, there was some limited evidence of
organisational approaches to link specialist knowledge and skills to clinical practice. These included
ward-based resources:
there’s a communication folder that’s in the staff room and anything that’s new, any articles, any
research or any information that needs to be passed onto staff we tend to put it into the big folder so
it’s available for all the staff to read so that’s quite a good idea that we have on the ward.
DD06; 76
Other approaches relied on the availability of specialist staff as a source of support and advice:
there is a lady who works in the community that works with continence and I remember a year or two
ago we used to ask her for advice and things and she came in [to deliver training].
DD06; 50
there’s a community continence nurse that we can access but only generally post discharge . . . I did
ask them to come and see a patient on the ward recently and on discussion she said she would but it
was for faecal incontinence actually not urinary . . . but I think afterwards when the staff contacted her
she doesn’t come into the hospital
LL02; 38
we’ve always got that link with the continence service in the community you know to ring and they’ve
always got the knowledge of where to, you know who to contact
AA03; 193
There was some evidence of strategies that attempted to bridge expertise in specialist services or agencies
with the stroke service, but these were limited in scope:
we’ve got link nurses for every aspect and whatever you go and learn on your training day it’s then up
to you to filter down, but it’s equally up to us if we want to know something ask . . . your link nurses.
GG02; 81
In this case, the ‘link nurse role’ appeared to extend little further than providing a higher level of education
and training for one or two members of staff within a clinical team.
Availability and use of clinical information
The data appear to indicate that, in terms of post-stroke UI, the clinical system could be characterised as
‘data rich, information poor’:
at the moment if I am being totally honest, I get very little information coming out about continence.
AA02; 24
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Services peripheral to the stroke service provided limited, detailed information on continence:
when they come from the medical admissions unit . . . we get like a handover sheet if they’re
continent, incontinent.
DD03; 11
Within the stroke clinical settings, pathway-specific documentation tended to include more detailed
information, including pre-stroke continence status:
they have got an integrated stroke pathway and from day one and from the beginning . . . continence
is as it were identified pre . . . stroke and post-stroke.
FF09; 23
Generally there was little, if any, evidence of access to patient-specific information on ongoing continence
issues or outcome after discharge from hospital, preventing evaluation of care provision:
we don’t really know what happens to them when they get home is what I’m trying to say.
MM01; 79
There was some evidence that clinical documentation played a role in sharing relevant clinical information;
however, this tended to be reported as burdensome in terms of volume:
we’ve got that much paperwork take for instance we’ve got a patient that’s . . . has continence issues,
we’ve got the assessment to do, we’ve got intentional rounding which . . . is the problem and then
there’s another . . . fluid balance chart if we’re looking at the output and then they’re on a diet chart
. . . so there’s about four pieces of paper before you start and all of them you know are probably
saying the same thing.
JJ01; 125
Perhaps unsurprisingly there was evidence of reliance on oral, and consequently fragile, modes
of communication:
when a problem’s identified really, and then you know we pass it back to we go through the
communications through handover and you know lets all staff become aware of that.
DD01; 65
Oral communication was also prone to shaping by the priorities of individual staff members, meaning that
continence issues could be lost:
we don’t really get a handover from the acute or rehab about particularly about a patient’s continence
issues it’s more around therapy issues.
EE04; 8
Continuity across the clinical system (experience, provision and service)
There was a clear recognition of the potential mismatch between the configuration of care services
within the stroke pathway, and the delivery of continuity within the clinical system. Unsurprisingly,
particular challenges to continuity were identified at the point of transfer of care to rehabilitation or
community-based services:
On discharge for some patients if they need like continence assessments in the community, district
nurses tend to do them and look at if they need like continence equipment when they go home
DD07; 46
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if we do . . . want district nursing service to follow patients up at home there’s quite a gap between
the time that they leave and the time that the district nurse gets round to doing the continence
assessment and supply the pads, it can be up to 6 weeks
LL01; 23
This may reflect a lack of knowledge about service availability:
I know the NHS has . . . an incontinence nurse, but I’ve never seen them, unless they get when they’re
discharged they see them,
DD03; 74
or perhaps a more fundamental lack of integration of services around UI.
Synthesis
Within soft systems methodology, the development of a ‘root definition’ of the system under consideration
represents a stage in the change process underpinning soft systems work. Specifically, the use of the six
soft systems domains identified earlier provides a structured opportunity to identify and evaluate the
assumptions underpinning a system. Box 3 shows the root definition of the clinical system supporting
service provision around incontinence, whereas Table 74 shows emerging themes compared against what
could be viewed as the ‘gold standard’ system.
The analysis and findings from the soft systems analysis focused initially on the development of a rich
understanding of the organisation and delivery of intervention around post-stroke UI. This understanding is
useful in pointing to factors which may inhibit or enhance implementation of any intervention relevant to
continence in subsequent clinical trials, and informing the development of bespoke implementation strategies.
BOX 3 Root definition of the clinical system supporting service provision around UI within the stroke setting
The clinical paradigm reflected in the organisation and delivery of the system is mixed, dependent on the
degree to which individual staff members see UI as the legitimate focus of rehabilitation, or as a barrier to
meaningful engagement in rehabilitation activities. As a complex clinical problem, UI is a prevalent concern for
acute stroke patients, which may be compounded by other health conditions, and may be actively hidden by
patients. The degree of priority attached to UI is varied across patients and staff, and may differ between
individual cases according to beliefs about clinical significance relative to other clinical work, the nature of
recovery of continence and organisational pressures. Clinical staff work with patients, and occasionally family
members, to accurately evaluate the causes and patterns of incontinence, in order to deliver multiple impacts
around patient safety, dignity and urinary function. A key characteristic of service provision around the
management of UI is routinised, patterned practice, which has the capacity to support regimes that are more
tailored to the needs of individuals. This practice may reflect other patterned or routinised approaches to both
clinical work and organisational strategies to enhance service quality. The management of incontinence is
primarily a nursing responsibility, addressed with the health-care support workforce. Members of the MDT may
provide active support within the system depending on individuals’ understandings of UI, and reflecting broader
processes of multidisciplinary working within the acute stroke service. A complex, multifactoral organisational
context surrounds this complex system, including the configuration of clinical and organisational geography;
continuity of provision and experience; the availability of information, knowledge and skills; a culture of
evaluation and service improvement; financial and strategic influences.
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TABLE 74 Mapping emerging themes and descriptors to the root definition
Root definition
domains Themes Descriptors (against ICONS gold standard)
Customers The prevalence of incontinencea
The hidden nature of continencea
Family members as customers and actorsa
Actors Integrated working around (in)continence Integrated working around continence; different
professional perspectives; ‘everyone’s business’
Transformations The importance of assessmenta
The importance of routine Evidence of regularised approaches to managing
continence; patterning care
Balancing routine and individuals’ needsa
Worldview Balancing clinical priorities Incontinence being important (in whatever context)
relative to other interventions
The generalist nature of stroke
incontinence practicea
The inevitability and intractability of
incontinencea
The legitimacy of continence as a focus
for rehabilitation
Continence as an outcome (rather than mediator) of
rehabilitation endeavour; goal setting; progress review
Ownership Distributed leadership Multiple people leading continence issues;
co-ordinated approaches
Clinical impact of stock controla
Organisational strategy Understanding of the organisational importance of
continence care; audit and feedback; quality review
Environment Clinical geography Synergy between the clinical environment and
continence work
History of changea
Balancing risk in hospital and home
settingsa
Availability of knowledge, skills and
expertise
Co-ordinated and structured approaches to education
and training
Availability of clinical informationa
Continuity within the service model Integrated community and hospital services; continuity
of goals and interventions
a These themes do not provide meaningful opportunities to distinguish between clinical sites, or represent issues where
comparison would not be meaningful due to the exploratory nature of data collection processes.
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Response of clusters, recruitment and reach of individuals,
delivery to and response of individuals and maintenance of
processes over time
Normalisation process theory
The intervention is referred to as the SVP. Findings for each of the 16 NPT dimensions are presented, with
illustrative quotes. Single numbers in brackets, for example (4) identify the number of sites supporting a
finding. Letters and numbers in brackets after an italicised quote are the reference identifier for a specific
interview, for example (AA2) refers to the second interview from site AA. Table 75 provides the number of
quotes used from each site, to illustrate that the spread was equitable, and that each site contributed
some material to all sections, except for one site (AA), where no quote was used related to coherence.
However, the number of quotes from other sites tended to be low in this NPT category.
The discussion presents a short summary of the main findings and evaluates the strength of the evidence
for the main mechanisms of action, suggesting which might be the dominant explanations in the logic
model as a basis for testing in a future trial. Implications of the barriers and facilitators for intervention and
implementation design in a future trial are discussed later in the report (see Chapter 11).
Demographic data
Demographic data for the interview respondents are summarised in Table 76. Some respondents were
interviewed in small groups of two or three. Thirty-eight members of staff were interviewed in total, during
32 interviews.
TABLE 75 Number of quotes per site for each NPT category
Site Number of interviews
NPT category
Coherence Cognitive participation Collective action Reflexive monitoring
AA 4 0 6 7 6
BB 3 6 5 20 11
CC 2 2 5 15 8
EE 5 2 5 15 6
FF 3 2 5 16 16
HH 5 5 10 19 10
KK 4 2 10 8 8
LL 6 1 11 15 8
Total 32 20 57 115 73
TABLE 76 Number and grades of staff interviewed per site using NPT
Grade of staff
Intervention site Supported implementation site
AA BB CC EE FF HH KK LL
Band 7: ward manager 1 1 1 2 1 1 1
Band 6: sister/charge nurse 1 1 2
Band 5/6: staff nurse 1 1 1 1 2 2
Band 5: research nurse 1
Band 2/3: HCA 2 1 3 2 2 3 4
Number of interviewees per site 4 3 2 7 5 5 6 6
Number of interviews per site 4 3 2 5 3 5 4 6
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Findings
Coherence: the sense-making work that people do when faced with a new practice
Differentiation: whether or not people see how the new practice differs from what they were
doing before Sites differed in how much continence care they were providing prior to introduction
of the SVP: some were doing very little (4):
Prior to ICONS there wasn’t any managed systems of continence assessment. Patients came to us with a
catheter in, when that was taken out they either regained continence individually, or remained incontinent.
BB2
Other sites had regular toileting schedules (4). One respondent said that patients who were more likely to
succeed were chosen for toileting.
The most common changes identified were that the SVP was more structured and formal (5), timed (4)
and documented (8), for example:
I think ICONS put it into a more formal setting, you had your protocol to follow, initial assessment,
weekly reviews, you’d set programs for patients to work to. It was a more formalised way of doing it.
CC2
Basic toileting tasks were not seen as different, but the routine and the documentation were (5),
particularly the assessment of continence that staff were required to undertake as part of the SVP (3).
There was a strong suggestion in the findings that staff (HCAs in particular) did not necessarily
differentiate between the SVP and regular toileting (3):
We had quite a lot of dissent towards it [the SVP]. Whether people didn’t fully understand what we
were trying to do or just thought, ‘Well, we already do this, do we need to go down this avenue?’.
CC2
However, staff did report that attitudes towards continence management were changing:
Before ICONS we would wait for people to buzz us, or ask before mealtimes . . . You are more
conscious of it now;
FF2
with more therapeutic intention:
What we’re doing now is to get them where we can help them be continent, and not be wet, and
feeling better about themselves.
BB1
Communal specification: whether or not people agree with the new practice Most respondents felt
that staff agreed with the aim of the programme of prompting patients’ continence (6), and that it was
part of the nursing role and rehabilitation:
I know it’s been brought in because of research but really we should be looking at continence and
how it affects patients’ lives.
BB1
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The programme components were seen as logical:
It’s a thorough assessment to begin with, and then you plan the interventions you’re going to take,
and then there is an evaluation as well, so it does seem a good circle of events – continuous
assessment and planning. It’s a thorough way of doing it.
FF2
Four sites agreed with the SVP and did not mind doing it. Respondents said that being able to see benefit
(1) and having enough staff (2) influenced staff views. They perceived that some staff would not like it
because it was hard work, and more paperwork (2), ‘I’d say it’s about 70/30 for and against’ (L5).
Respondents from two sites said the SVP was not popular with staff because of the extra demands
incurred, but respondents from both also recognised some benefit, so lack of agreement was not severe in
any site, and there was reasonable agreement with the principle aims of the SVP overall. However,
respondents from most sites (6) were quite negative about the paperwork, particularly the assessment:
The paperwork is ridiculous, we don’t need to know all that,
HH1
with one respondent suggesting possible negative effects for patients:
As part of the assessment, we wouldn’t want to compare their life before to what it is now, because it
will be different and I think that can be quite damaging emotionally.
HH3
Respondents disagreed about the suitability of the SVP for some patient groups specified in the inclusion
criteria (3), especially those who were unwell, people with dementia, or long-term continence problems:
I couldn’t understand why some patients with catheters were signed up for ICONS. Even those with
long term prostate problems we still included, and that isn’t something you are going to solve. That
was where our sticking point wasn’t it, it was the long-term prostate problems and ladies with
long-term catheters.
FF4
Individual specification: whether or not people understand what the new practice requires of
them Respondents commented that it took a while to settle in and know what they were doing (5),
but that the SVP was logical and made sense:
It’s not rocket science. It’s actually quite a simple process: steps and documentation.
HH1
However, although seen as straightforward, there was a suggestion that aspects of the SVP were
sometimes misinterpreted, including:
The relationship between the diagnostic elements of the diary and the subsequent
timing schedule
The three day diary to start with was fairly self-explanatory, wasn’t too taxing, then we take it from
the next level whether they don’t need it or they do, and then it’s just prompted voiding – fairly
straightforward to be honest.
BB3
Respondents routinely referred to the programme as ‘regular toileting’.
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Eligibility for the SVP
I was struggling at first because we were told to put everybody on the programme then the research
nurse said not people who are continent or catheterised.
EE2
Confusion also arose in the same site around including younger people,
we knew they were continent and didn’t need it,
EE1
and people with urinary frequency.
Programme choice
Initially there was a lot of confusion, there was a different process for different patients. Staff didn’t
realise that you had to do this 3-day diary first and then the assessments, to choose the
correct procedure;
BB2
Distraction and extending the voiding interval in BT
In bladder training some staff will not let the person go to the toilet if it isn’t 2-hourly whereas we
understand it’s more that you encourage them not to go;
HH4
The purpose of the weekly reviews
I was just doing it every week. I didn’t look back to the week before, perhaps I should have
done though.
KK6
The understanding of certain staff groups was questioned:
I don’t think the auxiliaries understood for about the first half of the programme that there was a
process. It was just ‘Here’s ICONS’, and they’re put on prompted voiding.
BB2
Bank staff were also identified as lacking understanding, because of their lack of training and experience
with the SVP:
The problem was occasionally you’d get bank staff haven’t worked here before and then you have to
go through it all again.
KK6
Staff thought that most patients could understand the SVP to an extent (3), although some did
not understand:
The patient lacked understanding of what the whole purpose of the programme was about – he just
wanted to get continent again, he wasn’t interested in anything else. So he lacked understanding of
the process with it.
HH4
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One respondent said that the structured plans could help patients to understand, as well as staff. Two
respondents commented that most relatives understood the programme (3), but staff felt that explaining
the programme to relatives could be difficult, especially explaining the research component (1); and the
requirement for extending the voiding interval, which is a part of BT (1).
Internalisation: whether or not people see the potential value of a new practice A commonly cited
benefit of the SVP was an increase in the priority of continence care (5), and highlighting to nurses that
incontinence as a problem is amenable to change (3). There was recognition of the importance of
continence for patients (4), particularly in relation to community living, QoL and discharge destination (3).
Other potential benefits mentioned included increasing comfort, improved self-esteem and dignity, and
avoiding embarrassment and the adverse effects of incontinence. One respondent thought the SVP was
particularly suitable for people after stroke because of its structured approach, two other respondents
referred to the benefits of training for regaining normal routines.
Another commonly cited benefit was in some rebalancing of control between patient and staff (3):
As nurses, you tend to do everything, so this is a way of giving the patient back ownership and
getting them to start clicking in.
BB1
Staff recognised that continence control signals wider recovery from stroke (2) and gives the patient
hope (4):
It’s not ‘Oh, I’ve had a stroke and now I’m incontinent’, it’s ‘something can be done about this’.
KK6
This also linked to nurses feeling that they could help patients (4), and that the programme gave nurses an
increased therapeutic role:
I think patients on the programme felt quite secure, they knew they were incontinent and they knew
that we were addressing the situation, and that there was a plan to try and help them.
CC2
Staff also identified potential benefits for themselves. They saw the SVP as providing them with structure
and guidance (6), making staff think more about continence (3), and reducing workload in the long
run (3). Staff could see potential benefit, but the added work was unpopular (3). Overall value was
summarised by one respondent as:
It’s definitely better for the patient, but it does take more work and that was the biggest thing.
KK6
Cognitive participation: the relational work that people do to build and sustain a
new practice
Initiation: whether or not key individuals drive the new practice forward External people seen as
responsible for initiating the programme included the research team (2), matron (2) and stroke network
nurse (2), with the trial manager involved in training and ongoing support (3).
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Senior ward staff were consistently referred to as being responsible for pushing the new practice
forward (8). Their functions in embedding the new practice included:
l promoting the programme:
The key people were the trained nurses encouraging it and explaining it to the auxiliaries and
trying to get everybody behind the programme, they were very good at promoting it;
BB2
l providing direction and reminders:
Management and senior staff were influential by reminding and explaining;
AA4
l education and supervision:
The ward sister has an overall view and a supervisory and educational role making sure that the
team knows what they’re doing;
EE4
l organisation and delegation:
The senior sister is the main one organising the programme, saying the programme is everyone’s
responsibility, making sure we are all up-to-date with the programme;
HH4
l monitoring and feedback:
If we don’t know what we’re doing we’re soon told, we’re soon picked up on it by the ward
manager. She’s pretty good – keeps an eye on all that.
LL1
The style of management and direction was commented on by HCAs, including involvement:
The ward manager facilitated time to learn the programme and did not just delegate work to HCAs
but involved them in learning why;
AA3
and the availability of support:
The support we got was fantastic, it meant a lot to us. If you were stuck you could either go to the
ward manager or research nurse.
KK2
Ward managers commented on the key role of proactive senior staff nurses in three sites:
. . . we’ve also got some of the more senior staff nurses who are really confident in delivering the same
sort of thing: they were the ones who initiated in governance meetings what we needed to do to
make the programme more visible.
FF1
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Two sites commented on the lack of a key member of ward staff driving the programme:
We don’t seem to have an ICONS champion on the ward. We’ve got the research nurse but there isn’t
a nominated band 5 or 6.
HH5
The overall ward approach to embedding new practices was also obliquely referred to, with three sites
crediting the whole ward team as being responsible for and involved in implementation.
In six out of eight sites the research nurse was identified as a valuable resource, although their role
differed considerably across sites. In some sites, the research nurse managed the programme almost
independently of ward staff:
The research nurse would come in and do all the paperwork for the trained staff on the ward;
LL2
in other sites the research nurse supported the ward staff to deliver the programme:
We’ve got the research nurse for any queries, or to push the staff forward a little bit, that helped.
LL5
Roles undertaken by the research nurses included:
l teaching, explaining the programme, answering questions
l highlighting, reminding, acting as a trigger for what needed doing
l driving, co-ordinating, directing, helping everything run smoothly
l talking with the patient, working out the regime
l keeping on top of who should be on the programme
l working with HCAs, demonstrating the paperwork
l checking charts were updated, making sure assessments and weekly reviews were done
l taking control, doing all the paperwork if not done
l acting as a link between units
l updating ward staff of changes.
A research nurse presence was not consistent over the whole of the programme in a number of sites, and
their role and impact was influenced by whether they were successful in integrating with the ward staff:
Initially the research nurse got in the way of it working well, but now the clinical leader on the ward is
our link nurse with regards to research. If the research nurse needs anything implementing she asks
the ward managers to make sure it gets done, and we will delegate it;
FF1
and the timing of their presence:
The research nurse leaving three-quarters of the way through had a bit of an impact but it didn’t
make a massive difference on patients. It just made everything else a little bit more different, other
people coming on the ward. She was so good that we relied on her quite a bit really.
KK1
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It was difficult to discern how leadership by the ward staff integrated with the research nurse role, being
an interaction of personalities, role definitions, level of ownership of the programme, and continuity of
presence. Research nurse characteristics commented on included being: ‘. . . somebody visible, on the ward
fairly regularly, a named link’ (CC1); ‘. . . approachable’ (EE4); ‘. . . known and popular’ (AA1); ‘. . . clued
up’ (EE1); and patient:
. . .she would reiterate and reiterate just to help the flow through our heads.
HH5
Ward staff on one site commented favourably on the impact a research nurse who became involved at a
practical level had on their perceptions of the programme:
She did shifts with the ICONS nurses, her doing that warmed us up to it a little bit more.
HH4
The perspective provided by external research nurses was valued, for co-ordination:
We were lucky to have a strong research nurse. It might not have worked if we hadn’t had the
research nurse pulling everyone together;
AA3
for monitoring performance,
The research nurses have been a big help because we were floundering, we had somebody to bounce
off and see that we were doing it right;
BB1
or to counteract established perceptions,
People you wouldn’t think would be a candidate, somebody from the outside would come in and say
to us give it a go and see how they do. And yes they did well.
BB1
Five sites commented on the role of the extra staff provided to the sites (known as ICONS HCAs or band
3s) in promoting the programme:
The key people driving it were the research nurse, sister, and three ICONS nurses.
KK2
Management external to the ward was not seen as providing input to the programme (2), for example:
There’s been no input from management.
FF2
Two sites out of the four that received external facilitation as part of the trial commented on the help
provided by the facilitator, and one site commented on the perceived lack of external facilitation:
We haven’t had much external support, somebody was supposed to be visiting four times but they
only visited once.
HH1
This is described in more detail later in this chapter, see Supported implementation.
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Enrolment: whether or not people agree that the new practice should be part of their work There
was recognition that staff needed to be involved in the programme and motivated (4):
We needed to involve all of the staff, get ourselves more on board.
EE1
Four sites thought their staff were on board with the programme, or at least not negative. Staff attributed
willingness to be involved to enjoyment (1), a decrease in workload in the long run (1), or wanting to be
involved in the research (2).
Three sites reported that there was quite a lot of dissent in the initial stages, and that it took time to get
the programme going, get people on board and keep them motivated:
I struggled to get people on board and to keep it up. It was fine if certain people were on shift who
really knew about it but if somebody wasn’t here it would lapse a bit.
BB1
Respondents from two of these sites went on to say that once staff had been involved, they realised that
the SVP did not require much extra work. Facilitators to enrolment included whether or not staff saw
that the programme could be done, and their experience of success. In general, staff appeared prosaic
about involvement over time,
I don’t think people mind doing it. It’s just something you get on and do,
FF2
although the paperwork remained a significant barrier for some (2).
There was a general recognition across sites (6) that there is always some resistance to taking up
new practices:
There is a core of people but then it’s not just the ICONS – it’s anything; it’s whatever we’ve
introduced they’ve been very anti. It’s a case of saying ‘this is what is in now and this is what we’re
doing and you have to do it, you are accountable’. But it’s the same ones you are going to hit a brick
wall with.
BB1
A proportion of staff remained resistant and could significantly influence uptake, but even they could
come round eventually,
It was quite interesting to see how influential one person and their negative thoughts could be, but
bizarrely this person is now the first person to start suggesting regular toileting.
CC2
Nurses thought that AHPs such as physiotherapists and occupational therapists were not involved, possibly
because they had not approached them:
Therapists don’t get involved because we haven’t asked.
FF2
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This may have been because the SVP was seen as a nursing role:
It was very difficult to get any of the therapists on board – they do seem to think that continence is a
nursing issue. The head OT [occupational therapist] and physio should have been involved in the
beginning to make sure they participated as well. They knew about it but didn’t think they were part
of it. They have got OT assistants or physio assistants who do hands-on personal care but they weren’t
used to help towards the continence programme.
KK3
In one site, therapists accommodated the SVP in the daily routine:
The therapist was very good about it. They would look in the diary and change the times that they
would take the patient down to the Department,
KK6
but would not necessarily get involved:
We could have worked the timetable round the therapy sessions. They should have thought over there
‘It’s 11 o’clock now the patient is on ICONS’, but they’d bring them back for the toilet even though
they’ve got the facilities there.
KK3
Doctors were also not involved:
The doctor didn’t know who was on ICONS.
KK6
Respondents from four sites commented that most patients were quite happy to be involved, although
staff also commented that some were not. Staff thought this was possibly because it was research or
because it might extend the hospital stay:
I think maybe they’re a bit worried that going on the programme will prolong their stay. They want to
get out of hospital as quickly as possible and go back home;
LL6
or because it drew attention to incontinence:
I think it might be drawing attention to their problem as well. Sometimes in the early stages they’ve
got so much else going on its making them focus on another problem.
CC1
One respondent commented that patients were happy to be involved until it came down to
the practicalities:
Sometimes patients agree to it and then when you put it into practice they don’t want to know, when
you are saying every 2 hours come to the loo, that’s different.
FF2
Legitimation: whether or not people buy into the new practice, and whether or not they are
willing and able to organise themselves The main feature of ward organisation altered by ICONS was
the introduction of new staff. Each ward was able to hire 2.8 band 3 HCAs to cover daytime shifts.
Recruitment of additional staff differed between sites: five sites recruited new HCAs to target and maintain
a reasonable presence over the length of the SVP; two sites failed to hire new staff or had severe staffing
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problems throughout; one site mainly used bank staff or ward staff overtime because of hiring difficulties
at the trust. The way the new staff were used also differed between sites: three sites relied totally
on ICONS HCAs or bank staff to deliver the programme; two sites integrated ICONS HCAs into the ward
staffing such that there was no role differentiation; and three sites moved from relying on ICONS HCAs
at first to shared responsibility for the programme. There was some evidence of role conflict for ICONS
HCAs who were not fully integrated into the ward staff:
If somebody phoned in sick they would be one short to go and wash in the morning, then I was
in-between which way to go.
KK2
Five sites referred to role differentiation between trained staff and HCAs in terms of delivering the SVP,
The staff nurses set it up for the HCAs, do the checks, and progress the patient to the next level, so
it’s there for HCAs to fill in on the right page,
AA3
although not all paperwork was done by trained staff:
HCAs do the 3-day diary, staff nurses decide which programme the patient goes on.
EE1
Responsibilities did need attention to sort out:
It takes a while to get into who is doing the paperwork and three day assessment,
EE4
and role demarcation was not without a hint of resentment about the familiar split between cognitive and
physical work in nursing:
The nurse looking after the patient is doing the two main parts, and everybody else is just doing the
hard work.
FF2
Three sites identified role demarcation between the research nurse and ward staff for undertaking
programme activities, with the research nurse generally involved in recruitment, but also undertaking the
continence assessment and weekly reviews in two sites, and SVP design and co-ordination in another:
The research nurse puts out the three day diary, or tells us who to put on it, then she formulates the
toileting plan.
FF2
Although senior ward staff were seen as having overall responsibility for monitoring and co-ordinating
programme delivery in all eight sites on a day-to-day basis, responsibility for specific aspects of the
paperwork differed: staff nurses or junior sisters were responsible for paperwork associated with their
allocated patients in six sites, one site relied almost totally on the research nurse to manage the
programme and paperwork, and on one acute ward the ward sister undertook the assessment and
trained staff did everything else.
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Role allocation was influenced by the type of ward,
I think it’s more difficult in this acute setting, maybe in rehab it would have been a lot more
involvement from the staff nurses, but here it was more the nursing assistants that would get involved,
KK1
and also by the amount of time the research nurse was present on the ward,
The Band 6s tend to know what’s going on with the patients, more so than the research nurses.
The Band 6s go around on the doctor’s round so know the catheter is coming out.
HH5
In the site where the research nurse was running the programme, role allocation was attributed to
ward pressures:
It is running smoothly and the paperwork is getting completed, but the research nurse is doing the
assessment and the weekly reviews rather than nursing staff doing them. If that didn’t happen they
probably wouldn’t get done. It’s because it’s so busy it just doesn’t get round to being done by the
staff nurse looking after the patient. If there is one staff nurse looking after 18 people they are not
going to fill in the questionnaire. As far as they’re concerned that’s not important at the moment due
to direct care.
LL5
Overall, the SVP was not perceived to have made a significant difference to patterns of workload allocation
on the wards,
ICONS hasn’t affected how work is allocated, or the ward routine,
LL5
although it did make a difference to workload,
It has affected the ward in trying to make sure that it’s done properly, making sure we have taken the
people who need to go to the toilet regularly and that it is noted down.
LL4
Activation: whether or not people work together to develop the new practice All of the sites had
undertaken activities to incorporate the SVP into the ward routines and procedures, including having
ICONS symbols on the ward whiteboard and on individual boards behind the patient’s bed to discretely
remind staff who was on the programme:
We have handover sheets where ICONS is highlighted, and triangles that we report by somebody’s
name above their bed to highlight, because we do have a lot of bank agency staff. It’s easier to say if
they’ve got a triangle they are on a toileting programme, you need to look at the notes at the bottom
of the bed.
CC1
Including ICONS on the handover charts and sheet was particularly important in reminding staff on a daily
basis which stage of the SVP patients had reached, and whether or not new patients were ready to
start yet:
The 3-day diary will tell us the person isn’t ready for intervention, and it’s reported on the handover
sheet to do a reassessment.
HH2
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The handover sheet was also used as an impromptu data collection form:
We also put tick boxes on the handover sheet to say that things had been done in case we didn’t
have time to fill in the paperwork.
HH5
Staff recognised that it was important to start the programme early. Wards had developed routines for the
night staff or ICONS HCAs to put out paperwork at the start of the morning shift (2). The SVP itself was
not seen as complex, but staff recognised that it needed embedding into the ward routines or it was in
danger of being forgotten. Prompting mechanisms included use of care clocks to help remind staff about
the timing of toileting (1) and leaving reminder notes in diaries for weekly reviews (1). Paperwork for the
SVP had to compete with other tasks and paperwork for attention:
It was really hard to keep vigilant about ICONS because it was getting lost within all the other
paperwork . . . It needs to be visual.
BB1
One site rationalised the overlap in paperwork between fluid balance charts and the SVP records:
We did have the fluid balance chart and now we have the ICONS chart, so people said if they don’t
need their fluid recording just use the ICONS, so we got better organised really.
CC2
During the period when the SVP was operating, intentional rounding was introduced into the NHS with the
aim of ensuring that all patients were seen by staff on a regular basis to meet basic needs, including fluid
intake, skin care and toileting. On the one hand, this worked in favour of the SVP because staff were
required to pay attention to the toileting needs of all patients on a regular basis:
The Proactive Patient Rounds initiative [intentional rounding] made it easier with ICONS because
people were looking at charts every two hours anyway.
HH4
However, it could also work against implementing the SVP as it was designed: the SVP tended to be merged
with the regular toileting required by intentional rounding, rather than an individualised timing regime:
When we’re going back doing the rounding which is done on a 2-hourly basis we’ll ask as well,
‘Do you want the toilet?’ so we try tying the two together.
BB3
There was some suggestion that fidelity to other aspects of the SVP may have been problematic in some
sites. For example, it is not clear if BT was used as a first choice for people who were cognitively able.
At least one site might have used PV as a generic initial stage for everyone:
Yeah, I think we started off with the prompting, then bladder training for the people who are
cognitively okay.
LL5
Respondents from another site said:
Most people go on PV.
HH1
We don’t get a lot of people on bladder training.
HH4
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However, it was also evident that staff on other sites did individualise programme timings:
The programme was good. It was more structured, something to work to, obviously people are individual
and sometimes something didn’t work but then you had structure to tailor it, you adjusted a little.
KK6
Collective action: the operational work that people do to enact a new practice
Interactional workability: whether or not people are able to do the tasks required by the new
practice Every site referred to initial difficulties in the first few weeks, but that the programme became
embedded and routine over time,
It was running smooth towards the end. Because we’ve done it for a good period of time it’s become
second nature, it’s now part of our daily routine;
BB3
although reminders were still needed (2):
You’ve got to keep on top of it all the time and keep pushing it, keep the momentum, because once
it goes off the boil, something else takes over,
EE1
and it might not be done properly all the time (3). Time constraints and staffing levels influenced whether
or not the programme was done (3):
If it wasn’t done it’s because of time pressures and being short staffed.
LL4
Too many people on the programme at once could also overwhelm capacity (2), but too few meant staff
could lose focus:
We will have a run of continent people . . . and get out of the habit of doing the programme.
HH3
The SVP was seen to place extra demand on nurses, both physically,
It’s hard work to toilet people every 2 hours . . . You seem to be toileting them forever,
EE2
and cognitively:
I always say the nurses on the ward haven’t got time to think. They can think about things they’ve got
to, but they can’t think why they should be doing this.
KK1
The programme needed to be simple, quick, and easy to do:
There’s so much to do in a day’s work, they like it being simple, it’s easier managed and maintained.
HH1
There were four main decision points in the SVP at which any difficulties in fidelity to the programme as
designed would be evident: decisions about eligibility; pathway (BT or PV); timing; and adaptations.
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Making a decision about eligibility The SVP required the completion of a screening register for
everyone admitted to the unit, to ensure that all eligible patients were identified and started on the
algorithm. Patients with UI or those who were catheterised in the acute phase were eligible for
recruitment, once they were conscious and medically stable. All eligible patients were started on a 3-day
bladder diary after catheter removal.
Ward staff had to ‘maintain vigilance’ about eligibility with a changing patient population as new patients
were admitted:
It’s just being vigilant on top of patients coming over to us and are they accounted for on ICONS, are
they somebody you could do it with?
BB1
One strategy was to view the screening register and 3-day diary together as a blanket screening process:
There weren’t very many patients being put on the programme. By screening every patient that came
in, by putting everybody on the three day diary we captured a lot more patients. Most patients now
go on the programme, it’s embedded, part and parcel of stroke practice.
EE1
Maintaining vigilance also required management at different time points for each patient:
One glitch is that people are not put on the 3-day diary when the catheter comes out.
HH5
The SVP was seen as sufficiently flexible to be able to adapt when a patient’s health status
was changeable,
The programme works with poorly patients because it can be stopped for periods of illness then
gradually started again,
AA3
but it could also be difficult for staff to keep the SVP in mind over time:
The patient goes backwards and forwards – catheterised, not catheterised, starts the programme, goes
into retention, is re-catheterised, comes back, starts the programme again. This can happen a few
times because our patients do go up and down. They’re the ones that can be easily left.
HH2
The SVP paperwork did not provide a way of managing this ‘surveillance’ activity for each patient. It
generally fell to senior ward staff to keep track of which stage each patient was at, which they found hard
to manage:
On return from annual leave there was a massive list of people that could be started on
3-day diaries.
HH3
One site enrolled HCAs into monitoring the programme start for specific patients:
Because then if the HCAs have a name they’ll keep saying to me, ‘How is Mr X, is he ready?’, and
that’s how we’ve been working it. It’s just getting them to think like that.
BB1
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Health-care assistants were responsible for diary completion in most sites, and although the diary process
was not a problem to them, it could be forgotten,
A lot of them tend to forget the 3-day diary and go straight into the forms,
BB1
or not completed consistently over 3 days:
A 3-day diary it’ll start one day and it doesn’t get filled in so we have to start the next day and it
doesn’t get filled in and then you’re here so you do it 2 days and then the third day it doesn’t get
filled so you have to start it again.
HH4
Patient transfer between acute and rehabilitation wards could also cause problems with continuity of
diary completion:
If part of the diary is being done on the acute unit we didn’t know whether to start again. We started
again because we didn’t know whether it was reliable, because it was only part done, or done
too early.
EE4
Staff in acute wards reported difficulties with diary completion:
By the time we had done the 3-day diary they were going to rehab so we didn’t get involved with it as
much as we’d like to have.
KK1
Respondents from one acute site thought involvement in the SVP was a good thing, but questioned diary
completion for 3 days when people were found to be continent,
Sometimes you start the 3-day diary off and after 2 days we noticed the patient is continent so it was
‘Do we need to carry this on?’;
KK6
or when people were found to be incontinent:
The three day diary is a bit too long to be assessing people when they could be at risk of excoriation.
I would rather start two-hourly prompting earlier. The 3-day diary is brilliant if they are just having little
accidents, but when they are actually incontinent it’s too long to keep them on that.
KK1
There were patient groups that some staff thought were not suitable for the SVP at all, including:
l continuous incontinence:
Some patients are a bit impossible to manage on toileting because they are wet all the time;
LL3
l poorly patients and patients with dementia:
A lot of patients have dementia and were confused and didn’t understand what we were trying to do
and in that respect it wasn’t appropriate at all, they couldn’t learn anything from it;
AA4
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l the frail elderly:
We seem to be having general rehab patients who were not up to rehabilitation, not well enough
even to come out of the bed, more dependent, need to be fed, a lot of older care patients;
KK3
l lack of awareness:
We had one lady . . . no knowing of when she needed to go and she was wet so many times and her
skin started to break, it was very distressing for her to have the catheter put back in but she felt it had
to be done.
BB1
Making a decision about the pathway The protocol required that patients who met the criteria for
eligibility began care according to the algorithm, which included a continence assessment, and a decision
about whether to start the patient on PV (cognitive impairment or no bladder control), or BT (little or no
cognitive impairment and some bladder control). The continence assessment was a 30-page document
used to assess the type, duration and severity of continence, and any influencing factors. Part of the
assessment process included medication review, and staff were provided with cards to summarise
the effects of the most common drugs on continence. Wards were also provided with a bladder scanner
and training in its use to aid assessment of urinary retention, a common reason for catheter use. Although
not explicit in the protocol, staff were encouraged in training to remove catheters as soon as possible.
Staff liked the bladder scanner:
Having the bladder scanning has made care more technical, and improved explaining things to
patients. It’s reduced the panic about the patient being in retention because you can see how much
they have in their bladder.
EE4
Nothing was said in the interviews about managing the consequences of assessment, medication review or
bladder scanning in terms of activities to resolve problems. It is not known if this was because these tasks
were uneventfully completed, but it may be that they were not completed because there was no
requirement for them to be recorded in the SVP.
Completing the assessment was generally disliked (5). Staff attributed difficulty to lack of time,
Realistically it would take an hour to an hour and a half to fill it out properly which is an enormous
amount when you’ve got all the other workload that you’ve got to do;
HH2
lack of privacy,
Finding the time and privacy to do the continence assessments has been a bit of a struggle;
CC1
and because staff often could not obtain the information easily:
The thing at the front seems to be the hardest because most of the patients aren’t able to talk to you
or can’t remember, so you’re waiting for families to come in.
BB1
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
243
Staff questioned whether or not all of the information in the assessment was needed:
Whether the assessment is giving them a more detailed picture or whether it’s overwhelming them
with information I’m not sure. People say this is too much about one specific area of this person’s care
when I’ve got this other huge backlog of history.
HH2
The sequence of events from bladder diary, through assessment, to programme choice had to be
remembered and managed over a number of days:
Sometimes we’d start the two-hourly prompting and I’d think ‘Oh I can’t, I haven’t done the
assessment.’ Or we’d put it on the board – ICONS assessment needs doing, and perhaps it wouldn’t
get done for a few days . . . so you have to go back then . . . to the assessment and then back to the
toileting again, but we got into it after a few weeks – we weren’t too bad.
EE6
Sites had different ways of managing this continuity, including monitoring by a nominated person,
One of the ANPs [Adult Nurse Practitioners] is going to be keeping on top of it. She’s in charge of the
new catheter forms we have to fill in now to keep a check on how long the catheters are in and when
the bags are changed so ICONS can run alongside of that;
BB1
monitoring by the ward sister or research nurse,
It is running smoothly and the paperwork is getting completed, but the research nurse is doing the
assessment and the weekly reviews rather than nursing staff doing them. If that didn’t happen they
probably wouldn’t get done;
LL5
and using handover and whiteboards to record status, although these were not perfect:
Sometimes the handover sheet got missed for a few days but they were more or less up-to-date with
what was happening.
CC2
Programme choice was not explicitly referred to, but PV seemed to be the more common option:
I think we ended up doing more prompted voiding than bladder training. Possibly because the
patients who were incontinent tended to be people with more cognitive problems, they needed
the prompting rather than being able to take charge of their own destiny.
CC2
This was not necessarily just for people with cognitive problems, but for everyone:
We start off with prompting and then bladder training for the people who are cognitively okay.
LL5
It is unclear whether or not this was due to misunderstanding or was a purposive deviation from
the protocol.
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Bladder training The BT protocol asked staff to encourage patients to follow their voiding timetable as
closely as possible. If able, patients were encouraged to complete a 7-day voiding diary as part of the
programme. If the patient was unable to complete it, staff recorded their progress. Although staff were
generally positive about patient involvement, one member of staff commented that patients could get
over-involved:
We’ve got one patient who is too obsessed with his bladder training – he’s constantly on the buzzer
after you’ve just seen to him.
LL6
Three sites identified that distraction (as it was being implemented) was challenging for the staff and
the patient,
We are saying try and hold it as long as you can, they are saying ‘Please why won’t you let me go?’
and getting quite agitated about it.
HH4
One respondent said,
Very agitated patients who want to go to the toilet every 5 minutes, I feel a bit awkward saying
you’ve been now and you got two hours to go, it feels a bit hard. I do tell them and then they get
anxious more and more and get quite irate so you’ve got to give them a bottle. You keep them
calm – they’ve already had one stroke you don’t want them to have another.
LL1
Respondents from two sites commented that it also looks bad to relatives when staff appear to be
stopping people from going to the toilet. The comments suggest that the principles of extending the
voiding interval by small increments in BT may not have been fully understood by all staff.
Prompted voiding In the initial stage of PV, the person was asked if they were wet, then the nurse
would check and give feedback on whether the patient’s awareness was correct. Patients could
lack awareness,
Some can’t tell you if they’re wet or not, they don’t realise, you ask them but they don’t realise,
FF4
but repeatedly asking people if they were wet was uncomfortable for staff,
I don’t like asking the patient if they’re wet because they are embarrassed, but I know it’s got to
be done;
LL1
and possibly for the patient:
Asking the same question about whether they’re wet or not is perhaps a bit tedious after a while for
the patient.
LL4
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Regular prompting to use the toilet could be difficult with some patients:
There were a couple of patients that we started on the programme and we stopped it because they
have such huge problems, they were confused. I think they just got to the point where every time you
asked them to go to the toilet they were getting very angry, frustrated, so we just backed off because
it was distressing them . . . I think maybe it was the frequency that they couldn’t deal with, the last
thing they remembered was you asking them to go to the toilet, and here you were again.
CC2
Staff talked about avoiding confusion, ‘moving the bed can really mix them up’ (E4), and using methods of
asking which encouraged participation:
I think it depends how you ask them. It says on the thing to ask ‘are you wet? Do you want to go to
the toilet?’ They quite often say no, but if you say ‘Come along, we’ll take you to the toilet’ they will
come, so it depends how you word it.
FF4
Staff thought that regular toileting could also be difficult for people who needed hoisting:
You have to hoist them onto the bed, remove their clothes, hoist them onto the toilet, hoist them
back on the bed, and then back into the chair and the whole process can take up to 45 minutes and
patients aren’t always compliant because of that.
CC1
Using bedpans was not as effective,
Because of the cognition again, very often if you sit patients on a toilet they’ll go, but a bedpan
doesn’t have the same effect – it’s harder for them.
FF4
Other conditions affecting patients who staff found challenging for regular prompting included:
l depression:
She was quite capable of being continent. It was just that she had got herself in such a low mood
and didn’t want to bother;
BB1
l fatigue:
there are some patients who you can try to walk to the toilet every two hours and they are
absolutely shattered as a result of it. Fatigue can be really problematic for some people;
FF1
l dependency:
A lot of the elderly patients who perhaps needed a bit of care prior to the stroke perhaps weren’t
as motivated to regain their continence;
BB2
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l communication problems:
for patients who have a lack of communication it’s difficult to get them to understand the
programme if they’re not able to tell you when they need to go;
HH4
l urge incontinence:
We sometimes can’t get there quickly enough for people with urge incontinence.
AA4
Making a timing decision For BT or PV, staff had to choose a timing interval (the time span between
voids), based on the bladder diary. This was translated into scheduled voiding times throughout the day
and recorded daily on a treatment log. Staff then had to complete the log for each scheduled voiding time
throughout the day, including the actual time they attended the patient, whether or not care had been
delivered as prescribed, the outcome (i.e. whether the patient was wet or dry), and if they had successfully
used the toilet or bedpan.
Timing was the most commented on aspect of the SVP. As all of the documentation surrounding the SVP
was based at an individual patient level, the first point about timing was remembering who (out of up to
32 patients on a ward) was on a TV programme:
People were having difficulty remembering who was on ICONS despite the little red triangle on the
name board.
CC2
Timing could be difficult to schedule, remember and adhere to,
It’s hard to keep track of who needs doing at what time,
HH4
especially in relation to therapy, visiting times, or mealtimes:
Mealtimes are protected so usually we work around them, and take patients to the toilet before but
that doesn’t always work. Patients sometimes don’t want to delay going, and you can’t not take them
because it looks bad, so that doesn’t work.
LL1
Keeping to time for patients with physical limitations was a challenge:
Toileting people 2-hourly if they are very dependent is difficult, because of the time it takes to finish,
the two hours are nearly up again.
CC1
The programme timings set up expectations which could have negative consequences for patients if not
met, but also for staff:
If you haven’t got enough staff some days you’re called everywhere, you can’t get there in time which
is quite frustrating.
LL1
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Staff were aware that patients lacked confidence in their ability to keep to timings,
That’s one thing you must remember to do if you‘ve promised that you’re going to come back, you
must go back,
BB1
and that patients could be reluctant to buzz:
Some people won’t press the buzzer for assistance, they don’t like to use their buzzers.
LL6
Staff identified strategies to keep to timings, such as enrolling patients:
We make sure they’ve got the buzzer and say ‘Right, we’re due to come back at such a time, if you
press 10 minutes before then we’re not leaving you on the last-minute,’ especially if they have to walk
to the toilet.
BB1
Staff said they sometimes could not complete the daily treatment logs immediately after they had attended
to the patient, and might forget to go back:
In some cases you would find that the documentation had been forgotten to be completed, but when
you asked had people been to the toilet they had at the times they should have gone.
CC2
One problem with the completion of the daily treatment logs was that staff did not know how to
record refusal,
If the patient has refused you’ve got to write no and that looks like that we haven’t bothered to
toilet them,
CC1
or accidents:
The patients who can walk to the toilet are the ones we’ve found hard to manage . . . We don’t know
what to write down for patients who make an attempt to go to the toilet, and then have an accident,
although they did instigate going.
EE4
Ambulant patients also created recording difficulties because staff did not necessarily know if they had
actually used the toilet. There was overlap between the daily treatment logs and fluid balance charts, and
one suggestion that recording on the daily treatment logs sometimes might not match actual practice:
There are occasional days where the charts aren’t filled in as accurately and you wonder whether it
has been done routinely.
HH3
The tendency to merge the SVP with intentional rounding had benefits for workload,
Because the ICONS and the skin and safety round came at the same time they support each other, it’s
not an extra job. This was fortunate otherwise it would have been a nightmare,
FF1
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but perhaps created problems for individualised timings if everyone was checked at the same time:
when the ward rounds came in, that made it easier, because it’s become the norm to check everybody
every 2 hours.
HH2
Adapting the timing or programme The protocol suggested reviewing patient progress at weekly
intervals using the daily treatment logs and the 7-day bladder diary completed by the patient. The voiding
schedule for the following week was to be documented in the back of the patient information booklet,
the nursing care plan, and the weekly review form. The weekly review was identified as an ideal time to
discuss progress with patients, and provide support and encouragement to continue.
Patients’ completion of a 7-day bladder diary seemed useful for those patients who could manage it:
Those people who went on bladder training quite enjoyed being in charge of their piece of paper and
their pen. It was something that they felt they had some control over in this environment where
everything is so completely different.
CC2
There was no reference to discussing weekly progress reviews with the patient.
Despite placing reminders in the diary, weekly reviews could be forgotten:
We’re not doing very well with the weekly assessments. That should be done automatically, part of
the risk assessment, so . . . it’s as important as your falls assessment every week because that gives you
a scale of where you are up to. We are having to go back and fill them in which is just giving
ourselves extra work.
BB1
Two sites suggested that weekly reviews should all happen at the weekend so that they were the same as
reviews of other aspects of care.
At least one respondent might have misunderstood the process of weekly review,
I was just doing it every week. I didn’t look back to the week before, perhaps I should have
done though,
KK6
but comments on the consequences of missing reviews suggests that its purpose was clear to others:
It didn’t matter if people didn’t change very much but there is the chance that you might have missed
a couple of weeks where somebody might have moved a lot faster if you’d got the assessment done
on time.
CC2
The protocol was not explicit about whether or not the SVP could be stopped, and staff from one site
commented that they did not know how to stop it:
Sometimes we’ve carried on for days because we didn’t know we could discontinue it.
EE4
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Relational integration: whether or not people are confident in each others’ work and expertise in
relation to the new practice Change was recognised as bringing challenge,
Change in routines is difficult, people have got to be supportive of it mentally,
AA1
with specific challenges for nursing culture,
Nurses have a reactive rather than proactive nature – they expect incontinence and use pads.
Changing that culture is quite a struggle;
HH3
and in respect of individualising care:
we’re asking people not just walk into work and blanket think about everyone, and that
means – you’ve really got to think.
HH2
At the start of the trial when they were beginning to implement the SVP, most sites had a period of
learning, where they were unsure:
We were a bit muddled about it initially because people were saying different things . . . It took a few
weeks for us to understand it.
AA4
In some sites, the initial rollout was rushed,
The initial rollout could have been done better. It wasn’t a flow of information, somebody knew about
it on one shift but didn’t pass it over to another shift.
BB1
By the time of the interviews, staff were expressing confidence in each other,
We can rely on each other in regards to how it gets done each day,
AA2
I think the team as a whole are doing pretty good,
FF2
although some staff remained less enthusiastic than others:
It was explained well enough but it was whether the staff took it. Here’s something else for us we’ve
got to do again, and they just had a negative [attitude] from there on, so it was overcoming that but
as time’s gone on they have got better.
FF2
Individual staff required ongoing monitoring for some aspects:
Documentation can be left to some nurses but not others, whether that’s down to confidence or
personalities, I’m not sure.
EE4
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Respondents from three sites expressed confidence that the programme was being run properly,
and respondents from two sites thought that the programme would not run properly all the time without
being driven:
It’s hard to judge if people are genuinely on-board with it, I like to think that people are fully engaged
but when I’m not here I couldn’t vouch for that.
FF1
Respondents from one site thought that this was just the process of developing routine:
You need to keep saying to people every day this is what we’re doing . . . And then eventually it
sinks in.
HH2
Reasons suggested for lack of compliance included maintaining attention in the face of
competing priorities,
It’s almost like persistent nagging making sure that the ICONS stays there and the focus stays at
that level;
FF1
the necessity to complete paperwork,
It’s more the paperwork that you’re constantly nagging certain people for;
FF1
and shortage of time:
you’ve pretty much got to encourage people constantly to get involved but it’s not because they don’t
want to do it, it’s just they haven’t got time.
KK1
There was improvement in compliance over time:
Gradually we got to where the named nurses were making sure that things were up-to-date as far as
possible, people took more ownership as time went on, they didn’t need as much chasing up in the
end so I think people did start to embrace it more.
CC2
Lack of staff involvement with the programme in one site was attributed to maintenance of separate roles
for the ICONS HCAs:
The major issue on the ward is communication between staff. If we were all sat down and told it’s
everybody’s responsibility we would just do it like normal, like everything else we do on the ward.
HH4
Bringing inexperienced new staff into the ward as ICONS HCAs was seen as ineffective in influencing
existing ward routines:
It was very difficult for the ICONS nurses who were young girls to walk into a new workforce and know
what to do . . . because you are trying to change people’s mentality and maybe challenge their work ethic,
HH2
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as was the use of an external research nurse:
For the new research nurse it is very hard to come on to a ward two days a week and have any sort
of presence.
HH2
The practical aspects of the SVP became an accepted part of routine ward practice and staff gained more
confidence in their own knowledge of continence,
I certainly learnt a lot and I thought I was quite knowledgeable about continence,
HH3
and their ability to manage it, ‘Nurses have been empowered by it’ (EE1). Extra staff impacted on staff
confidence that they could do the programme consistently:
I think the staff getting on board has helped, and having the extra staff. As long as we’ve got the staff
to do it, I think everyone’s quite happy to do it.
LL4
One practical aspect that remained problematic in two sites was getting staff to maintain vigilance for
eligible patients for the SVP:
It’s just making that part of the admission process, trying to look at ways of making it more in the
front of their minds, triggering the staff to think about it.
BB1
Respondents from one site thought that the SVP had adversely impacted on ward relationships,
There were negative interactions because of it. The auxiliaries were in high demand, quite rightfully
overstressed regarding it, and it did cause some bad morale and some bad attitudes on the ward, but I
think they were resolved further down the line and things began to work better,
BB2
but respondents from two sites thought the number of positive interactions between staff had increased:
It has brought the team closer together for the simple fact that they are talking, as well as continence,
about how they plan their day. It has made people co-operate more with each other.
CC1
Respondents from three sites also thought that the programme had improved liaison with therapists,
The occupational therapists are thinking is there anything they can help a person to use the toilet. One
of the ladies we were struggling with, the physiotherapist did extra work with her so she could get
onto a standard hoist,
FF1
with respondents from one site also identifying increased nursing input to MDT meetings:
Continence is something that a nurse now expects to be asked about, or expects to share in the
multidisciplinary team ward rounds.
FF1
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Skill set workability: whether or not the work of the new practice is appropriately allocated to
people with the rights skills or training Although it was thought that staff were aware of the need to
promote continence (1), some skill deficits were acknowledged such as moving and handling skills for new
ICONS HCAs (2), communication about continence (2), and assessing continence (2).
The SVP was seen as relatively difficult to learn at first (3):
ICONS was more challenging to get to grips with than other research projects.
AA2
Training given by the research staff or senior ward staff was seen as meeting needs by some staff,
We had a presentation, what it was all about, why we were doing it . . . That was it. I don’t think she
could have explained anymore, or highlighted anything differently
LL5
but there were often mixed views in the same site. Some staff would have liked more training,
We didn’t get enough direction at first, we only had one meeting which wasn’t enough information,
LL3
or training for specific staff grades:
The education was focussed on the qualified nurses. There wasn’t enough direction for HCAs at the
beginning. There should be more support and more advice for unqualified people.
AA3
The timing of the training relative to starting the SVP varied between sites, with some having a delay of a
few weeks, and others having a rapid start. There were problems with delaying the start,
There was a gap between the initial training and the start of the trial, it would be better to have the
training just as we were about to start,
FF2
but staff from three sites also suggested that a more gradual lead in to the programme would have
been beneficial,
We should have done a couple of trial cases, learnt and reflected on that. You could do with a few
months being on the program and not actually entering the results sort of a trial,
EE4
or that cascade training might have been better:
Because the trial manager did the training it doesn’t become your own. It might be better to cascade
training by senior staff. I struggled to get my head round it at first, so as senior nurses we should have
understood it more.
EE4
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Although suggesting potential improvements to the training, staff did think that they had the skills and
knowledge to deliver the programme (4). They also thought that they had learned new things, such as the
potential for intervention,
Nurses are more aware that continence doesn’t have to be a big problem if you can get it in the
early stages;
EE1
assessment,
The bladder scanning was a skill we never had before, it’s a skill we’ve got now, continue to use;
KK3
and improved ability to talk to patients about continence:
Because we have more knowledge we were having more informed conversations with patients.
FF1
There were positive comments about the educational resources, including the information packs that staff
received (3) and the medication cards (1). Only one person reported that they had completed the online
training, and they thought it was good. Six other respondents said they had not done the online training:
two said they did not know about it; one blamed lack of time but with a hint that online training was
perhaps not the most preferred delivery route:
We’ve had so much online training coming through from the trust itself. We’ve got to do it for the BM
[measures blood sugar] machines, for nutrition. They’re pushing through so many online but it’s
finding time. I don’t get time, I have never read my e-mails.
KK3
Some wards identified staff to take on specific roles within the programme:
I specifically picked staff nurse to be that educator because if one person kept up, making sure all the
paperwork was there, and then it’s a case of her cascading it down to everybody.
BB1
Comments on inappropriate staff allocation included the use of bank staff, ‘It’s got to be permanent staff
doing it’ (FF4); disagreement with the ward sister being involved in trial recruitment,
A ward sister looking after a team of 12 patients hasn’t got time to get consent for a clinical trial;
FF2
and using HCAs to complete reviews:
Staff nurses got us to do the weekly reviews at the end of each week: the new research nurse doesn’t
let us do that because we’re not supposed to.
HH4
Contextual integration: whether or not the new practice is adequately supported by the host
organisation Although at least two sites did not manage to recruit or maintain adequate extra staffing,
all eight sites said that having extra staff helped:
With three extra staff . . . We thought we’d died and gone to heaven.
EE6
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Extra staffing was perceived as a negotiating device to involve staff in delivering the SVP, ‘The extra nurses
were like a bargaining tool’ (H1), and meant that staff could deliver the programme consistently:
If you were caught up with something else perhaps you couldn’t get back there to make sure there
was consistency. The extra staff made sure you could follow it through.
KK3
However, having extra staff did not seem to affect perceptions that workload had increased. Seven out
of eight sites commented on the extra work of the programme on what were already busy wards, six
identified inadequate staffing as a barrier to delivering the programme, five identified problems with
sickness or short staffing during the programme delivery period:
We struggled when we were short staffed to try and make sure everybody was going to the toilet at
the right time, and you didn’t always have time to do the paperwork and weekly reviews as you
should do.
CC2
The extra staffing provided by the research programme was generally well protected from trust demand,
but not always:
And what happened with the ICONS staff they were counted in the numbers. If someone was short,
one of ours would have to go off to cover, so we were no better off. I know that’s not what you want
to hear because the university funded it, but that’s the reality, that’s what happens.
FF4
Owing to the presence of extra staff supplied by the research, support from the trust for adequate staffing
was something that had to be actively defended,
That’s when I have to speak to people about my finances and they wonder why, they look at the ward
level staff, they are needed because of this programme;
BB1
or creatively used:
One of the things that helped us with ICONS is enhanced support, bank carers who are allocated a
bay of patients, and they tend to do a lot of the intentional rounding, and attempt to do a lot of the
ICONS as well.
BB2
However, new or bank staff could be difficult to integrate:
If you’ve got your own staff who know about ICONS and what they are supposed to do, it’s fine – but
when there’s three or four of you and the rest are bank staff, it’s difficult.
FF4
Adequate staffing appeared to be important in whether or not staff felt positive about the programme:
The programme has worked generally as long as we’ve got enough staff to make sure that all the
paperwork is done, and chasing it up – I think it’s good.
LL4
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Problems meant that staff felt bad about not being able to deliver the programme properly:
If you haven’t got enough staff some days you can’t get there in time which is quite frustrating.
LL1
Delivery of the SVP during a shift was also perceived to require relentless effort,
We never stopped from start to finish there isn’t a break because we’re constantly doing all the time;
BB1
and needed to compete with other demands on the attention and effort of ward staff:
The paperwork for the CQC [Care Quality Commission] visits was phenomenal. It was really hard to
keep vigilant about ICONS because it was getting lost within all the other paperwork.
BB1
Three sites identified difficulties with the environment or equipment, such as lack of toileting facilities,
Toilet facilities are a problem because of the mix of patients we have only one male toilet;
CC1
lack of space for hoisting equipment,
They added extra beds up here. The space for manoeuvring the machinery around [is limited], and the
patients are very needy;
LL2
or lack of equipment:
Lack of equipment can be a barrier, we sometimes have to wait for it, or they are broken.
EE6
Reflexive monitoring: the appraisal work that people do to assess and understand how a
new practice affects them and others
Systematisation: the ability of people to determine the effectiveness of an intervention Success
was variously defined by respondents as:
l getting continent, no accidents, dry every time:
I would say success is no leaking, no accidents;
HH4
l partial continence:
If someone had the odd accident I wouldn’t say it was a failure. If you can get it right 80% of the
time it’s better than nothing at all;
FF4
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l less wet:
those who it didn’t work with were more continent doing ICONS than they were without it. They
were drier more of the time when they were being toileted regularly than they were without it so
that was obviously better than being wet all the time;
CC2
l not getting urgency, aware of need:
Success is knowing that you don’t get that urgency, you can walk them to the toilet and they’ve
got time and that’s because they’re getting that feeling of going to the toilet but the urgency is
not there;
BB1
l asking to go to the toilet, not wearing pads:
Success is when a person has gone from wearing a pad, to asking to go to the toilet, and actually
being dry every time.
LL6
Staff from five sites said they could see change in the patient’s progress,
Staff can see the patient’s reaction to success, and can see improvement over time,
AA3
and in patient outcome,
I could see it had a positive effect on quality of life and discharge destination and for that reason
I liked it.
BB2
One acute site talked about the disappointment in not being able to see outcome:
It was a bit disappointing at first because we didn’t know the outcome most of the time, we didn’t
have any feedback for how well we had done . . . in acute all you’re seeing are the very ill, you can’t
think what’s to come, what the person who can do nothing is going to be like three months down
the line.
KK6
The long-term outcome for any patient was also not known because of lack of follow up into
the community:
We don’t follow anybody up. It might be beneficial for the community stroke teams to follow
them up.
EE1
Staff could see patient progress reflected in the paperwork:
Once they started noticing a lot of the patients we did get them triggered back into timing and it was
only as you were discharging and having it in paperwork, the fact is we got them into a routine and it
makes a big difference.
BB1
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Sometimes, staff were surprised that particular patients progressed,
We have seen people who were incontinent who finished up being continent or better than they
were. There have been a few that we have been quite surprised at,
HH3
but also that incontinence was not necessarily as prevalent as was expected in acute stroke:
You have this perception that incontinence goes hand-in-hand with stroke, but since we’ve been
doing the trial we’ve noticed that incontinence as a whole isn’t as bad as we first thought.
FF1
Visible success was important for staff motivation:
We did have some success stories over an 18 month period. As auxiliaries started to realise and started
seeing more of the benefit because they weren’t constantly going back to these patients it did
become more popular over time.
BB2
Focusing on success was used proactively to encourage and motivate HCAs:
Some of the people who were in the further training were my stronger more proactive staff nurses.
They worked with the clinical support workers and tried to link continence to mortality and discharge
destination, making them think about outcome rather than the task in front of them at the time.
FF1
Feedback from the family was also influential:
It’s when the family start saying oh she’s continent now, that made the difference, that started
people thinking.
BB1
Senior staff and research nurses found the programme hard to monitor, ‘It was hard to keep a handle on
the programme’ (A1). Four sites talked about informal evaluation of outcome:
We haven’t formally assessed the value of the programme other than through observation: just
watching and seeing what’s happening on the ward such as less use of resources, less wet beds, less
wet clothes, less nursing time, less buzzers going off.
F1
The programme appeared to influence the amount of monitoring of continence,
I suppose we are monitoring their continence more closely, that gives us a better picture,
LL5
which confirmed fewer incontinent patients than expected:
I was personally surprised how few there was. A lot of patients from the acute unit do the 3-day diary
and we find they’re not actually incontinent.
CC1
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More formal evaluation was not frequently referred to, but included the auditing of skin and safety
rounds; buzzer audits; emotional touch point groups, where patients are asked about their concerns; and
Care Quality Commission (CQC) visits. Stakeholders external to the ward required measurement of
progress: from the research team,
Having the research nurses coming in from the University is really good because they’ll keep us on
our toes;
BB1
and from the trust:
Skin and safety rounds are being audited on a weekly basis, and fed back to the trust board. We’ve
been told to hold people to account if they are not filling in their paperwork. Auditing the skin and
safety rounds every week tells the ward manager whether or not we’re achieving what we are
supposed to be achieving, and that is fed down to the staff and the governance meetings . . . and
nobody likes to be seen to fail do they?
FF1
The ICONS research was seen to feed into external monitoring, ‘ICONS provides evidence for the Sentinel
Audit’ (EE1). One site referred to increased nursing discussion of continence in team meetings:
It’s discussed at MDT [Multidisciplinary Team Meetings], it’s become our nursing issue. It is a big issue
at discharge planning.
EE4
One respondent questioned whether ICONS had resulted in increased attention to evaluating continence
care in their trust:
Whether it’s to do with this or other Trust issues they are looking at the type of pads we use, which
are now changing; there is a feeling that continence is increasing in importance within the Trust.
CC1
One bar to continuing evaluation was the lack of paperwork for continence other than that supplied by
the research:
I hope our hospital might create our own paperwork: we can’t use any paperwork that hasn’t been
approved. Without ICONS we haven’t got anything to monitor patients’ progress: there needs to be a
care plan issued specifically for this.
HH3
Awareness was shown of the need to underpin practice with research evidence:
There is such a lack of research out there, the trials that have been done previously were small, and
we didn’t really have any good clinical evidence to support what we were doing.
FF1
Respondents recognised that linking the SVP to outcome was challenging,
It’s difficult to say whether people who have been successful on ICONS might have been
successful anyway,
HH3
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including wider outcomes:
A recent audit done by the Stroke Association has said we are in the upper quarter for patient
satisfaction and experience, but linking that to the ICONS trial is difficult.
FF1
The research outcome was needed to support continued use of the SVP:
If we can demonstrate it [the SVP] promotes continence we would adapt and use it but confirmation is
needed because of the commitment needed to enforce implementation. If it is successful, there would
be a lot of pressure to implement it from specialist nurse, consultants, senior management.
AA1
Communal appraisal: whether or not people can use formal monitoring to collectively evaluate if
a practice is worthwhile People generally thought that – despite the extra work – the programme was
better than previous continence practice,
It is definitely better for the patient, it does take more work and that was the biggest thing,
KK6
conditional on having the staff to do it,
As long as we’ve got the staff to do it, yeah, I think it’s good.
LL4
All eight sites reported that the intervention worked for a proportion of people,
It has promoted continence in lots of people so ultimately it is good . . . I think you can see that
it works,
LL4
with some attempting to put a figure on the proportion:
I’d say they made improvements about 75% of the time.
KK2
There was a degree of surprise about the perceived effectiveness of the intervention from both
qualified staff,
What we do now is better – no question. I’ve been surprised, I think it has worked,
HH1
and non-qualified staff:
I got a bit upset at first, it was like here we go again, but this time I’ve actually seen a few benefits.
LL1
There was general agreement (8) that some patient groups tended to do better:
It worked for patients with less cognitive impairment, more mobility, better communication and
understanding, younger people.
EE6
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However, two respondents pointed out that it could also work for people with cognitive difficulties:
Quite a few people did end up being continent before they were discharged which was quite good for
the patients who were more cognitively impaired and didn’t necessarily know exactly what we
were doing.
CC2
One respondent speculated about the reasons:
Sometimes the ones with cognitive impairment were the ones that would respond better to the
routine. In some ways it helped the ones that were more cognitively impaired . . . who are quiet and
withdrawn and don’t demand attention – it gives them attention. The ones that are more alert, verbal,
demanding of attention – they get more of the attention on a ward. The ones with communication
difficulties would lose out. Whereas if they are on ICONS they are getting that input as well.
FF4
Regaining continence was important in determining discharge destination:
One frail elderly man came in really poorly, doubly incontinent. We did ICONS with him and
persevered and by the end of his stay he was continent, going to the toilet regularly himself, able to
recognise when he needed to go, which had a massive impact on his discharge destination because
he was deemed safe to go to his home environment whereas if he’d been mobile and incontinent that
can be more problematic because it’s a higher risk of patients falling and they might need a higher
package of care or a nursing home.
BB2
Even without full continence, the development of a routine for cognitively impaired people was valuable
for their discharge – whether going home or to a nursing home:
The fact is we got them into a routine and it makes a big difference, especially when you’re handing
over . . . It may be you would always have to be the one to go to them and say would you like to try
the toilet, maybe they would never trigger themselves but if you had that routine you would keep the
patient dry and it would give them self-respect.
BB1
Some patients also managed to wait for longer before going to the toilet:
And some you got lengthened time between toileting, you could get 3- to 4-hourly with some.
FF4
Patients could respond fairly quickly to the intervention,
It’s worked really really well for other patients, straightaway you’ve seen an improvement,
HH4
but some might take longer to respond:
It has worked with some but not for others, although it could still be working.
HH1
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Two respondents said that patients did not always become continent at night:
One of the ladies has gone from being totally incontinent, to more or less continent, but at night time
they revert back because they seemed to relax.
LL1
Mobility was a major issue affecting the likelihood of success:
It’s usually the ones that progress who are sitting quite well in the chair, so then you could transfer
them onto the toilet. Those types of patients came out far better than those who were medically
unwell and not coming out of the bed.
KK3
There was disagreement about the impact of gender, with two respondents seeing more improvement in
men, and another more improvement in women. One respondent thought that the impact of not having
to use pads was greater in men:
The men had been more impressed because for them to be continent has made a big difference
because they don’t want to be having pads at any time;
BB1
whereas women still liked to use pads:
We managed to get a few ladies home and be continent, but even though they were continent they
still like to use Tena pads, they’ve always had them and they’ll always have them.
BB1
The same respondent speculated about why men do better:
The men seem to have got better than the ladies, they seem to be quicker in getting themselves into a
routine. I’m wondering whether it’s just because it’s easier to manage a bottle.
BB1
There was a fairly general view, (4) expressed that the programme would not work with some patients:
It wasn’t going to work with some people no matter how much we toileted them.
EE6
Respondents attributed non-response to pre-existing incontinence or lack of awareness (3), or cognitive
problems (3), but thought that response was to some extent unpredictable:
Some it didn’t have any impact on at all. You couldn’t get any pattern or rhyme or reason to what
was happening. It wasn’t a particular type of patient, it was variable; it depends on the mental
capacity, the cognition – but it could vary even with that.
FF4
One respondent said:
But it’s a fact that sometimes you . . . do have to implement it to see does it work?
AA2
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However, although patient response to the SVP was known to be unpredictable, this attitude of needing
to try the SVP with everyone did not appear to be a commonly held view.
Five respondents identified that patients felt better, physically and emotionally:
Improvement is not only in incontinence but in personality, they become mentally a lot better, happier
as well because they aren’t getting emotional about being wet.
HH4
Three respondents thought that there were benefits for self-esteem, independence and dignity of the
patient, and five respondents felt that more involvement, ownership and control of the patients’ recovery
improved their confidence:
Patients are getting self-esteem and confidence in themselves because they are getting back to their
normal ways like they would at home.
LL6
One respondent thought this helped patients feel that their needs were being met:
We are pre-empting what might be coming by addressing needs on a regular basis, patients feel their
needs are being met. We do emotional touch point groups and things like helplessness used to come
up quite a lot, but that hasn’t come up for quite a while.
FF1
Benefits for nurses and nursing care included:
l Increased nursing awareness, knowledge or confidence. Six respondents identified improved nursing
awareness, interest, knowledge or confidence:
They [the assessments] make you think a lot more about the type of continence problems people
are having. Educationally it’s very good there’s been a lot of teaching, it’s made people interested;
HH3
l Making nursing care easier, reducing workload. Five respondents identified that nursing workload
had reduced:
Workload – I still think it’s made our lives easier. A full bed change takes two staff half an hour
maybe three-quarters of an hour. Standing the person to the toilet takes five minutes – the time
difference is a plus for us,
HH5
or that the work had shifted from less physical work, to more paperwork:
So it has made an impact in nursing time. It’s more paperwork but the actual physical work has eased
off a little bit;
BB1
l Reduction in pad use. Five respondents identified reductions in pad use:
Our pad usage seems to be going down because we are taking people to the bathroom;
FF1
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l Improved communication with patients and relatives. Three respondents identified improved
communication with patients:
I think we’re much more open about continence with patients, people actually discussing why
we’re doing things, and the importance of it, and asking for the patient’s opinion more. If patients
are having problems still with their incontinence we are giving them much more choices as well as
the toileting, which pads to use and things like that,
CC1
and with relatives:
Involving the relatives in assessment takes a lot of time;
KK6
l Improved communication between staff. Two respondents identified more interaction between staff
about continence:
With the time management, people are talking about that with each other and planning, and I
hear staff saying, ‘Well we’ve got so and so will need to go on at such a time,’ so they are
interacting and planning between themselves, rather than responding all the time which is what I
think they tended to do before;
CC1
l Changing nursing attitudes towards incontinence. Three respondents thought nurses now saw
incontinence as more amenable to intervention:
It did alter attitudes towards strokes and continence that something could be done;
KK6
l Increased therapeutic role for nursing. Two respondents identified improvements in nurses’ ability to
proactively assist patient recovery:
It is showing that we’ve looked at it and we are identifying that there is a problem, and we can
help you with it, or at least we can try;
FF2
l Changes to care planning. Three respondents identified changes to care planning and continuity:
It certainly helped us improve the consistency of care. It’s given us knowledge and a structured
plan of action. Nurses like to have a clear management plan to follow: you’re more likely to get
consistency and continuity;
FF1
l Increase in use of bladder scanner. Three respondents talked about increases in bladder scanning:
I thought the bladder scanner was excellent too. We do scan bladders much more frequently than
we used to;
CC2
l Reduction in catheter use. Two respondents thought that there was less use of catheters,
There’s less catheterisation;
EE4
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l Calmer ward, fewer buzzers going off. Two respondents said that there were fewer requests from patients:
It didn’t take long to work out that buzzers were going off less, so you were pre-empting care,
being proactive rather than reactive;
FF1
l Increase in investigations. One respondent identified a change in continence assessment:
Increased consciousness of continence results in more investigations e.g. dipping urine, sending
samples off. They probably do this more now than before.
EE4
The extra staff were seen to impact on aspects of care wider than just continence:
We have got the extra staff, which is brilliant. That has certainly had an impact on the care that we
can deliver . . . Not just continence but all aspects of care.
FF1
Views on the impact of the SVP on cost were mixed. One respondent thought it would save money:
Costs have probably balanced out: having to send the patient home with a pack of pads at 60 or
70 pounds a pack and the costs in changing patients versus the paid costs of the labour. If it ran long
term you would probably find significant savings but you would have to get more wards on board;
HH5
another thought the costs would probably even out:
But at the end of the day the time and nursing time we are saving by toileting these patients and not
having wet clothes and beds to change if you added it up in a total week, it would actually reduce
nursing time and hopefully break even.
FF1
Individual appraisal: whether or not individuals think a practice is worth doing Staff at seven out
of eight sites thought that the SVP should be continued, and that it was worth doing. Staff at five out of
eight sites identified that they were still doing the physical components of the SVP, at least in terms of
regular toileting. Only one site suggested that the SVP was not continuing, with some expressed regret:
It probably wouldn’t be a popular decision to carry it on but personally I think it’s a shame it has
stopped. Since the trial is finished it’s not in place anymore. We manage it with nappy pads like we
did before. Some patients have been encouraged to use urinals and bedpans as much as they can.
There is no formal assessment in place anymore.
BB2
However, despite this overwhelmingly positive evaluation of the impact of the SVP and its continuation in some
form in over half of the sites, even without extra staffing, this wasn’t unconditional, per protocol, or wholesale.
Respondents said that staffing levels would affect whether or not the programme was continued (4), toileting
was to be merged with skin and safety rounds (2), and the paperwork would not be continued in its present
form (4). In two sites, the programme was continued, but only with those patients thought likely to succeed.
One site thought that doing the programme intermittently when staffing allowed was probably not worth it:
Maybe not continuing it if we haven’t got staffing levels, because we’re doing it one day and then not
doing it another day and then it’s pointless.
LL5
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The structure provided by the programme was identified as motivating (1), as was experience of success (3):
It’s all down to education, confidence, and knowing the result of it really, knowing that it’s going to work.
AA2
Reconfiguration: how people modify their work in response to their evaluation of the new
practice There were some deviations from the protocol that might have been due to misunderstanding
or misinterpretation, such as putting everyone on the diary (1), then on PV (2); regular as opposed to
individualised toileting (2); promoting the use of the toilet instead of a bedpan (1); and stopping the
programme for people who were incontinent (1). Other deviations appeared to be in response to
perceived problems with the protocol fit with individual patient need or context, including adaptation of
the process for unco-operative patients (1); or fitting in to the reality of ward routines such as mealtimes
and visiting times (2). Other deviations appeared to be creative reinterpretations of the SVP protocol,
such as starting prompting before the diary finished in acute areas (1).
People made suggestions for how the programme should be modified, including a focus on those people
for whom it was likely to work:
If we were going to change anything it would be concentrated on the ones that we know are going
to do well, and less time on the ones that we know aren’t,
KK3
although there was a recognition that this would miss some people for whom it might work:
. . . there has got to be the odd one or two who we thought wouldn’t do well who actually do.
KK3
One respondent wondered about the necessity of repeatedly asking people if they were wet:
I wonder whether it’s a bit too much sometimes for the patient constantly saying they are wet, each
time you have to ask them – but then they’ve got to be aware haven’t they.
LL4
Two respondents suggested extending the programme to the night-time.
The main changes suggested were to the paperwork, including simplifying the assessment (2), moving
the weekly review to the weekend (1) and designing a care plan to take over recording when ICONS
finished (1). However, three respondents suggested not changing anything until the programme had run
for longer.
People also suggested improvements to the implementation of the programme, including having a
co-ordinator in the early stages (1); doing an initial rollout to senior staff first (1); having a longer interval
between training and starting the programme (1); and changing the training to a full day course (2).
Other suggestions to aid implementation included providing symbols for boards (1); visual aids for people
with aphasia (1); and badges to identify ICONS HCAs (1).
Four respondents suggested that the programme was being, or should be used for other patient groups,
such as those with other medical or neurological conditions, or suggested continuing the programme in
community settings.
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Summary of findings related to the implementation of the systematic
voiding programme
Coherence: the sense-making work that people do when faced with a
new practice
Sites differed in how much continence care they were providing before implementation of the SVP, some
having very little (4), others using regular toileting (4). The SVP was seen as structured (5), timed (4) and
documented (8). Nursing tasks were similar, but routine and documentation were different (5), particularly
the assessment (3). The SVP was not consistently differentiated from regular toileting.
Staff agreed with the aim of the programme (6) and its role in nursing care and rehabilitation, but were
negative about some aspects such as the paperwork (6) and extra work (2). Having enough staff and
seeing positive results facilitated agreement with the SVP (4). Some staff disagreed with the suitability of
including all patient groups (3), especially people who were unwell, or who had cognitive or long-term
continence problems.
Although it took some time to learn and settle in, the SVP was seen as easy to understand (5). It was
felt that most staff understood the programme (6), although there were indications that some
misinterpretation of components of the SVP occurred, particularly around the differentiation between
regular toileting and programmes tailored to individuals. Staff thought that most patients and relatives
understood (3), but that explaining the programme to patients and relatives could be difficult (3).
Staff could see the value of the new practice in terms of increasing the priority of continence care (5),
and highlighting that continence is amenable to change (3). There was recognition of the importance of
continence for patients (4), and that continence control could also signal wider recovery to the patient (2).
Nurses felt they were helping patients (4). The SVP provided structure and guidance (6) and reduced
workload in the long run (3). Although staff recognised the benefits, the extra work was unpopular (3).
Cognitive participation: the shared work that people need to do to build and
sustain a new practice
Key individuals introducing the new practice included the research team, matron, stroke network nurse
and trial management. Senior ward staff were seen as responsible for pushing the new practice forward
(8). Their role included promoting the programme; providing direction and reminders; education and
supervision; organisation and delegation; and monitoring and feedback.
Proactive senior staff nurses were also seen as influential in driving the programme forward (3).
Although not consistent over the whole of the programme in a number of sites, the research nurse was
recognised as a valuable resource (6). Their external perspective was valued for co-ordination, monitoring
performance and countering established views. The extra HCAs (5) and the external facilitation (2)
provided by the ICONS research study also influenced perceptions of the programme.
Staff in half of the sites were said to be involved and motivated. Positive influences on staff engagement
included enjoyment, work reduction and seeing success. Three sites reported a lot of dissent in the initial
stages, with people taking some time to become involved and motivated. Some of this dissent related
to how the SVP was implemented. Therapists were not directly involved (3), but could act to facilitate
the SVP in scheduling therapy sessions around toileting times (1). Patients were generally happy to be
involved (4); reluctance to get involved was attributed to fear of extending hospital stay, or drawing
attention to incontinence.
The main feature of ward organisation altered by introduction of the SVP was the recruitment of new
staff, and sites had variable success with this. Sites also differed in how they utilised the new staff, from
complete integration into the ward team, to allocating them full responsibility for implementing the SVP.
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The research nurse also had varying responsibilities for co-ordination and paperwork between sites.
Overall, the SVP was not perceived to have made a significant difference to patterns of workload
allocation, with normal role differentiation between staff nurses and HCAs (5). However, respondents
referred to potential enhancements to the HCA role, in response to increased training, involvement and
perceived impact.
All of the sites had constructed reminders to facilitate delivery of the SVP (5) such as whiteboard symbols;
entries in the diary; recording status in the handover sheets; or involving night-staff in preparing paperwork.
Respondents also talked about the need to harmonise SVP paperwork with other recording systems (4).
The co-ordinating and informing functions of the paperwork were seen as valuable (3), as were the
information resources provided by the ICONS research programme (2).
Collective action: the operational work that people need to do to enact a
new practice
After initial teething problems, staff felt the SVP ran smoothly most of the time (7), although reminders
were still required (2). Staff reported problems with delivering some aspects of the intervention: maintaining
surveillance to put new people on the SVP and scheduling people through the different stages was hard
to keep tabs on (4); the assessment was difficult to complete (5); 3-day diaries were thought too long in
some instances (2); and the weekly reviews could be forgotten (3). Timed toileting could be challenging to
schedule, remember and adhere to within the ward routine (4), and staff did not know how to record some
occurrences (3). Frequent regular toileting was difficult to manage with some patient groups (3), especially
those with physical or cognitive difficulties. Using distraction and extending the time interval before use
of the toilet (3), or repeatedly asking patients if they were wet (2) was thought difficult or uncomfortable for
staff and patients. Staff made suggestions about how to better manage the SVP on a daily basis, including
how to involve patients, and schedule care to take account of ward practices.
Change was recognised as bringing challenge (3), and most sites had a period of learning during which
they felt unsure, but confidence had increased in themselves (2), and in the programme being done
properly (3), although perhaps not all the time (2). Senior staff felt it was hard to maintain motivation and
attention in relation to continence because of competing priorities and the need to provide constant
reminders (4), especially around recruitment to the SVP (2). However, staff felt more confident and skilled
in their ability to manage continence (2). They talked to each other more about continence (3), although
relationships could also suffer around new responsibilities (1). There was increased communication about
continence with the wider team (2), although continuity between separate acute and rehabilitation areas
could be a problem (1).
The SVP was felt to be difficult to learn at first (3) and suggestions were made to adapt training and
implementation methods. Although some specific skill deficits were acknowledged in communication and
assessment, overall, staff felt they had learned new things (3) and had the skills and knowledge to deliver
the programme (4). The training (4) and educational resources (3) provided were useful but there was poor
uptake of the online training (6). Ongoing updating of new staff needed monitoring (3), and there were
problems with using bank staff unfamiliar with the SVP (2).
Although respondents in all eight sites valued having the extra staff, the majority also commented on
the extra work required by the SVP on already busy wards (7). Delivery of the SVP had been affected by
inadequate staffing or sickness at some points in time (7), which adversely impacted on staff morale if
they then could not deliver the SVP properly. Trust support was needed to protect extra staffing resources.
Three sites reported difficulties with environmental resources for toileting, but staff liked the bladder
scanner provided by the research (2).
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Reflexive monitoring: the appraisal work that people do to assess and
understand how a new practice affects them and others
Success was defined by respondents as patients becoming continent, but they also saw partial continence
or being less wet as worthwhile outcomes. Their definition of success also included patients not having
urgency, being aware of their need and asking to go to the toilet. Staff said they could see changes in
patients (5), which were highlighted by the paperwork (6). Visible success was important for staff
motivation (5), staff also noted comments from families (2).
The programme was monitored by senior staff and research nurses (5), but staff found monitoring
difficult (3). They referred to observation (4), and monitoring continence more closely. More formal
evaluation from the trust and external bodies such as skin and safety audits or CQC visits were ongoing
and ICONS was seen to contribute to Sentinel Audit results (1), but linking the SVP to wider changes in
outcome was thought problematic (2). One site referred to increased nursing discussion of continence
at MDT meetings and in discharge planning.
Despite the extra work – the SVP was deemed to be better than previous practice, conditional on having
the staff to do it (2). Respondents from sites were unanimous in saying that the intervention worked for a
proportion of people (8). There was general agreement that people without problems of understanding,
communication or mobility were likely to do better (3). However, people with cognitive problems could
benefit from attention and being less incontinent (2) or the development of routine (1) and continence
status could have a big impact on discharge destination (2).
There was variation in speed of recovery, and people could regain continence in the day time but still need
pads at night (2). People had different views on the impact of gender (3). There was a fairly consistent
view that the programme would not work with some patients (4), with failure attributed to pre-existing
continence problems, lack of awareness, or cognitive problems, although it was recognised that the
response of individual patients to the SVP was unpredictable, and could be surprising (2).
Staff identified physical and emotional benefits of regaining continence for patients (5), as well as benefits
for self-esteem, ownership and control of recovery (5). Benefits for nursing and nursing care included
changed attitudes towards continence (3); increased awareness, knowledge and confidence (6); reduced
workload (5); improved communication between staff (4) and with patients (2); increased therapeutic role
for nursing (2); better assessment and care planning (4); and a calmer ward (2). Staff thought costs might
be lower (1); respondents from five sites said pad use had reduced (5).
Although respondents from the majority of sites thought the programme worth continuing (7), and
respondents from five out of eight did maintain the core aspects of the programme after the research was
completed, respondents said that staffing would affect continuation (4); or that the programme would not
be maintained without pressure from senior staff (2). Respondents from four sites indicated that toileting
would be merged into skin and safety rounds; respondents from two sites said the programme would be
done with those patients thought likely to succeed. Although the structure of the programme was
valuable, respondents said the paperwork was unlikely to continue in its current form (4).
People made suggestions for ways in which the SVP content could be modified and for improving the
implementation of the programme, around co-ordination (3), timing of implementation (1), training (2) and
additional resources (3). Respondents from three sites said they planned to use the programme with other
patient groups.
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Supported implementation
External and internal facilitators
The EFs were Dr Chris Burton (CB), Senior Research Fellow in Evidence-Based Practice at Bangor University,
Gwynedd, UK, and Dr Jane Williams (JW), Consultant Nurse in Stroke Care and Chief of Service, Clinical
Service Centre of Medicine for Older People, Rehabilitation and Stroke, Portsmouth Hospitals NHS Trust,
Portsmouth, UK. CB and JW have many years’ experience of running a successful leadership programme
for stroke service managers for the Department of Health; CB has a special interest and track record in
implementation science. Responsibility for sites was allocated solely on practical grounds, with facilitators
linked to sites closest to their place of work: CB worked with sites FF and HH, and JW with sites KK and LL.
Each site was asked to choose their internal facilitator based on the criteria outlined previously
(see Chapter 3); sites were also encouraged to nominate one or more deputy facilitators to help share
the work and ensure cover for annual leave and sickness. Table 77 shows the number and grade of
facilitators in supported implementation sites.
Documents supplied to the research team
Table 78 shows documents received. Meeting notes indicate that sites HH, KK and LL met with their EFs
on a regular basis throughout the intervention period. FF, KK and LL completed a diary of weekly activities,
although these were only completed for 5 and 6 weeks at LL and FF respectively. Weekly diaries showed
internal facilitators were engaging in the full range of activities, from planning to evaluating change; a
more detailed analysis of these was not undertaken owing to the large variability in terms of number of
diaries submitted.
TABLE 77 Characteristics of internal facilitators
Site (codes removed to
protect anonymity)
Internal facilitators
Number Grade Comments
Site 1 1 Band 7 – ward managera
1 Band 6 – ward sistera
Site 2 1 Band 7 – ward managera ICONS research nurse (band 7) also
acted in a facilitation role between
August 2011 and 31 January 2012
1 Band 6 – ward sister
Site 3 acute unit 1 Band 7 – ward manager
1 Band 6 – stroke co-ordinator
Site 3 rehabilitation unit 1 Band 6 – staff nurse
1 Band 5 – staff nurse
Site 4 1 Band 7 – ward managera
2 Band 6 – ward sister; staff nurse Ward sister absent from unit throughout
intervention period
a Interviewed as part of the evaluation of supported implementation.
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TABLE 78 Documentary evidence received from sites
Meeting notes, action plans and weekly facilitation logs
Site Meetings with EF Action plans: implementation objectives Weekly facilitation logs (weeks beginning) Other
Site 1 22 May 2012 (notes of
telephone conversation)
6 weeks (no dates available, but known to be
consecutive)
Site 2 29 June 2011
19 April 2012
17 May 2012
12 June 2012
18 July 2012
1. Engaging (and keeping engaged) with key individuals in the
implementation of the SVP
2. ‘Re-visioning’ urinary incontinence as a focus, rather than a barrier
to, rehabilitation. Objective is to develop and implement a ‘new
vision’ for UI management that reflects the SVP
3. Ensuring the appropriate staff know ‘who is doing what’ within
the SVP
None completed
Site 3 10 January 2012
28 February 2012
23 May 2012
(telephone update)
12 June 2012
10 July 2012
Acute unit:
1. To ensure adequate staffing of the ward for ICONS patients
2 January 2012 30 April 2012
16 January 2012 14 May 2012
6 February 2012 28 May 2012
20 February 2012 4 June 2012
5 March 2012 11 June 2012
26 March 2012 18 June 2012
16 April 2012 25 June 2012
23 April 2012 2 July 2012
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TABLE 78 Documentary evidence received from sites (continued )
Meeting notes, action plans and weekly facilitation logs
Site Meetings with EF Action plans: implementation objectives Weekly facilitation logs (weeks beginning) Other
Rehabilitation unit:
1. To continue to implement continence management, ensuring there is
clarity for all staff including AHPs, not just nurses; also to continue
with consistent re-enforcement in performing new practice
2. All staff to undertake e-learning, including AHPs. To continue to
implement continence management with increased
multiprofessional approach
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Meetings between internal and external facilitators
Both EFs met internal facilitators either before or at the beginning of the intervention period. The purpose
of the initial meeting was to orientate them to their new role using the facilitation handbook and to help
them develop a set of ‘higher level’ implementation objectives. The number of meetings held is shown
in Table 78 and ranged from three (FF) to five (HH and KK). Meeting notes were analysed using NPT.
Findings: analysis of meeting notes
Coherence: the sense-making work people do when faced with a new practice
Differentiation (whether or not staff see a difference between what they were doing before and
the new practice) Discussion with facilitators in the first meeting at HH suggested that the SVP looked
like a return to task allocation and 2 hourly ‘toilet rounds’; although this was not viewed as problematic,
staff stressed the need to emphasise the individual nature of the ICONS programme.
Communal specification (whether or not people have a shared understanding of the new
practice) Developing a shared understanding of the practical implications of delivering the programme,
as well as ensuring staff knew what was expected of them, was discussed at HH and subsequently
incorporated into an action plan with the objective ‘Ensuring the appropriate staff know “who is doing
what” within the systematic voiding programme’.
There was evidence from LL suggesting all staff were aware of what was involved in delivering the
programme, with HCAs singled out particularly as actively involved and beginning to take on the role of
prompting others to initiate parts of the programme.
Internalisation (whether or not people see the potential value of a new practice) The value of the
programme in raising the profile of continence management was discussed in meetings at HH and LL;
the ICONS study was viewed as providing a focus for continence and also as a trigger for people to think
more about continence (LL) and adopt therapeutic, rehabilitative strategies rather than containment (HH).
The relevance of continence management in facilitating early supported discharge was raised in KK
acute unit.
Cognitive participation: the relational work people do to build and sustain a
new practice
Initiation (whether or not key individuals drive the new practice forward) Nurses were viewed
as key to introducing the ICONS programme, described by facilitators at KK (rehabilitation unit) as ‘very
much nurse led to date’. Nurses singled out as key leaders were the research nurse (HH), band 5 staff (HH),
HCAs (LL) and the lead nurse (KK, rehabilitation unit). The research nurse in HH was particularly highly
regarded for her practice development skills, which led facilitators to view her as a ‘massive driver’ of the
programme and as providing reinforcement for the facilitation work undertaken by the designated internal
facilitator and her deputy. Her presence on the unit every day was highly valued and she was viewed as
particularly good at encouraging staff to complete paperwork.
The lead nurse was regarded as supportive in KK (rehabilitation unit). Band 5 staff were identified
pre implementation as having a leading role in the initiative in HH, whereas at LL HCAs were singled
out as ‘good champions’ of the project.
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Enrolment (whether or not people agree that the new practice should be part of their work)
At LL, there was evidence that relatives were taking a more proactive role in terms of checking their
relative was receiving the continence care prescribed. Meeting notes report this was welcomed by staff:
It doesn’t hurt that relatives sometimes ‘have a go’ at the nursing staff for not taking their relative to
the toilet at the right time.
Meeting notes, LL
Activation (whether or not people work together to develop the new practice) Meeting notes
suggested staff were using a variety of strategies to organise the work of implementing the SVP.
A common strategy to facilitate this was discussion in meetings, including weekly meetings (HH),
multidisciplinary meetings (HH), unit planning meetings (LL) and ward rounds (KK rehabilitation unit).
Allocating specific responsibility was also discussed at KK acute unit and LL, where one HCA at each
end of the ward had responsibility for ensuring paperwork was completed. The system was more
diffuse at KK rehabilitation unit where no one designated person was responsible for ensuring patients
on the programme received the care they needed. Informing bank staff about ICONS also fell within
the remit of HCAs in KK (rehabilitation unit).
Ward staff discussed techniques to ensure patients on the programme were visible; these included
identifying patients on the patient board (HH, KK acute unit, LL) and ensuring they were included in
handovers (LL). There was some evidence that completion of paperwork had improved over time
(KK rehabilitation unit), with night staff also involved in weekly reviews (LL).
Collective action: the operational work people do to enact a new practice
Interactional workability (whether or not staff and patients are able to do the tasks required of a
new practice) Too many patients suitable for and on the programme was cited as a barrier in KK
rehabilitation unit, whereas at HH, KK acute unit and LL there were occasions on which there were not
enough patients suitable; at KK this was due to norovirus closing the ward to new admissions, whereas at
LL it was due in part to the addition of four medical beds to the unit. Paperwork was viewed as something
staff were not getting round to doing (HH) and as putting pressure on regular staff (LL), but LL staff also
commented that the continence assessment had become embedded in routine practice. Staff on KK acute
unit liked and were using the documentation to good effect by June 2012.
Patients’ PV schedules were disrupted by therapy sessions (LL). As sessions were not timetabled, it was not
possible to plan scheduled voiding times to fit around these.
Relational integration (whether or not staff are confident in each others’ work and expertise in
relation to the new practice) In two sites (KK and LL) there were sustained attempts to involve the MDT
in the ICONS programme. For example, transferring and mobilising were identified in KK (rehabilitation
unit) as areas where a multiprofessional approach could enhance care; facilitators were also keen for
physiotherapists to review use of pelvic floor exercises for suitable patients and for occupational therapists
to incorporate continence into their rehabilitation planning. Both occupational therapy and physiotherapy
teams were encouraged to become involved in patients’ toileting regimes to facilitate adherence
throughout the day, and processes were put into place to expedite this, for example informing therapists
every Monday who was on the programme. Championing the multidisciplinary approach was of particular
importance to the facilitator at KK (rehabilitation unit), as she describes:
I said now look this is supposed to be a multidisciplinary approach, not a nursing one, so [they] said
‘oh yeah we’re all willing you know’, I said ‘the thing is you all need to know how to do the
paperwork, it’s no good you just being’, she said ‘you know one of the therapists said, oh we always
take them to the toilet’, I said ‘it’s not as simple as taking them to the toilet, there’s a plan’.
Internal facilitator, KK
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The research nurse, who covered both KK and LL, was also instrumental in ‘planting the seed’ of MDT
involvement by attending MDT meetings as well as inviting therapists to ICONS facilitation meetings. Both
acute and rehabilitation units at KK added MDT involvement to their action plans in the second month
of the intervention period. LL identified many benefits of working more closely with therapists, including
increasing nursing staff knowledge of and ability to solve problems around positioning and handling; more
proactive multidisciplinary meetings; early identification of continence goals; and more effective discharge
planning. To facilitate this, the team agreed to pilot multidisciplinary ward based working.
In LL, HCAs were reported to be taking the initiative in implementing the programme and prompting other
staff, for example when patients were ready to go on the 3-day diary.
Towards the end of the intervention period, the facilitator at LL stated that staff morale was low,
contributing to lethargy towards change.
Skill set workability (whether or not the work of the new practice is appropriately allocated to
people with the right skills or training) The research nurse covering KK and LL undertook initial
training with the majority of the staff in the three units, including some night staff. ‘Refresher’ training
was provided in February 2012. Staff were also keen for members of the MDT to access training, as
knowledge was viewed as a means of increasing motivation to engage with ICONS (KK rehabilitation unit).
However, although meeting notes indicated the research nurse was investigating the feasibility of doing
this, there is no evidence it actually took place. Meeting notes from KK acute unit in February 2012
suggested staff were completing the online training; however, in June staff were prompted further as
many had not completed it. MDT members also requested access to the online training (KK acute unit),
but it is not known if any completed it.
Training in using the bladder scanner was well received and staff commented on the positive influence this
had on continence management (KK rehabilitation unit).
The EF at HH provided additional training focusing on leadership within the work of internal facilitators.
Staff were invited to complete the Multifactor Leadership Questionnaire; however, as none had done so in
advance, the session comprised a presentation on transformational leadership.
Contextual integration (whether or not the new practice is adequately supported by the host
organisation) Inadequate staff was identified as an issue in all sites. In FF the problem was particularly
acute, with the unit working with 66% establishment in May 2012.
The availability of ICONS-funded HCAs was discussed at meetings in HH, KK acute and rehabilitation units
and LL. In KK and LL, the full complement of ICONS HCAs were working on the units and, despite these
being bank staff at KK, there were regular staff assigned. However, the perception at both KK (both units)
and LL was that staffing was ‘a struggle’ due to staff sickness (KK rehabilitation unit) and insufficient bank
staff to provide cover (LL). Staff at KK rehabilitation unit commented on the employment of therapy nurses
on their unit; these covered the whole week and their role was to work alongside nursing and therapy
staff in the provision of therapy. Their input was viewed as an asset in assisting patients to progress. In HH,
one ICONS-funded HCA left in March 2012 and there was discussion about employing bank nurse cover
for this post.
Staffing issues were cited as hindering the ability of staff to implement the programme. Use of many bank
staff, all needing to know about ICONS, posed a communication challenge (KK rehabilitation unit). High
levels of temporary staff also gave rise to poor continuity (LL). A further issue specific to supported
implementation arose in LL, with two out of three facilitators not present on the unit, in one case for the
duration of the intervention period. This was addressed by asking a band 5 staff nurse to stand in,
although this was not entirely satisfactory as this person had many other commitments.
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Reaction to change was mentioned in discussions at HH. In the first meeting at HH, internal facilitators
articulated how the unit was very used to and able to cope with change. By April 2012, however, the
impetus for the programme had ‘fallen off’ due to the original research nurse leaving and being replaced
by a new person who spent only 2 days a week on the unit and did not have a similar background in
practice development.
Environmental issues were raised by staff in KK rehabilitation unit. The therapy area was viewed as not
conducive to toileting patients, therefore they were returned to the ward for this purpose which mitigated
against nursing staff efforts to involve therapy staff in continence activities. The environment at KK acute
unit was also regarded as highly unsuitable, with poor access to toilet facilities and lack of space within
toilets leading to dignity, privacy and safe transfer issues.
Equipment issues regarding bladder scanners were discussed at both KK units. The bladder scanner was
greatly valued at the rehabilitation unit. As the project was only able to provide one scanner per trial site,
KK acute unit did not have one but the research nurse liaised with the equipment library to ensure the unit
could access one when required.
Reflexive monitoring: the appraisal work that people do to assess and understand how a
new practice affects them and others
Systematisation (the ability of people to determine the effectiveness of the intervention) At KK
rehabilitation unit, success of the intervention was discussed; there was a strong belief that practice
had changed for the better, and continence history taking and assessment were viewed as being much
more in-depth and accurate towards the end of the intervention period. This assessment also led to a
greater number of referrals to urology.
Individual specification (whether or not individuals think a practice is worth doing) Staff at KK
(both units) and LL believed the programme was working in terms of helping patients regain continence,
with this outcome directly attributed to the programme. There was a feeling at KK rehabilitation unit that
the programme may not work quite so well with cognitively impaired patients:
we’ve had a few though, . . . like a gentleman with cognitive problems, and . . . we’ve tried, and we’ve
tried you know like you say to him well you’re nice and dry now try the toilet, no I’m dry, and we’re
not getting through to him, so that’s been a difficult one.
KK rehabilitation unit
At LL, the programme was also credited with changing the ‘silo’ culture between nurses and therapists,
albeit slowly.
Communal appraisal (whether or not people can use formal monitoring to collectively evaluate if
a practice is worthwhile) On KK rehabilitation unit, there was general agreement around the benefits
of the programme, with staff having ‘nothing negative to say’; this is also evidenced by their intention
to continue with assessment and PV when the study ended. At LL also, successes with patients had
encouraged staff to continue with the approach.
There was evidence of a dip in enrolment at HH 3 months before the intervention period ended;
a ‘re-launch’ was planned to emphasise achievements and successes so far and encourage everyone
to keep going until the end of the intervention period.
Findings: interviews with internal and external facilitators
Interviews were conducted with both EFs and with internal facilitators indicated with ‘a’ in Table 77.
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Coherence: the sense-making work people do when faced with a new practice
Differentiation (whether or not staff see a difference between what they were doing before and
the new practice) In FF, the internal facilitators viewed facilitation work as part of their everyday job;
there was no change in role, just a change of focus.
Communal specification (whether or not people have a shared understanding of the new
practice) In one site, understanding of the scope and nature of external facilitation was not shared
between the external and internal facilitators. The EF expected to visit the site at the beginning, middle
and end of the intervention period, with ways of working and reporting mechanisms being established at
the first visit. However, the site expected monthly meetings and, when these did not happen in the early
stages, there was a feeling that the site was not receiving what they were entitled to:
if you’re going to say you’re going to do something then you do it, and I think when something is said
that people are going to do and they don’t, then it becomes quite difficult
IF-HH
The initial plan for visits and reporting needed revision based on the demands of the site; given the
emphasis put on face-to-face meetings, these were increased to monthly even though progress with action
plans around multidisciplinary working and the visibility of the SVP was good. Meetings therefore focused
on aspects other than implementing the SVP, for example leadership development and peer review of the
internal facilitator’s leadership style. These activities were viewed by the EF as:
relevant in terms of enhancing the background of implementation by not necessarily related to . . .
what we were doing
EF1
An additional issue was the introduction of an additional implementation mechanism, peer networking,
where two internal facilitators visited another trial site to see how the SVP was operating. This was
suggested by another member of the project team without consultation with the EF, and was viewed as
potentially ‘muddying the waters’:
encouraging the sites to network . . . so they visited other sites which you know networking, peer
networking is a . . . keen mechanism for supporting service improvement which isn’t facilitation
EF1
The integration of ‘normalisation’ was also viewed by EF1 as blurring the theoretical basis of facilitation
through the addition of another theoretical framework.
Issues around understanding of the EF role also arose in the other site led by EF1. This site identified
issues for discussion related to running the trial rather than implementing the SVP, for example recruiting
patients. The facilitator role became one of broker, blurring the boundaries between supporting the
research and supporting implementation:
so there I was sort of more facilitating the conversations between research support, research support
managers, the clinical staff, the . . . internal facilitators, not really around issues to do with the trial, but
in terms of sorting out you know personality issues and problems and you know resource issues
around the trial rather than around the . . . intervention per se
EF1
Individual specification (whether or not individuals think a practice is worth doing) In HH, there
was uncertainty about what the internal facilitator role would involve.
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Internalisation (whether or not people see the potential value of a new practice) This was
not mentioned.
Cognitive participation: the relational work people do to build and sustain a
new practice
Initiation (whether or not key individuals drive the new practice forward) HH singled out the
research nurse, who also worked in a facilitator role:
although I was a facilitator I had another band 7 with me, she was absolutely exceptional, she was
absolutely fantastic and she just really got on with the job
IF-HH
Enrolment (whether or not people agree that the new practice should be part of their work) Both
EFs commented that strategies used to encourage engagement of internal facilitators (other than
meetings) did not seem to be working, for example there was little correspondence by telephone or e-mail
in between meetings. EF2 concluded that internal facilitators did not take advantage of support available:
I did site visits with [LT] fairly early on, and . . . then . . . further visits as . . . the . . . research was about
to get underway, so I set up e-mail . . . distribution lists and e-mailed people, said you know I’m here,
I gave people my . . . e-mail, my . . . direct telephone number to contact me, I e-mailed to ask how
people were getting on, but . . . there it was I have to say that the communication was all one way
from me to them, and . . . often I . . . heard nothing back, very little came back . . . at all.
EF2
EF2 believed that although there was a flurry of activity before meetings, internal facilitators lost focus
in between. As well as little contact between EF2 and internal facilitators, there was also little discussion
or support between facilitators working in the acute and rehabilitation units within the same site.
EF2 expressed disappointment that the internal facilitators had not really grasped the research and were
not pushing it forward; they were viewed as being in ‘victim mode’ and perhaps hampered by not being
advanced in terms of clinical leadership. Internal facilitators focused on engagement with ward staff
implementing the SVP rather than with EFs.
Legitimation (whether or not people ‘buy into’ the new practice, and if they are willing and able
to organise themselves) In terms of expectations about how facilitation would be managed, EF1
believed it would include problem-solving, supporting the staff and developing organisational context,
for example leadership. Initially, the focus for EF1 was on building relationships, establishing ways
of working and introducing internal facilitators to the model of facilitation embodied in the facilitation
manual. This included thinking through how to implement the SVP in their stroke service, identifying
and prioritising challenges and selecting which ones to develop into action plans:
a . . . handbook for them as internal facilitators, and that included . . . an action planning framework
for them to use to highlight issues or challenges that they as internal facilitators came up against
when they were trying to get the algorithm into practice, and then helping them to think through
those action plans what you know the barriers and enablers to achieving the action plan, what the
objectives would be you . . . know breaking it down into small manageable chunks of activity that they
could do to get round the . . . problem that they were facing, or to . . . change the problem . . . in
terms of getting the algorithm into practice.
EF1
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For EF2, there was also a focus on directing staff towards project-specific and external resources, for
example ICONS online training and the Stroke Improvement Programme. Keeping up momentum was
important to both EFs through flexibility and willingness to help (EF1), seeking (EF1) and giving feedback
(EF2), reassurance and positive reinforcement (EF2).
Internal facilitators focused on challenges in engaging both the organisation (LL), nursing staff and the
MDT (FF and LL). Informal approaches were used to roll out the programme, for example discussions over
‘coffee in the staff room’ in FF, and a ‘try it and see’ approach in HH:
it was very much fed to the staff that . . . you know . . . just let’s roll it, let’s just roll, roll it out see
where we go, pick up the problems as we . . . go along.
IF-HH
Momentum was increased by ICONS being ‘high on the agenda’ (FF), focusing on positive aspects at
ward meetings and handovers, maintaining a positive attitude (LL) and providing feedback and positive
reinforcement (FF).
Action plans were mentioned in FF and LL; FF cited the process through which the EF guided their
development and implementation, whereas in LL the action plan described what was going to be
implemented, how practice was going to change and how this would be communicated with staff.
Activation (whether or not people work together to develop the new practice) Communication
between external and internal facilitators took the form of visits (EF1, EF2, FF and LL) and e-mail contact
(EF1, EF2, FF). Although EF1, EF2 and FF viewed e-mail as a means of keeping up momentum, the
facilitator at HH stated there was no e-mail contact, and also that visits did not happen. LL also pointed
out that there was little telephone contact with the EF.
In terms of internal facilitator ‘work’ at the sites, at LL there were weekly discussions between facilitators
and the research nurse, with issues fed back to staff in ward meetings.
Collective action: the operational work people do to enact a new practice
Interactional workability (whether or not staff and patients are able to do the tasks required of a
new practice).
EF2 commented that in some units the SVP was quickly absorbed into routine work, whereas in others this
was less successful. Delays in starting ICONS and the consequent time lag between initial site visits and
the intervention starting were problematic, with units ‘going off the boil’ by this time (EF2).
No internal facilitators mentioned whether or not they were able to undertake facilitation tasks, but
focused instead on factors affecting whether or not units were able to do the SVP, for example staffing
issues forcing a temporary halt to recruitment (FF) and problems engaging staff and the organisation (LL).
Relational integration (whether or not staff are confident in each others’ work and expertise in relation to
the new practice).
External facilitators had differing perceptions of their role. For EF1, it was viewed as encouraging staff to
use theory to think through problems and conflict resolution, whereas for EF2 it was more practical:
supporting the delivery of the intervention, providing clinical support and pointing staff in the direction
of project-specific and external resources. Both viewed the role as bringing about service development
through developing leaders. Although EFs worked largely independently because their sites started at
different times, there was liaison to check consistency (EF2).
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Both EFs commented on the internal facilitator role. EF1 was unclear how internal facilitators had
been selected:
. . . I’m not sure for example whether the internal facilitators that I worked with are ones that had
been selected for the role or put themselves forward, whether they’d just agreed to do it or whether
they were told to do it you know . . . we actually didn’t, we weren’t involved in identifying how the
internal facilitators would be recruited and worked out, our job was very much, I thought our job was
as supporting them really and that perhaps is a limitation.
EF1
Furthermore, EF1 did not view their role as informing internal facilitators what their role was; this meant
working with their own perceptions of the role. In one site this was problematic, as there was
unwillingness to engage other members of the team, whereas in another site EF1 was successful in
developing a team of facilitators, including an experienced HCA.
In terms of relationships between internal and EFs, for EF1 the key to managing this was flexibility and
consistency in communication; EF2 did not comment on this specifically but suggested that the research nurse
role was more important than her role in terms of keeping ICONS current with internal facilitators. In FF there
was uncertainty about the role of the EF and how this fitted with the internal facilitator role; however,
in LL the EF was viewed as a colleague with whom to discuss issues and problems.
Internal facilitators viewed their role as facilitating the smooth running of the trial (FF) and introducing
the SVP (LL), taking the lead in supporting staff, ensuring they had the necessary knowledge and
skills (FF and LL), ‘seeing the whole picture’ and making sure things were done; knowing the team helped
in this regard (FF). In two sites the facilitator role was shared with the research nurse (HH) and staff
nurses and HCAs (LL); this was perceived to be both useful and necessary as they were ‘hands on’ and
better able to keep track compared with the ward manager. Consequently, there was little role change
for the internal facilitator in HH:
although I was a facilitator I had another band 7 with me, she was absolutely exceptional, she was
absolutely fantastic and she just really got on with the job, and in actual fact I think . . . I could say she
probably took all of that role off me
IF-HH
Relationships with the members of the project team were cited as important by EF1:
there was certainly good relationships . . . developed with [name] and [name] you know which you
know sort of enabled some discussion about these sorts of issues to be addressed in a . . . more
positive and fruitful way.
EF1
Skill set workability (whether or not the work of the new practice is appropriately allocated to
people with the right skills or training) Credibility was an important attribute of EFs (EF1), and
knowledge and skills brought to the role included knowledge of leadership theory and the theory
underpinning facilitation; expertise in supporting service development; and communication skills (EF1).
For EF2 skills centred around practical experience, for example of tackling staffing issues and introducing
early supported discharge. EF2 also mentioned interest in the staff and their units and an approachable
manner as requisites.
Internal facilitators described the following knowledge and skills as necessary: knowledge of and rationale
behind the project (HH and LL); leadership and management skills (FF); ability to ‘sell’ to the team (HH);
practice development skills (HH); and the ability to assess what is important (LL). For FF, ICONS developed
existing skills rather than teaching new ones. Skills of EFs were recognised, these included facilitation skills;
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the ability to ask the right questions and draw out solutions from internal facilitators; and the immediate
understanding of problems (FF and LL).
In terms of skills development, internal facilitators in HH and LL pointed to a lack of training for the facilitator
role; however, the internal facilitator at HH did not believe any additional knowledge was necessary.
EF2 questioned the nature of the internal facilitators themselves and if they were indeed the right people
for the job.
Contextual integration (whether or not the new practice is adequately supported by the host
organisation) Difficulties in engaging the organisation was highlighted by both the internal and EF at LL;
although it was involved at the stage of organising funding, there were problems navigating the system to
recruit HCAs leading to complex negotiations. In terms of internal facilitators, EF1 commented that they
did not have designated time for their role.
Reflexive monitoring: the appraisal work that people do to assess and understand how a
new practice affects them and others
Systematisation (the ability of people to determine the effectiveness of an intervention) Success
of facilitation was assessed by both EFs through examining the extent of achievement of action plans:
solely through . . . the . . . action plans, whether action plans are being achieved or not, that was the
framework that we were going to use . . . so . . . looking at you know whether the actions were
resolving, if they weren’t resolving how could we . . . either look at barriers and enablers
EF1
Internal facilitators talked largely about success of the SVP, rather than facilitation; HH mentioned that
staff feeling positive about what they were doing was a mechanism for judging success, but whether this
was success of facilitation or implementation of the SVP was unclear.
Communal appraisal (whether or not people can use formal monitoring to collectively evaluate
whether a practice is worthwhile) Responses from internal facilitators focused on appraisal of the SVP
rather than on facilitation, with the exception of HH, who did not view EF visits as helpful.
Individual appraisal (whether or not individuals think a practice is worth doing) Issues raised by EFs
included lack of involvement in the stage of recruiting internal facilitators,
we actually didn’t, we weren’t involved in identifying how the internal facilitators would be recruited
and worked out, our job was very much, I thought our job was as supporting them really and that
perhaps is a limitation.
EF1
increased demands from study sites, becoming diverted into helping resolve personality and resource issues
(with suggested dilution of the facilitation intervention) (EF1) and lack of engagement of internal
facilitators both in dialogue (e.g. e-mail correspondence) and in active use of action plans as a tool to
implement facilitation. EF2 concluded that internal facilitators did not take full advantage of the support
on offer:
I don’t think the teams used me as . . . well as they could have done you know I was willing to . . . give
a lot more support . . . and . . . I think they yeah they . . . could have used me more effectively.
EF2
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The internal facilitator at HH did not view supported implementation, or assistance from the EF,
as successful:
I’d have been probably just as happy not to have had external facilitation.
HH-IF
She did, however, find the visit to another ICONS site ‘incredibly helpful’ in preparing her for the role of
facilitator, and also valued the input of the research nurse highly in terms of sharing the internal facilitator role.
There was mention of the facilitation manual in LL:
I would say I was slightly shocked how big that was.
IF-LL
Reconfiguration (how people modify their work in response to their evaluation of the new
practice) A greater focus on negotiating roles and relationships between internal and EFs was suggested
by EF1, including involvement in recruiting internal facilitators; more attention to role definition and
relationships between internal and EFs; and shared expectations of roles:
making sure that there is a clear framework that . . . provides a . . . common ground, absolutely crucial
. . . being clear about expectations with all partners, that all partners are . . . you know have shared the
same expectations of the role would be important, I think trying to get internal and EFs working
together from, right up front would be really important.
EF1
Closer working with other EFs was also advocated in terms of sharing learning about which strategies
are or are not working. Finally, EF1 suggested greater clarity was needed about what was actually being
facilitated: ‘getting the trial up and running’ or ‘getting the intervention into practice’.
EF2 suggested practical solutions for strengthening links with internal facilitators:
what I could have done . . . in future rather than just e-mails is perhaps log book, and some we did do
some by telephone, but whether you know you just have more of a weekly touching base.
EF2
EF2 also commented that facilitation visits should begin when the site is ready to start rather than
(as happened in practice) 6 months beforehand:
we got all very excited and . . . dashed off and visited the units sort of in I think it was about July or
something, and then actually we didn’t get started till . . . November, and then a couple of units . . .
into the sort of January I think it was, so I think there was . . . an element of the . . . units had gone off
the boil a bit really.
EF2
Suggestions from internal facilitators included simplification rather than using ‘big jargon’ (HH) and
utilising a supernumerary, ward-based facilitator:
if we’d have had a ward based facilitator that was not in . . . the numbers and that was solely you
know implementing this . . . research and what have you it would have . . . been implemented a lot
more effectively, a lot more effectively, cos it was an extra role for us.
IF-LL
Barriers and facilitators to implementing facilitation are shown in Table 79.
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TABLE 79 Barriers and facilitators to implementing facilitation
Barriers, difficulties Facilitators, suggestions
Differentiation: can people see how the new practice differs?
No change in role perceived as necessary
Communal specification: do people agree with the new practice?
View of external facilitation not shared between internal
and EFs
Introduction of peer networking as additional mechanism
Individual specification: do people understand what the new practice requires of them?
Uncertainty about what internal facilitator role would involve
Internalisation: do people see the potential value of the new practice?
No comments
Initiation: who are the key individuals driving the new practice forward?
Research nurse (experienced in change management) also
worked in facilitator role
Enrolment: do people agree that the new practice should be part of their work?
Little correspondence by telephone or e-mail between
internal and EFs
Little discussion between internal facilitators within same site
Legitimation: do people organise themselves to undertake the work required by the new practice?
EFs kept up momentum through flexibility and willingness
to help
Internal facilitators adopted strategies to engage the
organisation, nursing staff and MDT
Facilitation handbook and action plans provided a focus
for facilitation activity
Activation: do people work together to build the procedures needed to sustain the new practice?
Not enough EF visits EF site visits
Little e-mail and telephone contact with EF in between visits E-mail and telephone contact with EF in between visits
Interactional workability: can people do what the new practice requires?
Time lag between initial visits and intervention starting
Relational integration: are people confident in each other’s work and expertise?
Internal facilitators uncertain about the role of the EF EF role in bringing about service development through
developing leaders
Development of team of internal facilitators
Skill set workability: do people have the right skills and training?
Internal facilitators may not have been right people Skills of EFs recognised
Lack of training in for internal facilitators
Is the new practice adequately supported and resourced?
Internal facilitators not given designated time for the role
Systematisation: can people determine the effects of the new practice?
Success assessed through achievement of action plans
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Exploration of individual site rankings
In order to explain which processes potentially contributed to patient outcome, we examined pooled
process data related to level of embedding and adherence. This was done at the level of the individual
site (intervention groups only) rather than by trial arm, as heterogeneity across sites meant it would be
misleading to provide an overall score by trial arm. Aggregated data for quantitative data on adherence to
intervention protocols and qualitative data (organisational context assessed using soft systems analysis and
embedding of the intervention in practice, together summarised in an ‘embedding’ score) are shown in
Table 80; in all rankings 1= best and 8=worst. Both sites where the intervention was well embedded
were in supported implementation (HH and KK), and there was only one site in this trial arm where the
intervention was poorly embedded (LL). In contrast, no intervention sites had an embedding score of 1,
with two showing conflicted or neutral and two poor embedding. Three sites with best adherence to the
protocol were in the supported implementation trial arm.
TABLE 79 Barriers and facilitators to implementing facilitation (continued )
Barriers, difficulties Facilitators, suggestions
Communal appraisal: do people agree about the worth of the new practice?
EF visits not viewed as helpful
Individual appraisal: do people think it is worth doing?
Lack of involvement of EFs in internal facilitator recruitment Visit by internal facilitators to another ICONS site good
preparation for role
Unrealistic demands from study sites
Lack of engagement of internal facilitators
Reconfiguration: do people make changes to the new practice?
Greater attention to negotiating roles of both internal and EFs
Closer working between EFs
Begin facilitation visits when site ready to begin
implementation
TABLE 80 Individual site rankings for embedding and adherence
Embedding and adherence measures
Intervention Supported implementation
Site
AA
Site
BB
Site
CC
Site
EE
Site
FF
Site
HH
Site
KK
Site
LL
Embedding score (soft systems and NPT analysis) 2 3 3 2 2 1 1 3
3-day diary: number with entry on all 3 days 6 5 4 7 8 3 2 1
Daily clinical logs 6 4 8 3 5 1 2 7
Number of patients catheterised in acute stage 5 4 2 8 7 6 1 3
Time to catheter removal 4 6 1 7 3 2 8 5
Number of patients catheterised at baseline and at
discharge
6 5 1 8 7 4 1 3
Number of eligible patients put on regime 3 6 8 4 5 7 1 2
Length of time from last day of 3-day diary to
regime commencing
2 5 8 3 6 7 1 4
Allocation to correct regime 6 5 4 3 7 1 2 8
Combined ranking 5 6 4 7 8 2 1 3
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Chapter 9 Economic analysis
Study design
Study question
Background
The potential effectiveness of the ICONS SVP has been explored and described (see Chapter 7). In order
to obtain a more complete picture of whether or not this voiding programme is worth implementing in
practice, it is necessary to understand the potential effect on costs as well as outcomes. There is currently
a lack of economic evaluations in the area of continence management after stroke. In this chapter the
cost of delivering the intervention (a SVP; hereafter, the programme) will be explored and described,
as well as the impact of the programme on subsequent health and social service costs. Obtaining data
on costs requires the development of methods to record resource use in a variety of settings and from
a range of sources. Therefore, this chapter is also concerned with exploring the feasibility of the methods
for collection of cost data. The results from this chapter are aimed at informing the approach to data
collection in a definitive trial.
Study aims and objectives
Develop and test data collection methods for an economic evaluation within a full-scale cluster
randomised trial.
l develop data collection methods based on discussion with staff and patients
l explore completeness of the data
l identify if there are areas of resource use relevant to the programme not covered by the data collection
l describe the costs associated with the ICONS SVP
l explore the data for evidence of potential cost-effectiveness
l identify lessons learned to inform a definitive clinical trial.
Perspective
The analysis follows the current technology appraisal guidelines used by the NICE and so will take the
perspective of the UK NHS and Personal Social Services (PSS).177
Selection of alternatives
Current treatment
As outlined in the introduction (see Chapter 1), UI following acute stroke is common, affecting between
40% and 60% of people in hospital after a stroke.16 Despite the availability of clinical guidelines for the
management of UI after stroke,10 national audit data11 suggest incontinence is often poorly managed.
Current usual care does not necessarily include a continence management plan (63% patients had one in
the latest Sentinel audit11) so although there are recommendations in guidelines, such recommendations
are not systematically implemented in practice. Often, the aim of usual care for incontinence involves
containment rather than developing a proactive plan to promote continence. The programme is described
in detail elsewhere (see Chapter 3) and focuses on those conservative strategies shown to have some
effect with participants in studies included in Cochrane systematic reviews,25,27,29,53,54 but which had not
had their effectiveness demonstrated with stroke patients. These strategies included BT and PV. We also
evaluated whether or not supported implementation, through targeted organisational development aimed
at ‘normalising’ the programme,55–58 showed more preliminary evidence of effectiveness than introduction
of the programme alone. The programme aimed to develop, implement and evaluate the preliminary
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clinical effectiveness and cost-effectiveness of a SVP, with or without supported implementation, for the
management of UI after stroke in secondary care as compared with usual care.
Form of evaluation
In order to explore the potential range of benefits of the SVP, we are considering cost–utility analyses
and cost-effectiveness approaches. The cost–utility analysis will assess gains in quality-adjusted life-years
estimated from the EQ-5D.166 Although such a cost–utility analysis will allow an exploration of the impact
of the programme on QoL, the generic nature of the assessment means that it may not be an outcome
that meaningfully reflects the impact of programme to stroke patients. Consequently, we will perform a
cost-effectiveness analysis by assessing urinary frequency and exploring symptom-free days: this will be
estimated using the first question from the ISI151 – for the purpose of this study, this question also had an
option of ‘never,’ and the first question from the ICIQ-SF.162
Data collection
Efficacy data
The efficacy data used in the analyses are those from the exploratory trial reported elsewhere
(see Chapter 7). Measures of efficacy will be those recorded at 52 weeks.
Benefit measurement and valuation
Two measures of health outcome have been used: quality-adjusted life-years gained and symptom-free days.
Quality of Life
The EQ-5D,166 a generic QoL measure, which measures health on five items (mobility; self-care; usual
activities; pain and discomfort; anxiety and depression) was recorded on the outcome questionnaire.
It is being used to facilitate comparison with other diseases and interventions and will allow us to estimate
the potential benefit of the programme in terms of quality-adjusted life-years gained using the UK tariff
value,178 and subsequently estimate a cost per quality-adjusted life-year gained. Calculation of the tariff and
subsequent adjustment of the outcome quality-adjusted life-year for baseline value179 is described below.
However, it has been suggested that the EQ-5D has a large ceiling effect and poor responsiveness in
a non-stroke sample of women with UI.180 We therefore also used a condition-specific measure, the
incontinence-specific QoL instrument I-QOL,164,165 which has been shown to be the best continence-specific
measure for use in clinical trials in terms of reliability, validity and responsiveness to change.180 However, the
I-QOL has been validated only for those who are incontinent. We aim to explore the association between
the I-QOL and the utility values calculated from the EQ-5D using Spearman’s rank-order coefficient, overall
and by trial arm.
Quality-adjusted life-year calculation and adjustment
For each of the five items in the EQ-5D there are three levels: no problems, some problems and extreme
problems. Each EQ-5D health state obtained from the EQ-5D descriptive system was converted in to a
single summary index – the tariff. The tariff was calculated using a formula that attaches weights to each
of the three levels in each of the five dimensions. Deducting the appropriate weights from the value of 1
which indicates full health (i.e. state 11111) will produce a corresponding index for this health state.
The weights used in the UK are given in Table 81. For participants who are of full health (i.e. state 11111),
no weight is deducted (including the morbidity constant of 0.081), hence giving a tariff of 1. For all other
health states, a morbidity constant of 0.081 is also deducted in addition to appropriate weights. Finally, for
participants who have answered level 3 to at least one of the five dimensions (i.e. state 11133) a further
weight of 0.269 is also deducted in addition to the appropriate weights. The quality-adjusted life-years
calculated for each participant were based on the tariff value computed from their response to the EQ-5D
at 52 weeks.
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A mixed model was used to control for baseline utility. The following equation was applied:
Q12wi = β0 þ β1t i þ β2Oi þ β3Ei þ β4Q
b
i , (1)
where i is the patient identifier (i= 1, 2, . . . , N), ti is the trial arm (1= usual care, 2= intervention,
3= supported implementation), Oi is the OCSP classification, Ei is the Edinburgh case-mix and Q
b
i is the
baseline utility value.
Symptom-free days
The symptom-free days were based on the response to the ISI questionnaire and the ICIQ-UI. With regards
to frequency of incontinence, the ISI questionnaire has four levels, and the numbers of symptom-free days
assigned to each of these levels were 28 ‘less than once a month;’ 24 ‘one or several times a month’;
20 ‘one or several times a week’; and 0 ‘every day and/or night’. For the purpose of this study, because
the outcome questionnaire was being sent to people who may not have incontinence, we included a
response option of ‘never’ which was assigned a value of ‘0’. The ICIQ-UI has six levels, which were
assigned the values 28 ‘never’; 24 ‘about once a week or less often’; 18 ‘two or three times a week’;
4 ‘about once a day’; 0 ‘several times a day’; 0 ‘all the time’. Owing to minor inconsistencies in responses
to the two questionnaires we developed a contingency table where we estimated the number of
symptom-free days based on the scores on the two questionnaires (Table 82). Twenty-eight was used
as a maximum value because it reflects 4 weeks.
TABLE 81 Calculating the tariffs for the EQ-5D
Attribute Level Decrement
Constant –0.081
Mobility No problems (1) 0
Some problems (2) –0.069
Confined to bed (3) –0.314
Self-care No problems (1) 0
Some problems (2) –0.104
Unable to (3) –0.214
Usual activities No problems (1) 0
Some problems (2) –0.036
Unable to (3) –0.094
Pain/discomfort None (1) 0
Moderate (2) –0.123
Extreme (3) –0.386
Anxiety/depression None (1) 0
Moderate (2) –0.071
Extreme (3) –0.236
N3 (level 3 at least once) –0.269
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Assessment of feasibility
For each of the different data collection methods we recorded response rates. The postal questionnaire
had a section at the back where respondents could add comments about the questionnaire. The admission
data recorded were collected from both the postal questionnaire and the individual centres. The data
from the two sources were compared using Cohen’s kappa statistic.181
Costing
Seven areas of resource use were identified from hospital: (i) research staff providing training around the
programme, staff receiving training [(ii) ward staff and (iii) internal facilitators]; (iv) EFs; (v) staff performing
the programme; and after discharge, (vi) community health and social service input; (vii) admissions to
hospital, subsequent to the admission for the stroke. For each of these areas, data collection forms were
constructed to record data.
In-hospital resources
Staff training: ward staff
Training was provided by the ICONS research team, which allowed an estimate of time spent in delivering
and receiving training. Hospital staff were asked to provide details on the amount of time spent on the
online training.
Staff training: internal facilitators
For those staff acting as internal facilitators, we asked them to estimate time spent being trained by the
EFs and the time they subsequently spent on internal facilitation.
External facilitators
The EFs were asked to record the number of site visits and travel costs.
Staff performing the programme
It was originally intended that staff would be asked to record the amount of time they spent performing
the programme on a case-by-case basis. However, following initial discussions with hospital sites, it was felt
that there was a danger of overburdening ward staff with paperwork, the consequences of which might
have diluted provision of the programme: because the programme itself requires completion of paperwork
(see Chapter 6, Delivery of the intervention to individuals). As a result it was decided to make estimates of the
likely resource required for the programme by asking each of the 12 centres about the staff input required
for toileting a patient. At each centre a member of the senior ward staff was asked to complete a paper
questionnaire, which asked them to consider for a single occasion of toileting a patient, the method of
TABLE 82 Symptom-free days assigned to the response on the ISI and ICIQ-UI questionnaire
ISI response
ICIQ-UI response
Never
About once a week
or less often
Two or three
times a week
About once
a day
Several
times a day
All the
time
Nevera 28.0 26.0 23.0 16.0 14.0 14.0
Less than once a month 27.5 25.5 22.5 15.5 13.5 13.5
One or several times
a month
26.0 24.0 21.0 14.0 12.0 12.0
One or several times
a week
24.0 22.0 19.0 12.0 10.0 10.0
Every day and/or night 14.0 12.0 9.0 2.0 0.0 0.0
a Response included for purpose of this study.
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toileting (toilet, commode, bed-pan), number of staff involved in the toilet process, whether or not this
number of staff would be involved throughout the process and the levels (bands) of staff involved. The staff
member was asked to consider the input required for four different types of patients, based on differing
levels of dependency. The four levels were based around the Barthel149 transfer item: independent; transfers
with the help/supervision of one; needs help of two people; bed-bound. We asked staff to make the
estimates based on their experience/knowledge of the toileting process and not specifically in relation to
the ICONS programme. Questionnaires were received from eight of the sites and an average figure for time
spent and staff involved in toileting each type of patient on a single occasion was estimated.
The nature of the programme means that patients are toileted on multiple occasions throughout the day. The
number of occasions is dependent on the regime interval recorded on the daily clinical logs (see Chapter 6).
As it was not possible to identify the actual number of occasions every patient was toileted on a case-by-case
basis, we used the sample of daily clinical logs (described in Chapter 8) to make estimates of the likely daily
number of toileting occasions for each patient receiving the programme. Where we had daily clinical logs
for a patient, the average number of occasions they were toileted each day was based on the average of all
their available daily clinical logs. For all other patients, we based the number of occasions that patients were
toileted each day on the average calculated from all of the daily clinical logs available at that site. This daily
average was then multiplied by the number of days each person was known to have received the programme
(or ‘time spent on the regime’, see Chapter 6) to estimate the total number of toileting episodes per patient.
Post-hospital resources
Community health and social service input
A postal questionnaire designed for self-completion was sent to patients and carers. The postal questionnaire
was based on a design used previously by the applicants when querying input after discharge in a cohort
of stroke patients.182 The questionnaire was developed further for ease of use by patients and carers
through discussion with the ICONS PPC groups. So as not to overburden patients, at 12 weeks the resource
use questionnaire was sent out 2 weeks after the outcome questionnaire. Therefore, this resource use
questionnaire was sent out at 14-weeks post stroke: to maintain consistency between the resource use and
outcome questionnaires, this resource use questionnaire will still be referred to as 12 weeks. At 14 weeks,
questionnaires were only sent to patients discharged by week 12, because the questionnaire was designed to
record resource use in the community, i.e. patients had to have been in the community for at least 2 weeks
to merit sending out a questionnaire. If patients did not return their questionnaire within 2 weeks a further
questionnaire was sent out. If there was still no response, the patient would be contacted by telephone.
The postal questionnaire recorded use of the following resources: general practitioner (GP) contacts, practice
nurse contacts, number of admissions to hospital (subsequent to the index admission), physiotherapy,
occupational therapy, chiropody, district nurse, home care (home help), continence advisor, stroke family
support worker and day centre visits. Patients living in non-residential care also provided information about
aids and adaptations to their residence: walking stick, wheelchair, hoist (or similar), height adjustable bed,
mattress cover, chair raiser, toilet seat raiser, bedpan/urinal, commode, toilet rails, adapted bath/shower,
alarm call. In addition, patients had the option to list any other aids not covered in the list above.
Admissions
In addition to obtaining the number of admissions from patients, centres were asked to send details of any
patient admissions to hospital, which were subsequent to the index admission, up to 52 weeks. Due to a
pre-planned process (and consequently allocation of resources) this data retrieval was only possible for those
patients who should have completed the 52 weeks resource use questionnaire by 19 November 2012. The
dates and reasons for the admissions were recorded. If the patient only attended the A&E department, the
date and reason were recorded. If an admission was elective it was excluded from the analysis. The hospital
data were considered to be ‘correct’, but not all hospitals provided data. Comparisons were made between
patient-reported readmissions and hospital data and agreement was explored using the kappa statistic. In
order to keep the estimates of costs for readmissions simple, readmissions were split into two types: short
stay (an admission for 1 night) and long stay (an admission of ≥ 2 nights).
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Currency and price data
Unit costs were obtained from national data,183 Lancashire Teaching Hospitals’ Aids and Adaptations
Catalogue184 or Boots online.185 All costs are reported in pounds sterling at 2011/12 prices, unit costs can
be seen in Table 83.
TABLE 83 Resources and corresponding cost data
Item of resource use Cost (£) Source
Post discharge
Health care
GP 52.00 Curtis (2012)183
Practice nurse 14.00 Curtis (2012)183
Physiotherapy 33.00 Curtis (2012)183
Occupational therapy 33.00 Curtis (2012)183
District nurse 70.00 Curtis (2012)183
Continence advisora 49.00 Curtis (2012)183
Chiropody 30.00 Curtis (2012)183
Social care
Home care 23.00 Curtis (2012)183
Stroke family support worker 29.00 Curtis (2012)183
Day centre visits 40.00 Curtis (2012)183
Aids and adaptations
Walking stick 6.70 LTHTR184
Wheelchair 172.00 Curtis (2012)183
Hoist (or similar) 319.00 Curtis (2012)183
Height adjustable bedb 27.53 LTHTR184
Mattress cover 48.90 Boots185
Chair raiser 21.62 LTHTR184
Toilet seat raiser 15.00 LTHTR184
Bedpan/urinal 6.50 LTHTR184
Commode 25.00 LTHTR184
Toilet rails 6.00 Curtis (2012)183
Adapted bath/shower 407.00 Curtis (2012)183
Alarm call 54.00 Curtis (2012)183
A&E attendance (not admitted) 130.00 Curtis (2012)183
Admissions to hospital
Short stay 586.00 Curtis (2012)183
Long stay 2461.00 Curtis (2012)183
LTHTR, Lancashire Teaching hospitals NHS Foundation Trust.
a Based on community specialist nurse.
b Bed raisers.
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Performing the programme
In order to value the cost of the time performing the programme we made estimates of the cost for a
minute of staff time, which could then be multiplied up as necessary. The costs for different bands of staff
were based on the Pay-Circular (AforC) 2/2011.186 Adjustments were made for on-costs and overheads
and a cost per minute was calculated (Table 84).
The cost per minute was then combined with the estimates of time taken to toilet a patient (see Appendix 30)
to calculate a cost to toilet the different patient types (Table 85).
TABLE 84 Estimation of a cost per minute for different bands of staff
Level Point Basic (£) On-costs (£)a
Overheads
(staff) (£)b
Overheads
(non-staff) (£)c
Cost per
annum (£)
Hours per
annumd
Cost per
minute (£)
Band 2 5 15,444 3707 3089 6178 28,417 1593 0.30
Band 3 9 17,368 4168 3474 6947 31,957 1593 0.33
Band 4 14 20,183 4844 4037 8073 37,137 1593 0.39
Band 5 20 24,554 5893 4911 9822 45,179 1573 0.48
Band 6 25 29,464 7071 5893 11,786 54,214 1573 0.57
Band 7 30 35,184 8444 7037 14,074 64,739 1573 0.69
a Estimated at 24%.
b Estimated at 20%.
c Estimated at 40%.
d Curtis (2012).183
TABLE 85 Cost of toileting different patient types
Item of resource use (in hospital) Cost (£) Reference
An occasion of toileting patient types
Independent 2.19 See Appendix 30
Transfers with the help/supervision of one 4.49 See Appendix 30
Needs help of two people 9.65 See Appendix 30
Bed-bound 12.84 See Appendix 30
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Cost of training
The cost of the training was based on staff time in delivering the training and the cost of staff time undertaking
the training. The unit costs related to delivering and receiving training can be found in Table 86. As the initial
training was only provided in 30-minute sessions, an hourly rate was used as a basis from which to calculate
the costs of delivering and receiving the training. For staff who were being trained to be internal facilitators an
hourly rate was used. The structure of the process for delivery of facilitator training meant that the EFs were
costed at a daily rate. One of the EFs was paid on a consultancy basis, whereas for the other EF, a daily rate
was calculated from the original application.
The uptake of training at the eight sites (intervention and supported implementation) is described
elsewhere in the report as part of the process evaluation (see Chapter 8). As the cost of training staff is
dependent on the number of staff in a particular centre it was felt that estimating an average cost across
all centres would better reflect the likely cost of the (training part of the) programme. The numbers of staff
ranged from 13 to 30, the type of staff included nurses and therapists. Details of costs attributed to
different staff types attending the training can be found in Appendix 31. Staff spent up to 2 hours (usually
four 30-minute sessions) undertaking face-to-face training with ICONS senior research staff. In addition,
staff also had the opportunity to undertake online training: no data in relation to the uptake of the online
training were available. We therefore made the assumption that the staff attending the face-to-face
training would also spend 1 hour performing the online training. The average cost of face-to-face training
per centre with regards to ward staff receiving training was estimated to be £1550 (see Appendix 31).
TABLE 86 Training-related costs (hourly rate unless otherwise stated)
Item of resource use Cost (£) Reference
Delivery of training
Staff trainer 1 34 From application
Staff trainer 2 28 From application
EF 1 379a From application
EF 2 500a Consultancy rate
Research nurse 25 From application
Travel (delivery of training only) 45b Average per site
Receipt of training
Ward managers/sisters 58 Curtis (2012)183
Ward sister 50 Curtis (2012)183
Staff nurse 41 Curtis (2012)183
Research nurse 25 From application
HCA 21 Curtis (2012)183
Physiotherapists 34 Curtis (2012)183
Occupational therapists 34 Curtis (2012)183
Assistant practitioners 22 Curtis (2012)183
a Daily rate.
b Average per site visit.
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This is then added to the estimated cost of online training (£775 and the sum is multiplied by four to
produce a cost for the trial arm, approximately £9300 [see Table 86 (includes rounding error)]. The cost of
all aspects of training staff in the different trial arms can be found in Table 87. Facilitation, internal and
external, added £9642 to cost of the supported implementation arm (including travel). In calculating the
mean cost per patient we used the annual number of patients admitted with an acute stroke and who
would have been eligible for the programme as the denominator because it was felt that this would better
represent the cost of training in practice rather than base it on the numbers in the trial arms, which is
more of a reflection of the research process.
Cost of the systematic voiding programme
The estimated input required for the SVP and the associated cost can be seen in Table 88. The table
shows, by trial arm and for each patient type, the number of patients in that category and the estimated
average number of occasions that patients of that type were toileted as part of the programme. SVP had a
higher cost in the supported implementation arm, which was due to the high number of occasions of
toileting bed-bound patients.
TABLE 87 Resources used per trial arm for staff training
Resource Usual care (£) Intervention (£)
Supported
implementation (£)
Training development 0 1770 1770
Delivering training to hospital staff
Staff costs 0 933 933
Travel 0 180 180
Hospital staff receiving training (including online) 0 9302 9302
Internal facilitators (being trained and providing training) 0 0 3922
EFs
Staff costs 0 0 4653
Travel 0 0 1067
Staff training total 0 12,185 21,828
Mean cost per patient of staff training 0 13 25
TABLE 88 Mean resource use and costs attributable to the SVP
Resource
Intervention Supported implementation
na Occasionsb Cost (£) n Occasions Cost (£)
Patient type
Independent 6 233 510 7 145 317
Transfers with the help/supervision of one 22 124 557 10 121 541
Needs help of two people 60 184 1775 52 192 1854
Bed-bound 13 159 2045 10 300 3857
Overall mean 171 1469 193 1805
a Number of patients.
b Number of times the person is toileted.
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
295
Analysis and interpretation of results
Adjustments for timing of costs and benefits
The cost of stroke tends to be higher in the acute stage, when patients are cared for in hospital: these
costs are borne by the NHS. Once care is transferred to the community, there are costs for the NHS,
generally through GP contacts and subsequent hospital admissions and costs for PSS, through social
support and residential care. On the whole, the cost of stroke tends to lessen as time since the event
lengthens. Any intervention in the acute stage such as the ICONS SVP will incur costs early after the stroke
event. Any benefits of this programme are more likely to be seen after this initial stage. For a definitive trial
it would be important to consider resource use and measures of effectiveness beyond the acute stage.
Consequently, one of the aims of this exploratory trial is to consider longer-term data capture. In addition,
this trial aims to explore evidence of potential cost-effectiveness. Consequently, for the purpose of this
exploratory trial the time horizon for the cost analysis will be from admission to the stroke unit to 52 weeks
post stroke. All health and social care resources are included in the analysis because it is unclear which ones
incontinence might affect. As a result of this 1-year time horizon, no discounting will be performed.
Allowance for uncertainty
Resource use and cost data are described separately for each trial arm and described using means and SDs,
or numbers and percentages where appropriate. The outcome effectiveness data can be found in full
elsewhere in the report (see Chapter 7) and are summarised in the Results section of this chapter.
Resource use data are described in three ways.
Complete cases
Data are described using all data available at each of 12 and 52 weeks.
Base case
For the base-case analysis we report data for all patients. We used the data from the 52-week resource
use questionnaires when available and for admissions to hospital we used the data from the hospitals
when it had been supplied. If data were missing from either source, we performed imputations. The
method of imputation was as follows: the average usage for each of the post-hospital resources was
estimated from the available data; this average figure was estimated separately for stroke types, based on
the OCSP classification (see Chapter 5). This method was chosen because it was assumed that resource use
was likely to be affected by severity of stroke. The average value calculated for each resource within a
stroke type was imputed for the missing values within that resource.
Sensitivity analyses
From the resource use data in the base case we used the lower and upper limits of the 95% CIs to explore
the potential range of resources used. For the training, we did not have CIs and so we varied the cost of
the training by ± 25%. From the outcome data we used the lower and upper limits of the 95% CIs to
explore the potential range of effects.
Results
Assessment of feasibility (completeness of data)
For the requests to provide estimates of how long it would take to toilet a patient, 8 out of 12 (66.7%)
sites provided a response (usual care, n= 2; intervention, n= 3; supported implementation, n= 3).
Admission data were provided by 9 out of 12 (75%) sites (usual care, n= 2; intervention, n= 4; supported
implementation, n= 3). One usual care site and one intervention site provided no data to either request.
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Postal questionnaires: resource use
At 12 weeks, post-hospital resource use data were collected for 193 out of 263 (73.4%) patients eligible
to be sent a postal questionnaire. Table 89 shows the number of responses in each of the trial arms.
One-hundred and fifty patients were not contacted regarding resource use because of withdrawal (n= 9),
death (n= 45) or still being in hospital due to the index stroke (n= 96). Considering eligible patients only,
the proportion of respondents was similar across all three trial arms (between 72% and 75%).
The completion rates of the individual items within the 12-week postal questionnaires are shown in
Tables 90 and 91. The health and social care items (see Table 90) had an overall completion rate of 95%;
for the individual items the completion rates were above 90%, with some items being completed by all
participants. For most of the items, the completion rate in the usual care arm tended to be the highest,
with the intervention arm generally completing a higher proportion of items than the supported
implementation arm.
TABLE 89 Response to the 12-week resource use questionnaire in the three trial arms and overall
Record status at 12 weeks
Usual care
(n= 124)
Intervention
(n= 164)
Supported implementation
(n= 125)
Overall
(n= 413)
Missing: lost to follow-up at this
time point
22 (17.7%) 24 (14.6%) 19 (15.2%) 65 (15.7%)
Withdrawn 1 (0.8%) 4 (2.4%) 4 (3.2%) 9 (2.2%)
Dead 13 (10.5%) 21 (12.8%) 11 (8.8%) 45 (10.9%)
Received and entered 57 (46%) 83 (50.6%) 53 (42.4%) 193 (46.7%)
Missing lost to study 0 5 (3.1%) 0 5 (1.2%)
In other hospital (from ICONS) 31 (25%) 27 (16.5%) 38 (30.4%) 96 (23.3%)
TABLE 90 Response rates for each of the health and social care resource items in the postal questionnaire at
12 weeks
Resource
Usual care (n= 57) Intervention (n= 83)
Supported implementation
(n= 53)
n % n % n %
Health-care contacts
GP 55 96.5 80 96.4 49 92.5
Practice nurse 56 98.2 81 97.6 48 90.6
Physiotherapy 54 94.7 78 94.0 49 92.5
Occupational therapy 56 98.2 76 91.6 51 96.2
District nurse 53 93.0 80 96.4 50 94.3
Continence advisor 55 96.5 80 96.4 49 92.5
Chiropody 56 98.2 81 97.6 49 92.5
Social care contacts
Home carea 36 97.3 46 97.9 32 94.1
Stroke family support worker 56 98.2 78 94.0 49 92.5
Day centre visitsa 36 97.3 47 100 33 97.1
Hospital admissions 57 100.0 75 90.4 50 94.3
Overall mean 97.1 95.7 93.6
a n-values: 37, 47 and 34, for usual care, intervention and supported implementation, respectively, due to patients in
residential care.
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For the aids and adaptations (see Table 91), the overall response rate to the items in the 12-week
postal questionnaire was 85.8%. There was some variability in the completion rates, which ranged from
70.6% up to 97.3%. Completion rates for the usual care and intervention arms were similar, with the
supported implementation arm generally having a lower proportion of responses.
At 52 weeks, post-hospital resource use data were collected for 167 out of 299 (55.9%) patients eligible
to be sent a postal questionnaire. Table 92 shows the number of responses in each of the trial arms.
One-hundred and fourteen patients were not contacted regarding resource use because of withdrawal
(n= 16) and death (n= 98). Considering those patients eligible to be sent a postal questionnaire,
a similar proportion responded in each trial arm [50/91 (54.9%) usual care; 66/118 (55.9%) intervention;
and 51/90 (56.7%) supported implementation].
TABLE 91 Response rates for each of the aids and adaptation resource items in the postal questionnaire at
12 weeks
Resource
Usual care (n= 37) Intervention (n= 47)
Supported implementation
(n= 34)
n % n % n %
Aids and adaptations
Walking stick 36 97.3 43 91.5 31 91.2
Wheelchair 31 83.8 44 93.6 30 88.2
Hoist (or similar) 31 83.8 41 87.2 25 73.5
Height adjustable bed 31 83.8 41 87.2 25 73.5
Mattress cover 31 83.8 41 87.2 25 73.5
Chair raiser 33 89.2 40 85.1 26 76.5
Toilet seat raiser 33 89.2 42 89.4 30 88.2
Bedpan/urinal 29 78.4 42 89.4 24 70.6
Commode 33 89.2 44 93.6 27 79.4
Toilet rails 33 89.2 41 87.2 29 85.3
Adapted bath/shower 34 91.9 42 89.4 30 88.2
Alarm call 35 94.6 41 87.2 27 79.4
Overall mean 87.9 89.0 806.0
TABLE 92 Response to the 52-week resource use questionnaire in the three trial arms
Record status at 52 weeks
Usual care
(n= 124)
Intervention
(n= 164)
Supported
implementation
(n= 125)
Overall
(n= 413)
Missing: lost to follow-up
at this time point
37 (29.8%) 46 (28.0%) 34 (27.2%) 117 (28.3%)
Withdrawn 4 (3.2%) 6 (3.7%) 6 (4.8%) 16 (3.9%)
Dead 29 (23.4%) 40 (24.4%) 29 (23.2%) 98 (23.7%)
Received and entered 50 (40.3%) 66 (40.2%) 51 (40.8%) 167 (40.4%)
Missing lost to study 4 (3.2%) 6 (3.7%) 5 (4.0%) 15 (3.6%)
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The completion rates of the individual items within the 52-week postal questionnaires are shown in
Tables 93 and 94. For the health and social care items (see Table 93), the overall completion rate was
95.3%, with only a modest variation between items, ranging from 87.8% to 100.0%. The intervention
arm showed the most variability in completion of items. The supported implementation arm had,
fractionally the highest response rate.
TABLE 93 Response rates for each of the health and social care resource items in the postal questionnaire at 52 weeks
Resource
Usual care (n= 50) Intervention (n= 66)
Supported implementation
(n= 51)
n % n % n %
Health-care contacts
GP 47 94.0 66 100.0 51 100.0
Practice nurse 47 94.0 64 97.0 50 98.0
Physiotherapy 49 98.0 64 97.0 50 98.0
Occupational therapy 46 92.0 63 95.5 49 96.1
District nurse 48 96.0 64 97.0 50 98.0
Continence advisor 46 92.0 62 93.9 48 94.1
Chiropody 49 98.0 64 97.0 50 98.0
Social care contacts
Home carea 34 97.1 40 97.6 34 94.4
Stroke family support worker 46 92.0 62 93.9 47 92.2
Day centre visitsa 33 94.3 36 87.8 33 91.7
Hospital admissions 46 92.0 63 95.5 47 92.2
Overall mean 94.5 95.6 95.7
a n-values: 35, 41 and 36, for usual care, intervention and supported implementation, respectively, due to patients in
residential care.
TABLE 94 Response rates for each of the aids and adaptation resource items in the postal questionnaire at 52 weeks
Resource
Usual care (n= 35) Intervention (n= 41)
Supported implementation
(n= 36)
n % n % n %
Aids and adaptations
Walking stick 33 94.3 37 90.2 32 88.9
Wheelchair 31 88.6 40 97.6 32 88.9
Hoist (or similar) 27 77.1 38 92.7 26 72.2
Height adjustable bed 27 77.1 38 92.7 30 83.3
Mattress cover 27 77.1 38 92.7 30 83.3
Chair raiser 31 88.6 38 92.7 30 83.3
Toilet seat raiser 30 85.7 35 85.4 31 86.1
Bedpan/urinal 26 74.3 34 82.9 28 77.8
Commode 30 85.7 40 97.6 31 86.1
Toilet rails 32 91.4 34 82.9 30 83.3
Adapted bath/shower 30 85.7 34 82.9 31 86.1
Alarm call 29 82.9 35 85.4 29 80.6
Overall mean 84.0 89.6 83.3
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For the aids and adaptations (see Table 94), the overall response rate to items in the 52-week postal
questionnaire was 85.6%. There was a wide range of completion rates for the individual items, ranging
from 72.2% up to 97.6%. On average, the completion rate for the intervention arm was highest at
89.6%, with the supported implementation arm having an average completion rate of 83.3%.
Of the 12- and 52 week questionnaires, 9 out of 193 (4.7%) and 12 out of 167 (7.2%), respectively, had
comments written in the free-text box. Most of the comments were either general statements around care
input or related to descriptions of difficulties faced by the patient and their families following the stroke.
There were five comments that were relevant to completion of the form and can be seen below:
I am an Age UK Community Officer and I took 30 minutes to complete this form (asking client and
son the questions) so 10 minutes to complete this is an unreasonable estimate either by client or with
help from family/Age UK.
No, I have no problems completing these forms they are self-explanatory.
Stapling double-sided forms together makes it very difficult to complete all the forms fully.
This form took at least an hour to complete. Fortunately doctors/therapist appointments were marked
on a calendar so dates are accurate – other points have to be recalled which all take time.
Well set out. Covers all aspects of having had a stroke. Thank you.
A further five comments indicated the potential problem of using a postal questionnaire to gather
information in this client group:
A lot of the questions appeared to presume that I had returned home to a domestic setting – they do
not really cater for people who do not fit that box. However, I have tried to give as much information
as possible to assist your project. Thank you.
Quite a number of the questions are not relevant for someone who has no communication and as his
wife I also can’t answer them on his behalf.
Sorry some answers are vague but they are not relevant to this lady.
. . . cannot communicate adequately to complete this form. Filled in by RGN [registered general nurse]
to best ability.
. . . was unable to complete this survey – hence, help was provided.
Postal questionnaires: outcome data
The response rates for the outcome variables relevant to economic analyses are presented in Table 95.
At 12 weeks the response rates for the EQ-5D items were all above 90%. The participants in the usual
care arm tended to have higher completion rates. We were able to estimate symptom-free days for
approximately 80% of participants, with similar numbers responding in each of the trial arms. The
responses to the I-QOL at 12 weeks was variable across trial arms, with only a 59.3% response rate in the
supported implementation arm compared with 91.1% in usual care. At 52 weeks the completion rate for
the EQ-5D items was again high, with a > 94% response rate for all items in all of the trial arms. We were
able to estimate symptom-free days in nearly 100% of patients. The completion rate of the I-QOL was,
overall, lower than at 12 weeks with less variability across trial arms, ranging from 54.5% (supported
implementation) to 65.4% (usual care).
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Postal questionnaires: hospital data
Admission data were sought for 200 patients from across the 12 centres. Only nine centres provided admission
data and in these centres, 37 patients were reported to have been readmitted, with an additional five A&E
department attendances. The patient reported admissions for all sites indicated 19 admissions to hospital
(including two A&E department attendances), with 15 admissions (or A&E department attendance) being
reported by patients for those sites that had returned hospital data. It was possible to compare hospital and
patient report for 51 patients. The comparison of the two sources of data, showed reasonable agreement
between the numbers reported (Table 96). Analysis of these data revealed very good agreement (kappa= 0.66;
95% CI 0.39 to 0.94).
TABLE 95 Number of responses for each of the economic-relevant variables in the postal questionnaires
Outcome
Usual care Intervention
Supported
implementation
n % n % n %
Questionnaires returned (12 weeks) n = 98 n = 132 n = 100
EQ-5D (12 weeks)
Mobility 96 98.0 129 97.7 92 92.0
Self-care 97 99.0 126 95.5 92 92.0
Usual activity 97 99.0 126 95.5 91 91.0
Pain 95 96.9 123 93.2 93 93.0
Anxiety 95 96.9 122 92.4 92 92.0
Symptom-free days at 12 weeks (non-catheterised patients only) 80 81.6 104 78.8 86 86.0
I-QOL relevant (incontinent) n= 56 n= 62 n= 59
I-QOL at 12 weeks 51 91.1 47 75.8 35 59.3
Questionnaires returned (52 weeks) n = 50 n = 66 n = 51
EQ-5D (52 weeks)
Mobility 49 98.0 63 95.5 49 96.1
Self-care 50 100 65 98.5 50 98.0
Usual activity 48 96.0 65 98.5 50 98.0
Pain 48 96.0 66 100 50 98.0
Anxiety 47 94.0 66 100 48 94.1
Symptom-free days at 52 weeks (non-catheterised patients only) n= 47 n= 58 n= 48
47 100 58 100 47 97.9
I-QOL relevant (incontinent) n= 26 n= 35 n= 33
I-QOL at 52 weeks 17 65.4 20 57.1 18 54.5
TABLE 96 Comparison of patient report and hospital data for readmissions, where data were available from
both sources
Admission within 52 weeks (from patient report)
Admission within 52 weeks (from hospital records)
TotalNo Yes
No 33 4 37
Yes 3 11a 14
Total 36 15 51
a Includes two A&E department attendances.
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Resource use: complete cases
Resource use in each of the trial arms at 12 weeks can be seen in Tables 97 and 98.
Although more of the intervention arm patients saw a therapist, the average number of contacts was
smaller, this was similar for the practice nurse contacts. Only a couple of people in the usual care arm saw
a stroke family support worker. No one in the supported implementation arm visited a day centre. Slightly
more of the intervention arm saw a district nurse, and the average number of contacts was much higher.
No one in the supported implementation arm had a bedpan/urinal and a smaller proportion received a
commode; however, a higher proportion received toilet rails. A higher proportion of patients in the
intervention arm had mattress covers.
TABLE 97 Mean number of resources used per trial arm at 12 weeks (complete cases)
Resource
Usual care Intervention
Supported
implementation Overall
n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD)
Health-care contacts
GP 34 2.62 (2.17) 45 2.22 (1.57) 34 2.15 (1.42) 113 2.32 (1.73)
Practice nurse 14 4.07 (5.00) 22 1.77 (1.54) 12 5.33 (3.80) 48 3.33 (3.70)
Physiotherapy 26 9.27 (7.91) 32 7.54 (6.83) 23 10.94 (16.12) 81 9.06 (10.54)
Occupational therapy 6 11.17 (11.45) 12 5.58 (5.17) 6 8.00 (11.69) 29 7.66 (9.34)
District nurse 7 8.20 (6.46) 13 23.58 (32.02) 10 5.43 (6.07) 30 13.94 (22.78)
Continence advisor 4 4.55 (2.72) 4 0.5 (0.58) 5 6.01 (8.74) 13 3.87 (5.77)
Chiropody 12 3.85 (9.30) 27 0.95 (0.84) 8 1.06 (0.93) 47 1.71 (4.78)
Social care contacts
Home care 22 42.43 (28.17) 19 74.11 (51.90) 18 63.73 (75.91) 59 59.13 (54.15)
Stroke family support worker 2 1.5 (0.71) 11 3.77 (5.04) 7 4.53 (5.22) 20 3.81 (4.77)
Day centre visits 4 6.82 (3.34) 2 11.36 (8.18) 0 0 6 8.33 (5.06)
A&E department attendance
(not admitted)
0 0 0 0 0 0 0 0
Hospital admissions
Short stay 0 0 2 1 (0) 1 1 (0) 3 1 (0)
Long stay 6 1 (0) 17 1.12 (0.33) 6 1.17 (0.41) 29 1.10 (0.31)
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Resource use in each of the trial arms at 52 weeks can be seen in Tables 99 and 100. The mean values in
Table 99 are based on patients who accessed those resources. The data indicate that patients who saw
their GP or practice nurse tended to see them on an average of five occasions. The number of contacts
with therapy services is very high in all trial arms, particularly the intervention arm. This may be a
consequence of how these data were recorded in the questionnaires, which consequently informed
how they were calculated. Contacts with the district nurse and support with home care were markedly
higher in the intervention arm, and again the method of recording in the questionnaire is likely to
have affected the estimates of the magnitude of the input. The distribution of aids and adaptations is
mostly similar across trial arms except for wheelchairs, mattress covers, bedpans/urinals and commodes,
which were more frequently supplied to patients in the intervention arm.
TABLE 98 Proportion of aids and adaptations received per trial arm at 12 weeks (complete cases)
Resource
Usual care
(n= 35)a
Intervention
(n= 42)
Supported implementation
(n= 33)
Overall
(n= 110)
n % n % n % n %
Aids and adaptations
Walking stick 18 51.4 23 54.8 18 54.5 59 53.6
Wheelchair 11 31.4 24 57.1 14 42.4 49 44.5
Hoist (or similar) 2 5.7 7 16.7 1 3.0 10 9.1
Height adjustable bed 4 11.4 6 14.3 2 6.1 12 10.9
Mattress cover 7 20.0 15 35.7 6 18.2 28 25.5
Chair raiser 9 25.7 10 23.8 6 18.2 25 22.7
Toilet seat raiser 12 34.3 11 26.2 14 42.4 37 33.6
Bedpan/urinal 4 11.4 14 33.3 0 0 18 16.4
Commode 18 51.4 27 64.3 13 39.4 58 52.7
Toilet rails 14 40.0 9 21.4 15 45.5 38 34.5
Adapted bath/shower 10 28.6 12 28.6 12 36.4 34 30.9
Alarm call 5 14.3 14 33.3 7 21.2 26 23.6
a The n-values in the table refer to the number of forms returned from participants in non-residential settings.
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TABLE 99 Mean number of resources used per trial arm at 52 weeks (complete cases)
Resource
Usual care Intervention
Supported
implementation Overall
n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD)
Health-care contacts
GP 30 5.2 (4.37) 49 5.04 (3.93) 30 3.6 (2.90) 109 4.69 (3.83)
Practice nurse 17 5.41 (5.24) 30 6.67 (9.82) 22 7.41 (10.05) 69 6.59 (8.91)
Physiotherapy 23 24.67 (23.94) 35 45.97 (57.54) 28 36.37 (41.92) 86 37.15 (45.88)
Occupational
therapy
6 15.17 (18.00) 17 52.05 (64.65) 10 29.69 (37.94) 33 38.57 (52.62)
District nurse 11 19.57 (18.25) 16 63.49 (92.33) 15 12.29 (13.89) 42 33.7 (61.91)
Continence
advisor
1 4.27 (0.00) 7 9.11 (14.77) 2 2.74 (1.57) 10 7.35 (12.41)
Chiropody 26 6.79 (5.00) 32 6.05 (3.58) 23 6.28 (4.93) 81 6.35 (4.42)
Social care contacts
Home care 16 391.46 (373.52) 19 678.83 (480.07) 15 281.01 (335.74) 50 467.53 (435.23)
Stroke family
support
4 11.73 (19.38) 9 10.25 (14.41) 7 1.23 (0.93) 20 7.39 (12.99)
Day centre visits 5 60.17 (47.88) 3 15.29 (20.94) 1 13.57 (0) 9 40.03 (42.74)
A&E department
attendance (not
admitted)
0 2 1.50 (0.71) 3 1 (0.00) 5 1.20 (0.45)
Hospital admissions
Short stay 0 8 1.13 (0.35) 1 1 9 1.11 (0.33)
TABLE 100 Number of aids and adaptations used per trial arm at 52 weeks (complete cases)
Resource
Usual care
(n= 35)a
Intervention
(n= 41)
Supported implementation
(n= 36)
Overall
(n= 112)
n % n % n % n %
Aids and adaptations
Walking stick 22 62.9 22 53.7 18 50.0 62 55.4
Wheelchair 14 40.0 27 65.9 19 52.8 60 53.6
Hoist (or similar) 5 14.3 12 29.3 6 16.7 23 20.5
Height adjustable bed 6 17.1 11 26.8 9 25.0 26 23.2
Mattress cover 7 20.0 15 36.6 7 19.4 29 25.9
Chair raiser 13 37.1 11 26.8 10 27.8 34 30.4
Toilet seat raiser 13 37.1 10 24.4 13 36.1 36 32.1
Bedpan/urinal 5 14.3 16 39.0 5 13.9 26 23.2
Commode 12 34.3 25 61.0 16 44.4 53 47.3
Toilet rails 12 34.3 13 31.7 14 38.9 39 34.8
Adapted bath/shower 9 25.7 13 31.7 10 27.8 32 28.6
Alarm call 8 22.9 8 19.5 10 27.8 26 23.2
a The n-values in the table refer to the number of forms returned from participants in non-residential settings.
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Resource use: base case
The imputed data, showed slightly different patterns to the data in the returned questionnaires. The use
of post-hospital resources was similar in the three trial arms, with the exception of district nurse input,
which was higher in the intervention arm and day centre visits, which were higher in the usual care
arm (Table 101).
There were some differences between the trial arms in terms of receipt of aids and adaptations (Table 102).
Calculation of the mean number of aids and adaptations was based on the patients not in residential care.
Provision of bedpans/urinals and commodes were slightly higher in the intervention arm compared with the
other trial arms.
TABLE 101 Mean (SD) number of resources used per trial arm at 52 weeks (base case); as Table 99 but with
imputed values
Resource
Usual care
(n= 124)
Intervention
(n= 164)
Supported implementation
(n= 125)
Health-care contacts
GP 3.55 (2.69) 3.76 (2.57) 3.18 (1.89)
Practice nurse 2.59 (2.58) 3.15 (4.66) 3.15 (4.78)
Physiotherapy 24.57 (13.94) 30 (30.21) 29.09 (23.57)
Occupational therapy 15.11 (10.00) 16.89 (26.33) 15.76 (14.63)
District nurse 8.66 (8.18) 14.92 (33.4) 9.1 (5.34)
Continence advisor 0.39 (0.58) 0.92 (3.36) 0.64 (0.59)
Chiropody 3.81 (2.91) 3.98 (2.10) 4.13 (2.53)
Social care contacts
Home carea 262.57 (155.34) 295.52 (237.64) 239.5 (128.76)
Stroke family support worker 1.33 (3.63) 1.47 (3.89) 1.15 (0.61)
Day centre visitsa 7.16 (16.87) 4.1 (3.95) 3.8 (7.15)
A&E department attendance (not admitted) 0.03 (0.08) 0.03 (0.18) 0.06(0.17)
Hospital admissions
Short stay 0.06 (0.04) 0.09 (0.25) 0.06 (0.09)
Long stay 0.34 (0.26) 0.44 (0.56) 0.29 (0.23)
a n-values 108, 136 and 110, for usual care, intervention and supported implementation, respectively, due to patients in
residential care.
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
305
Combining resource use and costs
The combined resource use and cost data at 52 weeks can be seen in Table 103. The hospital costs were
higher in the supported implementation arm mainly due to the cost of the programme. The cost of the
staff training was less than 2% of the in-hospital costs. Health and social care costs were higher in
the intervention arm, whereas the supported implementation had the lowest social care costs. The cost
of admissions was higher in the intervention compared with the other trial arms. The cost of the aids and
adaptations were marginally lower in the usual care arm and similar in the other trial arms. The mean
cost per patient in the usual care arm was lower than in either of the intervention arms, with the cost in
the intervention arm higher than that in the supported implementation arm.
TABLE 102 Mean (SD) number of aids and adaptations used per trial arm at 52 weeks (base case) for participants
in non-residential settings); as Table 100 but with imputed values
Resource Usual care (n= 108) Intervention (n= 136) Supported implementation (n= 110)
Aids and adaptations
Walking stick 0.39 (0.39) 0.35 (0.38) 0.35 (0.38)
Wheelchair 0.30 (0.36) 0.43 (0.40) 0.38 (0.39)
Hoist (or similar) 0.10 (0.23) 0.13 (0.28) 0.09 (0.23)
Height adjustable bed 0.13 (0.26) 0.16 (0.29) 0.15 (0.27)
Mattress cover 0.17 (0.29) 0.25 (0.35) 0.19 (0.30)
Chair raiser 0.23 (0.33) 0.20 (0.31) 0.20 (0.31)
Toilet seat raiser 0.25 (0.34) 0.20 (0.30) 0.24 (0.35)
Bedpan/urinal 0.14 (0.26) 0.23 (0.35) 0.12 (0.22)
Commode 0.28 (0.35) 0.38 (0.39) 0.30 (0.36)
Toilet rails 0.28 (0.35) 0.23 (0.32) 0.27 (0.35)
Adapted bath/shower 0.20 (0.30) 0.21 (0.31) 0.27 (0.36)
Alarm call 0.17 (0.29) 0.15 (0.27) 0.19 (0.31)
TABLE 103 Summary of mean costs per trial arm (base case)
Resource Usual care (£) Intervention (£) Supported implementation (£)
In hospital
Staff training 0 13 25
Cost of programme 0 1469 1805
Mean in-hospital costs 0 1482 1830
Post discharge
Health care 2270 2996 2481
Social care 6230 6590 5630
A&E department
attendance
0 0 0
Hospital admissions 884 1145 753
Aids and adaptations 178 210 219
Mean post-discharge costs 9563 10,941 9083
Total mean costs 9563 12,423 10,913
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The distribution of costs for by each trial arm can be seen in Figures 29–31. In the usual care arm, the
costs went up to around £35,000 but this was only for one patient (see Figure 29). The majority of
patients contributed less than £10,000 to the total cost. In the intervention arm, the range of costs was
much wider, ranging from around £2500 up to £45,000 (see Figure 30). Although some patients had
higher costs, the majority of patients had costs of under £12,500. The supported implementation arm
had a similar range of cost to the intervention arm, spanning from a minimum of around £4000 to a
maximum of £34,000 (see Figure 31). Over half the patients in this trial arm had costs less than £12,000.
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Total costs at 52 weeks (£)
Mean = £9562.82
SD = £3731.801
n = 124
FIGURE 29 Distribution of costs in the usual-care arm.
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FIGURE 30 Distribution of costs in the intervention arm.
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SD = £3472.331
n = 125
FIGURE 31 Distribution of costs in the supported-implementation arm.
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Patient outcomes
The efficacy outcomes relevant to the economic analysis are summarised in Table 104. There were clear
differences between the groups at baseline, with the intervention arm having much lower utility values.
The unadjusted utility values were higher at 52 weeks in all groups. However, once data were imputed
and utilities adjusted for baseline variables there was a loss of quality-adjusted life-years in all groups, with
the lowest value seen in the usual-care arm. The loss of quality-adjusted life-years was similar whether
imputed or complete cases were used, although in contrast to the imputed data, the usual-care arm had
the highest value. The number of symptom-free days was similar across groups, with the usual-care arm
having the highest values. There was a marked difference between the symptom-free days when imputed
data as opposed to complete cases were used: values for the latter were twice those of the former.
The I-QOL was similar across groups.
Comparing the Incontinence Quality of Life questionnaire
with the quality-adjusted life-year
The association between the I-QOL and the utility values from the EQ-5D was explored overall and within
trial arms. At 52 weeks the overall comparison revealed a significant correlation [ρ= 0.36 (n= 84,
p= 0.001)]. The association between the two measures differed between trial arms, with the usual-care
arm showing a non-significant correlation [ρ= 0.30; (n= 24, p= 0.16)], the intervention arm showed a
significant correlation [ρ= 0.47 (n= 32, p= 0.007)], with a marginally non-significant effect for the
supported-implementation arm [ρ= 0.34 (n= 28, p= 0.07)].
TABLE 104 Outcomes in the three trial arms; cells are mean (SD) unless otherwise stated
Variable Usual care Intervention Supported implementation
Utility values at baseline 0.31 (0.34), n= 100 0.13 (0.35), n= 116 0.3 (0.36), n= 83
Utility values at 52 weeks 0.46 (0.36) n= 47 0.26 (0.39), n= 65 0.39 (0.38), n= 49
Utility at 52 weeks (imputed and
adjusted for baseline)
–0.14 (0.20), n= 99 –0.24 (0.20), n= 113 –0.11 (0.19), n= 83
Quality-adjusted life-years gained
(imputed) (52 weeks – baseline)
–0.45 (0.20), n= 99 –0.36 (0.22), n= 113 –0.41 (0.24), n= 83
Utility at 52 weeks (complete case,
adjusted for baseline)
0.06 (0.29), n= 41 –0.29 (0.24), n= 47 –0.11 (0.22), n= 39
Quality-adjusted life-years gained
(complete case) (52 weeks – baseline)
–0.33 (0.36), n= 41 –0.42 (0.21), n= 47 –0.47 (0.25), n= 39
Symptom-free days at 52 weeks
(using worst case imputed values)
7.53 (11.69), n= 124 6.26 (10.86), n= 164 7.04 (11.48), n= 125
Symptom-free days at 52 weeks
(using complete case values)
18.68 (11.42), n= 50 16.55 (11.91), n= 62 17.96 (11.85), n= 49
I-QOL at 52 weeks 68.12 (25.00), n= 26 68.71 (27.10), n= 33 67.37 (28.05), n= 28
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Estimates of cost–utility and cost-effectiveness
In Table 105 a summary of the costs and outcomes is presented. The table shows the base-case values and
associated lower and upper estimates, based on the 95% CIs, which are used in the sensitivity analysis.
Table 106 summarises the results of the cost–utility and cost-effectiveness analysis for the base case.
The analysis revealed that when compared with usual care, both intervention trial arms had an
incremental cost-effectiveness ratio (ICER) that exceeded £30,000. This was also true when the
supported-implementation arm was compared with the intervention arm. The cost per symptom-free day
showed that usual care was dominant over both intervention trial arms. The supported-implementation
arm was dominant over the intervention arm.
TABLE 105 Summary of costs and outcomes, showing the mean and lower and upper estimates (base case)
Variable Usual care Intervention Supported implementation
Cost per patient (£)
Mean 9563 12,423 10,913
Lower estimate 8647 10,558 9486
Upper estimate 10,479 14,287 12,340
Quality-adjusted life-years gained
Mean –0.45 –0.36 –0.41
Lower estimate –0.49 –0.41 –0.46
Upper estimate –0.41 –0.32 –0.36
Symptom-free days
Mean 7.53 6.26 7.04
Lower estimate 5.47 4.60 5.03
Upper estimate 9.59 7.92 9.05
TABLE 106 Summary of cost-utility and cost-effectiveness results (base case)
ICERs Usual care Intervention Supported implementation
Cost per quality-adjusted life-year gained
Compared with usual care – £31,775 £33,755
Compared with intervention – – £30,191
Cost per symptom-free day
Compared with usual care – Usual care dominant Usual care dominant
Compared with intervention – – Supported implementation dominant
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Resource use and costs: sensitivity analysis
The effect of changing costs while keeping the effect sizes at base-case values can be seen in Table 107. The
lower cost estimates resulted in ICERs of around £21,000 for both intervention and supported-implementation
arms when compared with usual care. The supported-implementation arm had an ICER of £21,446 compared
with the intervention arm. For the symptom-free days, usual care was dominant over both intervention trial
arms. The supported-implementation arm was dominant over the intervention arm.
The effect of changing estimates of effectiveness, while keeping the costs at base-case values can be seen
in Table 108. For the lower estimates of effectiveness, both intervention trial arms have ICERs above
£30,000 when compared with usual care, whereas the supported-implementation arm has an ICER of
£24,718 compared with the intervention arm. These data contrast with the results from the upper
estimates of effectiveness. When compared with usual care, the ICER for the intervention arm has changed
little, but the ICER for the supported-implementation arm is less than £30,000. Compared with the
intervention arm, the ICER for the supported-implementation arm is £38,776. Within the symptom-free
days, usual care is dominant over the intervention trial arms, while the supported-implementation arm is
dominant over the intervention arm.
TABLE 107 Summary of ICERs in sensitivity analyses (varying costs)
Variable
Lower cost estimates Upper cost estimates
Intervention
Supported
implementation Intervention
Supported
implementation
Cost per quality-adjusted life-year gained
Compared with
usual care
£21,240 £20,983 £42,309 £46,526
Compared with
intervention
– £21,446 – £38,935
Cost per symptom-free day
Compared with
usual care
Usual care
dominant
Usual care dominant Usual care
dominant
Usual care dominant
Compared with
intervention
– Supported implementation
dominant
– Supported implementation
dominant
TABLE 108 Summary of ICERs in sensitivity analyses (varying effect size)
ICERs
Lower estimates of effect Upper estimates of effect
Intervention
Supported
implementation Intervention
Supported
implementation
Cost per quality-adjusted life-year gained
Compared with
usual care
£32,190 £48,620 £31,370 £25,851
Compared with
intervention
– £24,718 – £38,776
Cost per symptom-free day
Compared with
usual care
Usual care
dominant
Usual care dominant Usual care
dominant
Usual care dominant
Compared with
intervention
– Supported implementation
dominant
– Supported implementation
dominant
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Discussion
We aimed to explore the feasibility of assessing the cost-effectiveness of a SVP for people with incontinence
after stroke. The assessment of feasibility was through examining the data collection methods and an
analysis of the potential costs and cost-effectiveness of the programme.
We identified problems with the data recording procedures at all stages of the process. Having originally
planned to ask staff to record the time they spent providing the programme and time spent on activities
related to toileting, it became clear from our discussions with clinical teams that this approach would not
be feasible. Therefore, in order to calculate the cost of the programme we relied on estimates of the time
taken to toilet patients, rather than asking staff to keep records, and extrapolated the number of times
patients were toileted from other data, i.e. sampling from the clinical logs used in the assessment of
fidelity (see Chapter 6). This pragmatic approach was adopted because it was felt that the onerous nature
of staff making and keeping notes would have affected whether they completed the documentation
required for the programme – the clinical logs. Given that the clinical logs were not always completed
fully, this belief has some degree of credibility. An alternative approach would have been for a third party
to record the toileting process when staff were conducting the programme. Although this would have
provided more accurate data it would have been much more resource intensive, likely requiring full-time
commitment over a number of weeks in order to obtain a representative sample of data. In a definitive
trial it is imperative that the right balance is found between the input required for collection of resource
data and the representativeness of those data.
Having an individual specifically recording data prospectively, should result in more complete data being
obtained. The method adopted in this study meant that four (one-third) of the sites did not return
questionnaires about the time take to toilet patients. A similar problem was found with the admission
data, where again two-thirds of the sites did not return data. Dedicated research staff are required in order
to ensure that the hospital database can be interrogated up to 52 weeks after the last patient is recruited.
The admission data revealed problems with other methods of recording data. Patients (and carers) were
asked to record the number of hospital admissions on their postal questionnaire. When this was compared
with the data from the hospitals there was a reasonable level of agreement, but agreement was not total.
A potential explanation for this disagreement is that patients’ admissions abstracted from hospital records
were only considered in relation to the hospital where they were admitted with the index stroke. If they had
been admitted to a different hospital this would not have been identified. However, patients both under
and overestimated the number of admissions and so this does not explain all the disagreements. In the
postal questionnaire we only asked patients to record the number of admissions and not the dates of the
readmissions or the reasons. Using the hospital records meant that we were able to record more detail about
the admission, which helps to develop a more comprehensive picture of the costs. It is possible that patients
would not have sufficient recall at the 52-week assessment to detail exactly when they were admitted to
hospital, the reasons for the admission and if it was an admission or just a visit to the A&E department.
The completion rate of the postal questionnaires was good, with over a 70% response rate at 12 weeks.
The response rate at 52 weeks was lower at approximately 56%. The lower response rate for the long-term
follow-up may be a result of sending the outcome and resource use questionnaires at the same time.
Alternatively, the response rate may be a reflection of a reduced familiarity with the trial and its processes
by 52 weeks, whereas at 12 weeks a commitment to the study would have been tangible. Given that the
resource use questionnaire is requiring a recall of inputs, patients may have felt better able to answer such
questions at 12 weeks when the inputs would have been more recent, fewer, and possibly still ongoing.
In contrast, at 52 weeks patients may have less recall about the trial, have had further morbidities and
been less sure about inputs, particularly those that had been completed, and so were more reticent to
complete a questionnaire. At both 12 and 52 weeks, similar proportions in each trial arm completed their
questionnaires, suggesting estimates of resource use are unlikely to be biased by differential reporting
between the trial arms.
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When questionnaires were returned, there were some differences in the completion rates of the individual
items. At 12 weeks the health and social care items had an overall completion rate of 95%. There were
slight differences between the trial arms but completion rates did not vary by more than 10%. The
proportion of responses for the aids and adaptations items was generally lower, averaging around 85%,
and with few items having more than a 90% completion rate. This may be a reflection of the format
of responses for these items, which were presented in a list (i.e. participants may have focused on only
those items that were relevant to them). At 52 weeks the overall completion rates were similar to those
at 12 weeks.
When calculating the number of units used for each resource, the data informing the calculations were
taken at face value from the questionnaires. For certain resources, this led to improbable estimates of
usage, for example physiotherapy and occupational therapy. The estimates of use for other resources
appeared more plausible, for example GP and practice nurse contacts. This difference is likely to relate to
how the patients are asked to supply information. For contacts that were recorded as single events
patients had to record the number of visits, whereas for ongoing resources, such as therapy and social
support, patients were asked to give start and end dates as well as contacts per week. In future, these
recurring inputs may be best obtained through either interviewing patients, where questioning may allow
a more accurate recording of data, or by contacting the service providers such as GPs, or interrogating the
hospital information systems.
Of the questionnaires that were returned, not many had comments about the format and structure.
There was one positive comment and two negative comments. One of the negative comments related to
use of a double-sided form: it is understood that single-sided forms are better,187 but this does translate into
thicker and heavier questionnaires. The completion rates for the individual items did not appear to have
been influenced by having double-sided forms. The other comment related to the suggested time taken
to complete the questionnaire, suggesting it was a gross underestimation, but this was the only complaint
along these lines and was made by a third party helping the patient rather than by an individual completing
the form themself. Some minor rewording around the estimates of completion time may be appropriate.
For the follow-up at 12 weeks we had split the outcome and resource use questionnaires up so as not
to overburden the patients. This worked reasonably well given the response rate. In addition, we also
decided not ask the same question on both questionnaires. Therefore, because we had included place of
residence on the outcome assessment questionnaire it was not included on the resource use questionnaire.
This led to problems at 12 weeks because it was clear that some patients had been discharged from
hospital when they completed their resource use questionnaire, but they were recorded as being
in hospital from their outcome questionnaire, which had been sent earlier.
The costs in the three trial arms showed some differences between the usual-care arm and the two trial
arms providing the programme where the costs were higher. This was partly due to the cost of the
programme. The cost of post-hospital care was actually lowest in the supported-implementation arm and
highest in the intervention arm. The biggest single contributor to the programme cost was due to staff
training (when considering the individual elements – data not shown), although when averaged out across
staff, the overall contribution of the training cost to the mean cost per patient was small. Social care
made the biggest contribution to the post-hospital costs. The health and admission costs were higher in
the intervention group. The SVP contributed nearly all the costs of the programme, with the cost of the
training contributing very little. The SVP cost is the area for which we have the least robust cost data,
so we need to be cautious in interpreting these findings. For the post-hospital costs, the patient report
information has some measure of reliability as evidenced by the similarity between patient-reported
and hospital data for the admissions to hospital. The admission data demonstrated differing costs in
the three trial arms, with the costs in the intervention arm nearly 50% more than those in the
supported-implementation arm. The analysis of the admission data was kept simple by splitting the
admissions into short and long stay. Potentially these data could have been explored in further detail
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to identify the exact reasons for the admissions and assign more detailed costs based on the length of
stay. However, if an analysis explored the data to this level, it would be worth considering clinical review
of the admission information and including only those admissions linked to incontinence.
The total cost of the training was estimated to be around £3000 at each of the 12 sites, which translated
into a cost of just over £12,000 for each trial arm. When the cost of facilitation was added on to this,
the figure was nearly doubled. For the purpose of the cost analyses, an average cost per patient needed to
be calculated. This average cost was based on patient throughput rather than numbers recruited into the
trial arms so that the cost was more a reflection of clinical practice than the research process. If we had
used the number of patients in the trial arms as the denominator it would have increased the average
cost of training by a factor of six, but this would have had little impact on the cost analyses because the
average cost for the staff training is a small proportion of the total average cost. Although the training did
not contribute greatly to the overall costs it would still need to be included in any future study exploring
cost-effectiveness. Having now developed this resource, the cost of training would be reduced from the
delivery side; although the materials may need updating and the online resource would require some
maintenance. The receipt of training would still make a substantial contribution to the training costs, with
ward staff taking time out of their day for face-to-face or online training. Further costs may be incurred
when new staff start on the ward, primarily for the online training. If considered to be of value, the
training could be embedded in practice as part of staff induction, which may have less of an impact on
subsequent staff–patient contact time.
One of the aims of this study was to explore the potential cost–utility and cost-effectiveness of the SVP.
The base-case analysis used data from 167 out of 299 (55.9%) patients who had returned resource use
questionnaires. The number of questionnaires returned was similar across groups. For the patients who did
not return questionnaires and for those that died or withdrew, data were imputed. This meant that for
the analysis, data were being imputed for circa 60% of the patients who entered the trial. Consequently,
any interpretation of the cost-effectiveness analysis has to be treated with caution.
Using unadjusted EQ-5D data for available cases showed an increase from the baseline values. However,
once the EQ-5D was adjusted for baseline data, the utility values were worse than baseline and this was
consistent across the trial arms, with usual care having the highest value. This could reflect that either
the EQ-5D is showing that the intervention package does not work or that the EQ-5D is not sensitive to
any impact of the intervention. The outcome data at 52 weeks did demonstrate an improvement since
baseline – contrasting with the EQ-5D, although the usual-care arm did tend to have (non-significantly)
better outcomes – similar to the EQ-5D. Our uncertainty over the sensitivity of this measure to reflect the
impact of the intervention was explored further by comparing it with the I-QOL, a continence-specific
QoL assessment.
The exploration of the association between the I-QOL and the utility values, calculated from the EQ-5D,
revealed mixed results. Overall, at 52 weeks there was a significant association, although the coefficient
was less than 0.4. There were differences when this association was explored within trial arms, with
the intervention arm revealing a significant correlation, and the supported-implementation arm a
marginally non-significant correlation. The usual-care arm showed a non-significant correlation. The
differences in these results make interpretation of the findings difficult. Looking overall, the data suggest
that the EQ-5D is potentially able to reflect the impact of incontinence on QoL. However, there are two
caveats to this suggestion. First, the associations explored QoL at 52 weeks and not changes from baseline
because no data were collected on the I-QOL at baseline. Second, the analysis has only been conducted
in those patients who were incontinent because the I-QOL is intended for use in those people with
incontinence, and so by definition these respondents have a poor outcome. Where data allow, it would
be worth exploring the association between the measures in all patients to determine the extent to which
the EQ-5D reflects the impact of incontinence on QoL. Likewise, future work could record the I-QOL in the
early stages to allow an analysis of the change scores as well as a comparison of the measures at each
time point, particularly if there is a marked difference in utility values at baseline as was seen in this study.
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The lack of association between the measures in the usual-care arm is somewhat at odds with the
other trial arms and merits further exploration, although the coefficients for the usual-care and
supported-implementation arms are only marginally different.
Initial inspection of the costs and quality-adjusted life-years revealed that compared with the usual-care
arm the intervention and supported-implementation arms had ICERs of just over £30,000, a value greater
than the £30,000 threshold used by NICE.177 However, when using the lower estimates of the costs in
the sensitivity analysis the ICERs were around £20,000. In the other sensitivity analyses, the ICERs varied,
depending on the assumptions made, but the usual-care arm did not dominate either of the intervention
arms, nor were any of the ICERs greater than £50,000.
Initial inspection of the costs and symptom-free days revealed a different pattern of data to the
quality-adjusted life-year analysis. The usual-care arm dominated both the intervention groups.
The supported-implementation arm dominated the intervention arm. There are no figures to compare
these data with, but they may inform discussions with patient groups to explore a willingness to pay.
We aimed to be inclusive in collecting resource use data after hospital and consequently sought data
about a range of health and social care inputs. This inclusive approach means that a number of resources
unlikely to be related to incontinence or a regaining of continence will have been included. This has the
potential to bias the cost estimates if the non-related costs are much higher than the related costs, thereby
masking the impact of the programme on resource use. For this reason we have not included costs related
to residential care, because a cost of circa £1000 per week has the potential to bias the results, particularly
for longer-term costs. An alternative to this blanket coverage, and alluded to earlier, is to investigate the
reasons for resource use, particularly those related to health (e.g. GP visits and hospital admissions), and
only include those related to incontinence. This approach has the potential benefit of identifying relevant
costs but it requires a judgement call by a researcher and would also be much more labour intensive.
Patients in the intervention arm had more admissions to hospital. This may be due to the fact that there
were more severe patients in this trial arm (see Chapter 7). Some patients had multiple admissions and this
may result in higher costs in one trial arm. This could lead to bias, particularly if the reasons for admission
are unlikely to be due to the outcome or programme. This may support the suggestion that there should
be a review of the reasons why resources are used, and consequently exclude those resources considered
to be not relevant to the outcome.
When data items were missing we performed imputations using mean values and basing these means
around the OCSP classification. Although this approach is one method of performing imputations, it is
has its limitations and reduces the variability within parameters. A future trial would need to consider a
range of methods to impute outcome and cost data such as multiple imputation approaches.169 Where
possible, the methods of imputing data could mimic the methods used in the imputation of outcome data
from the trial, including last observation carried forward; although it would be difficult to agree how to
represent a value based on a worst-case scenario. Parameters to consider when making imputations might
include patient factors such as age, sex and dependency.
In exploring the feasibility of assessing the cost-effectiveness of a SVP to promote continence after stroke
we have identified a number of factors, described above, that need consideration in a full trial. One of the
areas where we will be able to inform a future trial is the cost of resource items. The data in this report
could be used in a future study, with the inclusion of a factor for inflation, or the sources of the data could
be reaccessed for updated information.
Limitations
One of the purposes of an exploratory trial such as this study is to identify limitations to the research
processes. A number of limitations have been identified.
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With regards to the programme, the estimates of resources were not based on empirical data rather they
used expert opinion, which is considered to be suboptimal.188 The estimates were made independently and
averaged so there was no undue influence that might occur with an expert panel. Related to this issue is
the additional cost of equipment or consumables that might be used to support someone regaining their
continence, for example pads. Although we can gather estimates on how much this contributes to the
costs, this would be better identified by observation and recording in real life. A clear understanding
of the programme cost is critical in order to obtain an accurate assessment of its cost-effectiveness. At the
same time it is important to know the cost of not providing the programme: to do so, we would need to
consider the costs attributable to incontinence in the usual care arm (i.e. how much staff time and
consumables are required to support someone that has an episode of incontinence). This was not
undertaken in this study, but would be important in future research. These assessments are likely to be
resource intensive for the research, particularly because the recording of the cost of incontinence would
also need to be performed in the trial arms providing the programme.
The calculation of the 1-year costs included data provided by the postal questionnaires. Asking patients
to recall resource use over such a long period may lead to inaccurate data capture. This issue may be
overcome by either more frequent follow-up, although this may increase dropout rates or by obtaining
data from service providers, which may be more resource intensive.
We have calculated utility values and consequently quality-adjusted life-years using published weights.
A future trial should consider an alternative approach such as the area under the curve approach, using
responses at baseline, 12 and 52 weeks to map out the curves.189
Summary
The training associated with the programme has been developed and costed, and the process of costing
the training would not need to be repeated in a future trial. The training would still contribute to the
costs of the programme in a future trial but, because it has been developed, the training would command
less of a cost. Although the training contributes little to the overall cost, there would still be some cost
associated with it through the maintenance of the online resource.
The cost and source of the individual resource use items has been identified.
In-hospital episodes of incontinence and the resources required to respond to such episodes should be
recorded in all trial arms.
The resources required to perform the programme should be identified through direct observation,
although some extrapolation may still be required.
Postal questionnaires may be useful to record resource use for patients, and consideration should be given
whether or not they are single sided and the estimates of time taken to complete them.
Although postal questionnaires are relatively inexpensive to use, consideration should be given to
obtaining post-hospital resource use data by asking patients to maintain diaries or going directly to the
providers of services.
In those patients with incontinence, the EQ-5D appears to reflect the impact of incontinence on QoL as
assessed by the I-QOL, but this requires further exploration.
Identifying resource use items more directly related to the programme and the effects of incontinence may
allow a more realistic conclusion to be drawn around cost-effectiveness.
Any cost-effectiveness analysis needs to have a time horizon of at least 1 year after stroke.
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Chapter 10 Patient, public and carer involvement
Overview
This chapter describes the process of PPC involvement within ICONS. We describe how PPC involvement
was integrated into the study from the stage of developing the research proposal to the
dissemination phase.
Background
A ‘service user’ is defined by the Department of Health190 as any person who has, is, or may access NHS or
independent sector health services in the UK. Service users have been central to the NHS research strategy
since the publication of Best Research for Best Health;191 patient and public involvement is fundamental
to its vision of ‘conducting leading-edge research focused on the needs of patients and the public’.
This was reflected in the creation of two funding streams, Research for Patient Benefit and Programme
Grants for Applied Research, and the central role of INVOLVE (formerly Consumers in NHS Research)
in promoting and empowering the public to become involved in research. Best Research for Best Health191
goes on to specify that patients and the public must be involved at all stages of the research process,
from setting priorities, through selecting research methodology and patient recruitment, to dissemination
of findings.
According to the Department of Health,191 the outcome of patient and public involvement is research that
is more relevant to people’s needs and concerns, more reliable and more likely to be implemented in
practice. This view of service user involvement leading to ‘better’ research is echoed by Beresford,192 who
further adds that involvement can ensure research methods are more sensitive to the needs of research
participants and therefore facilitate greater engagement. However, Smith et al.’s193 review of service user
involvement in nursing, midwifery and health visiting research found few studies with an explicit rationale
or set of objectives for service user involvement.
The classification adopted by INVOLVE identifies three categories: consultation (views are sought out but
with no guarantee of a change in outcomes); collaboration (service users work together with providers
of services); or user control (users can shape the process at all levels). However, debate has recently
focused on whether or not it is ever possible for anyone to have ultimate power over a project, with
funding considerations and accountability influencing the process.
INVOLVE194 uses the term ‘diversity’ to reflect the growing range of people and groups, backgrounds and
characteristics found in the UK population. Diverse groups are increasingly involved in research, but there is
a growing realisation that there are sectors of society whose members are frequently excluded. Within
stroke research, people with aphasia (a relatively unknown and complex communication difficulty which
can affect the ability to use speech and understand the speech of other people) have traditionally been less
likely to be invited to become actively involved in research, despite the fact that they make up 34% of
stroke survivors.195 In fostering true participation for people with aphasia there must be a ‘paradigm shift’
so that inclusion is ‘more than the addition of new practices to an existing toolkit’ and where ‘inclusionary
practices are seen as a fundamental rethinking of values and practices’.196 Recent aphasia research
projects,197,198 many from within aphasia-specific organisations, demonstrate that when the required
changes are made to values and practices then there can be successful involvement. Reflection on this
involvement indicates both benefits and challenges for both the project and the individuals involved.197
However, the over-riding theme for these studies is the importance of adhering to the principles of
reducing barriers and providing facilitators to enable people with aphasia to participate.
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Patient, public and carer involvement in Identifying Continence
OptioNs after Stroke
Involvement prior to submission of the research proposal
Although the idea and plan for the research programme originated from the research team, prior to
submission of the proposal, the team began forming links with existing local groups of stroke survivors
[e.g. the Royal Preston Hospital Stroke Club, Preston; Speakeasy, a specialist aphasia charity based in
Ramsbottom, Bury (www.buryspeakeasy.org.uk/)]; and other groups including service users in their
membership, for example the North West Users Research Advisory Group. We also consulted the University
of Central Lancashire COMENSUS (COMmunity ENgagement and Service User Support) project. Operating
at the level of consultation,199 the researchers hoped to obtain feedback on the proposal, and also to
develop links with individuals who might be called on to join programme-specific advisory groups if the
programme was successful in obtaining funding.
Feedback from these groups helped shape the section within the proposal on ‘patient involvement within
the proposed research’. For example, one member of the North West Users Research Advisory Group
commented that although a wide range of expertise was represented among the co-applicants, there was
no nominated individual to manage PPC involvement; this was viewed as a significant deficiency in the
current climate. Accordingly, the research team approached a named individual (JV) to lead the PPC
involvement in the programme and to chair the PPC group. Commenting on plans to introduce the
conservative interventions for continence management, service users also emphasised the importance of
debating issues such as delivery, uptake and patient and health professional adherence with a group
of patients and carers before finalising plans. The finished version of the PPC involvement section of the
research proposal is shown in Box 4.
Forming the patient, public and carer involvement groups
The original plan in the proposal was for one dedicated PPC group. Following notification that funding
for the research programme had been secured, the team visited groups consulted in the proposal
preparation phase, explained the programme and asked for volunteers to form the PPC group. Four
members were recruited from the Royal Preston Hospital Stroke Club, one from the North West Users
Research Advisory Group and one service user who was already active within COMENSUS (the PPC group
chairperson). Other founding group members included two lay members, one representative from the
Stroke Association, the director of Speakeasy and a nurse specialising in continence from a local primary
care trust; a total of 12 members. The group comprised stroke survivors, carers, lay members and health
professionals with an interest in UI after stroke (hereafter known as the Preston Group).
The research team originally planned to include stroke survivors with aphasia as part of the Preston Group.
However, further discussion with the director of Speakeasy led to the decision to form another group
(hereafter known as the Speakeasy Group). Meeting separately enabled the involvement of people with
aphasia to be supported in an appropriate manner through an experienced facilitator, Gill Pearl (GPe). To
recruit volunteers for this group, LT visited the routine Speakeasy Group meetings and discussed recruiting
participants for the ICONS programme through an ongoing process including a presentation to the whole
group and one-to-one discussions with members who expressed an interest. The Speakeasy Group
comprised eight stroke survivors with aphasia, one carer, one volunteer with Speakeasy and the director.
LT led each meeting; members were supported to contribute by GPe.
The Preston Group began meeting in January 2009. Over the course of the programme, one member died,
one health professional was no longer able to dedicate time to the group, one had a further stroke and
was unable to participate further and four members left for other reasons. Four additional members joined
the group, bringing membership to nine. The Speakeasy Group also began meeting in January 2009 and
had only one change of membership, with the volunteer with Speakeasy leaving the group approximately
half way through the 5-year period.
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Aims of the groups
Patient, public and carer involvement groups were established to:
l contribute to all aspects of the research programme
l produce a publication using the ICONS project as an example of good practice in PPC involvement.
Group structures and processes
The ‘getting to know you’ process began before the first formal meetings of both groups. This approach
is recommended by INVOLVE194 as a means of developing trust with people you would like to work with.
It is particularly recommended when recruiting people not often involved in research who may view a
university researcher as an ‘elite, authority figure or remote from their everyday lives’.194 This process was
continued in the first meeting of the Preston Group, with carefully planned activities to facilitate members
getting to know each other and the research team. These included an informal lunch prior to the meeting,
and an initial ‘icebreaker’ activity involving members chatting about themselves with a partner for 2 minutes,
changing over, and introducing their partner to the group. The agenda was formed in discussion between
the group chairperson (JV) and LT. LT and JV also agreed to have a section at the end of each meeting for
evaluation: members were asked to report, in turn, three aspects of the meeting that had gone well and
three aspects that could have gone better. This information was then used by LT to build on positive
BOX 4 Section from the proposal entitled ‘patient involvement within the proposed research’
Representatives from local stroke support groups, the North West Users Research Advisory Group (facilitated by
SM, Steering Group member) and Bury Speakeasy have been involved in the development of the grant
application by meeting with the research team and commenting on drafts of the proposal.
The programme will have a dedicated Patient, Public and Carer Involvement (PPC) Group, led by Jacqui Vella
(recent chairperson, Preston PPI) and comprising 6–8 members; the Group will contribute to all components of
the programme. Two members will sit on the Steering and Management Groups. Roles throughout the
programme will include participating in the interpretation of data and research dissemination.
The intervention, and how delivery, uptake and adherence could be improved, will be debated by the
Group before finalising the intervention. The Group will be provided with structured summaries of
the available research based on the Canadian Institute for Health Services Research model. The Group will
also be invited to participate in the systematic review using techniques from the Social Care Institute
for Excellence.
Given the sensitivity of the topic, the Group will advise on appropriate ways to involve patients in the research:
advice will be sought on recruitment strategies, and ways in which researchers can build rapport and trust with
patients before beginning any data collection.
The Group will assist health professionals in delivering the education programme in each phase. Group
members will evaluate findings from the programme and assess the effectiveness of the intervention
and its components.
PPC Group members will be paid £100 for attending Steering and Management Group meetings, £35.60 for
education activities and £10 per hour for all other activities. They will also receive travel expenses.
The University of Central Lancashire COMENSUS (COMmunity ENgagement and Service User Support) project
will provide key links with service users, carers and user groups.
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comments and address negative ones in subsequent meetings. The information was also reported in the
minutes in an anonymised form. After the initial meeting, group members commented:
very friendly meeting; provided a valuable and different perspective; enlightening and enjoyable
experience; very positive; great enthusiasm among the group; learnt a lot, very interesting.
The first meeting also involved an introduction to the research programme, presented by LT. Much debate
ensued, for example about the methodology to be adopted, but members were also keen to share their
own experiences of living with stroke and, in some cases, incontinence, as well as their experiences of the
hospital system.
Although the Preston Group met at the ‘home’ of the research team at the university, the Speakeasy
Group met in the Speakeasy offices on the same day as the Speakeasy Group’s usual Speakeasy meeting.
This ensured members did not need to travel some distance to the university and also that members did
not have to make an additional trip for ICONS meetings. Issues discussed above in relation to group
formation did not apply to the Speakeasy Group, as all members knew one another and the majority had
worked together on another large research study, Accessing Communication Therapy in the North West
(ACTNoW).197 However, there were many other challenges for the researcher in terms of facilitating
involvement. For example, the process of arranging meetings needed to accommodate the needs of
people with aphasia: simply writing to members with meeting dates in an aphasia-friendly format was not
sufficient; GPe advised telephoning all members 1 day in advance of the meeting to remind them of the
meeting details.
The agenda for all meetings was set by the ICONS Programme Co-ordinator (LT). In contrast to the
Preston Group, which was chaired by a group member (JV), the Speakeasy Group was chaired by GPe, an
experienced speech and language therapist and the director of Speakeasy. All materials and presentations
for this group were developed in an aphasia-friendly format, for example using pictures and white space
in between text. Meetings were also designed to ensure all members were able to contribute through a
process of skilled facilitation provided by GPe. This included strict adherence to a set of ‘meeting rules’,
for example: no one person was allowed to ‘hog the limelight’ and only one person was allowed to speak
at any one time.
Patient, public and carer role in programme management
Two members of the Preston Group attended all Programme Steering and Management Group meetings;
they acted at the interface between programme management and the PPC group in order to ensure
co-ordination and transparency. Both the Steering Group (who meet bi-annually) and the Management
Group (who meet quarterly) had regular agenda slots where PPC representatives reported on the work
of the group. PPC members were encouraged to contribute to all discussions in both groups and their
input was actively encouraged and valued by the project team.
In the data analysis and interpretation phase of the programme, two members from the Speakeasy Group
were also invited to join joint Steering and Management Group meetings to enable them to contribute
their views on how data should be interpreted. Although not totally aphasia friendly, the project team
tried to adhere to Speakeasy Group rules, paying particular attention to the rule of only one person
speaking at any one time. All presentations were prepared in both aphasia-friendly and ‘normal’ format
and shown simultaneously during the meeting.
Examples of the work of the groups
Review of documents and development of aphasia-friendly versions
A key task for both groups was critical review of documents prior to submission to the Research Ethics
Committee. These included patient, carer and consultee information leaflets and case study interview
questionnaires for patients, carers and health professionals. The Speakeasy Group focused on compiling
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aphasia-friendly versions of consent forms and information leaflets, whereas the Preston Group critically
reviewed documents for patients and carers without aphasia.
Both groups reviewed interview schedules and substantially revised the clarity of the questions compiled
by the research team. Box 5 shows how questions asking patients for their experiences of the study
intervention, have been shaped by PPC input. An example of an aphasia-friendly consent form is shown
in Appendix 32.
Preliminary validation of the main outcome measure for use with patients
with stroke
Six members of the Preston Group participated in some preliminary validation of the main outcome
measure to be used in the trial phase, the ICIQ-UI Short Form.162 To our knowledge, the ICIQ-UI Short
Form has not been used in the post-stroke population. We conducted preliminary validation of the tool
with six stroke survivors from the Preston Group using the approach recommended by the ICIQ developers
(Dr Nikki Cotterill, personal communication). This involved asking participants to complete the ICIQ Short
Form and to answer some questions relating to ease of completion, clarity of items and instructions and
adequacy of coverage of issues related to urinary leakage.
Development of online training programme for ward staff
Two members of the Preston Group completed an early version of the online training programme
designed for ward staff to complete before beginning to deliver the intervention. Their suggestions for
improvement were incorporated in the final version.
BOX 5 Interview questions before and after PPC Group revision
Researchers’ version
l How easy (or difficult) did you find it to follow the regime? What was the biggest challenge for you?
l Did you feel that the regime you were being asked to follow had been individually designed for you?
l Did you resent the regime at all?
l What helped you to stick to the regime?
l Was the regime explained to you clearly enough? What suggestions would you have to help make the
regime clearer to people in your situation?
l Was the written information you were given clear enough (in terms of language, readability, clarity)?
l What was the most surprising aspect of the regime?
Version following patient, public and carer input
l What do you think of the programme?
l What was the biggest challenge?
l What was the easiest part?
l Did you feel that the programme was designed specially for you?
l Did you have enough support?
l How well did you understand what you had to do?
l What could have been made clearer?
l Was anything about the programme a surprise to you?
¢ What was this?
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The Speakeasy Group helped develop a section for the online training programme. The group identified
the need for this section based on their experiences (both positive and negative) of communicating
with stroke unit staff following their stroke. The group defined two aims for this training: helping ward
staff identify patients with aphasia and outlining strategies for communicating effectively with them.
Content was designed to meet these and included sections on common communication problems after
stroke; difficulties faced by people with aphasia after stroke; what nurses can do to help people with
aphasia communicate; how to help people understand and express themselves; and overcoming associated
difficulties (e.g. visual problems, auditory problems, attention span and fatigue). Finally, presentation and
layout was finalised and the material incorporated into the online programme.
Speakeasy Group members expressed the view that the best way to improve nurses’ communication with
patients with aphasia would be for them to go out to study sites and share techniques, together with the
opportunity to practise. However, this did not prove feasible as it was not included in expenditure requests
in the original bid and there were practical issues given the wide geographical spread of study sites.
Involvement in facilitating implementation of the systematic
voiding programme
Following feedback from the research team about problems embedding the SVP in some intervention sites,
the groups proposed a novel implementation strategy in the form of a series of ‘motivational’ visits to
stroke units. The visits aimed to encourage staff to think about continence from another angle and
motivate staff to improve their continence management practices. Both groups developed a short
presentation to share their perspectives on incontinence and to trigger discussion of what it is like to
experience incontinence from a patient point of view. One member of each group visited four sites with
LT or GPe. The presentation was followed by a question and answer session with nursing staff and, in some
sites, members of the MDT. Twenty-nine evaluation forms were returned. Examples of comments were:
l very informative
l [presenters were] honest and open
l I thought it was very good that those giving the presentation had an inside and personal knowledge
l Made me think!
l Really interesting to have an insight into ICONS. Able to understand how patients feel and how
they can cope after stroke.
Dissemination and publicity
Both groups were involved in discussions regarding appropriate channels for dissemination, including
identifying relevant conferences. The groups combined to present at a range of national and international
conferences, including a section on user involvement in ICONS within symposiums at the Royal College
of Nursing International Research Conferences in 2010 and 2014 and a showcase entitled ‘User involvement
in the ICONS: Identifying Continence OptioNs after Stroke study: a model of consultation and collaboration’
at the INVOLVE annual conference in Nottingham (2010).
The groups have also commented on all conference abstracts and programme publications prior to
submission, a substantial task given there have been over 50 international, national and local presentations
from the ICONS programme. Their contribution has been recognised through authorship on all published
conference abstracts and research publications.
A further example of dissemination was an interview on BBC Radio Cumbria on 14 September 2011,
where a PPC group representative and LT discussed challenges involved in changing continence practice.
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Discussion
Group processes
The process of putting together a project-specific group through the Speakeasy organisation was viewed
as highly successful by group members. It enabled us to ‘reach out’ to people with aphasia who had
previous experience of working with researchers as well as those for whom this was the first time. In
working with this group, the researcher adopted the ‘Speakeasy culture’, for example using ‘tried and
tested’ group rules to facilitate contribution and inclusion of all members, and procedures for setting up
meetings (e.g. telephoning all participants the day before). According to the group, these systems worked
well and, in their view, should be adopted more widely.
The two groups’ different ways of working did, however, pose some challenges when the groups asked to
meet together so they could get to know one another. This worked well when the meeting had a social
focus, for example one member of the Speakeasy Group completed a sponsored cycle ride in India in aid
of charity and presented his findings to the combined groups. Issues arose, however, when a joint meeting
was scheduled outside Speakeasy and where the groups were required to complete a specific task, putting
together a draft publication for the INVOLVE newsletter. The Preston Group were not familiar with the
Speakeasy rules, or indeed communicating with people with aphasia, and the researcher had not asked
GPe to facilitate the combined group. Consequently, the Preston Group unwittingly broke the rules, for
example by finishing off the sentences of the Speakeasy Group members, and the meeting was generally
viewed by the Speakeasy Group as not successful. Following expert guidance by GPe, the Preston Group
learned to conform to meeting rules and subsequent joint meetings were productive and enjoyable.
Reasons for lack of broader involvement at the proposal development stage
INVOLVE199 recommend that involvement with patients, carers and others should begin at the stage of
identifying topics for research, prioritising these and advising on what research should be commissioned.
This may be practically difficult unless researchers have immediate access to a number of individuals or
groups with relevant experience. In ICONS, PPC input began at the ‘designing research’ stage; user
involvement in the proposal development phase fitted the INVOLVE definition of ‘consultation’,199 generally
regarded as a low level of involvement with the researcher maintaining control over the agenda.193 The
grant application arose out of several smaller studies (including a systematic review for the Cochrane
Collaboration), none of which involved service users. The researcher who designed the study and wrote
the proposal had no experience of service user involvement and was ‘feeling her way’ in terms of both
finding appropriate existing groups to approach and also working with service users. The possibility exists
that had service users been involved at the proposal development stage, the research might have taken a
different direction: our plan was to focus on continence management in secondary care, but one member
commented that incontinence largely became a problem when adapting to life at home after discharge,
as in hospital there was ready availability of toilet facilities.
Issues of empowerment
Since obtaining funding we based our approach on a model of full collaboration (according to the
INVOLVE classification199). Views of user involvement as a hierarchy with increasing levels of empowerment
up to the point where service users lead the research have been criticised for not reflecting the fact that
involvement could be occurring at multiple levels simultaneously, or at different levels depending on the
phase of the research study.193 For example, in the ICONS study two PPC group members were part of
the programme management structure and attended Programme Management and Steering Group
meetings, as well as PPC group meetings. This increased to four PPC group members in the data analysis
and interpretation phase of the programme. As with other members of the programme team, it is likely
that the level of decision-making they contributed to differed depending on the group in which they
were working.
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There were no power struggles between the team and the PPC groups with members keen to allow the
research team to set the agenda. However, this did not mean that members were entirely malleable:
differences existed on the relevance and importance of the sociological philosophising about
empowerment and hierarchical issues in user involvement in research. For the users participating in this
study, their only concern was that they were allowed to contribute to the best of their ability as mutually
respected partners with the research team.
Members: problem of recruiting members for the Preston Group
The process of recruiting and retaining members for the Preston Group was challenging. Despite visiting
and sending out publicity to all the local groups involving stroke survivors and the help of COMENSUS and
wider groups such as the North West Users Research Advisory Group, only six members were recruited
over an initial 3-month period; this suggests there may be a serious lack of availability of service users
and carers willing to take part in research. As the original aim was for the group to comprise eight
members, we took the decision to supplement the group with members of professional bodies: the Stroke
Association, NHS community stroke services and PromoCon, a national organisation for the promotion
of continence (and part of Disabled Living). Two and a half years into the programme, only two of the
original service users remained in the group. Given the demographic of our members, people leaving
the group through illness, death (in one case) and inability to spare the time because of other caring
commitments, was not unforeseen. Although new recruits joined, lack of a stable membership presented
a continuing challenge in terms of group dynamics and people ‘getting up to speed’ with a complex
research programme.
The death of one member of the group, although not totally unexpected given the demographics of
group members, was nonetheless disturbing. It reminded members of their mortality and the particular
vulnerability of those who have suffered a stroke. The impact was especially poignant because the
deceased was the youngest member of the Preston Group. It says much for the maturity and resilience
of the other group members that they came to terms with the sad loss without the need for external
support but constitutes an important lesson for other researchers aiming to work with similar groups of
patients with long-term (or terminal) conditions to be alert to this risk and the distress it may cause.
Tension between group forming processes and ‘doing the work’
Group members welcomed the opportunity to share their experiences of stroke and their recovery
trajectory. On reflection, discussions such as these are likely to be fundamental to the process of forming
a new group, but in the researcher’s mind there was a tension between focusing on the tasks allocated
for the meeting (in the first meeting working on the participant information sheet) and going through
the group forming phase. Part of the learning process for the researcher has involved a recognition of the
need to allow much more time to complete each task and focussing on only one or two tasks in each
meeting. Understanding the characteristics of stroke survivors is also important; all are different, but there
may be commonalities such as fatigue, meaning they tire easily, and limited powers of concentration.
Financial issues
INVOLVE200 outlines the benefits of paying members of the public for their involvement in research, for
example as supporting equity of power between the research team and the public, supporting inclusion
and reducing barriers to involvement, such as ability to cover the cost of transport to meetings. Our policy
at the proposal stage was to pay all members an hourly fee for meeting attendance, a fixed sum for
attending Management and Steering Group meetings and all expenses. However, several factors emerged
during the course of the project that meant the funds allocated for patient and public involvement were
not adequate to cover expenditure. These included forming two groups rather than the expected single
group; PPC group members attending conferences to present papers about ICONS (with costs including
conference fees, overnight accommodation, travel and a fee of £60 per day) and members undertaking
site visits to talk to stroke unit staff about the importance of continence from a patient perspective.
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Fortunately, the National Institute for Health Research (NIHR) allowed virement between different budget
headings and this enabled us to make payments to all PPC group members as well as funding attendance
at conferences and site visits.
A further issue was reconciling the needs of PPC members with the university system. For example,
members in the Speakeasy Group were not able to complete the standard university claim form; in
negotiation with the university finance department, a simple table with details of what each person was
due was compiled by the researcher; all members had to do was sign against their name. The university
system of paying in advance for travel, etc., and claiming this back proved problematic for some members,
but payments were allowed on the university credit card to cover these.
Conclusion
Patient, public and carer Involvement has been a particular strength of the ICONS research programme
and has been recognised by INVOLVE as incorporating many elements of good practice. This was
evidenced in 2011 by an invitation to contribute to an INVOLVE project developing guidelines for
encouraging greater diversity and better inclusion for public involvement in research. This has now been
published with an acknowledgement of the contribution of the ICONS team.36
Many activities, for example motivational visits to study sites, were triggered by the groups themselves.
Other suggestions from the groups (e.g. members of the Speakeasy Group doing ‘hands on’ training
in communicating with people with aphasia) proved not to be feasible due to financial and practical
constraints. Future studies would benefit from a greater focus on relevant PPC activities at the planning
stage, with all activities included in expenditure estimates within the proposal.
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Chapter 11 Discussion
Overview
In this chapter, we discuss findings according to the each of the objectives of the exploratory trial, and
present recommendations for potential modifications to the intervention, addressing issues of feasibility
identified, and design of a full-scale evaluation of its clinical effectiveness and cost-effectiveness.
Feasibility: centre and participant recruitment and retention
Recruitment
Centres
We originally planned to begin recruiting into the Phase II trial in October 2010, including stroke services
solely in north-west England; however, stroke services in Cheshire and Merseyside were unable to supply
excess treatment costs. Having gained agreement from NIHR, we began the process of recruiting sites in
Wales, as funds are held centrally by the NISCHR and we were given early in-principle agreement that
funds would be forthcoming. Further delays in starting the Phase II trial were due to:
l negotiating different research and development approval systems in England and Wales and the
variable time scales (with the process in Wales taking over 7 months for all sites and, in some cases,
over a year)
l obtaining excess treatment costs to fund the additional staff required to implement the intervention
[2.8 whole-time equivalent (WTE) HCAs in each stroke service] in a climate of cost savings in the NHS
l recruiting HCAs and research nurses in a climate of vacancy control procedures (in some sites, this took
around 1 year).
Despite all of these challenges, recruitment only started 3 months later than planned, in January 2011.
Two centres dropped out following randomisation; one withdrew due to changes taking place within their
stroke service leaving little scope for supporting a new study, the other was found to have a much lower
number of admissions per annum than anticipated (around 120 compared with an original estimate of
300). As both clusters were in intervention arms, this could have posed a problem in terms of new sites
needing to catch up with sites who had already started their training. However, due to the varying lengths
of time taken to receive site-specific approvals and recruitment of the additional 2.8 WTE HCAs, sites
started as soon as the above were in place and the majority of staff had completed their training. The issue
of replacement sites being behind in terms of their training therefore did not arise.
The feasibility trial has addressed the issue of cluster dropout and lessons learned should minimise the risk
of occurrence in the full trial. We will not recruit small centres, obtain more robust estimates of the annual
numbers of stroke patients and not employ additional 2.8 WTE HCAs. We will also increase the number
of centres randomised by around 10% to account for dropout post randomisation due to other
unforeseen reasons.
Participants
The number of potential participants available for recruitment was affected by the capacity of participating
stroke units and the large proportion of people who did not have a stroke being admitted; nearly half of
people admitted to intervention (49%) and supported implementation (49%) units had not had a stroke.
In one service the acute unit had only 12 dedicated stroke beds. Other units may have had ineffective
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screening in the A&E department, and/or a lack of nurse specialist and/or stroke-specific consultant
physician roles.
The actual numbers of people admitted with a confirmed stroke, according to our screening of consecutive
people admitted at each of the participating units, were up to 65% lower per annum than initial figures
provided. This difference was particularly marked in intervention groups with proportions 33% and
34% lower than estimates in intervention and supported implementation, respectively, compared with
just 4% lower in usual care. This reduced the number of patients eligible to participate in this study, and
needs to be accounted for in our future trial, and in stroke trials more generally.
The proportion of people admitted with stroke who were eligible for the trial was half that expected based
on prevalence reported in previous studies,4,16 with 19% in usual care and 17% in implementation and
supported implementation units. Possible explanations for this are a larger than expected proportion
of patients who were (a) not medically stable and receiving end-of-life care and (b) continent by the time
they were classed as medically stable.
The percentage of eligible people recruited ranged from 50% to 98% across sites. A higher percentage of
eligible people tended to be recruited in sites where research nurses were project specific and funded
from the ICONS programme (three sites in each trial arm), compared with locations where CLRN or SRN
research nurses were recruiting participants in addition to their other workload (one site in each trial arm).
Interpretation of the inclusion criterion ‘medically stable’ was variable across sites and contributed to delays
in recruiting patients by up to 6 weeks (34 patients) and, in one case, up to 12 weeks post stroke. These
delays could explain the lower than expected number of people with mild incontinence, which could have
resolved by the time people were deemed to be medically stable. Although some of these people may
have experienced spontaneous recovery, guidance suggests all those who are incontinent 2 weeks after
diagnosis, should be reviewed and a treatment plan developed.10
Issues with recruitment necessitated a reduction in the target sample size from 752 to 500 in July 2011.
Retention
There were an acceptable proportion (< 20% attrition), as specified by the Oxford Centre for Evidence-Based
Medicine,201 of participants for whom outcome data were available at 6 and 12 weeks; and a particular
achievement given the nature of the patient population. Strategies for minimising loss to follow-up were
revised in December 2011 to include reminder telephone calls when questionnaires were 1- to 2-weeks
overdue, with the option to complete over the telephone. At 6 weeks, the response rate was 85% (306/362),
excluding participants recruited at 6 weeks and those who had died (usual care 96/114, 84%; intervention
122/139, 88%; supported implementation 88/109, 80.7%). At 12 weeks, the response rate was 88%
(330/374), excluding one participant recruited at 12 weeks and those who had died (usual care 98/112,
88%; intervention 132/148, 89%; supported implementation 100/114, 88%). At 52 weeks, the overall
response rate was 56%, excluding 98 who had died (usual care 53/95, 56%; intervention 70/124, 57%;
supported implementation 53/96, 55%).
The response rate at 52 weeks is disappointing. One explanation might be that outcome and resource use
questionnaires were sent together at this time point, unlike at 12 weeks where the resource use questionnaire
was only sent once the outcome questionnaire had been returned. Receiving the two together may have
been viewed as burdensome. Also, participants would not have been contacted about the study for almost
9 months so their interest in the study may have lessened. Possible ways of increasing the response rate long
term might involve maintaining greater contact with participants over the fully study period, possibly including
the addition of an interim time point (e.g. 6 months post stroke), or seeking outcome data over the telephone
and sending the resource use questionnaire if the participant agrees to this.
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Fidelity to the intervention
Adherence to the systematic voiding programme: quantitative findings
The protocol recommended avoiding catheterisation (except for the management of urinary retention or
where fluid balance was critical) and reviewing and removing catheters as soon after stroke as possible in
line with current guidance.10 Nearly half of patients in intervention arms were catheterised in the acute
stage (139/289, 48.1%); although this is much higher than the 20% reported in the 2010 National
Sentinel Audit,11 this percentage is of those recruited and cannot necessarily be extrapolated to all people
admitted to the stroke unit. Some aspects of catheterisation appeared closer to protocol recommendations
in the supported implementation arm in terms of catheter removal (median 13 days, IQR 5–35 days
compared with 20 days, IQR 8.75–35.25) and participants still catheterised at discharge (n= 19, 15.2%
compared with n= 35, 21.3%). This finding must be viewed with caution, however, as information on
reasons for catheterisation were not collected systematically after baseline and may have been legitimate.
In terms of adherence to clinical logs, documentation of the regime interval and the schedule of
proposed voiding times was done on less than half of occasions (38.9% in intervention; 31.9% in
supported implementation). Given that the regime interval and schedule are essential for undertaking the
programme, these figures are disappointingly low. Only clinical logs for which the regime interval and
schedule had been documented correctly were then examined further: documented voiding times showed
that, on average, patients were toileted within 30 minutes of the proposed time on 54.8% of occasions in
intervention and 56.0% of occasions in supported implementation. For these select clinical logs (on which
a regime interval and schedule were correctly documented), documentation of two key components of
‘best practice’ was also examined: asking the patient if they were dry or wet (PV programmes only) and
giving the patient encouragement. These ‘best practice’ components were done on over half of occasions
(asking the participant if they were wet: 57.9% in intervention; 65.9% in supported implementation;
giving encouragement: 58.4% in intervention; 57.5% in supported implementation). It is important to
acknowledge that only clinical logs that had a regime interval and schedule of proposed times correctly
documented were examined for documentation of the actual voiding times and of the best practice
components: this select group of clinical logs is not necessarily representative of all the clinical
logs collected.
Completion of daily clinical logs has been used as a measure of adherence to the SVP. Evidence from the
qualitative process evaluation suggests nursing staff did not necessarily document everything they did, and
completion of clinical logs may therefore underestimate the true level of adherence to the programme.
In both intervention arms, the majority of people eligible to receive BT or PV actually received it
(intervention 102/114, 89.5%; supported implementation 82/93, 88.2%). Furthermore, there is evidence
that conservative interventions started promptly after completion of the 3-day diary in line with the
protocol (intervention: median 2 days, IQR 1–4 days; supported implementation: median 1 day,
IQR 1.00–2.25 days).
Just under half of participants received the correct intervention (BT or PV, 86/180, 47.8%); this was similar
across intervention arms (intervention 42/100, 42%; supported implementation 44/80, 55%). The majority
of participants in both trial arms (158/180, 87.8%) were put on PV with only 22 (12.2%) subsequently
going onto BT. It is not clear whether this was a conscious deviation from the protocol, perhaps because
staff found PV ‘easier’ to implement, or whether staff misunderstood the guidance provided. Although the
purpose of BT is to improve bladder function with the aim of regaining continence, PV has a different aim
of minimising incontinent episodes through prompt intervention by nursing staff.114 BT assumes an active
role on the part of the person and may not have been possible given the level of functional ability and
also the priority afforded to this part of their rehabilitation by participants, particularly in the early stages.
Unit staff might have preferred PV for participants with no cognitive impairment given that our patient
population may have had many other disabilities precluding active involvement in BT, for example inability
to complete their own bladder diaries or read the time. In the future trial, more emphasis needs to be
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placed on training nursing staff how to interpret the 3-day diary and how to tailor a voiding schedule
for BT. Specific criteria for transferring participants to BT when appropriate will also be required. At 6 weeks,
there is some evidence that BT may have led to a better outcome than PV or usual care, particularly in
the intervention arm (p= 0.070 dichotomised, p= 0.094 ordinal categorisation), therefore encouraging BT
with suitable patients may maximise chances of regaining continence.
Despite extensive liaison with therapy staff, no intervention sites included PFMT as part of a combined
intervention with BT. Lack of therapist involvement in identifying, assessing and managing UI after stroke
was highlighted in the case study (see Chapter 4) and is out of alignment with the key role recommended
by both evidence157–159 and policy.141 Delivering the intervention as intended (i.e. as a combined intervention
of BT and PFMT) may have led to more improvement in participant outcomes; this needs to be addressed
in the future trial through specific training for physiotherapists, occupational therapists and nursing staff
in the latter type of therapy.
Given the high rate of catheterisation found in this study, avoidance and management of catheterisation
needs to be incorporated into the SVP. More detailed guidance needs adding to intervention protocols
in the future trial, particularly around avoiding unnecessary catheterisation, conducting a ‘trial without
catheter’ as soon as possible and reviewing catheterised patients on a weekly basis.
Qualitative assessment of feasibility from the perspective of
multiple stakeholders
Soft systems analysis
The organisational and clinical work contexts of implementation activity, described within a clinical system,
can be characterised as a rich matrix of forces127 that may constrain or enable implementation. Within
implementation research, current approaches for the consideration of context focus primarily on a
diagnostic analysis of barriers and enablers which may be addressed through tailored implementation
approaches,52 or through the measurement of context as an explanatory variable at specific time points.130
Thinking about context from a soft systems perspective may provide new insights into the challenge of
implementation at the interface of organisational attributes and systems, and clinical work. Although
generated solely through the perspectives of health-care professionals, our data demonstrate that the
management of post-stroke UI is characterised as a soft system with multiple and potentially competing
understandings, embedded with other clinical microsystems within the stroke service. The data identify
multiple influences on implementation, not least the degree of synergy across systems. Our data do not
demonstrate how these influences might play out in practice as implementation progresses, but wider
theory provides some indication of those that may be most important to consider.
Across these interviews, there is an obvious lack of a consistent, and fully shared, clinical paradigm into
which the ICONS SVP is to be implemented, with essentially two ‘competing’ paradigms potentially
reflecting differences in views about clinical priorities and other contextual influences. One paradigm
sees incontinence care as a legitimate focus for rehabilitation, around which careful assessment and
goal-oriented approaches to intervention can be organised. The other paradigm sees post-stroke UI as
a barrier to rehabilitation, limiting the ability of people with stroke to engage actively in planned
rehabilitation activities. Paradigms are enacted through the decisions and practices of individual staff
members, and unsurprisingly there is evidence that both clinical paradigms can exist within individual
clinical sites. There was some evidence that these practices were associated with wider organisational
cultures and approaches to rehabilitation. The SVP intervention is associated with a shift in practice away
from haphazard assessment and an organisational routine approach to the management of post-stroke UI,
towards a more individually tailored regime with embedded monitoring and feedback of continence.
This shift in practice appears to be more consistent with the first clinical paradigm, and implementation
may be more successful where this clinical paradigm predominates.202
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The way that health-care professional participants describe the nature of their clinical work in interviews
suggests that, other than for the assessment of UI, the active management of post-stroke urinary
continence within clinical sites can be characterised by organisational routines. These routines form the
basic structure of clinical work around which individualised approaches to patient care, and multidisciplinary
practices, can be negotiated. The organisational emphasis on routines appears to be growing alongside the
introduction of ‘intentional rounds’ which address wider political concerns about the quality of health
care.203 The SVP requires staff to move from organisational routine to personalised practice, for example in
tailoring PV to a pattern of continence highlighted in a 3-day diary. Implementation will therefore require
considerable ‘tinkering around the edges’ of these organisational routines. Clearly, there will be significant
potential to regress towards organisational routine, justified by the efficient use of resources where
individual voiding patterns being implemented in clinical settings are actually quite similar.
The data indicate varying degrees of priority attached to urinary continence relative to other aspects of
practice, with some staff clearly of the view that the acute stroke period is not the time to be focusing on
this aspect of care. This runs counter to the narrative around the significant workload attached to reacting
to episodes of incontinence. Logically, time spent dealing with incontinence may limit the ability to
perform essential activities in other areas of care, particularly where staffing resources are limited. It may
also be linked to wider views about the intractability of UI, or perceptions of the futility of professional
interventions within this area of practice. Regardless of which explanations apply, and all probably do to
some extent, successful implementation of the ICONS interventions may be dependent on raising the
importance of continence issues within the acute stroke period. These data would suggest that success
in limiting the workload impacts of UI will be an important mediator of implementation.
Integrated working around continence by a wide range of health-care professionals was clearly evident
in those sites which espoused rehabilitation approaches to managing post-stroke urinary continence.
Although effective teamworking is seen as an essential prerequisite for good stroke care,10 it is also seen
as a positive attribute of organisational contexts conducive to implementation.40 It can be assumed that
integrated working is characteristic of some shared endeavour around which different staff groups can
collaborate. Integrated working appeared to manifest in collaborative action around continence in a
number of ways, and from which collaborative action on implementation within the ICONS programme
could build. Specific examples included therapists’ embedding continence work into nursing strategies
targeting broader, functional issues such as washing and dressing, and mobility; and the reorganisation of
clinical schedules to accommodate different contributions to continence care.
The data provide examples of multiple potential drivers for good practice around continence within the
clinical microsystem, many consistent with the principles underpinning the ICONS interventions. However,
maintenance of the clinical system appears to be somewhat fragile, largely dependent on the professional
interests of individuals such as link nurses. In addition, despite knowledge and skills around post-stroke
UI being key components of the Stroke-Specific Education Framework,204 the provision of education and
training for staff appeared to be haphazard. This situation may reflect a generalist view of what is required
of staff in this clinical system, and is consistent with reports in the wider literature on the nursing role
in stroke care.155 In the data, there were examples of talk which demonstrated that there was little
intellectual challenge in addressing continence needs in clinical practice. Inevitably, there appears to be an
over-reliance on experiential sources of knowledge in clinical practice. Although an important source of
‘evidence’ for practice, it is essential that this is complemented by other forms of evidence, including
research, evaluation and performance feedback.205 Organisational approaches which synthesise different
forms of knowledge for practice through, for example, structured education and training and performance
review may be associated with implementation of the ICONS programme.40
Although there is no potential to redesign clinical environments to support implementation of the ICONS
interventions, the data demonstrate that staff, particularly nurses, are not passively constrained by the
clinical environment and facilities within which they are working. Although the nursing role has always
included attention to maintaining an environment conducive to rehabilitation,155 there is also evidence of
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creative use of facilities when these were lacking. These structural aspects of implementation should not
be overlooked, and highlight the importance of engagement with staff and understanding clinical
microsystems before any redesign takes place.
Our data do not map out the clinical systems in their entirety; this would require an alternative approach
to sampling within clinical sites. However, the data indicate the complexity of the system, with multiple
staff members, teams and organisations contributing to work within the system. Inevitably then, this
multiplicity is associated with increased potential for problems and error.206 Interestingly, there is some
evidence of the strong influence of individuals from outside the immediate clinical work associated with
urinary continence, specifically in relation to purchasing related stock and equipment. It is important to
ensure that these perspectives are accounted for within implementation activity within the ICONS
programme, and any subsequent roll-out of trial interventions.
Normalisation process theory
The aim of the NPT analysis was to identify factors in the implementation of the SVP which might have
influenced the success of the programme. It was very clear from the analysis that the staff thought the
programme had been successful in improving patient outcome, so the findings were further analysed to
consider the mechanisms of action potentially linking the SVP to outcome. Figure 32 summarises the
potential mechanisms.
Potential mechanisms of action of the systematic voiding programme
The SVP processes are in the clear outlined boxes (see Figure 32). The main feature of the SVP that
respondents referred to was its logical and structured approach to organising the management of
continence (see Figure 32). Three major mechanisms of action are labelled across the top of the diagram
as increased priority, increased ownership, and different care, with their component causal chains
illustrated by the blue, dark green and light green coloured boxes. Some of the components are
linked together.
Mechanism 1: increased priority
The SVP resulted in changed perceptions about incontinence, from an inevitable and intractable
consequence of stroke, towards a symptom that could be responsive to intervention. Owing to the
research, there was a strong drive from senior staff to focus on continence care, resulting in junior grade
staff being consistently reminded, supported, monitored and encouraged to take responsibility. Staff had
a heightened awareness of continence: they talked about being surprised at the lower prevalence of
incontinence than expected; and the potential for improvement in people with stroke thought unlikely to
benefit. Those with stroke and relatives were also more aware of continence, and staff were conscious of
their expectations.
Mechanism 2: increased ownership
A major feature of the findings was staff talking about the benefits of their intervention. They saw
improvement in individual people’s continence and they also saw a trajectory of improvement in the
paperwork. Staff talked about their enjoyment in seeing people progress and the consequences of
developing a continence routine sufficient for people to go home safely. After experiencing the SVP,
staff also noted that the extra work was balanced out by a reduction in workload from changing beds,
and also that wards were calmer, with fewer buzzers going off because they were pre-empting care. This
also linked to people with stroke being aware that continence problems were being attended to, and
having knowledge and confidence that staff would attend them when scheduled.
Staff thought the structured approach of the SVP was beneficial for people with stroke as well as for staff,
and that it was suitable for people after stroke. They talked about people with stroke being actively
involved in working towards control of continence, which gave them hope for wider recovery from stroke.
Nurses talked about being more skilled in assessing and managing continence, and in talking to people
with stroke. They felt that they were providing constructive help and were proud of their therapeutic role.
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FIGURE 32 Potential mechanisms of action linking SVP process to outcome.
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This was especially the case with HCAs, who liked the training and were often described by senior staff as
taking ownership and driving the programme. Senior staff talked about increased discussion of continence
by nurses at MDT meetings and in discharge planning.
Mechanism 3: different care
Increased priority and ownership of continence contributed towards differences in the kind and amount of
care provided. The logical and structured nature of the SVP meant that staff knew what they were doing.
The SVP also provided a basis for co-ordinating care delivery so that everyone was working towards the
same goals. The regularity of the intervention meant that it was likely to be remembered and delivered
more consistently. Increased vigilance about continence meant that intervention was probably occurring
with a wider group of people with stroke than previously; and staff were persevering for longer with
people who they might have given up on previously. Extra staff meant that care was able to be delivered
consistently, staff were more proactive in intervening and active in managing rather than containing
incontinence, and people were also getting more attention. As a result of the assessment and bladder
scanning, staff may also have been delivering different care, such as increased investigations, or referrals.
Evaluation of supported implementation
Sites were free to choose their own facilitators, assuming they met the criteria outlined (see Chapter 3).
In practice, seven facilitators were in ward manager/ward sister posts and perhaps did not have sufficient
time to commit to the role alongside managerial commitments. This may have contributed to a lack of
engagement between internal and EFs in between meetings. However, this was true of all internal
facilitators, none of whom had dedicated time for facilitation activities. Involvement of EFs in choosing
appropriate people may have identified less obvious candidates.
The facilitation manual (see Appendix 14) was the main resource for internal facilitators and outlined both
their role and that of EFs. Perceptions of what the internal facilitator role would comprise, and how this
would interact with that of EFs, was generally unclear, perhaps suggesting the manual had not been
consulted for guidance. This is concerning, as little understanding of the facilitator role has been identified
as mitigating against successful facilitation.132 A consequence was unrealistic expectations of the EF,
particularly in two sites.
All sites developed action plans, although there is little evidence these were systematically used to monitor
progress. There is no evidence that the many implementation strategies outlined in the manual, for example
using ‘rich pictures’ to visualise the intervention, or role modelling, were used in practice. Emphasis within
the manual on underpinning theory (e.g. NPT) could have inhibited engagement and there was some
suggestion that ‘big jargon’ should be simplified.
Data from interviews and meeting notes suggested internal and EFs were using the key components
of the process identified by Stetler et al.,132 interactive problem-solving and supporting staff through the
process. The supportive role fits with the concept analysis by Harvey et al.,129 and also empirical work by
Stetler et al.132 and Cheater et al.,207 and may have contributed to evidence from process evaluation
suggesting embedding the intervention and some aspects of care were more likely to be done well in this
trial arm. However, with the exception of action planning and progress meetings with EFs, it is difficult to
determine the extent to which facilitators used processes different to those used in the intervention group
in introducing the SVP. The similarity of techniques used to manage change in both intervention groups
highlighted in NPT analysis may suggest little difference.
Patients’ perspectives
We were able to undertake only 12 interviews with patients and carers in the trial phase, and not all sites
were represented. The small number of participants consenting to an interview may have been partly due
to the recruitment process. Patients or consultees were asked to consent to a possible interview at the
time of initial recruitment into the study. At this time point, soon after the acute stroke event, participants
and consultees may have been reluctant to agree, even provisionally, to giving an interview in the future.
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The study protocol did not allow for participants to defer this decision to a later date, when some may
have regained the capacity to consent. The geographical spread of sites also meant that even when
participants did consent to be interviewed, it was not always possible for a member of the research team
to do this before the person was discharged.
Data collection was limited to those who had experienced the SVP. It is possible those from usual care may
have reported similar experiences to the sample interviewed, but there is no data to support or refute
this. Interviews were undertaken in the hospital setting, and we were unable to explore participants’
experiences of the long-term impact of the programme post discharge.
It was apparent that some participants with functional UI held a view that this was not ‘true’ UI, and were
therefore unsure why they had been included in the programme. Educational materials may need
modification to address this misconception.
Proposed theory explaining how the systematic voiding programme worked
in practice
Considering all the data from the process evaluation, we developed hypotheses relating to each main
mechanism in the logic model (thinking, planning, doing and evaluating) and considered the evidence for
what might have led to mechanisms ‘firing’ consistently and whether or not each hypothesis was
supported by the data. Proxy outcomes (i.e. how the effects of the SVP might be seen) were used to
articulate if hypothesised mechanisms operated or not. Appendices 33–35 provide evidence from soft
systems and NPT analysis to support hypotheses.
Thinking
Table 109 shows the hypotheses and proposed mechanisms of action.
Prior to the intervention, nursing was ascribed with expertise in continence management but in reality
there was no evidence that expertise was being used and nursing practice revolved around containment.
Nurses did not consistently view UI as an important priority in care delivery relative to other aspects of care
and what we were proposing was potentially at odds with their approach to supporting people with
continence problems.
TABLE 109 Thinking: hypothesis and mechanisms of action
Main mechanism
Submechanisms: how the SVP
might work
Proxy outcomes: how effects of the
SVP might be seen
Hypothesis:
The SVP changed thinking about UI from it being a barrier to rehabilitation to a legitimate focus of planned, therapeutic
activity
Contextual barriers:
l acute stroke context serves as a barrier to giving priority to UI due to competing demands and pressures
l system not generally rehabilitative
l role change largely affected HCAs rather than qualified staff
Changed perceptions: UI, role Therapeutic potential Increased relative priority/attention
Changed attitude – guilt, pride
Incontinence role (nursing) Increased nursing knowledge and skill
MDT contribution More nursing input to MDT
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
335
There were three possible explanations for how thinking might have been changed by the SVP. First,
taking part in ICONS and introducing the SVP led to changed perceptions of continence as a legitimate
focus for rehabilitative practice. The increased focus on continence and training in underpinning theory
and practice led to a change of paradigm: incontinence was now viewed as amenable to change, rather
than intractable. There was evidence increased knowledge and skill in promoting continence led to this
work being valued and pride in the rehabilitative, therapeutic nursing role. The SVP delivered increases in
knowledge and skill and an opportunity for nurses to demonstrate this, providing legitimacy for claims
that extended the nursing contribution around UI management. However, this was more apparent in
rehabilitation than acute units where competing priorities (i.e. more technical interventions) still came first.
A second potential explanation was a change in nurses’ perception of their specialist role. As well as
changed attitudes towards continence, role change and increased status was evident for HCAs, who often
took the lead driving and co-ordinating continence care. This change was less obvious and widespread for
qualified staff.
There is some evidence to suggest qualified staff continued to view incontinence work as low level, suggesting
their work was less discernibly different to their existing role and may have failed to provide reward. Although
the potential for continence to reconfigure the nursing role within the MDT was recognised, there were fewer
examples of the change occurring. This could be owing to less involvement from qualified staff: their role
typically focused on assessment and they were not necessarily actively involved in other continence activities.
Lack of engagement in the whole cycle meant their practice was not sufficiently different to trigger an
observable shift in their recognition and enactment of a specialist nursing role within continence care.
A third potential explanation was a change in the perception of nurses about their role and contribution
within the MDT. Although there was some discussion at the MDT meeting and increased expectation
of the requirement of nurses to report on continence, the uptake and promotion of a specialist nursing
role in the management of continence within the MDT was not seen.
In summary, consistency across data sources and settings suggest there was a regular pattern of impact
around changed thinking about continence, particularly its relative priority and value in rehabilitation
settings. However, role change was largely specific to HCAs rather than qualified staff, and perceptions of
a specialist nursing role for continence care within the MDT remained an aspiration rather than reality.
Planning
Table 110 shows the hypotheses and proposed mechanisms of action for possible changes in the planning
of care.
TABLE 110 Planning: hypothesis and mechanisms of action
Main mechanism Submechanisms: how the SVP might work
Proxy outcomes: how effects of the
SVP might be seen
Hypothesis:
The SVP made a structure for UI care explicit, enhancing consistent, knowledge-based delivery
Contextual barriers:
l evidence of extensive effort at embedding the SVP (due to taking part in a research study)
l some misunderstandings
Logical structure: Codifying and embedding care at an individual level More people receiving UI care
Improved organisational consistency Less variation
More continence talk
Fewer system failures
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Prior to the intervention, and reflecting the disparity between ascribed and practised roles in continence,
the default position regarding services was a lack of focus for clinical leadership of continence care and a
mismatch between skills, knowledge and practice. In addition, configuration of services did not facilitate
collective working and planning. The logical structure provided by the SVP enabled a route to improved
planning of care at two levels: individual patient and organisational.
At the individual patient level, protocols designed to codify and embed the new practice appeared to
engender improvements in consistency and organisation, and increased communication between staff and
between staff and people with stroke. Findings suggest the logical structure was hugely successful for both
participants and staff, with more people identified as needing and receiving continence care and less
variation in practice. However, some elements of the SVP were difficult to implement, for example
distraction.
Enacting the plan at an organisational level was not without difficulty, for example assessment proved
unpopular and the SVP was not perceived as helpful with all client groups (e.g. people with functional
incontinence). The logical structure ensured there were fewer system failures at an organisational
level, such as patients not having a management plan. However, organising and ensuring consistent
delivery of a tailored SVP to individual people within the ward environment and routine was problematic,
with some over-rigid adherence to 2 hourly toileting following the introduction of national safety initiatives
(e.g. intentional rounding) and a tendency to regress to routinised care when under pressure.
In summary, changes in the ability to plan care has explanatory power at the individual level but findings
illustrated more work would be needed to help staff to embed the SVP into organisational planning.
Doing
Table 111 shows the hypothesis and proposed mechanisms of action for changes in what nurses did in
terms of continence care.
TABLE 111 Doing: hypothesis and mechanisms of action
Main mechanism
Submechanisms: how the SVP
might work
Proxy outcomes: how effects of the
SVP might be seen
Hypothesis:
The SVP helped staff to make the shift from an organisational approach to continence that was unsystematic, routine and
selective to one that promoted regularity, inclusion and individualised management
Contextual barriers:
l Insurmountable routine systems in practice
l Intervention was focused at an individual level rather than an organisational level
l The programme was subject to peripheral ‘tweaking’
Changed clinical work: Selection Different patients receiving care
Diagnosis Differentiated/correct care
Routine More care regularity
Perseverance Sustained delivery
‘Different talking’
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Pre intervention, there were strong contextual barriers to individualised continence management, including
insurmountable routine systems and focus at an individual, rather than an organisational, level. An
explanatory hypothesis across the data was that the SVP helped staff make the shift from a routinised
organisational approach to continence to integrated working around individualised management. Two main
mechanisms around this shift in practice were changes to who received care, and to the care received.
The selection and diagnosis of patients changed from opportunistic to protocol driven: different patients
(including young and cognitively impaired patients) received different care (assessment, bladder scanning,
consistent and systematic attention and individualised regimes). However, although there was evidence
patients were put on different regimes (BT or PV), individualising voiding intervals based on assessment
data was difficult to achieve, with practice moving from unsystematised to routinised around 2 hourly
toileting. Care was less selective with more people receiving a structured approach, but individualisation
was difficult to implement, although it appeared easier to achieve with people able to participate fully in
their own regime.
Changes to care included delivery on a more regular basis for different time periods (longer contact
time; prolonged involvement) and a change in discourse around continence issues between staff and
people with stroke (persuading, negotiating, expressing). Staff recognised that changes in people’s
outcomes were the result of doing the SVP over a sustained period. Staff also recognised the reduced
workload associated with catching people in time (i.e. managing incontinence rather than increasing
continence), but sustained delivery of the SVP proved to be an uphill struggle.
In summary, although there was some explanatory power that the SVP promoted regularity and inclusion,
individualisation was difficult to implement.
Evaluating
Table 112 shows the hypothesis and proposed mechanisms of action for evaluating continence care.
Findings from interviews with stakeholders revealed that at the start of the intervention period, services
within the trial demonstrated little, if any, attention to systematic evaluation of clinical practice or
patient outcomes around UI. The data demonstrated that the SVP increased the visibility of continence
management in three ways: increased surveillance of process; greater evaluation of patients’ trajectories
and outcomes (including scrutiny of nurse performance in achieving these); and closer attention
to workload.
TABLE 112 Evaluating: hypothesis and mechanisms of action
Main mechanism Submechanisms: how the SVP might work
Proxy outcomes: how effects of the
SVP might be seen
Hypothesis:
The SVP and its interpretation increased visibility and enabled staff and patients to evaluate process trajectory, workload
performance and outcome
Contextual barriers:
l Progress linked to patient responsiveness
l Visibility does not work in the acute setting
Visibility: Process More surveillance
Trajectory/outcome More evaluation
Workload Recognition
Patient and family More patient control
More relative involvement
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For people with stroke and their families, documentation provided a visible means of monitoring progress.
Families perusing daily clinical logs provided an incentive for nurses to ensure toileting was timely, and
also documented. People with stroke liked the fact that nurses were actively managing their continence
and the control the SVP afforded. In addition to triggering the provision and review of care, the paperwork
provided a means through which performance of individual nurses could be monitored by other clinical
staff and managers.
The second mechanism involved making patient trajectories and changes in outcome obvious through the
daily and weekly paperwork. Although there was evidence of increased monitoring, systems were at an
individual, rather than an organisational level. The SVP was less effective in facilitating systemic outcome
monitoring over time and across organisational boundaries, i.e. after discharge to the community.
Contextual barriers included progress being dependent on participant’s responsiveness. This explanation
did not apply consistently in the acute setting where staff had limited opportunity to see success due to
the relatively short length of stay
Third, staff appeared to be motivated to continue by a visible reduction in workload, for example where
there was less incontinence to deal with.
The hypothesis that the SVP enabled staff and participants to evaluate increased visibility of process,
trajectory, workload, performance and outcome was well supported.
A preliminary evaluation of intervention and supported
implementation relative to usual care
Primary outcome
There was no suggestion of a beneficial effect of the SVP (with or without supported implementation) on
outcome at 6 weeks post stroke. However, almost 50% of patients had received less than 2 weeks of their
allocated intervention by this time point and over 25% had spent less than 7 days on the programme.
Findings were similar at 12 weeks post stroke (intervention vs. usual care: OR 1.02, 95% CI 0.54 to 1.93;
supported implementation vs. usual care: OR 1.06, 95% CI 0.54 to 2.09, respectively) and the intervention
arm outcomes were no better at 52 weeks (intervention vs. usual care: OR 0.56, 95% CI 0.27 to 1.16;
supported implementation vs. usual care: OR 0.60, 95% CI 0.27 to 1.30).
Overall, 161 (39.7%) of participants were continent at discharge; 38 (31%) in usual care, 72 (44%) in
intervention and 51 (41%) in supported implementation. Relative to usual care, the intervention arm had
an OR of 1.47 (95% CI 0.81 to 2.67) of being discharged continent, with supported implementation
having an OR of 1.54 (95% CI 0.83 to 2.85); the overall difference between trial arms was non-significant
(p= 0.32). Overall, participants in the two intervention arms had 1.50 (95% CI 0.88 to 2.57) (p= 0.13)
times the odds of continence at discharge than usual care participants. This suggests intervention arms
may have been more successful in helping patients regain continence before they left the stroke unit.
Difference is adjusted for stroke subtype prognosis, albeit assuming that the intervention is equally
effective for all.
However, exploratory evidence suggests that continence status may not have been maintained when the
SVP ended on discharge from the stroke unit, with over half of participants continent at discharge (and
discharged before 6 weeks) incontinent at 6 weeks (22/38, 57.9%) and two-fifths of participants continent
at discharge (and discharged before 12 weeks) incontinent at 12 weeks (22/54, 40.7%). Ways in which
the SVP can be extended to facilitate maintenance of continence after discharge need exploring and,
if feasible, incorporating into a future trial.
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Per-protocol analysis suggested that those who received the intervention according to protocol may have
had better 12-week outcomes than those in the usual care arm, although this did not appear to hold
for supported implementation; for those who received at least 14 days of intervention, the estimated
continence OR relative to usual care was 1.54 (95% CI 0.69 to 3.47), and that for supported
implementation was 1.07 (95% CI 0.40 to 2.90). However, this apparent relatively better outcome in the
intervention arm was not maintained at 52 weeks, with estimated continence ORs for intervention and for
supported implementation relative to usual care both below 1.
Secondary outcomes
There was no evidence of better outcomes on the ICIQ or ISI at 6 weeks post stroke. At 12 weeks
post stroke, there was some evidence of better outcomes on the ICIQ in supported implementation
(OR 1.22, 95% CI 0.72 to 2.08). Both intervention arms had a higher estimated odds of continence for
UUI than usual care (intervention: OR 1.58, 95% CI 0.83 to 2.99; supported implementation: OR 1.73,
95% CI 0.88 to 3.43). There was a similar increase in the estimated odds of continence for SUI in
supported implementation (OR 1.82, 95% CI 0.82 to 4.01), but this was not so marked in intervention
(OR 1.04, 95% CI 0.45 to 1.82). Although none of these increases was statistically significant, they are
suggestive of a potential reduction in the odds of specific types of incontinence. The evidence is more
consistent across the arms for UUI. This finding is encouraging, but consistent implementation of BT
(recommended for those with urge incontinence) was limited, potentially attenuating the effect estimate.
However, disappointingly, there was no real suggestion that this apparent effect was maintained to
12 months post stroke.
In summary, there appears to be a trend towards more favourable continence outcomes in intervention
arms at 12 weeks, particularly in those participants with UUI and (to a lesser extent) SUI. Per protocol
analysis also demonstrated that participants in intervention who received at least 14 days of intervention
were one and a half times more likely to be continent than those in usual care at 12 weeks. However, it is
unclear whether this is an indication of effectiveness, selection or reporting bias. A higher proportion of
participants were continent at discharge in intervention groups.
Linking process and outcome data
Three of the highest ranking sites on process indicators were in supported implementation; in two of
these the intervention was well embedded. In contrast, no intervention sites had a score indicating high
embedding, with two showing conflicted or neutral and two poor embedding. It is tempting to link these
processes with the trend towards improved outcomes at 12 weeks in this trial arm. Process data were not
uniformly positive, however, with one supported implementation site achieving the lowest ranking in terms
of adherence data. This site was characterised by severe staffing shortages throughout the intervention
period which affected their ability to maintain the SVP despite their best efforts.
Measurement issues
The amount of missing data on the LUSQ question used to identify SUI at baseline suggests this might
not be the right tool for diagnostic purposes. Furthermore, participants’ answers in terms of whether they
had UUI or SUI correlated poorly with nurses’ opinions of type of UI. Obtaining a valid assessment of type
of UI is further complicated in participants with cognitive impairment, as UUI in particular is not easily
established if the participant is unable to answer questions themselves.
Adverse events
As people receiving the SVP were theoretically taken to the toilet more often, an increase in the number of
falls might have been evident; however, this was not the case and indeed there were slightly fewer falls in
supported implementation (three, compared with eight in other arms).
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Methodological issues
Risk of bias
Randomisation was carried out by an external trials unit ensuring researchers were unable to influence
the randomisation process. Stroke services were aware of their allocation, as were staff identifying and
recruiting trial participants who also conducted outcome assessment for participants who were still in
hospital at 6 and 12 weeks post stroke. Although we originally intended research nurses to collect
outcome data in sites other than their own (and in which they were unaware of allocation), the
geographical spread of sites meant this was not feasible. The trial statistician was not blinded during the
analysis, although the statistical analysis plan was finalised prior to any outcome data being available.
Some additional exploratory analyses were performed, but these are identified clearly as post hoc.
Heterogeneity
There were some differences in baseline characteristics across trial arms, with relatively more males in
intervention (86, 52%) compared with usual care (51, 41%) and supported implementation (52, 42%).
The proportion of participants with no symptoms on the mRS was slightly higher in usual care (52, 42%)
compared with the intervention (54, 33%) and supported implementation (33, 27%) arms. There were
also fewer patients with the most severe stroke subtype (TACS) in usual care [37/124 (29.8%)] compared
with intervention [80/164 (48.8%)] and supported implementation [68/125 (54.4%)].
This may have occurred due to consent bias, with research nurses in usual care selecting all people with
stroke meeting the inclusion criteria, including those with milder strokes and UI, even though their stay in
hospital may have been short; the observation that the length of stay was typically slightly shorter in usual
care is consistent with this possibility. In intervention arms, it could be that research nurses recruited
patients who they considered would be worthwhile and feasible to take part in the SVP rather than all
those eligible for the trial. An alternative explanation could be that intervention arms admitted less
‘milder’ strokes.
Patient-related factors affecting patient outcome
At 6 weeks, there is some evidence to suggest people with pre-stroke incontinence were more likely to
be continent in supported implementation (p= 0.069). In terms of participant characteristics, 65 out of
66 participants continent at 6 weeks were independent pre stroke as measured by the mRS. ISI category
may have had less impact on 6-week ICIQ incontinence frequency in intervention and supported
implementation than in usual care; a similarly lesser impact of baseline severity was evident in the
intervention (but not the supported implementation) arm at 52 weeks.
At 12 weeks, stroke subtypes other than TACS may be more likely to be continent in intervention and
supported implementation (p= 0.054) arms. People with UI pre stroke, and older people may be more
likely to be continent in supported implementation (p= 0.048 and p= 0.02 respectively). Only six
participants dependent pre stroke were continent at 12 weeks; none of these were in usual care. In terms
of other participant characteristics, people with right-sided weakness may be more likely to have greater
incontinence frequency (p= 0.080) at 12 weeks; a similar effect was detected at 52 weeks.
There is evidence from the process evaluation that all people with UI received the intervention regardless
of pre-stroke continence status or stroke severity, in contrast to usual care, where continence provision
may have been less systematic and determined by staff perceptions of who might benefit. It is possible the
SVP contributed to people with pre-stroke incontinence regaining continence in supported implementation
at 6 weeks, and also those with stroke subtypes other than TACS in both intervention groups at 12 weeks,
but not those with severe pre-stroke disability.
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Choice of primary and secondary outcome measures for a
full-scale cluster randomised trial to evaluate effectiveness
Findings from the exploratory trial suggest presence/absence of incontinence as the primary outcome
measure is appropriate to use in the future trial. Given the level of both incontinence and stroke severity in
the population recruited, as well as the proportion of those incontinent before stroke, measurement of
reduction in incontinent episodes could be measured by the ICIQ question ‘How often do you leak urine?’
This is preferable to objective measurement using the 24-hour pad test, as pad use may lead to more
incontinent episodes in this patient group. Furthermore, the ICIQ has been shown to correlate well with
the 24-hour pad test in women with urodynamic SUI.208
The main outcome point selected initially in the exploratory trial, 6 weeks post stroke, requires revision
as people were recruited later than expected and almost 50% had received less than 2 weeks of their
allocated intervention by this time point. Setting the main outcome point at 12 weeks will provide better
evidence of the effectiveness of the SVP in a future trial, particularly if removing the exclusion criterion
‘medically stable’ (as outlined above) contributes to earlier recruitment and a longer length of exposure to
the intervention.
Using an incontinence-specific QoL measure, the I-QOL, proved problematic as the majority of questions
apply only to those with incontinence and are not all applicable to patients who regain continence.
However, it has been recommended for use due to its responsiveness to change in comparison with the
EQ-5D180 and, in the absence of a more psychometrically robust alternative, it could be retained with
guidance for people who regain continence to answer ‘not at all’ to questions that do not apply.
Developing and testing data collection tools for an economic
evaluation within a full-scale cluster randomised trial
We have explored the feasibility of different methods to collect resource use data, summarised the data
recorded and have identified issues that will need to be addressed in a future trial.
In order to record fully the costs associated with the programme it would be necessary to have research
staff observe and record what the clinical staff are doing – the latter do not have the time to keep
comprehensive records, particularly when they are also completing the paperwork necessary for the
programme. The benefits of the programme within the hospital may include reduced episodes of
incontinence but data reflecting such reductions were not recorded. A future trial will need to consider
methods to obtain data reflecting the cost of incontinence from all groups.
The resource use postal questionnaires had a reasonable response rate at 12 weeks and most of the items
were answered. At 52 weeks the response rate was lower, and completion of the individual items was also
slightly lower, this reduction was more marked for the health and social care items than the aids and
adaptations. The response rates to the resource use questionnaires overall were similar between groups at
12 and 52 weeks. Completion of the individual items was similar at 52 weeks compared with 12 weeks.
The lower response rate for the questionnaires at 52 weeks needs further consideration and alternative
methods of collecting resource use data may need to be considered.
The programme aimed at promoting continence after stroke is resource intensive and generated substantial
costs in the short term. Although patients were followed up at 52 weeks, there were substantial amounts
of missing data, partly due to around one-quarter of patients having died, but this meant that limited
resource use data were available. Consequently, cost-effectiveness was explored using imputed data.
The ICERs generated were of a magnitude to suggest that the programme has the potential to be
cost-effective, but caution should be taken in interpreting these results given the large amount of imputed
data. The need to identify strategies that allow more complete data to be collected is clear.
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A definitive trial will need to consider a range of strategies to record resource use data. It is imperative that
the right balance is found between the level of input required for collection of resource data and the
accuracy of those data. This may include time spent observing and recording clinical practice – in relation
to the research – asking patients to keep diaries, and sourcing resource information from the providers.
Consideration may also need to be given whether or not the post-programme data collection focuses on
those resource items related directly to the programme’s impact.
Recommendations
Recruitment
Centres
Only stroke services with 300 or more people admitted with confirmed stroke per annum should be
considered for inclusion in the future trial. This should enhance embedding of the intervention through
greater number of patients receiving the intervention and reduce costs in terms of staff training.
Homogeneity of sample size within clusters will also minimise the number of clusters required.
Patients
The inclusion criterion ‘medically stable’ should be removed, and the recruitment process should begin
as soon as people are identified as incontinent or catheterised. The assessment process can then begin as
early as possible, with conservative interventions beginning when the unit team judge the person to
be ready.
Intervention design
Potential adaptation to the systematic voiding programme design
All of the individual linkages described above (see Figure 32) are reflected to some extent in the findings,
but link together into themes that suggest potential adaptations to the SVP and its implementation in the
future trial. These adaptations are consistency, visibility and individualisation.
Consistency
The major strength of the SVP appeared to be the focus and knowledge of continence management that
it gave to staff and patients, in a format that was logical and documented. Despite problems with the
documentation, it did form the locus of attention for defining action and monitoring outcome. It meant
that staff and patients worked together on the same plan, and that people had role clarity. Care was
delivered consistently each day, and over the whole trajectory of the patient’s recovery. The SVP was also
very accessible to HCAs, giving more meaning and value to a major component of their daily activity. A
future intervention could focus on ensuring SVP components stress the value of planning, co-ordination
and management of continence care.
Visibility
Perhaps the most surprising finding related to the importance of visibility of outcome on motivation and
effort, and the powerful effect of visibility on proactive and therapeutic intent in nursing. Being able to link
the effect of nursing actions in improving patients’ lives in the longer term was a powerful driver. It is
notable that senior staff found the programme hard to monitor informally, relying on the research nurse to
monitor performance. Owing to the holistic nature of nursing care, attention is often diffuse, and it is rare
to receive feedback on outcome that can be directly attributed to nursing action. A future trial could focus
on ensuring SVP components make continence process and outcome linkages more visible.
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Individualisation
The findings suggested a lack of differentiation between regular toileting and the SVP. This, together with
the linking of the SVP with intentional rounding, means it is unclear if any improvement in outcome is
attributable to the SVP as a whole, or rather to regular and consistent toileting. There was evidence that
staff were individualising care to some extent, but it was also evident that this aspect of the SVP was not
carried out perfectly. A future trial could focus on comparing regularised with individualised
continence care.
Barriers and facilitators to implementation
Appendix 36 summarises the barriers or difficulties, and facilitators or suggestions, for each question posed
by the NPT framework. The four main implications for any future trial are discussed below and summarised
in Figure 33, for each decision stage in the SVP pathway.
The first stage of the SVP requires the identification of eligible people, removal of catheter and completion
of a 3-day diary to make a decision about whether or not a person is incontinent. Difficulties and
suggested solutions for this stage of the SVP included:
l Revise inclusion guidelines There was some confusion and disagreement around the eligibility of
people with long-term continence problems, catheters or urinary symptoms without incontinence for
inclusion in the SVP. One site suggested improving the information about who to put on the SVP;
another site started screening everyone that consented, and said they captured more people, earlier.
Preliminary
• Identify eligible patients
• If catheterised, remove
   catheter 
3-day diary
Decision about
incontinence
Asessment
• Medication review,
   bladder scanning
• Resolution of 
   exacerbating problems  
Pathway decision
Core
Patient education
Timing decision
Encouragement/
positive feedback
Daily log
Weekly review
Adapt timing or
programme
• Revise inclusion guidelines
• Target acute pathway
• Screening reminder system
• Increase HCA responsibility 
• Revise assessment
• Problem resolution recording
• Require pathway decision
• Night staff training
• Review distraction,
   checking
• Guide for difficult 
   patients  
• Set day for weekly
   review
• Monitor patient
   trajectory 
A
B
C
D
FIGURE 33 Suggestions for improving the SVP pathway in future trials.
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Supporting the decision about incontinence
l Target the acute pathway On sites with acute and rehabilitation wards, a 3-day diary completed in the
acute ward could be perceived as unreliable in the rehabilitation ward because it might be partial, or
too early. One acute area also thought that a 3-day diary was too long for a short stay area, and that
they would be better starting to prompt, but they did think it was worth doing the assessment in
the acute area. Review of the use of the 3-day diary in an acute setting is needed.
l Screening reminder system Maintaining surveillance of potential recruits who were not ready for the
3-day diary because of catheterisation or being unwell was difficult in the absence of a co-ordinating
research nurse, because no-one was responsible. One site allocated this responsibility to a HCA for
individual people, another to a staff nurse. Either role allocation or some form of trajectory recording
could be considered.
l Increase HCA responsibility Two sites commented that HCAs had responded positively to their
involvement with the SVP, two sites thought it important that HCAs saw the link between their input
and outcome for the patients to maintain motivation. HCAs were important in continuously monitoring
eligibility; tailoring the SVP approach to the needs of individuals and responding positively and
persuasively to people who were anxious, demanding or reluctant; and completing the 3-day diary and
daily logs. Some sites saw ICONS HCAs take a lead role in promoting the programme. An increased
therapeutic role for the HCA in managing continence care seems feasible.
Supporting the pathway decision
The second stage of the SVP requires completion of the assessment and a decision about which pathway
the participant will follow – whether PV or BT – and the timing interval based on the 3-day diary.
Difficulties and suggested solutions for this stage included:
l Revise the assessment The assessment was problematic because it was long and because staff had to
consult the family to gain the required information. However, staff liked their increased skill and
confidence in assessing continence. Streamlining the assessment with staff and linking this to training
would be essential.
l Require a pathway decision Although the programme was seen as providing a clear structure and
management plan, there was some evidence of a lack of understanding about different processes
for different people, the individualisation of toileting routines based on the bladder diary, and BT
processes. Making the link between assessment and the management plan more explicit within
protocols might be helpful.
Supporting the timing decision
The third stage of the SVP requires implementing the chosen pathway, scheduling of the timing intervals
on a daily basis, and keeping a record of care processes. Difficulties and suggested solutions for this
stage included:
l Night staff training It was important that daily plans were initiated early in the day, and some wards had
involved night staff in the preparation of paperwork to facilitate this. Staff also noted that people could
regain continence during the day, but still require pads at night. At a minimum, night staff training could
help the correct completion of daily individualised toileting plans. Training and involving night staff may also
facilitate extending the SVP time period for those people who are continent during the day but not at night.
l Review distraction and checking methods Staff reported difficulty with the practice of distraction and
delay in BT: participants did not like it, and relatives did not understand it. Staff also reported
discomfort with repeatedly asking people if they were dry or wet during PV. These aspects of the SVP
need reviewing to help staff to manage them better.
l Methods for encouraging participation Staff reported difficulties with managing people who were over
anxious; irritated by being repeatedly asked if they wanted to go to the toilet; or reluctant to follow the
programme. Staff had some ideas about how to phrase requests, and examples could be included in
future training.
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Supporting adaptation of the systematic voiding programme
The fourth stage of the SVP requires reviewing a person’s progress weekly and revising the programme
and/or schedule based on the daily logs. Difficulties and suggested solutions for this stage included:
l Reschedule the weekly review Because the weekly review could fall on different days for different
people, it was sometimes missed. One staff nurse scheduled review due dates in the ward diary. Two
sites suggested doing all reviews at the weekend, when other reviews traditionally took place.
l Monitor patient trajectory Staff did not know how deal with people who had to stop and restart
the programme – perhaps because of a setback. They also did not know if and how to stop the
programme for people who were not making progress, or had a complete lack of awareness. Guidance
for these situations could be given. For patients who had had a break in the SVP, there was then the
problem of maintaining awareness of when and how to restart. Being able to track each person’s
progress in the paperwork had a positive impact on staff motivation. This seems an easy thing to
strengthen, perhaps by the use of graphic methods that make improvement in outcome easily visible,
such as the average number of incontinent episodes per day. A trajectory summary might also serve
the purpose of making breaks in the programme visible, as a reminder for restarting.
Other barriers
The findings also illustrated more generic facilitators that were noteworthy, in particular the crucial role of
senior ward staff and the research nurse role in programme overseeing and co-ordination. Involvement
of physiotherapy and occupational therapy staff was seen as lacking, and more effort could be directed
to exploring their potential contribution. The integration of ward and research staff evolved differently to
cater for local circumstances and had a significant impact on the implementation of the SVP, and
potentially on differences in outcome between sites. The observation that employing relatively
inexperienced HCAs as ICONS nurses had little influence on ward staff is also an important point for
integration in the future trial.
Senior staff discussed the difficulty of ‘keeping a handle’ on the programme overall, and some attention
could be given to supporting the work of monitoring the SVP in the paperwork, both at an individual
person and ward level.
The importance of adequate staffing and the impact of workload was a perennial comment; monitoring
staffing levels and patient dependency should be a component of process evaluation. Given the
importance of visible improvement, perhaps making the reduction in workload more visible (e.g. fewer bed
changes, fewer buzzers) by ward audit might be useful.
Keeping new and bank staff trained and updated about the research programme also needs specific
attention, as does the lack of uptake of the online training resource. Training processes need revision to
ensure fit with working routines. The training given to staff in explaining the SVP needs to be checked
to avoid potential misunderstanding by people with stroke and relatives about the consequences of
involvement in the SVP on length of stay.
Summary of recommendations for the design and implementation of the
systematic voiding programme
Recommendations for the design and implementation of the SVP are shown in Table 113.
Design
The intervention was successful in changing perceptions about incontinence from an inevitable
consequence of stroke to a symptom amenable to intervention as part of rehabilitative activity. Future
implementation of the SVP needs to reinforce this focus on continence as a legitimate focus of
rehabilitation. A shift in thinking is also required to legitimate continence work with people with stroke
who may never achieve unassisted continence; for these people the aim should be ‘managing
incontinence’, i.e. ‘catching’ people before incontinent episodes.
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TABLE 113 Recommendations for the design and implementation of the SVP
Recommendation
Hypothesised mechanisms
Thinkinga Planningb Doingc Evaluatingd
Intervention design l Use of language around
‘managing incontinence’
l Focus on continence as part of
rehabilitative activity
l Revise inclusion guidelines
l Devise rules for stopping
programme
l Introduce a guide for
‘difficult’ patients
l Involve clinical staff in
document development
l Incorporate avoidance and
management of catheterisation
within the SVP
l Encourage BT (and transfer to BT
from PV)
l Introduce a combined intervention
(including PFMT)
l Balancing inclusion and promoting
continence with a focus on
managing incontinence
l Revised continence assessment and
3-day diary and link these to
patient plan
l Add rules for stopping programme
l Add protocols for avoidance and
management of catheterisation,
including ‘trial without catheter’
l Enable staff to see the
longitudinal trajectory
(through organisational
monitoring)
Implementation l Increased training in rehabilitation
l Targeting messages to the pathway
(more appropriate for rehabilitation/
community setting)
l Increased multidisciplinary working with
formalised reporting of continence
within a multidisciplinary context
l Target SVP to different types
of patients
l Support staff at the interface of
organisation and individualised
practice (through link nurse?)
l Provide education and underpinning
theory, including training of therapy
and nursing staff in PFMT
l Engagement of therapy staff in
combined intervention
l Screening reminders
l Extending from ‘routinised’
environment through additional/
external support
l ‘Link nurse’ working with HCAs
l Incorporate facilitation into link
nurse role
l Create a feedback loop
for staff and patients
l Facilitate organisational
monitoring (as part of
‘link nurse’ role)
l Set date for
weekly review
l Review distraction and
checking techniques
a The SVP changed thinking about UI away from a barrier to rehabilitation to a legitimate focus of planned, therapeutic activity.
b The SVP made a structure for UI care explicit, enhancing consistent, knowledge-based delivery.
c The SVP helped staff make the shift from an organisational approach to continence that was unsystematic yet routine and selective to one that promoted regularity, inclusion and
individualised management.
d The SVP and its interpretation increased visibility of process, trajectory and workload and enabled staff and patients to evaluate performance and outcome.
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Guidance about how the SVP should be used for certain groups of patients, for example those with long
standing continence problems or functional incontinence (e.g. inability to manipulate bottles), needs
adding to protocols. More specific guidance on minimising catheterisation on the stroke unit and
introducing a more systematic approach to TWOC is also required.
For people on the programme, strategies for encouraging participation of ‘difficult’ people, for example
those who found regular prompting irritating, need consideration. Further guidance is also required on
when to take people off all or part of the programme, for example if people have become continent or if
the programme is thought not to be working.
Linkages between SVP documentation need to be more explicit to enable understanding of how different
components inform each other, for example pattern of incontinence in the 3-day diary should be used in
decisions about the initial voiding interval. The continence assessment was widely regarded as too long to
use in routine practice; this and other documentation need revising in collaboration with ward staff and
linking with the training programme.
Training in pelvic floor muscle exercises (PFMEs) for physiotherapists and nursing staff, in particular
assessing whether or not people with stroke are able to exercise their pelvic floor muscles and whether
or not exercises are being performed correctly, needs to be considered.
Implementation
Methods of increasing uptake of training need consideration; given the low uptake of online training,
other approaches may be more fruitful, for example transferring online content into ward-based hard
copies or extending face-to-face training and incorporating this within mandatory training days.
Implementing the programme in an acute setting proved problematic; consideration needs to be given to
which elements of the SVP should be delivered in this context, for example the 3-day diary and continence
assessment, with conservative interventions starting in the rehabilitation phase and extending into
the community.
Sites where the intervention became well embedded tended to be those where there was strong
leadership from the research nurse in managing, co-ordinating and systematising the intervention. HCAs
were also instrumental in driving implementation in many sites. Future implementation could be led
and managed by a ‘link nurse’ (possibly continence specific), with designated time for the role, working
with and supporting HCAs within the ward team. Given the difficulties internal facilitators had in making
time for the role, facilitation activities (and dedicated time for these) could also be incorporated within
the link nurse role.
Embedding mechanisms, for example organisational monitoring of outcome over time, were not part of
the SVP but were instigated in sites where the intervention was well embedded by research nurses. These
provided a means of linking nursing input to patient outcome which served as a powerful driver in terms
of motivating staff to continue implementation. Future implementation needs to incorporate systematic
means of monitoring patient progress at an organisational level and feeding results back to staff. This role
could also fall within the remit of the link nurse.
Engaging the MDT in the SVP is essential and processes to facilitate this, for example formal reporting
within a multidisciplinary context, need incorporating into future implementation strategies.
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Estimates of the number of sites and participants required for a full-scale
cluster randomised trial to evaluate effectiveness
In our original application for funding, we provided the following sample size calculation for our main trial:
In an individually-randomised trial, detection of a minimally clinically important reduction of 10%
(from 70% [people expected to have UI at 6 weeks in the usual care group] to 60% [people expected
to have UI at 6 weeks in the intervention groups]) would be achieved with 80% power by a sample
size of 356 or 90% power by a sample size of 477 (based on a chi-square test using a 5% significance
level). This difference has been found in similar studies in the elderly [32,33]. Inflating this to
account for the design effect based on an a priori assumption of an intra-cluster correlation
coefficient of 0.02* for the presence/absence of incontinence, suggests that recruiting an average
of 125 participants to 30 clusters will achieve 80% power (an average of 200 people randomised
to 36 clusters would be required for 90% power). After Phases I and II, we will review our estimate
of the ICC and the prevalence of incontinence and revise our sample size estimate accordingly.
Should our a priori estimate of the ICC lead to an under-powering of the study, we shall review
the study design and consider including more clusters, possibly with a shorter recruitment period
(i.e. less patients).
*It is suggested (Campbell et al., 2000) that ICCs for patient outcome variables are generally between
0 and 0.05; we expect that the ICC for incontinence will be towards the lower end of this range after
adjustment for cluster-level factors.
Given the estimated ICC from our feasibility trial, there is no suggestion that the ICC of 0.02 used here
is anticonservative. We have suggested that a 12-week post-stroke outcome is more appropriate, given
the observed distribution of intervals between stroke and recruitment and the necessary duration of
intervention to potentially affect those recruited. We found that, in usual care, only approximately
20% (24/124) of participants reported being continent; given the broadening of our inclusion criteria
to include those catheterised at recruitment, we also suggest a somewhat smaller than 10% improvement
should now be considered minimally clinically important (e.g. 7%). This suggests that an OR of 1.48
or greater would be viewed as clinically important to detect, which is consistent with some of the ORs
observed in our study. Using a two-arm trial, with equal number of clusters randomised to each in a
parallel design:
l to detect an OR of this magnitude with 80% power, assuming an ICC of 0.02, would require
34 clusters, each with 126 participants
l if is deemed appropriate to assume a somewhat lower ICC, such as 0.0125, this sample size would
achieve slightly over 90% power, or to achieve 80% power the sample size could be reduced to 65 per
cluster, or the number of clusters reduced to 13 per arm.
Alternative designs should also be considered. A stepped-wedge design would potentially improve
efficiency by reducing the effect of the ICC by incorporating both between- and within-cluster estimation.
However, given our problems with gaining funding and approvals to start sites at comparable times in
this exploratory trial, improvements in governance processes and staggered starting times would appear
to be necessary for this to be practical. Given the assumptions inherent in stepped-wedge designs, the
practicality and corresponding limitations to evidence would bring into question their applicability for a
full-scale evaluation of a SVP in the NHS.
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Recommendations for future trial design
The exploratory trial has demonstrated it is feasible to conduct a full-scale cluster RCT. The future trial will
adopt this design with the following modifications.
Trial arms
l Include two trial arms only, intervention and usual care.
¢ Including a third trial arm may not be feasible given the number of sites required and is not
warranted given the difficulty identifying the distinctive contribution of supported implementation
in the exploratory trial.
Recruitment
l Screen all potential participants within 72 hours of admission to the stroke unit.
l Obtain consent as soon as possible, regardless of whether or not participants are medically stable and
without completion of the 3-day bladder diary.
¢ This will minimise imbalances at baseline caused by different recruitment procedures between
intervention and usual care, and ensure earlier recruitment.
Data collection
l Include reduction in incontinence episodes as a secondary outcome.
l Retain the I-QOL, but add guidance for people who regain continence to answer ‘not at all’ to
questions that do not apply.
l Seek an alternative to the LUSQ to identify type of incontinence.
l Consider approaches to increasing response rate at long-term follow-up, for example:
¢ use an interim data collection point at 26 weeks post stroke
¢ obtain outcome data in telephone interviews
¢ delay collection of resource use data until outcome data is obtained.
l Introduce more rigorous procedures for monitoring catheterisation (including ‘trial without catheter’).
Health economic component
l Record in-hospital episodes of incontinence and the resources required to respond to such episodes.
l Identify resources required to perform the programme through direct observation.
l Consider obtaining post-hospital resource use data by asking patients to maintain diaries or going
directly to providers of services.
l Identify resource use items more directly related to the programme and the effects of incontinence to
allow a more realistic conclusion to be drawn around cost-effectiveness.
DISCUSSION
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Appendix 1 MEDLINE final search
Date of search: 10 October 2008 (3048).
Search strategy
1. exp urinary incontinence/
2. Urination/ or urodynamics/
3. Urinary catheterization/
4. Urinary bladder, neurogenic/
5. Urinary bladder, overactive/
6. Urination disorders/
7. Toilet training/
8. Incontinence pads/
9. Dysuria/ or nocturia/
10. Toilet training/
11. Incontinence pads/
12. Pelvic floor/
13. toilet$.tw.
14. (incontinen$ or continen$).tw.
15. urodynamic$.tw.
16. ((bladder or detrusor or vesic$) adj5 (instability or stab$ or unstable or irritab$ or hyperreflexia or dys?
ynerg$ or dyskinesia or overactive$)).tw.
17. (void$ adj5 (prompt$ or diar$)).tw.
18. (urin$ adj2 leak$).tw.
19. dribbl$.tw.
20. diaper$.tw.
21. (bladder$ adj2 (neuropath$ or neurogen$ or neurolog$)).tw.
22. bodyworn$.tw.
23. underpad$.tw.
24. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or
20 or 21 or 22 or 23
25. ((pelvic or habit or bladder or toilet or sensory) adj5 (train$ or re?train$ or re?educat$ or drill)).tw.
26. (timed void$ or prompted void$).tw.
27. 25 or 26
28. exp behavior therapy/
29. (behav$ adj25 (therap$ or intervention$ or train$ or re?train$ or modif$)).tw.
30. exp cognitive therapy/
31. (cognit$ adj25 (therap$ or intervention$ or train$ or re?train$)).tw.
32. Combined Modality Therapy/
33. (skill$ adj5 (train$ or re?train$)).tw.
34. *Health promotion/
35. Health Education/ or Patient Education as Topic/
36. exp *Exercise/
37. Motor skills/
38. Group processes/
39. Psychotherapy, group/
40. Social support/
41. ((group or social) adj5 support).tw.
42. Self care/
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43. Cues/
44. Reminder Systems/
45. Tape recording/
46. exp motivation/
47. Feedback/
48. (monitor$ or feedback or goal$).tw.
49. 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or
45 or 46 or 47 or 48
50. 27 and 24
51. 49 and 24
52. 27 and 49
53. 52 or 50 or 51
54. Randomized Controlled Trials/
55. random allocation/
56. Controlled Clinical Trials/
57. control groups/
58. clinical trials/ or clinical trials, phase i/ or clinical trials, phase ii/ or clinical trials, phase iii/ or clinical
trials, phase iv/
59. Clinical Trials Data Monitoring Committees/
60. double-blind method/
61. single-blind method/
62. Placebos/
63. placebo effect/
64. cross-over studies/
65. Multicenter Studies/
66. Therapies, Investigational/
67. Drug Evaluation/
68. Research Design/
69. Program Evaluation/
70. evaluation studies/
71. randomized controlled trial.pt.
72. controlled clinical trial.pt.
73. clinical trial.pt.
74. multicenter study.pt.
75. evaluation studies.pt.
76. meta analysis.pt.
77. meta-analysis/
78. random$.tw.
79. (controlled adj5 (trial$ or stud$)).tw.
80. (clinical$ adj5 trial$).tw.
81. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
82. (surgical adj5 group$).tw.
83. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.
84. ((multicenter of multicentre or therapeutic) adj5 (trial$ or stud$)).tw.
85. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
86. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
87. (coin adj5 (flip or flipped or toss$)).tw.
88. latin square.tw.
89. versus.tw.
90. (cross-over or cross over or crossover).tw.
91. placebo$.tw.
92. sham.tw.
93. (assign$ or alternate or allocat$ or counterbalance$ or multiple baseline).tw.
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94. controls.tw.
95. (treatment$ adj6 order).tw.
96. (meta-analy$ or metaanaly$ or meta analy$ or systematic review or systematic overview).tw.
97. or/54-96
98. 53 and 97
99. exp epidemiologic studies/
100. Intervention studies/ or Feasibility studies/ or Pilot projects/
101. exp Controlled Clinical Trial/
102. Nursing evaluation research/
103. Evaluation studies/ or multicenter study/
104. Program development/
105. behavioral research/ or empirical research/
106. (determinant$ or factor$ or barrier$ or enabler$ or facilitator$ or predictor$ or characteristic$).tw.
107. Guideline adherence/ or exp "outcome and process assessment (health care"/ or exp program
evaluation/ or Guidelines as topic/ or Clinical Protocols/
108. Health plan implementation/
109. Organizational innovation/
110. Diffusion of innovation/
111. Patient compliance/
112. Patient satisfaction/
113. exp health behavior/
114. exp consumer satisfaction/
115. exp patient acceptance of health care/
116. Information dissemination/
117. 99 or 100 or 101 or 102 or 103 or 104 or 105 or 106 or 107 or 108 or 109 or 110 or 111 or 112 or
113 or 114 or 115 or 116
118. 53 and 117
119. exp Pregnancy/
120. 98 or 118
121. 120 not 119
122. Child/ or Adolescent/
123. Adult/
124. 122 not 123
125. 121 not 124
126. limit 125 to english language
127. exp *Prostatectomy/
128. 126 not 127
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Appendix 2 Identifying Continence OptioNs after
Stroke screening criteria
Inclusion criteria Guidance/details
Relevant to any form of incontinence (i.e. SUI, UUI or MUI),
except incontinence associated with prostate surgery or
incontinence as a consequence of childbirth
Studies with inclusion criteria within 12 months of surgery
or childbirth should be excluded
Intervention includes one of the core behavioural
interventions for UI, i.e. PFMT (BT/retraining, PV)
At the screening stage, include studies referring to HT,
scheduled or TV or toileting, even though these
interventions are excluded – because terminology is not
used consistently
Intervention includes more than one cognitive, behavioural
or psychosocial component
Cognitive interventions are those interventions which
attempt to influence the knowledge, thinking or attitudes of
the client, and can include things like education, or
motivation strategies
Behavioural interventions are non-physical interventions
designed to influence the behaviour of the client, for
example training
Psychosocial interventions are those interventions designed
to influence the feelings of the client towards the
intervention, for example acceptability, group delivery.
These last are not strictly the focus of the review but can be
a component of a complex or mixed intervention
Intervention is not combined with another physical
intervention, for example drugs, surgery, vaginal cones,
electrostimulation
NB: BIO can be a component of PFMT and can be included
if it is just used to teach PFMT. Some exercise to encourage
toileting mobility may also be acceptable as a component of
the overall intervention
Relating to adults Aged ≥ 18 years
Intervention is compared against no treatment/usual care,
or any other treatment, or a single behavioural intervention
Nurse delivery of a CBI can be included if compared against
usual care, for example GP care
Research designs
For the effectiveness review
l RCT or quasi-RCT of combined or mixed behavioural
interventions for UI
Include RCTs or quasi-RCTs of CBIs (i.e. more than one
behavioural method) or enhanced behavioural interventions
(a CBI plus a method of enhancing uptake/adherence,
e.g. reminder system)
For the narrative review
l Qualitative study of perceptions of behavioural
treatment for UI
This can be client or professional views of any
cognitive–behavioural, or psychosocial intervention for UI
l Observational study of factors influencing behavioural
treatment process or outcome
These are likely to be concerned with moderators of
treatment uptake or success. Trial data can also be used
l Evaluative study of a behavioural treatment for UI Include reports of the design, development or process
evaluation of any behavioural intervention (single or
combined). Do not include outcome evaluations if they are
just uncontrolled clinical trials
For citation searching
l Systematic reviews of behavioural interventions for UI
Exclude
l Case studies/series, information articles
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Appendix 3 Identifying Continence OptioNs after
Stroke review: filtration sheet (version 5)
NO
YES
Neither of theseRCT/Quasi RCT of a behavioural 
intervention for UI?
IMPLEMENTATION or 
EXPERIENCE of behavioural 
intervention for UI?
Exclude –
NOT BEH
If unsure: 
continue to 
screen and 
mark for 
author contact 
IS IT:
(Tick one) Number new:
Refs checked?
Exclude –
NOT RES
Relevant to the treatment of urinary symptoms including 
urgency/frequency?
NO
Exclude 
NOT UIYES
Relevant to adults (18+)?
Exclude 
NOT ADULT
Add to 2ndary refs database and retreive
ICONS REVIEW – FILTRATION SHEET (V5)
TITLE (1st
few words)
Reviewer 
initials
AUTHOR/ 
YEAR
RefMan
ID
Not 
sure
YES NO
Includes MORE THAN 
ONE cognitive, 
behavioural or psycho-
social component
YES
Information?
(keep info if useful)
Systematic review 
Process for secondary 
references
Primary research
Continue with screen
Exclude NOT 
DESIGN
Check for predictors and if 
no - Exclude – NOT COMPLEX
C) |Observational 
study of moderators 
of outcome
B) Qualitative 
research of 
client/staff views or 
experiences
A) formative/process 
evaluation
Does NOT include a major 
PHYSICAL component in the 
intervention
YES NO
Exclude -
CONFOUNDED
Other (specify)PVBTPFMT
Includes material related to one or more of the core 
behavioural interventions (BI) (tick which)
COMMENTS:
IS IT: (Tick one)
AND
INCLUDE AS 
IMPLEMENT?
Tests a METHOD OF 
DELIVERY of a 
behavioural 
intervention?
YES UNSUREUNSURE
UNSURE
NO NO
OR
INCLUDE 
AS TRIAL?
What are the additional 
components?
UV
MV
OCAdherenceO/C
SingleCombined
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Appendix 4 Identifying Continence OptioNs after
Stroke review: data abstraction form (version 2)
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Appendix 5 Identifying Continence OptioNs after
Stroke review: guide to data extraction
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Appendix 6 Table of included studies: review
of effectiveness
Aslan et al. 200871
Aim To determine the efficiency of BT and Kegel exercises for older women living in a rest home
Study details 2002–4. Quasi-randomised trial comparing behavioural training with a no treatment control group
Country and
participants
Country Turkey
Number of participants 64 participants, 33 received behavioural intervention, 31 in control group
Sample Women, aged ≥ 65 years, cognitively able and with sufficient functional
ability to participate, living in one rest home in Turkey, self-reporting UI or
urinary symptoms, and agreeing to participate
Inclusion criteria Incontinence (two or more episodes per month) or other urinary symptoms
(frequency, urgency, nocturia). 8 out of 64 women were continent but had
urinary symptoms
Exclusion criteria Chronic or neurological illness affecting daily life
Mean age (years) Treatment group= 78 (SD 4.8)
Control group= 79 (SD 5.3)
Type of incontinence SUI 40%; MUI 10%; UUI 42%; continent 8%
Severity of incontinence 52% had one or more UI episodes per day
Intervention Behavioural intervention BT, urge suppression techniques and Kegel exercises implemented by
individual visits from a nurse practitioner over 6–8 weeks
Comparison group(s) ‘Control group’ details NS
Outcomes Primary outcome Volume of UI: measured by 1-hour pad test
Secondary outcome(s) Pelvic floor muscle strength, QoL, urinary symptoms
Timing 8 weeks, 6-month follow-up
Notes Study quality Quasi-randomised: alternate allocation, concealment and blinding of
outcome assessment unclear, some incomplete outcome reporting, some
secondary outcome data not fully reported
Intervention quality Pelvic muscle contraction checked if participants were willing. Follow-up
visits checked performance and tailored intervention
NS, not stated.
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Bear et al. 199773
Aim To test the effectiveness of known behavioural UI techniques in a home setting with older rural women
Study details May–December 1993
Pilot study (for Dougherty et al. 200276) with random assignment to behavioural management or a control
group
Country and
participants
Country USA
Number of participants n= 24
Sample Older women, living independently in a rural area. Extensive outreach efforts
made to reach eligible women. Frail elders targeted but participants had few
functional limitations, and elder/carer dyads difficult to recruit
Inclusion criteria Women, aged ≥ 55 years, resident in the community, involuntary urine loss
twice a week or more, of 1 gm/day or more, any type of UI. People with
cognitive deficits not excluded, but required a caregiver to be willing to be
involved
Exclusion criteria Residual urine volume more than 75ml, urine infection, bladder or kidney
disease
Mean age (years) 68
Type of incontinence All
Severity of incontinence NS
Intervention Behavioural intervention BMC intervention, consisting of three sequenced phases: (1) self-monitoring;
(2) BT or PV; (3) pelvic muscle exercise. Intervention was individualised, so
not all participants completed all phases. Nurse delivery at home, over
24 weeks
Outcomes Comparison group(s) Control group received initial and final visit
Primary outcome NS
Secondary outcome(s) Urine loss: gms/day, volume, number of incontinent episodes per day
Timing 24 weeks
Notes Study quality Sequence generation and allocation concealment unclear, blinding unclear.
Numbers and general reasons for attrition are reported, with 50% loss to
follow-up from experimental group. Data for incontinence impact profile not
reported, and SDs for episodes and volume of urine loss not reported
Intervention quality It is not clear how many people received each phase of the intervention, or
how often they were visited
BMC, behavioural management for continence; NS, not stated.
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Burgio et al. 199833
Aim Comparison of the effectiveness of BIO-assisted behavioural treatment with both a standard drug
treatment (oxybutynin chloride) and a control condition for the treatment of UUI
Study details 1989–95 RCT, with three arms: behavioural treatment; drug treatment; and placebo control. Participants
stratified by type and severity of incontinence
Country and
participants
Country USA
Number of participants 197 participants: 65 behavioural intervention, 67 drug treatment, 65 placebo
control
Sample Volunteer sample, recruited via local adverts and professional referrals
Inclusion criteria Women, aged ≥ 55 years, community dwelling, with UUI incontinence
predominant (at least two accidents per week persisting for 3 months) and
urodynamic evidence of bladder dysfunction
Exclusion criteria Continual leakage, post-void residual urine > 200ml, uterine prolapse,
impaired mental status, medical contra-indications
Mean age (years) 67.7 (SD 7.5)
Type of incontinence UUI 48.7%; MUI/SUI+UUI 51.3%
Severity of incontinence Mild 18.3%; moderate 28.9%; severe 52.8%
Intervention Behavioural intervention BIO-assisted behavioural treatment implemented by nurse practitioners,
consisting of PFMT and urge strategies
Intervention included information provision, self-monitoring, external
monitoring, individualised tailoring of the intervention and external
motivation/reinforcement
Participants had four clinic visits at 2-week intervals. Anorectal BIO was used
on the first visit to teach correct pelvic muscle contraction, and repeated on
the third visit if necessary (26%). Urge strategies were taught on the second
visit. Home practice included three sets of 15 exercises every day, practised
in various positions, gradually increasing individualised duration of
contraction to 10 seconds
Comparison group(s) Drug treatment: oxybutinin dosage adjusted for the individual+ clinic
visits+ bladder diary
Placebo condition: clinic visits+ bladder diary
Outcomes Primary outcome % reduction in frequency of incontinent episodes, measured by bladder
diary
Secondary outcome(s) Perception of improvement and comfort, adverse events, satisfaction
Timing 2 weeks post treatment
Notes Study quality Adequate sequence generation, allocation concealment unclear, blinding of
outcome analysis and complete data for primary outcome. Attrition for
secondary outcomes unclear. All prespecified outcomes reported
Intervention quality Correct pelvic muscle contraction checked. Follow up visits checked
performance and tailored intervention to individual
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Dougherty et al. 200276
Aim To evaluate a BMC intervention to manage UI symptoms with older rural women in their homes
Study details RCT comparing BMC intervention against no treatment control
Country and
participants
Country USA
Number of participants 218 participants. Number at first follow-up: 78 BMC intervention; 69 control
group
Sample Women living in seven rural counties in Florida, recruitment method NS
Inclusion criteria Older women (aged ≥ 55 years), private residence in a rural area, urine loss
at least twice a week of 1 g per 24 hours or more, urine negative for
bacteria, experiencing symptoms of SUI, UUI or MUI incontinence
Exclusion criteria Bladder cancer or kidney disease, indwelling urinary catheter, residual urine
100 cc or more, caregiver needed but unavailable
Mean age (years) 67.9 (SD 8.2)
Type of incontinence 68% MUI; 16% SUI; 16% UUI
Severity of incontinence NS
Intervention Behavioural intervention BMC designed to structure the efforts of a nurse and a woman to
implement procedures to manage UI in the woman’s home, consisting of
three sequenced phases: (a) 2–4 weeks self-monitoring (for women assessed
against lifestyle criteria); (b) 6–8 weeks BT; and (c) 12 weeks pelvic muscle
exercise (if required)
Comparison group(s) No treatment control group
Outcomes Primary outcome Urine loss in grams over 24 hours
Secondary outcome(s) Frequency of incontinent episodes, subjective report of urine loss, micturition
frequency, voiding interval, subjective report of QoL, IIQ, goal achievement
Timing Post treatment 6 months; follow-up at 12, 18 and 24 months
Notes Study quality No details of allocation sequence and allocation concealment. Blinding of
primary outcome measure, but not secondary outcome measures. Attrition
reasons incomplete
Intervention quality No details of teaching methods or content
BMC, behavioural management for continence; NS, not stated.
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Kafri et al. 200781
Aim To compare the effectiveness of rehabilitation treatment with a standard drug treatment for urge UI in
women
Study details Parallel clinical trial with alternate allocation, comparing behavioural or drug treatment
Country and
participants
Country Israel
Number of participants 44 participants, number at first follow-up: 16 in behavioural training group;
21 in drug treatment group
Sample Women, attending an outpatient urogynaecologic clinic in Tel Aviv
Inclusion criteria Women, aged ≥ 18 years, diagnoses with UUI, who demonstrated an
overactive bladder in urodynamic testing
Exclusion criteria Residual urine greater than 100ml, urinary tract infection, previous
retropubic suspension surgery, urethral obstruction, cognitive or psychiatric
impairment or drug treatment for depression
Mean age (years) 55 (SD 9)
Type of incontinence UUI
Severity of incontinence NS
Intervention Behavioural intervention Educational programme teaching PFMT, urge suppression and lengthening
the interval between voiding, delivered to individuals in five meetings over
12 weeks by an experienced nurse. Participants maintained a urinary diary,
but it is unclear whether or not this was continuous or intermittent
Comparison group(s) Oxybutinin 5mg daily for 12 weeks, attending clinic for baseline and
post-treatment outcome measurements
Outcomes Primary outcome Frequency of void per day, and per night
Secondary outcome(s) Frequency of episodes of incontinence, adverse events, QoL (I-QOL)
Timing 3 months (post treatment), 6 months, 21 months
Notes Study quality No reports of blinding, incomplete outcome data
Intervention quality Author contacted for details of intervention protocol, but no further details
available
NS, not stated.
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Macaulay et al. 198787
Aim Comparison of psychotherapy, bladder drill and propantheline for detrusor instability or sensory urgency
Study details Randomised trial
Country and
participants
Country UK
Number of participants n= 50
Sample Women attending a urodynamic clinic who agreed to take part in a
treatment trial
Inclusion criteria Detrusor instability or sensory urgency
Exclusion criteria NS
Mean age NS
Type of incontinence Detrusor instability or sensory urgency
Severity of incontinence NS
Intervention Behavioural intervention BT+ PFMT: participants were seen by the unit nurse fortnightly for 3 months,
and again after 1 month (i.e. seven sessions)
Comparison group(s) Comparison group: brief eclectic psychotherapy 8–12 weekly sessions for
50 minutes. Control group: propantheline
Outcomes Primary outcome NS
Secondary outcome(s) Bladder capacity, first sensation, nocturia, urgency, incontinence, somatic
symptoms
Timing Post treatment= 12 weeks, 6 months
Notes Study quality No details of randomisation method or of allocation concealment. Blinding
NS. Numeric outcome data not reported
Intervention quality Intervention content not described in any detail
NS, not stated.
APPENDIX 6
NIHR Journals Library www.journalslibrary.nihr.ac.uk
404
McDowell et al. 199989
Aim To examine the short-term effectiveness of behavioural therapies in homebound older adults
Study details Randomised crossover trial comparing CBI against attention control
Country and
participants
Country USA
Number of participants n= 124 [data only reported for cognitively intact individuals (n= 105)]
Sample Older homebound adults living within the catchment area of two large
home health-care agencies
Inclusion criteria Individuals aged ≥ 60 years, homebound, who understand and speak
English, are willing to participate, and report at least two urinary accidents
per week, with incontinence persisting for at least 3 months
Exclusion criteria Severe pelvic prolapse, terminal illness, post void residual urine greater than
100ml, unable to toilet independently and with no caregiver willing and
able to assist, unable to provide satisfactory self-report bladder diary data
after three attempts
Mean age (years) 76.8 (SD 7.2)
Type of incontinence Any
Severity of incontinence Most participants (n= 76, 72.4%) had severe incontinence (10 or more
accidents/week)
Intervention Behavioural intervention PFMT+ electromyography BIO, with urge or stress strategies dependent
on the type of incontinence, and BT for people reporting frequency.
The programme could also include environmental and lifestyle advice
including restricting caffeine, timing fluid intake and advice/treatment for
lower limb oedema and constipation. The programme was delivered over
8 weeks by a nurse practitioner
Comparison group(s) The control group received visits from a nurse practitioner every 1–2 weeks
to provide social interaction, but no advice about continence was given and
participants were not asked to keep a continuous bladder diary
Outcomes Primary outcome Reduction in number of incontinent episodes per day
Secondary outcome(s) Adherence
Timing Post treatment (8 weeks), and 3, 6, 9 and 12 months post treatment
Notes Study quality Sequence generation and completeness of outcome reporting are adequate,
but the details of allocation concealment and blinding are not reported
Intervention quality PFMT BIO used and repeated if necessary, and advice given to maintain
practice after 8-week intervention ended. Weekly monitoring and feedback
provided
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McFall et al. 200090
Aim To assess a community-based small group behavioural intervention for UI in older women
Study details RCT with waitlist control group
Country and
participants
Country USA
Number of participants n= 145
Sample Women in four US states responding to a call for participation as part of
public health education
Inclusion criteria Women, aged ≥ 65 years, self-reporting UI for 3 months or more
Exclusion criteria Urological conditions such as prolapse or infection, raised blood glucose;
sensory, functional or disability problems; cognitive impairment
Mean age 74
Type of incontinence MUI
Severity of incontinence Mild
Intervention Behavioural intervention BT, PFMT and urge strategies, delivered over five sessions by trained
personnel in small group community settings
Comparison group(s) Waitlist control
Outcomes Primary outcome % reduction in UI episodes
Secondary outcome(s) UI symptoms, QoL, UI impact, satisfaction
Timing Post treatment (9 weeks), and 3 and 12 months post programme
Notes Study quality Methods of randomisation, allocation concealment and blinding are unclear.
Data are reported on 108 participants. No outcome data are reported for
QoL measures
Intervention quality No details of the content of the BT or PFMT programme, or of teaching
methods
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Subak et al. 2002100
Aim To evaluate the effect of a low-intensity behavioural therapy programme (BT) on UI in older women
Study details Randomised clinical trial comparing low-intensity behavioural intervention against no treatment control
Country and
participants
Country USA
Number of participants 152 participants, number at first follow-up: 66 (86%) behavioural
intervention, 57 (76%) control group
Sample Women aged ≥ 55 years with UI recruited at a northern California health
maintenance organisation
Inclusion criteria (1) Women, aged ≥ 55 years; (2) ambulatory, living independently in the
community; (3) functionally capable of independent toileting; (4) reporting at
least one UI episode weekly over the past 6 months
Exclusion criteria (1) Uncontrolled diabetes mellitus; (2) urinary tract infection; (3) history
suggestive of urinary obstruction or overflow, functional incontinence,
or urinary tract anomalies
Mean age (years) 69 (SD 7)
Type of incontinence SUI; UUI; MUI
Severity of incontinence Approximately 50% mild, 25% moderate, 25% severe
Intervention Behavioural intervention Educational programme, BT and PFMT, delivered by nurse educators over
six weekly sessions of 30 minutes, to groups of three to five women.
Participants maintained a daily urinary diary
Comparison group(s) Women received no instruction, but kept urinary diaries for 6 weeks,
then received the behavioural training over the next 6 weeks
Outcomes Primary outcome Number of incontinent episodes per week
Secondary outcome(s) Number of diurnal and nocturnal voids per week, subject report of how
much the behavioural therapy programme had helped them
Timing Post treatment at 6 weeks and 6 months
Notes Study quality Adequate sequence generation and allocation concealment. Blinding of
statistical analysts to group allocation for primary outcome, but unclear for
outcome data collection for subject report. Analysis only included women
completing 6 weeks. Subject report not presented, and outcomes not
reported separately at 6 months
Intervention quality PFMT by verbal and written instruction only. No details of adherence check,
although bladder diaries used as basis for weekly review
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Wyman et al. 199831
Aim To evaluate the relative efficacy of BT, pelvic muscle exercises with BIO-assisted instruction, and
combination therapy incorporating both interventions in women
Study details Randomised clinical trial with three arms
Country and
participants
Country USA
Number of participants 204 participants: 67 combination therapy, 68 BT, 69 PFMT
Sample Sample recruited via adverts and referrals to two centres in Southeastern
USA
Inclusion criteria Community-dwelling women, aged ≥ 45 years, who were ambulatory,
cognitively intact, able to toilet independently, reporting urine loss at least
once per week, and with urodynamic evidence of SUI or detrusor instability
Exclusion criteria Reversible causes of UI, uncontrolled metabolic conditions, residual urine
volume > 100ml, urinary tract infection, genitourinary fistula or indwelling
catheterisation, inability to correctly perform a pelvic muscle contraction
Mean age (years) 61 (SD 1)
Type of incontinence 71% SUI; 14% UUI; 15% MUI
Severity of incontinence No details given
Intervention Behavioural intervention Combination therapy included a structured programme of education
(audiovisual presentation with written and verbal instructions) delivered by
trained nurses over 12 weeks. The programme covered BT, PFMT, urge
suppression and stress leakage prevention techniques, and included
self-monitoring of voiding behaviour with daily treatment logs, compliance
assessment and positive reinforcement techniques. Clinic visits were
on weeks 1–6, with bi-weekly telephone follow-up and mailing of diaries
weeks 7–12
Comparison group(s) 1. BT, using the same programme structure
2. PFMT, using the same programme structure
Outcomes Primary outcome Number of incontinent episodes per week
Secondary outcome(s) QoL, perception of improvement, adherence, satisfaction
Timing 3 months (post treatment), and 6 months
Notes Study quality No details of randomisation or concealment method given, blinding not
undertaken for practical reasons, outcomes only reported for participants
with follow up data
Intervention quality Attention given to correct procedure, adherence, follow-up, self-monitoring
and positive reinforcement
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Table of included studies: review of barriers and enablers
Dingwall and McLafferty 200675
Aim To explore whether or not nurses working in older peoples’ or acute medical care settings promote urinary
continence in older people
Study details Qualitative: focus groups and one to one semistructured interviews
Country and
participants
Country UK, Scotland
Number of participants n= 21
Sample Convenience sample from two Scottish NHS regions of all registered
(Grades G to C), and non-registered nurses (HCAs and nursing auxiliaries)
from seven acute medical wards and one acute medical ward for older
people within one teaching hospital and 15 medical wards for older people
from three hospitals in another region, including acute, assessment,
rehabilitation and continuing care wards
Characteristics Seven charge nurses from continuing care, seven qualified staff from
continuing care and assessment, and three non-registered nurses from
medical care for older people participated in focus groups, with another
four charge nurses interviewed from acute areas. High number of staff from
one region were continence link nurses
Data
collection
Method Five focus groups arranged by area and grade of staff, and four individual
interviews to capture views from acute area where focus groups did not
happen
Questions/areas Questions developed from the literature review
Data analysis Method Transcripts were divided into comprehensible units. Features and patterns
identified and labelled as themes by one researcher. Emergent categories
and themes checked by a second researcher
Themes Assessment of urinary continence
Barriers to promoting continence
Nurses perceptions of patients’ attitudes towards UI
Interventions to promote urinary continence
Notes Study quality NHS regions chosen based on convenience, but all registered nurses
(Grades G to C) and non-registered nurses (HCAs and nursing auxiliaries)
invited to participate. Sample was approximately 3% of the population.
Questions used were based on previous research. Data analysis not described
in detail. Categories and themes checked by second researcher
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Lekan-Rutledge et al. 199886
Aim To investigate NAs perceptions of problems associated with the implementation of PV in a LTC nursing
facility
Study details Survey, questionnaire
Country and
participants
Country USA
Number of participants n= 141
Sample Convenience sample of 165 NAs from 33 LTC facilities in two US states,
who were participating in an educational workshop. Response rate 85%
Characteristics NS
Data
collection
Method Questionnaire. Primary objective of questionnaire was to assess the NAs’
perception of barriers to their ability to implement the PV programme
Questionnaire was given to NAs 6 weeks after PV programme was
implemented
Questionnaires distributed by staff development nurses and returned
anonymously
Questions/areas 11 multiple choice items assessing knowledge attitudes and skills related to
UI care. Questionnaire based on literature review and consultation with
nurse researchers and clinicians
Data analysis Method Descriptive statistics and correspondence analysis
Themes Barriers to implementing PV
Enablers to implementing PV
Notes Study quality Sampling clearly described, but sample characteristics unknown. No
information on content, or validity/reliability of data collection tool, or
analysis procedure. Impact of subgroups assessed by cluster analysis, and
percentage responses given
NS, not stated.
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Mather and Bakas 200277
Aim To describe NAs perceptions of the specific factors that promote or hinder their ability to promote urinary
continence in nursing home residents
Study details Qualitative, focus groups
Country and
participants
Country USA
Number of participants n= 31
Sample NAs currently employed at two LTC facilities (one privately owned with
188 beds, one non-profit with 240 beds) in a metropolitan region of the
Midwest USA were invited to participate, using flyers that listed focus group
dates and times
Characteristics 100% female, 77% African American, 68% on day shift, age range from
21 to 52 years, experience mean 5 years
Data
collection
Method 60-minute, semistructured focus groups with three to seven women.
Interview questions provided
Questions/areas Influences on decision to work in nursing home, experiences of helping
residents stay dry, things helpful in helping residents stay continent, things
which make it difficult to provide continence care, what advice would you
give to new NAs about this part of your work, what other experience have
you had that might affect your ideas about promoting continence care
Data analysis Method Individual transcripts were analysed for trends, patterns and recurring themes
using concept analysis
Themes Desire to promote continence/keep residents dry
Barriers to continence care
Promoters of continence care
Notes Study quality Convenience sample. Questions clearly described. Response rates per group
and total given. Description of analysis is not in-depth, and possible bias
not discussed, but some checking of internal consistency
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Resnick et al. 200698
Aim To consider the current beliefs of NAs and directors of nursing about UI management in nursing home
residents
Study details Qualitative, focus groups
Country and
participants
Country USA
Number of participants n= 38
Sample Directors of nursing (n= 11) recruited from the members of the
Maryland State Chapter of the National Association of Directors of
Nursing Administration by postal invitation. NAs (n= 27) recruited from
two urban not-for-profit nursing homes in Maryland, USA (flyers distributed)
Characteristics NS
Data
collection
Method Focus groups facilitated by two people, tape recorded and transcribed
Questions/areas Interview guide provided, covering causes of UI, treatment options available,
challenges and support when working with residents to maintain
continence, barriers and enablers to helping residents maintain continence
Data analysis Method Content analysis using ‘in vivo’ or ‘grounded’ coding, which used informants
own words to capture a particular idea. One nurse coded, one reviewed
codes. Coding was then reviewed by two external researchers with
experience in the topic. Description of findings to focus group participants
who confirmed the themes that were developed
Themes Resident influence on UI
Staff/family and other contributors to UI
System problems
Recommended solutions to UI faculty/staffing related:
l solutions to UI: resident level solutions
l solutions to UI: technology
Notes Study quality Some details of recruitment not clear, for example proportion and
representativeness of the NA and directors of nursing samples. Data
collection and analysis are in the main clearly described, but there is no
description of the representativeness of responses. Second researcher
reviewed and revised the codes, with external evaluator and respondent
feedback
NS, not stated.
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Remsburg et al. 199997
Aim To assess staff perceptions of overall effectiveness of a PV programme, and to compare staff perceptions
of continence outcomes with actual continence outcomes
Study details Survey, questionnaire
Country and
participants
Country USA
Number of participants n= 64
Sample NAs and qualified nursing staff on four units within one 255-bed geriatric
medical centre campus (one rehabilitation unit and three continuing care
units), which was running a 12-week PV programme implemented by the
NAs, with weekly feedback to nursing staff on compliance
Characteristics 64/88 nurses who participated in the PV intervention responded to the
survey (response rate 73%), including registered nurses (n= 12), licensed
practical nurses (n= 11) and NAs (n= 41)
Data
collection
Method Questionnaire circulated at the end of the 12-week PV programme to all
nursing staff on units that had been involved
Questions/areas Questions were:
Overall, the residents on your unit who participated in the programme were
better/no change/worse
Overall, the staff on your unit completed the toileting most of the time
(80–100%), some of the time (50–79%), occasionally (< 50%), do not know
Do you think the residents who are drier are happier? Yes/no
Do you think that the programme should be continued? Yes/no
Rating of residents response to the PV programme (better/worse, no
difference, do not know)
Open response option
NAs completed self-monitoring forms to document the number+ result of
PVs, translated into a weekly compliance rate and dryness rate by research
staff
Data analysis Method Descriptive statistics
Themes Staff perceptions of the effectiveness of PV
Staff reasons why the programme should not be continued
Notes Study quality The sampling was clear with a high response rate to survey. No report of
testing data collection. Data analysis did not clearly report response rates
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Johnson et al. 200180
Aim To describe and compare preferences for different UI treatments in LTC from groups likely to serve as
proxy decision-makers for LTC residents, i.e. residents, staff, family
Study details Descriptive comparative study, mailed survey
Country and
participants
Country USA
Number of participants n= 171/403 family members
n= 66 nurses
n= 70 volunteer residents, plus nine cognitively intact nursing home
residents
Sample Family members of residents with UI in four LTC facilities
Licensed practical and registered nurses in the same four LTC facilities
Residential care residents were recruited from a different facility by putting a
table inviting people to volunteer in the dining room. Several cognitively
intact nursing residents were also approached from the four facilities
Characteristics Residents were average age of 87 years, 80% female and most were
continent
Data
collection
Method Tool tested with focus group of eight family members. Survey mailed out,
with reminder after 2 weeks. Staff at the four facilities were interviewed in
groups during nursing in-services. A small proportion were interviewed
individually. Trained research assistants administered the survey, mostly by
individual interview but some groups of two to five residents
Questions/areas Tool to elicit choice using hypothetical scenarios based on a balanced
description of the advantages and disadvantages of five potential UI
treatments: catheters, PV, nappies, electrical stimulation, medications.
Seven questions, pairing two of the five possible UI treatments. Measured
on a graphic rating scale with 11 points anchored at 0 (do not know or
uncertain). 5= definitely would prefer this treatment, 3= probably would
prefer this treatment. Open question for qualitative response
Data analysis Method Qualitative responses were categorised by inductive content analysis,
i.e. post hoc, data driven
Themes 1. Nappies vs. PV
2. Criteria of older adults
3. Criteria of nurses
4. Most frequent criteria overall
5. Ideal criteria
6. Negative comment
Notes Study quality There is adequate explanation of the targeted sample and the quantitative
data collection in the survey. The final sample is not detailed, analysis of
qualitative data are less clearly explained. No reference to testing the
robustness of the findings/analysis
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Milne and Moore 200693
Aim To enhance understanding of self-care strategies individuals employ, the perceived benefits of these
strategies, the factors that influence their self-care choices, and the factors that impede or facilitate
maintenance of behavioural therapies
Study details 2002. Qualitative descriptive study, using individual and focus group interviews
Country and
participants
Country Canada
Number of participants n= 38
Sample Advertising in health clinics, newspapers and womens’ health educational
sessions (n= 14), and purposive sampling from three local clinics specialising
in the treatment of UI (n= 300). Participants assigned to individual or focus
group interviews based on the order of their phone call to researcher. First
15 interviewed individually; subsequent callers (n= 23) invited to attend
group interviews. Inclusion criteria were (a) community-dwelling adults aged
≥ 18 years, (b) history of UI, (c) independent in ADLs, (d) able to provide
informed consent in English, (e) able to articulate self-care strategies they
had initiated. Sample includes people continent at the time of interview but
with experience of UI
Characteristics 33 women, 5 men. Mean age 65 (range 24–86) years, 14/38 had sought
help from the same physiotherapist in private practice; 2/38 recently
undergone surgery and were continent; 3 had had surgery; 6/38 had tried
medication
Data
collection
Method 15 individual interviews and 3 focus group interviews. Interviews were
conducted in participants home, and taped. Notes taken were validated with
respondent. Focus groups were held at a University, and three individuals
who knew each other met at home
Questions/areas Topic guide: self-care strategies for UI, factors participants believed had
impacted self-care choices
Data analysis Method Content analysis, preliminary coding of broad substantive category of
content (e.g. psychosocial issues, help-seeking) for each unit of analysis.
Categories then re-examined for patterns
Codes/categories reviewed with another researcher. Third level of analysis:
links or threads existing within/between categories
Themes Dietary modification, BT barriers and facilitators, PFME barriers and
facilitators
Notes Study quality Participants recruited through advertising in health clinics and local
newspapers, followed by purposive sampling of physiotherapy clients.
Sample selection, and methods of data collection and analysis are
adequately explained
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Hay-Smith et al. 200779
Aim To seek the women’s experiences of PFMT, exploring the women’s understandings of the exercises and
the way they exercised, thereby providing insights for interpreting the trial findings
Study details 2001. Qualitative study with women who had participated in a trial of PFMT
Country and
participants
Country New Zealand
Number of participants n= 20
Sample Purposive sampling of women participating in an trial of PFMT, to select
women from both intervention groups (two different types of muscle
exercise), with a range of treatment outcomes, ages, referral sources and
date of trial entry
Characteristics Women were from one city in New Zealand. Three-quarters had
self-referred, but two-thirds of women in the trial had been referred from
a health-care professional. Women were English speaking and willing to
be involved. Mean age 51 years (SD 14). All had SUI
Data
collection
Method Respondents were interviewed between 1 and 16 months after trial
completion by first author. Respondent chose interview place, interviews
lasted 30–90 minutes
Questions/areas Prompt sheet used: content of the PFMT programme used during and after
the trial, adaptations to the recommended training programme, incentives
and disincentives to training, knowledge and beliefs about PFMT
Data analysis Method Descriptive content analysis, blocks of text coded and grouped into
categories. Categories grouped into themes. Theme development was based
on similarities (consistency and strength of data across interviews), and
differences (i.e. diversity and breadth) in the blocks of text and categories of
meaning. Independent researcher (KR) checked the validity of the identified
categories and themes
Themes 1. It’s my fault, isn’t it?
2. The silent, private exercise
3. Gaining control
4. Establishing the habit
5. Sustaining the habit
6. Doing enough of what suits me
Notes Study quality Methods of sampling, data collection and analysis are clear, although the
spread and distribution of responses is not presented. An independent
researcher was used to verify analysis, no description of method is given.
Researchers may have been involved in both trial management and
interviewing
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O’Dell et al. 200894
Aim To increase understanding of the views of frail, older women in residential care about their QoL; how their
pelvic floor dysfunction influenced their QoL and their self-perceived needs and preferences for pelvic floor
dysfunction care
Study details Qualitative study, interviews
Country and
participants
Country USA
Number of participants n= 25
Sample Study participants were recruited from assisted living and LTC facilities in one
US state. Facilities were purposefully selected for diversity in setting, size,
organisation (single or multiple care levels) and location (urban/rural). In
assisted living facilities recruitment was by flyers through in house mail.
In LTC facilities, staff asked potential participants. Inclusion criteria were
current signs or symptoms of urinary or faecal dysfunction or vaginal
prolapse, minimum age 65 years, conversant in English, cognitively intact.
People were excluded if declined audiotaping, or were severely hearing or
speech impaired
Characteristics Pelvic floor dysfunctions include problems with urination, defaecation or
pelvic organ prolapse
23/25 had UI, 13/25 had other problems. All respondents were female.
Mean age of people in assisted living facilities 87 (range 73–97) years; and in
LTC, mean age 81 (range 65–89) years
Data
collection
Method Semistructured interviews, taped
Questions/areas Questions for interview included: how does pelvic floor dysfunction affect
your life? Are there things you would like to do that you cannot because of
your pelvic floor dysfunction? Have you sought care for your pelvic problems
before? What would you want for any treatment? What change would you
want to see that would make the effort worth it?
Data analysis Method Coding of descriptive categories, ‘searching for representation of participants
views’
Peer review with geriatrician, urogynecologist and qualitative researcher.
Clarity and validity of interpretation and analysis checked with three willing
participants
Themes 1. Impact of pelvic floor dysfunction (aims of women)
2. Making do: you really do not have much choice
3. Preferences for care: I’d really have to think about it
Notes Study quality Purposive sampling used to increase diversity of settings and type of pelvic
floor dysfunction. Description of sampling, data collection and testing for
robustness were adequate, description of analysis method lacked detail.
Clarity and validity of interpretation and analysis reviewed by three
participants
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MacInnes 200892
Aim To understand why some women with SUI do not complete their therapy, and to make recommendations
to improve treatment rates
Study details Qualitative, telephone interviews
Country and
participants
Country UK, Scotland
Number of participants n= 12
Sample Convenience sample of women with SUI aged ≥ 16 years who had attended
a nurse-led continence promotion clinic but not completed the SUI pathway
(i.e. missed two consecutive follow-up appointments), over a 6-month
period. SUI pathway based on conservative treatment, progressing to the
prescription of duloxetine. Informed consent was prospective – at first clinic
visit, and they were then included if they later dropped out. Women
were excluded if they had predominant symptoms of another kind of
incontinence; learning disability or cognitive impairment, or had been
treated by the researcher
Characteristics 11/12 white British. Mean age 51.8 years (SD 11.6). All had SUI
Data
collection
Method Telephone interviews, using topic guide
Questions/areas NS
Data analysis Method Results were compared and checked for emerging themes
Themes Perceptions and satisfaction with the pathway
Main reasons for failing to complete therapy
Notes Study quality It is unclear what proportion the 12 participants are of the total number of
women who dropped out, and there are no details of non-responders.
Data collection was by telephone interview. No description of data collection
topic guide. The analysis method is not described. No description of
validating findings
NS, not stated.
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Kincade et al. 199983
Aim To explore why patients who have presented for treatment for UI withdrew from a behavioural
programme, by determining their perceptions of causes of UI, beliefs about UI treatments and their
effectiveness, and stated reasons for failure to complete the programme
Study details Qualitative, interviews
Country and
participants
Country USA
Number of participants n= 25
Sample People who did not complete a programme of behavioural treatment were
contacted until 10 were found who agreed to be interviewed
Characteristics Respondents were all white, all female, mean age 68–8 (range 48–85) years.
Those who agreed to be interviewed had been incontinent for longer, with
slightly higher educational attainment than people who withdrew from the
programme but did not agree to be interviewed
Data
collection
Method Interviews conducted by trained interviewer not involved in the care at the
clinic
Questions/areas Semistructured interview guide used including patients definitions of UI and
the ways that they are incontinent, their knowledge and beliefs about the
causes, symptoms and treatments of incontinence, their perceptions of their
health-care providers attitudes towards UI, their reasons for not completing
treatment at the continence clinical, the behaviours and procedures they use
to control or accommodate UI and the social or interpersonal aspects of UI
Data analysis Method NS
Themes Treatments to address UI
Reasons for discontinuing treatment
Notes Study quality Sampling is clear, except for reasons for non-response. The data collected is
explained, details of method of collection are less clear. No details given of
analysis method, testing for robustness of analysis, or of methods of
validating findings
NS, not stated.
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Table of included studies: review of feasibility
Perrin et al. 200596
Aim To determine the feasibility of using physical therapies to treat UI in older women
Study details 2002. Feasibility study
Country and
participants
Country Canada
Number of participants n= 10
Sample Women aged ≥ 75 years, with UI, recruited from an outpatient urology clinic
and waiting list for incontinence surgery
Characteristics Mean age 77.3 years (SD 2.9), all female. Four SUI; two UUI; four MUI
Intervention Details Six treatments at a clinic over 6–9 weeks consisting of BT and PFMT with
BIO, with a home exercise programme
Data
collection
Method Exercise journal in the form of a calendar in which participants marked an
‘X’ each time exercises were performed
Questions/areas Data were collected on participation rates, treatment adherence, recording
adherence, dropout/follow-up and long-term sustainability rates
Data analysis Method Compliance was reviewed by calculating the proportion of women reporting
execution of the prescribed exercises, completion of the diary and pad test,
and attendance at sessions
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Table of included studies: review of moderators of adherence
and treatment outcome
Alewijnse et al. 200169
Aim To elucidate the relative importance of determinants of adherence to PFME therapy among women
Study details 1995 and 1998. Cross-sectional survey, data obtained as a pretest of an RCT of a behavioural intervention
Country and
participants
Country Netherlands
Number of participants n= 129
Sample Women recruited from 23 GP practice registers in the Netherlands
Inclusion criteria Risk factor for UI, self-reported UI
Exclusion criteria Neurological conditions, venereal disease, vaginal infection, women using
medication for UI or that influences UI, women pregnant or within 3 months
of delivery, operated on for UI condition, physical impairment making PFME
impossible, unable to fill out questionnaires
Mean age (years) 55.3 (SD 10.8)
Type of incontinence 39% SUI; 49% MUI; 12% UUI
Severity of incontinence 21% mild (max one episode per week), 42% moderate (two to seven
episodes per week), 37% severe (several times a day)
Basis for
choice of
predictors
Theory Attitude–social influence self-efficacy theory
Literature Extensive literature search for determinants of intention to adhere to PFME
therapy+ interviews/focus group with women with and without PFME
experience, and one focus group with physiotherapists specialising in PFME
therapy
Outcomes Independent variables
(predictors)
Attitude (pros, cons); social influences (norms, modelling, support, pressure);
self-efficacy (expectations); incontinence frequency, duration; type of UI;
subjective severity (I-QOL, IIQ); self-esteem; body esteem; history of sexual
abuse; subjective general health; morbidity; use of medication; use of
health-care resources; social desirability; sociodemographic variables
Dependent variables Intention to adhere
Notes Study quality Predictor selection was based on a theoretical model, and in the main,
categorisation and measurement was clearly described. Outcome and
predictors based on self-report. Outcome derived without methodological
rigour within this study so psychometric properties are unclear. Some scales
were found to have poor validity or reliability, i.e. attitude, social desirability,
body esteem. Ordering of questioning unclear so difficult to assess potential
for different forms of information bias. Poor methodology for selection of
confounders, failing to provide a clear assessment of independent effect of
self-efficacy variables. Rare predictor variables were excluded from analysis,
and the sample included at least 10 cases with the lesser outcome for each
predictor variable in the multivariate analysis, but not the univariate analysis
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Alewijnse et al. 200370
Aim To reveal predictors of long-term adherence among women with UI involved in PFME therapy
Study details 1995 and 1998. Longitudinal prospective study in which participants were exposed to either PFME therapy
alone or PFME therapy supplemented with health education self help guide
Country and
participants
Country Netherlands
Number of participants n= 129
Sample Women recruited from 23 GP practice registers
Inclusion criteria Risk factor for UI, self-report UI
Exclusion criteria Neurological conditions, venereal disease, vaginal infection, women using
medication for UI or that influences UI, women pregnant or within 3 months
of delivery, operated on for UI condition, physical impairment making PFME
impossible, unable to fill out questionnaires
Mean age (years) 55.6 (SD 10.9)
Type of incontinence 37% SUI; 31% MUI; 9% UUI; 23% missing diagnosis
Severity of incontinence Mean 24.5 (SD 25) wet episodes per week
Basis for
choice of
predictors
Theory Attitude–social influence self-efficacy theory
Literature Extensive literature search for determinants of intention to adhere to PFME
therapy+ interviews/focus group with women with and without PFME
experience, and one focus group with physiotherapists specialising in
PFME therapy
Outcomes Independent variables
(predictors)
Intention to adhere; post-test adherence; attitude (pros, cons); social
influences (norms, modelling, support, pressure); self-efficacy (expectations);
incontinence frequency, duration; type of UI; subjective severity (I-QOL, IIQ);
self-esteem; body esteem; sexual experiences; sex education; subjective
general health; social desirability; sociodemographic variables; intervention
(self-help guide or not)
Dependent variables
(outcomes)
Adherence (7-day diary, questionnaire)
Notes Study quality Predictor selection was based on a theoretical model, and in the main,
categorisation and measurement was clearly described, although there is
lack of clarity in definition of the outcome. Some measurement scales were
found to have poor validity or reliability, i.e. attitude, social desirability, body
esteem. Rare predictor variables were excluded from analysis, and the
sample included at least 10 cases with the lesser outcome for each predictor
variable condition included. Exclusion of large numbers of the original
sample for various reasons, including data-driven reasons (outliers) limits the
interpretation, particularly of any non-significant variables
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Burgio et al. 200374
Aim To identify predictors of outcome of a multicomponent behavioural training programme for UUI and SUI
in community-dwelling women
Study details Secondary analysis of data from three randomised clinical trials of behavioural interventions for UI
Country and
participants
Country USA
Number of participants n= 258
Sample Community-dwelling women recruited from the community and by
professional referral
Inclusion criteria Average of at least two UI episodes per week and received behavioural
treatment for persistent UI
Exclusion criteria Continual leakage, elevated post-void residual urine, uterine prolapse, heart
failure, impaired mental status
Mean age (years) 64
Type of incontinence 23% SUI; 76% UUI
Severity of incontinence Approximately 19% mild (five or less episodes per week), 29% moderate
(5–10 episodes per week), 52% severe (more than 10 episodes per week)
Basis for choice of predictors Variables thought to have potential for influencing the outcome of
behavioural treatment
Outcomes Independent variables
(predictors)
Demographic characteristics; type, frequency and volume of incontinence;
duration of UI; use of garment protection; previous evaluation and
treatment; frequency of urination; impact of UI; medical history; medications;
obstetric history; BMI; pelvic examination; urodynamic parameters; mental
status; psychological distress; self-efficacy; mobility
Dependent variables
(outcomes)
Cure (100% reduction in UI episodes as defined by bladder diary)
Improvement (75% of more reduction in UI episodes, as defined by bladder
diary)
Notes Study quality The selection of predictors was based on what was thought likely to act as
predictors of outcome of behavioural training. No details of dropouts from
trials. Unclear as to validity and reliability of predictor variables, with
exception of details provided for use of bladder diaries. Outcome variable
was self-report and therefore not collected blind to predictor variable
collection. Analysis was not completed on variables with too few
respondents, and was restricted to at least 10 cases for each predictor
variable in the multivariate analysis, but not the univariate analysis
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McDowell et al. 199989
Aim To identify characteristics of short-term responders and non-responders in a trial of behavioural therapies
for UI in homebound older adults
Study details Observational study within a prospective controlled clinical trial with cross-over design and two arms
(cognitively intact and cognitively impaired participants). Within each arm, participants were randomised to
a control or treatment group. Only results for cognitively intact participants are included
Country and
participants
Country USA
Number of participants n= 105
Sample Individuals with UI identified by nurses in two large health organisations
Inclusion criteria Aged 60 years or older, homebound, report at least two urinary accidents
per week, UI persisting at least 3 months
Exclusion criteria MMSE scores of less than 24, prolapse, terminal illness, elevated post-void
residual urine, unable to toilet independently and with no caregiver available
and willing to assist, fewer that two urinary accidents per week recorded in
diary, unable to provide satisfactory self report bladder diary data
Mean age (years) 76.8 (SD 7.2)
Type of incontinence All
Severity of incontinence NS
Basis for choice of predictors NS
Outcomes Independent variables
(predictors)
Sociodemographics; social influences; self-care ability; general health;
cognitive ability; previous treatment; type, duration and severity of UI
Dependent variables
(outcomes)
% reduction in number of UI episodes, treatment responder vs.
non-responder
Notes Study quality Data sources and measurement appear good, although predictor response
categories are unclear in places. It is also not clear exactly which variables
were considered for univariate models and subsequently multivariate models.
The sample does not include enough cases for the number of predictor
variables tested. Key prognostic variables (severity of UI, toileting skills,
cognitive ability) are not included in final model. Independence of chosen
predictors therefore somewhat unclear relative to these variables
NS, not stated.
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Oldenburg and Millard 198695
Aim Examination of the relationship between a number of clinical, demographic, social and psychological
factors, and outcome immediately following treatment and at 18 months follow-up
Study details Clinical trial of a behavioural treatment programme
Country and
participants
Country Australia
Number of participants n= 53
Sample Consecutive attenders of one clinic who entered a treatment programme
consisting of BT with or without BIO techniques
Inclusion criteria Female, suffering from chronic excessive frequency and urgency of
micturition, and UI without any definitive organic basis
Exclusion criteria None stated
Mean age (years) 43 (range 18–77)
Type of incontinence NS, but may be predominantly urge UI (see discussion)
Severity of incontinence NS
Basis for choice of predictors None stated, other than ‘factors thought likely to be predictive or either
immediate or long-term treatment outcome’
Outcomes Independent variables
(predictors)
Severity/degree of UI; psychological problems; previous treatment; duration
of UI; perceptions of control; perceptions of seriousness; adherence
Dependent variables
(outcomes)
1. Therapist rating of degree of symptom improvement post treatment
2. Patient rating of degree of symptom improvement at 18 months
3. Urinary symptoms of frequency, urgency and incontinence totalled to
form a Bladder Symptom Score at 18 months
Notes Study quality Lack of clarity in definition of and justification for predictors. Lack of stated
validity of both predictors and outcome. Invalid use of multiple linear
regression in analysis of outcome. Lack of power so non-significant variables
not necessarily unimportant
NS, not stated.
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Subak et al. 2002100
Aim To identify moderators of treatment outcome of a CBI in older women
Study details Secondary analysis of RCT
Country and
participants
Country USA
Number of participants n= 152
Sample Women, recruited from a health maintenance organisation, referred by
health professionals
Inclusion criteria Female, aged ≥ 55 years, living independently in the community, functionally
capable of independent toileting, and reporting at least one episode of UI
weekly in the last 6 months
Exclusion criteria Uncontrolled diabetes mellitus, urinary tract infection, history suggestive of
urinary obstruction, overflow or functional incontinence, or urinary tract
abnormalities
Mean age (years) 69
Type of incontinence 24% SUI; 38% UUI; 37% MUI
Severity of incontinence Approximately 50% mild (one to seven episodes per week); 25% moderate
(8–15 episodes per week); 25% severe (15 or more episodes per week)
Basis for choice of predictors None stated
Outcomes Independent variables
(predictors)
Severity of UI, type of UI
Dependent variables
(outcomes)
Number of UI episodes per week
Notes Study quality Differential between-group dropout is a minor concern. Reported findings
limited (no estimates, precision, etc., or p-values for tests of effect
modification)
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Tadic et al. 2007102
Aim To determine whether or not prior depression or current depressive symptoms affect response to PFMT
therapy
Study details Secondary analysis of RCT
Country and
participants
Country USA
Number of participants n= 42
Sample Participants recruited from the community through local adverts
Inclusion criteria Functionally independent, community-dwelling women aged ≥ 60 years with
at least two UUI episodes per week for at least 3 months, despite correction
of potentially reversible causes. UI had to be pure or predominantly urge
according to history and voiding diary
Exclusion criteria Women with significant cognitive impairment, i.e. MMSE ≤ 24, history of
bladder/urological conditions, spinal cord lesions or multiple sclerosis,
expected medication change or medically unstable
Mean age (years) 73.2 (SD 8.1)
Type of incontinence 100% urge-predominant
Severity of incontinence Mean 12.9 (SD 7.4) episodes of UI over 3 days
Basis for choice of predictors Hypothesis that the psychological burden of UUI is greater in older women,
so they may respond better to therapy
Outcomes Independent variables
(predictors)
Psychological burden (Urge Impact Scale UUI); current depression status
(Mental Component Subscale)
Dependent variables
(outcomes)
UUI frequency
Notes Study quality The analysis does not seem to include severity of incontinence as a covariate.
Measures of current and previous depression have acknowledged limitations,
and assessor blinding is NS. The magnitude of the effects and the
corresponding strength of evidence for the chosen confounders is not
presented, nor is the rationale for their choice. No estimates of precision
given
NS, not stated.
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Wyman et al. 199831
Aim To examine the relative efficacy of three forms of behavioural intervention: (1) BT; (2) pelvic muscle
exercises with BIO-assisted instruction; and (3) combination therapy incorporating both interventions
Study details Subgroup analysis of RCT results
Country and
participants
Country USA
Number of participants n= 204
Sample Participants recruited from two academic health science centres. Recruitment
sources included newspaper articles and advertisements (41%), investigators
practices (17%), other health-care provider referral (19%), and miscellaneous
sources (23%)
Inclusion criteria Community-dwelling women aged ≥ 45 years who were ambulatory,
mentally intact (MMSE score > 23), able to perform toileting independently,
reported urine loss at least once per week, and had urodynamic evidence of
genuine stress incontinence, detrusor instability or both
Exclusion criteria Reversible causes of UI, uncontrolled metabolic conditions, elevated residual
urine volume, urinary tract infection, genitourinary fistula or indwelling
catheterisation, and inability to correctly perform a pelvic muscle contraction
on digital examination
Mean age (years) 61 (SD 10)
Type of incontinence 71% SUI; 15% MUI; 14% UUI
Severity of incontinence NS
Basis for choice of predictors None stated: model included terms for stratification variables: urodynamic
categorisation, baseline incontinence severity (+ treatment site)+ treatment
group and baseline value of outcome variable
Outcomes Independent variables
(predictors)
Type of incontinence, severity of incontinence
Dependent variables
(outcomes)
Number of weekly UI episodes, pad weight, symptom impact (IIQ), symptom
distress (UDI)
Notes Study quality All outcomes self-reported by patients. Results were analysed for the two
variables most likely to act as predictors of outcome. Variable conditions
were specified and assessors would have been blind to treatment outcome
at the time of data collection. The sample was of a sufficient size for the
number of variables and variable conditions included in the analysis, and
follow-up was over 80% at both time points
NS, not stated.
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Appendix 7 Table of excluded studies
Author/date Reason for exclusion
Studies of effectiveness
Berghmans 2002 UI was not included as an outcome measure
Brown 2007; Yap 2006 UI was not included as an outcome measure
Fonda 1994, 1995 Intervention predominantly combined BT+ PFMT, but also included medication review
and prescription if necessary
Kincade 2005, 2007 Randomisation was in two stages, initially to self-monitoring vs. waitlist, and subsequently
to different versions of a single behavioural intervention
Lagro-Janssen 1992, 1998 Only MUI group got combined intervention, no separate outcome data available
Lee 2005 No comparison group data
O’Brien 1991, 1995, 1996 Only people with UUI got combined intervention, no separate outcome data available
Song 2006 UI was not included as an outcome measure
Studies of barriers and enablers
Diokno and Yuhico 1995 Only provides data relating to frequencies of choice, no data relating to barriers and
enablers of choice
St John 2006 Not related to behavioural treatment
Simons 2005 Collects data to test reliability of different response formats, no data relating to barriers
and enablers of choice
Levy Storms 2007 Collects data to test reliability of different response formats, no data relating to barriers
and enablers of choice
McVean 2003 Confounded by medical condition, therefore cannot attribute data to UI
Tannenbaum 2008 Collects data to compare client and professional ratings, no data relating to barriers and
enablers of choice
Studies of feasibility
Pfister and Dougherty 1994 Feasibility of a single intervention
Ouslander 2005 Feasibility of a mixed intervention
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Appendix 8 3-day bladder diary
 
 
Patient 3 day Diary 
 
 
 
Name: -----------------
-- 
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How to fill in the 
diary 
Please fill in this diary over 3 
consecutive days.   
 
Whenever you pass urine, please 
tick the box and mark if you had any 
leakage. Put S (Small), M (Medium) 
or L (Large) depending on how 
much leakage you had 
 
Whenever you have a drink, please 
mark what you had to drink and 
how much. If possible try to use the 
same type of cup so you know the 
amount. 
e.g. cup/glass or beaker = 200ml 
 
Example 
 Time 
Passed 
urine  
Leaked  
 
Yes/No 
Small 
Moderate  
Large 
Reason 
for 
leakage 
Drink 
type 
Amount 
drank(mls) 
8-9am 
 
 
7.45 
 
yes 
 
S 
Struggled 
with 
clothes 
  
9-10am 
 
   
 
 tea 200mls 
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10-12 
 
 
11 
 
yes 
 
L 
Could not 
stop it 
  
 Time 
passed 
urine  
Leaked  
 
Yes/No 
Small 
Moderate  
Large 
Reason 
for 
leakage 
Drink 
type 
Amount 
Drank 
7-8am       
8-9am       
9-10am       
10-11am       
11-12am       
12-1pm       
1-2pm       
2-3pm 
 
      
3-4pm       
4-5pm  
 
     
5-6pm       
6-7pm       
7-8pm  
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Date: 
Date: 
 Time 
passed 
urine  
Leaked  
 
Yes/No 
Small 
Moderate  
Large 
Reason 
for 
leakage 
Drink 
type 
Amount 
Drank 
7-8am       
8-9am       
9-10am       
10-11am       
11-12am       
12-1pm       
1-2pm       
2-3pm 
 
      
3-4pm       
4-5pm  
 
     
5-6pm       
6-7pm       
7-8pm  
 
     
8-9pm       
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8-9pm       
 
Date: 
 Time 
passed 
urine  
Leaked  
 
Yes/No 
Small 
Moderate  
Large 
Reason 
for 
leakage 
Drink 
type 
Amount 
Drank 
7-8am       
8-9am       
9-10am       
10-11am       
11-12am       
12-1pm       
1-2pm       
2-3pm 
 
      
3-4pm       
4-5pm  
 
     
5-6pm       
6-7pm       
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Comments: please record any thoughts 
or ideas about your continence progress 
this week and how you have found 
completing the paperwork. 
 
 
 
 
 
 
 
 
 
 
 
 
 
7-8pm  
 
    
8-9pm      
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Appendix 9 Continence assessment completed by
nursing staff
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Section 1: Details about the patient 
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 Section 2: Clinical investigations 
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Section 3: Continence aids  
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Section 4: Mood and cognitive ability 
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Section 5: Experience of continence PRIOR TO stroke 
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Section 6: Experience of continence AFTER stroke 
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 Review of assessment 
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History/ 
Symptom 
assessment 
(day 1) 
Clinical 
diagnosis 
(day 3) 
Review all 
information 
and 
diagnose 
problem 
 
Initial 
management 
(days 3-7) 
Decide on 
treatment 
option 
Bladder Training 
Plus information booklet 
 
Patient-held voiding diary 
Weekly Review Complete weekly review sheet         
Improvement or no change         continue with SVP or reassess
 
Ongoing 
management 
weekly 
review 
(day 7 
onwards) 
Deterioration in continence status          Consider need for specialist assessment 
  
 
Urge UI 
Cognitively Impaired 
Prompted Voiding 
Plus information booklet
Optional patient-held voiding 
diary 
Cognitively Able 
Prompted Voiding (IF NO 
CONTROL OVER BLADDER) 
Plus information booklet 
3 day bladder 
diary 
 
Continence 
assessment 
 
Bladder scan 
Dipstick urine 
MSSU 
Stress UI 
 
Mixed UI 
Disability 
related 
UI/impaired 
awareness 
All Patients with 
Incontinence  
Catheter patients  
Consider removing catheter as 
soon as possible 
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Appendix 10 Algorithm for ward staff
Is patient medically stable and consciousness state is alert or drowsy?
If yes to both then proceed to pathway
Patient is continent Patient is catheterised
Fill in continence assessment (patient details
and pre-stroke continence assessment sections) 
give letter of invitation, information sheets
and inform researcher
Catheter is removed, wait 24 hours and start
patient on 3-day bladder diary. On the third
day fill in the section; post-stroke continence
assessment (second half of continence 
assessment booklet)
What is patient’s continence
status?
Patient is incontinent
Unsure if patient 
is incontinent, perhaps 
due to functional
issues?
Start 3-day bladder diary
On the third day fill in 
continence assessment
What is patient’s continence
status?
Patient is
continent
Patient is
continent
Patient is 
incontinent decide;
on programme pathway,
inform researcher
Patient is 
incontinent decide on; 
programme pathway,
give letter of invitation, 
information sheets and 
inform researcher
No further action is
needed but monitor
patient for any 
change in status
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
463

Appendix 11 Bladder training protocol
 
 
 
Bladder training protocol 
 
Overview 
The objectives of the bladder training protocol are to: 
· increase the time interval between voids to a maximum of 4 hours 
· this may lead to an increase in bladder capacity, leading to reduction in 
incontinence.  
 
Please implement the protocol for 14 hours a day (7.30am to 9.30pm), 7 days a 
week. 
 
Protocol 
Patient education 
Go through the Patient Education booklet with the patient; family and/or friends can 
be present if the patient would like them to be. 
Bladder diary review 
The patient (or nursing staff if the patient is not able) will have completed a baseline 
bladder diary for at least three days.  At the first discussion with the patient (following 
the explanation of the patient education materials), review the baseline bladder diary 
with the patient, noting the time and circumstances of each accident.  Decide on 
initial voiding interval based on the table below: 
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
465
Guidelines for initial voiding intervals prescribed 
 
If diary shows urinary frequency (or 
leakage) 
occurring on average of: 
 
30 minutes 
 
60 minutes or less 
 
90 minutes 
 
Prescribe initial voiding interval of: 
 
 
 
30 minutes 
 
60 minutes 
 
90 minutes 
 
 
 
Bladder training 
Explanation for participants 
Explain the purpose of the bladder training programme; suggested wording: 
 
“Bladder training will help you regain control by strengthening your brain's 
ability to control your bladder. You do this by practicing emptying your bladder 
to a specific timetable. Initially, the time between toilet visits will be brief. 
However, the time will gradually be lengthened until you achieve a normal 
toilet pattern without leakage or problems controlling the need to go.” 
 
Protocol 
1 Encourage patients to follow the voiding timetable as closely as possible 
during the day time only. (Grace period: 10 minutes on either side of hour). 
 
2 Explain to patients that if they feel they need to empty their bladder prior to 
their schedule voiding time, they should try to wait until their due time.  Explain that if 
they can distract themselves long enough, often the urge to empty their bladder will 
pass.  Suggest the following strategies which may help put off the desire to void: 
 
· Use mind games to distract your attention. Count backwards from 100 by 7's 
or work on a crossword puzzle. 
 
 
APPENDIX 11
NIHR Journals Library www.journalslibrary.nihr.ac.uk
466
 · Concentrate on a task which requires a great deal of concentration.  For 
example, writing a letter, count backwards from 100 by 7’s, do some therapy 
exercises, or some other activity that requires a great deal of attention. 
 
· Try to distract yourself by concentrating on another body sensation, such as 
deep breathing. Sit down and take five slow deep breaths.  Try to concentrate 
on the air moving in and out of your lungs, and not on your bladder sensation. 
· Use self-statements when urgency occurs such as -I can wait," "I don't have 
to go," "I can conquer this,' or "It's not time yet to go."  Create a statement 
that fits your situation the best. 
 
· Time how long you can push off the feeling of urgency and try to double this 
time when urgency occurs again. For example, if you could only control your 
urgency for 1 minute the first time, aim for controlling your urgency for 2 
minutes the next time, and for 4 minutes the time after that. 
 
If patients have to interrupt their schedule, they should get back on schedule at the 
assigned time even if it has been only a few minutes.  For example, if they had to 
void 15 minutes before their assigned time, they should be asked to void again at 
their assigned time.  Encourage patients to continue on their voiding schedule, trying 
not to interrupt it again. 
 
4 Encourage patients to follow the voiding schedule as closely as they can.  
Suggested wording: 
 
“Even if you do not feel the desire to void, go to the toilet at the assigned 
time, and try to empty your bladder. Remember, the amount of urine in your 
bladder is not important; the important part is your effort to empty it. Whether 
you pass a few drops or a pint, it really does not matter. The important thing 
is the effort.” 
 
5 Record each voiding on the Daily Treatment Log. 
 
6 If the patient misses one or more scheduled voiding, ask them to return to the 
schedule as soon as they remember. 
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Please document all activities (e.g. taking patients to the toilet and the 
outcome of each scheduled void) on the DAILY TREATMENT LOG for each 
patient. 
 
Review  
Review patient at weekly intervals using 
· bladder diary  
· log of bladder training activities in the last week. 
 
If patient has managed to control their bladder using the schedule without any 
problems, increase voiding interval by half an hour. 
 
If the patient has had difficulty controlling their bladder, the time period between 
voidings may remain the same or be shortened.  Adjust this to meet the patients’ 
needs. 
 
Decide on voiding schedule for the following week and document this in the back of 
the Patient Information Booklet and in the nursing care plan. 
 
Maintenance 
Weekly progress reviews are an ideal time to discuss progress with patients and to 
provide support and encouragement to help motivate patients to continue with their 
schedule. 
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Appendix 12 Prompted voiding protocol
 
 
 
Prompted voiding protocol 
 
Overview 
The objectives of the prompted voiding protocol are to: 
· help patients learn how to identify the cues to bladder fullness and to request 
assistance if needed. 
· help patients to develop 
o  an increased ability to control voiding 
o  an increased sense of control over their toileting practices 
o  an increased motivation to use the toilet appropriately. 
 
Please implement the protocol for 14 hours a day (7.30am to 9.30pm), 7 days a 
week. 
 
Protocol 
Patient education 
Go through the Patient Education booklet with the patient; family and/or friends can 
be present if the patient would like them to be. 
Bladder diary review 
The patient (or nursing staff if the patient is not able) will have completed a baseline 
bladder diary for at least three days.  At the first discussion with the patient (following 
the explanation of the patient education materials), review the baseline bladder diary 
with the patient, noting the time and circumstances of each accident. 
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Prompted voiding 
1. depending on findings from the bladder diary, decide (in consultation with the 
patient if possible) on an appropriate initial toileting interval: this is likely to be 
either every two or every three hours. 
2. approach patient at this interval (e.g. every 2 hours) during waking hours and 
ask if he or she is wet or dry. 
3. check the patient to see if his or her undergarment or pad was wet or dry. 
4. give the patient feedback on the correctness of his or her response and 
praise the patient if dry. 
Suggested wording: 
Feedback as to accuracy: “That’s right, Mrs X, you are dry.” 
 
Praise if the patient is dry: “Good, you’re dry.  Isn’t that more 
comfortable?” 
 
5. ask the patient if he or she would like to use the toilet 
 
Suggested wording: 
This should ensure that the patient is given the best opportunity to 
request assistance, e.g. “Mrs ---, do you need to go to the bathroom?” 
 
6. if the patient’s response was yes, take them to the toilet.  If the response was 
no, encourage the patient to toilet, but not to force him or her to do so. 
7. provide toileting assistance as needed. 
8. provide positive feedback for appropriate toileting. 
9. end the prompting session by telling the patient that the staff will return at the 
specified interval (e.g. in two hours) and to be sure to ask for assistance if 
they need to go to the toilet before then. 
 
Please document all activities (e.g. taking patients to the toilet and the 
outcome of each scheduled void) on the DAILY TREATMENT LOG for each 
patient. 
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Note: prompt patients to hold their urine until the next check, but tell them that if they 
needed to use the toilet before that time they should inform the nursing staff so that 
appropriate assistance can be provided and data recorded. 
 
Review  
Review patient at weekly intervals using 
· bladder diary 
· log of prompted voiding activities in the last week. 
 
If patient was dry on 80% of prompts, increase interval by half an hour. 
 
If the patient had a time of day (often in the morning) when he or she was 
consistently wet on the specified interval, add an extra prompt. 
 
Decide on voiding schedule for the following week and document this in the back of 
the Patient Information Booklet and in the nursing care plan. 
 
Maintenance 
Weekly progress reviews are an ideal time to discuss progress with patients and to 
provide support and encouragement to help motivate patients to continue with their 
schedule. 
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Appendix 13 Pelvic floor muscle training protocol
 
 
Pelvic floor muscle training protocol 
Overview 
Pelvic floor muscle training will be introduced following an assessment by a 
physiotherapist to ensure the patient is able to exercise their pelvic floor muscles. 
 
The objectives of the pelvic floor muscle training programme are to: 
· deliver the pelvic floor muscle training  
o including initial and ongoing training 
· evaluate adherence with the exercise regime (in the form of a daily record) 
· identify barriers to adherence and provide advice on how to overcome these. 
 
ONCE THE PATIENT HAS BEEN ASSESSED AS ABLE TO BEGIN THE 
PROGRAMME, IMPLEMENT THE FOLLOWING PROTOCOL. 
 
EACH SET OF EXERCISES TO BE DONE TWICE A DAY and to be supervised 
by a member of nursing staff if at all possible. 
Protocol 
Patient education 
Go through the Patient Education booklet with the patient; family and/or friends can 
be present if the patient would like them to be. 
Pelvic floor muscle training 
Explanation of how to do pelvic floor exercises 
You may like to use the following wording: 
“Choose any comfortable supported sitting or lying position, with your knees 
slightly apart. 
 
Tighten up your back passage as though you are going to stop passing wind.   
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 Then tighten the muscles that you would use to stop yourself from passing urine.  
Do these two together and you should be exercising your pelvic floor muscles. 
 
Another way to think about this is by thinking of someone pursing their lips while 
drinking through a straw.” 
 
Exercise set 1 
Ask the patient to perform 5 quick muscle contractions (1 second hold followed by a 
2 second rest).   
 
Exercise set 2 
Ask the patient to perform 10-20 sustained contractions of 8-10 seconds, followed by 
a 10 second relaxation period. 
 
During exercise, the patient should not demonstrate abdominal activity or muscle 
activity at the buttocks and thighs.  If the patient performs a Valsalva manoeuvre 
(straining down instead of pulling the muscles up and in) during exercise, provide 
additional information to correct their task performance.   
Teach the patient to place a hand on the abdomen to detect abdominal muscle 
tension: 
“Keep your tummy, buttocks and thighs  relaxed while you do these 
exercises.  Tensing your tummy muscles can work against bladder control 
because it can press on your bladder and increase pressure inside.  This 
pushes urine out, rather than holding urine in. 
 
To keep from straining down when you do a pelvic muscle contraction: 
· breath out gently and keep your mouth open each time you 
tighten your muscles; 
· rest a hand lightly on your abdomen 
· if you feel your stomach pushing out against your hand, you 
are straining down. 
When you are first learning it takes practice and concentration to exercise 
correctly, but it will get more automatic with time.” 
 
 
Here are some other tips to help patients relax their abdominal and hip muscles: 
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· When you contract your pelvic floor muscles and exercise correctly, no one 
can tell you are exercising. 
· Don’t hold your breath while squeezing your muscles. 
· Breath in and out through your mouth. 
· Place your hands on your tummy to make sure you are not tightening the 
wrong muscles. 
· Do not squeeze your buttocks together. 
· Do not arch your back. 
· Your buttocks should not lift up from the bed. 
 
Encourage patients to check if they are doing the exercises correctly.  You may like 
to use the following wording: 
 
“If able you can check if you are doing the exercises properly. 
Women 
· Put your thumb or two fingers inside your vagina.  Tighten your pelvic 
floor muscles.  You should feel the muscles move around your 
thumb/fingers. 
· Check with a mirror.  Hold a small mirror so that you can see the area 
between your legs.  Tighten the muscles.  The skin between the anus 
and the vagina should move away from the mirror. 
Men 
· Put your fingers on the skin just behind the scrotum (balls).  Try to 
tighten your pelvic floor muscles.  You should feel the muscles 
moving the skin away from your fingers. 
· A correct contraction should cause the testicles to move back and 
the penis to lift up or twitch.” 
 
During this set of contractions, also emphasise the importance of relaxing pelvic floor 
muscles completely between each contraction.  Use the following phrases to 
encourage muscle relaxation: 
 
“Contracting your muscles repeatedly will make them stronger, but relaxing 
the muscles is equally important.  Relaxation allows blood and oxygen to get 
back into the muscles and prepare them for exercising.  Allowing the muscles 
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to completely relax between squeezes also helps the muscle to build and 
‘bulk up’ faster.” 
 
Additional tips: 
· Remind the patient that these exercises are new for most people and that 
they will get better with practice. 
· It takes time and practice to become skilful. 
· Encourage persistence. 
· Praise subject efforts. 
 
Please document all activities undertaken with patients on the DAILY 
TREATMENT LOG for each patient. 
 
Review 
Review patient at weekly intervals using 
· bladder diary 
· log of exercises patient has done in the previous week. 
 
Decide on exercise schedule for the following week and document this in the back of 
the Patient Information Booklet and in the nursing care plan. 
 
Maintenance 
Weekly progress reviews are an ideal time to discuss progress with patients and to 
provide support and encouragement to help motivate patients to continue with their 
schedule. 
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 Coherence Cognitive 
Participation 
Collective Action Reflexive Monitoring Norms, conventions 
structures 
Planning for change What sense do staff 
members have of the 
systematic voiding 
programme? 
 
How do staff members 
think this differs from 
current 
practice? 
 
What factors will 
influence how people 
see the value of the 
systematic voiding 
programme? 
What staff members are 
likely to play a role in 
implementing the 
systematic voiding 
programme? 
 
What are the actual and 
potential barriers and 
enablers of staff 
involvement?  
 
Do relevant staff have 
the knowledge and 
skills to implement the 
systematic voiding 
programme? 
 
Are the necessary 
resources in place? 
What information 
would be helpful for 
staff to use in 
evaluating the impacts 
of implementing the 
systematic voiding 
programme? 
 
How can this 
information be collected 
and reviewed by staff? 
How conducive is the 
clinical setting to 
change? 
 
What are the actual and 
potential barriers and 
enablers of 
implementation? 
Leading and 
managing change 
What can we do to help 
people make sense of 
the change? 
 
How can we get staff to 
share expectations and 
experience? 
 
How can facilitators 
raise the importance of 
continence care in the 
minds of key staff? 
 
How can we encourage 
staff to work together in 
planning work to 
implement the 
systematic voiding 
programme? 
 
How can those with 
leadership roles be 
supported? 
How can we support 
staff to act on the 
education and training 
provided?  
 
How can we support 
these staff to understand 
their own role, and the 
roles of others? 
Who should appraisal 
information be provided 
to and how? 
 
What reporting 
mechanisms are 
required? 
 
What communication 
channels should be used 
to share appraisal 
information? 
Where will clinical 
leadership for 
implementation be 
found? 
 
How can this be 
bolstered? 
Monitoring progress How can we evaluate 
how people make sense 
of the systematic 
voiding programme? 
 
Are key people 
involved? How can 
facilitators influence 
staff engagement? 
 
Have staff developed 
the appropriate 
knowledge and skills? 
 Are staff clear of their 
own and others’ roles? 
What constitutes good 
progress with 
implementation? 
 
What might explain 
What formal and 
informal opportunities 
are there to raise and 
maintain the profile of 
the systematic voiding 
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Is a collective 
agreement about the 
systematic voiding 
programme developing? 
 
What disagreement is 
there? 
How can teamwork 
around the systematic 
voiding programme be 
promoted? 
how implementation is 
progressing? 
 
How can we let key 
staff know how they are 
doing? 
programme? 
Evaluating change Do people see the 
potential value of the 
systematic voiding 
programme? 
 
How do we need to 
adapt facilitation to 
enhance how people 
value the systematic 
voiding programme? 
Has consensus 
developed about how 
the systematic voiding 
programme should be 
implemented? 
 
Are there other 
activities we can use to 
support change? 
 
Who else do we need to 
involve, and how 
should we do this? 
Are there any resource 
issues limiting the 
implementation of the 
systematic voiding 
programme? 
 
What else can we do to 
help staff perform the 
systematic voiding 
programme together? 
How do people feel 
their work around 
continence has 
changed? 
 
How can we support 
staff to refine ways of 
working to maximise 
implementation? 
What systems and 
processes can be used to 
monitor and highlight 
progress with 
implementation? 
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Phase Internal Facilitators External facilitators 
Action planning (1-2 months 
pre-intervention) 
Review of ‘Internal Facilitation 
Manual’ 
Assessment of organisational 
learning context using ARCS 
Introducing mapping of 
continence system and work 
 
Site visit 
Introduce Facilitation Manual 
Establish ways of working and 
communication 
Supporting the development of 
the action plan 
Delivery (months 1-9/12) Delivering facilitation action 
plan interventions 
Supporting personal 
development with facilitation 
Monitoring progress 
Providing monthly supervision 
to the internal facilitator 
Ongoing problem-solving / 
trouble shooting 
Evaluation (month 9/12) Self evaluation of facilitation 
and implementation 
Peer evaluation of facilitation 
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Week commencing Monday (please insert date): Internal Facilitator: 
Activity Description YES / 
NO 
(please 
delete) 
Notes 
PLANNING FOR CHANGE 
Increasing 
awareness 
 
Highlighting need for change to SVP; 
stimulating enquiry and questions 
about SVP; evaluating baseline 
continence practice; providing insight; 
emphasizing benefits of SVP 
YES / 
NO 
 
Developing a plan 
 
Developing action plan; helping 
identify solutions to barriers to 
implementing SVP; setting goals and 
establishing consensus about SVP 
YES / 
NO 
 
LEADING AND MANAGING CHANGE 
Knowledge and 
data management 
Disseminating evidence underpinning 
SVP; helping people interpret 
evidence underpinning SVP; 
providing tools / resources for SVP 
YES / 
NO 
 
Project 
management 
 
Identifying leadership; establishing 
and allocating roles and 
responsibilities within the SVP and its 
implementation; advocating for 
resources and change in practice 
YES / 
NO 
 
Recognising 
importance of 
context 
Creating an environment conducive to 
change; helping staff to overcome 
obstacles to using the SVP; creating 
local ownership; fitting SVP with local 
systems 
YES / 
NO 
 
Team building 
 
Relationship building; encouraging 
effective team work around SVP; 
enabling group and individual 
development; encouraging 
participation; overcoming resistance to 
change;  
YES / 
NO 
 
Administrative or 
project support 
Organising meetings; participating in 
meetings; gathering information and 
compiling reports; planning; training; 
providing practical assistance to staff 
YES / 
NO 
 
MONITORING PROGRESS AND ONGOING IMPLEMENTATION 
Problem solving 
 
Addressing specific issues / problems; 
making changes to the action plan; 
networking. 
YES / 
NO 
 
Providing support 
 
Mentoring and role modelling 
implementation of the SVP; 
maintaining momentum and 
enthusiasm; acknowledging ideas and 
efforts; providing advice, support and 
reassurance 
YES / 
NO 
 
Effective 
communication 
 
Providing regular communication; 
keeping staff members informed. YES / 
NO 
 
EVALUATING CHANGE 
Assessment 
 
Performing / assisting with evaluation; 
liking implementation to improved 
processes and outcomes; 
acknowledging success and 
celebrating achievement. 
YES / 
NO 
 
APPENDIX 14
NIHR Journals Library www.journalslibrary.nihr.ac.uk
508
Appendix 15 Action plan
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
509
APPENDIX 15
NIHR Journals Library www.journalslibrary.nihr.ac.uk
510
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
511
APPENDIX 15
NIHR Journals Library www.journalslibrary.nihr.ac.uk
512
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
513
APPENDIX 15
NIHR Journals Library www.journalslibrary.nihr.ac.uk
514
DOI: 10.3310/pgfar03010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 1
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Thomas et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
515

Appendix 16 Case study participant
information sheet
        
 
 
PARTICIPANT INFORMATION SHEET 
ICONS: Identifying Continence OptioNs after Stroke 
 
Invitation to participate 
We would like to invite you to take part in a research study.  Before you decide you 
need to understand why the research is being done and what it would involve for 
you.  Please take time to read the following information carefully.  Talk to others 
about the study if you wish. 
(Part 1 tells you the purpose of this study and what will happen to you if you take 
part. 
Part 2 gives you more detail about the conduct of the study). 
Ask us if there is anything that is not clear or if you would like more information.  
Take time to decide whether or not you wish to take part. 
 
Part 1 
What is the purpose of the study? 
Urinary incontinence (difficulty in controlling emptying of the bladder) is common after 
stroke and can be very unpleasant and a cause of distress and embarrassment for 
patients and their carers. Urinary incontinence may hamper rehabilitation and delay 
patients from returning home and resuming leisure activities, work or an active social 
life.  There are also financial costs for families and for the Health Service. We want to 
try out a treatment plan for urinary incontinence with hospital inpatients aimed at 
helping them become continent again.  We will assess how acceptable the plan is for 
patients and those looking after them.  
Why have I been invited? 
The health care team have been using our plan to look after you since you had your 
stroke.  We would like you to take part so we can find out your experiences of being 
looked after using the plan. 
 
Do I have to take part? 
It is up to you to decide; taking part is entirely optional.  We will describe the study 
and go through this information sheet with you.  We will then ask you to sign a 
consent form to show you have agreed to take part.  You are free to withdraw at any 
time, without giving a reason.  This would not affect the standard of care you receive. 
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What will happen to me if I take part? 
You will be invited to: 
a) allow nursing and research staff to check your progress OR 
b) allow nursing and research staff to check your progress AND take part 
in interviews with researchers 
 
A) Checking your progress 
We would like to note some details about how you are progressing with your 
treatment.  The nursing staff will keep a diary of what treatment you have had for 
continence and how you are progressing.  This information and information from your 
case notes relevant to this study will be used by the research staff to monitor your 
progress. 
 
B) Interviews 
You will be invited to take part in two or three interviews (depending on how long you 
stay in hospital) about the hospital management of your continence.  These will take 
place at different time points during your stay and will be arranged at a time 
convenient for you and to fit in with your care and treatment.  It is likely one will take 
place during the first two weeks of your admission to the stroke service and another 
just before you are discharged.  Depending on how long you are in hospital, you may 
be invited to take part in another interview between the other two dates.  We 
anticipate that each interview will last between half an hour and one hour. 
 
The interviews will take place in a quiet and private location on the unit.  They will be 
carried out by a member of the research team who is experienced at interviewing 
patients.  The researcher will ask you if you are happy to have the interview tape-
recorded; you may refuse if you prefer not to have your comments recorded but still 
continue in the project.  Names will not be recorded and all tapes will be destroyed 
within three months of project completion. 
 
You may find talking about continence upsetting.  You will be able to stop the 
interview at any time and nursing and medical staff will be there to support you if you 
are upset during or after the interview.  If you would like support, please contact: 
 
Ward 23, Arrowe Park Hospital:  Sister Helen Aitken 
 
 
Stroke Rehabilitation Unit, Clatterbridge Hospital:  Sister Gillian Ayriss 
 
If you would like a relative or friend to come along to the interviews with you, they 
would be very welcome. 
 
What are the possible disadvantages of taking part? 
We will ask you to talk about how your continence has been assessed and managed, 
and we realise this is a sensitive subject.  We will do all we can to minimise 
embarrassment for you and any relative or friend you have with you.  Interviews will 
be developed very carefully to focus on assessment and treatment received rather 
than focussing on the details of your continence problems. 
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What are the possible benefits of taking part? 
You may welcome the opportunity to discuss the care you have received and to 
suggest ways this could be improved.   
 
Will my taking part in the study be kept confidential? 
Yes.  We will follow ethical and legal practice and all information about you will be 
treated in confidence.  The details are included in Part 2. 
 
 
This completes Part 1.  If the information in Part 1 has interested you and you 
are considering participation, please read the additional information in Part 2 
before making any decision. 
 
Part 2 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw from the study at any time, without giving a reason.  If you 
withdraw from the study, we will destroy all the information you have provided. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions (01772 893643).  If you 
remain unhappy and wish to complain formally, you can do this through the NHS 
Complaints Procedure.  Details can be obtained from the hospital. 
 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone’s negligence then you may have grounds for a legal 
action for compensation against Lancashire Teaching Hospitals NHS Foundation 
Trust but you may have to pay your legal costs.  The normal National Health Service 
complaints mechanisms will still be available to you (if appropriate). 
 
Will my taking part in the study be kept confidential? 
All research data will be treated and stored according to the Data Protection Act 
(1998) and the Caldicott Principles.  All data will be treated as confidential according 
to the Medical Research Council definition: “any information obtained by a person on 
the understanding that they will not disclose it to others” (MRC, Personal Information 
in Medical Research. 2000).  All patients who consent to take part will be allocated a 
code number and all data recorded about that patient will be identified by their code 
number.   
 
All quotations from participants used in reports and publications will exclude personal 
details.  No individuals will be identifiable from them. 
 
Computers used in the study will be password protected.  All paper records will be 
stored in locked filing cabinets in a locked office.  Only research staff from the study 
will have access to the records. 
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Your personal details will be destroyed at the end of the study.  Data forms and 
interview transcripts will be stored for 10 years in line with the recommendations of 
the Medical Research Council document Good Research Practice (2000).   
Data will be stored in a locked cabinet in the programme coordinator's office (also 
locked).  Access will be given only to the research team via the programme 
coordinator. 
 
 
 
 
 
What will happen to the results of the research study? 
Findings will be shared widely using a range of methods following advice from the 
Programme Patient, Public and Carer Involvement Group. These will include: 
a) Written feedback will be provided to all study participants who would like it. 
b) Presentations at a range of stroke and incontinence related conferences, for 
example the Society for Research in Rehabilitation, UK Stroke Forum and 
Royal College of Nursing Continence Forum. 
c) Presentations to appropriate forums within the participating Trust. 
d) Findings will be disseminated via the North West Stroke Task Force 
information sharing channels, for example clinical practice sharing meetings, 
newsletters, patient and carer information documents (produced with Cumbria 
Social Services and Help the Aged), attendance at Service User Groups and 
local conferences. Findings will also be shared via the Stroke Research 
Networks. 
e) We will submit findings to peer-reviewed academic (e.g. Stroke) and popular 
(e.g. Nursing Times) journals to maximise readership. 
 
Who is organising and funding the research? 
The research is sponsored by the Lancashire Teaching Hospitals Foundation NHS 
Trust.  It is funded by the National Institute for Health Research under the 
Programme Grants scheme. 
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a 
Research Ethics Committee, to protect your safety, rights, wellbeing and dignity.  
This study has been reviewed and given a favourable opinion by Bolton Research 
Ethics Committee. 
 
You may keep this information sheet and you will also be given a copy of the signed 
consent form to keep. 
 
Further information 
Specific information about this research project 
Please contact the Programme Coordinator: 
 
Dr Lois Thomas 
School of Nursing and Caring Sciences 
University of Central Lancashire 
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Preston 
PR1 2HE 
 
Email address: lhthomas@uclan.ac.uk 
 01772 893643 
 
Who you should approach if unhappy with the study 
Please contact Dr Lois Thomas, details as above. 
 
For any concerns during the study 
Please contact the Research Nurse (TBC) or Denise Forshaw either on site or as 
below; 
 
Denise Forshaw 
Research Coordinator 
University of Central Lancashire 
Email address: dforshaw@uclan.ac.uk 
 01772 893713 
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Appendix 17 Case study health professional
information sheet
        
 
 
HEALTH PROFESSIONAL INFORMATION SHEET 
ICONS: Identifying Continence OptioNs after Stroke 
 
Invitation to participate 
We would like to invite you to take part in a research study.  Before you decide you 
need to understand why the research is being done and what it would involve for 
you.  Please take time to read the following information carefully.  Talk to others 
about the study if you wish. 
(Part 1 tells you the purpose of this study and what will happen to you if you take 
part. 
Part 2 gives you more detail about the conduct of the study). 
Ask us if there is anything that is not clear or if you would like more information.  
Take time to decide whether or not you wish to take part. 
Part 1 
What is the purpose of the study? 
Urinary incontinence is common after stroke and can be very unpleasant and a 
cause of distress and embarrassment for patients and their carers. Urinary 
incontinence may hamper rehabilitation and may affect whether or not patients are 
able to return to their own home, as well as return to leisure activities, work or an 
active social life. It is also costly for families and for the Health Service. We would 
like to try out a package of assessment and treatment of urinary incontinence while 
people are in hospital, which is designed to help them become continent again.   
 
In this phase, we would like to assess how acceptable the package is for patients 
and those looking after them. We will modify and develop the package based on 
what patients and health professionals tell us. 
 
Our study is, to our knowledge, the first to rigorously test a package designed to 
assess and treat urinary incontinence after stroke in a hospital setting. 
 
We would like to invite you to take part in Phase I of the study. 
 
Why have I been invited? 
We would like to invite you to take part because you are part of the health care team 
who have been using our package to look after patients who have urinary 
incontinence after their stroke.  We would like you to take part so we can find out 
your experiences of using the package. 
 
Your views will be very valuable to the research team, who will use your experiences 
and suggestions to improve the package before introducing it in a larger number of 
stroke services. 
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Do I have to take part? 
It is up to you to decide.  We will describe the study and go through this information 
sheet, which we will then give to you.  We will then ask you to sign a consent form to 
show you have agreed to take part.  You are free to withdraw at any time, without 
giving a reason. 
 
What will happen to me if I take part? 
Interviews 
You will be invited to take part in six focus group interviews (one per month) with 
other health professionals from your stroke service.  These will be arranged at a date 
and time convenient for you.  We anticipate that each interview will last around one 
hour. 
 
The interviews will take place in a quiet and private location on the unit.  They will be 
facilitated by a member of the research team.  The researcher will ask you if you are 
happy to have the interview audio taped. 
 
What are the possible disadvantages of taking part? 
We do not anticipate any disadvantages of taking part. 
 
What are the possible benefits of taking part? 
Taking part will give you the opportunity to share and discuss your views of the 
package of care with other health professionals, who have also been using the 
package, at regular time points throughout the six month intervention period.   
Will my taking part in the study be kept confidential? 
Yes.  We will follow ethical and legal practice and all information about you will be 
treated in confidence.  The details are included in Part 2. 
 
 
This completes Part 1.  If the information in Part 1 has interested you and you 
are considering participation, please read the additional information in Part 2 
before making any decision. 
 
Part 2 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw from the study at any time, without giving a reason.  It may 
not be possible to separate out your contributions to focus group interviews, so if you 
decide to withdraw we will ask your permission to use the data you have provided up 
to the point of withdrawal. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions (01772 893643).  If you 
remain unhappy and wish to complain formally, you can do this through the NHS 
Complaints Procedure.  Details can be obtained from the hospital. 
 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone’s negligence then you may have grounds for a legal 
action for compensation against Lancashire Teaching Hospitals NHS Foundation 
Trust but you may have to pay your legal costs.  The normal National Health Service 
complaints mechanisms will still be available to you (if appropriate). 
APPENDIX 17
NIHR Journals Library www.journalslibrary.nihr.ac.uk
524
Will my taking part in the study be kept confidential? 
All research data will be treated and stored according to the Data Protection Act 
(1998) and the Caldicott Principles.  All data will be treated as confidential according 
to the Medical Research Council definition: “any information obtained by a person on 
the understanding that they will not disclose it to others” (MRC, Personal Information 
in Medical Research. 2000).  All health professionals who consent to take part will be 
allocated a code number and all data recorded about them will be identified by their 
code number. 
 
All quotations from respondents used in reports and publications will be anonymised 
and individual respondents will not be identifiable from them. 
 
Computers used in the study will be password protected.  All paper data will be 
stored in locked filing cabinets in a locked office.  Access to all data will only be 
available to research staff from the study. 
 
Your personal details will be destroyed at the end of the study.  Data forms and 
interview transcripts will be stored for 10 years in line with the recommendations of 
the Medical Research Council document Good Research Practice (2000).   
Data will be stored in a locked cabinet in the programme coordinator's office (also 
locked).  Access will be given only to the research team via the programme 
coordinator. 
 
What will happen to the results of the research study? 
Findings will be shared widely using a range of methods following advice from the 
Programme Patient, Public and Carer Involvement Group. These will include: 
a) Written feedback will be provided to all study participants who would like it. 
b) Presentations at a range of stroke and incontinence related conferences, for 
example the Society for Research in Rehabilitation, UK Stroke Forum and 
Royal College of Nursing Continence Forum. 
c) Presentations to appropriate forums within the participating Trust. 
d) Findings will be disseminated via the North West Stroke Task Force 
information sharing channels, for example clinical practice sharing meetings, 
newsletters, patient and carer information documents (produced with Cumbria 
Social Services and Help the Aged), attendance at Service User Groups and 
local conferences. Findings will also be shared via the Stroke Research 
Networks. 
e) We will submit findings to peer-reviewed academic (e.g. Stroke) and popular 
(e.g. Nursing Times) journals to maximise readership. 
 
Who is organising and funding the research? 
The research is sponsored by the Lancashire Teaching Hospitals Foundation NHS 
Trust.  It is funded by the National Institute for Health Research under the 
Programme Grants scheme. 
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a 
Research Ethics Committee, to protect your safety, rights, wellbeing and dignity.  
This study has been reviewed and given a favourable opinion by Bolton Research 
Ethics Committee. 
 
You may keep this information sheet and you will also be given a signed consent 
form for you to keep. 
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Further information 
Specific information about this research project 
Please contact the Programme Coordinator: 
 
Dr Lois Thomas 
School of Nursing and Caring Sciences 
University of Central Lancashire 
Preston 
PR1 2HE 
 
Email address: lhthomas@uclan.ac.uk 
 01772 893643 
 
Who you should approach if unhappy with the study 
Please contact Dr Lois Thomas, details as above. 
 
For any concerns during the study 
Please contact <add details of research nurse> 
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Appendix 18 Coding frame for analysing
normalisation process theory interviews
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ICONS NPT DATA ANALYSIS CODING FRAME version 3 (13/11/12) 
 
COHERENCE: the sense making work that people do when they are faced with using a 
new set of practices 
Negotiating the intervention  
Differentiation Perceived differences between 
old and new systems of work, 
that have consequences for how 
people operate in practice 
Can people easily describe the new 
practice, and appreciate how it differs from 
what they were doing before? 
Reference to differences or similarities in processes or 
components of the intervention e.g. praise, prompted voiding, 
recording, timing, frequency. It’s what we’re used to, we used 
to do that, it’s different in that... 
Communal 
specification 
There is collective agreement 
about the purpose and function 
of the intervention, and how it 
works 
Is there evidence of variation in 
understanding of the aims, objectives, 
processes, or expected outcomes of the 
intervention? 
Reference to disagreement (people may not explicitly refer 
to agreement so look for lack of evidence of disagreement);  
intervention acting as a focus or goal for staff or patients; 
misunderstanding by staff, patients, or families; reference to 
differences in interpretation, or conflicts 
Individual 
specification 
Individuals understand what the 
new practice requires of them 
Can people easily make sense of how the 
new practice will work, and what their new 
tasks and responsibilities are? 
Reference to people being clear about what they were 
doing; not understanding or not being informed, keeping up 
with changes; some people knowing and others not knowing 
Internalisation People see the potential value 
of the new practice 
What do people think about the potential 
or likely value, cost, benefits, relative 
importance, of the new practice? 
Reference to aspects of the practice that were are valued 
e.g. if continence is important, what we should be doing, a 
priority, the importance for the patient, potential benefits for 
staff such as improved nursing role 
COGNITIVE PARTICIPATION: the relational work that people do to build and sustain a 
new practice 
Developing the intervention processes 
Initiation Key individuals drive the new 
practice forward 
Key individuals  are able and willing to get 
others involved 
Reference to influential people e.g. specific healthcare 
assistants, qualified staff, ward managers, practice 
development, family members 
Enrolment People agree that the new 
practice should be part of their 
work 
Do people believe they should be involved 
and that they can make a contribution? 
Reference to who should be involved (both staff and 
patients); suitability for involvement; response to methods of 
formal and informal influence to get people involved e.g. 
talks, booklets etc 
Legitimation People “buy in” to the new 
practice 
Are people managing and organising 
themselves and their area of work to 
facilitate the introduction of the new 
practice?  
Reference to methods of managing and organising the new 
practice e.g. rotas, being discussed at handover, allocation 
of staff responsibilities, patient organisation e.g. programme 
at visiting times, difficulty of organising e.g. timing 
Activation People work together to 
develop the new work processes  
Are people working together to build and 
activate the policies and procedures 
needed to sustain the new practice? 
Reference to methods of embedding the new practice in 
policies, procedures, processes i.e. developing the 
intervention, recording or written documentation e.g. 
registers, all reference to paperwork, embedding into ward 
routines. 
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COLLECTIVE ACTION: the operational work that people do to enact a new practice Implementing the new practice 
Interactional 
workability 
Staff and patients can perform 
the tasks required by the new 
practice 
Can people do what is required? Does the 
intervention suit all patient groups? 
Reference to the logistics of actually doing the work, 
developing or becoming a routine and fitting it into the day; 
the feasibility of doing the intervention with different client 
groups, or at different times of day; difficulties, choices of 
how to do things e.g. scheduling toileting 
Relational 
integration 
Staff trust each other’s work and 
expertise in the new practice 
People are confident in themselves and 
others abilities 
Reference to people’s roles, responsibilities, and experience; 
confidence in knowledge, whether people are doing what 
they are supposed to  
Skill set 
workability 
The work involved in the new 
practice is appropriately 
allocated 
Do people have the right skills and training 
to do the new practice? 
Reference to appropriate allocation of work to people; 
whether people have the knowledge, training, skills, 
competencies to do the work; division of labour, people 
being capable of doing what is asked of them e.g. patients 
filling out diaries, all reference to education, training, 
knowledge 
Contextual 
integration 
The new practice is adequately 
supported by the host 
organisation 
Do people have the resources to do the new 
practice e.g. time, staff, money, equipment, 
policy etc? 
Reference to perceptions of management support in relation 
to staffing amount, consistency, type; time for training; 
manageability of workload to staff. 
REFLEXIVE MONITORING: the appraisal work that people do to assess and understand 
how a new practice affects them and others 
Evaluating the new practice 
Systematization People access information about 
the effects of the intervention 
How do people determine how effective 
and useful the intervention is? 
Reference to how people are evaluating success; sources of 
evidence; how improvement is recognised and measured, 
how documentation and paperwork is being used e.g. diary 
Communal 
appraisal 
People collectively evaluate the 
new practice as worthwhile 
Whether as a result of some form of 
monitoring or outcome evaluation, people 
agree about the actual worth of the effects 
of the new practice? 
Reference to the criteria used for evaluation e.g. long term 
outcome, continuity, comparative performance; judgements 
made about whether aspects of the programme are working 
or not e.g. forms, giving praise etc  
Individual 
appraisal 
Individuals evaluate the new 
practice as worthwhile 
Do individuals affected by or involved with 
the intervention think it is worth doing? 
Reference to reflection about whether the programme is 
worth doing for specific individuals or not;  the balance of 
benefits and costs for patients or staff 
Reconfiguration People modify their work in 
response to their evaluation of 
the new practice 
Can/do people make changes to the new 
practice? 
 
Reference to adaptations and changes that people make to 
the techniques, paperwork, scheduling, allocation, what work 
is done, when it is reviewed, how to respond to patients 
wishes, how the programme is ended, etc. Include suggestions 
for programme extension to other areas, client groups 
 
NB Don’t just think of staff, also think about patients and whether they agree, understand, and can do the work of organising themselves. 
NB Be careful to look for the absence of negatives, as it is easy to spot complaints, but things going well may not be mentioned 
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Appendix 19 Daily clinical logs: summary of
stages and quality indicators
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Stage Key quality indicator Key quality indicator: descriptor
Terminate data
input if not achieved? Additional information gathered
1 Regime interval
(This ‘regime interval’ determines the
frequency of toileting throughout
the day)
Is the regime interval present and appropriately documented?
‘Appropriate’ documentation refers to the documentation of
an individual number (such as ‘2-hourly’) and NOT as a range
(such as ‘2–3 hourly’)
Yes What is the regime interval?
2 Proposed times
(‘Proposed times’ should be
documented at the start of each day,
based on the regime interval.
The proposed times form a schedule
of times for toileting, which clinical
staff should then try to follow)
Are (in-range) proposed times present and documented correctly?
There should be no missing entries between the first and last
documented in-range proposed time
Each interval between consecutive proposed times should be
identical to the regime interval (e.g. 2 hours between proposed
times for a regime interval of 2-hourly)
Yes How many (in-range) proposed
times are documented?
3(a) Times toileted
Documentation
For how many (in-range) proposed times is a corresponding
‘time toileted’ documented?
The ‘times toileted’ are the actual times at which the patient was
toileted and are recorded by clinical staff
No
3(b) Times toileted
Within schedule
For how many (in-range) proposed times is the ‘time toileted’
WITHIN 30 minutes?
The ‘gold standard’ for the ICONS programme is that a ‘time
toileted’ should be within 30 minutes of a proposed time
No For how many (in-range) proposed
times is the ‘time toileted’ OUTSIDE
OF 30 minutes?
For how many is it MISSING?
4(a) Good practice: asking the patient if
they are weta
‘Did you ask the patient if they were wet?’ – For how many
(in-range) proposed times is ‘YES’ documented?
For each toileting occasion, clinical staff are required to indicate on
the clinical log if they have undertaken a number of ‘best practice’
components of the regime. These include asking the patient whether
or not they are wet (if on PV regime) and giving encouragement to
the patient
No The number of occasions on which
‘NO’ is documented and number of
occasions on which answer is
MISSING
4(b) Good practice: encouragement ‘Did you give encouragement?’ – For how many (in-range) proposed
times is ‘YES’ documented?
As above
No The number of occasions on which
‘NO’ is documented and number of
occasions on which answer is
MISSING
a NB: This criterion refers to PV clinical logs only.
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Appendix 20 Daily clinical logs: proforma used
for data input
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Appendix 21 Exploratory trial: participant
screening form
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Appendix 22 Exploratory trial: participant
information sheet
        
 
 
PARTICIPANT INFORMATION SHEET 
Invitation to participate 
We would like to invite you to take part in a research study.  Before you 
decide you need to understand why the research is being done and what it 
would involve for you.  Please take time to read the following information 
carefully.  Talk to others about the study if you wish. 
(Part 1 tells you the purpose of this study and what will happen to you if you 
take part. 
Part 2 gives you more detail about the conduct of the study). 
Ask us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to take part. 
 
Part 1 
What is the purpose of the study? 
Urinary incontinence (difficulty in controlling emptying of the bladder) is 
common after stroke and can be very unpleasant and a cause of distress for 
patients and their carers. Urinary incontinence may hamper rehabilitation and 
delay patients from returning home and resuming leisure activities, work or an 
active social life.  There are also financial costs for families and for the Health 
Service. We would like to try out a treatment plan for urinary incontinence with 
hospital inpatients aimed at helping them become continent again.  We will 
assess whether the plan seems to work and how acceptable it is for patients 
and those looking after them.  
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Why have I been invited? 
The health care team will be using our plan to look after you.  We would like 
you to take part so we can find out how you have progressed and your 
experiences of being looked after using the plan. 
 
Do I have to take part? 
It is up to you to decide; taking part is entirely optional.  We will describe the 
study and go through this information sheet with you.  We will then ask you to 
sign a consent form to show you have agreed to take part.  You are free to 
withdraw at any time, without giving a reason.  This would not affect the 
standard of care you receive. 
 
What will happen to me if I take part? 
You will be invited to: 
a) allow nursing and research staff to check your progress OR 
b) allow nursing and research staff to check your progress AND take 
part in interviews with researchers 
 
A) Checking your progress 
We would like to note some details about how you are progressing with your 
treatment.  The nursing staff will keep a diary of what treatment you have had 
for continence and how you are progressing.  This information and information 
from your case notes relevant to this study will be used by the research staff 
to monitor your progress. 
 
We would also like to ask you some questions about your condition and 
progress before you start the plan and at six weeks, three months and, for 
some participants, at twelve months after the date you had your stroke. 
We will write to your GP to tell them you are in the study and also to check 
you are still at the same address before we post questionnaires to you at 
home. 
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B) Interviews 
You will be invited to take part in an interview about the hospital management 
of your continence.  This will take place during your stay and will be arranged 
at a time convenient for you and to fit in with your care and treatment.  We 
anticipate that the interview will last between half an hour and one hour. 
 
The interview will take place in a quiet and private location on the unit.  It will 
be carried out by a member of the research team who is experienced at 
interviewing patients.  The researcher will ask you if you are happy to have 
the interview tape-recorded; you may refuse if you prefer not to have your 
comments recorded but still continue in the project.  Names will not be 
recorded and all tapes will be destroyed within three months of project 
completion. 
 
You may find talking about continence upsetting.  You will be able to stop the 
interview at any time and nursing and medical staff will be there to support 
you if you are upset during or after the interview.  If you would like support, 
please contact: 
 
Ward:  Sister  
  
 
Ward:  Sister  
  
 
If you would like a relative or friend to come along to the interview with you, 
they would be very welcome. 
What are the possible disadvantages of taking part? 
We will ask you to talk about how your continence has been assessed and 
managed, and we realise this is a sensitive subject.  We will do all we can to 
minimise embarrassment for you and any relative or friend you have with you.  
The interview has been developed very carefully to focus on assessment and 
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treatment received rather than focussing on the details of your continence 
problems. 
What are the possible benefits of taking part? 
You may welcome the opportunity to discuss the care you have received and 
to suggest ways this could be improved.   
 
Will my taking part in the study be kept confidential? 
Yes.  We will follow ethical and legal practice and all information about you 
will be treated in confidence.  The details are included in Part 2. 
 
This completes Part 1.  If the information in Part 1 has interested you 
and you are considering participation, please read the additional 
information in Part 2 before making any decision. 
 
Part 2 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw from the study at any time, without giving a reason.  
If you withdraw from the study, we will destroy all the information you have 
provided. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak 
to the researchers who will do their best to answer your questions (01772 
893643).  If you remain unhappy and wish to complain formally, you can do 
this through the NHS Complaints Procedure.  Details can be obtained from 
the hospital. 
 
In the event that something does go wrong and you are harmed during the 
research and this is due to someone’s negligence then you may have grounds 
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for a legal action for compensation against Lancashire Teaching Hospitals 
NHS Foundation Trust but you may have to pay your legal costs.  The normal 
National Health Service complaints mechanisms will still be available to you (if 
appropriate). 
Will my taking part in the study be kept confidential? 
All research data will be treated and stored according to the Data Protection 
Act (1998) and the Caldicott Principles.  All data will be treated as confidential 
according to the Medical Research Council definition: “any information 
obtained by a person on the understanding that they will not disclose it to 
others” (MRC, Personal Information in Medical Research. 2000).  All patients 
who consent to take part will be allocated a code number and all data 
recorded about that patient will be identified by their code number.   
 
All quotations from participants used in reports and publications will exclude 
personal details.  No individuals will be identifiable from them. 
 
Computers used in the study will be password protected.  All paper records 
will be stored in locked filing cabinets in a locked office.  Only research staff 
from the study will have access to the records. 
 
Your personal details will be destroyed at the end of the study.  Data forms 
and interview transcripts will be stored for 10 years in line with the 
recommendations of the Medical Research Council document Good Research 
Practice (2000).   
Data will be stored in a locked cabinet in the programme coordinator's office 
(also locked).  Access will be given only to the research team via the 
programme coordinator. 
 
What will happen to the results of the research study? 
Findings will be shared widely using a range of methods following advice from 
the Programme Patient, Public and Carer Involvement Group. These will 
include: 
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a) Written feedback will be provided to all study participants who would 
like it. 
b) Presentations at a range of stroke and incontinence related 
conferences, for example the International Continence Society, Society 
for Research in Rehabilitation, UK Stroke Forum and Royal College of 
Nursing Continence Forum. 
c) Presentations to appropriate forums within the participating Trusts. 
d) Findings will be disseminated via the Clinical Practice Research Unit 
information sharing channels, for example clinical practice sharing 
meetings, Service User Groups and local conferences. Findings will 
also be shared via the Stroke Research Networks. 
e) We will submit findings to peer-reviewed academic (e.g. Stroke) and 
popular (e.g. Nursing Times) journals to maximise readership. 
 
Who is organising and funding the research? 
The research is sponsored by the Lancashire Teaching Hospitals Foundation 
NHS Trust.  It is funded by the National Institute for Health Research under 
the Programme Grants scheme. 
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, 
called a Research Ethics Committee, to protect your safety, rights, wellbeing 
and dignity.  This study has been reviewed and given a favourable opinion by 
Bradford Research Ethics Committee. 
 
You may keep this information sheet and you will also be given a copy of the 
signed consent form to keep. 
Further information 
Specific information about this research project 
Please contact the Programme Coordinator: 
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Dr Lois Thomas 
School of Nursing and Caring Sciences 
University of Central Lancashire 
Preston 
PR1 2HE 
Email address: lhthomas@uclan.ac.uk   01772 893643 
 
Who you should approach if you are unhappy with the study? 
Please contact Dr Lois Thomas, details as above. 
 
For any concerns during the study 
Please contact the Research Nurse add name or Denise Forshaw, the Trial 
Manager, either on site or as below; 
 
Denise Forshaw      
Trial Manager     Research Nurse 
University of Central Lancashire    
Preston PR1 2HE     
Email address: dforshaw@uclan.ac.uk  email address  
 01772 893713       
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Appendix 23 Exploratory trial: patient
consent form
   
WRITTEN CONSENT FORM FOR PATIENTS 
 
Title of study: ICONS: Identifying Continence OptioNs after Stroke 
Name of Principal Investigator: Professor Caroline Watkins 
Participant Information Number: 
Please initial 
the box 
1. I confirm that I have read and understood the information sheet for 
the above study, dated 31 March 2010 (Version 1). I have had the 
opportunity to consider the information and ask questions and have had 
these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected. 
 
3. I understand that relevant sections of my medical notes and data 
collected during the study may be looked at by individuals from the 
University of Central Lancashire or from Lancashire Teaching Hospitals 
NHS Foundation Trust, where it is relevant to my taking part in this 
research.  I give permission for these individuals to have access to my 
records. 
 
4. I agree to: 
 
Answer questions about my condition and progress 
 
Complete one interview about my care.   
 
 
Allow the interview to be audio-taped and transcribed. 
 
Allow the information I supply to be used anonymously 
in reports, publications or for teaching purposes. 
 
Allow my GP to be informed about my participation in the 
study. 
 
5. I would like a summary of the results of the study when it is completed. 
 
  
-------------------------------   ------------  -------------------- 
Name of participant    Date   Signature 
 
-------------------------------   ----------  -------------------- 
Name of researcher    Date   Signature 
 
Dr Lois Thomas, ICONS Programme Coordinator 
School of Nursing & Caring Sciences 
University of Central Lancashire 
PRESTON, PR1 2HE 
 01772 893643   E-mail lhthomas@uclan.ac.uk 
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Appendix 24 Exploratory trial: outcome
assessment questionnaire
 
 
Patient Outcome Survey 
Six weeks after stroke 
 
 
 
 
Clinical Practice Research Unit 
University of Central Lancashire 
Preston 
PR1 2HE 
Telephone: 01772 895136 
Email: ahadley@uclan.ac.uk 
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How to answer the questions in this booklet 
 
In this booklet, you will find some questions about your health and some questions about 
bladder problems. 
 
Please work through the booklet, answering each question as you go.  At the start of each 
set of questions, there are some instructions on how to answer those questions.  Most of the 
questions can be answered by ticking a box.  Sometimes, you need to write a number in a 
box.  Here is an example of how you would answer if you are completing these questions on 
the fourth of January 2011. 
 
What date is it today?  
     
Day           Month             Year     
 
Please answer every question, unless the instructions tell you to do something else.  Some of 
the questions may seem to be asking the same thing, but there are important differences and 
we need to know how you feel about each. 
 
Do not think too long about any question.  What comes into your head first is probably better 
than a long, thought-out answer.  If you have a problem answering any question, please write 
that problem beside the question. 
 
Your name does not appear anywhere on this booklet.  Only the study team will know 
who answered the questions.  We will not tell anyone else what you said.  
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Section 1: Where you live 
1 What date is it today? 
(Please write the date in the boxes provided.  For example, 1st January 2011 would be 
written as)  
     
    Day        Month             Year     
2 Who has completed this form? 
(Please tick all that apply) 
 
          Patient   
          Relative/Friend     
          Researcher          
          Professional Carer   
3 Are you in hospital? 
 (Please tick one box) 
 
           Yes 
 No 
If you ticked ‘yes’, please go to Section 2. 
If you ticked ‘no’, please continue with Question 4. 
 
The next few questions are about where you live. 
4a Where are you (the patient) living now? 
(Please tick one box only) 
 
          House      
          Flat             
          Sheltered housing              
          Residential home             
          Nursing home 
          Other 
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4b If you ticked house/flat/sheltered housing please indicate who else lives with you 
 (Please tick one box only) 
          I live alone    
          I live with a partner              
          I live with another family member or friend 
 
5 When did you start living here?   
(Please tick one box only) 
          Before I had my stroke               
          Immediately I left hospital after my stroke 
          I moved here at some point after discharge from hospital 
(If you pick the last option please write the date you moved in the boxes below) 
Please write the date in the boxes provided.  For example, 1st January 2011 would be 
written as  
     
    Day        Month             Year     
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Section 2: Your state of health 
 
The next few questions are about how you are at present.  For each of the questions below, 
please tick one box that is nearest to your ability today. 
1       Bathing: do you need any help to get in and out of the bath/shower? 
(Please tick one box only) 
          Need help 
          Independent 
 
2 Stairs: do you climb stairs? 
 (Please tick one box only) 
          Unable to manage or have not tried stairs  
          With help                        
          Independent 
 
3 Dressing: do you need any help with dressing? 
(Please tick one box only) 
          Dependent                 
          Need help, can do about half                   
          Independent (includes buttons, zips, laces) 
 
4 Mobility: do you need any help to walk about indoors? 
(Please tick one box only) 
          Immobile 
          Can get about in wheelchair 
          Need help/supervision of 1 person                
          Independent 
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5 Transfers: do you need any help to get in and out of bed? 
(Please tick one box only) 
          Unable to sit out of bed                            
          Need help of 2 people but can sit out of bed 
          Need help/supervision of 1 person 
          Independent 
 
6 Feeding: do you need any help with feeding or cutting up your food? 
(Please tick one box only) 
          Dependent 
          Need some help, e.g. cutting 
          Independent in all actions 
 
7 Toilet: do you need any help in the toilet (getting on or off, dealing with your clothes) 
(Please tick one box only) 
          Dependent 
          Need some help                     
          Independent in all actions 
 
8 Grooming: do you need any help with brushing teeth, combing hair, or (men only) 
shaving? 
(Please tick one box only) 
          Need help                
          Independent for face/hair/teeth/shaving 
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9 Urinary function: do you have any problems controlling your bladder? 
(Please tick one box only) 
         Incontinent (or catheter)                
         Occasional accident                   
         Fully continent (no accidents) 
 
10 Bowel function: do you have any problems controlling your bowels? 
(Please tick one box only) 
         Incontinent (or cannot go without enemas)                
         Occasional accident               
         Fully continent (no accidents)  
  
The next question is about how you would rate your general health. 
11 As a result of your stroke, how would you rate your general health? 
(Please tick one box to show which answer is most appropriate for you) 
 
         I am fit and well with no problems 
 
         I have some problems but I am able to perform all usual duties and activities 
 
I am unable to perform all previous activities but I am able to look after my own affairs             
without assistance 
 
         I require some help with everyday activities but I am able to walk without assistance 
 
I am unable to walk without assistance and I am unable to attend to my own bodily 
needs without assistance 
 
         I am bedridden and require constant nursing care and attention 
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Section 3: Your experiences of bladder problems 
 
The next few questions are about your experiences of bladder problems.  Please tick one 
box for each question. 
1 How often do you experience urinary leakage? 
(Please tick one box only) 
         Never 
         Less than once a month 
         One or several times a month 
         One or several times a week 
         Every day and/or night 
         Other 
 If you have ticked ‘other’, please specify how often in the box below: 
 
 
 
 
2 How much urine do you lose each time? 
(Please tick one box only) 
         None 
         Drops or little                 
         More                    
         Other 
 If you have ticked ‘other’, please specify how much in the box below: 
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The next four questions are about how you have been on average over the past 4 weeks. 
3 How often do you leak urine?  
(Please tick one box only) 
 
        Never 
        About once a week or less often               
        Two or three times a week 
        About once a day                  
        Several times a day               
        All the time                  
 
 
4 We would like to know how much urine you think leaks. 
How much urine do you usually leak (whether you wear protection or not)?  
(Please tick one box only) 
 
        None 
        A small amount                
        A moderate amount               
        A large amount 
 
 
 
 
5 Overall, how much does leaking urine interfere with your everyday life? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
 
   0         1         2         3         4         5         6         7         8         9         10 
Not at all                                                                                                   A great deal 
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6 When does urine leak? 
(Please tick all that apply to you) 
          Never – urine does not leak 
          Leaks before you can get to the toilet 
          Leaks when you cough or sneeze 
          Leaks when you are asleep 
          Leaks when you are physically active/exercising 
          Leaks when you have finished urinating and are dressed 
          Leaks for no obvious reason 
          Leaks all the time 
The next few questions ask some more about your experiences of bladder problems.   
7 Thinking over the last 12 months, have you ever found you leak urine/water when you 
don’t mean to? 
(Please tick one box only) 
          Yes 
          No 
8 Do you ever leak urine when you do the following?  
(Please tick all that apply)  
          Never – urine does not leak 
          Sneeze 
          Exercise 
          Cough 
          Laugh 
          Bend 
          Stand up 
          Other 
If you have ticked “other”, please specify in the box below: 
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9  When you have the urge to pass urine, does any leak before you get to the toilet?  
(Please tick one box only) 
          Most of the time 
          Sometimes    
          Occasionally 
          Never 
 
10 How much do you leak usually?  
(Please tick one box only) 
          A few drops                                      
          A dribble                                   
          A stream 
          A flood                                              
 
11 When you leak urine, are you?  
(Please tick one box only) 
          Soaked 
          Wet 
          Damp 
          Almost dry                                        
 
12 How would you describe the amount of urine you leak? Is it 
(Please tick one box only) 
          Not noticeable                                 
          Noticeable to yourself only                 
          Potentially noticeable to others 
          Noticeable to others                      
          Don’t know 
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13 When you first feel the need to pass urine how strong is the urge to go usually? 
(Please tick one box only) 
          Overwhelming 
          Very strong 
          Strong 
          Normal 
          Weak 
          No sensation 
 
14 Do you have difficulty holding urine once you feel the urge to go? 
(Please tick one box only) 
          Most of the time 
          Sometimes 
          Occasionally 
          Never 
 
15 How many times do you go to the toilet to pass urine during the daytime?  
(This is during waking hours, please put your average number in the box below, e.g. 3 times 
would be            times) 
 Times 
 
16 How often do you get up at night to pass urine, if at all?  
(Please tick one box only) 
          Not usually 
          Once a night                    
          Twice a night                
          Three times a night 
          Four times a night or more            
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Section 4: What you think about your health 
 
The next few questions are about what you think about your heath.  For questions 2 to 6 
below, please tick one box that gives the best picture of what you think about your health. 
 
1 How well do you feel at the moment? 
(Please tick one box that best describes how you are feeling)  
 
          No illness 
          Illness present, minimal/no symptoms 
          Definite illness, mild/controlled symptoms 
          Definite illness, symptoms not under control 
          Definite illness, needs vigorous treatment/potentially life threatening situation 
 
For questions 2 to 5, please tick one box only for each question 
 
2 
          I have no problems in walking about 
          I have some problems in walking about 
          I am confined to bed 
 
3 
          I have no problems with self care 
          I have some problems washing or dressing 
          I am unable to wash or dress myself 
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4 
          I have no problems performing my usual activities  
          (e.g. work, study, housework, family or leisure activities) 
          I have some problems in performing usual activities 
          I am unable to perform my usual activities 
 
5 
          I have no pain or discomfort 
          I have moderate pain or discomfort 
          I have extreme pain or discomfort 
 
6 
          I am not anxious or depressed 
          I am moderately anxious or depressed 
          I am extremely anxious or depressed 
 
 
APPENDIX 24
NIHR Journals Library www.journalslibrary.nihr.ac.uk
560
For each of questions 7 to 28, please put a tick in the one box that is nearest to how you feel: 
7  I worry about not being able to get to the toilet on time. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
8  I worry about coughing and sneezing because of my urinary problems or incontinence. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
9 I have to be careful about standing up after I’ve been sitting down because of my 
urinary problems or incontinence. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
10 I worry where the toilets are in new places. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
11 I feel depressed because of my urinary problems or incontinence. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
12 Because of my urinary problems or incontinence, I don’t feel free to leave my home for 
long periods of time. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
13 I feel frustrated because my urinary problems or incontinence prevents me from doing 
what I want. 
Extremely  Quite a bit  Moderately  A little  Not at all 
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For each of questions 7 to 28, please put a tick in the one box that is nearest to how you 
feel:: 
 
14 I worry about others smelling urine on me. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
15 Incontinence is always on my mind. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
16 It’s important for me to make frequent trips to the toilet. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
17 Because of my urinary problems or incontinence, it’s important to plan every detail in 
advance. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
18 I worry about my urinary problems or incontinence getting worse as I grow older. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
19 I have a hard time getting a good night of sleep because of my urinary problems or 
incontinence 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
20 I worry about being embarrassed or humiliated because of my urinary problems or 
incontinence 
Extremely  Quite a bit  Moderately  A little  Not at all 
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For each of questions 7 to 28, please put a tick in the one box that is nearest to how you feel: 
 
21 My urinary problems or incontinence make me feel like I’m not a healthy person. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
22 My urinary problems or incontinence makes me feel helpless. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
23 I get less enjoyment out of life because of my urinary problems or incontinence. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
24 I worry about wetting myself. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
25 I feel like I have no control over my bladder. 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
 
26 I have to watch what or how much I drink because of my urinary problems or 
incontinence. 
 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
27 My urinary problems or incontinence limit my choice of clothing. 
 
Extremely  Quite a bit  Moderately  A little  Not at all 
 
 
28 I worry about having sex because of my urinary problems or incontinence. 
 
Extremely  Quite a bit  Moderately  A little  Not at all 
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THANK YOU VERY MUCH FOR ANSWERING OUR QUESTIONS! 
Please check that you have answered all the questions in this 
booklet.  When you have finished, please return the booklet to us in 
the envelope provided.  No stamps are needed. 
If you would like to ask us anything about the questions or the study 
in general, please contact Lois Thomas, Denise Forshaw or Alison 
Hadley at the following address: 
ICONS Study 
Clinical Practice Research Unit 
University of Central Lancashire 
PRESTON 
PR1 2HE 
Telephone: 01772 895136 
Email address: ahadley@uclan.ac.uk
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Appendix 25 Patient interview schedule:
intervention groups
Identifying Continence OptioNs after Stroke: Phase II
exploratory trial – questions for interviews with patients,
version 1
Overview of interview: consent, guidance and thanks
Consent will already have been gained for participation in the study. So prior to the interview, the
researcher will check (a) that the person is still willing to participate; (b) that they understand the interview;
and (c) to determine if the person is still willing to be audio-recorded. Once the researcher is assured that
the person is informed and still willing to participate, the semistructured interview would commence.
These questions aim to be prompts to allow the researchers to broadly cover the same ground with each
person, but the schedule will not necessarily be rigidly adhered to.
If the person has already addressed a topic, then a question covering that topic later in the interview may
well be skipped (unless the researcher feels that asking it will result in an additional perspective).
If a person becomes tired or indicates they wish to terminate the interview, then the remaining
questions will not be asked. If the person would like to continue with the interview at a later date,
either face-to-face or over phone, then this could be arranged at a mutually convenient time.
If a person chooses not to answer a question or appears reluctant to answer a question or provide more
detail, then they will not be pressed to do so.
The person will then be thanked for agreeing to take part in the interview, told that we think that their
views are really important to us and that they should feel free to be frank about the things they tell us and
that we will assure their anonymity and confidentiality.
The questions have been grouped to help focus the person’s thoughts about each component of the
package with some introductory questions to help engage and settle the person into the interview.
Before the start of the conversational aspect of the interview some key data will be collected.
Please note: the researcher should establish early on the preferred language to use in relation to terms
such as voiding; for example, if the carer prefers to talk about emptying their bladder or passing water or
having a wee, etc., and then use this language as appropriate. If the term ‘going to the toilet’ is used, the
researcher should be sure that the participant does mean voiding rather than defecating and they should
be aware that ‘going to the toilet’ is not necessarily the same as going to the toilet and voiding.
Section 1: introductory questions
These first questions are about how you feel about your urinary symptoms:
1. Can you tell me a little bit about how your urinary symptoms have affected you?
2. What impact have they had on you?
3. How have you been feeling about your urinary symptoms?
4. How confident are you that you will be able to get over these symptoms?
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Section 2: questions about the continence programme
The next questions are fairly general ones that help us to find out about your general impressions of the
continence programme (the programme that is helping you train your bladder):
1. How has the programme helped you?
2. Imagine that a friend asked you to explain the programme. What would you tell them?
3. What are your expectations of the programme for yourself?
¢ What would you like to see happening by the time you leave hospital?
4. What do you think has been the best thing of taking part in the programme?
5. Has there been anything that you found difficult?
¢ Please explain.
¢ What did you do to overcome this?
¢ How did this help?
¢ What could we have done to help?
6. How have you found sticking to the programme?
7. Has it been hard to stick to the programme at times?
¢ Can you tell me a bit more about this?
8. What has helped you stick to the programme?
9. How are you feeling about continuing with the programme?
10. Have you spoken about the programme with family or friends?
¢ Who have you discussed it with?
¢ If you haven’t discussed it, would you like to?
11. If someone had a similar problem to you, would you suggest that they followed the programme?
¢ What advice would you give them?
¢ What would you do to encourage them?
12. Progress can be slow. If your symptoms are not better before you leave hospital, how would you feel
about that?
¢ Would you carry on with the programme?
Section 3: questions about the information you were given
I’d like to know about the information you were given. This was about how your bladder works and how
a stroke can give you bladder problems. You learned about the programme and the reasons why it could
be helpful. You also learned about how to improve emptying your bladder:
1. What was the most useful thing you learned from the education leaflet?
2. How was this useful?
3. We’d like to know what you think about the education leaflet.
¢ What did you like about the education leaflet?
¢ What did you not like about the education leaflet?
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4. How could we make the education leaflet better?
¢ Too much information, or too little, or about right?
¢ Too difficult? Too boring?
¢ Couldn’t remember it all?
5. How helpful was the section on how the bladder works?
¢ How was it helpful?
6. You were taught about distraction and relaxation strategies. How well did the nurses explain how
they work?
7. How helpful is it to know how things are supposed to work?
8. Is there anything else you would like in the education leaflet?
9. How well did the nurses answer any questions that you had?
Section 4: questions about the voiding programme/bladder
training component
These questions are about the BT part of the programme to help you get back to the pattern of voiding
(passing urine/having wee/passing water/emptying bladder) before you had your stroke:
1. What do you think of the programme?
¢ What was the biggest challenge?
¢ What was the easiest part?
2. Did you feel that the programme was designed especially for you?
3. Did you have enough support?
4. How well did you understand what you had to do?
¢ What could have been made clearer?
5. Was anything about the programme a surprise to you?
¢ What was this?
6. Sometimes people following a programme have ‘bad or not so good days’ when it doesn’t seem to
be working.
¢ Have you had a day like this?
¢ What did you do?
¢ What helped you to get ‘back on track’?
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Section 5: questions about the diary component
These questions ask you to think about the diary you have been filling in about your voiding habits:
1. How did you find filling in the diary? (Easy/difficult, interesting/boring/chore?)
2. When did you fill it in? (Every few hours, every day, kept forgetting about it?)
3. Did the diary help you become more aware of when you have a wee/when you pass urine/your
voiding pattern?
¢ Tell me more.
¢ Has the diary shown you what helps and what doesn’t help?
¢ Please tell me more.
4. How could we improve the diary?
Section 6: questions about the pelvic floor exercises
These questions ask you to think about the pelvic floor exercises:
1. How easy was it to learn the exercises?
2. How easy is it for you to do the exercises?
3. Tell me about how you have fitted the exercises into your day.
¢ When do you do them?
¢ Does someone remind you?
¢ Does someone check you have done them?
4. Do you always do the exercises twice a day?
¢ If not, what stops you?
5. How much have the exercises helped?
¢ When did you first notice a difference?
¢ What has changed?
Section 7: questions about the outcome criteria
These questions ask you about the ways the researchers can find out if the programme is working:
1. How has the programme helped your problems with your bladder?
2. We hope that the programme will stop patients being incontinent, or reduce the number of times that
they are incontinent. Are there any other things that the researchers need to know?
¢ You might not feel the need to go to the toilet so often.
¢ You can ‘hold on’ for longer.
¢ You might like home support (visit from a specialist).
¢ You might like a telephone number for advice and support.
¢ You might want advice about coping with your bladder problems when you go out.
¢ You might want to know about other things that can help you manage with your bladder problems.
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Section 8: final question(s)
If they are still having problems:
1. How confident are you that you can stick to the programme over the next 4 weeks?
¢ Do you have any anxieties about it?
¢ What kind of things will help you to stick to the programme?
¢ What kind of things may stop you sticking to the programme?
These questions help to round-off the interview:
1. What is the most important thing we should know about your experience of the programme?
2. What could make the programme better for you?
3. Is there anything else you would like to tell us?
Thank you so much for taking part; it’s been very interesting talking to you.
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Appendix 26 Health professional normalisation
process theory interview schedule
Health professional questions using normalisation process
theory framework (intervention groups)
Dimensions Outcome questions NPT questions Prompts
Coherence/sense-making: how is a complex intervention made coherent by its users?
Differentiation What has the SVP changed
in your current practice?
Is it worse or better that
what you were doing
before?
Do you think your practice is
different now from what it
was before ICONS?
What is the same, and what
is different?
What has the SV
programme changed?
For you?
For patients?
For different staff groups?
Individual specification Does the programme make
sense to people?
What do you understand the
purpose of the SVP to be?
Has using the SVP helped
you as an individual in
providing continence care?
Do you think people
understand the SVP and
what they have to do?
Are there any groups who
have particular difficulties?
Senior staff?
HCAs?
Patients?
Communal specification How did the team look after
patients with UI after stroke
before ICONS?
Has using the SVP helped
the team in providing
continence care?
Is the SVP compatible with
what you do?
Do you think people agree
about the SV programme in
terms of its:
Purpose?
How it works?
Do all stakeholders agree
on what to do and why?
Qualified/non-qualified?
Nursing/medical?
Patient/relative?
Different wards?
Internalisation What were your initial
impressions of the
programme?
Does it make sense to use
the SVP to look after
patients with UI?
What do you think of the
content of the SVP?
Do you think people like the
new programme, or not?
What are the costs and
benefits of doing things this
way? Would everyone
agree?
Are there particular aspects
that are liked more or less?
Content: PV? BT? Praise?
Paperwork?
Support?
Cognitive participation: the relational work that people do to build and sustain a new practice
Initiation
People drive the new
practice forward
How did you find out about
your unit’s involvement in
the SVP?
Has there been enough
direction for the
programme?
Who are the key people
driving the implementation
of the programme?
Has this changed over time?
How have different groups
been influential?
Management?
External staff?
Ward staff?
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Dimensions Outcome questions NPT questions Prompts
Enrolment
Agreement on the new
practice
How do you see your role
with respect to the SVP? Do
you see this as part of your
role/someone else’s role?
Has involvement been
sufficient?
Do people think they should
be doing this?
Is everyone on board, or are
some people more involved
than others?
Are any areas not involved
that you think should be?
For example:
A&E?
Nurses?
Medical/others?
Legitimation
People buy in and
organise themselves
How have the team worked
together to change their
practice?
How have the team
organised themselves to
deliver the SVP?
Did anything get in the way
of the programme working
well?
Is the SVP running smoothly
now, or are there still
glitches?
What sort of changes have
you had to make to get the
programme running
smoothly on your ward?
Has it affected groups
differently? For example:
Ward managers?
Qualified staff?
HCAs?
Activation
People work together
to develop the new
practice
What has helped staff
introduce the SVP?
How has the introduction of
this SVP compared with
other practice development
initiatives?
Has it affected how work is
organised on the ward?
How?
What about how:
People are allocated to
different areas of the
ward?
Communication occurs?
The routine of the day
works?
Night/day staff work?
Collective action: the operational work that people do to enact a new practice
Interactional workability
(How does the work get
done?)
How did using the SVP
affect your interactions with
patients?
How did using the SVP
affect your interactions with
other staff?
How did you act to solve
problems?
Is it realistic to do the SVP
on a day-to-day basis?
Can people do what is being
asked of them? Have there
been any problems other
than the ones you’ve
mentioned (summarise)?
Can different groups do it?
Staff on all shifts?
All days of the week?
Patients?
Relational integration
(Staff trust each other’s
work and expertise)
How did introducing the SVP
change the management of
continence on the unit?
Have you noticed any other
changes (or spin-offs) from
the introduction of the SVP
on the unit?
Do you think everyone
would feel confident that
things are being done right?
Are you confident that the
programme is being done as
it should be?
By everyone?
Has it affected interactions
between:
Staff and patients?
Qualified/HCA?
Different ward areas?
Different professions?
Day and night staff?
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Dimensions Outcome questions NPT questions Prompts
Skill set workability
(How is the work
distributed?)
How did using the SVP
affect ‘who does what’ in
the management of
continence?
What did you think about
the training you got?
Is the work allocated to the
right people?
Do people have the right
skills and knowledge now?
Is everyone trained up as
much as they need to be?
Do different groups have
the ability to do the SV
programme?
HCAs?
Patients?
Contextual integration
(How is the work
supported?)
Are there resource
implications of the SVP?
Are there any other
implications of using the
SVP?
Is there sufficient support
and resources for the
programme?
What sort of things have
supported the
implementation of the SVP?
Time?
Money?
Staff?
Reflexive monitoring: the appraisal work that people do to assess and understand how a new practice affects
them and others
Systematisation How did you assess the
value of the SVP?
How does this fit with other
systems in place to monitor
and evaluate practice?
Is the programme working?
How do you know if the
programme is working or
not?
Do you know this for
everyone?
What would success be for
you? What would failure
be?
Do you think this would be
the same for the patients?
Communal appraisal What factors might affect
the decision of the team to
support the SVP?
What factors might affect
the decision of the team to
continue to use the SVP
when our project ends?
On the basis of what you
have seen of its results,
would the ward staff think it
worth continuing?
Do you think people would
agree about whether it
works or not?
Ward managers?
All groups of staff?
Patients?
Individual appraisal What factors might affect
your decision to support the
SVP?
What factors might affect
your decision to continue to
use the SVP when our
project ends?
If it was up to you, would
you carry on doing it?
What would affect your
decision?
Reconfiguration Do you think using the SVP
has affected the way clinical
practice is organised?
How easy was it to
implement?
If you could change one
thing to improve the
programme, what change
would you make?
Do you think it is being
done according to the
instructions?
Has the programme been
modified in any way to suit
the ward, other than what
you have already
mentioned?
For better? For worse?
How compatible was it
with other aspects of
stroke patients’ care?
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Appendix 27 Trial manager’s report
Trial manager’s report
Site name:
Narrative report (describe any major features of set up and running of the trial in this site that could be pertinent
to outcome):
Dimension Low Neutral/mixed High
Comment,
justification
Agreement/
engagement
Ward staff resistant, reluctant
to engage with programme
Staff enthusiastic, strongly
motivated to engage
Recruitment Low or inconsistent
recruitment
High steady recruitment rate
Research
nurse
Weak involvement,
problematic or inconsistent
presence
Strong, competent, consistent
research nurse presence
Ward
leadership
Inconsistent leadership at
ward level
Ward manager consistently
drove and supervised
programme
Fidelity Deviations from programme,
problems with implementation
Programme delivered
smoothly, few problems
Training/
support
Training/support missed, lack
of attendance
Training/support well attended
Staffing Frequent/extended staffing
problems with permanent
staff
Ward staffing maintained at a
reasonable level
ICONS
staffing
Frequent/extended staffing
problems with ICONS staff
ICONS staffing maintained at a
reasonable level throughout
Workload Heavy: high turnover,
dependency, number
Moderate: uncommented on
Adverse
Incidents
Ward disruptions, events that
interfered with programme
No unforeseen adverse
incidents
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Appendix 28 Example of normalisation process
theory site summary
S ite code:
NPT code Dimension Low Neutral/mixed High
Comment,
justification
Agree with trial
manager/soft
systems
analysis?
Differentiation No previous
intervention:
mainly
containment
✗ Programme
components
already in place
We were doing
very little before
(ID1.1)
Agreement
Understanding
Definition Tight: only
frank
incontinence
✗ Loose: includes
people with
frequency
No reference
Understanding/
agreement
Problems with
interpretation/
agreement
✗ ✗
a
Good
understanding
and agreement
Some problems
with
understanding
reviews
Value,
importance
Value Continence
not a priority
✗ High value
placed on
continence
Incontinence
wasn’t always a
priority
Key people Champion: RN Inconsistent or
distant
championing
✗ Strong and
consistent
programme
leadership
RN was good, but
she left
Champion:
ward
Inconsistent or
distant
championing
✗ Strong and
consistent
programme
leadership
RN and ICONS
HCAs appeared
to be more
referenced
Enrolment Involvement RN plus ICONS
HCA run
programme
✗ Ward staff fully
involved in
programme
Most days
covered by ICONS
or bank staff
(ID6.5)
Recruitment Low or
inconsistent
recruitment
High steady
recruitment
rate
Legitimation
Activation
Work
allocation
HCAs deliver
toileting alone
unhappy about
it
✗ All ward staff
involved in
delivering
programme
HCAs in the main
did toileting
Workability Fidelity Deviations
from
programme,
problems
✗ Programme
delivered
smoothly, few
problems
‘It worked well’
some confusion
about weekly
review
Skills Training/
support
Training/
support missed,
inadequate
✗ Training/
support
adequate, well
received
‘The training was
fine’
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NPT code Dimension Low Neutral/mixed High
Comment,
justification
Agree with trial
manager/soft
systems
analysis?
Resources Staffing Frequent/
extended
staffing
problems
✗ Staffing
maintained at a
reasonable level
Workload Heavy: high
turnover,
dependency,
number
✗ Moderate:
uncommented
on
Comment on
busy ward
Appraisal Outcomes Lack of visible
success,
patchy, few
✗ Visible success,
staff agree it is
working
‘It’s better’
Continuation Not continued ✗ Continued Toileting
continued
RN, registered nurse.
a Some evidence that understanding/agreement was high, but also evidence it was neutral.
Shading represents agreement between trial manager sites ratings and soft systems analysis.
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Appendix 29 Soft systems analysis interview
schedule
Systems analysis of post-stroke continence management
The interviews aim to:
l explore participants’ understanding of the organisation and delivery of urinary continence care
throughout the stroke pathway
l identify how organisational issues (patient, staff, team, service and setting) shape the delivery of
post-stroke continence care
l determine barriers and facilitators which are anticipated to influence the degree to which a SVP
algorithm can be embedded in acute stroke care.
Interview schedule
Introductions
Introduction of research staff.
Explain purpose of the interview.
Check provision of relevant study information sheet.
Confirm informed consent.
Clarification of role
Ask for a description of the participant’s role.
Confirm role setting and operational boundaries in terms of stroke pathway:
l prevention/acute/rehabilitation/LTC
l hospital/outpatients/community.
Check any previous involvement in:
l clinical management of UI
l relevant education and training
l relevant service development
l research studies.
Systems analysis
Provide visual map of generic stroke pathway.
Confirm appropriateness of map (to be developed iteratively during interviews).
Confirm that the interview will now focus on the management of a patient’s post-stroke UI across the
whole pathway.
Continue to use the map as a visual prompt.
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Customers (size and significance of the problem)
When in the pathway is patients’ urinary continence status assessed?
How is urinary continence assessed? Any differences in assessment in pathway components (e.g. acute
and rehabilitation units; hospital and community)?
Who assesses continence?
Are any patients or problems with UI missed?
To what extent do you think current continence care meets needs? Are all needs met? Whose needs are
not met by this service and why?
Are families involved in continence management? Does involvement differ in different components of the
pathway (e.g. hospital and community)?
For patients who experience UI (and their families), what information is provided, when and by whom?
Who monitors the information for patients (before it is given out)? How is this done?
Actors
Which staff are responsible for aspects of the management of UI? Consider:
l assessment
l planning/goal-setting
¢ delivering generalist interventions (providing continence care within the stroke team)
¢ delivering specialist interventions (integrating specialist continence practitioners or services)
l co-ordinating individual patients’ continence care.
What are the core activities of staff? Do these differ across the pathway?
What education and training do staff have in relation to continence care?
What links are there with specialist continence services across the pathway?
For each link:
l When are patients referred and why?
l How are patients referred and what information is shared (at referral and end of
specialist intervention)?
l How is specialist and generalist (delivered by stroke service staff) continence care integrated?
Transformations
What are the main aims of continence management at different parts of the stroke pathway
(e.g. cure/containment)?
How easy is it for patients to receive different continence interventions at different times (e.g. for stroke
patients in community settings, how can they reaccess continence assessments?)
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Can you tell me about relevant documentation/protocols which describe plans for continence management
across the pathway?
l Referral processes?
l Records, methods, storage, access?
Are any aspects patient held?
How are records monitored or audited? Who is involved in this?
World view
What aspects of post-stroke UI do you think should be able to managed within the stroke service?
What is good about the management of post-stroke UI?
Why is this? Who else thinks so?
What is not so good about the management of post-stroke UI care?
Why is this? Who else thinks so?
What opportunities are there for sharing information (e.g. new research) about continence management
to relevant staff across the pathway?
Are data about UI (e.g. audit and evaluation information) shared across the pathway? Who takes
responsibility for this?
What would be the key levers for change if you wished to alter the management of post-stroke UI in the
acute stroke phase?
Who would be the key individuals that you would need to influence?
What do you think the key obstacles would be?
Are there any examples of successful research or service development projects about post-stroke UI?
Have any projects not been successful? If so, who do you think they were not?
Owners
Have commissioners made any specific recommendations or requirements about the management of
post-stroke UI?
Are any aspects of post-stroke UI included in service specifications or business plans?
Who do you anticipate would be involved in considering the results or feedback from any evaluation
studies or audits (e.g. Sentinel Stroke Audit) that included aspects of continence management?
Has continence ever been the key/sole issue, or is it included as one aspect of the whole package of stroke
care? To what degree to commissioners get involved in these types of activity?
In your experience, have issues around UI cropped up in any patient/public consultation activity?
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Environment
What do you think the different environmental challenges in delivering post-stroke urinary continence care
across the stroke pathway?
l Equipment and resources.
l Practicalities of managing UI in hospital compared with home.
Interview closure
Is there anything else you’d like to tell me about the management of UI after stroke that you feel we
should have asked you?
Many thanks for your time.
Confirm any arrangements for checking accuracy of interpretation of views.
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Appendix 30 Total staff time spent toileting
one patient on one occasion, with associated cost
Patient 1a Patient 2b Patient 3c Patient 4d
Average total staff time with patient (minutes) 5.75 11.79 25.30 33.69
Proportion of time
Band 2 0.46 2.62 5.37 11.52 15.33
Band 3 0.18 1.02 2.10 4.50 5.99
Band 4 0.05 0.29 0.59 1.26 1.68
Band 5 0.20 1.14 2.35 5.04 6.71
Band 6 0.08 0.48 0.98 2.11 2.81
Band 7 0.03 0.20 0.41 0.88 1.17
Associated cost (£)
Band 2 0.30 0.78 1.60 3.42 4.56
Band 3 0.33 0.34 0.70 1.50 2.00
Band 4 0.39 0.11 0.23 0.49 0.65
Band 5 0.48 0.55 1.12 2.41 3.21
Band 6 0.57 0.28 0.56 1.21 1.61
Band 7 0.69 0.14 0.28 0.60 0.81
Cost per patient per occasion (£) 2.19 4.49 9.65 12.84
a Independent.
b Transfers with the help/supervision of one.
c Needs help of two but can sit out of bed.
d Unable to sit out of bed/needs hoist.
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Appendix 31 Mean cost of receiving face-to-face
training per site
Staff type Cost per staff type per hour (£) Total staff (from four centresa) Cost (£)
Ward managers/sisters 58 4 464
Ward sister 50 7 700
Staff nurse 41 38 3116
Research nurse 25 2 99
HCA 21 29 1218
Physiotherapists/therapy assistants 34 3 204
Occupational therapists 34 2 136
Assistant practitioners 22 6 264
Average cost/centre 1550
a Data not available from four centres.
All staff costs are based on Curtis (2012),183 except for the research nurse, which is based on the original application.
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Appendix 32 Aphasia-friendly consent form
 
        
 
 
 
ICONS 
Identifying Continence OptioNs after Stroke 
 
 
Main researcher:  
 
Professor Caroline Watkins   
 
Researcher: 
Dr Lois Thomas     
 
School of Nursing & Caring Sciences 
University of Central Lancashire  
Preston 
PR1 2HE 
 
 01772 893643 
 
 
email address: lhthomas@uclan.ac.uk 
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I have read  and understood the 
information sheet.  
 
 YES  
 
 
 
 
I have had time to think about  the 
information and ask questions.   
                                                           
  YES  
 
 
 
 
I am happy    with the answers. 
    
   YES  
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I understand that I can stop at any time.  
I do not have to give a reason. 
                                                       
 YES  
 
 
 
 
 
I will answer questions about my condition     
and progress 
 
 YES  
 
 
 
 
I will allow researchers to look at my medical notes. 
  
 
 YES  
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I will take part in 1 interview about my care. 
 
 YES  
 
 
I will allow the interview to be audio-taped      
and typed up. 
 
 YES  
 
 
I understand that people will be told about the study but 
my name will never be used. 
 
 YES  
 
 
 
I understand that my GP will be told I am in the study. 
 
 YES  
 
APPENDIX 32
NIHR Journals Library www.journalslibrary.nihr.ac.uk
590
I will allow the information I supply to be used 
anonymously in magazines, reports,  lectures 
and conferences. 
 
 YES  
 
 
I would like to see the results of the study  when it 
is completed.  
 
                                                      
 YES  
 
 
-------------------------- --------------                  --------------- 
 
Name of participant              Date                           
Signature 
 
 
--------------------------              --------------                  -----------
---------- 
Name of researcher            Date                           
Signature 
 
 
--------------------------              --------------                  -----------
---------- 
Name of witness                  Date                           
Signature 
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Appendix 33 Evidence to support hypotheses
from soft systems analysis
Thinking
Hypothesis: the SVP changed hearts and minds about UI from it being a barrier to rehabilitation to a legitimate focus of
planned, therapeutic activity
Balancing clinical priorities Incontinence being important (in whatever context) relative to other interventions
Rehabilitation Continence as an outcome (rather than mediator) of rehabilitation endeavour; goal-setting,
progress review
Planning
Hypothesis: the SVP made a structure for UI care explicit, enhancing consistent, knowledge-based delivery
Distributed leadership Multiple people leading continence issues; co-ordinated approaches
Knowledge and skills Needs-led education and training around continence
Clinical geography Synergy between the clinical environment and continence work
Doing
Hypothesis: the SVP helped staff to make the shift from an organisational approach to continence that was haphazard,
routine and selective to one that promoted regularity, inclusion and individualised management
The importance of routine Evidence of regularised approaches to managing continence; patterning care
Integrated working Integrated working around continence; different professional perspectives; ‘everyone’s
business’
Continuity Integrated community and hospital services; continuity of goals and interventions.
Evaluating
Hypothesis: the SVP and its interpretation increased visibility and enabled staff and patients to evaluate process trajectory,
workload performance and outcome
Organisational strategy Understanding of the organisational importance of continence care; audit and feedback;
quality review
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Appendix 34 Qualitative assessment of clinical
sites relative to anticipated mechanisms of change
Themes
Site
AA BB CC DD EE FF GG HH JJ KK LL MM
Thinking
Hypothesis: the SVP changed hearts and minds about UI from it being a barrier to rehabilitation to a legitimate focus of
planned, therapeutic activity
BCP
Rehab
Planning
Hypothesis: the SVP made a structure for UI care explicit, enhancing consistent, knowledge-based delivery
DL
K&S
Clin Geog
Doing
Hypothesis: the SVP helped staff to make the shift from an organisational approach to continence that was haphazard,
routine and selective to one that promoted regularity, inclusion and individualised management)
Routine
Int Work
Continuity
Evaluating
Hypothesis: the SVP and its interpretation increased visibility and enabled staff and patients to evaluate process, trajectory,
workload performance and outcome
Org Strat
BCP, continence being important; Clin Geog, synergy between environment and clinical work; Continuity, integrated
services around continence; DL, multiple people leading continence issues; Int Work, integrated working around
continence; K&S, co-ordinated approaches to education and training; Org Strat, organisational importance attached to
continence; Rehab, continence as outcome of rehabilitation; Routine, regularised approaches to managing continence.
Blue shading: no evidence to support the hypothesis.
Light green shading: some evidence to support the hypothesis.
Dark green shading: strong evidence to support the hypothesis.
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Appendix 35 Evidence to support hypotheses
from normalisation process theory
SVP
Main mechanism Submechanisms Proxy outcomes Evidence of effect
Thinking
Hypothesis: the SVP changed hearts and minds about UI from it being a barrier to rehabilitation to a legitimate
focus of planned, therapeutic activity
Changed perceptions: UI, role
It’s made us mini specialists
(H3.1)
Incontinence role
(nursing)
Increased nursing
knowledge and skill
Positive
The staff are more focused on promoting
continence as opposed to other things
being potentially more important
(F1.2)
Therapeutic
potential
Increased priority/
attention
Positive in
rehabilitation
settings
It’s made people realise that continence is
important, it’s not a nice thing for the
patient to go through
(E1.15)
Changed attitude:
guilt, pride
Positive
It’s increased the interest and knowledge
of the HCAs: it’s not just a job, they are
more aware of why they’re doing it
(E4.19)
Role change Present for HCAs
only
Staff have been going over to the acute
unit to the MDT meeting to pull patients
through, but continence is
never mentioned
(E4.25)
Continence is something that a nurse
now expects to be asked about, or expects
to share in the multidisciplinary team
ward rounds
(F1.18)
More nursing input
to MDT
Negative
Planning
Hypothesis: the SVP made a structure for UI care explicit, enhancing consistent, knowledge-based delivery
Logical structure
Most patients now go on the program,
it’s embedded, part and parcel of
stroke practice
(E1.19)
Codifying and
embedding
People receiving
UI care
Positive
The programme was more structured and
there was more consistency in the way
they were timed
(K3.4)
Consistency Less variation Positive
You couldn’t get your jobs done, you
couldn’t organise your work because you
are constantly with them (incontinent
patients)
(B2.13)
We work as an organised team
(A2.11)
Organisation Fewer system
failures
Some people fell
outside structure
or were trapped
within it
It got better just by communicating between
each other, making sure everyone’s aware
how to fill the forms out
(L4.10)
Communication More continence
talk
Positive
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SVP
Main mechanism Submechanisms Proxy outcomes Evidence of effect
Doing
Hypothesis: the SVP helped staff to make the shift from an organisational approach to continence that was
haphazard, routine and selective to one that promoted regularity, inclusion and individualised management
Changed clinical work
In some ways it helped all the ones that
were more cognitively impaired . . .
Who are quiet and withdrawn and don’t
demand attention – it gives them attention
(F4.7)
ICONS has formalised continence care, and
individualised it. We are treating the
patient as an individual
(E1.18)
Selection Different patients
receiving care
Negative
It means we’re not taking incontinence for
granted, it’s highlighted the need to
assess patients
(E4.2)
Diagnosis Differentiated/
correct care
Positive
ICONS is much more regimental and rigid,
whereas before things could be forgotten,
perhaps we didn’t toilet regularly
(L4.1)
Routine More care regularity Positive
We did ICONS with him and persevered
and by the end of his stay he
was continent
(B2.7)
Perseverance Sustained delivery Positive
With the time management, people are
talking about that with each other
and planning
(C1.15)
‘Different talking’ Positive
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Appendix 36 Barriers and facilitators to
systematic voiding programme implementation
Barriers, difficulties Facilitators, suggestions
Can people see how the new practice differs?
Routine and documentation seen as different Some sites had regular toileting in place
Do people agree with the new practice?
Extra work and paperwork influences agreement
Assessment was disliked
SVP seen as unsuitable for some patient groups
Being able to see benefit influences agreement
Having enough staff influences agreement
Do people understand what the new practice requires of them?
Some staff groups might not understand fully
Some components of the SVP misinterpreted
Explaining the SVP to relatives was difficult
SVP seen as logical and thorough
The SVP was easily understood, made sense
Most patients accepted/understood the SVP
Structured plans could help patients understand
Do people see the potential value of the new practice?
Added work was unpopular SVP seen to increase priority of continence
Incontinence seen as amenable to change
Rebalances control between staff and patient
Continence control signals recovery to patient
Increase nurse therapeutic role
Gives nursing care structure and guidance
Cuts workload in the long run
Who are the key individuals driving the new practice forward?
Lack of staff member driving programme Senior staff seen as key to driving the new practice
Management style facilitated involvement
Availability of support facilitated involvement
Proactive senior staff nurses played a key role
Research nurse identified as a valuable resource
ICONS HCAs promoted the programme
Some help provided by external facilitation
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Barriers, difficulties Facilitators, suggestions
Do people agree that the new practice should be part of their work?
It took time to get people on board and motivated
Paperwork remained a significant barrier
Some staff remained resistant
Therapists were not involved
Fear of extending hospital stay blocks involvement
Enjoyment and reducing work helped staff engage
Involvement showed not much extra work required
Seeing that SVP can be done facilitated involvement
Experience of success facilitated involvement
Therapists did accommodate SVP in daily routine
Do people organise themselves to undertake the work required by the new practice?
Role responsibilities need sorting out
Do people work together to build the procedures needed to sustain the new practice?
Symbols on whiteboard and bedboard
SVP status included on handover sheet
Night staff help to put paperwork out
Use of care clocks as a reminder system
Reminder notes in diary for weekly reviews
Rationalise overlap in paperwork
Co-ordinating function of paperwork valuable
Other information resources valuable
Can people do what the new practice requires?
Extra work: physical and cognitive Needs reminders to run smoothly
Maintaining surveillance for screening Use 3-day diary as blanket screening
Remembering/managing stages over time
Keeping track of SVP progress overall
Hard to remember who is on SVP
Flexibility for change in health status
Using whiteboards and handover
Monitoring by nominated person
Difficulties with diary completion
Assessment disliked – too long
Weekly review can be misunderstood or forgotten
Suggest not using diaries in acute areas
Shorten time of diary completion
Schedule weekly reviews at weekend
Timing difficult to schedule, remember, adhere to
Staff did not know how to record refusal, accidents
Ambulant patients hard to monitor
Daily logs and fluid balance charts overlap
Staff did not know how to stop the programme
Patient completion of 7-day diary useful
Enrol patients to remind staff
Merge SVP timing with intentional rounding
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Barriers, difficulties Facilitators, suggestions
Distraction/delay challenging for staff and patient
Repeatedly asking about wetness disliked
Some patients dislike regular prompting
Regular toileting difficult for certain patients
Some patient groups thought unsuitable for SVP
Use methods to encourage participation and avoid confusion
Are people confident in each other’s work and expertise?
Challenging to individualise care on a busy ward
Some staff required ongoing monitoring
Hard to maintain focus against competing priorities
Adverse impact on ward relationships
Continuity between acute and rehabilitation areas
Increased confidence in managing continence
Positive impact on interaction between staff
Improved liaison with therapists
Increased nursing input to MDT meetings
Do people have the right skills and training?
Skill deficits in continence management
SVP relatively difficult to learn at first
Staff would have liked more training
Problems with timing training and implementation
Poor take up of online training
Training for bank or new staff needs maintaining
Suggest more training
Suggest use of cascade training methods
Suggest gradual lead in to implementation
Improved skill in continence management
Educational resources were useful
Nominate staff for specific roles
Is the new practice adequately supported and resourced?
Inadequate staffing or sickness
Poor delivery impacts on staff morale
Problems with use of bank staff
Equipment or space could be lacking
Extra staff facilitated consistent care
Support from trust to protect staffing
Staff liked the bladder scanner
Can people determine the effects of the new practice?
Senior staff found the SVP hard to monitor
There is a lack of paperwork for continence
Visible success is important for motivation
Feedback from the family was influential
External stakeholders require evaluation
Do people agree about the worth of the new practice?
Benefits for patients are recognised
Benefits for staff are recognised
Extra staff also impact on wider aspects of care
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Barriers, difficulties Facilitators, suggestions
Do people think it is worth doing?
Staffing levels would affect continuation
Paperwork would affect continuation
The programme structure is motivating
Do people make changes to the new practice?
Need for a co-ordinator in the early stages
Do an initial roll out to senior staff first
Have a longer interval between training and start
Change training to full day course
Provide visual aids for people with aphasia
Focus on patients likely to succeed
Extend programme to night-time
Simplify the assessment
Design a care plan for recording
Provide symbols for boards, badges for ICONS HCAs
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